PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hypponen, E; Leon, DA; Kenward, MG; Lithell, H				Hypponen, E; Leon, DA; Kenward, MG; Lithell, H			Prenatal growth and risk of occlusive and haemorrhagic stroke in Swedish men and women born 1915-29: historical cohort study	BRITISH MEDICAL JOURNAL			English	Article							SYSTOLIC BLOOD-PRESSURE		Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; Inst Child Hlth, Dept Paediat Epidemiol & Biostat, London WC1N 1EH, England; Univ Uppsala, Dept Publ Hlth & Caring Sci, SE-75125 Uppsala, Sweden	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Uppsala University	Leon, DA (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.		Leon, David A/G-2195-2010; Hypponen, Elina/B-2596-2014	Leon, David A/0000-0001-9747-1762; Hypponen, Elina/0000-0003-3670-9399				Eriksson JG, 2000, STROKE, V31, P869, DOI 10.1161/01.STR.31.4.869; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Leon DA, 2000, AM J EPIDEMIOL, V152, P597, DOI 10.1093/aje/152.7.597; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; *NAT BOARD HLTH WE, HOSP DISCH REG	5	46	46	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 3	2001	323	7320					1033	1034		10.1136/bmj.323.7320.1033	http://dx.doi.org/10.1136/bmj.323.7320.1033			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MP	11691760	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000172055900016
J	Janssen, C				Janssen, C			Does symmetry drive isotopic anomalies in ozone isotopomer formation?	SCIENCE			English	Editorial Material							RATE COEFFICIENTS		Max Planck Inst Kernphys, Atmospher Phys Div, D-69029 Heidelberg, Germany	Max Planck Society	Janssen, C (corresponding author), Max Planck Inst Kernphys, Atmospher Phys Div, POB 103980, D-69029 Heidelberg, Germany.		Janssen, Christof/A-1867-2012	Janssen, Christof/0000-0003-1131-5385				Anderson SM, 1997, J CHEM PHYS, V107, P5385, DOI 10.1063/1.474247; ANDERSON SM, 1989, CHEM PHYS LETT, V156, P175, DOI 10.1016/S0009-2614(89)87115-5; Gao YQ, 2001, SCIENCE, V293, P259, DOI 10.1126/science.1058528; Hathorn BC, 2000, J CHEM PHYS, V113, P9497, DOI 10.1063/1.1321045; HEIDENREICH JE, 1986, J CHEM PHYS, V84, P2129, DOI 10.1063/1.450373; Janssen C, 1999, J CHEM PHYS, V111, P7179, DOI 10.1063/1.480045; JANSSEN C, IN PRESS PHYS CHEM C; MAUERSBERGER K, 1993, GEOPHYS RES LETT, V20, P1031, DOI 10.1029/93GL01080; Mauersberger K, 1999, SCIENCE, V283, P370, DOI 10.1126/science.283.5400.370; Thiemens MH, 2001, SCIENCE, V293, P226, DOI 10.1126/science.1063648	10	16	16	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					951A	951A		10.1126/science.294.5544.951a	http://dx.doi.org/10.1126/science.294.5544.951a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691954				2022-12-28	WOS:000172013800001
J	Scales, SJ; Finley, MFA; Scheller, RH				Scales, SJ; Finley, MFA; Scheller, RH			Cell biology - Fusion without SNAREs?	SCIENCE			English	Editorial Material							MEMBRANE-FUSION; SYNAPTOBREVIN; DROSOPHILA; SYNTAXIN; COMPLEX		Genentech Inc, S San Francisco, CA 94080 USA; Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Roche Holding; Genentech; Stanford University	Scales, SJ (corresponding author), Genentech Inc, S San Francisco, CA 94080 USA.		Sharkey, Thomas D/B-4032-2009; Oka, Yoshitaka/C-9670-2010; Scales, Suzie J./H-4507-2019	Sharkey, Thomas D/0000-0002-4423-3223; Oka, Yoshitaka/0000-0002-3482-3051; Scales, Suzie J./0000-0003-2544-0283; Finley, Michael/0000-0002-5547-5519				Adolfsen B, 2001, CELL MOL LIFE SCI, V58, P393, DOI 10.1007/PL00000865; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; Chen YA, 2001, NEURON, V30, P161, DOI 10.1016/S0896-6273(01)00270-7; Coco S, 1999, J NEUROSCI, V19, P9803; Deitcher DL, 1998, J NEUROSCI, V18, P2028; Nonet ML, 1998, J NEUROSCI, V18, P70; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Sudhof TC, 2001, SYNAPSES, P177; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649	16	17	19	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1015	1016		10.1126/science.1066728	http://dx.doi.org/10.1126/science.1066728			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691976				2022-12-28	WOS:000172013800032
J	Scholes, RJ; Noble, IR				Scholes, RJ; Noble, IR			Climate change - Storing carbon on land	SCIENCE			English	Editorial Material									CSIR, Div Water Environm & Forest Technol, ZA-0001 Pretoria, South Africa; Cooperat Res Ctr Greenhouse Accounting, Canberra, ACT, Australia	Council for Scientific & Industrial Research (CSIR) - South Africa	Scholes, RJ (corresponding author), CSIR, Div Water Environm & Forest Technol, Box 395, ZA-0001 Pretoria, South Africa.	bscholes@csir.co.za; ian.noble@greenhouse.crc.org.au		Scholes, Robert/0000-0001-5537-6935				Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; Caspersen JP, 2000, SCIENCE, V290, P1148, DOI 10.1126/science.290.5494.1148; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Orr JC, 2001, GLOBAL BIOGEOCHEM CY, V15, P43, DOI 10.1029/2000GB001273; Pacala SW, 2001, SCIENCE, V292, P2316, DOI 10.1126/science.1057320; PRENTICE IC, 2001, IPCC 3 ASS REP, V1, P183; SCHIMEL DS, IN PRESS NATURE; Schlesinger WH, 2001, NATURE, V411, P466, DOI 10.1038/35078060; WATSON RT, 2000, IPCC SPECIAL REPORT, P12	9	76	97	3	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2001	294	5544					1012	1013		10.1126/science.1065307	http://dx.doi.org/10.1126/science.1065307			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691975				2022-12-28	WOS:000172013800031
J	Huang, Q; Liu, DY; Majewski, P; Schulte, LC; Korn, JM; Young, RA; Lander, ES; Hacohen, N				Huang, Q; Liu, DY; Majewski, P; Schulte, LC; Korn, JM; Young, RA; Lander, ES; Hacohen, N			The plasticity of dendritic cell responses to pathogens and their components	SCIENCE			English	Article							T-HELPER CELL; GENE-EXPRESSION; SURFACE EXPRESSION; CANDIDA-ALBICANS; IMMUNITY; DIFFERENTIATION; MATURATION; MIGRATION; PATTERNS	Dendritic cells are involved in the initiation of both innate and adaptive immunity. To systematically explore how dendritic cells modulate the immune system in response to different pathogens, we used oligonucleotide microarrays to measure gene expression profiles of dendritic cells in response to Escherichia coli, Candida albicans, and influenza virus as well as to their molecular components. Both a shared core response and pathogen-specific programs of gene expression were observed upon exposure to each of these pathogens. These results reveal that dendritic cells sense diverse pathogens and elicit tailored pathogen-specific immune responses.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Whitehead Inst, Ctr Genome Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Hacohen, N (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	hacohen@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; ASHMAN RB, 1995, MICROBIOL REV, V59, P646, DOI 10.1128/MMBR.59.4.646-672.1995; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BHARDWAJ N, 1994, J CLIN INVEST, V94, P797, DOI 10.1172/JCI117399; Braun MC, 2000, J IMMUNOL, V164, P3009, DOI 10.4049/jimmunol.164.6.3009; Cella M, 1999, J EXP MED, V189, P821, DOI 10.1084/jem.189.5.821; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; Dietz AB, 2000, BIOCHEM BIOPH RES CO, V275, P731, DOI 10.1006/bbrc.2000.3372; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hashimoto S, 2000, BLOOD, V96, P2206, DOI 10.1182/blood.V96.6.2206.h8002206_2206_2214; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HUANG Q, UNPUB; Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Ludwig S, 1999, VIRAL IMMUNOL, V12, P175, DOI 10.1089/vim.1999.12.175; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Milstien S, 1996, J BIOL CHEM, V271, P19743, DOI 10.1074/jbc.271.33.19743; Murphy G, 1999, CURR OPIN CELL BIOL, V11, P614, DOI 10.1016/S0955-0674(99)00022-8; O'Reilly LA, 1999, INFLAMM RES, V48, P5, DOI 10.1007/s000110050369; Rescigno M, 1998, P NATL ACAD SCI USA, V95, P5229, DOI 10.1073/pnas.95.9.5229; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Sallusto F, 1999, EUR J IMMUNOL, V29, P1617, DOI 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3; Sousa CRE, 2001, IMMUNITY, V14, P495; Sousa CRE, 1999, CURR OPIN IMMUNOL, V11, P392, DOI 10.1016/S0952-7915(99)80066-1; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wenger RH, 2000, J EXP BIOL, V203, P1253	30	619	646	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					870	875		10.1126/science.294.5543.870	http://dx.doi.org/10.1126/science.294.5543.870			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679675				2022-12-28	WOS:000171851800052
J	Mange, KC; Cherikh, WS; Maghirang, J; Bloom, RD				Mange, KC; Cherikh, WS; Maghirang, J; Bloom, RD			A comparison of the survival of shipped and locally transplanted cadaveric renal allografts.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the American-Society-of-Transplantation	MAY 12-16, 2001	CHICAGO, ILLINOIS	Amer Soc Transplantat			KIDNEY-TRANSPLANTS; MODELS	Background: The effect on allograft survival of the shipment of cadaveric renal allografts from one organ-procurement organization to another is uncertain. Methods: Using data from the Organ Procurement and Transplantation Network of the United Network for Organ Sharing, we identified 5446 pairs of cadaveric kidneys (10,892 allografts) in which one kidney was shipped and the other was transplanted locally. We compared the risk of graft failure using statistical models that accounted for confounding variables, including the degree of HLA mismatching. Results: After adjustment for the degree of HLA mismatching, shipped organs had a significantly higher rate of allograft failure than locally transplanted organs in the first year after transplantation (adjusted hazard ratio, 1.17; 95 percent confidence interval, 1.05 to 1.31; P=0.004), but not thereafter. An association between the shipment of organs with no HLA mismatches and allograft failure was not confirmed. Conclusions: The shipment of cadaveric renal allografts increases the risk of failure of HLA-mismatched grafts during the first year after transplantation.	Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Hosp Univ Penn, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; United Network Organ Sharing, Dept Res, Richmond, VA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; United Network for Organ Sharing	Mange, KC (corresponding author), 700 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.							Collett D, 1994, MODELLING SURVIVAL D; COX DR, 1972, J R STAT SOC B, V34, P187; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; HELD PJ, 1994, NEW ENGL J MED, V331, P765, DOI 10.1056/NEJM199409223311203; Kouwenhoven EA, 2001, KIDNEY INT, V59, P1142; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Serrick C, 1997, ANN THORAC SURG, V63, P202; Shackleton CR, 1998, TRANSPLANT P, V30, P4264, DOI 10.1016/S0041-1345(98)01408-0; TAKEMOTO S, 1992, NEW ENGL J MED, V327, P834, DOI 10.1056/NEJM199209173271202; Takemoto SK, 2000, NEW ENGL J MED, V343, P1078, DOI 10.1056/NEJM200010123431504; [No title captured]	11	33	33	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2001	345	17					1237	1242		10.1056/NEJMoa010793	http://dx.doi.org/10.1056/NEJMoa010793			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485RU	11680443				2022-12-28	WOS:000171773100003
J	Billuart, P; Winter, CG; Maresh, A; Zhao, XS; Luo, LQ				Billuart, P; Winter, CG; Maresh, A; Zhao, XS; Luo, LQ			Regulating axon branch stability: The role of p190 RhoGAP in repressing a retraction signaling pathway	CELL			English	Article							LONG-TERM POTENTIATION; NUCLEOTIDE EXCHANGE FACTOR; GTPASE-ACTIVATING PROTEIN; LINKED MENTAL-RETARDATION; C-SRC; ACTIN CYTOSKELETON; NEUROBLAST PROLIFERATION; NEURONAL MORPHOGENESIS; MUSHROOM BODIES; CELL-ADHESION	Mechanisms that regulate axon branch stability are largely unknown. Genome-wide analyses of Rho GTPase activating protein (RhoGAP) function in Drosophila using RNA interference identified p190 RhoGAP as essential for axon stability in mushroom body neurons, the olfactory learning and memory center. p190 inactivation leads to axon branch retraction, a phenotype mimicked by activation of GTPase RhoA and its effector kinase Drok and modulated by the level and phosphorylation of myosin regulatory light chain. Thus, there exists a retraction pathway from RhoA to myosin in maturing neurons, which is normally repressed by p190. Local regulation of p190 could control the structural plasticity of neurons. Indeed, genetic evidence supports negative regulation of p190 by integrin and Src, both implicated in neural plasticity.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Luo, LQ (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	lluo@stanford.edu	Billuart, Pierre/K-3832-2017; Zhao, Xuesong/B-2762-2012	Billuart, Pierre/0000-0003-1913-1687; Zhao, Xuesong/0000-0003-3007-7124; Luo, Liqun/0000-0001-5467-9264	NINDS NIH HHS [R01-NS 36632] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGNEL M, 1992, MOL CELL BIOL, V12, P5111, DOI 10.1128/MCB.12.11.5111; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bernstein M, 1999, CURR OPIN NEUROBIOL, V9, P364, DOI 10.1016/S0959-4388(99)80053-1; Beumer KJ, 1999, DEVELOPMENT, V126, P5833; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bonini NM, 1997, DEVELOPMENT, V124, P4819; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brouns MR, 2000, DEVELOPMENT, V127, P4891; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; BUNCH TA, 1992, GENETICS, V132, P519; Burbelo PD, 1995, J BIOL CHEM, V270, P30919, DOI 10.1074/jbc.270.52.30919; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Dodson GS, 1998, DEVELOPMENT, V125, P2883; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Haskell MD, 2001, J CELL SCI, V114, P1699; Heisenberg M, 1998, LEARN MEMORY, V5, P1; HU HL, 2001, IN PRESS NEURON; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Ito K, 1997, DEVELOPMENT, V124, P761; Jordan P, 1997, J CELL BIOL, V139, P1805, DOI 10.1083/jcb.139.7.1805; Jullien-Flores V, 2000, J CELL SCI, V113, P2837; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kojima N, 1997, P NATL ACAD SCI USA, V94, P4761, DOI 10.1073/pnas.94.9.4761; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Li R, 1997, J BIOL CHEM, V272, P32830, DOI 10.1074/jbc.272.52.32830; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Nakahara H, 1998, J BIOL CHEM, V273, P9, DOI 10.1074/jbc.273.1.9; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Rohrbough J, 2000, J NEUROSCI, V20, P6868, DOI 10.1523/JNEUROSCI.20-18-06868.2000; Roof RW, 2000, FEBS LETT, V472, P117, DOI 10.1016/S0014-5793(00)01439-3; Roof RW, 1998, MOL CELL BIOL, V18, P7052, DOI 10.1128/MCB.18.12.7052; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sagnier T, 2000, MECH DEVELOP, V94, P267, DOI 10.1016/S0925-4773(00)00291-4; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sharma SV, 1998, ONCOGENE, V17, P271, DOI 10.1038/sj.onc.1201921; Sotillos S, 2000, DEVELOPMENT, V127, P5427; Staubli U, 1998, J NEUROSCI, V18, P3460; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tatsis N, 1998, J BIOL CHEM, V273, P34631, DOI 10.1074/jbc.273.51.34631; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WILDER EL, 1995, DEVELOPMENT, V121, P477; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Wong WT, 2000, J NEUROSCI, V20, P5024	73	171	174	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					195	207		10.1016/S0092-8674(01)00522-0	http://dx.doi.org/10.1016/S0092-8674(01)00522-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672527	Bronze			2022-12-28	WOS:000171694800009
J	Schaefer, M; Petronczki, M; Dorner, D; Forte, M; Knoblich, JA				Schaefer, M; Petronczki, M; Dorner, D; Forte, M; Knoblich, JA			Heterotrimeric G proteins direct two modes of asymmetric cell division in the Drosophila nervous system	CELL			English	Article							NEURAL PRECURSOR GENE; ELEGANS EMBRYOS; SUBUNIT GENE; LOCALIZATION; PROSPERO; MELANOGASTER; NEUROBLASTS; BAZOOKA; ORIENTATION; SEGREGATION	In Drosophila, distinct mechanisms orient asymmetric cell division along the apical-basal axis in neuroblasts and along the anterior-posterior axis in sensory organ precursor (SOP) cells. Here, we show that heterotrimeric G proteins are essential for asymmetric cell division in both cell types. The G protein subunit G alphai localizes apically in neuroblasts and anteriorly in SOP cells before and during mitosis. Interfering with G protein function by G alphai overexpression or depletion of heterotrimeric G protein complexes causes defects in spindle orientation and asymmetric localization of determinants. G alphai is colocalized and associated with Pins, a protein that induces the release of the beta gamma subunit and might act as a receptor-independent G protein activator. Thus, asymmetric activation of heterotrimeric G proteins by a receptor-independent mechanism may orient asymmetric cell divisions in different cell types.	Res Inst Mol Pathol, IMP, A-1030 Vienna, Austria; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97212 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Oregon Health & Science University	Knoblich, JA (corresponding author), Res Inst Mol Pathol, IMP, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	knoblich@nt.imp.univie.ac.at	Matthias, Schaefer Ronald/E-9157-2015; Knoblich, Juergen A/C-2974-2015	Matthias, Schaefer Ronald/0000-0003-1952-8115; Knoblich, Juergen A/0000-0002-6751-3404; Petronczki, Mark/0000-0003-0139-5692				BRAND AH, 1993, DEVELOPMENT, V118, P401; BRAND M, 1993, DEVELOPMENT, V119, P1; Broadus J, 1997, CURR BIOL, V7, P827, DOI 10.1016/S0960-9822(06)00370-8; Chant T, 1999, ANNU REV CELL DEV BI, V15, P365, DOI 10.1146/annurev.cellbio.15.1.365; CHOU TB, 1992, GENETICS, V131, P643; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; DOLPH PJ, 1994, NATURE, V370, P59, DOI 10.1038/370059a0; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Jones KH, 1996, GENETICS, V142, P205; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Kraut R, 1996, DEV BIOL, V174, P65, DOI 10.1006/dbio.1996.0052; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; MASTERS SB, 1989, J BIOL CHEM, V264, P15467; Mochizuki N, 1996, GENE, V181, P39, DOI 10.1016/S0378-1119(96)00456-8; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Nern A, 2000, J CELL BIOL, V148, P1115, DOI 10.1083/jcb.148.6.1115; Newsome TP, 2000, DEVELOPMENT, V127, P851; Offermanns S, 2001, ONCOGENE, V20, P1635, DOI 10.1038/sj.onc.1204189; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; PROVOST NM, 1988, J BIOL CHEM, V263, P12070; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; SCHUPBACH T, 1989, GENETICS, V121, P101; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; SPANA EP, 1995, DEVELOPMENT, V121, P3187; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; THAMBI NC, 1989, J BIOL CHEM, V264, P18552; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; YARFITZ S, 1991, NEURON, V7, P429, DOI 10.1016/0896-6273(91)90295-B; YARFITZ S, 1988, P NATL ACAD SCI USA, V85, P7134, DOI 10.1073/pnas.85.19.7134; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	48	258	264	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2001	107	2					183	194		10.1016/S0092-8674(01)00521-9	http://dx.doi.org/10.1016/S0092-8674(01)00521-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672526	Bronze			2022-12-28	WOS:000171694800008
J	Vaziri, H; Dessain, SK; Eagon, EN; Imai, SI; Frye, RA; Pandita, TK; Guarente, L; Weinberg, RA				Vaziri, H; Dessain, SK; Eagon, EN; Imai, SI; Frye, RA; Pandita, TK; Guarente, L; Weinberg, RA			hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase	CELL			English	Article							HUMAN-DIPLOID FIBROBLASTS; DNA-DAMAGE; IONIZING-RADIATION; SILENCING PROTEIN; STRAND BREAKS; SIR2 PROTEIN; CELL-LINES; PHOSPHORYLATION; ACTIVATION; ACETYLATION	DNA damage-induced acetylation of p53 protein leads to its activation and either growth arrest or apoptosis. We show here that the protein product of the gene hSIR2(SIRT1), the human homolog of the S. cerevisiae Sir2 protein known to be involved in cell aging and in the response to DNA damage, binds and deacetylates the p53 protein with a specificity for its C-terminal Lys382 residue, modification of which has been implicated in the activation of p53 as a transcription factor. Expression of wild-type hSir2 in human cells reduces the transcriptional activity of p53. In contrast, expression of a catalytically inactive hSir2 protein potentiates p53-dependent apoptosis and radiosensitivity. We propose that hSir2 is involved in the regulation of p53 function via deacetylation.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA; Vet Adm Med Ctr, Pittsburgh, PA 15240 USA; Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Columbia University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Massachusetts General Hospital	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Pandita, Tej K/AAM-9188-2020		NCI NIH HHS [R01 CA78461] Funding Source: Medline; NHLBI NIH HHS [K08HL04463] Funding Source: Medline; NINDS NIH HHS [NS34746] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078461] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL004463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034746] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abraham J, 2000, J MOL BIOL, V295, P853, DOI 10.1006/jmbi.1999.3415; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Dhar S, 2000, MOL CELL BIOL, V20, P7764, DOI 10.1128/MCB.20.20.7764-7772.2000; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guarente L, 1999, NAT GENET, V23, P281, DOI 10.1038/15458; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; Liu L, 1999, MOL CELL BIOL, V19, P1202; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; McAinsh AD, 1999, CURR BIOL, V9, P963, DOI 10.1016/S0960-9822(99)80424-2; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; MITSUDOMI T, 1992, ONCOGENE, V7, P171; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Shieh SY, 2000, GENE DEV, V14, P289; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; TSANG NM, 1995, ONCOGENE, V10, P2403; Vaziri H, 1997, EMBO J, V16, P6018, DOI 10.1093/emboj/16.19.6018; Vaziri H, 1999, MOL CELL BIOL, V19, P2373; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675	34	2136	2263	5	157	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					149	159		10.1016/S0092-8674(01)00527-X	http://dx.doi.org/10.1016/S0092-8674(01)00527-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672523	Bronze			2022-12-28	WOS:000171694800005
J	Bowie, C				Bowie, C			Was the paper I wrote a fraud?	BRITISH MEDICAL JOURNAL			English	Editorial Material																		WILLIAMS MH, 1993, BMJ-BRIT MED J, V306, P95, DOI 10.1136/bmj.306.6870.95	1	8	8	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 6	1998	316	7146					1755	1756		10.1136/bmj.316.7146.1755a	http://dx.doi.org/10.1136/bmj.316.7146.1755a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZT806	11682718				2022-12-28	WOS:000074129500087
J	Bodine, SC; Latres, E; Baumhueter, S; Lai, VKM; Nunez, L; Clarke, BA; Poueymirou, WT; Panaro, FJ; Na, EQ; Dharmarajan, K; Pan, ZQ; Valenzuela, DM; DeChiara, TM; Stitt, TN; Yancopoulos, GD; Glass, DJ				Bodine, SC; Latres, E; Baumhueter, S; Lai, VKM; Nunez, L; Clarke, BA; Poueymirou, WT; Panaro, FJ; Na, EQ; Dharmarajan, K; Pan, ZQ; Valenzuela, DM; DeChiara, TM; Stitt, TN; Yancopoulos, GD; Glass, DJ			Identification of ubiquitin ligases required for skeletal muscle atrophy	SCIENCE			English	Article							PROTEIN-TURNOVER; FINGER; FAMILY; RING	Skeletal muscle adapts to decreases in activity and load by undergoing atrophy. To identify candidate molecular mediators of muscle atrophy, we performed transcript profiling. Although many genes were up-regulated in a single rat model of atrophy, only a small subset was universal in all atrophy models. Two of these genes encode ubiquitin ligases: Muscle RING Finger 1 (MuRF1), and a gene we designate Muscle Atrophy F-box (MAFbx), the latter being a member of the SCF family of E3 ubiquitin ligases. Overexpression of MAFbx in myotubes produced atrophy, whereas mice deficient in either MAFbx or MuRF1 were found to be resistant to atrophy. These proteins are potential drug targets for the treatment of muscle atrophy.	Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; Appl Biosyst Inc, Foster City, CA 94404 USA; Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA	Regeneron; Thermo Fisher Scientific; Applied Biosystems; Icahn School of Medicine at Mount Sinai	Glass, DJ (corresponding author), Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	david.glass@regeneron.com	Panaro, Fabrizio/Q-1355-2017; Glass, David/AAI-3910-2021; Xia, Xianfeng/F-9169-2011; Glass, David/C-4782-2012	Glass, David/0000-0001-6187-4164; Bodine, Sue/0000-0002-5742-9145				BAINS W, 1984, MOL CELL BIOL, V4, P1449, DOI 10.1128/MCB.4.8.1449; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448; Chen A, 2000, J BIOL CHEM, V275, P15432, DOI 10.1074/jbc.M907300199; Cooney RN, 1997, SHOCK, V7, P1, DOI 10.1097/00024382-199701000-00001; DECHIARA TM, UNPUB; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; GOLDBERG AL, 1969, J BIOL CHEM, V244, P3223; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; JOAEIRO CA, 2000, CELL, V102, P549; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Lisztwan J, 1998, EMBO J, V17, P368, DOI 10.1093/emboj/17.2.368; NUNEZ L, UNPUB; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; THOMASON DB, 1987, J APPL PHYSIOL, V63, P130, DOI 10.1152/jappl.1987.63.1.130; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4	19	2469	2597	13	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2001	294	5547					1704	1708		10.1126/science.1065874	http://dx.doi.org/10.1126/science.1065874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11679633				2022-12-28	WOS:000172307400041
J	Banks, I				Banks, I			No man's land: men, illness, and the NHS	BRITISH MEDICAL JOURNAL			English	Article									European Mens Hlth Forum, London WC1H 9JP, England		Banks, I (corresponding author), European Mens Hlth Forum, London WC1H 9JP, England.							BIDDULPH M, 2001, MOVING GOALPOSTS SET; Courtenay W. H., 2002, International Journal of Men's Health, V1, P281, DOI 10.3149/jmh.0103.281; FRANCOME G, 2000, IMPROVING MENS HLTH, P6; GOOD GE, 1989, J COUNS PSYCHOL, V36, P295, DOI 10.1037/0022-0167.36.3.295; JEWELL D, 2001, PROMOTING MENS HLTH, P151; KIRBY MG, 1999, MENS HLTH, P321; LLOYD T, 2000, PROMOTING MENS HLTH, P3; MARTIN RM, 2001, NATL STAT Q, V9, P29; McClure GMG, 2001, BRIT J PSYCHIAT, V178, P469, DOI 10.1192/bjp.178.5.469; White AK, 2000, J CLIN NURS, V9, P534, DOI 10.1046/j.1365-2702.2000.00413.x; WILKE G, 2001, BEING GOOD ENOUGH GP	11	140	143	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 3	2001	323	7320					1058	1060		10.1136/bmj.323.7320.1058	http://dx.doi.org/10.1136/bmj.323.7320.1058			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	490MP	11691768	Green Published			2022-12-28	WOS:000172055900025
J	Rakic, P				Rakic, P			Neurobiology - Neurocreationism - Making new cortical maps	SCIENCE			English	Editorial Material							PRIMATE VISUAL-CORTEX; AREA IDENTITY; SPECIFICATION; NEOCORTEX; ABSENCE		Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA	Yale University	Rakic, P (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06520 USA.							ALLMAN JM, 1971, BRAIN RES, V31, P85, DOI 10.1016/0006-8993(71)90635-4; ARIMATSU Y, 1992, P NATL ACAD SCI USA, V89, P8879, DOI 10.1073/pnas.89.19.8879; BARBE MF, 1991, J NEUROSCI, V11, P519; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; CREUTZFELDT OD, 1977, NATURWISSENSCHAFTEN, V64, P507, DOI 10.1007/BF00483547; CROSSLEY PH, IN PRESS NEUROSCIENC; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Gitton Y, 1999, J NEUROSCI, V19, P4889; KULJIS RO, 1990, P NATL ACAD SCI USA, V87, P5303, DOI 10.1073/pnas.87.14.5303; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1991, P NATL ACAD SCI USA, V88, P2083, DOI 10.1073/pnas.88.6.2083; Rubenstein JLR, 1999, CEREB CORTEX, V9, P521, DOI 10.1093/cercor/9.6.521; Sestan N, 2001, CURR BIOL, V11, P39, DOI 10.1016/S0960-9822(00)00043-9; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834	17	14	15	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1011	1012		10.1126/science.294.5544.1011	http://dx.doi.org/10.1126/science.294.5544.1011			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691974				2022-12-28	WOS:000172013800030
J	Mechsner, F; Kerzel, D; Knoblich, G; Prinz, W				Mechsner, F; Kerzel, D; Knoblich, G; Prinz, W			Perceptual basis of bimanual coordination	NATURE			English	Article							INTERLIMB COORDINATION; MOVEMENT PATTERNS; DYNAMICS; CONSTRAINTS; TRANSITIONS; MODEL; PHASE	Periodic bimanual movements are often the focus of studies of the basic organizational principles of human actions(1-25). In such movements there is a typical spontaneous tendency towards mirror symmetry. Even involuntary slips from asymmetrical movement patterns into symmetry occur, but not vice versa. Traditionally, this phenomenon has been interpreted as a tendency towards co-activation of homologous muscles, probably originating in motoric neuronal structures. Here we provide evidence contrary to this widespread assumption. We show for two prominent experimental models-bimanual finger oscillation(1) and bimanual four-finger tapping(2)-that the symmetry bias is actually towards spatial, perceptual symmetry, without regard to the muscles involved. We suggest that spontaneous coordination phenomena of this kind are purely perceptual in nature. In the case of a bimanual circling model, our findings reveal that highly complex, even 'impossible' movements can easily be performed with only simple visual feedback. A 'motoric' representation of the performed perceptual oscillation patterns is not necessary. Thus there is no need to translate such a 'motoric' into a 'perceptual' representation or vice versa, using 'internal models' (ref. 29). We suggest that voluntary movements are organized by way of a representation of the perceptual goals, whereas the corresponding motor activity, of sometimes high complexity, is spontaneously and flexibly tuned in.	Max Planck Inst Psychol Res, Dept Cognit & Act, D-80799 Munich, Germany	Max Planck Society	Mechsner, F (corresponding author), Max Planck Inst Psychol Res, Dept Cognit & Act, Amalienstr 33, D-80799 Munich, Germany.	mechsner@mpipf-muenchen.mpg.de	Knoblich, Günther/C-9465-2012; Galantucci, Bruno/E-5770-2010	Knoblich, Gunther/0000-0003-4463-5318				Amazeen PG, 1998, J MOTOR BEHAV, V30, P199, DOI 10.1080/00222899809601337; BALDISSERA F, 1982, NEUROSCI LETT, V34, P95, DOI 10.1016/0304-3940(82)90098-2; BUCHANAN JJ, 1993, EXP BRAIN RES, V94, P131; CARSON RG, 1995, EXP BRAIN RES, V105, P465; Carson RG, 1997, Q J EXP PSYCHOL-A, V50, P664, DOI 10.1080/027249897392062; Cattaert D, 1999, BIOL CYBERN, V81, P343, DOI 10.1007/s004220050567; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; HAKEN H, 1996, PRINCIPLES BRAIN FUN, DOI [10.1007/978-3-642-79570-1_11, DOI 10.1007/978-3-642-79570-1_11]; HEUER H, 1993, PSYCHOL RES-PSYCH FO, V55, P83, DOI 10.1007/BF00419639; Johnson KA, 1998, BRAIN, V121, P743, DOI 10.1093/brain/121.4.743; Jordan Michael I., 1995, P597; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; KELSO JAS, 1991, EXP BRAIN RES, V85, P432; KELSO JAS, 1994, HUM MOVEMENT SCI, V13, P393, DOI 10.1016/0167-9457(94)90047-7; Kelso JAS, 2001, P ROY SOC B-BIOL SCI, V268, P1207; Kelso S., 1995, DYNAMIC PATTERNS SEL; Lee TD, 1996, PSYCHOL RES-PSYCH FO, V59, P100, DOI 10.1007/BF01792431; Park H, 2001, J EXP PSYCHOL HUMAN, V27, P32, DOI 10.1037/0096-1523.27.1.32; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Riek S, 1992, J HUM MOVEMENT STUD, V23, P251; Riley MA, 2001, AM J PSYCHOL, V114, P160, DOI 10.2307/1423388; Saltzman E., 1995, MIND MOTION DYNAMICS, P149; Schmidt R. A., 1982, HUMAN MOTOR BEHAV IN, P189; SCHOLZ JP, 1989, J MOTOR BEHAV, V21, P122; SEMJEN A, 1995, J EXP PSYCHOL HUMAN, V21, P1139, DOI 10.1037/0096-1523.21.5.1139; Sternad D, 2000, HUM MOVEMENT SCI, V19, P407, DOI 10.1016/S0167-9457(00)00024-5; Swinnen SP, 1998, BEHAV BRAIN RES, V90, P79, DOI 10.1016/S0166-4328(97)00083-1; Swinnen SP, 1997, J COGNITIVE NEUROSCI, V9, P348, DOI 10.1162/jocn.1997.9.3.348; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Zaal FTJM, 2000, J EXP PSYCHOL HUMAN, V26, P1209, DOI 10.1037//0096-1523.26.3.1209	30	460	464	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					69	73		10.1038/35102060	http://dx.doi.org/10.1038/35102060			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487VC	11689944				2022-12-28	WOS:000171898900043
J	Warren, MS; Hill, JK; Thomas, JA; Asher, J; Fox, R; Huntley, B; Roy, DB; Telfer, MG; Jeffcoate, S; Harding, P; Jeffcoate, G; Willis, SG; Greatorex-Davies, JN; Moss, D; Thomas, CD				Warren, MS; Hill, JK; Thomas, JA; Asher, J; Fox, R; Huntley, B; Roy, DB; Telfer, MG; Jeffcoate, S; Harding, P; Jeffcoate, G; Willis, SG; Greatorex-Davies, JN; Moss, D; Thomas, CD			Rapid responses of British butterflies to opposing forces of climate and habitat change	NATURE			English	Article							AVAILABILITY; DIVERSITY; ABUNDANCE; RANGES	Habitat degradation and climate change are thought to be altering the distributions and abundances of animals and plants throughout the world, but their combined impacts have not been assessed for any species assemblage(1-4). Here we evaluated changes in the distribution sizes and abundances of 46 species of butterflies that approach their northern climatic range margins in Britain-where changes in climate and habitat are opposing forces. These insects might be expected to have responded positively to climate warming over the past 30 years, yet three-quarters of them declined: negative responses to habitat loss have outweighed positive responses to climate warming. Half of the species that were mobile and habitat generalists increased their distribution sites over this period (consistent with a climate explanation), whereas the other generalists and 89% of the habitat specialists declined in distribution size (consistent with habitat limitation). Changes in population abundances closely matched changes in distributions. The dual forces of habitat modification and climate change are likely to cause specialists to decline, leaving biological communities with reduced numbers of species and dominated by mobile and widespread habitat generalists.	Univ Leeds, Sch Biol, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England; Ctr Ecol & Hydrol, Huntingdon PE28 2LS, Cambs, England; Winfrith Technol Ctr, Dorset Lab, Ctr Ecol & Hydrol, Dorchester DT2 8ZD, England; Univ Durham, Dept Biol Sci, Environm Res Ctr, Durham DH1 3LE, England; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; Butterfly Conservat, Wareham BH20 5QP, Dorset, England	University of Leeds; UK Centre for Ecology & Hydrology (UKCEH); UK Centre for Ecology & Hydrology (UKCEH); Durham University; University of York - UK	Thomas, CD (corresponding author), Univ Leeds, Sch Biol, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England.	c.d.thomas@leeds.ac.uk	Willis, Stephen G/F-8503-2015; Thomas, Chris D/A-1460-2014; Hill, Jane K/G-5151-2011; Thomas, Chris D/A-1894-2012; Roy, David/A-6619-2009; Fox, Richard/G-3873-2011; Hill, Jane K./AAJ-3374-2021	Willis, Stephen G/0000-0002-8656-5808; Thomas, Chris D/0000-0003-2822-1334; Thomas, Chris D/0000-0003-2822-1334; Roy, David/0000-0002-5147-0331; Hill, Jane K./0000-0003-1871-7715; Fox, Richard/0000-0001-6992-3522				Asher J, 2001, MILLENNIUM ATLAS BUT; Coope G. R., 1995, P29; Cowley MJR, 1999, P ROY SOC B-BIOL SCI, V266, P1587, DOI 10.1098/rspb.1999.0819; Cowley MJR, 2001, J ANIM ECOL, V70, P410, DOI 10.1046/j.1365-2656.2001.00508.x; Dennis RLH, 1997, BIOL J LINN SOC, V60, P257, DOI 10.1006/bijl.1996.0099; Groombridge B., 1992, GLOBAL BIODIVERSITY; Heath J., 1984, ATLAS BUTTERFLIES BR; Hill Jane K., 2001, Symposia of the Royal Entomological Society of London, V20, P415, DOI 10.1079/9780851994567.0415; Hill JK, 2001, ECOL LETT, V4, P313, DOI 10.1046/j.1461-0248.2001.00222.x; Hill JK, 1999, P ROY SOC B-BIOL SCI, V266, P1197, DOI 10.1098/rspb.1999.0763; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Huntley B, 1995, J BIOGEOGR, V22, P967, DOI 10.2307/2845830; Jones Philip D., 1997, CLIMATES BRIT ISLES, P173; Leemans R., 1991, RR9118 IIASA; Maes D, 2001, BIOL CONSERV, V99, P263, DOI 10.1016/S0006-3207(00)00182-8; MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W; MOSS D, 1993, ECOL ENTOMOL, V18, P77, DOI 10.1111/j.1365-2311.1993.tb01083.x; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; POLLARD E, 1994, MONITORING BUTTERFLI; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Roy DB, 2000, GLOB CHANGE BIOL, V6, P407, DOI 10.1046/j.1365-2486.2000.00322.x; Roy DB, 2001, J ANIM ECOL, V70, P201, DOI 10.1046/j.1365-2656.2001.00480.x; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Thomas CD, 2000, P ROY SOC B-BIOL SCI, V267, P139, DOI 10.1098/rspb.2000.0978; THOMAS JA, 1994, ECOGRAPHY, V17, P215, DOI 10.1111/j.1600-0587.1994.tb00096.x; THOMAS JA, 1993, ECOGRAPHY, V16, P278, DOI 10.1111/j.1600-0587.1993.tb00217.x; Thomas JA, 1999, FUNCT ECOL, V13, P55, DOI 10.1046/j.1365-2435.1999.00008.x; Tolman T, 1997, BUTTERFLIES BRITAIN; Van Swaay C.A.M., 1999, NATURE ENV SERIES, V99	29	925	980	15	593	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					65	69		10.1038/35102054	http://dx.doi.org/10.1038/35102054			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689943				2022-12-28	WOS:000171898900042
J	Lau, NC; Lim, LP; Weinstein, EG; Bartel, DP				Lau, NC; Lim, LP; Weinstein, EG; Bartel, DP			An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans	SCIENCE			English	Article							C-ELEGANS; MESSENGER-RNA; GENE; INTERFERENCE; IDENTIFICATION; EXPRESSION; SEQUENCE	Two small temporal RNAs (stRNAs), lin-4 and let-7, control developmental timing in Caenorhabditis elegans. We find that these two regulatory RNAs are members of a large class of 21- to 24-nucleotide noncoding RNAs, called microRNAs (miRNAs). We report on 55 previously unknown miRNAs in C. elegans. The miRNAs have diverse expression patterns during development: a let-7 paralog is temporally coexpressed with let-7; miRNAs encoded in a single genomic cluster are coexpressed during embryogenesis; and still other miRNAs are expressed constitutively throughout development. Potential orthologs of several of these miRNA genes were identified in Drosophila and human genomes. The abundance of these tiny RNAs, their expression patterns, and their evolutionary conservation imply that, as a class, miRNAs have broad regulatory functions in animals.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartet@wi.mit.edu		Lau, Nelson/0000-0001-9907-1404				Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Malinsky S, 2000, GENETICS, V156, P1147; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Ratcliff FG, 1999, PLANT CELL, V11, P1207, DOI 10.1105/tpc.11.7.1207; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yang D, 2000, CURR BIOL, V10, P1191, DOI 10.1016/S0960-9822(00)00732-6; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	29	2489	2856	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					858	862		10.1126/science.1065062	http://dx.doi.org/10.1126/science.1065062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679671				2022-12-28	WOS:000171851800048
J	Gardin, JM; Weissman, NJ; Leung, C; Panza, JA; Fernicola, D; Davis, KD; Constantine, GD; Reid, CL				Gardin, JM; Weissman, NJ; Leung, C; Panza, JA; Fernicola, D; Davis, KD; Constantine, GD; Reid, CL			Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AORTIC REGURGITATION; FENFLURAMINE; PHENTERMINE; PREVALENCE; ABNORMALITIES	Context Use of anorexigen therapy is associated with valvular abnormalities, although there is limited information on long-term changes in valvular regurgitation following discontinuation of these agents. Objective To evaluate changes in valvular regurgitation, valve morphology, and clinical parameters 1 year after an initial echocardiogram in patients previously treated with dexfenfluramine or phentermine/fenfluramine and in untreated controls. Design and Setting A reader-blinded, multicenter, echocardiographic and clinical 1-year follow-up study at 25 outpatient clinical sites. Patients A total of 1142 obese patients (1466 participated in the initial study) who had follow-up echocardiogram; all but 4 had a follow-up medical history and physical examination. Follow-up time from discontinuation of drug to follow-up echocardiogram for 371 dexfenfluramine patients was 17.5 months (range, 13-26 months) and for 340 phentermine/fenfluramine patients was 18.7 months (range, 13-26 months) after discontinuation of drug therapy. Main Outcome Measure Change in grade of valvular regurgitation and valve morphology and mobility. Results Echocardiographic changes in aortic regurgitation were observed in 8 controls (7 [1.7%] had decreases; 1 [0.2%]had an increase); 29 dexfenfluramine patients (23 [6.4%] had decreases; 6 [1.7%] had increases; P<.001 vs controls); and 15 phentermine/fenfluramine patients (4.5% all decreases; P=.03 vs controls). No statistically significant differences were observed when treated patients were compared with controls for changes in medical history, physical findings, mitral regurgitation, aortic or mitral leaflet mobility or thickness, pulmonary artery systolic pressure, ejection fraction, valve surgery, or cardiovascular events. Conclusion Progression of valvular abnormalities is unlikely in patients 1 year after an initial echocardiogram and 13 to 26 months after discontinuation of dexfenfluramine and phentermine/fenfluramine.	Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; Washington Hosp Ctr, Inst Cardiovasc Res, Washington, DC 20010 USA; NHLBI, Cardiol Branch, Bethesda, MD 20892 USA; Wyeth Ayerst Res, Philadelphia, PA USA	University of California System; University of California Irvine; MedStar Washington Hospital Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Pfizer	Gardin, JM (corresponding author), St Johns Hosp, Div Cardiol, 22201 Moross Rd,BP 2,Suite 470, Detroit, MI 48236 USA.							Gardin JM, 2000, JAMA-J AM MED ASSOC, V283, P1703, DOI 10.1001/jama.283.13.1703; HELMCKE F, 1987, CIRCULATION, V75, P175, DOI 10.1161/01.CIR.75.1.175; Hensrud DD, 1999, MAYO CLIN PROC, V74, P1191, DOI 10.4065/74.12.1191; Jollis JG, 2000, CIRCULATION, V101, P2071, DOI 10.1161/01.CIR.101.17.2071; Lebowitz NE, 2000, J AM COLL CARDIOL, V36, P461, DOI 10.1016/S0735-1097(00)00744-0; MANCINI MC, 1999, INT J OBES RELAT MET, V23, pS178; Mast ST, 2001, ANN INTERN MED, V134, P261, DOI 10.7326/0003-4819-134-4-200102200-00008; PERRY GJ, 1987, J AM COLL CARDIOL, V9, P952, DOI 10.1016/S0735-1097(87)80254-1; Ryan DH, 1999, OBES RES, V7, P313, DOI 10.1002/j.1550-8528.1999.tb00414.x; Shively BK, 1999, CIRCULATION, V100, P2161, DOI 10.1161/01.CIR.100.21.2161; WALLER BF, 1982, AM J CARDIOL, V49, P473, DOI 10.1016/0002-9149(82)90527-6; Weissman NJ, 2001, ANN INTERN MED, V134, P267, DOI 10.7326/0003-4819-134-4-200102200-00009	12	24	24	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2001	286	16					2011	2014		10.1001/jama.286.16.2011	http://dx.doi.org/10.1001/jama.286.16.2011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485JD	11667938	Bronze			2022-12-28	WOS:000171750500025
J	Fellay, J; Boubaker, K; Ledergerber, B; Bernasconi, E; Furrer, H; Battegay, M; Hirschel, B; Vernazza, P; Francioli, P; Greub, G; Flepp, M; Telenti, A				Fellay, J; Boubaker, K; Ledergerber, B; Bernasconi, E; Furrer, H; Battegay, M; Hirschel, B; Vernazza, P; Francioli, P; Greub, G; Flepp, M; Telenti, A		Swiss HIV Cohort Study	Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study	LANCET			English	Article							PROTEASE INHIBITORS; THERAPY; LIPODYSTROPHY	Background Data on adverse events to antiretroviral treatment have been recorded in clinical trials, postmarketing analyses, and anecdotal reports. Such data might not be an up-to-date or comprehensive assessment of all possible treatment combinations defined as potent antiretroviral treatment. Methods Using a standard clinical and laboratory method, we assessed prevalence of adverse events in 1160 patients who were receiving antiretroviral treatment. We measured the toxic effects associated with the drug regimen (protease inhibitor [PI], non-nucleoside and nucleoside analogue reverse transcriptase inhibitor) and specific compounds using multivariate analyses. Findings 47% (545 of 1160) of patients presented with clinical and 27% (194 of 712) with laboratory adverse events probably or definitely attributed to antiretroviral treatment. Among these, 9% (47 of 545) and 16% (30 of 194), respectively, were graded as serious or severe. Single-PI and PI-sparing-antiretroviral treatment were associated with a comparable prevalence of adverse events. Compared with single-PI treatment, use of dual-PI-antiretroviral treatment and three-class-antiretroviral treatment was associated with higher prevalence of adverse events (odds ratio [OR] 2.0 [95% CI 1.0-4.0], and 3.9 [1.2-12.9], respectively). Compound specific associations were identified for zidovudine, lamivudine, stavudine, didanosine, abacavir, ritonavir, saquinavir, indinavir, nelfinavir, efavirenz, and nevirapine. Interpretation We recorded a high prevalence of toxic effects attributed to antiretroviral treatment for HIV-1. Such data provides a reference for regimen-specific and compound-specific adverse events and could be useful in postmarketing analyses of toxic effects.	Univ Lausanne Hosp, Lausanne, Switzerland; Univ Zurich Hosp, CH-8091 Zurich, Switzerland; Univ Hosp Bern, CH-3010 Bern, Switzerland; Univ Basel Hosp, CH-4031 Basel, Switzerland; Univ Hosp Geneva, Geneva, Switzerland; Hosp Lugano, Lugano, Switzerland; Hosp St Gallen, St Gallen, Switzerland; Swiss HIV Cohort Study Data Ctr, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern; University of Basel; University of Geneva; Kantonsspital St. Gallen	Telenti, A (corresponding author), Univ Lausanne, CHU Vaudois, Div Infect Dis, CH-1011 Lausanne, Switzerland.	amalio.telenti@chuv.hospvd.ch	Fellay, Jacques/A-6681-2009; Telenti, Amalio/AAY-1674-2021; Greub, Gilbert GG/K-5804-2017; Ledergerber, Bruno/B-5656-2009; Furrer, Hansjakob/G-6768-2013; VALLET, Yannick/F-9979-2011	Fellay, Jacques/0000-0002-8240-939X; Greub, Gilbert GG/0000-0001-9529-3317; Ledergerber, Bruno/0000-0002-6881-4401; Furrer, Hansjakob/0000-0002-1375-3146; 				BERGMANN JF, 1993, BRIT MED J, V307, P1397, DOI 10.1136/bmj.307.6916.1397; Blake M, 2000, CLIN INFECT DIS, V30, pS96, DOI 10.1086/313859; BOUBAKER K, IN PRESS CLIN INFECT; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; Clarke S, 2000, INT J STD AIDS, V11, P336, DOI 10.1258/0956462001915831; Flexner C, 1998, NEW ENGL J MED, V338, P1281, DOI 10.1056/NEJM199804303381808; Hansel A, 2001, J ACQ IMMUN DEF SYND, V26, P191, DOI 10.1097/00126334-200102010-00016; Henry K, 2000, ANN INTERN MED, V132, P306, DOI 10.7326/0003-4819-132-4-200002150-00009; Hurst M, 1999, DRUGS, V58, P919, DOI 10.2165/00003495-199958050-00012; LAMBERT JS, 1990, NEW ENGL J MED, V322, P1333, DOI 10.1056/NEJM199005103221901; Martinez E, 2001, LANCET, V357, P592, DOI 10.1016/S0140-6736(00)04056-3; MCLEOD GX, 1992, ANN INTERN MED, V117, P487, DOI 10.7326/0003-4819-117-6-487; PIKE IM, 1993, CLIN INFECT DIS, V16, pS63, DOI 10.1093/clinids/16.Supplement_1.S63; Saint-Marc T, 1999, AIDS, V13, P1659, DOI 10.1097/00002030-199909100-00009; Struble Kimberly A., 1997, American Journal of Medicine, V102, P65, DOI 10.1016/S0002-9343(97)00065-X; SUDRE P, 2001, SCHWEIZ MED WOCHENSC, V130, P500	17	240	251	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2001	358	9290					1322	1327		10.1016/S0140-6736(01)06413-3	http://dx.doi.org/10.1016/S0140-6736(01)06413-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684213				2022-12-28	WOS:000171702500012
J	Pollock, MA; Sturrock, A; Marshall, K; Davidson, KM; Kelly, CJG; McMahon, AD; McLaren, EH				Pollock, MA; Sturrock, A; Marshall, K; Davidson, KM; Kelly, CJG; McMahon, AD; McLaren, EH			Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial	BRITISH MEDICAL JOURNAL			English	Article							BIOCHEMICALLY EUTHYROID PATIENTS	Objectives To determine whether thyroxine treatment is effective in patients with symptoms of hypothyroidism but with thyroid function tests within the reference range, and to investigate the effect of thyroxine treatment on psychological and physical Wellbeing in healthy participants. Design Randomised double blind placebo controlled crossover trial. Setting Outpatient clinic in a general hospital. Participants 25 patients with symptoms of hypothyroidism who had thyroid function tests within the reference range, and 19 controls. Methods Participants were given thyroxine 100 mug or placebo to take once a day for 12 weeks. Washout period was six weeks. They were then given the other to take once a day for 12 weeks. All participants were assessed physiologically and psychologically at baseline and on completion of each phase. Main outcome measures Thyroid function tests, measures of cognitive function and of psychological and physical wellbeing. Results 22 patients and 19 healthy controls completed the study. At baseline, patients' scores on 9 out of 15 psychological measures were impaired when compared with controls. Patients showed a significantly greater response to placebo than controls in 3 out of 15 psychological measures. Healthy participants had significantly lower scores for vitality when taking thyroxine compared to placebo (mean (SD) 60 (17) v 73 (16), P < 0.01). However, patients' scores from psychological tests when taking thyroxine were no different from those when taking placebo except for a poorer performance on one visual reproduction test when taking thyroxine. Serum concentrations of free thyroxine increased and those of thyroid stimulating hormone decreased in patients and controls while they were taking thyroxine, confirming compliance with treatment. Although serum concentrations of free triioclothyronine increased in patients and controls taking thyroxine, the difference between the response to placebo and to thyroxine was significant only in the controls. Conclusions Thyroxine was no more effective than placebo in improving cognitive function and psychological wellbeing in patients with symptoms of hypothyroidism but thyroid function tests within the reference range. Thyroxine did not improve cognitive function and psychological wellbeing in healthy participants.	Stobhill Hosp, Dept Clin Biochem, Glasgow G21 3UW, Lanark, Scotland; Stobhill Hosp, Dept Med, Glasgow G21 3UW, Lanark, Scotland; Gartnavel Royal Hosp, Dept Psychol Med, Glasgow G12 0XH, Lanark, Scotland; Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland	Gartnavel Royal Hospital; University of Glasgow	Pollock, MA (corresponding author), Stobhill Hosp, Dept Clin Biochem, Glasgow G21 3UW, Lanark, Scotland.							BECKWITH BC, 1998, MED NEUROPSYCHOLOGY; DENICOFF KD, 1990, AM J PSYCHIAT, V147, P94; HOLMES D, 1998, TEARS CLOSED DOORS; McLaren EH, 1997, BRIT MED J, V315, P1463, DOI 10.1136/bmj.315.7120.1463; OSTERWEIL D, 1992, J AM GERIATR SOC, V40, P325, DOI 10.1111/j.1532-5415.1992.tb02130.x; Reitan R.M., 1966, INT REV RES MENTAL R; Skinner G. R. B., 2000, Journal of Nutritional and Environmental Medicine (Abingdon), V10, P115, DOI 10.1080/13590840050043530; Skinner GRB, 1997, BRIT MED J, V314, P1764, DOI 10.1136/bmj.314.7096.1764; WARE JE, 1997, SF36 HLTH SURVEY MAN; Wechsler D., 1945, WECHSLER MEMORY SCAL; Williams G, 1997, BRIT MED J, V315, P814; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	12	64	67	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 20	2001	323	7318					891	895		10.1136/bmj.323.7318.891	http://dx.doi.org/10.1136/bmj.323.7318.891			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486BH	11668132	Green Published, Green Accepted			2022-12-28	WOS:000171798200016
J	Suri, R; Metcalfe, C; Lees, B; Grieve, R; Flather, M; Normand, C; Thompson, S; Bush, A; Wallis, C				Suri, R; Metcalfe, C; Lees, B; Grieve, R; Flather, M; Normand, C; Thompson, S; Bush, A; Wallis, C			Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial	LANCET			English	Article							HUMAN DNASE-I; MUCOCILIARY CLEARANCE; PULMONARY-FUNCTION; EFFICACY; SAFETY	Background Daily recombinant human deoxyribonuclease (rhDNase) is an established but expensive treatment in cystic fibrosis. Alternate-day treatment, if equally effective, would reduce the drug cost. Hypertonic saline improved lung function to the same degree as rhDNase in short-term studies. We compared the effectiveness of daily rhDNase, hypertonic saline, and alternate-day rhDNase in children with cystic fibrosis. Methods In an open cross-over trial, 48 children were allocated in random order to 12 weeks of once-daily rhDNase (2.5 mg), alternate-day rhDNase (2.5 mg), and twice-daily 5 mL 7% hypertonic saline. The primary outcome was forced expiratory volume in 1 s (FEV1). Secondary outcomes were forced vital capacity, number of pulmonary exacerbations, weight gain, quality of life, exercise tolerance, and the total costs of hospital and community care. Findings Mean FEV1 increased by 16% (SD 25%), 14% (22%), and 3% (21%) with daily rhDNase, alternate-day rhDNase, and hypertonic saline, respectively. There was no difference between daily and alternate-day rhDNase (2% [95% Cl -4 to 9], p=0.55). However, daily rhDNase showed a significantly greater increase in FEV, than hypertonic saline (8% [2 to 14], p=0.01). The average difference in 12-week cost between daily and alternate-day rhDNase was pound 513 (95% Cl -546 to 1510) and that between daily rhDNase and hypertonic saline was pound 1409 (440 to 2318). None of the secondary clinical outcomes showed significant differences between treatments. Interpretation Hypertonic saline, delivered by jet nebuliser, is not as effective as daily rhDNase, although there is variation in individual response. There is no evidence of a difference between daily and alternate-day rhDNase.	Great Ormond St Hosp Sick Children, Resp Unit, London WC1N 3JH, England; Royal Brompton & Harefield NHS Trust, Dept Resp Paediat, London, England; Royal Brompton & Harefield NHS Trust, Clin Trials & Evaluat Unit, London, England; Univ Bristol, Dept Social Med, Bristol, Avon, England; London Sch Hyg & Trop Med, London WC1, England; MRC, Biostat Unit, Inst Publ Hlth, Cambridge CB2 2BW, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; MRC Biostatistics Unit; University of Cambridge	Suri, R (corresponding author), Great Ormond St Hosp Sick Children, Resp Unit, 6th Floor,Cardiac Wing, London WC1N 3JH, England.	suriranjan@hotmail.com		Normand, Charles/0000-0002-0885-5754; Grieve, Richard/0000-0001-8899-1301; Metcalfe, Chris/0000-0001-8318-8907				ADAMS L, 1985, CLIN SCI, V69, P7, DOI 10.1042/cs0690007; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Balfour-Lynn IM, 1998, PEDIATR PULM, V25, P278, DOI 10.1002/(SICI)1099-0496(199804)25:4<278::AID-PPUL8>3.0.CO;2-G; BALLMANN M, 1998, PEDIAT PULMONOL S17, V26, P343; *BRIT MED ASS ROY, 1999, BRIT NAT FORM, V38; CHERNICK WS, 1959, PEDIATRICS, V24, P739; COOPER PJ, 1990, PEDIATR PULM, V8, P16, DOI 10.1002/ppul.1950080107; Davies J, 1997, PEDIATR PULM, V23, P243, DOI 10.1002/(SICI)1099-0496(199704)23:4<243::AID-PPUL1>3.0.CO;2-N; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Drummond MF, 2015, METHODS EC EVALUATIO; Eng PA, 1996, PEDIATR PULM, V21, P77, DOI 10.1002/(SICI)1099-0496(199602)21:2<77::AID-PPUL3>3.0.CO;2-M; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Geddes DM, 1999, LANCET, V353, P1727, DOI 10.1016/S0140-6736(98)00411-5; Gift A G, 1989, Rehabil Nurs, V14, P323; Gold MR, 1996, COST EFFECTIVENESS H; Netten A, 1999, UNIT COSTS HLTH SOCI; ORENSTEIN DM, 1989, CHEST, V95, P344, DOI 10.1378/chest.95.2.344; Polgar G, 1971, PULMONARY FUNCTION T; RAMSEY BW, 1994, PEDIATR PULM, V17, P404, DOI 10.1002/ppul.1950170613; RAMSEY BW, 1993, AM REV RESPIR DIS, V148, P145, DOI 10.1164/ajrccm/148.1.145; RANASINHA C, 1993, LANCET, V342, P199, DOI 10.1016/0140-6736(93)92297-7; Riedler J, 1996, J PAEDIATR CHILD H, V32, P48, DOI 10.1111/j.1440-1754.1996.tb01541.x; Robinson M, 1996, AM J RESP CRIT CARE, V153, P1503, DOI 10.1164/ajrccm.153.5.8630593; Robinson M, 1997, THORAX, V52, P900, DOI 10.1136/thx.52.10.900; SHAK S, 1990, P NATL ACAD SCI USA, V87, P9188, DOI 10.1073/pnas.87.23.9188; SMITH G, 1986, J ADOLESCENT HEALTH, V7, P134, DOI 10.1016/S0197-0070(86)80009-2; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197	29	116	120	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2001	358	9290					1316	1321		10.1016/S0140-6736(01)06412-1	http://dx.doi.org/10.1016/S0140-6736(01)06412-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684212				2022-12-28	WOS:000171702500011
J	Auer, S; Frenkel, D				Auer, S; Frenkel, D			Suppression of crystal nucleation in polydisperse colloids due to increase of the surface free energy	NATURE			English	Article							HARD; CRYSTALLIZATION; SUSPENSIONS	The formation of small crystallites is governed by two competing factors: the free energy gained upon transferring constituent atoms, molecules or colloidal particles from the metastable liquid to the more stable solid, and the free energy needed to create the surface area of the crystallite(1). Because the ratio of surface area to bulk is large for small particles, small crystallites dissolve spontaneously under conditions where larger crystallites are stable and macroscopic crystal growth occurs only if spontaneously formed crystallites exceed a critical minimum size. On theoretical grounds(1), the probability of forming such critical crystal nuclei is expected to increase rapidly with supersaturation. However, experiments show(1,2) that the rate of crystal nucleation in many systems goes through a maximum as the supersaturation is increased. It is commonly assumed that the nucleation rate peaks because, even though the probability of forming critical nuclei increases with increasing concentration, the rate of growth of such nuclei decreases. Here we report simulations of crystal nucleation in suspensions of colloidal spheres with varying size distributions that show that the probability that critical nuclei will form itself goes through a maximum as the supersaturation is increased. We rnd that this effect, which is strongest for systems with the broadest particle size distribution, results from an increase with supersaturation of the solid-liquid interfacial free energy. The magnitude of this effect suggests that vitrification at high supersaturations should yield colloidal glasses that are truly amorphous, rather than nano-crystalline.	FOM, Inst Atom & Mol Phys, NL-1098 SJ Amsterdam, Netherlands	AMOLF	Frenkel, D (corresponding author), FOM, Inst Atom & Mol Phys, Kruislaan 407, NL-1098 SJ Amsterdam, Netherlands.	Frenkel@amolf.nl	Frenkel, Daan/G-2580-2014; Auer, Stefan/F-8395-2011	Frenkel, Daan/0000-0002-6362-2021; 				Auer S, 2001, NATURE, V409, P1020, DOI 10.1038/35059035; Gasser U, 2001, SCIENCE, V292, P258, DOI 10.1126/science.1058457; Harland JL, 1997, PHYS REV E, V55, P3054, DOI 10.1103/PhysRevE.55.3054; KELTON KF, 1991, SOLID STATE PHYS, V45, P75; Kofke DA, 1999, PHYS REV E, V59, P618, DOI 10.1103/PhysRevE.59.618; OXTOBY DW, 1994, J CHEM PHYS, V100, P7665, DOI 10.1063/1.466859; Palberg T, 1999, J PHYS-CONDENS MAT, V11, pR323, DOI 10.1088/0953-8984/11/28/201; PUSEY PN, 1986, NATURE, V320, P340, DOI 10.1038/320340a0; PUSEY PN, 1991, LES HOUCH S, V51, P763; SHI FG, 1995, APPL PHYS LETT, V67, P350, DOI 10.1063/1.115441; tenWolde PR, 1997, SCIENCE, V277, P1975, DOI 10.1126/science.277.5334.1975; TENWOLDE PR, 1995, PHYS REV LETT, V75, P2714, DOI 10.1103/PhysRevLett.75.2714; Van Duijneveldt J. S., 1995, SCI TECHNOLOGY CRYST, P279; Zhu JX, 1997, NATURE, V387, P883, DOI 10.1038/43141	14	328	332	4	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					711	713		10.1038/35099513	http://dx.doi.org/10.1038/35099513			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607025	Green Published			2022-12-28	WOS:000171608000037
J	Djerassi, C				Djerassi, C			Who will mentor the mentors?	NATURE			English	Editorial Material									Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Djerassi, C (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.							ALTOM J, 1998, NY TIMES SUNDAY 1129; ALTOM J, 1998, NATURE, V395, P826	2	10	10	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 28	1999	397	6717					291	291		10.1038/16786	http://dx.doi.org/10.1038/16786			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162BE	11645137	Bronze			2022-12-28	WOS:000078324600020
J	Power, L				Power, L			Trial subjects must be fully involved in design and approval of trials	BRITISH MEDICAL JOURNAL			English	Article									Terrence Higgins Trust, London WC1X 8JU, England		Power, L (corresponding author), Terrence Higgins Trust, London WC1X 8JU, England.								0	6	6	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 28	1998	316	7136					1003	1004						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZF034	11645040				2022-12-28	WOS:000072856100032
J	[Anonymous]				[Anonymous]			The Nuremberg Code	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	50	51	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	1996	276	20					1691	1691						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VU209	11644854				2022-12-28	WOS:A1996VU20900040
J	BENATAR, SR				BENATAR, SR			AN ALTERNATIVE TO ACADEMIC BOYCOTT	NATURE			English	Editorial Material									GROOTE SCHUUR HOSP,CAPE TOWN 7925,SOUTH AFRICA	University of Cape Town	BENATAR, SR (corresponding author), UNIV CAPE TOWN,DEPT MED,CAPE TOWN 7925,SOUTH AFRICA.							BENATAR SR, 1985, HASTINGS CTR REP S S, V3; BUNDY C, 1988, HUMAN RIGHTS S AFRIC; CRAWSHAW R, 1989, JAMA-J AM MED ASSOC, V262, P1499; EDSALL JT, 1975, SCIENCE, V188, P687, DOI 10.1126/science.11643270; KATES RW, 1978, SCIENCE, V201, P502, DOI 10.1126/science.201.4355.502; MOGOBA S, 1988, SANCTIONS ALTERNATIV; OWEN CP, 1989, NATIONAL MED DENTAL; 1977, COUNCIL SCI SOC SCHO; 1986, STATEMENT ACADEMIC S	9	9	9	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	FEB 8	1990	343	6258					505	506		10.1038/343505a0	http://dx.doi.org/10.1038/343505a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM830	11642754				2022-12-28	WOS:A1990CM83000034
J	Groszer, M; Erickson, R; Scripture-Adams, DD; Lesche, R; Trumpp, A; Zack, JA; Kornblum, HI; Liu, X; Wu, H				Groszer, M; Erickson, R; Scripture-Adams, DD; Lesche, R; Trumpp, A; Zack, JA; Kornblum, HI; Liu, X; Wu, H			Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; EMBRYONIC-DEVELOPMENT; MICE LACKING; STEM-CELLS; ACTIVATION; GENERATION; SURVIVAL; NEURONS; PROTEIN; DIFFERENTIATION	The mechanisms controlling neural stem cell proliferation are poorly understood. Here we demonstrate that the PTEN tumor suppressor plays an important role in regulating neural stem/progenitor cells in vivo and in vitro. Mice lacking PTEN exhibited enlarged, histoarchitecturally abnormal brains, which resulted from increased cell proliferation, decreased cell death, and enlarged cell size. Neurosphere cultures revealed a greater proliferation capacity for tripotent Pten(-/-) central nervous system stem/progenitor cells, which can be attributed, at Least in part, to a shortened cell cycle. However, cell fate commitments of the progenitors were largely undisturbed. Our results suggest that PTEN negatively regulates neural stem cell proliferation.	Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, AIDS Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Microbiol & Mol Genet, Los Angeles, CA 90095 USA; Inst Suisse Rech Expt Canc, CH-1066 Epalinges, Switzerland	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Liu, X (corresponding author), Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	xliu@mednet.ucla.edu; hwu@mednet.ucla.edu	Trumpp, Andreas/Z-2141-2019	Trumpp, Andreas/0000-0002-6212-3466; Groszer, Matthias/0000-0002-6209-305X; Scripture-Adams, Deirdre/0000-0002-3676-1771	NICHD NIH HHS [U54 HD087101] Funding Source: Medline; NIMH NIH HHS [MH062800-01] Funding Source: Medline; NINDS NIH HHS [NS38489] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH062800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038489] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bates B, 1999, NAT NEUROSCI, V2, P115, DOI 10.1038/5669; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Fazekas de St Groth B, 1999, IMMUNOL CELL BIOL, V77, P530; Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4; Gimm O, 2000, HUM MOL GENET, V9, P1633, DOI 10.1093/hmg/9.11.1633; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; LEE EYHP, 1994, GENE DEV, V8, P2008, DOI 10.1101/gad.8.17.2008; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Luukko K, 1999, MECH DEVELOP, V83, P187, DOI 10.1016/S0925-4773(99)00050-7; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Morrison SJ, 2000, NEURON, V28, P1, DOI 10.1016/S0896-6273(00)00075-1; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; TAKAHASHI T, 1992, J NEUROCYTOL, V21, P185, DOI 10.1007/BF01194977; Takahashi T, 1999, J NEUROSCI, V19, P10357; Tropepe V, 1997, J NEUROSCI, V17, P7850	24	634	673	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2001	294	5549					2186	2189		10.1126/science.1065518	http://dx.doi.org/10.1126/science.1065518			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11691952				2022-12-28	WOS:000172647700057
J	Barry, MJ; Roehrborn, CG				Barry, MJ; Roehrborn, CG			Extracts from "Clinical Evidence" - Benign prostatic hyperplasia	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ACUTE URINARY RETENTION; TRANSURETHRAL MICROWAVE THERMOTHERAPY; RANDOMIZED CONTROLLED-TRIAL; SUSTAINED-RELEASE ALFUZOSIN; NATURAL-HISTORY; DOUBLE-BLIND; LASER-ABLATION; FOLLOW-UP; SEXUAL FUNCTION; RESECTION		Massachusetts Gen Hosp, Med Practices Evaluat Ctr, Gen Med Unit, Boston, MA 02114 USA; Univ Texas, SW Med Ctr, Dept Urol, Dallas, TX 75235 USA	Harvard University; Massachusetts General Hospital; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Roehrborn, CG (corresponding author), Massachusetts Gen Hosp, Med Practices Evaluat Ctr, Gen Med Unit, Boston, MA 02114 USA.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ahmed M, 1997, BRIT J UROL, V79, P181, DOI 10.1046/j.1464-410X.1997.02667.x; Andersen JT, 1997, UROLOGY, V49, P839, DOI 10.1016/S0090-4295(97)00185-4; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Barry MJ, 1997, J UROLOGY, V157, P10, DOI 10.1016/S0022-5347(01)65267-4; Barry MJ, 1998, 4 INT CONSULTATION B, P265; BOSCH JLHR, 1995, UROLOGY, V46, P34; Boyle P, 1996, UROLOGY, V48, P398, DOI 10.1016/S0090-4295(96)00353-6; Boyle P, 2000, UROLOGY, V55, P533, DOI 10.1016/S0090-4295(99)00593-2; Bruskewitz R, 1998, J UROLOGY, V159, P1588, DOI 10.1097/00005392-199805000-00048; Carter A, 1999, BJU INT, V83, P254; Clifford GM, 2000, EUR UROL, V38, P2, DOI 10.1159/000020246; COWLES RS, 1995, UROLOGY, V46, P155, DOI 10.1016/S0090-4295(99)80185-X; D'Ancona FCH, 1998, BRIT J UROL, V81, P259; Debruyne FMJ, 1998, EUR UROL, V34, P169, DOI 10.1159/000019706; Djavan B, 1999, J UROLOGY, V161, P139, DOI 10.1016/S0022-5347(01)62084-6; Djavan B, 1999, EUR UROL, V36, P1, DOI 10.1159/000019919; Donovan JL, 2000, J UROLOGY, V164, P65, DOI 10.1016/S0022-5347(05)67450-2; Flanigan RC, 1998, J UROLOGY, V160, P12, DOI 10.1016/S0022-5347(01)63011-8; Fourcade RO, 2000, PROG UROL, V10, P246; Francisca EAE, 1999, J UROLOGY, V161, P486, DOI 10.1016/S0022-5347(01)61930-X; Gallucci M, 1998, EUR UROL, V33, P359, DOI 10.1159/000019616; Gujral S, 2000, J UROLOGY, V164, P59, DOI 10.1016/S0022-5347(05)67449-6; Hammadeh MY, 1998, EUR UROL, V34, P188, DOI 10.1159/000019710; Hofner K, 1999, EUR UROL, V36, P335, DOI 10.1159/000019996; Jacobsen SJ, 1996, J UROLOGY, V155, P595, DOI 10.1016/S0022-5347(01)66461-9; Jacobsen SJ, 1997, J UROLOGY, V158, P481, DOI 10.1016/S0022-5347(01)64508-7; KABALIN JN, 1995, J UROLOGY, V153, P94, DOI 10.1097/00005392-199501000-00033; Kaplan S, 2000, UROLOGY, V56, P610, DOI 10.1016/S0090-4295(00)00724-X; Kaplan SA, 1996, UROLOGY, V48, P541, DOI 10.1016/S0090-4295(96)00242-7; Kaplan SA, 1998, J UROLOGY, V159, P454, DOI 10.1016/S0022-5347(01)63947-8; Keoghane SR, 2000, BJU INT, V85, P74, DOI 10.1046/j.1464-410x.2000.00407.x; Kupeli B, 1998, J ENDOUROL, V12, P591, DOI 10.1089/end.1998.12.591; Kupeli S, 1998, EUR UROL, V34, P15, DOI 10.1159/000019671; Larson TR, 1998, UROLOGY, V51, P731, DOI 10.1016/S0090-4295(97)00710-3; Lepor H, 1996, NEW ENGL J MED, V335, P533, DOI 10.1056/NEJM199608223350801; LUYAO GL, 1994, UROLOGY, V44, P692, DOI 10.1016/S0090-4295(94)80208-4; MacDonald R, 2000, BJU INT, V85, P836, DOI 10.1046/j.1464-410x.2000.00365.x; McAllister WJ, 2000, BJU INT, V85, P437, DOI 10.1046/j.1464-410x.2000.00439.x; McConnell JD, 1998, NEW ENGL J MED, V338, P557, DOI 10.1056/NEJM199802263380901; MCCONNELL JD, 1994, BENIGN PROSTATIC HYP, P91; McNeill SA, 1999, BJU INT, V84, P622; Mobley DF, 1998, CLIN THER, V20, P101, DOI 10.1016/S0149-2918(98)80038-6; Na YJ, 1998, J MED, V29, P289; OISHI K, 1998, 4 INT CONSULTATION B, P23; Okada H, 2000, BJU INT, V85, P676, DOI 10.1046/j.1464-410x.2000.00608.x; RIEHMANN M, 1995, UROLOGY, V45, P768, DOI 10.1016/S0090-4295(99)80081-8; Roehrborn CG, 1999, UROLOGY, V54, P662, DOI 10.1016/S0090-4295(99)00232-0; Roehrborn CG, 2000, EUR UROL, V37, P528, DOI 10.1159/000020189; Roehrborn CG, 1999, UROLOGY, V53, P473, DOI 10.1016/S0090-4295(98)00654-2; Roehrborn CG, 1996, UROLOGY, V47, P159, DOI 10.1016/S0090-4295(99)80409-9; Roehrborn CG, 1998, UROLOGY, V51, P19, DOI 10.1016/S0090-4295(98)00051-X; Shingleton WB, 1999, UROLOGY, V54, P1017, DOI 10.1016/S0090-4295(99)00319-2; Shokeir AA, 1997, BRIT J UROL, V80, P570, DOI 10.1046/j.1464-410X.1997.00428.x; Tuhkanen K, 1999, SCAND J UROL NEPHROL, V33, P31; WASSON JH, 1995, NEW ENGL J MED, V332, P75, DOI 10.1056/NEJM199501123320202; WILT T, 2000, COCHRANE DATABASE SY; Wilt TJ, 1999, BJU INT, V83, P976	57	42	42	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2001	323	7320					1042	1046		10.1136/bmj.323.7320.1042	http://dx.doi.org/10.1136/bmj.323.7320.1042			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MP	11691764	Green Published			2022-12-28	WOS:000172055900021
J	Pyne, SJ				Pyne, SJ			The fires this time, and next	SCIENCE			English	Editorial Material									Arizona State Univ, Dept Biol, Biol & Soc Program, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Pyne, SJ (corresponding author), Arizona State Univ, Dept Biol, Biol & Soc Program, Tempe, AZ 85287 USA.								0	39	40	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1005	1006		10.1126/science.1064989	http://dx.doi.org/10.1126/science.1064989			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691972				2022-12-28	WOS:000172013800026
J	Archibald, JD; Averianov, AO; Ekdale, EG				Archibald, JD; Averianov, AO; Ekdale, EG			Late Cretaceous relatives of rabbits, rodents, and other extant eutherian mammals	NATURE			English	Article							EVOLUTIONARY; MONGOLIA; ORIGINS	Extant eutherian mammals and their most recent common ancestor constitute the crown group Placentalia. This taxon, plus all extinct taxa that share a more recent common ancestor with placentals than they do with Metatheria (including marsupials), constitute Eutheria(1). The oldest well documented eutherian-dominated fauna in the world is Dzharakuduk, Uzbekistan(2). Among eutherians that it yields is Kulbeckia, an 85-90-Myr-old member of Zalambdalestidae (a family of Late Cretaceous Asian eutherians)(3). This extends Zalambdalestidae back by some 10 million years from sites in the Gobi Desert, Mongolia(4). A phylogenetic analysis of well described Late Cretaceous eutherians strongly supports Zalambdalestidae, less strongly supports 'Zhelestidae' (a Late Cretaceous clade related to Tertiary ungulates), but does not support Asioryctitheria (a group of Late Cretaceous Asian eutherians). A second analysis incorporating placentals from clades that include rodents (Tribosphenomys), lagomorphs (Mimotona) and archaic ungulates (Protungulatum and Oxyprimus) strongly supports Zalambdalestidae in a clade with Glires (rabbits, rodents and extinct relatives) and less strongly 'Zhelestidae' within a clade that includes archaic ungulates ('condylarths'). This argues that some Late Cretaceous eutherians belong within the crown group Placentalia. The ages of these taxa are in line with molecularly based estimates of 64-104 Myr ago (median 84 Myr ago) for the superordinal diversification of some placentals(5), but provide no support for a Late Cretaceous diversification of extant placental orders.	San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia	California State University System; San Diego State University; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences	Archibald, JD (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	darchibald@sunstroke.sdsu.edu	Averianov, Alexander/M-8490-2013	Averianov, Alexander/0000-0001-5948-0799				Archibald J. David, 2001, Journal of Mammalian Evolution, V8, P107, DOI 10.1023/A:1011317930838; Archibald JD, 1996, SCIENCE, V272, P1150, DOI 10.1126/science.272.5265.1150; ARCHIBALD JD, 1998, NEW MEXICO MUSEUM NA, V14, P21; ARCHIBALD JD, IN PRESS J VERT PALE; ARCHIBALD JD, 1998, TERTIARY MAMMALS N A, V1, P292; Averianov AO, 2001, ACTA PALAEONTOL POL, V46, P431; Cifelli RL, 1999, NATURE, V401, P363, DOI 10.1038/43861; Cooper A, 1998, TRENDS ECOL EVOL, V13, P151, DOI 10.1016/S0169-5347(97)01277-9; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Kielan-Jaworowska Z., 1968, PALAEONTOLOGIA POLON, V19, P171; Kielan-Jaworowska Zofia, 2000, P573; KIELANJAWOROWSKA Z, 1989, ZOOL SCR, V18, P347, DOI 10.1111/j.1463-6409.1989.tb00460.x; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; LI CK, 1993, NEW CRANIAL POSTCRAN, P151; LOPATIN AV, IN PRESS NEW MEX MUS; LUCKETT WP, 1985, EVOLUTIONARY RELATIO, P227; MADDISON WP, 1997, MACCLADE 3 07; Marshall L.G., 1990, Current Mammalogy, V2, P433; Martin T, 1997, TOOTH ENAMEL MICROSTRUCTURE, P163; MCKENNA MC, 1997, CLASSIFICATION MAMMA, V284, P104; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; NESOV LA, 1997, CRETACEOUS NONMARINE, P168; Nessov L.A., 1994, Trudy Zoologicheskogo Instituta, V249, P105; Nessov Lev A., 1998, Bulletin of Carnegie Museum of Natural History, V34, P40; Novacek M. J., 1998, Journal of Vertebrate Paleontology, V18, p67A; Novacek MJ, 1997, NATURE, V389, P483, DOI 10.1038/39020; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856; Swofford DL., 2001, PAUP PHYLOGENETIC AN; SZALAY FS, 1994, EVOLUTIONARY HIST MA, V362, P35; VAUGHAN TA, 2000, MAMMALOGY, P73; Wible John R., 2001, American Museum Novitates, V3322, P1, DOI 10.1206/0003-0082(2001)322<0001:EEERAP>2.0.CO;2	31	106	114	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					62	65		10.1038/35102048	http://dx.doi.org/10.1038/35102048			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689942				2022-12-28	WOS:000171898900041
J	Morais-Cabral, JH; Zhou, YF; MacKinnon, R				Morais-Cabral, JH; Zhou, YF; MacKinnon, R			Energetic optimization of ion conduction rate by the K+ selectivity filter	NATURE			English	Article							ELECTRON-DENSITY MAPS; CHANNEL; SKELETAL; COMPLEX	The K+ selectivity filter catalyses the dehydration, transfer and rehydration of a K+ ion in about ten nanoseconds. This physical process is central to the production of electrical signals in biology. Here we show how nearly diffusion-limited rates are achieved, by analysing ion conduction and the corresponding crystallographic ion distribution in the selectivity filter of the KcsA K+ channel. Measurements with K+ and its slightly larger analogue, Rb+, lead us to conclude that the selectivity filter usually contains two K+ ions separated by one water molecule. The two ions move in a concerted fashion between two configurations, K+-water-K+-water (1,3 conrguration) and water-K+-water-K+ (2,4 conrguration), until a third ion enters, displacing the ion on the opposite side of the queue. For K+, the energy difference between the 1,3 and 2,4 configurations is close to zero, the condition of maximum conduction rate. The energetic balance between these configurations is a clear example of evolutionary optimization of protein function.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockvax.rockefeller.edu	Morais-Cabral, Joao H/J-4914-2013	Morais-Cabral, Joao H/0000-0002-4461-9716				ALCAYAGA C, 1989, BIOPHYS J, V55, P367, DOI 10.1016/S0006-3495(89)82814-0; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEGENISICH T, 1980, J GEN PHYSIOL, V76, P83, DOI 10.1085/jgp.76.1.83; BESTERGAARDBOGI.B, 1985, J MEMBRANE BIOL, V88, P67; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CUELLO LG, 1988, BIOCHEMISTRY-US, V37, P3229; DOBLER M, 1969, HELV CHIM ACTA, V52, P2573, DOI 10.1002/hlca.19690520840; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DUNITZ JD, 1977, BIOL ASPECTS INORGAN, P113; EISENMAN G, 1986, BIOPHYS J, V50, P1025, DOI 10.1016/S0006-3495(86)83546-9; GAMBLIN SJ, 1996, P CCP4 STUD WEEK DAR, P163; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; KOONIN SE, 1986, COMPUTATIONAL PHYSIC; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; NEUPERTLAVES K, 1975, HELV CHIM ACTA, V58, P432, DOI 10.1002/hlca.19750580212; NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569; NEYTON J, 1988, J GEN PHYSIOL, V92, P549, DOI 10.1085/jgp.92.5.549; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	27	627	645	8	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					37	42		10.1038/35102000	http://dx.doi.org/10.1038/35102000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689935				2022-12-28	WOS:000171898900034
J	Paterson, WSB; Reeh, N				Paterson, WSB; Reeh, N			Thinning of the ice sheet in northwest Greenland over the past forty years	NATURE			English	Article							ELEVATION; ACCUMULATION; BALANCE	Thermal expansion of the oceans, as well as melting of glaciers, ice sheets and ice caps have been the main contributors to global sea level rise over the past century. The greatest uncertainty in predicting future sea level changes lies with our estimates of the mass balance of the ice sheets in Greenland and Antarctica(1). Satellite measurements have been used to determine changes in these ice sheets on short timescales, demonstrating that surface-elevation changes on timescales of decades or less result mainly from variations in snow accumulation(2). Here we present direct measurements of the changes in surface elevation between 1954 and 1995 on a traverse across the north Greenland ice sheet. Measurements over a time interval of this length should reflect changes in ice flow-the important quantity for predicting changes in sea level-relatively unperturbed by short-term fluctuations in snow accumulation. We find only small changes in the eastern part of the transect, except for some thickening of the north ice stream. On the west side, however, the thinning rates of the ice sheet are significantly higher and thinning extends to higher elevations than had been anticipated from previous studies(3).	Paterson Geophys Inc, Heriot Bay, BC VOP 1HO, Canada; Tech Univ Denmark, Orsted DTU, DK-2800 Kongens Lyngby, Denmark	Technical University of Denmark	Reeh, N (corresponding author), Paterson Geophys Inc, Box 303, Heriot Bay, BC VOP 1HO, Canada.							Anklin M, 1998, J GEOPHYS RES-ATMOS, V103, P28775, DOI 10.1029/98JD02718; Bamber JL, 2001, J GEOPHYS RES-SOL EA, V106, P6733, DOI 10.1029/2000JB900365; FAHENSTOCK M, 1993, SCIENCE, V262, P1530; HOUGHTON JT, 2001, CLIMATE CHANGE 2001, P664; Huybrechts P, 1999, POLAR RES, V18, P299, DOI 10.1111/j.1751-8369.1999.tb00307.x; Krabill W, 2000, SCIENCE, V289, P428, DOI 10.1126/science.289.5478.428; McConnell JR, 2000, NATURE, V406, P877, DOI 10.1038/35022555; Paterson W, 1956, EMPIRE SURVEY REV, V13, P252; Paterson W. S. B, 1955, MEDD GRONL, V137, P1; Patterson W.S.B, 1994, PHYS GLACIERS, Vthird, P496; Thomas R, 2000, SCIENCE, V289, P426, DOI 10.1126/science.289.5478.426	11	28	28	1	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 01	2001	414	6859					60	62		10.1038/35102044	http://dx.doi.org/10.1038/35102044			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689941				2022-12-28	WOS:000171898900040
J	Hofte, H				Hofte, H			Plant biology - A baroque residue in red wine	SCIENCE			English	Editorial Material									INRA, Biol Cellulaire Lab, F-78210 Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Hofte, H (corresponding author), INRA, Biol Cellulaire Lab, F-78210 Versailles, France.							CARPITA N, 2000, BIOCH MOL BIOL PLANT, P73; DARVILL AG, 1978, PLANT PHYSIOL, V62, P418, DOI 10.1104/pp.62.3.418; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319	3	11	11	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2001	294	5543					795	797		10.1126/science.1066242	http://dx.doi.org/10.1126/science.1066242			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679653				2022-12-28	WOS:000171851800028
J	Fuhrer, A; Luescher, S; Ihn, T; Heinzel, T; Ensslin, K; Wegscheider, W; Bichler, M				Fuhrer, A; Luescher, S; Ihn, T; Heinzel, T; Ensslin, K; Wegscheider, W; Bichler, M			Energy spectra of quantum rings	NATURE			English	Article							AHARONOV-BOHM OSCILLATIONS; PERSISTENT CURRENTS; SINGLE; SHELL; LOOP; SPIN; DOT	Quantum mechanical experiments in ring geometries have long fascinated physicists. Open rings connected to leads, for example, allow the observation of the Aharonov-Bohm effect(1), one of the best examples of quantum mechanical phase coherence(2,3). The phase coherence of electrons travelling through a quantum dot embedded in one arm of an open ring has also been demonstrated(4). The energy spectra of closed rings(5) have only recently been studied by optical spectroscopy(6,7). The prediction that they allow persistent current(8) has been explored in various experiments(9-11). Here we report magnetotransport experiments on closed rings in the Coulomb blockade regime(12). Our experiments show that a microscopic understanding of energy levels, so far limited to few-electron quantum dots(13), can be extended to a many-electron system. A semiclassical interpretation of our results indicates that electron motion in the rings is governed by regular rather than chaotic motion, an unexplored regime in many-electron quantum dots. This opens a way to experiments where even more complex structures can be investigated at a quantum mechanical level.	ETH Zurich, Solid State Phys Lab, CH-8093 Zurich, Switzerland; Univ Regensburg, D-93040 Regensburg, Germany; Tech Univ Munich, Walter Schottky Inst, D-85748 Garching, Germany; Univ Freiburg, Fak Phys, D-79104 Freiburg, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Regensburg; Technical University of Munich; University of Freiburg	Ensslin, K (corresponding author), ETH Zurich, Solid State Phys Lab, CH-8093 Zurich, Switzerland.		Ihn, Thomas/A-4470-2018; Wegscheider, Werner H/D-1493-2010; Fuhrer, Andreas/C-1109-2018	Ihn, Thomas/0000-0002-5587-6953; Fuhrer, Andreas/0000-0003-3537-5737; Heinzel, Thomas/0000-0001-5149-4379				AHARONOV Y, 1959, PHYS REV, V115, P485, DOI 10.1103/PhysRev.115.485; Beenakker CWJ, 1997, REV MOD PHYS, V69, P731, DOI 10.1103/RevModPhys.69.731; BERMAN D, 1990, PHYS REV B, V42, P9299, DOI 10.1103/PhysRevB.42.9299; BUTTIKER M, 1983, PHYS LETT A, V96, P365, DOI 10.1016/0375-9601(83)90011-7; BYERS N, 1961, PHYS REV LETT, V7, P46, DOI 10.1103/PhysRevLett.7.46; Casse M, 2000, PHYS REV B, V62, P2624, DOI 10.1103/PhysRevB.62.2624; CHAKRABORTY T, 1995, PHYS REV B, V52, P1932, DOI 10.1103/PhysRevB.52.1932; CHANDRASEKHAR V, 1991, PHYS REV LETT, V67, P3578, DOI 10.1103/PhysRevLett.67.3578; Heinzel T, 2001, PHYSICA E, V9, P84, DOI 10.1016/S1386-9477(00)00181-8; Held R, 1998, APPL PHYS LETT, V73, P262, DOI 10.1063/1.121774; KASTNER MA, 1992, REV MOD PHYS, V64, P849, DOI 10.1103/RevModPhys.64.849; Kouwenhoven LP, 1997, NATO ADV SCI I E-APP, V345, P105; LEVY LP, 1990, PHYS REV LETT, V64, P2074, DOI 10.1103/PhysRevLett.64.2074; Lorke A, 2000, PHYS REV LETT, V84, P2223, DOI 10.1103/PhysRevLett.84.2223; LOSS D, 1991, PHYS REV B, V43, P13762, DOI 10.1103/PhysRevB.43.13762; Luscher S, 2001, PHYS REV LETT, V86, P2118, DOI 10.1103/PhysRevLett.86.2118; MAILLY D, 1993, PHYS REV LETT, V70, P2020, DOI 10.1103/PhysRevLett.70.2020; Pedersen S, 2000, PHYS REV B, V61, P5457, DOI 10.1103/PhysRevB.61.5457; Schuster R, 1997, NATURE, V385, P417, DOI 10.1038/385417a0; SCHUSTER R, 1994, ADV SOLID STATE PHYS, V34, P195; Tan WC, 1996, SEMICOND SCI TECH, V11, P1635, DOI 10.1088/0268-1242/11/11/001; TIMP G, 1987, PHYS REV LETT, V58, P2814, DOI 10.1103/PhysRevLett.58.2814; Warburton RJ, 2000, NATURE, V405, P926, DOI 10.1038/35016030; WEBB RA, 1985, PHYS REV LETT, V54, P2696, DOI 10.1103/PhysRevLett.54.2696	25	428	432	2	58	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					822	825		10.1038/35101552	http://dx.doi.org/10.1038/35101552			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677600	Green Submitted			2022-12-28	WOS:000171750200039
J	Dinner, AR; Blackburn, GM; Karplus, M				Dinner, AR; Blackburn, GM; Karplus, M			Uracil-DNA glycosylase acts by substrate autocatalysis	NATURE			English	Article							HYDROGEN-BOND; ENERGY; MECHANISM; CATALYSIS; DYNAMICS; REPAIR; NMR; SIMULATION; ENZYME	In humans, uracil appears in DNA at the rate of several hundred bases per cell each day as a result of misincorporation of deoxyuridine (dU) or deamination of cytosine. Four enzymes that catalyse the hydrolysis of the glycosylic bond of dU in DNA to yield an apyridiminic site as the first step in base excision repair have been identified in the human genome(1). The most efficient and well characterized of these uracil-DNA glycosylases is UDG (also known as UNG and present in almost all known organisms)(2), which excises U from single- or double-stranded DNA and is associated with DNA replication forks(3). We used a hybrid quantum-mechanical/molecular-mechanical (QM/MM) approach(4) to determine the mechanism of catalysis by UDG. In contrast to the concerted associative mechanism proposed initially (5-10), we show here that the reaction proceeds in a stepwise dissociative manner(11,12). Cleavage of the glycosylic bond yields an intermediate comprising an oxocarbenium cation and a uracilate anion. Subsequent attack by a water molecule and transfer of a proton to D145 result in the products. Surprisingly, the primary contribution to lowering the activation energy comes from the substrate, rather than from the enzyme. This 'autocatalysis' derives from the burial and positioning of four phosphate groups that stabilize the rate-determining transition state. The importance of these phosphates explains the residual activity observed for mutants that lack key residues(6-9). A corresponding catalytic mechanism could apply to the DNA glycosylases TDG and SMUG1, which belong to the same structural superfamily as UDG(13,14).	Univ Oxford, Cent Chem Lab, Oxford OX1 3QH, England; Univ Sheffield, Krebs Inst, Dept Chem, Sheffield S3 7HF, S Yorkshire, England; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Univ Strasbourg, ISIS, Lab Chim Biophys, F-67000 Strasbourg, France	University of Oxford; University of Sheffield; Harvard University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Karplus, M (corresponding author), Univ Oxford, Cent Chem Lab, S Parks Rd, Oxford OX1 3QH, England.	marci@tammy.harvard.edu						BASH PA, 1991, BIOCHEMISTRY-US, V30, P5826, DOI 10.1021/bi00238a003; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen XY, 2000, J AM CHEM SOC, V122, P6527, DOI 10.1021/ja992751a; Desiraju GR, 1996, ACCOUNTS CHEM RES, V29, P441, DOI 10.1021/ar950135n; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Drohat AC, 2000, BIOCHEMISTRY-US, V39, P11865, DOI 10.1021/bi000922e; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11876, DOI 10.1021/bi9910880; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11866, DOI 10.1021/bi9910878; Drohat AC, 2000, J AM CHEM SOC, V122, P1840, DOI 10.1021/ja993254x; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MACKERELL AD, 1995, J AM CHEM SOC, V117, P11946, DOI 10.1021/ja00153a017; Mol CD, 1999, ANNU REV BIOPH BIOM, V28, P101, DOI 10.1146/annurev.biophys.28.1.101; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Reuter N, 2000, J PHYS CHEM A, V104, P1720, DOI 10.1021/jp9924124; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; Schaefer M, 1997, J PHYS CHEM B, V101, P1663, DOI 10.1021/jp962972s; SHAPIRO R, 1969, BIOCHEMISTRY-US, V8, P1806, DOI 10.1021/bi00833a004; Shroyer MJN, 1999, BIOCHEMISTRY-US, V38, P4834, DOI 10.1021/bi982986j; Simonson T, 1997, J PHYS CHEM B, V101, P8349, DOI 10.1021/jp9711499; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Weinhold F., 1998, ENCY COMPUTATIONAL C, P1792; Werner RM, 2000, BIOCHEMISTRY-US, V39, P14054, DOI 10.1021/bi0018178; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu N, 2000, P NATL ACAD SCI USA, V97, P2017, DOI 10.1073/pnas.050417797	30	202	203	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					752	755		10.1038/35099587	http://dx.doi.org/10.1038/35099587			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607036				2022-12-28	WOS:000171608000048
J	Bonell, C; Strange, V				Bonell, C; Strange, V			Reducing sexually transmitted infections among gay men - Social and behavioural interventions are effective in preventing HIV transmission	BRITISH MEDICAL JOURNAL			English	Letter									Univ London, Inst Educ, Social Sci Res Unit, London WC1H 0NS, England	University of London; University College London; UCL Institute of Education	Bonell, C (corresponding author), Univ London, Inst Educ, Social Sci Res Unit, London WC1H 0NS, England.							*CDCP, 1999, CDCS HIV AIDS PREV R; Imrie J, 2001, BRIT MED J, V322, P1451, DOI 10.1136/bmj.322.7300.1451; Nutbeam D, 1999, BMJ-BRIT MED J, V318, P944, DOI 10.1136/bmj.318.7188.944b; WANIGARATNE S, 1997, IMPACT AIDS PSYCHOL, P27; WILKINSON D, 2001, COCHRANE DATABASE SY, P2	5	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 13	2001	323	7317					868	868						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483RW	11683162				2022-12-28	WOS:000171650500048
J	Hines, PJ; Purnell, BA; Marx, J				Hines, PJ; Purnell, BA; Marx, J			Stem cells branch out	SCIENCE			English	Editorial Material																			0	10	12	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1417	1417		10.1126/science.287.5457.1417	http://dx.doi.org/10.1126/science.287.5457.1417			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	11645196				2022-12-28	WOS:000085531600028
J	RAMSAY, JHR				RAMSAY, JHR			A KING, A DOCTOR, AND A CONVENIENT DEATH	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	8	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 28	1994	308	6941					1445	1445		10.1136/bmj.308.6941.1445	http://dx.doi.org/10.1136/bmj.308.6941.1445			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NP420	11644545	Green Published			2022-12-28	WOS:A1994NP42000073
J	CURR, D				CURR, D			CONFIDENTIALITY	BRITISH MEDICAL JOURNAL			English	Editorial Material											CURR, D (corresponding author), MOSVOLD HOSP,INGWAVUMA,SOUTH AFRICA.								0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 26	1993	306	6894					1763	1763						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK367	11643146				2022-12-28	WOS:A1993LK36700096
J	Maquet, P				Maquet, P			The role of sleep in learning and memory	SCIENCE			English	Review							EYE-MOVEMENT SLEEP; SLOW-WAVE SLEEP; REM-SLEEP; PARADOXICAL SLEEP; COMPLEMENTARY RELATIONSHIP; CORTICOTHALAMIC NETWORKS; HIPPOCAMPAL; RAT; EXPERIENCE; CONSOLIDATION	Sleep has been implicated in the plastic cerebral changes that underlie learning and memory. Indications that sleep participates in the consolidation of fresh memory traces come from a wide range of experimental observations. At the network level, reactivations during steep of neuronal assemblies recently challenged by new environmental circumstances have been reported in different experimental designs. These neuronal assemblies are proposed to be involved in the processing of memory traces during steep. However, despite this rapidly growing body of experimental data, evidence for the influence of steep discharge patterns on memory traces remains fragmentary. The underlying role of steep in learning and memory has yet to be precisely characterized.	UCL, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Univ Liege, Cyclotron Res Ctr, B-4000 Liege, Belgium	University of London; University College London; University of Liege	Maquet, P (corresponding author), UCL, Wellcome Dept Cognit Neurol, London WC1N 3BG, England.			, Pierre/0000-0003-3106-3357				ADAM K, 1977, J ROY COLL PHYS LOND, V11, P376; Amzica F, 1997, P NATL ACAD SCI USA, V94, P1985, DOI 10.1073/pnas.94.5.1985; Amzica F, 1996, NEUROSCIENCE, V72, P309, DOI 10.1016/0306-4522(96)00012-7; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; BARRETT TR, 1972, J EXP PSYCHOL, V96, P321, DOI 10.1037/h0033625; BERGER RJ, 1995, BEHAV BRAIN RES, V69, P65, DOI 10.1016/0166-4328(95)00002-B; BUCHEGGER J, 1988, PERCEPT MOTOR SKILL, V67, P635, DOI 10.2466/pms.1988.67.2.635; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Chrobak JJ, 2000, HIPPOCAMPUS, V10, P457, DOI 10.1002/1098-1063(2000)10:4<457::AID-HIPO12>3.0.CO;2-Z; CRICK F, 1983, NATURE, V304, P111, DOI 10.1038/304111a0; Datta S, 1999, RAPID EYE MOVEMENT SLEEP, P91; Datta S, 2000, J NEUROSCI, V20, P8607, DOI 10.1523/JNEUROSCI.20-22-08607.2000; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; De Gennaro L, 2000, EXP BRAIN RES, V130, P105; DEGENNARO L, 1995, ELECTROEN CLIN NEURO, V95, P252, DOI 10.1016/0013-4694(95)00090-L; DEKONINCK J, 1989, INT J PSYCHOPHYSIOL, V8, P43, DOI 10.1016/0167-8760(89)90018-4; DEKONINCK J, 1991, CAN J PSYCHOL, V45, P125, DOI 10.1037/h0084290; DELACOUR J, 1990, NEUROSCIENCE, V34, P1, DOI 10.1016/0306-4522(90)90299-J; FISHBEIN W, 1971, SCIENCE, V172, P80, DOI 10.1126/science.172.3978.80; FOWLER MJ, 1973, SCIENCE, V179, P302, DOI 10.1126/science.179.4070.302; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; GIUDITTA A, 1995, BEHAV BRAIN RES, V69, P157, DOI 10.1016/0166-4328(95)00012-I; Graves L, 2001, TRENDS NEUROSCI, V24, P237, DOI 10.1016/S0166-2236(00)01744-6; GREENBERG R, 1974, PERSPECT BIOL MED, V17, P513; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; HENNEVIN E, 1977, PHYSIOL BEHAV, V18, P307, DOI 10.1016/0031-9384(77)90138-X; HENNEVIN E, 1971, CR ACAD SCI D NAT, V273, P2595; HENNEVIN E, 1995, BEHAV BRAIN RES, V69, P125, DOI 10.1016/0166-4328(95)00013-J; HERMAN JH, 1983, SCIENCE, V220, P1074, DOI 10.1126/science.6844929; HORNE JA, 1984, BIOL PSYCHOL, V18, P165, DOI 10.1016/0301-0511(84)90001-2; Horne JA, 2000, NEUROSCI BIOBEHAV R, V24, P777, DOI 10.1016/S0149-7634(00)00037-3; INOUE S, 1995, BEHAV BRAIN RES, V69, P91, DOI 10.1016/0166-4328(95)00014-K; JULIANO SL, 1991, P NATL ACAD SCI USA, V88, P780, DOI 10.1073/pnas.88.3.780; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; KATTLER H, 1994, J SLEEP RES, V3, P159, DOI 10.1111/j.1365-2869.1994.tb00123.x; Krueger JM, 1999, J SLEEP RES, V8, P53; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; LECONTE P, 1971, CR ACAD SCI D NAT, V273, P86; Lorincz A, 2000, ANN NY ACAD SCI, V911, P83; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; LUCERO MA, 1970, BRAIN RES, V20, P319, DOI 10.1016/0006-8993(70)90299-4; MANDAI O, 1989, PHYSIOL BEHAV, V46, P639, DOI 10.1016/0031-9384(89)90344-2; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; MCGINTY D, 1990, TRENDS NEUROSCI, V13, P480, DOI 10.1016/0166-2236(90)90081-K; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nakanishi H, 1997, EUR J NEUROSCI, V9, P271, DOI 10.1111/j.1460-9568.1997.tb01397.x; PAUL K, 1974, SLEEP 1974, P388; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; Quirk MC, 1999, J NEUROSCI METH, V94, P41, DOI 10.1016/S0165-0270(99)00124-7; RAMPIN C, 1991, NEUROSCI LETT, V126, P113, DOI 10.1016/0304-3940(91)90532-X; Ribeiro S, 1999, LEARN MEMORY, V6, P500, DOI 10.1101/lm.6.5.500; Roozendaal B, 2000, PSYCHONEUROENDOCRINO, V25, P213, DOI 10.1016/S0306-4530(99)00058-X; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; SMITH C, 1991, CAN J PSYCHOL, V45, P115, DOI 10.1037/h0084279; SMITH C, 1982, PHYSIOL BEHAV, V29, P469, DOI 10.1016/0031-9384(82)90268-2; SMITH C, 1980, SLEEP, V3, P67; SMITH C, 1985, NEUROSCI BIOBEHAV R, V9, P157, DOI 10.1016/0149-7634(85)90042-9; Steriade M, 1999, TRENDS NEUROSCI, V22, P337, DOI 10.1016/S0166-2236(99)01407-1; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Steriade M., 1990, BRAINSTEM CONTROL WA; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 1999, J COGNITIVE NEUROSCI, V11, P182, DOI 10.1162/089892999563319; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; VERSCHOOR G, 1984, AFR J PSYCHOL, V14, P69; Vertes RP, 2000, BEHAV BRAIN SCI, V23, P867, DOI 10.1017/S0140525X00004003; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; YAROUSH R, 1971, J EXP PSYCHOL, V88, P361, DOI 10.1037/h0030914	75	667	698	5	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1048	1052		10.1126/science.1062856	http://dx.doi.org/10.1126/science.1062856			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	489VU	11691982				2022-12-28	WOS:000172013800038
J	O'Neill, MA; Eberhard, S; Albersheim, P; Darvill, AG				O'Neill, MA; Eberhard, S; Albersheim, P; Darvill, AG			Requirement of borate cross-linking of cell wall rhamnogalacturonan II for Arabidopsis growth	SCIENCE			English	Article							FUCOSE-DEFICIENT MUTANT; PLANT-CELL; PECTIC POLYSACCHARIDE; BORON; THALIANA; ESTER; TRANSFERASE; GLYCANS; DIMER; MUR1	Turgor-driven plant cell growth depends on watt structure. Two allelic L-fucose-deficient Arabidopsis thaliana mutants (mur1-1 and 1-2) are dwarfed and their rosette leaves do not grow normally. mur1 leaf cell watts contain normal amounts of the cell watt pectic polysaccharide rhamnogalacturonan II (RG-II), but only half exists as a borate cross-linked dimer. The altered structure of mur1 RG-II reduces the rate of formation and stability of this cross-link. Exogenous aqueous borate rescues the defect. The reduced cross-linking of RG-II in dwarf mur1 plants indicates that plant growth depends on watt pectic polysaccharide organization.	Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	O'Neill, MA (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.							Blevins DG, 1998, ANNU REV PLANT PHYS, V49, P481, DOI 10.1146/annurev.arplant.49.1.481; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; Brown PH, 1997, PLANT SOIL, V196, P211, DOI 10.1023/A:1004245823080; Dell B, 1997, PLANT SOIL, V193, P103, DOI 10.1023/A:1004264009230; Duffels A, 2000, BIOORGAN MED CHEM, V8, P2519, DOI 10.1016/S0968-0896(00)00187-5; Fleischer A, 1999, PLANT PHYSIOL, V121, P829, DOI 10.1104/pp.121.3.829; Ishii T, 1999, J BIOL CHEM, V274, P13098, DOI 10.1074/jbc.274.19.13098; Kobayashi M, 1996, PLANT PHYSIOL, V110, P1017, DOI 10.1104/pp.110.3.1017; LOOMIS WD, 1992, BIOFACTORS, V3, P229; Matoh T, 1998, J PLANT RES, V111, P179, DOI 10.1007/BF02507164; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Perrin RM, 1999, SCIENCE, V284, P1976, DOI 10.1126/science.284.5422.1976; Rayon C, 1999, PLANT PHYSIOL, V119, P725, DOI 10.1104/pp.119.2.725; Reiter WD, 1998, PLANT PHYSIOL BIOCH, V36, P167, DOI 10.1016/S0981-9428(98)80101-0; Reiter WD, 1997, PLANT J, V12, P335, DOI 10.1046/j.1365-313X.1997.12020335.x; REITER WD, 1993, SCIENCE, V261, P1032, DOI 10.1126/science.261.5124.1032; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; RUEHS B, UNPUB; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; VANZIN GF, COMMUNICATION; VONSCHAEWEN A, 1993, PLANT PHYSIOL, V102, P1109, DOI 10.1104/pp.102.4.1109; YORK WS, UNPUB; Zablackis E, 1996, SCIENCE, V272, P1808, DOI 10.1126/science.272.5269.1808	23	462	490	9	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2001	294	5543					846	849		10.1126/science.1062319	http://dx.doi.org/10.1126/science.1062319			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679668				2022-12-28	WOS:000171851800045
J	Wootton, JT				Wootton, JT			Local interactions predict large-scale pattern in empirically derived cellular automata	NATURE			English	Article							FOREST-FIRES; DISTURBANCE; COMPETITION; SUCCESSION; COMMUNITY; DYNAMICS; ECOLOGY; MODELS; SIZE	An important unanswered question in ecology is whether processes such as species interactions that occur at a local scale can generate large-scale patterns seen in nature(1,2). Because of the complexity of natural ecosystems, developing an adequate theoretical framework to scale up local processes has been challenging. Models of complex systems can produce a wide array of outcomes; therefore, model parameter values must be constrained by empirical information to usefully narrow the range of predicted behaviour. Under some conditions, spatially explicit models of locally interacting objects (for example, cells, sand grains, car drivers, or organisms), variously termed cellular automata(3,4) or interacting particle models(5), can self-organize to develop complex spatial and temporal patterning at larger scales in the absence of any externally imposed pattern(1,6-8). When these models are based on transition probabilities of moving between ecological states at a local level, relatively complex versions of these models can be linked readily to empirical information on ecosystem dynamics. Here, I show that an empirically derived cellular automaton model of a rocky intertidal mussel bed based on local interactions correctly predicts large-scale spatial patterns observed in nature.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Wootton, JT (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57th St, Chicago, IL 60637 USA.		Wootton, J. Timothy/F-3191-2015	Wootton, J. Timothy/0000-0002-7715-0344				Bak P., 1996, NATURE WORKS SCI SEL; Clar S, 1996, J PHYS-CONDENS MAT, V8, P6803, DOI 10.1088/0953-8984/8/37/004; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; DENNY MW, 1987, J EXP MAR BIOL ECOL, V113, P231, DOI 10.1016/0022-0981(87)90103-1; DURRETT R, 1994, PHILOS T ROY SOC B, V343, P329, DOI 10.1098/rstb.1994.0028; ERMENTROUT GB, 1993, J THEOR BIOL, V160, P97, DOI 10.1006/jtbi.1993.1007; Jensen J. H., 1998, SELF ORG CRITICALITY; JOHNSON LE, 1992, J EXP MAR BIOL ECOL, V160, P251, DOI 10.1016/0022-0981(92)90241-2; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; Malamud BD, 1998, SCIENCE, V281, P1840, DOI 10.1126/science.281.5384.1840; Paine R. T., 1994, MARINE ROCKY SHORES; PAINE RT, 1981, ECOL MONOGR, V51, P145, DOI 10.2307/2937261; Sokal RR, 1995, BIOMETRY; SOLE RV, 1995, J THEOR BIOL, V173, P31, DOI 10.1006/jtbi.1995.0040; SOUSA WP, 1984, ECOLOGY, V65, P1918, DOI 10.2307/1937789; Stephenson T.A., 1972, LIFE TIDEMARKS ROCKY; WIENS JA, 1993, OIKOS, V66, P369, DOI 10.2307/3544931; WOLFRAM S, 1984, NATURE, V311, P419, DOI 10.1038/311419a0; WOOTTON JT, 1993, ECOLOGY, V74, P195, DOI 10.2307/1939514; WOOTTON JT, 1992, ECOLOGY, V73, P981, DOI 10.2307/1940174; WOOTTON JT, 1994, ECOLOGY, V75, P151, DOI 10.2307/1939391; Wootton JT, 2001, ECOLOGY, V82, P580, DOI 10.2307/2679881	23	137	144	1	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					841	844		10.1038/35101595	http://dx.doi.org/10.1038/35101595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677606				2022-12-28	WOS:000171750200045
J	Wu, WC; Rathore, SS; Wang, Y; Radford, MJ; Krumholz, HM				Wu, WC; Rathore, SS; Wang, Y; Radford, MJ; Krumholz, HM			Blood transfusion in elderly patients with acute myocardial infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC COMPENSATION; MEDICARE PATIENTS; OXYGEN DELIVERY; ANEMIA; HEMATOCRIT; MORTALITY; DISEASE; STRATEGIES; TRIAL; RISK	Background: Anemia may have adverse effects in patients with coronary artery disease. However, the benefit of blood transfusion in elderly patients with acute myocardial infarction and various degrees of anemia is uncertain. Methods: We conducted a retrospective study of data on 78,974 Medicare beneficiaries 65 years old or older who were hospitalized with acute myocardial infarction. Patients were categorized according to the hematocrit on admission (5.0 to 24.0 percent, 24.1 to 27.0 percent, 27.1 to 30.0 percent, 30.1 to 33.0 percent, 33.1 to 36.0 percent, 36.1 to 39.0 percent, or 39.1 to 48.0 percent), and data were evaluated to determine whether there was an association between the use of transfusion and 30-day mortality. Results: Patients with lower hematocrit values on admission had higher 30-day mortality rates. Blood transfusion was associated with a reduction in 30-day mortality among patients whose hematocrit on admission fell into the categories ranging from 5.0 to 24.0 percent (adjusted odds ratio, 0.22; 95 percent confidence interval, 0.11 to 0.45) to 30.1 to 33.0 percent (adjusted odds ratio, 0.69; 95 percent confidence interval, 0.53 to 0.89). It was not associated with a reduction in 30-day mortality among those whose hematocrit values fell in the higher ranges. In one of seven subgroup analyses (among patients who survived at least two days), transfusion was not associated with a reduction in mortality for patients with hematocrit values of 30.1 percent or higher. Conclusions: Blood transfusion is associated with a lower short-term mortality rate among elderly patients with acute myocardial infarction if the hematocrit on admission is 30.0 percent or lower and may be effective in patients with a hematocrit as high as 33.0 percent on admission.	Brown Univ, Sch Med, Div Cardiovasc Dis, Providence, RI 02912 USA; Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; Qualidigm, Middletown, CT USA	Brown University; Yale University; Yale University; Yale University	Wu, WC (corresponding author), Brown Univ, Sch Med, Div Cardiovasc Dis, Providence, RI 02912 USA.		, Harlan/AAI-2875-2020	Radford, Martha/0000-0001-7503-9557				[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; BERNSTEIN MJ, 1988, JAMA-J AM MED ASSOC, V260, P2700; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; BLAIR SD, 1986, BRIT J SURG, V73, P783, DOI 10.1002/bjs.1800731007; BOTTIGER LE, 1980, ATHEROSCLEROSIS, V36, P389, DOI 10.1016/0021-9150(80)90219-1; BRAZIER J, 1974, SURGERY, V75, P508; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Chiavetta JA, 1996, TRANSFUSION, V36, P699, DOI 10.1046/j.1537-2995.1996.36896374373.x; CZER LSC, 1978, SURG GYNECOL OBSTET, V147, P363; DALEY J, 1988, JAMA-J AM MED ASSOC, V260, P3617, DOI 10.1001/jama.260.24.3617; *DEP HLTH HUM SERV, 1989, DHHS PUBL; Ely EW, 1999, NEW ENGL J MED, V340, P467, DOI 10.1056/NEJM199902113400610; Eschbach J, 1997, AM J KIDNEY DIS, V30, pS192; FAUCI AS, 1998, HARRISONS PRINCIPLES, V1; FLEMING C, 1992, MED CARE, V30, P377, DOI 10.1097/00005650-199205000-00001; Friedman BA, 1982, CLIN LABORATORY ANN, V1, P147; Geha A S, 1978, World J Surg, V2, P645; GRINDON AJ, 1985, JAMA-J AM MED ASSOC, V253, P540, DOI 10.1001/jama.253.4.540; HASLEY PB, 1994, TRANSFUSION, V34, P110, DOI 10.1046/j.1537-2995.1994.34294143936.x; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 1997, AM J RESP CRIT CARE, V155, P1618, DOI 10.1164/ajrccm.155.5.9154866; Hebert PC, 1999, NEW ENGL J MED, V340, P1056; HEBERT PC, 1995, JAMA-J AM MED ASSOC, V274, P944; Innes G, 1998, J Emerg Med, V16, P129; JAN KM, 1977, AM J PHYSIOL, V233, pH106, DOI 10.1152/ajpheart.1977.233.1.H106; JOHNSON RG, 1992, J THORAC CARDIOV SUR, V104, P307; JOOSTEN E, 1992, GERONTOLOGY, V38, P111, DOI 10.1159/000213315; KALCHTHALER T, 1980, J AM GERIATR SOC, V28, P108, DOI 10.1111/j.1532-5415.1980.tb00242.x; LEVY PS, 1993, AM J PHYSIOL, V265, pH340, DOI 10.1152/ajpheart.1993.265.1.H340; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; MOST AS, 1986, CIRCULATION, V74, P1085, DOI 10.1161/01.CIR.74.5.1085; *ROYAL COLL PHYS E, 1994, BRIT J ANAESTH, V73, P857; Silverberg DS, 2000, J AM COLL CARDIOL, V35, P1737, DOI 10.1016/S0735-1097(00)00613-6; Smieja MJ, 1996, CAN MED ASSOC J, V155, P691; SORLIE PD, 1981, AM HEART J, V101, P456, DOI 10.1016/0002-8703(81)90136-8; VAMVAKAS EC, 1994, TRANSFUSION, V34, P464, DOI 10.1046/j.1537-2995.1994.34694295059.x; Weiskopf RB, 1998, JAMA-J AM MED ASSOC, V279, P217, DOI 10.1001/jama.279.3.217; Weiskopf RB, 1998, JAMA-J AM MED ASSOC, V280, P1404; WELCH HG, 1992, ANN INTERN MED, V116, P393, DOI 10.7326/0003-4819-116-5-393; WHO Scientific Group on Nutritional Anaemias & World Health Organization, 1968, NUTR AN REP WHO SCI; WILKERSON DK, 1988, SURGERY, V103, P665; Zimmermann R, 1997, TRANSFUSION, V37, P1075, DOI 10.1046/j.1537-2995.1997.371098016449.x	44	645	675	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2001	345	17					1230	1236		10.1056/NEJMoa010615	http://dx.doi.org/10.1056/NEJMoa010615			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485RU	11680442				2022-12-28	WOS:000171773100002
J	Edmunds, L; Waters, E; Elliott, EJ				Edmunds, L; Waters, E; Elliott, EJ			Evidence based paediatrics - Evidence based management of childhood obesity	BMJ-BRITISH MEDICAL JOURNAL			English	Review							OVERWEIGHT; CHILDREN; ADOLESCENTS; RISK		Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England; Univ Melbourne, Royal Childrens Hosp, Ctr Community Child Hlth, Parkville, Vic 3052, Australia; Univ Sydney, Sydney, NSW 2145, Australia; New Childrens Hosp, Sydney, NSW 2145, Australia	University of Oxford; Royal Children's Hospital Melbourne; University of Melbourne; University of Sydney; University of Sydney	Edmunds, L (corresponding author), Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England.	laurel.edmunds@dphpc.ox.ac.uk		Edmunds, Laurel/0000-0001-9677-3742; Elliott, Elizabeth/0000-0002-6501-5487				[Anonymous], 1983, J ROY COLL PHYS LOND, V17, P5; Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; BIDDLE SJH, 1994, PHYSICAL ACTIVITY PR; CAMPBELL K, 2001, COCHRANE DATABASE SY, V1; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dietz WH, 1999, AM J CLIN NUTR, V70, p123S; Epstein LH, 1998, PEDIATRICS, V101, P554; Flegal KM, 1999, MED SCI SPORT EXER, V31, pS509, DOI 10.1097/00005768-199911001-00004; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; FRENCH SA, 1995, OBES RES, V3, P479, DOI 10.1002/j.1550-8528.1995.tb00179.x; Gill TP, 1997, BRIT MED BULL, V53, P359, DOI 10.1093/oxfordjournals.bmb.a011618; GLENNY AM, 1997, SYSTEMATIC REV INTER; Golan M, 1998, INT J OBESITY, V22, P1217, DOI 10.1038/sj.ijo.0800749; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; Haddock C. Keith, 1994, Annals of Behavioral Medicine, V16, P235; Hughes JM, 1997, ARCH DIS CHILD, V76, P182, DOI 10.1136/adc.76.3.182; Lake JK, 1997, ARCH DIS CHILD, V77, P376, DOI 10.1136/adc.77.5.376; Owens S, 1999, MED SCI SPORT EXER, V31, P143, DOI 10.1097/00005768-199901000-00022; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Story M, 1999, INT J OBESITY, V23, pS43, DOI 10.1038/sj.ijo.0800859; SUMMERBELL C, 2001, COCHRANE LIB; Wake M, 2000, PEDIATR RES, V47, p160A; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e5; World Health Organization,, 1998, WHO TECHN REP SER	25	77	81	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2001	323	7318					916	919		10.1136/bmj.323.7318.916	http://dx.doi.org/10.1136/bmj.323.7318.916			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486BH	11668139	Green Published			2022-12-28	WOS:000171798200025
J	Barton, MK				Barton, MK			Giving meaning to movement	CELL			English	Review							MAIZE HOMEOBOX GENE; ARABIDOPSIS ROOT; KNOTTED1; SHOOT; EXPRESSION; LEAVES		Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA; Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	Carnegie Institution for Science; University of Wisconsin System; University of Wisconsin Madison	Barton, MK (corresponding author), Carnegie Inst Washington, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.							Crawford KM, 2001, PLANT PHYSIOL, V125, P1802, DOI 10.1104/pp.125.4.1802; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; FREELING M, 1985, GENETICS, V111, P617; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; JACKSON D, 1994, DEVELOPMENT, V120, P405; Jenik PD, 2001, DEVELOPMENT, V128, P13; Joliot A, 1998, CURR BIOL, V8, P856, DOI 10.1016/S0960-9822(07)00346-6; Kerstetter RA, 1997, DEVELOPMENT, V124, P3045; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Rinne PLH, 1998, DEVELOPMENT, V125, P1477; Sessions A, 2000, SCIENCE, V289, P779, DOI 10.1126/science.289.5480.779; SINHA N, 1990, DEV BIOL, V141, P203, DOI 10.1016/0012-1606(90)90115-Y; SMITH LG, 1992, DEVELOPMENT, V116, P21; Zambryski P, 2000, ANNU REV CELL DEV BI, V16, P393, DOI 10.1146/annurev.cellbio.16.1.393	15	5	8	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					129	132		10.1016/S0092-8674(01)00532-3	http://dx.doi.org/10.1016/S0092-8674(01)00532-3			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672520	Bronze			2022-12-28	WOS:000171694800002
J	Fields, BD				Fields, BD			Cosmology - A census of cosmic matter	SCIENCE			English	Editorial Material									Univ Illinois, Dept Astron, Ctr Theoret Astrophys, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Fields, BD (corresponding author), Univ Illinois, Dept Astron, Ctr Theoret Astrophys, 1002 W Green St, Urbana, IL 61801 USA.	bdfields@astro.uiuc.edu						CYBURT RH, IN PRESS ASTROPART P; Izotov YI, 1998, ASTROPHYS J, V500, P188, DOI 10.1086/305698; NETTERFIELD CB, IN PRESS ASTROPHYS J; O'Meara JM, 2001, ASTROPHYS J, V552, P718, DOI 10.1086/320579; Olive KA, 2000, PHYS REP, V333, P389, DOI 10.1016/S0370-1573(00)00031-4; PAGEL BEJ, 1992, MON NOT R ASTRON SOC, V255, P325, DOI 10.1093/mnras/255.2.325; PRYKE C, UNPUB; WAGONER RV, 1967, ASTROPHYS J, V148, P3, DOI 10.1086/149126	8	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					529	530		10.1126/science.1066158	http://dx.doi.org/10.1126/science.1066158			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641485				2022-12-28	WOS:000171695600029
J	Warner, JR				Warner, JR			Nascent ribosomes	CELL			English	Review							SMALL NUCLEOLAR RNAS; SACCHAROMYCES-CEREVISIAE; PROTEIN; COMPLEX		Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Warner, JR (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.							Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; BaudinBaillieu A, 1997, MOL CELL BIOL, V17, P5023, DOI 10.1128/MCB.17.9.5023; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Kressler D, 1999, MOL CELL BIOL, V19, P7897; KUMAR A, 1972, J MOL BIOL, V63, P233, DOI 10.1016/0022-2836(72)90372-5; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Ramakrishnan V, 2001, CURR OPIN STRUC BIOL, V11, P144, DOI 10.1016/S0959-440X(00)00184-6; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; TRAUB P, 1968, P NATL ACAD SCI USA, V59, P777, DOI 10.1073/pnas.59.3.777; UDEM SA, 1972, J MOL BIOL, V65, P227, DOI 10.1016/0022-2836(72)90279-3; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261	17	75	75	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					133	136		10.1016/S0092-8674(01)00531-1	http://dx.doi.org/10.1016/S0092-8674(01)00531-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672521	Bronze			2022-12-28	WOS:000171694800003
J	Bonjour, JP; Chevalley, T; Ammann, P; Slosman, D; Rizzoli, R				Bonjour, JP; Chevalley, T; Ammann, P; Slosman, D; Rizzoli, R			Gain in bone mineral mass in prepubertal girls 3.5 years after discontinuation of calcium supplementation: a follow-up study	LANCET			English	Article							DOUBLE-BLIND; ADOLESCENT GIRLS; SECULAR TRENDS; DENSITY; CHILDREN; GROWTH; ACQUISITION; PUBERTY; EXERCISE; TRIAL	Background Calcium supplementation during childhood and adolescence increases bone-mass accrual. Whether or not this benefit persists after discontinuation of supplementation is not known. We previously showed a favourable effect of milk-extracted calcium phosphate incorporated in various foods on accumulation of bone mineral mass in 8-year-old girls. We now report the results of a follow-up study undertaken more than 3 years after the end of calcium supplementation. Methods Anthropometric and bone variables were measured in 116 of the 144 girls whose data had been studied at the end of the supplementation period. The mean time elapsed between the end of the intervention period and this follow-up measurement was 3.5 years. Areal bone mineral density was measured by dual-energy X-ray absorptiometry at the same six skeletal sites as those studied during the intervention phase. Findings We were able to remeasure 62 and 54 girls of the calcium-supplemented and placebo groups, respectively. The increase from baseline in the overall mean bone mineral density of the six skeletal sites was still highly significant (calcium-supplemented group 179 mg/cm(2) [SE 8] vs placebo group 151 mg/cm(2) [7], p=0.012). A significant difference in favour of the supplemented group was also seen with respect to mean bone mineral content (p=0.031) and mean bone area (p=0.04). Difference in pubertal maturation did not seem to account for the recorded differences. Interpretation Our results suggest that this form of milk-extracted calcium phosphate taken during the prepubertal period can modify the trajectory of bone mass growth and cause a long-standing increase in bone mass accrual, which lasts beyond the end of supplementation.	Univ Hosp Geneva, Dept Internal Med, Div Bone Dis, WHO Collaborating Ctr Osteoporosis & Bone Dis, CH-1211 Geneva 14, Switzerland; Univ Hosp Geneva, Dept Radiol, Div Nucl Med, CH-1211 Geneva, Switzerland	University of Geneva; World Health Organization; University of Geneva	Bonjour, JP (corresponding author), Univ Hosp Geneva, Dept Internal Med, Div Bone Dis, WHO Collaborating Ctr Osteoporosis & Bone Dis, CH-1211 Geneva 14, Switzerland.		Chevalley, Thierry/AAQ-1412-2021	Chevalley, Thierry/0000-0003-3338-1148				[Anonymous], 1994, WHO TECHN REP SER; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; BARKER ME, 1998, BONE, V23, pS606; Bass S, 1999, J CLIN INVEST, V104, P795, DOI 10.1172/JCI7060; Bass S, 1998, J BONE MINER RES, V13, P500, DOI 10.1359/jbmr.1998.13.3.500; BONJOUR JP, 1991, J CLIN ENDOCR METAB, V73, P555, DOI 10.1210/jcem-73-3-555; Bonjour JP, 1997, J CLIN INVEST, V99, P1287, DOI 10.1172/JCI119287; BONJOUR JP, 1994, OSTEOPOROSIS INT S, V1, pS7; Bradney M, 1998, J BONE MINER RES, V13, P1814, DOI 10.1359/jbmr.1998.13.12.1814; Cadogan J, 1997, BMJ-BRIT MED J, V315, P1255, DOI 10.1136/bmj.315.7118.1255; Cole TJ, 2000, P NUTR SOC, V59, P317, DOI 10.1017/S0029665100000355; Cooper C, 1997, ANN RHEUM DIS, V56, P17, DOI 10.1136/ard.56.1.17; Dibba B, 2000, AM J CLIN NUTR, V71, P544; Ferrari S, 1998, J CLIN ENDOCR METAB, V83, P358, DOI 10.1210/jc.83.2.358; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; HEANEY RP, 1994, J BONE MINER RES, V9, P1515; JOHNSTON CC, 1992, NEW ENGL J MED, V327, P82, DOI 10.1056/NEJM199207093270204; LEE WTK, 1995, BRIT J NUTR, V74, P125, DOI 10.1079/BJN19950112; Lee WTK, 1996, AM J CLIN NUTR, V64, P71, DOI 10.1093/ajcn/64.1.71; LEE WTK, 1994, AM J CLIN NUTR, V60, P744, DOI 10.1093/ajcn/60.5.744; Lee WTK, 1997, ACTA PAEDIATR, V86, P570, DOI 10.1111/j.1651-2227.1997.tb08936.x; Leighton G, 1929, LANCET, V1, P40; LLOYD T, 1993, JAMA-J AM MED ASSOC, V270, P841, DOI 10.1001/jama.270.7.841; Loesch DZ, 2000, AM J PHYS ANTHROPOL, V111, P545, DOI 10.1002/(SICI)1096-8644(200004)111:4<545::AID-AJPA9>3.0.CO;2-X; Morris FL, 1997, J BONE MINER RES, V12, P1453, DOI 10.1359/jbmr.1997.12.9.1453; Nowson CA, 1997, OSTEOPOROSIS INT, V7, P219, DOI 10.1007/BF01622292; Okasha M, 2001, ANN HUM BIOL, V28, P68; Orr JB, 1928, LANCET, V1, P202; Seeman E, 1997, J BONE MINER RES, V12, P509, DOI 10.1359/jbmr.1997.12.4.509; Slemenda CW, 1997, J BONE MINER RES, V12, P676, DOI 10.1359/jbmr.1997.12.4.676; THEINTZ G, 1992, J CLIN ENDOCR METAB, V75, P1060, DOI 10.1210/jc.75.4.1060; Zamora SA, 1999, J CLIN ENDOCR METAB, V84, P4541, DOI 10.1210/jc.84.12.4541	32	152	163	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1208	1212		10.1016/S0140-6736(01)06342-5	http://dx.doi.org/10.1016/S0140-6736(01)06342-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675056				2022-12-28	WOS:000171527000008
J	Mutabingwa, T; Nzila, A; Mberu, E; Nduati, E; Winstanley, P; Hills, E; Watkins, W				Mutabingwa, T; Nzila, A; Mberu, E; Nduati, E; Winstanley, P; Hills, E; Watkins, W			Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania	LANCET			English	Article							PLASMODIUM-FALCIPARUM; DIHYDROPTEROATE SYNTHASE; DIHYDROFOLATE-REDUCTASE; SULFADOXINE-PYRIMETHAMINE; SELECTIVE PRESSURE; SYNTHETASE GENE; PARASITES; FANSIDAR; CHILDREN; AFRICA	Background Resistance to the affordable malaria treatments chloroquine and pyrimethamine-sulfadoxine is seriously impeding malaria control through treatment in east Africa. We did an open, alternate drug allocation study to assess the efficacy of chlorproguanil-dapsone in the treatment of falciparum malaria clinically resistant to pyrimethamine-sulfadoxine. Methods Children younger than 5 years with non-severe falciparum malaria, attending Muheza district hospital in Tanzania, were treated with the standard regimen of pyrimethamine-sulfadoxine. Patients whose clinical symptoms resolved but who remained parasitaemic 7 days after pyrimethamine-sulfadoxine were followed up for 1 month. Clinical malaria episodes were retreated with either single dose pyrimethamine-sulfadoxine or a 3-day regimen of chlorproguanil-dapsone. Those with parasitaemia after 7 days were treated with chlorproguanil-dapsone. Parasite DNA was collected on day 7 after first treatment with pyrimethamine-sulfadoxine and we looked for point mutations in the genes encoding dihydrofolate reductase (dhfr) and dyhydropteroate synthetase (dhps). Findings 360 children were enrolled and treated with pyrimethamine-sulfadoxine. On day 7, 192 (55%) of 348 had cleared parasitaemia. Of the remaining 156 parasitaemic children, 140 (90%) were followed up to day 28, and 92 (66%) of 140 developed clinical malaria. These 92 patients were alternately retreated with either pyrimethamine-sulfadoxine (46) or chlorproguanil-dapsone (46). 28 (61%) of 46 children retreated with pyrimethamine-sulfadoxine were still parasitaemic at day 7, compared with three (15%) of 46 children retreated with chlorproguanil-dapsone. Resistance to pyrimethamine-sulfadoxine increased from 45% (156/348) at the first treatment to 61% (28/46) after retreatment. 83 of 85 parasite isolates collected after the first pyrimethamine-sulfadoxine treatment, and before and after the second treatments with pyrimethamine-sulfadoxine and chlorproguanil-dapsone showed triple-mutant dhfr alleles, associated with a variety of dhps mutations. Interpretation Most patients treated with pyrimethamine-sulfadoxine, who remain parasitaemic at day 7, develop new malaria symptoms within 1 month. Chlorproguanil-dapsone was a practicable therapy under these circumstances. Analysis of parasite dhfr and dhps before and after treatment supports the view that pyrimethamine-sulfadoxine resistance in this part of Africa is primarily due to parasites with three mutations in the dhfr domain.	Amani Med Res Ctr, Natl Inst Med Res, Amani Tanga, Tanzania; Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England; Kenya Govt Med Res Ctr, Wellcome Trust Collaborat Programme, Nairobi, Kenya; Muheza Designated Dist Hosp, Muheza Tanga, Tanzania	University of Liverpool; Kenya Medical Research Institute	Mutabingwa, T (corresponding author), Amani Med Res Ctr, Natl Inst Med Res, POB 4, Amani Tanga, Tanzania.							Amukoye E, 1997, ANTIMICROB AGENTS CH, V41, P2261, DOI 10.1128/AAC.41.10.2261; Basco LK, 2000, J INFECT DIS, V182, P624, DOI 10.1086/315731; BRANDLINGBENNETT AD, 1988, T ROY SOC TROP MED H, V82, P833, DOI 10.1016/0035-9203(88)90009-0; BROOKS DR, 1994, EUR J BIOCHEM, V224, P397, DOI 10.1111/j.1432-1033.1994.00397.x; BZIK DJ, 1987, P NATL ACAD SCI USA, V84, P8360, DOI 10.1073/pnas.84.23.8360; Clyde David F, 1967, MALARIA TANZANIA; Goodman CA, 1999, LANCET, V354, P378, DOI 10.1016/S0140-6736(99)02141-8; HYDE JE, 1990, PHARMACOL THERAPEUT, V48, P45, DOI 10.1016/0163-7258(90)90017-V; KILIMALI VAEB, 1985, T ROY SOC TROP MED H, V79, P482, DOI 10.1016/0035-9203(85)90071-9; Marsh VM, 1999, TROP MED INT HEALTH, V4, P383, DOI 10.1046/j.1365-3156.1999.00403.x; MSUYA FHM, 1991, ACTA TROP, V49, P165, DOI 10.1016/0001-706X(91)90035-I; MUTABINGWA TK, 1999, MAL OTHER INFECT DIS, V10, P28; Nzila AM, 2000, J INFECT DIS, V181, P2023, DOI 10.1086/315520; Nzila AM, 2000, ANTIMICROB AGENTS CH, V44, P991, DOI 10.1128/AAC.44.4.991-996.2000; Ronn AM, 1996, T ROY SOC TROP MED H, V90, P179, DOI 10.1016/S0035-9203(96)90129-7; STICH AHR, 1994, T ROY SOC TROP MED H, V88, P150, DOI 10.1016/0035-9203(94)90271-2; Trigg JK, 1997, ACTA TROP, V63, P185, DOI 10.1016/S0001-706X(96)00617-1; Triglia T, 1997, P NATL ACAD SCI USA, V94, P13944, DOI 10.1073/pnas.94.25.13944; Triglia T, 1998, EMBO J, V17, P3807, DOI 10.1093/emboj/17.14.3807; TRIGLIA T, 1994, P NATL ACAD SCI USA, V91, P7149, DOI 10.1073/pnas.91.15.7149; Wang P, 1997, PARASITOLOGY, V115, P223, DOI 10.1017/S0031182097001431; WATKINS WM, 1993, T ROY SOC TROP MED H, V87, P75, DOI 10.1016/0035-9203(93)90431-O; Watkins WM, 1997, PARASITOL TODAY, V13, P459, DOI 10.1016/S0169-4758(97)01124-1; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; WHO, 1996, WHOMAL961077; Winstanley P, 1997, T ROY SOC TROP MED H, V91, P322, DOI 10.1016/S0035-9203(97)90093-6	26	148	149	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1218	1223		10.1016/S0140-6736(01)06344-9	http://dx.doi.org/10.1016/S0140-6736(01)06344-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675058				2022-12-28	WOS:000171527000010
J	Christian, CE				Christian, CE			Consequences of a biological invasion reveal the importance of mutualism for plant communities	NATURE			English	Article							ANT IRIDOMYRMEX-HUMILIS; ARGENTINE ANT; SEEDLING RECRUITMENT; ECOLOGY; MAYR	Seed-dispersal mutualisms have a fundamental role in regenerating natural communities(1,2). Interest in the importance of seed dispersal to plant communities has been heightened by worldwide declines in animal dispersers(3-5). One view, the 'keystone mutualist hypothesis', predicts that these human-caused losses will trigger a cascade of linked extinctions throughout the community(6). Implicitly, this view holds that mutualisms, such as seed dispersal, are crucial ecological interactions that maintain the structure and diversity of natural communities. Although many studies suggest the importance of mutualism(3,7), empirical evidence for community-level impacts of mutualists has remained anecdotal(8,9), and the central role of mutualism, relative to other species interactions, has long been debated in the theoretical literature(10,11). Here I report the community-level consequences of a biological invasion that disrupts important seed-dispersal mutualisms. I show that invasion of South African shrublands by the Argentine ant (Linepithema humile) leads to a shift in composition of the plant community, owing to a disproportionate reduction in the densities of large-seeded plants. This study suggests that the preservation of mutualistic interactions may be essential for maintaining natural communities.	Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Christian, CE (corresponding author), Univ Calif Davis, Ctr Populat Biol, 1 Shields Ave, Davis, CA 95616 USA.	cechristian@ucdavis.edu						Addicott J.F., 1984, P437; BOND W, 1984, ECOLOGY, V65, P1031, DOI 10.2307/1938311; BOND WJ, 1985, S AFR J ZOOL, V20, P150; BOND WJ, 1991, ANT - PLANT INTERACTIONS, P448; BOND WJ, 1994, PHILOS T R SOC B, V344, P83, DOI 10.1098/rstb.1994.0055; BROWN JH, 1990, SCIENCE, V250, P1705, DOI 10.1126/science.250.4988.1705; CHAPMAN CA, 1995, CONSERV BIOL, V9, P675, DOI 10.1046/j.1523-1739.1995.09030675.x; Chapman Colin A., 1995, Evolutionary Anthropology, V4, P74, DOI 10.1002/evan.1360040303; COLE FR, 1992, ECOLOGY, V73, P1313, DOI 10.2307/1940678; COX PA, 1991, CONSERV BIOL, V5, P448, DOI 10.1111/j.1523-1739.1991.tb00351.x; CUSHMAN JH, 1995, ISLANDS BIOL DIVERSI, P135; DEKOCK AE, 1989, J ENTOMOL SOC S AFR, V52, P157; DEKOCK AE, 1992, FIRE S AFRICAN MOUNT, P201; Gilbert L. E., 1980, Conservation biology. An evolutionary-ecological perspective., P11; Holldobler B., 1990, pi; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; HOWE HF, 1993, VEGETATIO, V108, P3; HUGHES L, 1994, J ECOL, V82, P933, DOI 10.2307/2261456; LAWTON JH, 1993, ECOL STU AN, V99, P255; Lopes MA, 2000, CONSERV BIOL, V14, P1658, DOI [10.1111/j.1523-1739.2000.98402.x, 10.1046/j.1523-1739.2000.98402.x]; May R.M., 1976, P49; MILLS LS, 1993, BIOSCIENCE, V43, P219, DOI 10.2307/1312122; PASSERA L, 1994, WESTV STUD, P23; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; SLINGSBY P, 1985, S AFR J BOT, V51, P30, DOI 10.1016/S0254-6299(16)31698-2; Slingsby P., 1981, VELD FLORA, V67, P39, DOI [10.10520/AJA00423203\_1083, DOI 10.10520/AJA00423203]; Visser D, 1996, AFR ENTOMOL, V4, P285; WARD PS, 1987, HILGARDIA, V55, P1; Way MJ, 1997, INSECT SOC, V44, P415, DOI 10.1007/s000400050062; WITT ABR, 1993, FACTORS AFFECTING MY	30	278	315	10	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2001	413	6856					635	639		10.1038/35098093	http://dx.doi.org/10.1038/35098093			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675787				2022-12-28	WOS:000171485700050
J	Rogers, A				Rogers, A			Europe join debate on care for the terminally ill	LANCET			English	News Item																		1999, LANCET, V353, P2220	1	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 3	1999	354	9172					55	55		10.1016/S0140-6736(05)75326-5	http://dx.doi.org/10.1016/S0140-6736(05)75326-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	212XP	11657547				2022-12-28	WOS:000081243200035
J	Smith, T				Smith, T			Mrs Simpson's knickers	BRITISH MEDICAL JOURNAL			English	Editorial Material																		BLOCH M, WINDSOR DUCHESS	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 6	1996	313	7048					57	57		10.1136/bmj.313.7048.57a	http://dx.doi.org/10.1136/bmj.313.7048.57a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UW667	11644792	Green Published			2022-12-28	WOS:A1996UW66700085
J	Zinn, C				Zinn, C			Australian doctors renew battle over euthanasia	BRITISH MEDICAL JOURNAL			English	News Item											Zinn, C (corresponding author), GUARDIAN,LONDON,ENGLAND.								0	1	1	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 8	1996	312	7044					1437	1437		10.1136/bmj.312.7044.1437	http://dx.doi.org/10.1136/bmj.312.7044.1437			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UQ296	11644788	Green Published			2022-12-28	WOS:A1996UQ29600007
J	ROBERTSON, I				ROBERTSON, I			TO A MAN WITH A HAMMER, EVERYTHING LOOKS LIKE A NAIL	BRITISH MEDICAL JOURNAL			English	Editorial Material											ROBERTSON, I (corresponding author), MRC,APPL PSYCHOL UNIT,CAMBRIDGE,ENGLAND.								0	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	APR 3	1993	306	6882					937	937						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KW387	11643123				2022-12-28	WOS:A1993KW38700081
J	Church, JA				Church, JA			Climate change - How fast are sea levels rising?	SCIENCE			English	Editorial Material									Antarctic CRC & CSIRO Marine Res, Hobart, Tas 7000, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Church, JA (corresponding author), Antarctic CRC & CSIRO Marine Res, Hobart, Tas 7000, Australia.		Church, John A/A-1541-2012	Church, John A/0000-0002-7037-8194				Cabanes C, 2001, SCIENCE, V294, P840, DOI 10.1126/science.1063556; Church JA, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P639; Douglas BC, 1997, SURV GEOPHYS, V18, P279, DOI 10.1023/A:1006544227856; GREGORY JM, IN PRESS CLIM DYN; LEVITUS S, 2000, NOAA ATLAS NESDIS 40	5	25	29	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2001	294	5543					802	803		10.1126/science.1065714	http://dx.doi.org/10.1126/science.1065714			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679657				2022-12-28	WOS:000171851800032
J	Levine, JA; Weisell, R; Chevassus, S; Martinez, CD; Burlingame, B; Coward, WA				Levine, JA; Weisell, R; Chevassus, S; Martinez, CD; Burlingame, B; Coward, WA			Sociology - The work burden of women	SCIENCE			English	Article									Mayo Clin & Mayo Fdn, Dept Internal Med, Div Endocrinol, Endocrine Res Unit, Rochester, MN 55905 USA; UN, Food & Agr Org, Rome, Italy; MRC, Human Nutr Res Elsie Widdowson Lab, Cambridge, England	Mayo Clinic; Food & Agriculture Organization of the United Nations (FAO); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Levine, JA (corresponding author), Mayo Clin & Mayo Fdn, Dept Internal Med, Div Endocrinol, Endocrine Res Unit, Rochester, MN 55905 USA.	levine.james@mayo.edu	Burlingame, Barbara A/H-6754-2017	Burlingame, Barbara A/0000-0002-9286-5751	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056650] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 56650] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1996, 6 WORLD FOOD SURV; COTT N, 1994, HIST WOMAN CULTURAL, P76; FAO, 2000, STATE FOOD INSECURIT; LEVINE JH, UNPUB; PELTO GH, 1989, RES METHODS NUTR ANT; Rennie KL, 1998, PUBLIC HEALTH NUTR, V1, P265, DOI 10.1079/PHN19980043	6	43	43	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					812	812		10.1126/science.1064627	http://dx.doi.org/10.1126/science.1064627			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679660				2022-12-28	WOS:000171851800035
J	Shoham, S; Halgren, E; Maynard, EM; Normann, RA				Shoham, S; Halgren, E; Maynard, EM; Normann, RA			Motor-cortical activity in tetraplegics	NATURE			English	Article							CORTEX; REORGANIZATION		Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, Charlestown, MA 02129 USA	Utah System of Higher Education; University of Utah; Harvard University; Massachusetts General Hospital	Shoham, S (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.			Shoham, Shy/0000-0003-0376-3495				Cheney PD, 2000, PROG BRAIN RES, V128, P135; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Green JB, 1999, NEUROLOGY, V53, P736, DOI 10.1212/WNL.53.4.736; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Lotze M, 1999, RESTOR NEUROL NEUROS, V14, P183; Nicolelis MAL, 2001, NATURE, V409, P403, DOI 10.1038/35053191; Nitschke MF, 1996, BRAIN, V119, P1023; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Turner JA, 2001, IEEE T NEUR SYS REH, V9, P154, DOI 10.1109/7333.928575; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	13	73	74	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					793	793		10.1038/35101651	http://dx.doi.org/10.1038/35101651			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677592	Bronze			2022-12-28	WOS:000171750200031
J	Moreira-Leite, FF; Sherwin, T; Kohl, L; Gull, K				Moreira-Leite, FF; Sherwin, T; Kohl, L; Gull, K			A trypanosome structure involved in transmitting cytoplasmic information during cell division	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; BRUCEI; CYCLE; INTERFERENCE; SEGREGATION; GLYCOPROTEIN; CYTOKINESIS; POLARITY; ADHESION; SYSTEM	African trypanosomes are protozoan parasites that cause sleeping sickness in humans through a tsetse fly vector. The procyclic form of Trypanosoma brucei has a single, attached flagellum that describes a helical path along the cell from posterior to anterior. During division, a specific flagellum-flagellum connection is elaborated between the new and old flagellum. This connector was present only during cell duplication and was found to be involved in the replication of the helical cell pattern and polarity. This finding implicates the concept of cytotaxis in cell morphogenesis in trypanosomes.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Gull, K (corresponding author), Univ Manchester, Sch Biol Sci, 2-205 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	k.gutt@man.ac.uk	Sherwin, Trevor/A-1217-2008	Sherwin, Trevor/0000-0002-9090-1034				Bastin P, 2000, J CELL SCI, V113, P3321; BASTIN P, 1996, PARASITOL TODAY, V12, P295; BEISSON J, 1965, P NATL ACAD SCI USA, V53, P275, DOI 10.1073/pnas.53.2.275; Chen T, 2000, SCIENCE, V290, P1975, DOI 10.1126/science.290.5498.1975; COOPER R, 1993, J CELL BIOL, V122, P149, DOI 10.1083/jcb.122.1.149; DOLAN MT, 1986, J CELL SCI, V80, P123; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GRIMES GW, 1982, AM ZOOL, V22, P35; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; LaCount DJ, 2000, MOL BIOCHEM PARASIT, V111, P67, DOI 10.1016/S0166-6851(00)00300-5; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Nozaki T, 1996, MOL BIOCHEM PARASIT, V82, P245, DOI 10.1016/0166-6851(96)02741-7; Ploubidou A, 1999, J CELL SCI, V112, P4641; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; SONNEBORN TM, 1964, P NATL ACAD SCI USA, V51, P915, DOI 10.1073/pnas.51.5.915; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	20	120	120	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					610	612		10.1126/science.1063775	http://dx.doi.org/10.1126/science.1063775			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641501				2022-12-28	WOS:000171695600051
J	Musser, JM; Kaplan, SL				Musser, JM; Kaplan, SL			Pneumococcal research transformed.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NIAID, Hamilton, MT 59840 USA; Baylor Coll Med, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Baylor College of Medicine	Musser, JM (corresponding author), NIAID, Hamilton, MT 59840 USA.							Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; WHITE B, 1938, BIOL PNEUMOCOCCUS BA, pR15; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001	6	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2001	345	16					1206	1207		10.1056/NEJM200110183451612	http://dx.doi.org/10.1056/NEJM200110183451612			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482YX	11642239				2022-12-28	WOS:000171605800011
J	Schon, JH; Meng, H; Bao, Z				Schon, JH; Meng, H; Bao, Z			RETRACTED: Self-assembled monolayer organic field-effect transistors (Retracted article. See vol 422 pg 92 2003)	NATURE			English	Article; Retracted Publication							ROOM-TEMPERATURE; TRANSPORT; SINGLE; ELECTRONICS; MOLECULES	The use of individual molecules as functional electronic devices was proposed in 1974 (ref. 1). Since then, advances in the field of nanotechnology have led to the fabrication of various molecule devices and devices based on monolayer arrays of molecules(2-11). Single molecule devices are expected to have interesting electronic properties, but devices based on an array of molecules are easier to fabricate and could potentially be more reliable. However, most of the previous work on array-based devices focused on two-terminal structures: demonstrating, for example, negative differential resistance(8), rectifiers(9), and re-configurable switching(10,11). It has also been proposed that diode switches containing only a few two-terminal molecules could be used to implement simple molecular electronic computer logic circuits(12). However, three-terminal devices, that is, transistors, could offer several advantages for logic operations compared to two-terminal switches, the most important of which is 'gain'-the ability to modulate the conductance. Here, we demonstrate gain for electronic transport perpendicular to a single molecular layer (similar to 10-20 Angstrom) by using a third gate electrode. Our experiments with field-effect transistors based on self-assembled monolayers demonstrate conductance modulation of more than five orders of magnitude. In addition, inverter circuits have been prepared that show a gain as high as six. The fabrication of monolayer transistors and inverters might represent an important step towards molecular-scale electronics.	Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA	Alcatel-Lucent; Lucent Technologies; AT&T	Schon, JH (corresponding author), Bell Labs, Lucent Technol, 600 Mt Ave, Murray Hill, NJ 07974 USA.	hendrik@lucent.com	Hong, Meng/T-2778-2018; Bao, Zhenan/AAC-5044-2019	Hong, Meng/0000-0001-5877-359X; Bao, Zhenan/0000-0002-0972-1715				Andres RP, 1996, SCIENCE, V272, P1323, DOI 10.1126/science.272.5266.1323; AVIRAM A, 1974, CHEM PHYS LETT, V29, P277, DOI 10.1016/0009-2614(74)85031-1; BURSHTEIN Z, 1978, J CHEM PHYS, V68, P983, DOI 10.1063/1.435837; Chen J, 2000, APPL PHYS LETT, V77, P1224, DOI 10.1063/1.1289650; Chen J, 1999, CHEM PHYS LETT, V313, P741, DOI 10.1016/S0009-2614(99)01060-X; Collier CP, 2000, SCIENCE, V289, P1172, DOI 10.1126/science.289.5482.1172; Collier CP, 1999, SCIENCE, V285, P391, DOI 10.1126/science.285.5426.391; Di Ventra M, 2000, APPL PHYS LETT, V76, P3448, DOI 10.1063/1.126673; Di Ventra M, 2000, PHYS REV LETT, V84, P979, DOI 10.1103/PhysRevLett.84.979; DODABALAPUR A, 1995, SCIENCE, V268, P270, DOI 10.1126/science.268.5208.270; Dunbar TD, 2000, J PHYS CHEM B, V104, P4880, DOI 10.1021/jp993724+; Ellenbogen JC, 2000, P IEEE, V88, P386, DOI 10.1109/5.838115; Emberly EG, 2000, PHYS REV B, V62, P10451, DOI 10.1103/PhysRevB.62.10451; Forrest S, 2000, IEEE SPECTRUM, V37, P29, DOI 10.1109/6.861775; Goldhaber-Gordon D, 1997, P IEEE, V85, P521, DOI 10.1109/5.573739; Hong S, 2000, SUPERLATTICE MICROST, V28, P289, DOI 10.1006/spmi.2000.0916; Horowitz G, 1998, ADV MATER, V10, P365, DOI 10.1002/(SICI)1521-4095(199803)10:5<365::AID-ADMA365>3.0.CO;2-U; Joachim C, 1997, CHEM PHYS LETT, V265, P353, DOI 10.1016/S0009-2614(97)00014-6; Joachim C, 2000, NATURE, V408, P541, DOI 10.1038/35046000; Karl N., 1985, LANDOLTBORNSTEIN, V17i, P106; Martel R, 1998, APPL PHYS LETT, V73, P2447, DOI 10.1063/1.122477; Metzger RM, 1999, ACCOUNTS CHEM RES, V32, P950, DOI 10.1021/ar9900663; NATORI K, 1994, J APPL PHYS, V76, P4879, DOI 10.1063/1.357263; Oh SH, 2000, INTERNATIONAL ELECTRON DEVICES MEETING 2000, TECHNICAL DIGEST, P65, DOI 10.1109/IEDM.2000.904260; RODGERS TJ, 1974, IEEE J SOLID-ST CIRC, VSC 9, P239, DOI 10.1109/JSSC.1974.1050509; Schon JH, 2000, SCIENCE, V288, P2338, DOI 10.1126/science.288.5475.2338; SZE SM, 1985, SEMICONDUCTOR PHYSIC, P431; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Tour JM, 1996, CHEM REV, V96, P537, DOI 10.1021/cr9500287; Tour JM, 2000, ACCOUNTS CHEM RES, V33, P791, DOI 10.1021/ar0000612	30	160	186	2	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					713	716		10.1038/35099520	http://dx.doi.org/10.1038/35099520			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607026				2022-12-28	WOS:000171608000038
J	Rogers, A				Rogers, A			Strasbourg - Britain denies prevarication over human-cloning ban	LANCET			English	News Item																			0	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 18	1997	350	9085					1151	1151		10.1016/S0140-6736(05)63805-6	http://dx.doi.org/10.1016/S0140-6736(05)63805-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YB199	11655107				2022-12-28	WOS:A1997YB19900031
J	Sauer, MV				Sauer, MV			An ethical dilemma - Should egg donors be paid? Exploitation or a woman's right?	BRITISH MEDICAL JOURNAL			English	Article									COLUMBIA UNIV COLL PHYS & SURG,DIV REPROD ENDOCRINOL,NEW YORK,NY 10032	Columbia University									0	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 10	1997	314	7091					1403	1403						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WZ169	11644927				2022-12-28	WOS:A1997WZ16900036
J	Elliott, C				Elliott, C			Philosopher assisted suicide and euthanasia	BRITISH MEDICAL JOURNAL			English	Editorial Material											Elliott, C (corresponding author), MCGILL UNIV,MONTREAL,PQ,CANADA.								0	9	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 26	1996	313	7064					1088	1089						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VP742	11644845				2022-12-28	WOS:A1996VP74200083
J	SHELDON, T				SHELDON, T			EUROPEAN EXPERTS PRODUCE DRAFT ON BIOETHICS	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 23	1994	309	6949					221	221		10.1136/bmj.309.6949.221	http://dx.doi.org/10.1136/bmj.309.6949.221			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NZ180	11644572				2022-12-28	WOS:A1994NZ18000009
J	Fransson, T; Jakobsson, S; Johansson, P; Kullberg, C; Lind, J; Vallin, A				Fransson, T; Jakobsson, S; Johansson, P; Kullberg, C; Lind, J; Vallin, A			Bird migration - Magnetic cues trigger extensive refuelling	NATURE			English	Article							SEA-TURTLES		Swedish Museum Nat Hist, Bird Ringing Ctr, SE-10405 Stockholm, Sweden; Stockholm Univ, Dept Zool, SE-10691 Stockholm, Sweden; Geol Survey Sweden, SE-75128 Uppsala, Sweden	Swedish Museum of Natural History; Stockholm University	Fransson, T (corresponding author), Stockholm Univ, Dept Zool, SE-10691 Stockholm, Sweden.							ABLE KP, 1993, TRENDS ECOL EVOL, V8, P367, DOI 10.1016/0169-5347(93)90221-A; Alerstam T., 1990, P331; Alerstam T, 1990, BIRD MIGRATION; BERTHOLD P, 1991, TRENDS ECOL EVOL, V6, P254, DOI 10.1016/0169-5347(91)90072-6; Berthold P, 1996, CONTROL BIRD MIGRATI; FRY CH, 1970, IBIS, V112, P58, DOI 10.1111/j.1474-919X.1970.tb00076.x; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; KULLBERG C, 1996, P R SOC LOND B, V263, P619; Lohmann KJ, 1996, NATURE, V380, P59, DOI 10.1038/380059a0; LOHMANN KJ, 1994, J EXP BIOL, V194, P23; Mandea M, 2000, GEOPHYS J INT, V141, P259; *SWED MUS NAT HIST, ANN REP SWED BIRD RI; Thorup K, 2001, J AVIAN BIOL, V32, P111, DOI 10.1034/j.1600-048X.2001.320203.x	13	125	133	2	46	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 01	2001	414	6859					35	36		10.1038/35102115	http://dx.doi.org/10.1038/35102115			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689932				2022-12-28	WOS:000171898900031
J	Cabanes, C; Cazenave, A; Le Provost, C				Cabanes, C; Cazenave, A; Le Provost, C			Sea level rise during past 40 years determined from satellite and in situ observations	SCIENCE			English	Article								The 3.2 +/- 0.2 millimeter per year global mean sea level rise observed by the Topex/Poseidon satellite over 1993-98 is fully explained by thermal expansion of the oceans. For the period 1955-96, sea level rise derived from tide gauge data agrees well with thermal expansion computed at the same locations. However, we find that subsampling the thermosteric sea level at usual tide gauge positions leads to a thermosteric sea level rise twice as large as the "true" global mean. As a possible consequence, the 20th century sea level rise estimated from tide gauge records may have been overestimated.	Ctr Natl Etud Spatiales, Lab Etud Geophys & Oceanog Spatiales, F-31400 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales	Cabanes, C (corresponding author), Ctr Natl Etud Spatiales, Lab Etud Geophys & Oceanog Spatiales, 18 Ave Edouard Belin, F-31400 Toulouse, France.							ANTONOV JI, UNPUB; Cabanes C, 2001, GEOPHYS RES LETT, V28, P9, DOI 10.1029/2000GL011962; Cazenave A, 2000, GEOPHYS RES LETT, V27, P3755, DOI 10.1029/2000GL006119; Church JA, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P639; Douglas B.C., 2001, INT GEOPHYS, P37, DOI [DOI 10.1016/S0074-6142(01)80006-1, 10.1016/S0074-6142(01)80006-1]; Douglas BC, 1997, SURV GEOPHYS, V18, P279, DOI 10.1023/A:1006544227856; FU LL, 2001, INT GEOPHYSICS SERIE, V69; Gill A., 1982, ATMOSPHERE OCEAN DYN, V30; *GLOSS, 1998, 50 GLOSS INT OC COMM, V50; Hong BG, 2000, J PHYS OCEANOGR, V30, P2088, DOI 10.1175/1520-0485(2000)030<2088:SLOTUS>2.0.CO;2; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; LEVITUS S, 2000, NOAA ATLAS NESDIS 40; Mitchell J, 2000, HUM STUD, V23, P145, DOI 10.1023/A:1005685919349; Peltier W.R., 2001, SEA LEVEL RISE HIST, P65, DOI DOI 10.1016/S0074-6142(01)80007-3	15	212	245	4	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					840	842		10.1126/science.1063556	http://dx.doi.org/10.1126/science.1063556			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679666				2022-12-28	WOS:000171851800043
J	Si, QM; Rabello, S; Ingersent, K; Smith, JL				Si, QM; Rabello, S; Ingersent, K; Smith, JL			Locally critical quantum phase transitions in strongly correlated metals	NATURE			English	Article							FERMI-LIQUID BEHAVIOR; EXTENDED HUBBARD-MODEL; MEAN-FIELD THEORY; CRITICAL-POINT; SPATIAL CORRELATIONS; SPIN; FLUCTUATIONS; TEMPERATURE; SYSTEMS; ANTIFERROMAGNETISM	When a metal undergoes a continuous quantum phase transition, non-Fermi-liquid behaviour arises near the critical point. All the low-energy degrees of freedom induced by quantum criticality are usually assumed to be spatially extended, corresponding to long-wavelength fluctuations of the order parameter. But this picture has been contradicted by the results of recent experiments on a prototype system: heavy fermion metals at a zero-temperature magnetic transition. In particular, neutron scattering from CeCu6-xAux has revealed anomalous dynamics at atomic length scales, leading to much debate as to the fate of the local moments in the quantum-critical regime. Here we report our theoretical finding of a locally critical quantum phase transition in a model of heavy fermions. The dynamics at the critical point are in agreement with experiment. We propose local criticality to be a phenomenon of general relevance to strongly correlated metals.	Rice Univ, Dept Phys & Astron, Houston, TX 77251 USA; Univ Florida, Dept Phys, Gainesville, FL 32611 USA	Rice University; State University System of Florida; University of Florida	Si, QM (corresponding author), Rice Univ, Dept Phys & Astron, Houston, TX 77251 USA.	qmsi@rice.edu		Ingersent, Kevin/0000-0001-7071-5800				Abanov A, 2000, PHYS REV LETT, V84, P5608, DOI 10.1103/PhysRevLett.84.5608; ANDERSON PW, 1961, PHYS REV, V124, P41, DOI 10.1103/PhysRev.124.41; ARONSON MC, 1995, PHYS REV LETT, V75, P725, DOI 10.1103/PhysRevLett.75.725; CHAKRAVARTY S, 1989, PHYS REV B, V39, P2344, DOI 10.1103/PhysRevB.39.2344; Chitra R, 2000, PHYS REV LETT, V84, P3678, DOI 10.1103/PhysRevLett.84.3678; Coleman P, 1999, PHYSICA B, V259-61, P353, DOI 10.1016/S0921-4526(98)00795-9; Coleman P, 2000, PHYS REV B, V62, P3852, DOI 10.1103/PhysRevB.62.3852; CONTINENTINO MA, 1993, PHYS REV B, V47, P11587, DOI 10.1103/PhysRevB.47.11587; DONIACH S, 1977, PHYSICA B & C, V91, P231, DOI 10.1016/0378-4363(77)90190-5; ESTRELA P, 2000, CONDMAT0009324; Georges A, 1996, REV MOD PHYS, V68, P13, DOI 10.1103/RevModPhys.68.13; HERTZ JA, 1976, PHYS REV B, V14, P1165, DOI 10.1103/PhysRevB.14.1165; Heuser K, 1998, PHYS REV B, V57, pR4198, DOI 10.1103/PhysRevB.57.R4198; Hewson A C, 1993, KONDO PROBLEM HEAVY; LEGGETT AJ, 1987, REV MOD PHYS, V59, P1, DOI 10.1103/RevModPhys.59.1; Lonzarich G. G., 1997, ELECTRON, P109; MAPLE MB, 1994, J LOW TEMP PHYS, V95, P225, DOI 10.1007/BF00754938; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; MILLIS AJ, 1993, PHYS REV B, V48, P7183, DOI 10.1103/PhysRevB.48.7183; RAYMOND S, 2001, CONDMAT0102427; Rosch A, 1999, PHYS REV LETT, V82, P4280, DOI 10.1103/PhysRevLett.82.4280; Rosch A, 1997, PHYS REV LETT, V79, P159, DOI 10.1103/PhysRevLett.79.159; Sachdev S, 1997, PHYS REV B, V55, P142, DOI 10.1103/PhysRevB.55.142; SACHDEV S, 1993, PHYS REV LETT, V70, P3339, DOI 10.1103/PhysRevLett.70.3339; Sachdev S., 1999, QUANTUM PHASE TRANSI; Schroder A, 1998, PHYS REV LETT, V80, P5623, DOI 10.1103/PhysRevLett.80.5623; Schroder A, 2000, NATURE, V407, P351, DOI 10.1038/35030039; Sengupta AM, 2000, PHYS REV B, V61, P4041, DOI 10.1103/PhysRevB.61.4041; Si QM, 1999, INT J MOD PHYS B, V13, P2331, DOI 10.1142/S0217979299002435; Si QM, 1996, PHYS REV LETT, V77, P3391, DOI 10.1103/PhysRevLett.77.3391; Smith JL, 1999, EUROPHYS LETT, V45, P228, DOI 10.1209/epl/i1999-00151-4; Smith JL, 2000, PHYS REV B, V61, P5184, DOI 10.1103/PhysRevB.61.5184; STEWARD G, 2001, IN PRESS REV MOD PHY, V73; Stockert O, 1998, PHYS REV LETT, V80, P5627, DOI 10.1103/PhysRevLett.80.5627; Trovarelli O, 2000, PHYS REV LETT, V85, P626, DOI 10.1103/PhysRevLett.85.626; VARMA CM, 1976, REV MOD PHYS, V48, P219, DOI 10.1103/RevModPhys.48.219; VARMA CM, 1989, PHYS REV LETT, V63, P1996, DOI 10.1103/PhysRevLett.63.1996; Vojta M, 2000, PHYS REV B, V61, P15152, DOI 10.1103/PhysRevB.61.15152; VONLOHNEYSEN H, 1994, PHYS REV LETT, V72, P3262, DOI 10.1103/PhysRevLett.72.3262; Wilson K.G., 1974, PHYS REP, V12, P75, DOI DOI 10.1016/0370-1573(74)90023-4	40	793	798	1	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2001	413	6858					804	808		10.1038/35101507	http://dx.doi.org/10.1038/35101507			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677597	Green Submitted			2022-12-28	WOS:000171750200036
J	Welch, RD; Zalenski, RJ; Frederick, PD; Malmgren, JA; Compton, S; Grzybowski, M; Thomas, S; Kowalenko, T; Every, NR				Welch, RD; Zalenski, RJ; Frederick, PD; Malmgren, JA; Compton, S; Grzybowski, M; Thomas, S; Kowalenko, T; Every, NR		Natl Registry Myocardial Infarctio	Prognostic value of a normal or nonspecific initial electrocardiogram in acute myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATIONAL REGISTRY; CHEST-PAIN; CLINICAL CHARACTERISTICS; RISK STRATIFICATION; HOSPITAL COMPLICATIONS; PLASMINOGEN-ACTIVATOR; EMERGENCY; VOLUME; CARE; ECG	Context Although previous studies have suggested that normal and nonspecific initial electrocardiograms (ECGs) are associated with a favorable prognosis for patients with acute myocardial infarction (AMI), their independent predictive value for mortality has not been examined. Objective To compare in-hospital mortality among patients with AMI who have normal or nonspecific initial ECGs with that of patients who have diagnostic ECGs. Design, Setting, and Patients Multihospital observational study in which 391208 patients with AMI met the study criteria between June 1994 and June 2000 and had ECGs that were normal (n = 30759), nonspecific (n = 137574), or diagnostic (n = 222 875; defined as ST-segment elevation or depression and/or left bundle-branch block). A logistic regression model was constructed using a propensity score for ECG findings and data on demographics, medical history, diagnostic procedures, and therapy to determine the independent prognostic value of a normal or nonspecific initial ECG. Main Outcome Measures In-hospital mortality; composite outcome of in-hospital death and life-threatening adverse events. Results In-hospital mortality rates were 5.7%, 8.7%, and 11.5% while the rates of the composite of mortality and life-threatening adverse events were 19.2%, 27.5%, and 34.9% for the normal, nonspecific, and diagnostic ECG groups, respectively. After adjusting for other predictor variables, the odds of mortality for the normal ECG group was 0.59 (95% confidence interval [CI], 0.56-0.63; P<.001) and for the nonspecific group was 0.70 (95% CI, 0.68-0.72; P<.001), compared with the diagnostic ECG group. Conclusion In this large cohort of patients with AMI, patients presenting with normal or nonspecific ECGs did have lower in-hospital mortality rates than those of patients with diagnostic ECGs, yet the absolute rates were still unexpectedly high.	Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI USA; Ovat Res Grp, Seattle, WA USA; HealthStat Conculting Inc, Seattle, WA USA; Vet Affairs Puget Sound Hlth Syst, Seattle, WA USA	Wayne State University	Welch, RD (corresponding author), Detroit Receiving Hosp & Univ Hlth Ctr, Dept Emergency Med 6GUHC, 4201 St Antoine, Detroit, MI 48201 USA.	rwelch@med.wayne.edu	Compton, Scott/AAF-5657-2020	Compton, Scott/0000-0003-3942-6490; Frederick, Paul/0000-0002-7936-5488				ANDERSEN HR, 1987, J AM COLL CARDIOL, V10, P1223, DOI 10.1016/S0735-1097(87)80122-5; Betriu A, 1997, NEW ENGL J MED, V336, P1621; Brailer DJ, 1997, MED DECIS MAKING, V17, P80, DOI 10.1177/0272989X9701700109; Braunwald E, 1994, AHCPR PUBLICATION, V94-0602, P1; BRUSH JE, 1985, NEW ENGL J MED, V312, P1137, DOI 10.1056/NEJM198505023121801; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; CANNON CP, 1994, J AM COLL CARDIOL, V24, P1602, DOI 10.1016/0735-1097(94)90163-5; Canto JG, 2000, NEW ENGL J MED, V342, P1573, DOI 10.1056/NEJM200005253422106; Canto JG, 2000, JAMA-J AM MED ASSOC, V283, P3223, DOI 10.1001/jama.283.24.3223; deBruyne MC, 1997, J CLIN EPIDEMIOL, V50, P947, DOI 10.1016/S0895-4356(97)00100-5; Every NR, 1999, J AM COLL CARDIOL, V33, P1886, DOI 10.1016/S0735-1097(99)00113-8; Fesmire FM, 1998, ANN EMERG MED, V31, P3, DOI 10.1016/S0196-0644(98)70274-4; FESMIRE FM, 1989, ARCH INTERN MED, V149, P1294, DOI 10.1001/archinte.149.6.1294; Goldberg RJ, 1998, AM J CARDIOL, V82, P259, DOI 10.1016/S0002-9149(98)00342-7; Goldman L, 1996, NEW ENGL J MED, V334, P1498, DOI 10.1056/NEJM199606063342303; Hannan EL, 1997, JAMA-J AM MED ASSOC, V277, P892, DOI 10.1001/jama.277.11.892; Holmvang L, 1999, AM HEART J, V137, P24, DOI 10.1016/S0002-8703(99)70456-4; KARLSON BW, 1991, AM J CARDIOL, V68, P171, DOI 10.1016/0002-9149(91)90739-8; KUDENCHUK PJ, 1991, J AM COLL CARDIOL, V17, P1486, DOI 10.1016/0735-1097(91)90636-N; Lee TH, 2000, NEW ENGL J MED, V342, P1187, DOI 10.1056/NEJM200004203421607; LEE TH, 1985, ARCH INTERN MED, V145, P65, DOI 10.1001/archinte.145.1.65; LEE TH, 1987, AM J CARDIOL, V60, P219, DOI 10.1016/0002-9149(87)90217-7; McCaig L F, 2000, Adv Data, P1; McCullough PA, 1998, CLIN CARDIOL, V21, P22, DOI 10.1002/clc.4960210105; Newby LK, 1996, J AM COLL CARDIOL, V27, P1646; Newby LK, 2001, CIRCULATION, V103, P1832; Nordgaard-Andersen I, 1991, Ugeskr Laeger, V153, P1049; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Roberts RR, 1997, JAMA-J AM MED ASSOC, V278, P1670, DOI 10.1001/jama.278.20.1670; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROUAN GW, 1989, AM J CARDIOL, V64, P1087, DOI 10.1016/0002-9149(89)90857-6; SANER H, 1987, SCHWEIZ MED WSCHR, V117, P1035; Savonitto S, 1999, JAMA-J AM MED ASSOC, V281, P707, DOI 10.1001/jama.281.8.707; Scull GS, 2000, J AM COLL CARDIOL, V35, P895, DOI 10.1016/S0735-1097(99)00643-9; SLATER DK, 1987, AM J CARDIOL, V60, P766, DOI 10.1016/0002-9149(87)91020-4; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Van de Werf F, 1999, LANCET, V354, P716, DOI 10.1016/S0140-6736(99)07403-6; Zalenski RJ, 1997, AM J CARDIOL, V79, P1579, DOI 10.1016/S0002-9149(97)00202-6; Zalenski RJ, 1996, ACAD EMERG MED, V3, P318, DOI 10.1111/j.1553-2712.1996.tb03444.x; ZALENSKI RJ, 1988, ANN EMERG MED, V17, P221, DOI 10.1016/S0196-0644(88)80110-0	43	68	70	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2001	286	16					1977	1984		10.1001/jama.286.16.1977	http://dx.doi.org/10.1001/jama.286.16.1977			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485JD	11667934	Bronze			2022-12-28	WOS:000171750500021
J	Marivaux, L; Welcomme, JL; Antoine, PO; Metais, G; Baloch, IM; Benammi, M; Chaimanee, Y; Ducrocq, S; Jaeger, JJ				Marivaux, L; Welcomme, JL; Antoine, PO; Metais, G; Baloch, IM; Benammi, M; Chaimanee, Y; Ducrocq, S; Jaeger, JJ			A fossil lemur from the Oligocene of Pakistan	SCIENCE			English	Article							MOLECULAR PHYLOGENY; SINGLE-ORIGIN; PRIMATE; CHEIROGALEIDAE; MADAGASCAR	In the absence of a comprehensive fossil record, the origin and early evolution of Malagasy lemurs have been subject to much uncertainty. We report here the discovery of a strepsirrhine fossil with strong cheirogaleid lemur affinities, Bugtilemur mathesoni gen. et sp. nov., from early Oligocene deposits of the Bugti Hills (Balochistan, Pakistan). Bugtilemur represents the earliest record of Lemuriformes, which hence appear to. have already diversified outside of Madagascar at least 30 million years ago. This fossil clearly enhances the critical role of the Indian subcontinent in the early diversification of lemurs and constrains paleobiogeographic models of strepsirrhine lemur evolution.	Univ Montpellier 2, CNRS, Inst Sci Evolut, Lab Paleontol,UMR 5554, F-34095 Montpellier 5, France; Univ Balochistan, Dept Geol, Quetta, Pakistan; Museum Natl Hist Nat, CNRS, Lab Paleontol, UMR 8569, F-75231 Paris 5, France; Univ Nacl Autonoma Mexico, Inst Geofis, Lab Paleomagnetismo, Mexico City 04510, DF, Mexico; Dept Mineral Resources, Geol Survey Div, Paleontol Sect, Bangkok 10400, Thailand	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Balochistan; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Universidad Nacional Autonoma de Mexico; Department of Mineral Resources - Thailand	Marivaux, L (corresponding author), Univ Montpellier 2, CNRS, Inst Sci Evolut, Lab Paleontol,UMR 5554, CC064,Pl E Bataillon, F-34095 Montpellier 5, France.	marivaux@isem.univ-montp2.fr; jaeger@isem.univ-montp2.fr	Métais, Grégoire/F-6916-2010	Benammi, Mouloud/0000-0003-4707-7518; chaimanee, yaowalak/0000-0002-8432-3880				BEARD KC, 1988, NATURE, V331, P712, DOI 10.1038/331712a0; Cartmill M., 1975, P313; CHARLESD.P, 1970, NATURE, V227, P257, DOI 10.1038/227257a0; CIOCHON RL, 1994, INTEGRATIVE PATHS PA, P37; DAGOSTO M, 1988, J HUM EVOL, V17, P35, DOI 10.1016/0047-2484(88)90048-6; Gheerbrant Emmanuel, 1993, Palaeovertebrata (Montpellier), V22, P141; Gingerich P.D., 1975, P65; Gingerich P. D., 1977, Geobios Lyon Memoire Special, VNo. 1, P165; GOODMAN M, 1994, AM J PHYS ANTHROPOL, V94, P3, DOI 10.1002/ajpa.1330940103; Gregory WK, 1915, BULL GEOL SOC AM, V26, P419; Jaeger JJ, 1999, SCIENCE, V286, P528, DOI 10.1126/science.286.5439.528; Jansa SA, 1999, CLADISTICS, V15, P253, DOI 10.1111/j.1096-0031.1999.tb00267.x; JODOT P, 1952, MEM I SCI MADAGASC D, V4, P131; Kappeler PM, 2000, FOLIA PRIMATOL, V71, P422, DOI 10.1159/000052741; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; MACPHEE RDE, 1986, VERTEBRATES PHYLOGEN, V3, P131; Martin R.D., 1990, PRIMATE ORIGINS EVOL; Martin RD, 2000, INT J PRIMATOL, V21, P1021, DOI 10.1023/A:1005563113546; McCall RA, 1997, P ROY SOC B-BIOL SCI, V264, P663, DOI 10.1098/rspb.1997.0094; Pastorini J, 2001, MOL PHYLOGENET EVOL, V19, P45, DOI 10.1006/mpev.2000.0904; Rage JC, 1996, COLLOQ SEMI, P27; Rasmussen DT, 1998, FOLIA PRIMATOL, V69, P250; ROSENBERGER AL, 1985, FOLIA PRIMATOL, V44, P15, DOI 10.1159/000156195; Ross C, 1998, J HUM EVOL, V35, P221, DOI 10.1006/jhev.1998.0254; SCHWARTZ J H, 1985, Anthropological Papers of the American Museum of Natural History, V60, P1; Simons EL, 1997, P NATL ACAD SCI USA, V94, P180, DOI 10.1073/pnas.94.1.180; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; SZALAY FS, 1973, FOLIA PRIMATOL, V19, P88, DOI 10.1159/000155535; TATTERSALL I, 1974, ANTHROPOL PAP AM MUS, V52, P137; Welcomme JL, 2001, GEOL MAG, V138, P397, DOI 10.1017/S0016756801005428; Yoder AD, 1997, EVOL ANTHROPOL, V6, P11, DOI 10.1002/(SICI)1520-6505(1997)6:1<11::AID-EVAN6>3.0.CO;2-Z; YODER AD, 1994, AM J PHYS ANTHROPOL, V94, P25, DOI 10.1002/ajpa.1330940104; Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122	33	61	65	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					587	591		10.1126/science.1065257	http://dx.doi.org/10.1126/science.1065257			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641497				2022-12-28	WOS:000171695600045
J	Jankovic, J				Jankovic, J			Medical progress: Tourette's syndrome.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; DEFICIT-HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NEUROPSYCHIATRIC DISORDERS; STREPTOCOCCAL INFECTIONS; MONOZYGOTIC TWINS; BOTULINUM TOXIN; TIC DISORDER; DOUBLE-BLIND; CHILDREN		Baylor Coll Med, Dept Neurol, Parkinsons Dis Ctr, Houston, TX 77030 USA; Baylor Coll Med, Movement Disorders Clin, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Jankovic, J (corresponding author), Baylor Coll Med, Dept Neurol, Parkinsons Dis Ctr, 6550 Fannin,Suite 1801, Houston, TX 77030 USA.							Abwender DA, 1998, BRAIN LANG, V62, P455, DOI 10.1006/brln.1998.1948; Allen AJ, 1997, CNS DRUGS, V8, P267, DOI 10.2165/00023210-199708040-00001; [Anonymous], 1999, Am J Hum Genet, V65, P1428; [Anonymous], 1994, DIAGN STAT MAN MENT, P100; BAER L, 1995, ARCH GEN PSYCHIAT, V52, P384; BARABAS G, 1984, ARCH NEUROL-CHICAGO, V41, P871, DOI 10.1001/archneur.1984.04050190077018; Berthier ML, 1996, NEUROLOGY, V47, P353, DOI 10.1212/WNL.47.2.353; Biederman J, 1999, BIOL PSYCHIAT, V46, P1234, DOI 10.1016/S0006-3223(99)00192-4; Bruun RD, 1996, J CLIN PSYCHIAT, V57, P29; Cardona F, 2001, J PEDIATR-US, V138, P71, DOI 10.1067/mpd.2001.110325; Chouinard S, 2000, J NEUROL NEUROSUR PS, V68, P738, DOI 10.1136/jnnp.68.6.738; Coffey BJ, 1997, NEUROL CLIN, V15, P277, DOI 10.1016/S0733-8619(05)70312-1; COHEN DJ, 2001, ADV NEUROLOGY, V85; COMINGS DE, 1990, J CLIN PSYCHIAT, V51, P463; Costello EJ, 1996, ARCH GEN PSYCHIAT, V53, P1129; DEMIRKIRAN M, 1995, ANN NEUROL, V38, P571, DOI 10.1002/ana.410380405; DODMAN NH, 1994, J AM VET MED ASSOC, V204, P1219; DODMAN NH, 1994, J AM VET MED ASSOC, V205, P1179; Efron D, 1997, PEDIATRICS, V100, P662, DOI 10.1542/peds.100.4.662; Eidelberg D, 1997, NEUROLOGY, V48, P927, DOI 10.1212/WNL.48.4.927; Elia J, 1999, NEW ENGL J MED, V340, P780, DOI 10.1056/NEJM199903113401007; Ernst M, 1999, J AM ACAD CHILD PSY, V38, P86, DOI 10.1097/00004583-199901000-00024; FAHN S, 1993, ARCH NEUROL-CHICAGO, V50, P1013; Farber RH, 1999, J NEUROL NEUROSUR PS, V66, P305, DOI 10.1136/jnnp.66.3.305; Feigin A, 1996, NEUROLOGY, V46, P965, DOI 10.1212/WNL.46.4.965; Flament MF, 1997, J CLIN PSYCHIAT, V58, P18; Freeman RD, 2000, DEV MED CHILD NEUROL, V42, P436, DOI 10.1017/S0012162200000839; Gadow KD, 1999, ARCH GEN PSYCHIAT, V56, P330, DOI 10.1001/archpsyc.56.4.330; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Goetz C G, 2001, Adv Neurol, V85, P31; GOETZ CG, 1992, NEUROLOGY, V42, P784, DOI 10.1212/WNL.42.4.784; Goldman LS, 1998, JAMA-J AM MED ASSOC, V279, P1100, DOI 10.1001/jama.279.14.1100; Goodman WK, 1998, PSYCHIAT ANN, V28, P641, DOI 10.3928/0048-5713-19981101-09; Grados M, 1999, CHILD ADOL PSYCH CL, V8, P617; Greenberg BD, 2000, NEUROLOGY, V54, P142, DOI 10.1212/WNL.54.1.142; Hallett JJ, 2000, J NEUROIMMUNOL, V111, P195, DOI 10.1016/S0165-5728(00)00320-9; Hallett M, 2001, Adv Neurol, V85, P237; Hamilton C S, 2001, Adv Neurol, V85, P311; Hanna PA, 1999, NEUROLOGY, V53, P813, DOI 10.1212/WNL.53.4.813; HANNA PA, IN PRESS SLEEP MOVEM; Hogan MB, 1999, J ASTHMA, V36, P253, DOI 10.3109/02770909909075408; HORRIGAN JP, 1995, J CHILD ADOL PSYCHOP, V5, P215, DOI 10.1089/cap.1995.5.215; HUNT RD, 1995, J AM ACAD CHILD PSY, V34, P50, DOI 10.1097/00004583-199501000-00013; HYDE TM, 1992, NEUROLOGY, V42, P652, DOI 10.1212/WNL.42.3.652; Jankovic J, 1998, ARCH DERMATOL, V134, P113, DOI 10.1001/archderm.134.1.113; Jankovic J, 1997, NEUROL CLIN, V15, P267, DOI 10.1016/S0733-8619(05)70311-X; Jankovic J, 1997, NEUROLOGY, V48, P358, DOI 10.1212/WNL.48.2.358; Jankovic J, 2001, Adv Neurol, V85, P15; JANKOVIC J, 1999, CURR THER, V51, P915; Klein RG, 1997, ARCH GEN PSYCHIAT, V54, P1073; Krauss JK, 1996, MOVEMENT DISORD, V11, P563, DOI 10.1002/mds.870110512; Kurlan R, 1998, NEUROLOGY, V50, P1530, DOI 10.1212/WNL.50.6.1530; KURLAN R, 1988, ARCH NEUROL-CHICAGO, V45, P1200, DOI 10.1001/archneur.1988.00520350038012; Kurlan R, 1998, MOVEMENT DISORD, V13, P178, DOI 10.1002/mds.870130136; Kushner HI, 1999, CNS SPECTRUMS, V4, P24; Kwak CH, 2000, ARCH NEUROL-CHICAGO, V57, P1190, DOI 10.1001/archneur.57.8.1190; Lang A E, 2001, Adv Neurol, V85, P355; Law SF, 1999, J AM ACAD CHILD PSY, V38, P944, DOI 10.1097/00004583-199908000-00009; Leckman J F, 2001, Adv Neurol, V85, P369; LECKMAN JF, 1994, AM J PSYCHIAT, V151, P675; Leckman JF, 1998, PEDIATRICS, V102, P14, DOI 10.1542/peds.102.1.14; LECKMAN JF, 1990, J AM ACAD CHILD PSY, V29, P220, DOI 10.1097/00004583-199003000-00010; Lichter DG, 1999, NEUROLOGY, V52, P308, DOI 10.1212/WNL.52.2.308; Manos MJ, 1999, J AM ACAD CHILD PSY, V38, P813, DOI 10.1097/00004583-199907000-00010; Marras C, 2001, NEUROLOGY, V56, P605, DOI 10.1212/WNL.56.5.605; Mason A, 1998, DEV MED CHILD NEUROL, V40, P292; Meyer P, 1999, NEUROLOGY, V53, P371, DOI 10.1212/WNL.53.2.371; Milanfranchi A, 1997, INT CLIN PSYCHOPHARM, V12, P131, DOI 10.1097/00004850-199705000-00002; Murphy TK, 1997, AM J PSYCHIAT, V154, P402; Perlmutter SJ, 1999, LANCET, V354, P1153, DOI 10.1016/S0140-6736(98)12297-3; Peterson B S, 2001, Adv Neurol, V85, P179; Peterson BS, 1998, J CLIN PSYCHIAT, V59, P62; Piacentini J, 2001, Adv Neurol, V85, P319; RAUCH SL, 1995, COMPR PSYCHIAT, V36, P141, DOI 10.1016/S0010-440X(95)90109-4; Riddle M A, 2001, Adv Neurol, V85, P343; Robertson MM, 1999, NEUROLOGY, V53, P2108, DOI 10.1212/WNL.53.9.2108; Robertson MM, 2000, BRAIN, V123, P425, DOI 10.1093/brain/123.3.425; ROBERTSON MM, 1989, BRIT J PSYCHIAT, V154, P147, DOI 10.1192/bjp.154.2.147; Rothenberger A, 2001, Adv Neurol, V85, P245; Sallee FR, 2000, J AM ACAD CHILD PSY, V39, P292, DOI 10.1097/00004583-200003000-00010; Sallee FR, 1997, AM J PSYCHIAT, V154, P1057; Scahill L, 2001, Adv Neurol, V85, P261; Scott BL, 1996, MOVEMENT DISORD, V11, P431, DOI 10.1002/mds.870110413; Singer HS, 2000, MOVEMENT DISORD, V15, P1051, DOI 10.1002/1531-8257(200011)15:6<1051::AID-MDS1001>3.0.CO;2-L; Singer HS, 1998, NEUROLOGY, V50, P1618, DOI 10.1212/WNL.50.6.1618; SINGER HS, 1995, J CHILD NEUROL, V10, pS58, DOI 10.1177/08830738950100S112; Stern E, 2000, ARCH GEN PSYCHIAT, V57, P741, DOI 10.1001/archpsyc.57.8.741; Swedo SE, 1997, AM J PSYCHIAT, V154, P110; Swerdlow N R, 2001, Adv Neurol, V85, P151; Tulen JHM, 1999, J NEUROL NEUROSUR PS, V67, P800, DOI 10.1136/jnnp.67.6.800; Vandewalle V, 1999, LANCET, V353, P724, DOI 10.1016/S0140-6736(98)05964-9; Walkup JT, 2001, NEW ENGL J MED, V344, P1279, DOI 10.1056/NEJM200104263441703; Wolf SS, 1996, SCIENCE, V273, P1225, DOI 10.1126/science.273.5279.1225; Zametkin AJ, 1999, NEW ENGL J MED, V340, P40, DOI 10.1056/NEJM199901073400107	94	295	329	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2001	345	16					1184	1192		10.1056/NEJMra010032	http://dx.doi.org/10.1056/NEJMra010032			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	482YX	11642235				2022-12-28	WOS:000171605800007
J	Warden, J				Warden, J			Xenotransplantation moves ahead in UK	BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 8	1998	317	7155					365	365						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	110YR	11645089				2022-12-28	WOS:000075409600006
J	Rankine, JJ				Rankine, JJ			Most patients don't read the BMJ	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Clever LH, 1997, JAMA-J AM MED ASSOC, V278, P628, DOI 10.1001/jama.278.8.628; Fontanarosa PB, 1997, JAMA-J AM MED ASSOC, V278, P682, DOI 10.1001/jama.278.8.682; RANKINE J, 1994, BRIT MED J, V309, P1666, DOI 10.1136/bmj.309.6969.1666a; Snider DE, 1997, JAMA-J AM MED ASSOC, V278, P624, DOI 10.1001/jama.278.8.624	4	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 28	1998	316	7136					1026	1027		10.1136/bmj.316.7136.1026a	http://dx.doi.org/10.1136/bmj.316.7136.1026a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZF034	11682717				2022-12-28	WOS:000072856100080
J	Bulford, R				Bulford, R			Personal view - Children have rights too	BRITISH MEDICAL JOURNAL			English	Editorial Material											Bulford, R (corresponding author), ARTICLE 12,8 WAKLEY ST,LONDON EC1V 7QE,ENGLAND.								0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 10	1997	314	7091					1421	1422						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WZ169	11644928				2022-12-28	WOS:A1997WZ16900077
J	Rogers, A				Rogers, A			Embryology debated in Strasbourg	LANCET			English	News Item																			0	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 4	1997	349	9044					40	40		10.1016/S0140-6736(05)62187-3	http://dx.doi.org/10.1016/S0140-6736(05)62187-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WA725	11660263				2022-12-28	WOS:A1997WA72500044
J	Goodman, N				Goodman, N			This is where I start to draw the line	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 14	1996	313	7058					696	696						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VH165	11644811				2022-12-28	WOS:A1996VH16500073
J	HARRIS, R				HARRIS, R			WHEN ETHICS DO NOT HELP	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	NOV 2	1991	303	6810					1143	1143		10.1136/bmj.303.6810.1143	http://dx.doi.org/10.1136/bmj.303.6810.1143			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GN209	11642935	Bronze, Green Published			2022-12-28	WOS:A1991GN20900077
J	Sakai, H; Honma, T; Aoyama, T; Sato, S; Kato, T; Tabata, S; Oka, A				Sakai, H; Honma, T; Aoyama, T; Sato, S; Kato, T; Tabata, S; Oka, A			ARR1, a transcription factor for genes immediately responsive to cytokinins	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; REGULATORS; EXPRESSION; PLANTS; TARGET	Cytokinins are a class of phytohormones involved in various physiological events of plants. The Arabidopsis sensor histidine kinase CRE1 was recently reported to be a cytokinin receptor. We used asteroid-inducible system to show that the transcription factor-type response regulator ARR1 directs transcriptional activation of the ARR6 gene, which responds to cytokinins without de novo protein synthesis. This fact, together with characteristics of ARR1-over-expressing plants and arr1 mutant plants, indicates that the phosphorelay to ARR1, probably from CRE1, constitutes an intracellular signal transduction occurring immediately after cytokinin perception.	Kyoto Univ, Chem Res Inst, Mol Biol Lab, Kyoto 6110011, Japan; Kazusa DNA Res Inst, Chiba 2920812, Japan	Kyoto University; Kazusa DNA Research Institute	Oka, A (corresponding author), Kyoto Univ, Chem Res Inst, Mol Biol Lab, Kyoto 6110011, Japan.		Sato, Shusei/A-3616-2015	Sato, Shusei/0000-0002-0293-5366				Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; HUA J, 1995, SCIENCE, V269, P1712, DOI 10.1126/science.7569898; Imamura A, 1999, PLANT CELL PHYSIOL, V40, P733, DOI 10.1093/oxfordjournals.pcp.a029600; Imamura A, 1998, P NATL ACAD SCI USA, V95, P2691, DOI 10.1073/pnas.95.5.2691; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Kubo M, 2000, PLANT J, V23, P385, DOI 10.1046/j.1365-313x.2000.00796.x; Lohrmann J, 1999, PLANT BIOLOGY, V1, P495, DOI 10.1111/j.1438-8677.1999.tb00775.x; MCKINNEY EC, 1995, PLANT J, V8, P613, DOI 10.1046/j.1365-313X.1995.8040613.x; Mok MC., 1994, CYTOKININS CHEM ACTI, P155, DOI DOI 10.1201/9781351071284; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P493, DOI DOI 10.1111/J.1399-3054.1962.TB08052.X; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Sakai H, 1998, PLANT CELL PHYSIOL, V39, P1232, DOI 10.1093/oxfordjournals.pcp.a029325; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; SAKAI H, UNPUB; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; Taniguchi M, 1998, FEBS LETT, V429, P259, DOI 10.1016/S0014-5793(98)00611-5; Urao T, 1999, PLANT CELL, V11, P1743, DOI 10.1105/tpc.11.9.1743; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582	25	355	375	6	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1519	1521		10.1126/science.1065201	http://dx.doi.org/10.1126/science.1065201			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11691951				2022-12-28	WOS:000172240500046
J	Brixner, T; Damrauer, NH; Niklaus, P; Gerber, G				Brixner, T; Damrauer, NH; Niklaus, P; Gerber, G			Photoselective adaptive femtosecond quantum control in the liquid phase	NATURE			English	Article							COHERENT CONTROL; CHARGE-TRANSFER; OPTIMIZATION; EXCITATION; FREQUENCY; DYNAMICS	Coherent light sources can be used to manipulate the outcome of light-matter interactions by exploiting interference phenomena in the time and frequency domain. A powerful tool in this emerging field of 'quantum control'(1-6) is the adaptive shaping of femtosecond laser pulses(7-10), resulting, for instance, in selective molecular excitation. The basis of this method is that the quantum system under investigation itself guides an automated search, via iteration loops, for coherent light fields best suited for achieving a control task designed by the experimenter(11). The method is therefore ideal for the control of complex experiments(7,12-20). To date, all demonstrations of this technique on molecular systems have focused on controlling the outcome of photo-induced reactions in identical molecules, and little attention has been paid to selectively controlling mixtures of different molecules. Here we report simultaneous but selective multi-photon excitation of two distinct electronically and structurally complex dye molecules in solution. Despite the failure of single parameter variations (wavelength, intensity, or linear chirp control), adaptive femtosecond pulse shaping can reveal complex laser fields to achieve chemically selective molecular excitation. Furthermore, our results prove that phase coherences of the solute molecule persist for more than 100 fs in the solvent environment.	Univ Wurzburg, Inst Phys, D-97074 Wurzburg, Germany	University of Wurzburg	Gerber, G (corresponding author), Univ Wurzburg, Inst Phys, D-97074 Wurzburg, Germany.	gerber@physik.uni-wuerzburg.de	Brixner, Tobias/S-1451-2016	Brixner, Tobias/0000-0002-6529-704X				Assion A, 1996, CHEM PHYS LETT, V259, P488, DOI 10.1016/0009-2614(96)00741-5; Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; BARDEEN CJ, 1995, PHYS REV LETT, V75, P3410, DOI 10.1103/PhysRevLett.75.3410; Bardeen CJ, 1997, CHEM PHYS LETT, V280, P151, DOI 10.1016/S0009-2614(97)01081-6; Bartels R, 2000, NATURE, V406, P164, DOI 10.1038/35018029; Baumert T, 1997, APPL PHYS B-LASERS O, V65, P779, DOI 10.1007/s003400050346; Brixner T, 1999, APPL PHYS B-LASERS O, V68, P281, DOI 10.1007/s003400050618; Brixner T, 2001, CHEM PHYS, V267, P241, DOI 10.1016/S0301-0104(01)00223-3; Brixner T, 2001, ADV ATOM MOL OPT PHY, V46, P1, DOI 10.1016/S1049-250X(01)80062-8; BROERS B, 1992, PHYS REV LETT, V69, P2062, DOI 10.1103/PhysRevLett.69.2062; Cerullo G, 1996, CHEM PHYS LETT, V262, P362, DOI 10.1016/0009-2614(96)01092-5; Damrauer NH, 1999, J PHYS CHEM A, V103, P8440, DOI 10.1021/jp9927754; Damrauer NH, 1997, J AM CHEM SOC, V119, P8253, DOI 10.1021/ja971321m; Hornung T, 2000, CHEM PHYS LETT, V326, P445, DOI 10.1016/S0009-2614(00)00810-1; JUDSON RS, 1992, PHYS REV LETT, V68, P1500, DOI 10.1103/PhysRevLett.68.1500; Kunde J, 2000, APPL PHYS LETT, V77, P924, DOI 10.1063/1.1288603; LALOVIC D, 1992, PHYS REV A, V46, P1206, DOI 10.1103/PhysRevA.46.1206; Levis RJ, 2001, SCIENCE, V292, P709, DOI 10.1126/science.1059133; Meshulach D, 1999, PHYS REV A, V60, P1287, DOI 10.1103/PhysRevA.60.1287; Meshulach D, 1998, NATURE, V396, P239, DOI 10.1038/24329; MEYER M, 1990, J PHYS CHEM-US, V94, P98, DOI 10.1021/j100364a015; Rabitz H, 2000, SCIENCE, V288, P824, DOI 10.1126/science.288.5467.824; Rice S. A., 2000, OPTICAL CONTROL MOL; Shapiro M, 2000, ADV ATOM MOL OPT PHY, V42, P287, DOI 10.1016/S1049-250X(08)60189-5; TANNOR DJ, 1985, J CHEM PHYS, V83, P5013, DOI 10.1063/1.449767; WARREN WS, 1993, SCIENCE, V259, P1581, DOI 10.1126/science.259.5101.1581; Weinacht TC, 1999, J PHYS CHEM A, V103, P10166, DOI 10.1021/jp991977x; Weinacht TC, 1999, NATURE, V397, P233, DOI 10.1038/16654; Weiner AM, 2000, REV SCI INSTRUM, V71, P1929, DOI 10.1063/1.1150614; Yelin D, 1997, OPT LETT, V22, P1793, DOI 10.1364/OL.22.001793	30	386	397	2	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					57	60		10.1038/35102037	http://dx.doi.org/10.1038/35102037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689940				2022-12-28	WOS:000171898900039
J	Cheah, J				Cheah, J			Chronic disease management: a Singapore perspective	BRITISH MEDICAL JOURNAL			English	Article							CHRONIC ILLNESS; CARE		Natl Univ Singapore, Dept Community Occupat & Family Med, Singapore 119074, Singapore	National University of Singapore	Cheah, J (corresponding author), Natl Univ Singapore, Dept Community Occupat & Family Med, Singapore 119074, Singapore.							COUCH JB, 1997, PHYSICIANS GUIDE DIS; ELLRODT G, 1997, JAMA-J AM MED ASSOC, V278, P687; FRIEDMAN N, 1999, DIS MANAGEMENT HLTH, V6, P355; FULLER MG, 1999, DIS MANAG HEALTH OUT, V6, P29; Ketner L, 1999, Healthc Financ Manage, V53, P36; KONGSTVEDT PR, 1998, BEST PRACTICES MED M; Leider H.L, 1999, DIS MANAG HEALTH OUT, V6, P327, DOI [10.2165/00115677-199906060-00003, DOI 10.2165/00115677-199906060-00003]; *MIN COMM DEV MIN, 1999, REP INT COMM AG POP; *MIN HLTH, 2001, ANN REP 2000; STONE RE, 1999, DIS MANAGEMENT HLTH, V5, P145; TODD W, 1997, DIS MANAGEMENT SYSTE; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569	14	36	38	6	19	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2001	323	7319					990	993		10.1136/bmj.323.7319.990	http://dx.doi.org/10.1136/bmj.323.7319.990			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488CU	11679392	Green Published			2022-12-28	WOS:000171918500023
J	Maurer, SM; Hugenholtz, PB; Onsrud, HJ				Maurer, SM; Hugenholtz, PB; Onsrud, HJ			Intellectual property - Europe's database experiment	SCIENCE			English	Editorial Material									Univ Maine, Dept Spatial Informat Studies, Orono, ME 04469 USA; Univ Amsterdam, Inst Informat Law, NL-1012 KX Amsterdam, Netherlands	University of Maine System; University of Maine Orono; University of Amsterdam	Maurer, SM (corresponding author), 2632 Hilgard St, Berkeley, CA 94709 USA.							BENDEGKEY L, COMMUNICATION; BENKLER Y, 2000, BERKELEY TECHNOL LAW, V15, P435; FIRESTONE RB, COMMUNICATION; *GAL GROUP, GAL DIR DAT; GASTER J, COMMUNICATION; HEYDEN T, 2000, COPYRIGHT WORLD, V102, P7; Hugenholtz P.B., 1998, INTELLECTUAL PROPERT, P183; HUGENHOLTZ PB, 2001, NEW DATABASE RIGHT E; MAURER S, 1998, 9811 SER LAW EC; MAURER S, 2001, IN PRESS INTELLECTUA; Maurer SM, 1999, SCIENCE, V284, P1129, DOI 10.1126/science.284.5417.1129; REICHMAN J, COMMUNICATION; REINBOTHE J, 1999, WIPOS PROT DAT WORKS	13	41	41	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2001	294	5543					789	790		10.1126/science.1062695	http://dx.doi.org/10.1126/science.1062695			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679651	Green Submitted			2022-12-28	WOS:000171851800024
J	Schneier, B				Schneier, B			Protecting privacy and liberty	NATURE			English	Editorial Material									Counterpane Internet Secur, Cupertino, CA 95014 USA		Schneier, B (corresponding author), Counterpane Internet Secur, 19050 Pruneridge Ave, Cupertino, CA 95014 USA.								0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					773	773		10.1038/35101663	http://dx.doi.org/10.1038/35101663			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677576				2022-12-28	WOS:000171750200020
J	West, M; Menke, W; Tolstoy, M; Webb, S; Sohn, R				West, M; Menke, W; Tolstoy, M; Webb, S; Sohn, R			Magma storage beneath axial volcano on the Juan de Fuca mid-ocean ridge	NATURE			English	Article							EAST PACIFIC RISE; DE-FUCA; PARTIAL MELT; SEA-FLOOR; GROUND DEFORMATION; SEISMIC TOMOGRAPHY; VELOCITY STRUCTURE; 1998 ERUPTION; ROCKS; TEMPERATURE	Axial volcano, which is located near the intersection of the Juan de Fuca ridge and the Cobb-Eickelberg seamount chain beneath the northeast Pacific Ocean, is a locus of volcanic activity thought to be associated with the Cobb hotspot(1). The volcano rises 700 metres above the ridge, has substantial rift zones extending about 50 kilometres to the north and south, and has erupted as recently as 1998 (ref. 2). Here we present seismological data that constrain the three-dimensional velocity structure beneath the volcano. We image a large low-velocity zone in the crust, consisting of a shallow magma chamber and a more diffuse reservoir in the lower crust, and estimate the total magma volume in the system to be between 5 and 21 km(3). This volume is two orders of magnitude larger than the amount of melt emplaced during the most recent eruption(3,4) (0.1-0.2 km(3)). We therefore infer that such volcanic events remove only a small portion of the reservoir that they tap, which must accordingly be long-lived compared to the eruption cycle. On the basis of magma flux estimates, we estimate the crustal residence time of melt in the volcanic system to be a few hundred to a few thousand years.	Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Columbia University; Columbia University; Woods Hole Oceanographic Institution	West, M (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.			Webb, Spahr/0000-0002-7277-174X; Sohn, Robert/0000-0002-9050-8603				Canales JP, 2000, J GEOPHYS RES-SOL EA, V105, P28411, DOI 10.1029/2000JB900301; Chadwick WW, 1999, GEOPHYS RES LETT, V26, P3441, DOI 10.1029/1999GL900498; CHEN WP, 1983, J GEOPHYS RES, V88, P4183, DOI 10.1029/JB088iB05p04183; CHRISTENSEN NI, 1979, J GEOPHYS RES, V84, P6849, DOI 10.1029/JB084iB12p06849; CUDRAK CF, 1993, J GEOPHYS RES-SOL EA, V98, P6329, DOI 10.1029/92JB02860; Dawson PB, 1999, GEOPHYS RES LETT, V26, P2805, DOI 10.1029/1999GL005379; DESONIE DL, 1990, J GEOPHYS RES-SOLID, V95, P12697, DOI 10.1029/JB095iB08p12697; Dunn RA, 2000, J GEOPHYS RES-SOL EA, V105, P23537, DOI 10.1029/2000JB900210; Dziak RP, 1999, GEOPHYS RES LETT, V26, P3429, DOI 10.1029/1999GL002332; Dziak RP, 1999, GEOPHYS RES LETT, V26, P3641, DOI 10.1029/1999GL002326; Embley RW, 1999, GEOPHYS RES LETT, V26, P3425, DOI 10.1029/1999GL002328; Fox CG, 2001, NATURE, V412, P727, DOI 10.1038/35089066; Fox CG, 1999, GEOPHYS RES LETT, V26, P3437, DOI 10.1029/1999GL900491; Hammond WC, 2000, J GEOPHYS RES-SOL EA, V105, P10975, DOI 10.1029/2000JB900041; HENSTOCK TJ, 1993, J GEOPHYS RES-SOL EA, V98, P4143, DOI 10.1029/92JB02661; HILDEBRAND JA, 1990, J GEOPHYS RES-SOLID, V95, P12751, DOI 10.1029/JB095iB08p12751; HOOFT EEE, 1995, J GEOPHYS RES-SOL EA, V100, P22499, DOI 10.1029/95JB02502; HUANG PY, 1988, J GEOPHYS RES-SOLID, V93, P13445, DOI 10.1029/JB093iB11p13445; JOHNSON HP, 1990, J GEOPHYS RES-SOLID, V95, P12689, DOI 10.1029/JB095iB08p12689; KAMPFMANN W, 1985, PHYS EARTH PLANET IN, V40, P223, DOI 10.1016/0031-9201(85)90132-3; KARATO S, 1993, GEOPHYS RES LETT, V20, P1623, DOI 10.1029/93GL01767; Mainprice D, 1997, TECTONOPHYSICS, V279, P161, DOI 10.1016/S0040-1951(97)00122-4; RHODES JM, 1990, J GEOPHYS RES-SOLID, V95, P12713, DOI 10.1029/JB095iB08p12713; SATO H, 1989, J GEOPHYS RES-SOLID, V94, P5689, DOI 10.1029/JB094iB05p05689; SCHMELING H, 1985, PHYS EARTH PLANET IN, V41, P34, DOI 10.1016/0031-9201(85)90100-1; SINTON JM, 1992, J GEOPHYS RES-SOL EA, V97, P197, DOI 10.1029/91JB02508; Sohn RA, 1997, J GEOPHYS RES-SOL EA, V102, P17679, DOI 10.1029/97JB00592; TOLSTOY M, UNPUB GEOLOGY; Webb SC, 2001, B SEISMOL SOC AM, V91, P304, DOI 10.1785/0120000110; WILCOCK WSD, 1993, J GEOPHYS RES-SOL EA, V98, P19913, DOI 10.1029/93JB01820	30	66	67	0	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					833	836		10.1038/35101581	http://dx.doi.org/10.1038/35101581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677604				2022-12-28	WOS:000171750200043
J	Wilson, JS; Dhoot, AS; Seeley, AJAB; Khan, MS; Kohler, A; Friend, RH				Wilson, JS; Dhoot, AS; Seeley, AJAB; Khan, MS; Kohler, A; Friend, RH			Spin-dependent exciton formation in pi-conjugated compounds	NATURE			English	Article							LIGHT-EMITTING-DIODES; CONTAINING POLY-YNES; LOWEST SINGLET; TRIPLET-STATES; ELECTROLUMINESCENCE; PLATINUM; RECOMBINATION; EFFICIENCY; RINGS	The efficiency of light-emitting diodes (LEDs) made from organic semiconductors is determined by the fraction of injected electrons and holes that recombine to form emissive spin-singlet states rather than non-emissive spin-triplet states. If the process by which these states form is spin-independent, the maximum efficiency of organic LEDs will be limited to 25 per cent(1). But recent reports have indicated fractions of emissive singlet states ranging from 22 to 63 per cent(2-5), and the reason for this variation remains unclear. Here we determine the absolute fraction of singlet states generated in a platinum-containing conjugated polymer and its corresponding monomer. The spin-orbit coupling introduced by the platinum atom allows triplet-state emission, so optically and electrically generated luminescence from both singlet and triplet states can be compared directly. We rnd an average singlet generation fraction of 22 +/- 1 per cent for the monomer, but 57 +/- 4 per cent for the polymer. This suggests that recombination is spin-independent for the monomer, but that a spin-dependent process, favouring singlet formation, is effective in the polymer. We suggest that this process is a consequence of the exchange interaction, which will operate on overlapping electron and hole wavefunctions on the same polymer chain at their capture radius.	Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; Sultan Qaboos Univ, Dept Chem, Al Khoud 123, Oman	University of Cambridge; Sultan Qaboos University	Kohler, A (corresponding author), Univ Cambridge, Cavendish Lab, Madingley Rd, Cambridge CB3 0HE, England.		Khan, Muhammad/AEO-1663-2022; Köhler, Anna/B-5447-2013	Khan, Muhammad/0000-0001-5606-6832; Köhler, Anna/0000-0001-5029-4420; Friend, Richard Henry/0000-0001-6565-6308				Baldo MA, 1999, PHYS REV B, V60, P14422, DOI 10.1103/PhysRevB.60.14422; Becker H, 1997, PHYS REV B, V56, P1893, DOI 10.1103/PhysRevB.56.1893; BELJONNE D, 1995, J CHEM PHYS, V102, P2042, DOI 10.1063/1.468726; Beljonne D, 1996, J CHEM PHYS, V105, P3868, DOI 10.1063/1.472207; Blom PWM, 1997, APPL PHYS LETT, V71, P930, DOI 10.1063/1.119692; Burin AL, 1998, J CHEM PHYS, V109, P6092, DOI 10.1063/1.477236; Cao Y, 1999, NATURE, V397, P414, DOI 10.1038/17087; Chawdhury N, 1998, MACROMOLECULES, V31, P722, DOI 10.1021/ma971267u; Chawdhury N, 1999, J CHEM PHYS, V110, P4963, DOI 10.1063/1.478382; Friend RH, 1999, NATURE, V397, P121, DOI 10.1038/16393; Hertel D, 2001, ADV MATER, V13, P65, DOI 10.1002/1521-4095(200101)13:1<65::AID-ADMA65>3.0.CO;2-Q; Ho PKH, 2000, NATURE, V404, P481, DOI 10.1038/35006610; HONG T, 2001, PHYS REV B; Kim JS, 2000, J APPL PHYS, V88, P1073, DOI 10.1063/1.373779; Kobrak MN, 2000, PHYS REV B, V62, P11473, DOI 10.1103/PhysRevB.62.11473; POPE M, 1999, ELECT PROCESSES ORGA, P958; Romanovskii YV, 2000, PHYS REV LETT, V84, P1027, DOI 10.1103/PhysRevLett.84.1027; Shuai Z, 2000, PHYS REV LETT, V84, P131, DOI 10.1103/PhysRevLett.84.131; Turro NJ, 1991, MODERN MOL PHOTOCHEM, P1; Wilson JS, 2000, J CHEM PHYS, V113, P7627, DOI 10.1063/1.1313527; Wilson JS, 2001, J AM CHEM SOC, V123, P9412, DOI 10.1021/ja010986s; WITTMANN HF, 1994, J CHEM PHYS, V101, P2693, DOI 10.1063/1.467650; Wohlgenannt M, 2001, NATURE, V409, P494, DOI 10.1038/35054025	23	433	443	0	104	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					828	831		10.1038/35101565	http://dx.doi.org/10.1038/35101565			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677602				2022-12-28	WOS:000171750200041
J	Chaudhuri, TK; Farr, GW; Fenton, WA; Rospert, S; Horwich, AL				Chaudhuri, TK; Farr, GW; Fenton, WA; Rospert, S; Horwich, AL			GroEL/GroES-mediated folding of a protein too large to be encapsulated	CELL			English	Article							THERMODYNAMIC COUPLING MECHANISM; CHAPERONIN GROEL; MOLECULAR CHAPERONES; ESCHERICHIA-COLI; BINDING; SUBSTRATE; POLYPEPTIDE; ATP; INTERMEDIATE; ACONITASE	The chaperonin GroEL binds nonnative proteins too large to fit inside the productive GroEL-GroES cis cavity, but whether and how it assists their folding has remained unanswered. We have examined yeast mitochondrial aconitase, an 82 kDa monomeric Fe4S4 cluster-containing enzyme, observed to aggregate in chaperonin-deficient mitochondria. We observed that aconitase folding both in vivo and in vitro requires both GroEL and GroES, and proceeds via multiple rounds of binding and release. Unlike the folding of smaller substrates, however, this mechanism does not involve cis encapsulation but, rather, requires GroES binding to the trans ring to release nonnative substrate, which likely folds in solution. Following the phase of ATP/ GroES-dependent refolding, GroEL stably bound apoaconitase, releasing active holoenzyme upon Fe4S4 co-factor formation, independent of ATP and GroES.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; MPI Enxymol Prot Folding, D-06120 Halle Saale, Germany	Howard Hughes Medical Institute; Yale University; Yale University	Horwich, AL (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06510 USA.			Rospert, Sabine/0000-0002-3089-9614				Bhutani N, 2000, J MOL BIOL, V297, P1037, DOI 10.1006/jmbi.2000.3648; BRUNSCHIER R, 1993, J BIOL CHEM, V268, P2767; Burston SG, 1996, NATURE, V383, P96, DOI 10.1038/383096a0; Chuang JL, 1999, J BIOL CHEM, V274, P10395, DOI 10.1074/jbc.274.15.10395; Clark AC, 1999, J MOL BIOL, V285, P1777, DOI 10.1006/jmbi.1998.2403; Coyle JE, 1999, NAT STRUCT BIOL, V6, P683; Dubaquie Y, 1998, EMBO J, V17, P5868, DOI 10.1093/emboj/17.20.5868; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; Feltham JL, 2000, CELL, V100, P193, DOI 10.1016/S0092-8674(00)81557-3; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GORDON CL, 1994, J BIOL CHEM, V269, P27941; Horovitz A, 1998, CURR OPIN STRUC BIOL, V8, P93, DOI 10.1016/S0959-440X(98)80015-8; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Huang YS, 1999, J BIOL CHEM, V274, P10405, DOI 10.1074/jbc.274.15.10405; Iametti S, 2001, EUR J BIOCHEM, V268, P2421, DOI 10.1046/j.1432-1327.2001.02130.x; KENNEDY MC, 1988, J BIOL CHEM, V263, P8194; KENT TA, 1985, J BIOL CHEM, V260, P6871; LAUBLE H, 1992, BIOCHEMISTRY-US, V31, P2735, DOI 10.1021/bi00125a014; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MORRISON JF, 1954, BIOCHEM J, V58, P685, DOI 10.1042/bj0580685; RANSON NA, 1995, J MOL BIOL, V250, P581, DOI 10.1006/jmbi.1995.0399; Ranson NA, 1997, J MOL BIOL, V266, P656, DOI 10.1006/jmbi.1996.0815; Ribbe MW, 2001, P NATL ACAD SCI USA, V98, P5521, DOI 10.1073/pnas.101119498; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Song JL, 2000, J BIOL CHEM, V275, P22305, DOI 10.1074/jbc.M002038200; VIITANEN PV, 1992, PROTEIN SCI, V1, P363; Walter S, 1996, P NATL ACAD SCI USA, V93, P9425, DOI 10.1073/pnas.93.18.9425; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; Yifrach O, 1996, J MOL BIOL, V255, P356, DOI 10.1006/jmbi.1996.0028; Zahn R, 1996, SCIENCE, V271, P642, DOI 10.1126/science.271.5249.642; ZAHN R, 1994, J MOL BIOL, V242, P165, DOI 10.1006/jmbi.1994.1567	38	139	142	1	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					235	246		10.1016/S0092-8674(01)00523-2	http://dx.doi.org/10.1016/S0092-8674(01)00523-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672530	Bronze			2022-12-28	WOS:000171694800012
J	Wild, K; Sinning, I; Cusack, S				Wild, K; Sinning, I; Cusack, S			Crystal structure of an early protein-RNA assembly complex of the signal recognition particle	SCIENCE			English	Article							SITE-DIRECTED MUTAGENESIS; RIBOSOMAL-RNA; BINDING; DOMAIN; SRP19; IDENTIFICATION; TRANSLOCATION; TETRALOOPS; SEQUENCE; LOOP	The signal recognition particle (SRP) is a universally conserved ribonucleoprotein complex that mediates the cotranslational targeting of secretory and membrane proteins to cellular membranes. A crucial early step in SRP assembly in archaea and eukarya is the binding of protein SRP19 to specific sites on SRP RNA. Here we report the 1.8 angstrom resolution crystal structure of human SRP19 in complex with its primary binding site on helix 6 of SRP RNA, which consists of a stem-loop structure closed by an unusual GGAG tetraloop. Protein-RNA interactions are mediated by the specific recognition of a widened major groove and the tetraloop without any direct protein-base contacts and include a complex network of highly ordered water molecules. A model of the assembly of the SRP core comprising SRP19, SRP54, and SRP RNA based on crystallographic and biochemical data is proposed.	Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany; European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble, France	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Wild, K (corresponding author), Univ Heidelberg, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	klemens.wild@bzh.uni-heidelberg.de	Sinning, Irmgard/A-2982-2010	Cusack, Stephen/0000-0002-9324-0796				Agalarov SC, 2000, SCIENCE, V288, P107, DOI 10.1126/science.288.5463.107; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Birse DEA, 1997, EMBO J, V16, P3757, DOI 10.1093/emboj/16.13.3757; Black SD, 1997, EUR J BIOCHEM, V245, P564, DOI 10.1111/j.1432-1033.1997.00564.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; CHITTENDEN K, 1994, J BIOL CHEM, V269, P20497; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; Diener JL, 2000, BIOCHEMISTRY-US, V39, P12862, DOI 10.1021/bi001180s; Doherty EA, 2001, NAT STRUCT BIOL, V8, P339, DOI 10.1038/86221; Esnouf R. M., 1997, J MOL GRAPHICS, V15, P133; GLUCK A, 1992, J MOL BIOL, V226, P411, DOI 10.1016/0022-2836(92)90956-K; Gowda K, 1997, NUCLEIC ACIDS RES, V25, P2835, DOI 10.1093/nar/25.14.2835; HAUSER S, 1995, EMBO J, V14, P5485, DOI 10.1002/j.1460-2075.1995.tb00235.x; Jagath JR, 2001, RNA, V7, P293, DOI 10.1017/S1355838201002205; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jucker FM, 1996, J MOL BIOL, V264, P968, DOI 10.1006/jmbi.1996.0690; LUTCKE H, 1995, EUR J BIOCHEM, V228, P531, DOI 10.1111/j.1432-1033.1995.0531m.x; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Canadillas JM, 2001, CURR OPIN STRUC BIOL, V11, P53, DOI 10.1016/S0959-440X(00)00164-0; PLEY HW, 1994, NATURE, V372, P111, DOI 10.1038/372111a0; Politz JC, 2000, P NATL ACAD SCI USA, V97, P55, DOI 10.1073/pnas.97.1.55; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; ROMISCH K, 1990, J CELL BIOL, V111, P1793, DOI 10.1083/jcb.111.5.1793; Rose MA, 2001, NAT STRUCT BIOL, V8, P515, DOI 10.1038/88577; UHLENBECK OC, 1990, NATURE, V346, P613, DOI 10.1038/346613a0; WALTER P, 1983, CELL, V34, P525, DOI 10.1016/0092-8674(83)90385-9; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Wild K, 1999, STRUCTURE, V7, P1345, DOI 10.1016/S0969-2126(00)80024-6; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467; ZWIEB C, 1992, J BIOL CHEM, V267, P15650; Zwieb C, 1997, NUCLEIC ACIDS RES, V25, P107, DOI 10.1093/nar/25.1.107	34	65	68	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					598	601		10.1126/science.1063839	http://dx.doi.org/10.1126/science.1063839			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641499				2022-12-28	WOS:000171695600048
J	Hall, AJ				Hall, AJ			Ecological studies and debate on rotavirus vaccine and intussusception	LANCET			English	Editorial Material									Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Hall, AJ (corresponding author), Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, Keppel St, London WC1E 7HT, England.							Kramarz P, 2001, PEDIATR INFECT DIS J, V20, P410, DOI 10.1097/00006454-200104000-00008; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; ROSE GA, 1985, EPIDEMIOLOGY HYPERTE, V6, P1	3	14	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1197	1198		10.1016/S0140-6736(01)06337-1	http://dx.doi.org/10.1016/S0140-6736(01)06337-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675051				2022-12-28	WOS:000171527000003
J	Park, M				Park, M			Durer's The Birth of the Virgin: art and midwifery in 16th century Nuremberg	LANCET			English	Editorial Material									Univ Glasgow, Dept Adult & Continuing Educ, Glasgow G3 1LP, Lanark, Scotland	University of Glasgow	Park, M (corresponding author), 1 Melford Ave, Glasgow G46 6NA, Lanark, Scotland.							DEVORAGINE J, 1260, LEGENDA AUREA; DIXON LS, 1995, PERILOUS CHASTITY, P114; GELIS J, 1991, HIST CHILDBIRTH, P96; Kramer H., 1486, MALLEUS MALEFICARUM; MARLAND H, 1993, ART MIDWIFERY EARLY, P78; METLINGER B, 1473, REGIMENT JUNGEN KIND; PORTER R, 1997, GREATEST BENEFIT MAN, P129; Rosslin E., 1513, SWANGERN FRAUWEN HEB; ROSSLIN E, 1540, BYRTH MANKYNDE BOOK; Rosslin Eucharius, 1545, BYRTH MANKYNDE; Temkin O., 1991, SORANUS GYNAECOLOGY; WEISNER ME, 1986, WORKING WOMEN RENAIS, P83; WEISNER ME, 1986, WORKING WOMEN RENAIS, P79	13	0	0	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1265	1267		10.1016/S0140-6736(01)06352-8	http://dx.doi.org/10.1016/S0140-6736(01)06352-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675084				2022-12-28	WOS:000171527000034
J	Ziman, J				Ziman, J			Why must scientists become more ethically sensitive than they used to be?	SCIENCE			English	Editorial Material											Ziman, J (corresponding author), 27 Little London Green, Aylesbury HP18 9QL, Bucks, England.								0	50	52	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 4	1998	282	5395					1813	1814		10.1126/science.282.5395.1813	http://dx.doi.org/10.1126/science.282.5395.1813			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144WG	11645122				2022-12-28	WOS:000077338100015
J	Mitchell, P				Mitchell, P			Human xenotransplantation trials may be licensed in the UK	LANCET			English	News Item																			0	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON WC1B 3SL, ENGLAND	0140-6736			LANCET	Lancet	AUG 8	1998	352	9126					464	464		10.1016/S0140-6736(05)79206-0	http://dx.doi.org/10.1016/S0140-6736(05)79206-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108EA	11656949				2022-12-28	WOS:000075252000036
J	Welsh, J				Welsh, J			Sins of youth	BRITISH MEDICAL JOURNAL			English	Editorial Material											Welsh, J (corresponding author), AMNESTY INT,MED PROGRAMME,LONDON,ENGLAND.								0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 15	1996	312	7045					1548	1548		10.1136/bmj.312.7045.1548	http://dx.doi.org/10.1136/bmj.312.7045.1548			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UR823	11644784	Green Published			2022-12-28	WOS:A1996UR82300085
J	Lister, AM; Sher, AV				Lister, AM; Sher, AV			The origin and evolution of the woolly mammoth	SCIENCE			English	Article								The mammoth lineage provides an example of rapid adaptive evolution in response to the changing environments of the Pleistocene. Using welt-dated samples from across the mammoth's Eurasian range, we document geographical and chronological variation in adaptive morphology. This work illustrates an incremental (if mosaic) evolutionary sequence but also reveals a complex interplay of local morphological innovation, migration, and extirpation in the origin and evolution of a mammalian species. In particular, northeastern Siberia is identified as an area of successive allopatric innovations that apparently spread to Europe, where they contributed to a complex pattern of stasis, replacement, and transformation.	UCL, Dept Biol, London WC1E 6BT, England; Russian Acad Sci, Severtsov Inst Ecol & Evolut, Moscow 117071, Russia	University of London; University College London; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution	Lister, AM (corresponding author), UCL, Dept Biol, London WC1E 6BT, England.	a.lister@ucl.ac.uk		Lister, Adrian/0000-0002-7985-138X				Azzaroli A, 1977, MEMORIE CLASSE SCI F, V14, P149; Carroll RL, 1997, PATTERNS PROCESSES V; Dietrich W.O., 1965, PALAONTOLOGISCHE A A, V2, P521; Dubrovo I. A, 1964, PAL ZH, V3, P82; Dubrovo I.A., 1966, B KOM IZUC CHETV, V32, P63; Ferretti MP, 1999, ECLOGAE GEOL HELV, V92, P503; Foronova Irina V., 1999, Deinsea, V6, P103; GARUTT VE, 1986, P ZOOL I ST PET, V149, P21; GOULD S J, 1977, Paleobiology, V3, P115; ILFORD KS, 1925, Q J GEOL SOC LOND, V81, P62; Jablonski D, 2000, PALEOBIOLOGY, V26, P15, DOI 10.1666/0094-8373(2000)26[15:MAMSAH]2.0.CO;2; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; KOTSAKIS T, 1978, Geologica Romana, V17, P411; Lister A.M., 1992, P185; Lister Adrian M., 1996, P203; Lister Adrian M., 1993, Quaternary International, V19, P77, DOI 10.1016/1040-6182(93)90026-C; Maglio V.J., 1973, Transactions Am phil Soc, V63, P1, DOI 10.2307/1006229; Roopnarine PD, 1999, PALEOBIOLOGY, V25, P41; SCHREVE D, IN PRESS FOSSIL MAMM; SHER A, UNPUB; Sher A.V., 1987, Palaeontographia Italica, V74, P97; Sher A.V., 1999, 2 INT MAMM C OFF C P, P58; Sher A.V., 1997, TERRESTRIAL PALEOENV, P3; SHER AV, 1985, DOKL AKAD NAUK SSSR+, V285, P221; STEINHEIM WO, 1912, JAHRESH VER VATERL N, V68, P42; Stuart AJ, 2001, QUATERNARY SCI REV, V20, P1677, DOI 10.1016/S0277-3791(01)00034-8	26	128	145	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1094	1097		10.1126/science.1056370	http://dx.doi.org/10.1126/science.1056370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691991				2022-12-28	WOS:000172013800048
J	Loreau, M; Naeem, S; Inchausti, P; Bengtsson, J; Grime, JP; Hector, A; Hooper, DU; Huston, MA; Raffaelli, D; Schmid, B; Tilman, D; Wardle, DA				Loreau, M; Naeem, S; Inchausti, P; Bengtsson, J; Grime, JP; Hector, A; Hooper, DU; Huston, MA; Raffaelli, D; Schmid, B; Tilman, D; Wardle, DA			Ecology - Biodiversity and ecosystem functioning: Current knowledge and future challenges	SCIENCE			English	Review							PLANT DIVERSITY; SPECIES RICHNESS; PRODUCTIVITY; STABILITY; GRASSLAND; CONSEQUENCES; COMMUNITIES; VARIABILITY	The ecological consequences of biodiversity loss have aroused considerable interest and controversy during the past decade. Major advances have been made in describing the relationship between species diversity and ecosystem processes, in identifying functionally important species, and in revealing underlying mechanisms. There is, however, uncertainty as to how results obtained in recent experiments scale up to landscape and regional levels and generalize across ecosystem types and processes. Larger numbers of species are probably needed to reduce temporal variability in ecosystem processes in changing environments. A major future challenge is to determine how biodiversity dynamics, ecosystem processes, and abiotic factors interact.	Ecole Normale Super, Ecol Lab, UMR 7625, F-75230 Paris 05, France; Univ Washington, Dept Zool, Seattle, WA 98195 USA; Swedish Univ Agr Sci, Dept Ecol & Crop Prod Sci, SE-75007 Uppsala, Sweden; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA; Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; Univ Zurich, Inst Umweltwissensch, CH-8057 Zurich, Switzerland; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; University of Washington; University of Washington Seattle; Swedish University of Agricultural Sciences; University of Sheffield; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Western Washington University; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of York - UK; University of Zurich; University of Minnesota System; University of Minnesota Twin Cities	Loreau, M (corresponding author), Ecole Normale Super, Ecol Lab, UMR 7625, 46 Rue Ulm, F-75230 Paris 05, France.	Loreau@ens.fr	Hector, Andrew/H-4199-2011; Schmid, Bernhard/C-8625-2009; Huston, Michael A./B-1434-2009; Tilman, David/ABD-5309-2021; Wardle, David A./F-6031-2011; Bengtsson, Jan/AAF-2325-2021	Hector, Andrew/0000-0002-1309-7716; Schmid, Bernhard/0000-0002-8430-3214; Huston, Michael A./0000-0001-9513-1166; Wardle, David A./0000-0002-0476-7335; 				Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Cottingham KL, 2001, ECOL LETT, V4, P72, DOI 10.1046/j.1461-0248.2001.00189.x; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Grime J. P., 2001, PLANT STRATEGIES VEG; Grime JP, 2000, SCIENCE, V289, P762, DOI 10.1126/science.289.5480.762; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Hulot FD, 2000, NATURE, V405, P340, DOI 10.1038/35012591; Huston M A, 2000, Science, V289, P1255; Huston M.A., 1994, BIOL DIVERSITY; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Ives AR, 2000, ECOL LETT, V3, P399, DOI 10.1046/j.1461-0248.2000.00144.x; Jonsson M, 2000, OIKOS, V89, P519, DOI 10.1034/j.1600-0706.2000.890311.x; Laakso J, 1999, OIKOS, V87, P57, DOI 10.2307/3546996; Lavorel S, 1997, TRENDS ECOL EVOL, V12, P474, DOI 10.1016/S0169-5347(97)01219-6; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Loreau M, 2001, P ROY SOC B-BIOL SCI, V268, P303, DOI 10.1098/rspb.2000.1366; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; MACGILLIVRAY CW, 1995, FUNCT ECOL, V9, P640, DOI 10.2307/2390156; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McCollin D, 2000, BIOL CONSERV, V92, P249, DOI 10.1016/S0006-3207(99)00070-1; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; MCNAUGHTON SJ, 1977, AM NAT, V111, P515, DOI 10.1086/283181; Mikola J, 1998, OIKOS, V83, P180, DOI 10.2307/3546560; Naeem S, 2000, NATURE, V403, P762, DOI 10.1038/35001568; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Norberg J, 2000, OECOLOGIA, V122, P264, DOI 10.1007/PL00008855; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schlapfer F, 1999, ECOL APPL, V9, P893, DOI 10.1890/1051-0761(1999)009[0893:EEOBAC]2.0.CO;2; Schulze E.D., 1993, BIODIVERSITY ECOSYST; Schwartz MW, 2000, OECOLOGIA, V122, P297, DOI 10.1007/s004420050035; Stephan A, 2000, J ECOL, V88, P988, DOI 10.1046/j.1365-2745.2000.00510.x; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Tilman D, 1997, SCIENCE, V278, P1866; Tilman D, 1999, SCIENCE, V286, P1099, DOI 10.1126/science.286.5442.1099; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; TILMAN D, 2001, BRIT ECOLOGICAL SOC, V41, P183; Troumbis AY, 2000, OECOLOGIA, V125, P101, DOI 10.1007/PL00008880; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wardle DA, 1998, NATURE, V394, P30, DOI 10.1038/27812; Wardle DA, 1999, ECOL MONOGR, V69, P535, DOI 10.1890/0012-9615(1999)069[0535:PRIPGV]2.0.CO;2; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	58	2859	3210	103	2794	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					804	808		10.1126/science.1064088	http://dx.doi.org/10.1126/science.1064088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679658	Green Submitted			2022-12-28	WOS:000171851800033
J	Mushlin, AI; Ruchlin, HS; Callahan, MA				Mushlin, AI; Ruchlin, HS; Callahan, MA			Costeffectiveness of diagnostic tests	LANCET			English	Article								We review the principles underlying cost-effectiveness analysis of diagnostic tests and procedures. We use two clinical examples, diagnostic testing for early multiple sclerosis and for Helicobacter pylori to illustrate the methods of analysis and to show how the results can be useful for physicians or payers of health services in making decisions about provision and use of diagnostic services. Economic assessments of diagnostic tests are Inherently more difficult than assessments of therapeutic interventions, mainly because of uncertainty about the relation between diagnosis and end results (outcomes) of care. Nonetheless, because of the increasing Importance of diagnostic technology in medicine and healthcare, only with such assessments will the most value be gained from restricted medical resources.	Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY 10021 USA	Cornell University	Mushlin, AI (corresponding author), Cornell Univ, Weill Med Coll, Dept Publ Hlth, 411 E 69th St, New York, NY 10021 USA.	aim2001@mail.med.cornell						Anderson GF, 2000, HEALTH AFFAIR, V19, P150, DOI 10.1377/hlthaff.19.3.150; *CAN COORD OFF HLT, 1997, GUID EC EV PHARM; *COMM DEP HUM SERV, 1995, GUID PHARM IND PREP; FENDRICK AM, 1995, ANN INTERN MED, V123, P260, DOI 10.7326/0003-4819-123-4-199508150-00003; Garber AM, 2000, HANDB ECON, V17, P181; MOONEY C, 1990, MED DECIS MAKING, V10, P77, DOI 10.1177/0272989X9001000201; MUSHLIN AI, 1994, ARCH NEUROL-CHICAGO, V51, P67, DOI 10.1001/archneur.1994.00540130093017; Mushlin AI, 1997, INT J TECHNOL ASSESS, V13, P21, DOI 10.1017/S0266462300010205; *NAT I CLIN EXC, 2001, APPR NEW EX TECHN IN; Rabin M, 1998, J ECON LIT, V36, P11; 1989, FED REG         0130, V54, P4308	11	42	43	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2001	358	9290					1353	1355		10.1016/S0140-6736(01)06417-0	http://dx.doi.org/10.1016/S0140-6736(01)06417-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	484RC	11684235				2022-12-28	WOS:000171702500032
J	Regenauer-Lieb, K; Yuen, DA; Branlund, J				Regenauer-Lieb, K; Yuen, DA; Branlund, J			The initiation of subduction: Criticality by addition of water?	SCIENCE			English	Article							PLASTIC-DEFORMATION; MANTLE CONVECTION; CREEP REGIME; LITHOSPHERE; OLIVINE; TEMPERATURE; TECTONICS; DYNAMICS; NECKING; STRESS	Subduction is a major process of plate tectonics; however, its initiation is not understood. We used high-resolution (less than 1 kilometer) finite-element models based on rheological data of the lithosphere to investigate the role played by water on initiating subduction. A solid-fluid thermomechanical instability is needed to drive a cold, stiff, and negatively buoyant lithosphere into the mantle. This instability can be triggered slowly by sedimentary loading over a time span of 100 million years. Our results indicate that subduction can proceed by a double feedback mechanism (thermoelastic and thermal-rheological) promoted by lubrication due to water.	ETH Honggerberg, Swiss Fed Inst Technol, Inst Geophys, CH-8093 Zurich, Switzerland; Univ Minnesota, Minnesota Supercomp Inst, Minneapolis, MN 55415 USA; Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55415 USA; SW Illinois Coll, Granite City, IL 62040 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Regenauer-Lieb, K (corresponding author), ETH Honggerberg, Swiss Fed Inst Technol, Inst Geophys, CH-8093 Zurich, Switzerland.	klaus@tomo.ig.erdw.ethz.ch	Regenauer-Lieb, Klaus/H-5706-2014; Regenauer-Lieb, Klaus/F-9560-2011	Regenauer-Lieb, Klaus/0000-0002-2198-5895; 				Bercovici D, 1998, EARTH PLANET SC LETT, V154, P139, DOI 10.1016/S0012-821X(97)00182-9; Branlund J, 2000, GEOPHYS RES LETT, V27, P1989, DOI 10.1029/1999GL008396; Branlund JM, 2001, EARTH PLANET SC LETT, V190, P237, DOI 10.1016/S0012-821X(01)00393-4; Braun J, 1999, J GEOPHYS RES-SOL EA, V104, P25167, DOI 10.1029/1999JB900214; CLOETINGH SAPL, 1982, NATURE, V297, P139, DOI 10.1038/297139a0; EVANS B, 1979, J GEOPHYS RES, V84, P5505, DOI 10.1029/JB084iB10p05505; GOETZE C, 1979, GEOPHYS J ROY ASTR S, V59, P463, DOI 10.1111/j.1365-246X.1979.tb02567.x; *HIBB KARLSS SOR P, 2000, ABAQUS STAND US MAN, V1; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; KARATO S, IN PRESS PHYS EARTH; KAULA WM, 1994, PHILOS T R SOC A, V349, P345, DOI 10.1098/rsta.1994.0137; Kohlstedt DL, 1996, CONTRIB MINERAL PETR, V123, P345, DOI 10.1007/s004100050161; McKenzie D.P., 1977, ISLAND ARCS DEEP SEA, V1, P57, DOI [10.1029/ME001p0057, DOI 10.1029/ME001P0057]; Mei S, 2000, J GEOPHYS RES-SOL EA, V105, P21471, DOI 10.1029/2000JB900180; Mei S, 2000, J GEOPHYS RES-SOL EA, V105, P21457, DOI 10.1029/2000JB900179; Moresi L, 1998, GEOPHYS J INT, V133, P669, DOI 10.1046/j.1365-246X.1998.00521.x; PRESNALL DC, 1993, J GEOPHYS RES-SOL EA, V98, P19777, DOI 10.1029/93JB01007; RANALLI G, 1994, TECTONOPHYSICS, V240, P107, DOI 10.1016/0040-1951(94)90266-6; Regenauer-Lieb K, 2000, PHYS EARTH PLANET IN, V118, P89, DOI 10.1016/S0031-9201(99)00136-3; Regenauer-Lieb K, 1998, GEOPHYS RES LETT, V25, P2737, DOI 10.1029/98GL02056; Regenauer-Lieb K, 1999, J GEODYN, V27, P1; REGENAUERLIEB K, 1999, ELECT GEOSCI, V4, P2; Roberts D. C., 2000, GEOCOMPLEXITY PHYS E, P97; SHEMENDA AI, 1993, J GEOPHYS RES-SOL EA, V98, P16167, DOI 10.1029/93JB01094; Toth J, 1998, J GEOPHYS RES-SOL EA, V103, P18053, DOI 10.1029/98JB01076; Trompert R, 1998, NATURE, V395, P686, DOI 10.1038/27185; TUCHOLKE BE, 1982, AAPG BULL, V66, P1393	27	282	288	4	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					578	580		10.1126/science.1063891	http://dx.doi.org/10.1126/science.1063891			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641494				2022-12-28	WOS:000171695600042
J	Goodare, H				Goodare, H			Studies that do not have informed consent from participants should not be published	BRITISH MEDICAL JOURNAL			English	Article							TRIAL											BRADBURN J, 1995, PSYCHO-ONCOLOGY, V4, P107, DOI 10.1002/pon.2960040204; BURTON MV, 1995, PSYCHO-ONCOL, V4, P1, DOI 10.1002/pon.2960040102; *CANC, 1990, DECL RIGHTS PEOPL CA; Dennis M, 1997, BRIT MED J, V314, P1071, DOI 10.1136/bmj.314.7087.1071; Douglas C, 1997, BRIT MED J, V314, P1134, DOI 10.1136/bmj.314.7087.1134; Doyal L, 1997, BMJ-BRIT MED J, V314, P1107, DOI 10.1136/bmj.314.7087.1107; Faulder C., 1985, WHOSE BODY IS IT TRO; HAMMOND L, 1993, B MED ETHICS, V92, P36; *IME, 1988, IME B, P13; McArdle JMC, 1996, BMJ-BRIT MED J, V312, P813; Moodie AR, 1996, BRIT MED J, V313, P362, DOI 10.1136/bmj.313.7053.362; PINCUS T, 1997, ADVANCES, V13, P3; *SCOTT BREAST CANC, 1996, SCOTT BREAST CANC AU; Smith R, 1997, BRIT MED J, V314, P1059, DOI 10.1136/bmj.314.7087.1059; STEINGRABER S, 1997, LIVING DOWNSTREAM EC, P121; Veatch RM, 1997, NEW ENGL J MED, V336, P869, DOI 10.1056/NEJM199703203361209; 1997, LANCET, V439, P1; 1996, BMJ, V313, P1448	18	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 28	1998	316	7136					1004	1005						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZF034	11645041				2022-12-28	WOS:000072856100033
J	SMITH, T				SMITH, T			GENES AND ETHICS	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	AUG 26	1995	311	7004					574	574		10.1136/bmj.311.7004.574a	http://dx.doi.org/10.1136/bmj.311.7004.574a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RR737	11644728	Green Published			2022-12-28	WOS:A1995RR73700066
J	CRAFT, I				CRAFT, I			AN ETHICAL DEBATE - SHOULD OLDER WOMEN BE OFFERED IN-VITRO FERTILIZATION - THE ROLE OF ETHICS COMMITTEES	BRITISH MEDICAL JOURNAL			English	Article											CRAFT, I (corresponding author), LONDON GYNAECOL & FERTIL CTR,COZENS HOUSE,112 HARLEY ST,LONDON W1N 1AF,ENGLAND.								0	0	0	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 3	1995	310	6992					1457	1458		10.1136/bmj.310.6992.1457a	http://dx.doi.org/10.1136/bmj.310.6992.1457a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RC105	11644711	Green Published			2022-12-28	WOS:A1995RC10500032
J	ROGERS, A				ROGERS, A			EUROPEAN BIOETHICS CONVENTION STALLED AGAIN	LANCET			English	Editorial Material																		1994, LANCET, V344, P48	1	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUL 9	1994	344	8915					117	118		10.1016/S0140-6736(94)91291-2	http://dx.doi.org/10.1016/S0140-6736(94)91291-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NV732	11644605				2022-12-28	WOS:A1994NV73200018
J	Modlin, RL; Bloom, BR				Modlin, RL; Bloom, BR			Immunology - Chip shots - Will functional genomics get functional?	SCIENCE			English	Editorial Material							MOLECULAR CLASSIFICATION		Univ Calif Los Angeles, Sch Med, Div Dermatol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Microbiol & Immunol, Los Angeles, CA 90095 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard T.H. Chan School of Public Health	Modlin, RL (corresponding author), Univ Calif Los Angeles, Sch Med, Div Dermatol, Los Angeles, CA 90095 USA.		Modlin, Robert L/M-7941-2014	Modlin, Robert L/0000-0003-4720-031X				Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Hill AVS, 1998, ANNU REV IMMUNOL, V16, P593, DOI 10.1146/annurev.immunol.16.1.593; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Kostrikis LG, 1998, SCIENCE, V279, P1228, DOI 10.1126/science.279.5354.1228; MAHAN MJ, 1993, SCIENCE, V259, P686, DOI 10.1126/science.8430319; Mitchell TC, 2001, NAT IMMUNOL, V2, P397, DOI 10.1038/87692; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093	11	8	9	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2001	294	5543					799	+		10.1126/science.1066314	http://dx.doi.org/10.1126/science.1066314			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679655				2022-12-28	WOS:000171851800030
J	Tilman, D; Reich, PB; Knops, J; Wedin, D; Mielke, T; Lehman, C				Tilman, D; Reich, PB; Knops, J; Wedin, D; Mielke, T; Lehman, C			Diversity and productivity in a long-term grassland experiment	SCIENCE			English	Article							ECOSYSTEM FUNCTION; SPECIES-DIVERSITY; PLANT COMPOSITION; BIODIVERSITY; PERFORMANCE; ALTER	Plant diversity and niche complementarity had progressively stronger effects on ecosystem functioning during a 7-year experiment, with 16-species plots attaining 2.7 times greater biomass than monocultures. Diversity effects were neither transients nor explained solely by a few productive or unviable species. Rather, many higher-diversity plots outperformed the best monoculture. These results help resolve debate over biodiversity and ecosystem functioning, show effects at higher than expected diversity levels, and demonstrate, for these ecosystems, that even the best-chosen monocultures cannot achieve greater productivity or carbon stores than higher-diversity sites.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; Univ Nebraska, Sch Nat Resource Sci, Lincoln, NE 68583 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Tilman, D (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	tilman@umn.edu	Tilman, David/ABD-5309-2021; Knops, Johannes/AAA-8546-2020; Wedin, David A/K-4093-2012	Reich, Peter/0000-0003-4424-662X				Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Garnier E, 1997, ACTA OECOL, V18, P657, DOI 10.1016/S1146-609X(97)80049-5; Grime JP, 1997, SCIENCE, V277, P1260, DOI 10.1126/science.277.5330.1260; Guterman L, 2000, CHRON HIGHER EDUC, pA24; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hodgson JG, 1998, FUNCT ECOL, V12, P843, DOI 10.1046/j.1365-2435.1998.00253.x; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Kaiser J, 2000, SCIENCE, V289, P1282, DOI 10.1126/science.289.5483.1282; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; NAEEM S, 1995, PHILOS T R SOC B, V347, P249, DOI 10.1098/rstb.1995.0025; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; SWIFT MJ, 1993, ECOL STU AN, V99, P15; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Vandermeer J.H., 1989, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; Wardle D.A., 2000, B ECOL SOC AM, V81, P235, DOI DOI 10.2307/20168451; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757	22	1503	1690	44	1035	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					843	845		10.1126/science.1060391	http://dx.doi.org/10.1126/science.1060391			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679667	Green Submitted, Green Published			2022-12-28	WOS:000171851800044
J	Lewis, S; Donaldson, C; Mitton, C; Currie, G				Lewis, S; Donaldson, C; Mitton, C; Currie, G			The future of health care in Canada	BRITISH MEDICAL JOURNAL			English	Article									Univ Calgary, Dept Community Hlth Sci, CHAPS, Calgary, AB T2N 4N1, Canada	University of Calgary	Donaldson, C (corresponding author), Univ Calgary, Dept Community Hlth Sci, CHAPS, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.			Donaldson, Cam/0000-0003-4670-5340; Lewis, Steven/0000-0002-4247-674X				*A REID GROUP, 2000, CAN ALB SPEAK ALB BI; *A REID GROUP, 2000, HLTH PARLIAMENT REOP; *A REID GROUP, 2000, HLTH CAR CAN; *CAN I HLTH INF, 2000, HLTH CAR CAN 1 ANN R; *CAN I HLTH INF, 2000, TOT HLTH CAR SPEND T; *CAN I HLTH INF, 2001, HLTH CAR CAN 2001; *CAN I HLTH INF, 2000, NAT HLTH EXP CAN 197; *CAN MED ASS, 2000, SEARCH SUST PROSP CA; DONALDSON C, 2000, HLTH POLICY FORUM, V13, P18; *EK RES ASS, 2000, RETH GOV CAN VIEW EM; *EK RES ASS, 1999, RETH GOV MILL BUST; *FED PROV TERR ADV, 1999, HLTH FUT 2 REP HLTH; Flood CM, 2001, CAN MED ASSOC J, V164, P825; *HLTH CAN ONL, 2000, 1 MIN M COMM HLTH SE; Lewis S, 2000, CAN MED ASSOC J, V162, P1297; *NAT FOR HLTH, 1996, MAINT NAT HLTH CAR S; National Forum on Health, 1997, CAN HLTH ACT BUILD L; *PREM COMM FUT HLT, 1989, RAINB REP OUR VIS HL; World Health Organization, 2000, WORLD HLTH REP 2000; 2000, HLTH EDITION, V5, P1	20	25	25	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 20	2001	323	7318					926	929		10.1136/bmj.323.7318.926	http://dx.doi.org/10.1136/bmj.323.7318.926			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486BH	11668143	Green Published			2022-12-28	WOS:000171798200029
J	Capewell, S; MacIntyre, K; Stewart, S; Chalmers, JWT; Boyd, J; Finlayson, A; Redpath, A; Pell, JP; McMurray, JJV				Capewell, S; MacIntyre, K; Stewart, S; Chalmers, JWT; Boyd, J; Finlayson, A; Redpath, A; Pell, JP; McMurray, JJV			Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986-95: a retrospective cohort study	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY HEART-DISEASE; MONICA PROJECT POPULATIONS; CASE-FATALITY; RISK-FACTORS; MORTALITY-RATES; EVENT RATES; REGISTER; SURVIVAL; CARDIOLOGY	Background Most deaths from coronary heart disease occur out of hospital. Hospital patients face social, age, and sex inequalities. Our aim was to examine inequalities and trends in out-of-hospital cardiac deaths. Methods We used the Scottish record linked database to identify all deaths from acute myocardial infarction that occurred in Scotland (population 5.1 million), in 1986-95. We have compared population-based death rates for men and women across age and social groups. Findings Between 1986 and 1995, 83 365 people died from acute myocardial infarction, out of hospital and without previous hospital admission (44 655 men, 38 710 women); and 117 749 were admitted with a first acute myocardial infarction, of whom 37 020 died within 1 year. Thus, out-of-hospital deaths accounted for 69.2% (95% CI 69.0-69.5) of all 120 385 deaths. Out-of-hospital deaths, measured as a proportion of all acute myocardial infarction events (deaths plus first hospital admissions), increased with age, from 20.1% (19.2-21.0) in people younger than 55 years, to 62.1% (61.3-62.9) in those older than 85 years. Population-based out-of-hospital mortality rates fell by a third in men and by a quarter in women. Mean yearly falls were larger in people aged 55-64 years (5.6% per year in men, 3.7% in women), than in those older than 85 years (2.5% in men and women), Mortality rates were substantially higher in deprived socioeconomic groups than in affluent groups, especially in people younger than 65 years. Interpretation These inequalities in age, sex, and socioeconomic class should be actively addressed by prevention strategies for coronary heart disease.	Univ Glasgow, Dept Publ Hlth, Glasgow, Lanark, Scotland; Common Serv Agcy NHS Scotland, Informat & Stat Div, Edinburgh, Midlothian, Scotland; Greater Glasgow Hlth Board, Glasgow, Lanark, Scotland; Glasgow Western Infirm, Dept Cardiol, Glasgow, Lanark, Scotland	University of Glasgow	Capewell, S (corresponding author), Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England.		Macintyre, Kate/J-7174-2014; mcmurray, John/B-2467-2013; Stewart, Simon/M-3316-2016	Macintyre, Kate/0000-0003-2741-0467; mcmurray, John/0000-0002-6317-3975; Boyd, James/0000-0002-8925-8811; Stewart, Simon/0000-0001-9032-8998; Pell, Jill/0000-0002-8898-7035				Blane D, 1998, BRIT MED J, V317, P255, DOI 10.1136/bmj.317.7153.255; Bowling A, 1999, BRIT MED J, V319, P1353, DOI 10.1136/bmj.319.7221.1353; Brophy JM, 1997, CAN J CARDIOL, V13, P474; Brown N, 1997, BMJ-BRIT MED J, V315, P159, DOI 10.1136/bmj.315.7101.159; Capewell S, 1999, BRIT MED J, V318, P1072, DOI 10.1136/bmj.318.7190.1072; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Capewell S, 1996, HEART, V76, P70, DOI 10.1136/hrt.76.1.70; Capewell S, 2000, EUR HEART J, V21, P1833, DOI 10.1053/euhj.2000.2318; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; Carstairs V., 1991, DEPRIVATION HLTH SCO; CRITCHLEY JA, 2000, J EPIDEMIOL COMMUNIT, V54, P774; Dobson AJ, 1999, J CLIN EPIDEMIOL, V52, P761, DOI 10.1016/S0895-4356(99)00052-9; Hallqvist J, 1998, INT J EPIDEMIOL, V27, P410, DOI 10.1093/ije/27.3.410; Harley K, 1996, Health Bull (Edinb), V54, P410; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Macintyre K, 2001, BRIT MED J, V322, P1152, DOI 10.1136/bmj.322.7295.1152; MARMOT M, 1999, INEQUALITIES CORONAR; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; MCMURRAY J, 1994, BMJ-BRIT MED J, V309, P1343, DOI 10.1136/bmj.309.6965.1343; Morrison C, 1997, BMJ-BRIT MED J, V314, P541, DOI 10.1136/bmj.314.7080.541; *NAT SERV, 2000, NAT SERV FRAM COR HE; NAYHA S, 1992, INT J EPIDEMIOL, V21, P30, DOI 10.1093/ije/21.1.30; NAYLOR CD, 1994, J AM COLL CARDIOL, V24, P1431, DOI 10.1016/0735-1097(94)90136-8; Rathore SS, 2000, CIRCULATION, V102, P642, DOI 10.1161/01.CIR.102.6.642; *REG GEN SCOTL, 1998, ANN REP; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; Rosen M, 2000, J INTERN MED, V248, P159, DOI 10.1046/j.1365-2796.2000.00716.x; Salomaa V, 2000, CIRCULATION, V101, P1913, DOI 10.1161/01.CIR.101.16.1913; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; Volmink JA, 1998, HEART, V80, P40, DOI 10.1136/hrt.80.1.40; Woodward M, 1996, J EPIDEMIOL COMMUN H, V50, P570, DOI 10.1136/jech.50.5.570	33	79	80	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1213	1217		10.1016/S0140-6736(01)06343-7	http://dx.doi.org/10.1016/S0140-6736(01)06343-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675057				2022-12-28	WOS:000171527000009
J	Sharma, DC				Sharma, DC			Indian xenotransplant surgeon seeks damages from government	LANCET			English	News Item																			0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 2	1999	353	9146					48	48		10.1016/S0140-6736(05)74854-6	http://dx.doi.org/10.1016/S0140-6736(05)74854-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155FC	11657167				2022-12-28	WOS:000077934800037
J	Farrell, L				Farrell, L			A professional opinion?	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	NOV 23	1996	313	7068					1337	1337						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VV153	11644863				2022-12-28	WOS:A1996VV15300073
J	SMITH, T				SMITH, T			CHOOSING SEX	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	AUG 14	1993	307	6901					451	451						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LR895	11643160				2022-12-28	WOS:A1993LR89500067
J	MUNDELL, I				MUNDELL, I			BIOETHICS - EUROPE DRAFTS A CONVENTION	NATURE			English	Editorial Material																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 2	1992	356	6368					368	368		10.1038/356368a0	http://dx.doi.org/10.1038/356368a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL830	11642984	Bronze			2022-12-28	WOS:A1992HL83000005
J	HARPER, P				HARPER, P			GENETICS AND PUBLIC-HEALTH	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	11	11	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAR 14	1992	304	6828					721	721		10.1136/bmj.304.6828.721	http://dx.doi.org/10.1136/bmj.304.6828.721			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HK761	11642991	Green Published, Bronze			2022-12-28	WOS:A1992HK76100078
J	Fitzmaurice, DA; Machin, SJ				Fitzmaurice, DA; Machin, SJ		British Soc Haematology Task Force	Recommendations for patients undertaking self management of oral anticoagulation	BRITISH MEDICAL JOURNAL			English	Article							COMPUTERIZED DECISION-SUPPORT; PROTHROMBIN TIME MONITOR; ATRIAL-FIBRILLATION; PRIMARY-CARE; GENERAL-PRACTICE; COST-EFFECTIVENESS; WARFARIN THERAPY; BLOOD; PHARMACIST; COMMUNITY		Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England; UCL Hosp, Dept Haematol, London WC1E 6DB, England	University of Birmingham; University College London Hospitals NHS Foundation Trust; University of London; University College London	Fitzmaurice, DA (corresponding author), Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.	d.a.fitzmaurice@bham.ac.uk						ANDERSON DR, 1993, ARCH INTERN MED, V153, P1441, DOI 10.1001/archinte.153.12.1441; Ansell JE, 1996, AM HEART J, V132, P1095, DOI 10.1016/S0002-8703(96)90040-X; BAGLIN T, 1994, CLIN LAB HAEMATOL, V16, P327; BISLEY C, 1997, ASTHMA J, V2, P152; *BRIT COMM STAND H, 1998, BRIT J HAEMATOL, V101, P374; England JM, 1995, CLIN LAB HAEMATOL, V17, P301; Fitzmaurice DA, 1996, BRIT J GEN PRACT, V46, P533; Fitzmaurice DA, 1996, BRIT MED J, V312, P1431, DOI 10.1136/bmj.312.7044.1431; GUSTAFSSON C, 1992, BRIT MED J, V305, P1457, DOI 10.1136/bmj.305.6867.1457; Hasenkam JM, 1997, THROMB RES, V85, P77, DOI 10.1016/S0049-3848(96)00224-1; Hobbs R, 1996, BRIT MED J, V312, P263; *IMS HLTH, 1999, MED AN OR ANT THER; KAPIOTIS S, 1995, THROMB RES, V77, P563, DOI 10.1016/0049-3848(95)00031-3; LOWE GDO, 1992, BRIT MED J, V305, P1445, DOI 10.1136/bmj.305.6867.1445; Macgregor SH, 1996, BRIT MED J, V312, P560, DOI 10.1136/bmj.312.7030.560; Machin SJ, 1996, CLIN LAB HAEMATOL, V18, P69, DOI 10.1046/j.1365-2257.1996.00168.x; MASSICOTTE P, 1995, J PEDIATR-US, V127, P389, DOI 10.1016/S0022-3476(95)70069-2; OBERHARDT BJ, 1991, CLIN CHEM, V37, P520; PELL JP, 1994, BRIT J GEN PRACT, V44, P357; Poller L, 1998, LANCET, V352, P1505, DOI 10.1016/S0140-6736(98)04147-6; RADLEY AS, 1995, J CLIN PATHOL, V48, P545, DOI 10.1136/jcp.48.6.545; RINK E, 1993, BRIT MED J, V307, P775, DOI 10.1136/bmj.307.6907.775; Rose PE, 1996, J CLIN PATHOL, V49, P5, DOI 10.1136/jcp.49.1.5; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; SANDERCOCK P, 1992, BRIT MED J, V305, P1460, DOI 10.1136/bmj.305.6867.1460; Sawicki PT, 1999, JAMA-J AM MED ASSOC, V281, P145, DOI 10.1001/jama.281.2.145; SUDLOW CM, 1995, BRIT MED J, V311, P558, DOI 10.1136/bmj.311.7004.558; Sudlow M, 1997, BRIT MED J, V314, P1529, DOI 10.1136/bmj.314.7093.1529; SWEENEY KG, 1995, BRIT J GEN PRACT, V45, P153; Taborski U, 1999, SEMIN THROMB HEMOST, V25, P103, DOI 10.1055/s-2007-996432; TAYLOR F, 1993, BRIT MED J, V307, P1493, DOI 10.1136/bmj.307.6917.1493; Taylor FC, 1996, BRIT MED J, V312, P286; WHITE RH, 1989, ANN INTERN MED, V111, P730, DOI 10.7326/0003-4819-111-9-730	33	61	63	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2001	323	7319					985	989		10.1136/bmj.323.7319.985	http://dx.doi.org/10.1136/bmj.323.7319.985			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488CU	11679391	Green Published			2022-12-28	WOS:000171918500022
J	Olivarius, ND; Beck-Nielsen, H; Andreasen, AH; Horder, M; Pedersen, PA				Olivarius, ND; Beck-Nielsen, H; Andreasen, AH; Horder, M; Pedersen, PA			Randomised controlled trial of structured personal care of type 2 diabetes mellitus	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONTINUING MEDICAL-EDUCATION; GENERAL-PRACTICE; CLINICAL GUIDELINES; DISEASE; PARTICIPATION; ADHERENCE; QUALITY; PATIENT	Objective To assess the effect of a multifaceted intervention directed at general practitioners on six year mortality, morbidity, and risk factors of patients with newly diagnosed type 2 diabetes. Design Pragmatic, open, controlled trial with randomisation of practices to structured personal care or routine care; analysis after 6 years. Setting 311 Danish practices with 474 general practitioners (243 in intervention group and 231 in comparison group). Participants 874 (90.1%) of 970 patients aged greater than or equal to 40 years who had diabetes diagnosed in 1989-91 and survived until six year follow up. Intervention Regular follow up and individualised goal setting supported by prompting of doctors, clinical guidelines, feedback, and continuing medical education. Main outcome measures Predefined clinical non-fatal outcomes, overall mortality, risk factors, and weight. Results Predefined non-fatal outcomes and mortality were the same in both groups. The following risk factor levels were lower for intervention patients than for comparison patients (median values): fasting plasma glucose concentration (7.9 v 8.7 mmol/l, P=0.0007), glycated haemoglobin (8.5% v 9.0%, P < 0.0001; reference range 5.4-7.4'%), systolic blood pressure (145 v 150 mm Hg, P=0.0004), and cholesterol concentration (6.0 v 6.1 mmol/l, P = 0.029, adjusted for baseline concentration). Both groups had lost weight since diagnosis (2.6 v 2.0 kg). Metformin was the only drug used more frequently in the intervention group (24% (110/459) v, 15% (61/415)). Intervention doctors arranged more follow up consultations, referred fewer patients to diabetes clinics, and set more optimistic goals. Conclusions In primary care, individualised goals with educational and surveillance support may for at least six years bring risk factors of patients with type 2 diabetes to a level that has been shown to reduce diabetic complications but without weight gain.	Univ Copenhagen, Panum Inst, Cent Res Unit, DK-2200 Copenhagen, Denmark; Univ Copenhagen, Panum Inst, Dept Gen Practice, DK-2200 Copenhagen, Denmark; Univ So Denmark, Odense Univ Hosp, Med Dept M, DK-5000 Odense, Denmark; Univ Copenhagen, Panum Inst, Inst Publ Hlth, Dept Biostat, DK-1168 Copenhagen, Denmark; Univ So Denmark, Odense Univ Hosp, Dept Clin Biochem, Odense, Denmark	University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Olivarius, ND (corresponding author), Univ Copenhagen, Panum Inst, Cent Res Unit, DK-2200 Copenhagen, Denmark.	no@gpract.ku.dk	de Fine Olivarius, Niels/K-6832-2015	de Fine Olivarius, Niels/0000-0001-6465-3615; Andreasen, Anne Helms/0000-0002-2350-9884				Beck HP, 1999, TROP MED INT HEALTH, V4, P1, DOI 10.1046/j.1365-3156.1999.00353.x; BECKNIELSEN H, 1988, NONINSULIN DEPENDENT, P1; BECKNIELSEN H, 1994, TIDSSKRIFT DIABETESB, V4, P1; Brandt CJ, 1997, LANCET, V349, P253, DOI 10.1016/S0140-6736(05)64863-5; Cantillon P, 1999, BMJ-BRIT MED J, V318, P1276; Curb JD, 1996, JAMA-J AM MED ASSOC, V276, P1886, DOI 10.1001/jama.276.23.1886; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; Dunn NR, 1996, BRIT J GEN PRACT, V46, P401; FARMER A, 1990, BRIT J GEN PRACT, V40, P56; FEDER G, 1995, BRIT MED J, V311, P1473, DOI 10.1136/bmj.311.7018.1473; Gaede P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1; GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921; Griffin S, 1998, BMJ-BRIT MED J, V317, P390; Grol R, 1998, BRIT MED J, V317, P858, DOI 10.1136/bmj.317.7162.858; Hetlevik I, 1997, SCAND J PRIM HEALTH, V15, P193, DOI 10.3109/02813439709035027; Kinmonth AL, 1998, BMJ-BRIT MED J, V317, P1202, DOI 10.1136/bmj.317.7167.1202; Lauritzen T, 1996, NONINSULIN DEPENDENT; Majeed A, 2000, BRIT MED J, V321, P1057, DOI 10.1136/bmj.321.7268.1057; McCormack J, 2000, BMJ-BRIT MED J, V320, P1720, DOI 10.1136/bmj.320.7251.1720; Medical Research Council (MRC), 2000, FRAM DEV EV RCTS COM; MELTON LJ, 1983, DIABETES CARE, V6, P75, DOI 10.2337/diacare.6.1.75; MOGENSEN CE, 1986, METHODS DIABETES RES, V2; Nagasawa M, 1990, Diabetes Educ, V16, P192, DOI 10.1177/014572179001600309; PRINGLE M, 1993, BRIT MED J, V306, P630, DOI 10.1136/bmj.306.6878.630; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Rose G, 1982, CARDIOVASCULAR SURVE; Ross S, 1999, J CLIN EPIDEMIOL, V52, P1143, DOI 10.1016/S0895-4356(99)00141-9; Sclar DL, 1999, DIABETES EDUCATOR, V25, P531, DOI 10.1177/014572179902500406; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UK Prospective Diabetes Study Grp, 1999, DIABETES CARE, V22, P1125; WEINER JP, 1995, JAMA-J AM MED ASSOC, V273, P1503, DOI 10.1001/jama.273.19.1503; Wensing M, 1998, BRIT J GEN PRACT, V48, P991	33	186	191	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2001	323	7319					970	975		10.1136/bmj.323.7319.970	http://dx.doi.org/10.1136/bmj.323.7319.970			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488CU	11679387	Green Published, Bronze			2022-12-28	WOS:000171918500018
J	Wolpert, HA; Anderson, BJ				Wolpert, HA; Anderson, BJ			Management of diabetes: are doctors framing the benefits from the wrong perspective?	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Joslin Diabet Ctr, Sect Adult Diabet, Boston, MA 02215 USA; Joslin Diabet Ctr, Behav & Mental Hlth Res Unit, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Joslin Diabetes Center, Inc.	Wolpert, HA (corresponding author), Joslin Diabet Ctr, Sect Adult Diabet, 1 Joslin Pl, Boston, MA 02215 USA.	howard.wolpert@joslin.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046887] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK046887, DK-46887] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		*AM DIAB ASS, 2001, DIABETES CARE S1, V24, pS33; *AM DIAB ASS, 1999, AM DIAB ASS COMPL GU; ANDERSON BJ, 1995, DIABETES SPECTRUM, V8, P69; ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943; Bott S, 1997, DIABETOLOGIA, V40, P926, DOI 10.1007/s001250050769; CLEMENT S, 1995, DIABETES CARE, V18, P1204, DOI 10.2337/diacare.18.8.1204; COYNE JC, 1988, MARSHALLING SOCIAL S, P309; *DAFNE STUD GROUP, 2001, DIABETIC MED S2, V18, P325; *DIAB UK, 2000, REC MAN DIAB PRIM CA; GALAZKA SS, 1984, FAMILY SYSTEMS MED, V2, P28; Gray A, 2000, BMJ-BRIT MED J, V320, P1373, DOI 10.1136/bmj.320.7246.1373; GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921; Howorka K, 2000, J PSYCHOSOM RES, V48, P37, DOI 10.1016/S0022-3999(99)00074-4; Miller W, 2002, MOTIVATIONAL INTERVI, V2nd; Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409; ROLLNICK S, 1993, BRIT MED J, V307, P188, DOI 10.1136/bmj.307.6897.188; Rollnick S., 1999, HLTH BEHAV CHANGE GU, V1st; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shannon H, 2000, NEW ENGL J MED, V342, P381; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644; Wolpert HA, 2001, DIABETES CARE, V24, P1301, DOI 10.2337/diacare.24.7.1301-a	23	76	76	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2001	323	7319					994	996		10.1136/bmj.323.7319.994	http://dx.doi.org/10.1136/bmj.323.7319.994			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488CU	11679393	Green Published			2022-12-28	WOS:000171918500027
J	Arellano, FM				Arellano, FM			Linezolid and reversible myelosuppression	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Pharmacia Corp, Peapeck, NJ 07977 USA	Pfizer	Arellano, FM (corresponding author), Pharmacia Corp, Peapeck, NJ 07977 USA.							Green SL, 2001, JAMA-J AM MED ASSOC, V285, P1291, DOI 10.1001/jama.285.10.1291; YUNIS AA, 1989, AM J MED, V87, pN44	2	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2001	286	16					1973	1974						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485JD	11667930				2022-12-28	WOS:000171750500017
J	Iseman, M				Iseman, M			A 52-year-old man with a positive PPD	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TUBERCULIN SKIN-TEST; ISONIAZID-ASSOCIATED HEPATITIS; PREVENTIVE THERAPY; UNITED-STATES; PULMONARY TUBERCULOSIS; FOREIGN-BORN; REACTORS; HEPATOTOXICITY; METAANALYSIS; PREVALENCE		Univ Colorado, Sch Med, Natl Jewish Med & Res Ctr, Denver, CO 80206 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Iseman, M (corresponding author), Univ Colorado, Sch Med, Natl Jewish Med & Res Ctr, 1400 Jackson St,Room J201, Denver, CO 80206 USA.							*AM THOR SOC, 1981, AM REV RESPIR DIS, V124, P356; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 1990, MMWR Recomm Rep, V39, P1; [Anonymous], 1890, NY TIMES, P1; BASS JB, 1994, AM J RESP CRIT CARE, V149, P1359, DOI 10.1164/ajrccm.149.5.8173779; Bishai WR, 1997, CLIN CHEST MED, V18, P115, DOI 10.1016/S0272-5231(05)70360-9; BLACK M, 1975, GASTROENTEROLOGY, V69, P289; *CDC, 2001, MMWR-MORBID MORTAL W, V50, P733; *CDCP, 2000, REP TUB US 1999; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P137; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P289; CHAPARAS SD, 1985, AM REV RESPIR DIS, V132, P175; CHAULK CP, 1995, JAMA-J AM MED ASSOC, V274, P945, DOI 10.1001/jama.274.12.945; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COMSTOCK GW, 1975, AM REV RESPIR DIS, V111, P573; COMSTOCK GW, 1974, AM REV RESPIR DIS, V110, P195; DASH LA, 1980, AM REV RESPIR DIS, V121, P1039; DOLIN PJ, 1994, B WORLD HEALTH ORGAN, V72, P213; Duchin JS, 1997, CLIN INFECT DIS, V25, P661, DOI 10.1086/513771; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Fennelly KP, 1998, INFECT CONT HOSP EP, V19, P754; Ferebee SH, 1967, B NATL TUBERCULO JAN, V53, P4; FEREBEE SH, 1970, ADV TUBERC RES, V17, P28; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; GARIBALDI RA, 1972, AM REV RESPIR DIS, V106, P357, DOI 10.1164/arrd.1972.106.3.357; Halpern M., 1993, Morbidity and Mortality Weekly Report, V42, P545; Hamman L, 1908, ARCH INTERN MED, V1, P443; HORWITZ O, 1970, SCAND J RESP DIS S, V72, P55; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; *INF DIS BRANCH CA, 1989, CALIFORNIA MORBIDITY, V28, P1; Keers R.Y., 1978, PULMONARY TUBERCULOS; KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991; Krebs A, 1979, B INT UNION TUBERC, V54, P65; LECOEUR HF, 1989, AM REV RESPIR DIS, V140, P1189, DOI 10.1164/ajrccm/140.5.1189; LIFSON AR, 1993, J INFECT DIS, V168, P1048, DOI 10.1093/infdis/168.4.1048; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; MENZIES R, 1992, AM REV RESPIR DIS, V146, P752, DOI 10.1164/ajrccm/146.3.752; MOULDING TS, 1989, AM REV RESPIR DIS, V140, P700, DOI 10.1164/ajrccm/140.3.700; NASH DR, 1980, CHEST, V77, P32, DOI 10.1378/chest.77.1.32; Nolan CM, 1999, JAMA-J AM MED ASSOC, V281, P1014, DOI 10.1001/jama.281.11.1014; PablosMendez A, 1997, AM J PUBLIC HEALTH, V87, P574, DOI 10.2105/AJPH.87.4.574; RIEDER HL, 1990, AM REV RESPIR DIS, V141, P347, DOI 10.1164/ajrccm/141.2.347; RISKA N, 1976, Bulletin of the International Union Against Tuberculosis, V51, P203; Salpeter SR, 1997, ANN INTERN MED, V127, P1051, DOI 10.7326/0003-4819-127-12-199712150-00001; *SECT EP AL DEP HL, 1992, STATE ALASKA EPIDEMI, V9, P1; SHAFER RW, 1991, MEDICINE, V70, P384, DOI 10.1097/00005792-199111000-00004; SHAIKH WA, 1992, ALLERGY, V47, P327, DOI 10.1111/j.1398-9995.1992.tb02063.x; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; STEELE MA, 1991, CHEST, V99, P465, DOI 10.1378/chest.99.2.465; TAYLOR WC, 1981, ANN INTERN MED, V94, P808, DOI 10.7326/0003-4819-94-6-808; Ungo JR, 1998, AM J RESP CRIT CARE, V157, P1871, DOI 10.1164/ajrccm.157.6.9711039; VONREYN CF, 1994, CLIN INFECT DIS, V19, P15, DOI 10.1093/clinids/19.1.15; *WHO, 1958, B WORLD HEALTH ORGAN, V19, P759; *WHO, 1996, WHO REP TUB EP 1996; Zuber PLF, 1997, JAMA-J AM MED ASSOC, V278, P304, DOI 10.1001/jama.278.4.304	57	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2001	286	16					2015	+		10.1001/jama.286.16.2015	http://dx.doi.org/10.1001/jama.286.16.2015			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485JD	11667939				2022-12-28	WOS:000171750500026
J	Luna, B; Feinglos, MN				Luna, B; Feinglos, MN			Drug-induced hyperglycemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ONSET DIABETES-MELLITUS; IMPAIRED GLUCOSE-TOLERANCE; BETA-BLOCKING-AGENTS; INSULIN SENSITIVITY; PROTEASE INHIBITORS; THIAZIDE DIURETICS; INDUCED DISORDERS; CLOZAPINE; KETOACIDOSIS; HYPERTENSION		Duke Univ, Med Ctr, Div Metab Endocrinol & Nutr, Dept Internal Med, Durham, NC 27710 USA; Campbell Univ, Sch Pharm, Dept Internal Med, Buies Creek, NC 27506 USA; Duke Univ Hlth Syst, Durham, NC USA	Duke University; Campbell University; Duke University	Feinglos, MN (corresponding author), Duke Univ, Med Ctr, Div Metab Endocrinol & Nutr, Dept Internal Med, Box 3921, Durham, NC 27710 USA.	feing002@mc.duke.edu						*AM DIAB ASS, 2001, DIABETES CARE, V24, pS 21; BAGDADE JD, 1978, DIABETES, V27, P677, DOI 10.2337/diabetes.27.6.677; Balkau B, 1998, DIABETES CARE, V21, P360, DOI 10.2337/diacare.21.3.360; Behrens G, 1999, AIDS, V13, pF63, DOI 10.1097/00002030-199907090-00001; Bettinger TL, 2000, ANN PHARMACOTHER, V34, P865, DOI 10.1345/aph.19327; Blake M, 2000, CLIN INFECT DIS, V30, pS96, DOI 10.1086/313859; Chan JCN, 1996, DRUG SAFETY, V15, P135, DOI 10.2165/00002018-199615020-00005; COARKIN PE, 2000, PSYCHOSOMATICS, V41, P369; Conley RR, 2000, J CLIN PSYCHIAT, V61, P26; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Curran P, 2000, SIGHT SOUND, V10, P62; Fertig MK, 1998, J CLIN PSYCHIAT, V59, P687, DOI 10.4088/JCP.v59n1208c; Gatta B, 1999, DIABETES CARE, V22, P1002, DOI 10.2337/diacare.22.6.1002; Giugliano D, 1997, ANN INTERN MED, V126, P955, DOI 10.7326/0003-4819-126-12-199706150-00004; GOLDSTEIN L, 2000, PRIMARY PSYCHIAT, V7, P65; Goldstein LE, 1999, PSYCHOSOMATICS, V40, P438, DOI 10.1016/S0033-3182(99)71210-7; Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301; GRINSPOON SK, 1992, NEW ENGL J MED, V327, P1360, DOI 10.1056/NEJM199211053271906; GURWITZ JH, 1993, ANN INTERN MED, V118, P273, DOI 10.7326/0003-4819-118-4-199302150-00005; Hadigan C, 2000, JAMA-J AM MED ASSOC, V284, P472, DOI 10.1001/jama.284.4.472; Hagg S, 1998, J CLIN PSYCHIAT, V59, P294, DOI 10.4088/JCP.v59n0604; HELDERMAN JH, 1983, DIABETES, V32, P106, DOI 10.2337/diabetes.32.2.106; Henderson DC, 2000, AM J PSYCHIAT, V157, P975, DOI 10.1176/appi.ajp.157.6.975; Isakov I, 2000, PSYCHOSOMATICS, V41, P373, DOI 10.1176/appi.psy.41.4.373; Jacob S, 1996, J HYPERTENS, V14, P489; KAMRAN A, 1994, AM J PSYCHIAT, V151, P1395; Kilby JM, 1998, J ACQ IMMUN DEF SYND, V17, P46, DOI 10.1097/00042560-199801010-00007; Kingsbury SJ, 2001, J CLIN PSYCHIAT, V62, P347, DOI 10.4088/JCP.v62n0507; Kostakoglu AE, 1996, ACTA PSYCHIAT SCAND, V93, P217, DOI 10.1111/j.1600-0447.1996.tb10635.x; KOVAL MS, 1994, AM J PSYCHIAT, V151, P1520; Lindenmayer JP, 1999, AM J PSYCHIAT, V156, P1471; MCMURRY JF, 1984, SURG CLIN N AM, V64, P769; Mukherjee S, 1996, COMPR PSYCHIAT, V37, P68, DOI 10.1016/S0010-440X(96)90054-1; Mulligan K, 2000, J ACQ IMMUN DEF SYND, V23, P35, DOI 10.1097/00042560-200001010-00005; Ober SK, 1999, AM J PSYCHIAT, V156, P970, DOI 10.1176/ajp.156.6.970; PANDIT MK, 1993, ANN INTERN MED, V118, P529, DOI 10.7326/0003-4819-118-7-199304010-00008; PETERS A, 1995, EXP CLIN ENDOCR DIAB, V103, P213, DOI 10.1055/s-0029-1211353; Peterson GA, 1996, AM J PSYCHIAT, V153, P737; Popli AP, 1997, J CLIN PSYCHIAT, V58, P108, DOI 10.4088/JCP.v58n0304; Procyshyn RM, 2000, CAN J PSYCHIAT, V45, P668; RAMIREZ EA, 1985, HYPERTENSION, V7, P1008; RAYFIELD EJ, 1982, AM J MED, V72, P439, DOI 10.1016/0002-9343(82)90511-3; Rigalleau V, 2000, DIABETIC MED, V17, P484, DOI 10.1046/j.1464-5491.2000.00296.x; Saint-Marc T, 1999, AIDS, V13, P1000, DOI 10.1097/00002030-199905280-00023; SAMUELSSON O, 1994, J HUM HYPERTENS, V8, P257; Sobel M, 1999, J CLIN PSYCHIAT, V60, P556, DOI 10.4088/JCP.v60n0809f; Tsiodras S, 2000, ARCH INTERN MED, V160, P2050, DOI 10.1001/archinte.160.13.2050; US Department of Health and Human Services, 2001, GUID US ANT AG HIV I; Walli R, 2000, RES EXP MED, V199, P253, DOI 10.1007/s004330050123; Walli R, 1998, AIDS, V12, pF167, DOI 10.1097/00002030-199815000-00001; White WB, 2000, AM J MED, V108, P238, DOI 10.1016/S0002-9343(99)00444-1; WICKLMAYR M, 1990, HORM METAB RES, V22, P29; WILSON PWF, 1991, AM HEART J, V121, P586, DOI 10.1016/0002-8703(91)90729-2; Wirshing DA, 1998, BIOL PSYCHIAT, V44, P778, DOI 10.1016/S0006-3223(98)00100-0; Yazici KM, 1998, EXP CLIN ENDOCR DIAB, V106, P475, DOI 10.1055/s-0029-1212019	55	110	113	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2001	286	16					1945	1948		10.1001/jama.286.16.1945	http://dx.doi.org/10.1001/jama.286.16.1945			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485JD	11667913				2022-12-28	WOS:000171750500001
J	Lumaret, R; Ouazzani, N				Lumaret, R; Ouazzani, N			Plant genetics - Ancient wild olives in Mediterranean forests	NATURE			English	Article							OLEA-EUROPAEA L		CNRS, Ctr Ecol Fonct & Evolut, F-34293 Montpellier 5, France; Ecole Natl Agr, Meknes, Morocco	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Moulay Ismail University of Meknes	Lumaret, R (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, 1919 Route de Mende, F-34293 Montpellier 5, France.							LUMARET R, 1997, BOCCONEA, V7, P39; Ouazzani N, 1996, EUPHYTICA, V91, P9, DOI 10.1007/BF00035271; OUAZZANI N, 1993, J HERED, V84, P34, DOI 10.1093/oxfordjournals.jhered.a111274; OUAZZANI N, 1995, AGRONOMIE, V15, P31, DOI 10.1051/agro:19950104; Terral JF, 1999, PALAEOGEOGR PALAEOCL, V153, P71, DOI 10.1016/S0031-0182(99)00079-6; TRUJILLO T, 1995, J AM SOC HORTIC SCI, V120, P318; TURRILL WB, 1951, KEW B, V3, P439; ZOHARY D, 1975, SCIENCE, V187, P319, DOI 10.1126/science.187.4174.319	8	76	77	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					700	700		10.1038/35099680	http://dx.doi.org/10.1038/35099680			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607022				2022-12-28	WOS:000171608000034
J	McDonald, LC; Rossiter, S; Mackinson, C; Wang, YY; Johnson, S; Sullivan, M; Sokolow, R; DeBess, E; Gilbert, L; Benson, JA; Hill, B; Angulo, FJ				McDonald, LC; Rossiter, S; Mackinson, C; Wang, YY; Johnson, S; Sullivan, M; Sokolow, R; DeBess, E; Gilbert, L; Benson, JA; Hill, B; Angulo, FJ			Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GASTROINTESTINAL-TRACT COLONIZATION; GLYCOPEPTIDE RESISTANCE; ANTIMICROBIAL RESISTANCE; HIGH PREVALENCE; FECAL CARRIAGE; UNITED-STATES; POULTRY MEAT; SATA GENE; VANCOMYCIN; ANIMALS	Background: The combination of the streptogramins quinupristin and dalfopristin was approved in the United States in late 1999 for the treatment of vancomycin-resistant Enterococcus faecium infections. Since 1974, another streptogramin, virginiamycin, has been used at subtherapeutic concentrations to promote the growth of farm animals, including chickens. Methods: To determine the frequency of quinupristin-dalfopristin-resistant E. faecium, we used selective medium to culture samples from chickens purchased in supermarkets in Georgia, Maryland, Minnesota, and Oregon and stool samples from outpatients. Results: Between July 1998 and June 1999, samples from 407 chickens from 26 stores in four states were cultured, as were 334 stool samples from outpatients. Quinupristin-dalfopristin-resistant E. faecium was isolated from 237 chicken carcasses and 3 stool specimens. The resistant isolates from stool had low-level resistance (minimal inhibitory concentration [MIC], 4 mug per milliliter; resistance was defined as a MIC of at least 4 mug per milliliter). The resistant isolates from chickens in general had higher levels of resistance (MICs ranging from 4 to 32 microg per milliliter; MIC required to inhibit 50 percent of isolates, 8 mug per milliliter). Conclusions: Quinupristin-dalfopristin - resistant E. faecium contaminates a large proportion of chickens sold in U.S. supermarkets. However, the low prevalence and low level of resistance of these strains in human stool specimens suggest that the use of virginiamycin in animals has not yet had a substantial influence. Foodborne dissemination of resistance may increase, however, as the clinical use of quinupristin-dalfopristin increases. (N Engl J Med 2001;345:1155-60.) Copyright (C) 2001 Massachusetts Medical Society.	CDCP, Foodborne & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Hosp Infect Program, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Univ Maryland, Baltimore, MD 21201 USA; Minnesota Dept Hlth, Minneapolis, MN USA; Oregon Hlth Div, Portland, OR USA; Georgia Div Publ Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University System of Maryland; University of Maryland Baltimore; Minnesota Department of Health (MHD); Oregon Health & Science University	Angulo, FJ (corresponding author), CDCP, Foodborne & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, 1600 Clifton Rd,MS A38, Atlanta, GA 30333 USA.	fangulo@cdc.gov						Aarestrup FM, 1995, MICROB DRUG RESIST, V1, P255, DOI 10.1089/mdr.1995.1.255; [Anonymous], 1997, M7A4 NCCLS; BATES J, 1994, J ANTIMICROB CHEMOTH, V34, P507, DOI 10.1093/jac/34.4.507; Bergeron M, 1997, J ANTIMICROB CHEMOTH, V39, P129, DOI 10.1093/jac/39.suppl_1.129; Borgen K, 2000, J APPL MICROBIOL, V89, P478, DOI 10.1046/j.1365-2672.2000.01137.x; *CDCP, 1999, MMWR-MORBID MORTAL W, V47, P1; *COMM DRUG US FOOD, 1999, US DRUG FOOD AN BEN; Dever LL, 1996, MICROB DRUG RESIST, V2, P415, DOI 10.1089/mdr.1996.2.415; Donskey CJ, 1999, J INFECT DIS, V180, P384, DOI 10.1086/314874; Eliopoulos GM, 1998, ANTIMICROB AGENTS CH, V42, P1088, DOI 10.1128/AAC.42.5.1088; Endtz HP, 1997, J CLIN MICROBIOL, V35, P3026, DOI 10.1128/JCM.35.12.3026-3031.1997; FORD M, 1994, J CLIN MICROBIOL, V32, P2999, DOI 10.1128/JCM.32.12.2999-3001.1994; GORDTS B, 1995, J CLIN MICROBIOL, V33, P2842, DOI 10.1128/JCM.33.11.2842-2846.1995; Hammerum AM, 1998, FEMS MICROBIOL LETT, V168, P145, DOI [10.1111/j.1574-6968.1998.tb13267.x, 10.1016/S0378-1097(98)00433-9]; Jacobsen B. L., 1999, Microbial Ecology in Health and Disease, V11, P241, DOI 10.1080/08910609908540834; Jensen LB, 1998, ANTIMICROB AGENTS CH, V42, P3330, DOI 10.1128/AAC.42.12.3330; JONES RN, 1995, DIAGN MICR INFEC DIS, V21, P85, DOI 10.1016/0732-8893(94)00147-O; Jones RN, 1998, DIAGN MICR INFEC DIS, V31, P437, DOI 10.1016/S0732-8893(98)80002-3; JORDENS JZ, 1994, J ANTIMICROB CHEMOTH, V34, P515, DOI 10.1093/jac/34.4.515; Klare I, 1999, MICROB DRUG RESIST, V5, P45, DOI 10.1089/mdr.1999.5.45; KLARE I, 1995, FEMS MICROBIOL LETT, V125, P165, DOI 10.1111/j.1574-6968.1995.tb07353.x; Mellon M., 2001, HOGGING IT ESTIMATES; Moller FM, 1998, APMIS, V106, P606, DOI 10.1111/j.1699-0463.1998.tb01391.x; National Committee for Clinical Laboratory Standards, 1999, PERF STAND ANT SUSC; Pantosti A, 1999, LANCET, V354, P741, DOI 10.1016/S0140-6736(99)02395-8; RENDEFOURNIER R, 1993, ANTIMICROB AGENTS CH, V37, P2119, DOI 10.1128/AAC.37.10.2119; Sahm DF, 1999, CLIN INFECT DIS, V29, P259, DOI 10.1086/520195; Schouten MA, 1999, ANTIMICROB AGENTS CH, V43, P2542, DOI 10.1128/AAC.43.10.2542; Schouten MA, 1997, LANCET, V349, P1258, DOI 10.1016/S0140-6736(05)62461-0; Soltani M, 2000, ANTIMICROB AGENTS CH, V44, P433, DOI 10.1128/AAC.44.2.433-436.2000; Stobberingh E, 1999, ANTIMICROB AGENTS CH, V43, P2215, DOI 10.1128/AAC.43.9.2215; Teixeira, 1999, MANUAL CLIN MICROBIO, P297; vandenBogaard AE, 1997, J ANTIMICROB CHEMOTH, V40, P454, DOI 10.1093/jac/40.3.454; VanderAuwera P, 1996, J INFECT DIS, V173, P1129, DOI 10.1093/infdis/173.5.1129; Wegener HC, 1999, EMERG INFECT DIS, V5, P329, DOI 10.3201/eid0503.990303; Welton LA, 1998, ANTIMICROB AGENTS CH, V42, P705, DOI 10.1128/AAC.42.3.705; Whitman MS, 1996, ANTIMICROB AGENTS CH, V40, P1526, DOI 10.1128/AAC.40.6.1526; 2000, FED REG, V65, P20992	38	72	78	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2001	345	16					1155	1160		10.1056/NEJMoa010805	http://dx.doi.org/10.1056/NEJMoa010805			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482YX	11642231				2022-12-28	WOS:000171605800002
J	Finetti, M				Finetti, M			Continuity and new beginnings in university medical schools after 1945 - German - Aumuller,G, Lauer,H, Remschmidt,H	NATURE			English	Book Review											Finetti, M (corresponding author), DEUTSCH UNIV ZEITUNG UNABHANGIGE HSCH MAGAZIN,KONIGSWINTERER STR 418,D-53227 BONN,GERMANY.							AUMULLER G, 1997, KONTINUITAT NEUANFAN	1	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	DEC 4	1997	390	6659					457	458		10.1038/37264	http://dx.doi.org/10.1038/37264			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YJ865	11644979	Bronze			2022-12-28	WOS:A1997YJ86500034
J	Greenberg, DS				Greenberg, DS			Much ado about mutton?	LANCET			English	Editorial Material																			0	1	1	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 21	1997	349	9068					1850	1850		10.1016/S0140-6736(05)61743-6	http://dx.doi.org/10.1016/S0140-6736(05)61743-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XF735	11654834				2022-12-28	WOS:A1997XF73500069
J	Bushby, K; Raybould, S; O'Donnell, S; Steele, JG				Bushby, K; Raybould, S; O'Donnell, S; Steele, JG			Social deprivation in Duchenne muscular dystrophy: population based study	BRITISH MEDICAL JOURNAL			English	Article									Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; Univ Newcastle Upon Tyne, Ctr Urban & Reg Dev Studies, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Newcastle Upon Tyne, Sch Med, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England; Univ Newcastle Upon Tyne, Dept Restorat Dent, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Bushby, K (corresponding author), Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.							Acheson D., 1998, INDEPENDENT ENQUIRY; Benzeval M, 1996, J PUBLIC HEALTH MED, V18, P33, DOI 10.1093/oxfordjournals.pubmed.a024459; Bushby KMD, 1999, LANCET, V353, P557, DOI 10.1016/S0140-6736(98)05279-9; Gorospe Jose Rafael M., 1992, Current Opinion in Rheumatology, V4, P794; Townsend PP., 1988, HLTH DEPRIVATION INE	5	9	9	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 3	2001	323	7320					1035	1036		10.1136/bmj.323.7320.1035	http://dx.doi.org/10.1136/bmj.323.7320.1035			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MP	11691762	Green Published, Bronze			2022-12-28	WOS:000172055900018
J	Siegel, JM				Siegel, JM			The REM sleep - Memory consolidation hypothesis	SCIENCE			English	Review							EYE-MOVEMENT SLEEP; IMMOBILIZATION STRESS; VISUAL-FIELD; RAT; HIPPOCAMPAL; STATES; PERFORMANCE; DEPRIVATION; PLASTICITY; INVERSION	It has been hypothesized that REM (rapid eye movement) steep has an important role in memory consolidation. The evidence for this hypothesis is reviewed and found to be weak and contradictory. Animal studies correlating changes in REM steep parameters with learning have produced inconsistent results and are confounded by stress effects. Humans with pharmacological and brain lesion-induced suppression of REM steep do not show memory deficits, and other human steep-learning studies have not produced consistent results. The time spent in REM steep is not correlated with learning ability across humans, nor is there a positive relation between REM steep time or intensity and encephalization across species. Although steep is clearly important for optimum acquisition and performance of learned tasks, a major role in memory consolidation is unproven.	Dept Vet Affairs Greater Los Angeles Healthcare S, Ctr Sleep Res, North Hills, CA 91343 USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Siegel, JM (corresponding author), Dept Vet Affairs Greater Los Angeles Healthcare S, Ctr Sleep Res, North Hills, CA 91343 USA.				NHLBI NIH HHS [R37 HL041370, HL60296] Funding Source: Medline; NIMH NIH HHS [MH64109] Funding Source: Medline; NINDS NIH HHS [NS14610] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014610, R37NS014610] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN SR, 1972, PSYCHOPHYSIOLOGY, V9, P498, DOI 10.1111/j.1469-8986.1972.tb01803.x; [Anonymous], 2000, PRINCIPLES PRACTICE; ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; BORROW SJ, 1980, BIOL PSYCHIAT, V15, P165; BUSBY K, 1983, J CHILD PSYCHOL PSYC, V24, P587, DOI 10.1111/j.1469-7610.1983.tb00134.x; CASTALDO V, 1973, J MENT DEFIC RES, V17, P231; Cirelli C, 2000, BRAIN RES, V885, P303, DOI 10.1016/S0006-8993(00)03008-0; COHEN HB, 1965, SCIENCE, V150, P1318, DOI 10.1126/science.150.3701.1318; CRICK F, 1983, NATURE, V304, P111, DOI 10.1038/304111a0; Datta S, 2000, J NEUROSCI, V20, P8607, DOI 10.1523/JNEUROSCI.20-22-08607.2000; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; DEKONINCK J, 1989, INT J PSYCHOPHYSIOL, V8, P43, DOI 10.1016/0167-8760(89)90018-4; DeKoninck J, 1996, J SLEEP RES, V5, P16, DOI 10.1046/j.1365-2869.1996.00001.x; DEKONINCK J, 1991, CAN J PSYCHOL, V45, P125, DOI 10.1037/h0084290; DEKONINCK J, 1995, SRS B; DEMENT W, 1960, SCIENCE, V131, P1705, DOI 10.1126/science.131.3415.1705; Dement WC, 1969, SLEEP PHYSIOLOGY PAT, P245; FEINBERG I, 1967, J PSYCHIAT RES, V5, P107, DOI 10.1016/0022-3956(67)90027-1; FEINBERG I, 1969, ELECTROEN CLIN NEURO, V27, P128, DOI 10.1016/0013-4694(69)90165-5; FEINBERG I, 1968, COMPR PSYCHIAT, V9, P138, DOI 10.1016/S0010-440X(68)80049-5; FEINBERG I, 1968, SCIENCE, V159, P1256, DOI 10.1126/science.159.3820.1256; Foulkes D, 1966, PSYCHOL SLEEP; GAARDER K, 1966, ARCH GEN PSYCHIAT, V14, P253; Georgotas A, 1983, Arch Gerontol Geriatr, V2, P249, DOI 10.1016/0167-4943(83)90028-6; GISQUETVERRIER P, 1989, BEHAV NEURAL BIOL, V52, P152, DOI 10.1016/S0163-1047(89)90271-9; Gonzalez MMD, 1995, NEUROSCI LETT, V202, P5; Helmuth L, 2000, SCIENCE, V290, P247; HENDLER N, 1980, AM J PSYCHIAT, V137, P828; HORNE JA, 1984, BIOL PSYCHOL, V18, P165, DOI 10.1016/0301-0511(84)90001-2; Horne JA, 2000, NEUROSCI BIOBEHAV R, V24, P777, DOI 10.1016/S0149-7634(00)00037-3; Izumi Y, 1999, SYNAPSE, V31, P196, DOI 10.1002/(SICI)1098-2396(19990301)31:3<196::AID-SYN4>3.0.CO;2-K; JONES BE, 1989, PRINCIPLES PRACTICE, P121; JOUVET M, 1962, Arch Ital Biol, V100, P125; Jouvet M., 1978, CEREBRAL CORRELATES, V6, P245; JOY RM, 1969, PHYSIOL BEHAV, V4, P809, DOI 10.1016/0031-9384(69)90122-X; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; KASAMATSU T, 1976, SCIENCE, V194, P206, DOI 10.1126/science.959850; Kleitman N., 1963, SLEEP WAKEFULNESS; LAVIE P, 1984, NEUROLOGY, V34, P118, DOI 10.1212/WNL.34.1.118; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Lyamin OI, 2000, J SLEEP RES, V9, P261; MARTASIAN PJ, 1992, PSYCHOL REP, V70, P339, DOI 10.2466/PR0.70.2.339-355; MCGRATH MJ, 1978, PSYCHOL BULL, V85, P24, DOI 10.1037/0033-2909.85.1.24; *MED EC CO, 2001, PHYS DESK REF; MORDEN B, 1968, PHYSIOL BEHAV, V3, P425, DOI 10.1016/0031-9384(68)90073-5; NEWMAN EA, 1965, NATURE, V206, P534, DOI 10.1038/206534a0; Oniani T N, 1988, Neurosci Behav Physiol, V18, P301, DOI 10.1007/BF01185522; Parent MB, 1999, PSYCHOPHARMACOLOGY, V142, P280, DOI 10.1007/s002130050890; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; RAMPIN C, 1991, NEUROSCI LETT, V126, P113, DOI 10.1016/0304-3940(91)90532-X; RECHTSCHAFFEN A, 1978, SLEEP, V1, P97, DOI 10.1093/sleep/1.1.97; Rechtschaffen A., 2000, PRINCIPLES NEURAL SC, P936; Reiss D, 2001, P NATL ACAD SCI USA, V98, P5937, DOI 10.1073/pnas.101086398; RIDER RA, 1961, PERCEPT MOTOR SKILL, V73, P219; ROFFWARG HP, 1966, SCIENCE, V152, P604, DOI 10.1126/science.152.3722.604; SIEGEL JM, 1988, BRAIN RES REV, V13, P213, DOI 10.1016/0165-0173(88)90007-0; Siegel JM, 1999, NEUROSCIENCE, V91, P391, DOI 10.1016/S0306-4522(98)00588-0; SIEGEL JM, 2000, PRINCIPLES PRACTICE, P112; Smith C, 1996, BEHAV BRAIN RES, V78, P49, DOI 10.1016/0166-4328(95)00218-9; Smith C, 2000, BEHAV BRAIN SCI, V23, P1007, DOI 10.1017/S0140525X00224035; SMITH C, 1985, NEUROSCI BIOBEHAV R, V9, P157, DOI 10.1016/0149-7634(85)90042-9; SMITH C, 1991, SLEEP, V14, P325, DOI 10.1093/sleep/14.4.325; Spieler DH, 1996, PSYCHOL AGING, V11, P607, DOI 10.1037/0882-7974.11.4.607; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2000, SCIENCE, V290, P350, DOI 10.1126/science.290.5490.350; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; VALLDEORIOLA F, 1993, SLEEP, V16, P184, DOI 10.1093/sleep/16.2.184; VANHULZEN ZJM, 1982, PHYSIOL BEHAV, V29, P581, DOI 10.1016/0031-9384(82)90223-2; Vertes RP, 2000, BEHAV BRAIN SCI, V23, P867, DOI 10.1017/S0140525X00004003; VIMONTVICARY P, 1966, ELECTROEN CLIN NEURO, V20, P439, DOI 10.1016/0013-4694(66)90101-5; VOGEL GW, 1975, ARCH GEN PSYCHIAT, V32, P749; Wagner U, 2001, LEARN MEMORY, V8, P112, DOI 10.1101/lm.36801; WYATT RJ, 1971, ARCH GEN PSYCHIAT, V24, P145; Zepelin H, 2000, PRINCIPLES PRACTICE, P82; ZIMMERMAN J, 1970, PSYCHOPHYSIOLOGY, V7, P298; ZIMMERMAN JT, 1978, BIOL PSYCHIAT, V13, P301	78	340	347	3	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1058	1063		10.1126/science.1063049	http://dx.doi.org/10.1126/science.1063049			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	489VU	11691984	Green Accepted			2022-12-28	WOS:000172013800040
J	Donovan, PJ; Gearhart, J				Donovan, PJ; Gearhart, J			The end of the beginning for pluripotent stem cells	NATURE			English	Review							PRIMORDIAL GERM-CELLS; TERATOCARCINOMA CELLS; ES CELLS; SELF-RENEWAL; IN-VITRO; DIFFERENTIATION; LINES; DERIVATION; CULTURE; RAT	Pluripotent stem cells can be expanded seemingly indefinitely in culture, maintain a normal karyotype and have the potential to generate any cell type in the body. As such they represent an incredible resource for the repair of diseased or damaged tissues in our bodies. These cells also promise to open a new window into the embryonic development of our species.	Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21287 USA	Jefferson University; Johns Hopkins University	Donovan, PJ (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA.	pdonovan@lac.jci.tju.edu; gearhart@jhmi.edu						Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Andrews PW, 1998, APMIS, V106, P158, DOI 10.1111/j.1699-0463.1998.tb01331.x; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Borlongan CV, 1998, NEUROREPORT, V9, P3703, DOI 10.1097/00001756-199811160-00025; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; BRINSTER RL, 1974, J EXP MED, V140, P1049, DOI 10.1084/jem.140.4.1049; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; EVANS MJ, 1972, J EMBRYOL EXP MORPH, V28, P163; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; ILLMENSEE K, 1976, P NATL ACAD SCI USA, V73, P549, DOI 10.1073/pnas.73.2.549; Jiang LI, 2001, MAMM GENOME, V12, P89, DOI 10.1007/s003350010257; KAHAN BW, 1970, J NATL CANCER I, V44, P1015; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; LABOSKY PA, 1994, DEVELOPMENT, V120, P3197; LABOSKY PA, 1994, CIBA F SYMP, V182, P157; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MARTIN GR, 1980, SCIENCE, V209, P768, DOI 10.1126/science.6250214; MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; McLaren A, 2001, CELL STRUCT FUNCT, V26, P119, DOI 10.1247/csf.26.119; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Muir JK, 1999, J NEUROTRAUM, V16, P403, DOI 10.1089/neu.1999.16.403; Muller M, 2000, FASEB J, V14, P2540, DOI 10.1096/fj.00-0002com; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; PAPAIOANNOU VE, 1975, NATURE, V258, P70, DOI 10.1038/258070a0; PAPAIOANNOU VE, 1978, J EMBRYOL EXP MORPH, V44, P93; Pera MF, 2000, J CELL SCI, V113, P5; Pesce M, 2000, MOL REPROD DEV, V55, P452, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;452::AID-MRD14&gt;3.0.CO;2-S; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; ROSENTHA.MD, 1970, J NATL CANCER I, V44, P1001; Scholz G, 1999, CELLS TISSUES ORGANS, V165, P203, DOI 10.1159/000016700; Shamblott MJ, 2001, P NATL ACAD SCI USA, V98, P113, DOI 10.1073/pnas.021537998; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; SKAKKEBAEK NE, 1987, INT J ANDROL, V10, P19, DOI 10.1111/j.1365-2605.1987.tb00161.x; Smith A, 2001, COLD SPRING HARBOR M, P205; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Soria B, 2000, DIABETES, V49, P157, DOI 10.2337/diabetes.49.2.157; Stevens L C, 1967, Adv Morphog, V6, P1; STEVENS LC, 1967, J NATL CANCER I, V38, P549; STEWART CL, 1994, DEV BIOL, V161, P626, DOI 10.1006/dbio.1994.1058; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada T, 1998, DEV GENES EVOL, V207, P551, DOI 10.1007/s004270050146; Tang DG, 2001, SCIENCE, V291, P868, DOI 10.1126/science.1056780; Terskikh AV, 2001, P NATL ACAD SCI USA, V98, P7934, DOI 10.1073/pnas.131200898; Thomson JA, 1996, BIOL REPROD, V55, P254, DOI 10.1095/biolreprod55.2.254; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; WILES MV, 1991, DEVELOPMENT, V111, P259; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; YOSHIDA K, 1994, MECH DEVELOP, V45, P163, DOI 10.1016/0925-4773(94)90030-2	72	223	323	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					92	97		10.1038/35102154	http://dx.doi.org/10.1038/35102154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689953				2022-12-28	WOS:000171898900052
J	Surani, MA				Surani, MA			Reprogramming of genome function through epigenetic inheritance	NATURE			English	Review							PRIMORDIAL GERM-CELLS; X-CHROMOSOME INACTIVATION; DNA METHYLATION; SOMATIC-CELLS; STEM-CELLS; MATERNAL-BEHAVIOR; TELOMERE LENGTH; IMPRINTED GENES; MOUSE CLONING; GROWTH	Most cells contain the same set of genes and yet they are extremely diverse in appearance and functions. It is the selective expression and repression of genes that determines the specific properties of individual cells. Nevertheless, even when fully differentiated, any cell can potentially be reprogrammed back to totipotency, which in turn results in re-differentiation of the full repertoire of adult cells from a single original cell of any kind. Mechanisms that regulate this exceptional genomic plasticity and the state of totipotency are being unravelled, and will enhance our ability to manipulate stem cells for therapeutic purposes.	Univ Cambridge, Wellcome CRC Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Physiol Lab, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge	Surani, MA (corresponding author), Univ Cambridge, Wellcome CRC Inst Canc & Dev Biol, Tennis Court Rd, Cambridge CB2 1QR, England.	as10021@mole.bio.cam.ac.uk		Surani, Azim/0000-0002-8640-4318				ALLEN ND, 1990, CELL, V61, P853, DOI 10.1016/0092-8674(90)90195-K; Arney KL, 2001, INT J DEV BIOL, V45, P533; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Betts DH, 2001, P NATL ACAD SCI USA, V98, P1077, DOI 10.1073/pnas.031559298; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kato Y, 1999, DEVELOPMENT, V126, P1823; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Kikyo N, 2000, SCIENCE, V289, P2360, DOI 10.1126/science.289.5488.2360; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; Mann JR, 2001, STEM CELLS, V19, P287, DOI 10.1634/stemcells.19-4-287; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; McLaren A, 1999, GENE DEV, V13, P373, DOI 10.1101/gad.13.4.373; Meeker AK, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1323; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; MONK M, 1987, DEVELOPMENT, V99, P371; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Obata Y, 1998, DEVELOPMENT, V125, P1553; Olek A, 1997, NAT GENET, V17, P275, DOI 10.1038/ng1197-275; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Reik W, 2001, NAT GENET, V27, P255, DOI 10.1038/85804; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753; Satijn DPE, 2001, MOL CELL BIOL, V21, P1360, DOI 10.1128/MCB.21.4.1360-1369.2001; Schumacher A, 1996, NATURE, V384, P648, DOI 10.1038/384648a0; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; SMITH AG, IN PRESS ANN REV CEL; Solter D, 2000, NAT REV GENET, V1, P199, DOI 10.1038/35042066; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; TADA M, IN PRESS CURR BIOL; Tada T, 1998, DEV GENES EVOL, V207, P551, DOI 10.1007/s004270050146; Tada T, 2000, DEVELOPMENT, V127, P3101; TAKAGI N, 1983, CELL, V34, P1053, DOI 10.1016/0092-8674(83)90563-9; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; TAM PPL, 1994, DEVELOPMENT, V120, P2925; Tamashiro KLK, 2000, BIOL REPROD, V63, P328, DOI 10.1095/biolreprod63.1.328; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Vrana PB, 1998, NAT GENET, V20, P362, DOI 10.1038/3833; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 2001, REPRODUCTION, V122, P49, DOI 10.1530/rep.0.1220049; Wakayama T, 2001, MOL REPROD DEV, V58, P376, DOI 10.1002/1098-2795(20010401)58:4<376::AID-MRD4>3.0.CO;2-L; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Yoshimizu T, 2001, DEVELOPMENT, V128, P481	75	320	345	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					122	128		10.1038/35102186	http://dx.doi.org/10.1038/35102186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689958	hybrid			2022-12-28	WOS:000171898900057
J	Horton, R				Horton, R			Screening mammography - an overview revisited	LANCET			English	Editorial Material							CANCER		The Lancet, London WC1X 8EE, England		Horton, R (corresponding author), The Lancet, London WC1X 8EE, England.							Clarke M, 2001, LANCET, V357, P1728, DOI 10.1016/S0140-6736(00)04934-5; de Koning HJ, 2000, LANCET, V355, P80, DOI 10.1016/S0140-6736(99)00419-5; Duffy SW, 2000, LANCET, V355, P747, DOI 10.1016/S0140-6736(05)72152-8; Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1; Jadad AR, 1998, JAMA-J AM MED ASSOC, V280, P278, DOI 10.1001/jama.280.3.278; Olsen O, 2001, BRIT MED J, V323, P829, DOI 10.1136/bmj.323.7317.829; Wilcken N, 2000, LANCET, V356, P1275, DOI 10.1016/S0140-6736(05)73880-0	7	51	51	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 20	2001	358	9290					1284	1285		10.1016/S0140-6736(01)06452-2	http://dx.doi.org/10.1016/S0140-6736(01)06452-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684203				2022-12-28	WOS:000171702500002
J	Kaplan, EL; Wotton, JT; Johnson, DR				Kaplan, EL; Wotton, JT; Johnson, DR			Dynamic epidemiology of group A streptococcal serotypes associated with pharyngitis	LANCET			English	Article							GROUP-A STREPTOCOCCI; RHEUMATIC-FEVER; INFECTIONS; PYOGENES; DISEASE; FAILURE	Background Despite the past 15 years of heightened awareness of the disease-causing potential of group A streptococci, the possible epidemiological influence of rapid changes in prevalent serotypes has not been fully appreciated. Methods We analysed throat cultures collected as part of routine medical care in a semi-closed community of nearly 500 children and adults between January, 1999, and April, 2000. beta -haemolytic streptococci from all positive cultures were characterised by serological grouping, T-agglutination pattern, and serotyping for M protein or opacity factor. Findings We saw an increase in the number of symptomatic individuals with pharyngitis beginning in mid-1999. Between July 1 and Dec 31, 1999, 111 (29%) of 378 throat cultures yielded group A streptococci, 102 (92%) of which were serotype M1. Between Jan 1 and Mar 31, 2000, 126 (45%) of 277 throat cultures yielded group A streptococci. Unexpectedly, 106 (84%) of these throat isolates were serotype M6, and only 16 (13%) were M1. 20 ((28%.) of the 71 individuals with M1 infection subsequently acquired infection with M6. Interpretation This rapid and almost complete shift in predominance of group A streptococcal serotype in this community draws attention to the dynamic epidemiology of these organisms. This change has important implications for further understanding the epidemiology of group A streptococcal infections, and for the development and use of a vaccine.	Univ Minnesota, Sch Med, Dept Pediat,WHO, Collaborating Ctr Reference & Res Streptococci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; World Health Organization	Kaplan, EL (corresponding author), Univ Minnesota, Sch Med, Dept Pediat,WHO, Collaborating Ctr Reference & Res Streptococci, MMC 296,420 Delaware St SE, Minneapolis, MN 55455 USA.							ANTHONY BF, 1976, AM J EPIDEMIOL, V104, P652, DOI 10.1093/oxfordjournals.aje.a112344; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; CLEARY PP, 1992, LANCET, V339, P518, DOI 10.1016/0140-6736(92)90339-5; CLEARY PP, 2000, STREPTOCOCCI STREPTO, P437; CORNFELD D, 1961, NEW ENGL J MED, V264, P211, DOI 10.1056/NEJM196102022640502; DALE JB, 2000, STREPTOCOCCI STREPTO, P473; Facklam R, 1999, EMERG INFECT DIS, V5, P247, DOI 10.3201/eid0502.990209; FISCHETTI VA, 2000, STREPTOCOCCI STREPTO, P433; GASTANADUY AS, 1980, LANCET, V2, P498; GAWORZEWSKA E, 1988, EPIDEMIOL INFECT, V100, P257, DOI 10.1017/S095026880006739X; JOHNSON DR, 1992, J INFECT DIS, V166, P374, DOI 10.1093/infdis/166.2.374; Johnson DR., 1996, LAB DIAGNOSIS GROUP; JONES KF, 1988, P NATL ACAD SCI USA, V85, P8271, DOI 10.1073/pnas.85.21.8271; KAPLAN EL, 1979, PEDIATRICS, V64, P904; KAPLAN EL, 1981, J LAB CLIN MED, V98, P326; KAPLAN EL, 1993, CIRCULATION, V88, P1964, DOI 10.1161/01.CIR.88.4.1964; MARTIN PR, 1990, SCAND J INFECT DIS, V22, P421, DOI 10.3109/00365549009027073; SCHWARTZ B, 1990, LANCET, V336, P1167, DOI 10.1016/0140-6736(90)92777-F; Stevens DL., 2000, STREPTOCOCCAL INFECT; WANNAMAKER LW, 1954, STREPTOCOCCAL INFECT	20	81	81	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 20	2001	358	9290					1334	1337		10.1016/S0140-6736(01)06415-7	http://dx.doi.org/10.1016/S0140-6736(01)06415-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684215				2022-12-28	WOS:000171702500014
J	Minnis, H; McMillan, A; Gillies, M; Smith, S				Minnis, H; McMillan, A; Gillies, M; Smith, S			Racial stereotyping: survey of psychiatrists in the United Kingdom	BRITISH MEDICAL JOURNAL			English	Article							ETHNICITY		Bethlem & Maudsley NHS Trust, London SE5 8AL, England; Yorkhill NHS Trust, Dept Child & Adolescent Psychiat, Glasgow G3 8SJ, Lanark, Scotland	South London & Maudsley NHS Trust	Smith, S (corresponding author), Bethlem & Maudsley NHS Trust, London SE5 8AL, England.			Smith, Shubulade/0000-0002-3797-6985				Davies S, 1996, BRIT MED J, V312, P533, DOI 10.1136/bmj.312.7030.533; Koffman J, 1997, BRIT J PSYCHIAT, V171, P238, DOI 10.1192/bjp.171.3.238; LEWIS G, 1990, BRIT J PSYCHIAT, V157, P410, DOI 10.1192/bjp.157.3.410; McKenzie K, 1996, BRIT MED J, V312, P1054; Nazroo JY, 1997, ETHNICITY MENTAL HLT	5	13	15	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 20	2001	323	7318					905	906		10.1136/bmj.323.7318.905	http://dx.doi.org/10.1136/bmj.323.7318.905			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486BH	11668135	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000171798200021
J	Okonofua, F				Okonofua, F			Optimising caesarean-section rates in west Africa	LANCET			English	Editorial Material									Univ Benin, Coll Med Sci, Dept Obstet & Gynecol, Benin, Nigeria	University of Benin	Okonofua, F (corresponding author), Univ Benin, Coll Med Sci, Dept Obstet & Gynecol, Benin, Nigeria.	wharc@hyperia.com	Okonofua, Friday/AAB-9703-2021					Anderson CL, 2000, INT REV LAW ECON, V20, P1, DOI 10.1016/S0144-8188(00)00018-1; [Anonymous], 1997, LANCET, V349, P815; AsowaOmorodion FI, 1997, SOC SCI MED, V44, P1817, DOI 10.1016/S0277-9536(96)00291-2; Brieger W R, 1994, Health Care Women Int, V15, P101; *COL U SCH PUBL HL, 1996, PMM C JUN 19 21 ACCR; Fortney JA, 2001, INT J GYNECOL OBSTET, V74, P95; Maine D, 1999, AM J PUBLIC HEALTH, V89, P480, DOI 10.2105/AJPH.89.4.480; MAINE D, 1992, STUD FAMILY PLANN, V23, P279, DOI 10.2307/1966526; Maine D, 1991, SAFE MOTHERHOOD PROG; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Weil O, 1999, LANCET, V354, P940, DOI 10.1016/S0140-6736(99)02369-7; *WHO TECHN WORK GR, 1996, 864 FHE WHO TECHN WO	12	15	15	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2001	358	9290					1289	1289		10.1016/S0140-6736(01)06456-X	http://dx.doi.org/10.1016/S0140-6736(01)06456-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	484RC	11684207				2022-12-28	WOS:000171702500006
J	Alvarez, B; Martinez, C; Burgering, BMT; Carrera, AC				Alvarez, B; Martinez, C; Burgering, BMT; Carrera, AC			Forkhead transcription factors contribute to execution of the mitotic programme in mammals	NATURE			English	Article							CELL-CYCLE; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; REGULATORY SUBUNIT; FACTOR FKHR; KINASE; MITOSIS; PROGRESSION; PROTEIN; GROWTH	Cell cycle progression is a process that is tightly controlled by internal and external signals. Environmental cues, such as those provided by growth factors, activate early signals that promote cell cycle entry(1-3). Cells that have progressed past the restriction point become independent of growth factors, and cell cycle progression is then controlled endogenously. The phosphatidylinositol 3OH kinase (PI(3)K)/protein kinase B (PKB) pathway must be activated in G1 to inactivate forkhead transcription factors (FKH-TFs)(4,5) and allow cell cycle entry(2,3). Here we show that subsequent attenuation of the PI(3)K/PKB pathway is required to allow transcriptional activation of FKH-TF in G2. FKH-TF activity in G2 controls mammalian cell cycle termination, as interference with FKH transcriptional activation by disrupting PI(3)K/PKB downregulation, or by expressing a transcriptionally inactive FKH mutant, induces cell accumulation in G2/M, defective cytokinesis, and delayed transition from M to G1 of the cell cycle. We demonstrate that FKH-TFs regulate expression of mitotic genes such as cyclin B and polo-like kinase (Plk). Our results support the important role of forkhead in the control of mammalian cell cycle completion, and suggest that efficient execution of the mitotic programme depends on downregulation of PI(3)K/PKB and consequent induction of FKH transcriptional activity.	Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain; Univ Med Ctr, Dept Hematol, NL-3584 CG Utrecht, Netherlands	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Utrecht University; Utrecht University Medical Center	Carrera, AC (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain.	acarrera@cnb.uam.es		Carrera, Ana/0000-0002-3999-5434				Borlado LR, 2000, FASEB J, V14, P895; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; BRAUNINGER A, 1995, ONCOGENE, V11, P1793; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Carmena M, 1998, J CELL BIOL, V143, P659, DOI 10.1083/jcb.143.3.659; COGSWELL JP, 1995, MOL CELL BIOL, V15, P2782; del Peso L, 1999, ONCOGENE, V18, P7328, DOI 10.1038/sj.onc.1203159; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Jackson JG, 2000, ONCOGENE, V19, P4574, DOI 10.1038/sj.onc.1203825; Jimenez C, 2000, J CELL BIOL, V151, P249, DOI 10.1083/jcb.151.2.249; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; Jones SM, 1999, CURR BIOL, V9, P512, DOI 10.1016/S0960-9822(99)80235-8; Klippel A, 1998, MOL CELL BIOL, V18, P5699, DOI 10.1128/MCB.18.10.5699; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kotani S, 1998, MOL CELL, V1, P371, DOI 10.1016/S1097-2765(00)80037-4; Kotani S, 1999, J CELL BIOL, V146, P791, DOI 10.1083/jcb.146.4.791; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Pic A, 2000, EMBO J, V19, P3750, DOI 10.1093/emboj/19.14.3750; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Takeshita T, 1997, IMMUNITY, V6, P449, DOI 10.1016/S1074-7613(00)80288-5; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Zachariae W, 1999, CURR OPIN CELL BIOL, V11, P708, DOI 10.1016/S0955-0674(99)00041-1; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	29	232	235	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					744	747		10.1038/35099574	http://dx.doi.org/10.1038/35099574			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607034				2022-12-28	WOS:000171608000046
J	White, DG; Zhao, S; Sudler, R; Ayers, S; Friedman, S; Chen, S; McDermott, PF; McDermott, S; Wagner, DD; Meng, JH				White, DG; Zhao, S; Sudler, R; Ayers, S; Friedman, S; Chen, S; McDermott, PF; McDermott, S; Wagner, DD; Meng, JH			The isolation of antibiotic-resistant Salmonella from retail ground meats.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYPHIMURIUM DT104 INFECTIONS; FIELD GEL-ELECTROPHORESIS; PHAGE TYPE DT104; RAW-MILK CHEESE; MULTIDRUG-RESISTANT; UNITED-STATES; ANTIMICROBIAL RESISTANCE; INTEGRONS; GENES; CONSEQUENCES	Background: Salmonella is a leading cause of food-borne illness. The emergence of antimicrobial-resistant salmonella is associated with the use of antibiotics in animals raised for food; resistant bacteria can be transmitted to humans through foods, particularly those of animal origin. We identified and characterized strains of salmonella isolated from ground meats purchased in the Washington, D.C., area. Methods: Salmonella was isolated from samples of ground chicken, beef, turkey, and pork purchased at three supermarkets. The isolates were characterized by serotyping, antimicrobial-susceptibility testing, phage typing, and pulsed-field gel electrophoresis. The polymerase chain reaction and DNA sequencing were used to identify resistance integrons and extended spectrum beta -lactamase genes. Results: Of 200 meat samples, 41 (20 percent) contained salmonella, with a total of 13 serotypes. Eighty-four percent of the isolates were resistant to at least one antibiotic, and 53 percent were resistant to at least three antibiotics. Sixteen percent of the isolates were resistant to ceftriaxone, the drug of choice for treating salmonellosis in children. Bacteriophage typing identified four isolates of Salmonella enterica serotype typhimurium definitive type 104 (DT104), one of DT104b, and two of DT208. Five isolates of S. enterica serotype agona had resistance to 9 antibiotics, and the two isolates of serotype typhimurium DT208 were resistant to 12 antibiotics. Electrophoretic patterns of DNA that were indistinguishable from one another were repeatedly found in isolates from different meat samples and different stores. Eighteen isolates, representing four serotypes, had integrons with genes conferring resistance to aminoglycosides, sulfonamides, trimethoprim, and beta -lactams. Conclusions: Resistant strains of salmonella are common in retail ground meats. These findings provide support for the adoption of guidelines for the prudent use of antibiotics in food animals and for a reduction in the number of pathogens present on farms and in slaughterhouses. National surveillance for antimicrobial-resistant salmonella should be extended to include retail meats. (N Engl J Med 2001;345:1147-54.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; US FDA, Ctr Vet Med, Div Anim & Food Microbiol Off Res, Laurel, MD USA	University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA)	Meng, JH (corresponding author), Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA.	jm332@umail.umd.edu	McDermott, Patrick F./ABE-4374-2021	McDermott, Patrick F./0000-0003-1868-8096; Chen, Sheng/0000-0003-3526-7808				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angulo FJ, 2000, MICROB DRUG RESIST, V6, P77, DOI 10.1089/mdr.2000.6.77; *AOAC INT, 1998, BACT AN MAN; Baggesen DL, 2000, J CLIN MICROBIOL, V38, P1581, DOI 10.1128/JCM.38.4.1581-1586.2000; BANNERMAN TL, 1995, J CLIN MICROBIOL, V33, P551, DOI 10.1128/JCM.33.3.551-555.1995; Calvert N, 1998, VET REC, V143, P351, DOI 10.1136/vr.143.13.351; *CDCP, 1998, STAND MOL SUBT FOODB; Cloeckaert A, 2000, ANTIMICROB AGENTS CH, V44, P1359, DOI 10.1128/AAC.44.5.1359-1361.2000; Cody SH, 1999, JAMA-J AM MED ASSOC, V281, P1805, DOI 10.1001/jama.281.19.1805; Davies A, 1996, Commun Dis Rep CDR Rev, V6, pR159; Davis MA, 1999, EMERG INFECT DIS, V5, P802, DOI 10.3201/eid0506.990610; Dunne EF, 2000, JAMA-J AM MED ASSOC, V284, P3151, DOI 10.1001/jama.284.24.3151; Fey PD, 2000, NEW ENGL J MED, V342, P1242, DOI 10.1056/NEJM200004273421703; Glynn MK, 1998, NEW ENGL J MED, V338, P1333, DOI 10.1056/NEJM199805073381901; Gomez Thomas M., 1997, World Health Statistics Quarterly, V50, P81; Grein T, 1999, IRISH MED J, V92, P238; Guerra B, 2000, ANTIMICROB AGENTS CH, V44, P2166, DOI 10.1128/AAC.44.8.2166-2169.2000; Hall RM, 1997, CIBA F SYMP, V207, P192; HALL RM, 1993, GENETICA, V90, P115, DOI 10.1007/BF01435034; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Izumiya H, 1999, JPN J INFECT DIS, V52, P133; Markogiannakis A, 2000, J CLIN MICROBIOL, V38, P1269, DOI 10.1128/JCM.38.3.1269-1271.2000; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; *NAT COMM CLIN LAB, 1999, M31A NCCLS; National Committee for Clinical Laboratory Standards, 2000, M7A5 NCCLS; Ridley A, 1998, MICROB DRUG RESIST, V4, P113, DOI 10.1089/mdr.1998.4.113; Sandvang D, 1998, FEMS MICROBIOL LETT, V160, P37, DOI 10.1016/S0378-1097(98)00006-8; Synnott M B, 1998, Commun Dis Public Health, V1, P176; Taylor JP, 1998, J CLIN MICROBIOL, V36, P2861, DOI 10.1128/JCM.36.10.2861-2864.1998; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tollefson L, 1997, REV SCI TECH OIE, V16, P709, DOI 10.20506/rst.16.2.1054; Tollefson L, 1998, VET CLIN N AM-FOOD A, V14, P141, DOI 10.1016/S0749-0720(15)30285-1; Villar RG, 1999, JAMA-J AM MED ASSOC, V281, P1811, DOI 10.1001/jama.281.19.1811; WHO, 2000, OV ANT RES; Winokur PL, 2000, ANTIMICROB AGENTS CH, V44, P2777, DOI 10.1128/AAC.44.10.2777-2783.2000; Witte W, 1998, SCIENCE, V279, P996, DOI 10.1126/science.279.5353.996; 1999, WKLY EPIDEMIOL REC, V74, P345; 1998, MMWR MORB MORTAL WKL, V47, P462	38	363	385	3	78	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2001	345	16					1147	1154		10.1056/NEJMoa010315	http://dx.doi.org/10.1056/NEJMoa010315			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482YX	11642230	Bronze			2022-12-28	WOS:000171605800001
J	Warden, J				Warden, J			Mental health law to be tightened	BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 8	1998	317	7155					365	365						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	110YR	11645089				2022-12-28	WOS:000075409600007
J	Rogers, A				Rogers, A			Europe takes steps to outlaw human cloning	LANCET			English	News Item																			0	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 4	1997	350	9083					1012	1012		10.1016/S0140-6736(05)64114-1	http://dx.doi.org/10.1016/S0140-6736(05)64114-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XZ710	11655213				2022-12-28	WOS:A1997XZ71000034
J	[Anonymous]				[Anonymous]			GUIDELINES FOR INTERACTIONS WITH PHARMACEUTICAL COMPANIES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	1993	270	10					1250	1250						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV649	11643149				2022-12-28	WOS:A1993LV64900035
J	[Anonymous]				[Anonymous]			MAPPING THE HUMAN GENOME	LANCET			English	Editorial Material																		ROBERTS L, 1989, SCIENCE, V243, P167, DOI 10.1126/science.2911730	1	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 4	1989	1	8632					287	287						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	T1287	11644426				2022-12-28	WOS:A1989T128700061
J	Antonova, I; Arancio, O; Trillat, AC; Wang, HG; Zablow, L; Udo, H; Kandel, ER; Hawkins, RD				Antonova, I; Arancio, O; Trillat, AC; Wang, HG; Zablow, L; Udo, H; Kandel, ER; Hawkins, RD			Rapid increase in clusters of presynaptic proteins at onset of long-lasting potentiation	SCIENCE			English	Article							TERM POTENTIATION; GLUTAMATE RECEPTORS; TRANSMITTER RELEASE; REDISTRIBUTION; EXPRESSION; LTP	A change in the efficiency of synaptic communication between neurons is thought to underlie learning. Consistent with recent studies of such changes, we find that long-tasting potentiation of synaptic transmission between cultured hippocampal neurons is accompanied by an increase in the number of clusters of postsynaptic glutamate receptors containing the subunit GLuR1. In addition, potentiation is accompanied by a rapid and long-tasting increase in the number of clusters of the presynaptic protein synaptophysin and the number of sites at which synaptophysin and GLuR1 are colocalized. These results suggest that potentiation involves rapid coordinate changes in the distribution of proteins in the presynaptic neuron as well as the postsynaptic neuron.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Howard Hughes Med Inst, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; SUNY Hlth Sci Ctr, Dept Anat & Cell Biol, Brooklyn, NY 11203 USA	Columbia University; Howard Hughes Medical Institute; New York State Psychiatry Institute; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Hawkins, RD (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, 722 W 168th St, New York, NY 10032 USA.	rdh1@columbia.edu	arancio, ottavio/AAB-7959-2019	arancio, ottavio/0000-0001-6335-164X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH026212] Funding Source: NIH RePORTER; NIMH NIH HHS [MH26212] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; BATTAGLIA F, 2000, SOC NEUR ABSTR, V26, P879; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BI QQ, 1998, J NEUROSCI, V18, P10469; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; DELSSEROTH K, 1996, NEURON, V16, P89; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; Huang Y Y, 1994, Learn Mem, V1, P74; Kim CH, 1999, J NEUROSCI, V19, P4314; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; Lissin DV, 1999, J NEUROSCI, V19, P1263; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Shen L, 2000, J NEUROSCI, V20, P7932; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498	28	138	143	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2001	294	5546					1547	1550		10.1126/science.1066273	http://dx.doi.org/10.1126/science.1066273			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11641465				2022-12-28	WOS:000172240500055
J	Goldstein, RH				Goldstein, RH			Paleoenvironment - Clues from fluid inclusions	SCIENCE			English	Editorial Material							HALITE; WATERS; RECORD		Univ Kansas, Dept Geol, Lawrence, KS 66045 USA	University of Kansas	Goldstein, RH (corresponding author), Univ Kansas, Dept Geol, Lawrence, KS 66045 USA.							Benison KC, 1999, CHEM GEOL, V154, P113, DOI 10.1016/S0009-2541(98)00127-2; Benison KC, 1998, NATURE, V392, P911, DOI 10.1038/31917; BERNER RA, 1988, SCIENCE, V239, P1406, DOI 10.1126/science.239.4846.1406; Hardie LA, 1996, GEOLOGY, V24, P279, DOI 10.1130/0091-7613(1996)024<0279:SVISCA>2.3.CO;2; HARVIE CE, 1984, GEOCHIM COSMOCHIM AC, V48, P723, DOI 10.1016/0016-7037(84)90098-X; Hazen RM, 2001, NATURE, V411, P155, DOI 10.1038/35075663; JOHNSON WJ, 1993, NATURE, V362, P335, DOI 10.1038/362335a0; Lowenstein T.K., 1994, GEOLOGICAL SOC AM SP, V289, P19; Lowenstein TK, 2001, SCIENCE, V294, P1086, DOI 10.1126/science.1064280; Lowenstein TK, 1998, CHEM GEOL, V150, P223, DOI 10.1016/S0009-2541(98)00061-8; MALLARINO G, 2001, INT ASS SED ANN M AB, V21; Newell KD, 1999, CHEM GEOL, V154, P97, DOI 10.1016/S0009-2541(98)00126-0; RAYNAUD D, 1993, SCIENCE, V259, P926, DOI 10.1126/science.259.5097.926; Vreeland RH, 2000, NATURE, V407, P897, DOI 10.1038/35038060; WENBO Y, 1995, PALAEOGEOGR PALAEOCL, V117, P279	15	28	36	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1009	+		10.1126/science.1066322	http://dx.doi.org/10.1126/science.1066322			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691973				2022-12-28	WOS:000172013800029
J	Barth, C; Reichling, M				Barth, C; Reichling, M			Imaging the atomic arrangements on the high-temperature reconstructed alpha-Al2O3(0001) surface	NATURE			English	Article							FORCE MICROSCOPY; OXIDE SURFACES; ALPHA-ALUMINA; WATER	Alumina is a technologically important oxide crystal because of its use as a catalyst and as a substrate for microelectronic applications(1). A precise knowledge of its surface atomic structure is a prerequisite for understanding and controlling the physical processes involved in many of its applications(2). Here we use a dynamic scanning force microscopy technique(3) to image directly the atomic structure of the high-temperature phase of the alpha -Al2O3 (0001) surface. Evidence for a surface reconstruction appears as a grid of protrusions that represent a rhombic unit cell, and we confirm that the arrangement of atoms is in the form of surface domains with hexagonal atomic order at the centre and disorder at the periphery. We show that, on exposing the surface to water and hydrogen, this surface structure is important in the formation of hydroxide clusters. These clusters appear as a regular pattern of rings that can be explained by self-organization processes involving cluster-surface and cluster-cluster interactions. Alumina has long been regarded as the definitive test for atomic-resolution force microscopy of insulators so the whole class of insulating oxides should now open for direct atomic-scale surface investigations.	Univ Munich, Dept Chem, D-81377 Munich, Germany	University of Munich	Reichling, M (corresponding author), Univ Munich, Dept Chem, Butenandtstr 5-13 E, D-81377 Munich, Germany.		Barth, Clemens/G-3543-2014; Reichling, Michael/B-1123-2011	Barth, Clemens/0000-0003-4250-4533; Reichling, Michael/0000-0003-3186-9000				ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347; Barth C, 2000, SURF SCI, V470, pL99, DOI 10.1016/S0039-6028(00)00916-X; BEITEL G, 1993, ADSORPTION ORDERED S, P71; Campbell CT, 1997, SURF SCI REP, V27, P1, DOI 10.1016/S0167-5729(96)00011-8; CHANG CC, 1968, J APPL PHYS, V39, P5570, DOI 10.1063/1.1656015; Coustet V, 1997, NUOVO CIMENTO D, V19, P1657, DOI 10.1007/BF03185360; de Lozanne A, 2001, SCIENCE, V291, P2561; Eng PJ, 2000, SCIENCE, V288, P1029, DOI 10.1126/science.288.5468.1029; Foster AS, 2001, PHYS REV LETT, V86, P2373, DOI 10.1103/PhysRevLett.86.2373; FRENCH TM, 1970, J PHYS CHEM-US, V74, P2489, DOI 10.1021/j100706a014; GAUTIER M, 1991, SURF SCI, V250, P71, DOI 10.1016/0039-6028(91)90710-A; Guggisberg M, 2000, PHYS REV B, V61, P11151, DOI 10.1103/PhysRevB.61.11151; Hass KC, 1998, SCIENCE, V282, P265, DOI 10.1126/science.282.5387.265; HENRICH VE, 1984, SURFACE SCI METAL OX; Liu P, 1998, SURF SCI, V417, P53, DOI 10.1016/S0039-6028(98)00661-X; Pang CL, 2000, SURF SCI, V460, pL510, DOI 10.1016/S0039-6028(00)00594-X; Reichling M, 1999, PHYS REV LETT, V83, P768, DOI 10.1103/PhysRevLett.83.768; RENAUD G, 1994, PHYS REV LETT, V73, P1825, DOI 10.1103/PhysRevLett.73.1825; Sasahara A, 2000, JPN J APPL PHYS 1, V39, P3773, DOI 10.1143/JJAP.39.3773; Toofan J, 1998, SURF SCI, V401, P162, DOI 10.1016/S0039-6028(97)01031-5; Van LP, 1998, SURF SCI, V411, P263, DOI 10.1016/S0039-6028(98)00329-X; Vilfan I, 1997, SURF SCI, V392, P62, DOI 10.1016/S0039-6028(97)00493-7	22	228	228	2	105	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 01	2001	414	6859					54	57		10.1038/35102031	http://dx.doi.org/10.1038/35102031			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689939				2022-12-28	WOS:000171898900038
J	Penuelas, J; Filella, I				Penuelas, J; Filella, I			Phenology - Responses to a warming world	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; TEMPERATURE; TRENDS		Univ Autonoma Barcelona, Ctr Ecol Res & Forestry Applicat, CSIC, Unitat Ecofisiol,Edifici C, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC)	Penuelas, J (corresponding author), Univ Autonoma Barcelona, Ctr Ecol Res & Forestry Applicat, CSIC, Unitat Ecofisiol,Edifici C, E-08193 Barcelona, Spain.		Filella, Iolanda/A-2860-2015; Penuelas, Josep/D-9704-2011; Gutierrez, Emilia/O-7568-2014	Penuelas, Josep/0000-0002-7215-0150; Gutierrez, Emilia/0000-0002-6085-5700; Filella, Iolanda/0000-0001-6262-5733				Abu-Asab MS, 2001, BIODIVERS CONSERV, V10, P597, DOI 10.1023/A:1016667125469; Ahas R, 1999, INT J BIOMETEOROL, V42, P119, DOI 10.1007/s004840050094; Beaubien EG, 2000, INT J BIOMETEOROL, V44, P53, DOI 10.1007/s004840000050; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Bradley NL, 1999, P NATL ACAD SCI USA, V96, P9701, DOI 10.1073/pnas.96.17.9701; Chmielewski FM, 2001, AGR FOREST METEOROL, V108, P101, DOI 10.1016/S0168-1923(01)00233-7; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Ellis Willem N., 1997, Entomologische Berichten (Amsterdam), V57, P66; FITTER AH, 1995, FUNCT ECOL, V9, P55, DOI 10.2307/2390090; Fleming R. A., 1995, P505; Gibbs JP, 2001, CONSERV BIOL, V15, P1175, DOI 10.1046/j.1523-1739.2001.0150041175.x; Harrington R, 1999, TRENDS ECOL EVOL, V14, P146, DOI 10.1016/S0169-5347(99)01604-3; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Larcher W., 1995, PHYSL PLANT ECOLOGY; MASON CF, 1995, BIRD STUDY, V42, P182, DOI 10.1080/00063659509477167; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Osborne CP, 2000, PLANT CELL ENVIRON, V23, P701, DOI 10.1046/j.1365-3040.2000.00584.x; PENUELAS J, IN PRESS GLOBAL CHAN; Price MV, 1998, ECOLOGY, V79, P1261, DOI 10.1890/0012-9658(1998)079[1261:EOEWOP]2.0.CO;2; Reid PC, 1998, NATURE, V391, P546, DOI 10.1038/35290; Roy DB, 2000, GLOB CHANGE BIOL, V6, P407, DOI 10.1046/j.1365-2486.2000.00322.x; Schwartz MD, 2000, INT J CLIMATOL, V20, P929, DOI 10.1002/1097-0088(20000630)20:8&lt;929::AID-JOC557&gt;3.0.CO;2-5; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Spiecker H., 1996, GROWTH TRENDS EUROPE; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Walker RD, 1998, J ANTIMICROB CHEMOTH, V41, P1, DOI 10.1093/jac/41.1.1	29	595	677	7	347	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2001	294	5543					793	+		10.1126/science.1066860	http://dx.doi.org/10.1126/science.1066860			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679652				2022-12-28	WOS:000171851800027
J	Buckley, SA; Evershed, RP				Buckley, SA; Evershed, RP			Organic chemistry of embalming agents in Pharaonic and Graeco-Roman mummies	NATURE			English	Article							EGYPTIAN MUMMIES	Chemical treatments were an essential element of ancient Egyptian mummification. Although the inorganic salt natron is recognized as having a central role as a desiccant(1), without the application of organic preservatives the bodies would have decomposed in the humid environment of the tombs(2). The nature of the organic treatments remains obscure, because the ancient Egyptians left no written record of the process. Secondary textual evidence for mummification is provided by Herodotus(3), Diodorus Siculus(4), Strabo(5) and Pliny(6). The most important account is that of Herodotus(3) (about 450 yr BC), although archaeological evidence shows that by this time the process had declined significantly and the best results had been achieved centuries before(7). His account mentions myrrh, cassia, palm wine, 'cedar oil' (still widely disputed(8-10)) and 'gum'; however, it is vague with respect to the specific natural products used. Here we report the results of chemical investigations of a substantial collection of samples of tissues, wrappings and 'resinous/bituminous' materials from provenanced and dated Egyptian mummies. We focused on examples of the 'classic' mummy-making culture of the Pharaonic or dynastic period, from which we can begin to track the development of mummification chronologically.	Univ Bristol, Sch Chem, Biogeochem Res Ctr, Organ Geochem Unit, Bristol BS8 1TS, Avon, England	University of Bristol	Evershed, RP (corresponding author), Univ Bristol, Sch Chem, Biogeochem Res Ctr, Organ Geochem Unit, Cantocks Close, Bristol BS8 1TS, Avon, England.							BAHN PG, 1992, NATURE, V356, P109, DOI 10.1038/356109a0; Barber MS, 2000, PHYTOCHEMISTRY, V54, P53, DOI 10.1016/S0031-9422(00)00038-8; BAUMANN BILL B., 1960, ECON BOT, V14, P84, DOI 10.1007/BF02859368; Buckley SA, 1999, ANALYST, V124, P443, DOI 10.1039/a809022j; Colombini MP, 2000, STUD CONSERV, V45, P19, DOI 10.2307/1506680; CONNAN J, 1991, CR ACAD SCI II, V312, P1445; Granville AB, 1825, PHILOS T ROY SOC LON, V1, P269; Herodotus, 1954, HISTORIES, P160; HUNTER J, 1996, STUDIES CRIME INTRO, P63; Koller J, 1998, NATURE, V391, P343, DOI 10.1038/34809; LUCAS A, 1908, CAIRO SCI J, V2, P133; Lucas A., 1931, J EGYPT ARCHAEOL, V17, P13; MENDELSOHN S, 1944, CIBA S, P1795; Mills J.S., 1994, ORGANIC CHEM MUSEUM; PLINY ELDER, 1968, NATURAL HIST; Raven M.J, 1983, WAX EGYPTIAN MAGIC S, V64, P7; RULLKOTTER J, 1988, NATURWISSENSCHAFTEN, V75, P618, DOI 10.1007/BF00366476; Sandison A. T., 1963, J NEAR E STUD, V22, P259; Serpico M., 2000, ANCIENT EGYPTIAN MAT, P430; Siculus Diodorus, 1935, LIB HIST; Smith GE., 1924, EGYPTIAN MUMMIES; Spielmann P.E., 1932, J EGYPT ARCHAEOL, V18, P177; Strabo, 1932, GEOGRAPHY; van der Doelen GA, 1998, STUD CONSERV, V43, P249, DOI 10.2307/1506734; ZAKI A, 1943, ANN SERV ANTIQUITES, V42, P223	25	130	137	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2001	413	6858					837	841		10.1038/35101588	http://dx.doi.org/10.1038/35101588			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677605				2022-12-28	WOS:000171750200044
J	Naureckas, ET; Solway, J				Naureckas, ET; Solway, J			Mild asthma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INHALED BUDESONIDE; EXERCISE; MONTELUKAST; INFLAMMATION; PLACEBO; SODIUM		Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA	University of Chicago	Naureckas, ET (corresponding author), Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, 5841 S Maryland MC 6076, Chicago, IL 60637 USA.	tnaureka@medicine.bsd.uchicago.edu	Solway, Julian/B-1116-2008	Solway, Julian/0000-0002-0898-8530	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064095, P50HL056399] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL64095, HL56399] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bleecker ER, 2000, J ALLERGY CLIN IMMUN, V105, P1123, DOI 10.1067/mai.2000.106043; Chetta A, 1997, CHEST, V111, P852, DOI 10.1378/chest.111.4.852; *CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343; Colice GL, 1999, AM J RESP CRIT CARE, V160, P1962, DOI 10.1164/ajrccm.160.6.9902112; Coreno A, 2000, J ALLERGY CLIN IMMUN, V106, P500; Drazen JM, 1996, NEW ENGL J MED, V335, P841, DOI 10.1056/NEJM199609193351202; Drazen JM, 1999, NEW ENGL J MED, V340, P663; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; HAAHTELA T, 1994, NEW ENGL J MED, V331, P700, DOI 10.1056/NEJM199409153311103; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; JONES KP, 1995, THORAX, V50, P851, DOI 10.1136/thx.50.8.851; Kamada AK, 1996, AM J RESP CRIT CARE, V153, P1739, DOI 10.1164/ajrccm.153.6.8665030; Leff JA, 1998, NEW ENGL J MED, V339, P147, DOI 10.1056/NEJM199807163390302; Louis R, 2000, AM J RESP CRIT CARE, V161, P9, DOI 10.1164/ajrccm.161.1.9802048; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; MCFADDEN ER, 1973, NEW ENGL J MED, V288, P221, DOI 10.1056/NEJM197302012880501; MCFADDEN ER, 1995, CLIN CHEST MED, V16, P671; MCFADDEN ER, 1986, J ALLERGY CLIN IMMUN, V77, P1, DOI 10.1016/0091-6749(86)90313-1; *NAT ASTHM ED PREV, 1997, NIH PUBL; *NAT HEART LUNG BL, 1995, NIH PUBL; Nelson JA, 1998, NEW ENGL J MED, V339, P141, DOI 10.1056/NEJM199807163390301; PEAT JK, 1987, EUR J RESPIR DIS, V70, P171; Schwartz HJ, 1996, CHEST, V109, P945, DOI 10.1378/chest.109.4.945; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; Teeter JG, 1998, CHEST, V113, P272, DOI 10.1378/chest.113.2.272; TULLETT WM, 1985, THORAX, V40, P41, DOI 10.1136/thx.40.1.41; VANSCHAYCK CP, 1991, BRIT MED J, V303, P1426, DOI 10.1136/bmj.303.6815.1426; VATHENEN AS, 1991, THORAX, V46, P811, DOI 10.1136/thx.46.11.811; Vidal C, 2001, ANN ALLERG ASTHMA IM, V86, P655, DOI 10.1016/S1081-1206(10)62294-6; Vignola AM, 1998, AM J RESP CRIT CARE, V157, P403, DOI 10.1164/ajrccm.157.2.96-08040	30	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2001	345	17					1257	1262		10.1056/NEJMcp010434	http://dx.doi.org/10.1056/NEJMcp010434			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485RU	11680447				2022-12-28	WOS:000171773100007
J	Whiteley, M; Bangera, MG; Bumgarner, RE; Parsek, MR; Teitzel, GM; Lory, S; Greenberg, EP				Whiteley, M; Bangera, MG; Bumgarner, RE; Parsek, MR; Teitzel, GM; Lory, S; Greenberg, EP			Gene expression in Pseudomonas aeruginosa biofilms	NATURE			English	Article							MICROBIAL BIOFILMS; BACTERIAL BIOFILMS; RESISTANCE; ANTIBIOTICS; GENTAMICIN; MUTATION; SEQUENCE; BINDING; SIGNALS; FLOW	Bacteria often adopt a sessile biofilm lifestyle that is resistant to antimicrobial treatment(1-5). Opportunistic pathogenic bacteria like Pseudomonas aeruginosa can develop persistent infections(1-3). To gain insights into the differences between free-living P. aeruginosa cells and those in biofilms, and into the mechanisms underlying the resistance of biofilms to antibiotics, we used DNA microarrays. Here we show that, despite the striking differences in lifestyles, only about 1% of genes showed differential expression in the two growth modes; about 0.5% of genes were activated and about 0.5% were repressed in biofilms. Some of the regulated genes are known to affect antibiotic sensitivity of free-living P. aeruginosa. Exposure of biofilms to high levels of the antibiotic tobramycin caused differential expression of 20 genes. We propose that this response is critical for the development of biofilm resistance to tobramycin. Our results show that gene expression in biofilm cells is similar to that in free-living cells but there are a small number of significant differences. Our identification of biofilm-regulated genes points to mechanisms of biofilm resistance to antibiotics.	Univ Iowa, Coll Med, Dept Microbiol, Iowa City, IA 52242 USA; Harvard Univ, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Northwestern Univ, Dept Civil Engn, Evanston, IL 60208 USA	University of Iowa; Harvard University; University of Washington; University of Washington Seattle; Northwestern University	Greenberg, EP (corresponding author), Univ Iowa, Coll Med, Dept Microbiol, Iowa City, IA 52242 USA.		Bumgarner, Roger E/K-3531-2015; Bumgarner, Roger/AAA-6846-2020	Bumgarner, Roger E/0000-0002-8168-6985; Greenberg, Everett/0000-0001-9474-8041				BANGERA MG, 2000, AM SOC MICR 100 GEN; BRYAN LE, 1976, J ANTIBIOT, V29, P743, DOI 10.7164/antibiotics.29.743; BRYAN LE, 1980, ANTIMICROB AGENTS CH, V17, P71, DOI 10.1128/AAC.17.1.71; BRYAN LE, 1983, ANTIMICROB AGENTS CH, V23, P835, DOI 10.1128/AAC.23.6.835; Burns J L, 1993, Adv Pediatr Infect Dis, V8, P53; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1994, J BACTERIOL, V176, P2137, DOI 10.1128/JB.176.8.2137-2142.1994; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; DAMPER PD, 1981, ANTIMICROB AGENTS CH, V20, P803, DOI 10.1128/AAC.20.6.803; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DEBEER D, 1994, BIOTECHNOL BIOENG, V44, P636, DOI 10.1002/bit.260440510; Greenberg EP, 2000, NATURE, V406, P947, DOI 10.1038/35023203; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; HILL DF, 1991, J MOL BIOL, V218, P349, DOI 10.1016/0022-2836(91)90717-K; HOIBY N, 1993, ANNU REV MED, V44, P1, DOI 10.1146/annurev.me.44.020193.000245; HOIBY N, 1998, PSEUDOMONAS CYSTIC F, P1; Ichikawa JK, 2000, P NATL ACAD SCI USA, V97, P9659, DOI 10.1073/pnas.160140297; JOHNSON JA, 1993, J CLIN MICROBIOL, V31, P732, DOI 10.1128/JCM.31.3.732-733.1993; LAWRENCE JR, 1991, J BACTERIOL, V173, P6558, DOI 10.1128/jb.173.20.6558-6567.1991; MacLeod DL, 2000, J INFECT DIS, V181, P1180, DOI 10.1086/315312; NIKAIDO H, 1985, MICROBIOL REV, V49, P872; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; RIVERA M, 1988, ANTIMICROB AGENTS CH, V32, P649, DOI 10.1128/AAC.32.5.649; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Suh SJ, 1999, J BACTERIOL, V181, P3890, DOI 10.1128/JB.181.13.3890-3897.1999; Whiteley M, 2000, J BACTERIOL, V182, P4356, DOI 10.1128/JB.182.15.4356-4360.2000; ZABRISKIE JB, 1966, ANNU REV MED, V17, P337, DOI 10.1146/annurev.me.17.020166.002005	30	797	852	3	151	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					860	864		10.1038/35101627	http://dx.doi.org/10.1038/35101627			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677611				2022-12-28	WOS:000171750200050
J	Hipps, KW				Hipps, KW			Molecular electronics - It's all about contacts	SCIENCE			English	Editorial Material							SCANNING-TUNNELING-MICROSCOPY; DNA-MOLECULES		Washington State Univ, Dept Chem, Pullman, WA 99164 USA; Washington State Univ, Mat Sci Program, Pullman, WA 99164 USA	Washington State University; Washington State University	Hipps, KW (corresponding author), Washington State Univ, Dept Chem, Pullman, WA 99164 USA.	hipps@wsu.edu						Cui XD, 2001, SCIENCE, V294, P571, DOI 10.1126/science.1064354; DUNLAP DD, 1993, P NATL ACAD SCI USA, V90, P7652, DOI 10.1073/pnas.90.16.7652; DURIG U, 1993, PHYS REV B, V48, P1711, DOI 10.1103/PhysRevB.48.1711; Fink HW, 1999, NATURE, V398, P407, DOI 10.1038/18855; GORMAN CB, 2001, LANGMUIR; JOACHIM C, 1995, PHYS REV LETT, V74, P2102, DOI 10.1103/PhysRevLett.74.2102; Jones L., 1995, POLYM PREPR, V36, P233; Kasumov AY, 2001, SCIENCE, V291, P280, DOI 10.1126/science.291.5502.280; Lang HP, 1996, SYNTHETIC MET, V77, P161, DOI 10.1016/0379-6779(96)80079-8; Metzger RM, 1999, ACCOUNTS CHEM RES, V32, P950, DOI 10.1021/ar9900663; Porath D, 2000, NATURE, V403, P635, DOI 10.1038/35001029; Postma HWC, 2001, SCIENCE, V293, P76, DOI 10.1126/science.1061797; Reed MA, 1997, SCIENCE, V278, P252, DOI 10.1126/science.278.5336.252	13	183	186	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					536	537		10.1126/science.1065708	http://dx.doi.org/10.1126/science.1065708			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641487				2022-12-28	WOS:000171695600033
J	Lawton, RO; Nair, US; Pielke, RA; Welch, RM				Lawton, RO; Nair, US; Pielke, RA; Welch, RM			Climatic impact of tropical lowland deforestation on nearby montane cloud forests	SCIENCE			English	Article							COSTA-RICA; CUMULUS; VARIABILITY; VEGETATION; PASTURES; MOISTURE; TRENDS	Tropical montane cloud forests (TMCFs) depend on predictable, frequent, and prolonged immersion in cloud. Clearing upwind lowland forest alters surface energy budgets in ways that influence dry season cloud fields and thus the TMCF environment. Landsat and Geostationary Operational Environmental Satellite imagery show that deforested areas of Costa Rica's Caribbean lowlands remain relatively cloud-free when forested regions have well-developed dry season cumulus cloud fields. Further, regional atmospheric simulations show that cloud base heights are higher over pasture than over tropical forest areas under reasonable dry season conditions. These results suggest that [and use in tropical lowlands has serious impacts on ecosystems in adjacent mountains.	Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA; Univ Alabama, Nat Sci Technol Ctr, Dept Atmospher Sci, Huntsville, AL 35806 USA; Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA	University of Alabama System; University of Alabama Huntsville; University of Alabama System; University of Alabama Huntsville; Colorado State University	Lawton, RO (corresponding author), Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA.	lawtonr@email.uah.edu	Pielke, Roger A/A-5015-2009					BASTABLE HG, 1993, INT J CLIMATOL, V13, P783, DOI 10.1002/joc.3370130706; BERENDES T, 1992, IEEE T GEOSCI REMOTE, V30, P430, DOI 10.1109/36.142921; BRUIJNZEEL LA, 1995, ECOL STU AN, V110, P38; CHEN F, 1994, J APPL METEOROL, V33, P1382, DOI 10.1175/1520-0450(1994)033<1382:IOLSMV>2.0.CO;2; Dietrich W.E., 1982, ECOLOGY TROPICAL FOR, P21; Haber W. A., 2000, MONTEVERDE ECOLOGY C, P39; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Lawton R. O., 1980, BRENESIA, V8, P101; Longman K. A., 1987, TROPICAL FOREST ITS; MEHERHOMJI VM, 1991, CLIMATIC CHANGE, V19, P163, DOI 10.1007/BF00142223; Nadkarni N. M., 2000, MONTEVERDE ECOLOGY C, P303; Nadkarni NM., 2000, MONTEVERDE ECOLOGY C, P15; Nair US, 1999, P SOC PHOTO-OPT INS, V3750, P345, DOI 10.1117/12.363530; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0; NOBRE CA, 1991, J CLIMATE, V4, P957, DOI 10.1175/1520-0442(1991)004<0957:ADARCC>2.0.CO;2; PIELKE RA, 1992, METEOROL ATMOS PHYS, V49, P69, DOI 10.1007/BF01025401; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; SADER SA, 1988, BIOTROPICA, V20, P11, DOI 10.2307/2388421; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; SHUKLA J, 1990, SCIENCE, V247, P1322, DOI 10.1126/science.247.4948.1322; Still CJ, 1999, NATURE, V398, P608, DOI 10.1038/19293; SUD YC, 1993, J ARID ENVIRON, V25, P5, DOI 10.1006/jare.1993.1038; UHL C, 1988, J ECOL, V76, P663, DOI 10.2307/2260566; Vaughan C., 1983, REPORT DENSE FOREST; Veldkamp E., 1992, Land Degradation & Rehabilitation, V3, P71, DOI 10.1002/ldr.3400030202; Weitz AM, 2001, SOIL BIOL BIOCHEM, V33, P1077, DOI 10.1016/S0038-0717(01)00013-X; Wheelwight Nathaniel T., 2000, P419; WRIGHT IR, 1992, Q J ROY METEOR SOC, V118, P1083, DOI 10.1002/qj.49711850804; Zeng N, 1999, SCIENCE, V286, P1537, DOI 10.1126/science.286.5444.1537	29	235	254	5	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					584	587						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641496				2022-12-28	WOS:000171695600044
J	Kvist, A; Lindstrom, A; Green, M; Piersma, T; Visser, GH				Kvist, A; Lindstrom, A; Green, M; Piersma, T; Visser, GH			Carrying large fuel loads during sustained bird flight is cheaper than expected	NATURE			English	Article							DISTANCE MIGRANT SHOREBIRD; BASAL METABOLIC-RATE; CALIDRIS-CANUTUS; WIND-TUNNEL; KNOT; MIGRATION	Birds on migration alternate between consuming fuel stores during flights and accumulating fuel stores during stopovers. The optimal timing and length of flights and stopovers for successful migration depend heavily on the extra metabolic power input (fuel use) required to carry the fuel stores during flight(1,2). The effect of large fuel loads on metabolic power input has never been empirically determined. We measured the total metabolic power input of a long-distance migrant, the red knot (Calidris canutus), flying for 6 to 10 h in a wind tunnel, using the doubly labelled water technique(3). Here we show that total metabolic power input increased with fuel load, but proportionally less than the predicted mechanical power output from the flight muscles. The most likely explanation is that the efficiency with which metabolic power input is converted into mechanical output by the flight muscles increases with fuel load. This will influence current models of bird flight and bird migration. It may also help to explain why some shorebirds, despite the high metabolic power input required to fly, routinely make nonstop flights of 4,000 km longer(4).	Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; Netherlands Inst Sea Res, NL-1790 AB Den Burg, Netherlands; Univ Groningen, Ctr Ecol & Evolutionary Studies, NL-9750 AA Haren, Netherlands; Ctr Isotope Res, NL-9747 AG Groningen, Netherlands	Lund University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Groningen; University of Groningen	Kvist, A (corresponding author), Lund Univ, Dept Anim Ecol, Ecol Bldg, S-22362 Lund, Sweden.		Piersma, Theunis/D-1871-2012	Kvist, Anders/0000-0002-1358-0695; Piersma, Theunis/0000-0001-9668-466X				Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; Alerstam T., 1990, P331; Ancel A, 1997, NATURE, V385, P304, DOI 10.1038/385304a0; Battley PF, 2000, P ROY SOC B-BIOL SCI, V267, P191, DOI 10.1098/rspb.2000.0986; Duke, 1997, ANIMAL PHYSL ADAPTAT, P169, DOI DOI 10.2307/2403350; GUDMUNDSSON GA, 1994, J AVIAN BIOL, V25, P15, DOI 10.2307/3677290; HEDENSTROM A, 1995, PHILOS T ROY SOC B, V348, P471, DOI 10.1098/rstb.1995.0082; Kullberg C, 1996, P ROY SOC B-BIOL SCI, V263, P1671, DOI 10.1098/rspb.1996.0244; Lindstrom A, 2000, J EXP BIOL, V203, P913; METCALFE NB, 1995, P ROY SOC B-BIOL SCI, V261, P395, DOI 10.1098/rspb.1995.0165; NOER H, 1979, Dansk Ornitologisk Forenings Tidsskrift, V73, P215; Pennycuick C.J., 1975, AVIAN BIOL, P1, DOI DOI 10.1016/B978-0-12-249405-5.50009-4; PENNYCUICK CJ, 1995, ISRAEL J ZOOL, V41, P307; Pennycuick CJ, 1997, J EXP BIOL, V200, P1441; Pennycuick CJ, 1996, J EXP BIOL, V199, P2757; PIERSMA T, 1995, J COMP PHYSIOL B, V165, P37, DOI 10.1007/BF00264684; Piersma T, 1996, PHYSIOL ZOOL, V69, P191, DOI 10.1086/physzool.69.1.30164207; RAYNER JMV, 1985, J THEOR BIOL, V117, P47, DOI 10.1016/S0022-5193(85)80164-8; RAYNER JMV, 1979, J EXP BIOL, V80, P17; Rayner JMV, 1999, P 22 INT ORN C DURB, P1786; Speakman J.R., 1997, DOUBLY LABELLED WATE; TUCKER VA, 1973, J EXP BIOL, V58, P689; Visser GH, 2000, J COMP PHYSIOL B, V170, P365, DOI 10.1007/s003600000112; VISSER GH, 2000, AM J PHYSIOL, V209, pR1795; [No title captured]	25	138	140	3	52	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					730	732		10.1038/35099556	http://dx.doi.org/10.1038/35099556			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607031	Green Published			2022-12-28	WOS:000171608000043
J	SMITH, T				SMITH, T			CHEAP, MANAGED DEATH	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAR 18	1995	310	6981					744	744		10.1136/bmj.310.6981.744	http://dx.doi.org/10.1136/bmj.310.6981.744			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QN461	11644673	Green Published			2022-12-28	WOS:A1995QN46100079
J	PALMER, K				PALMER, K			PEACE AND PAIN	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 23	1994	309	6949					279	279		10.1136/bmj.309.6949.279	http://dx.doi.org/10.1136/bmj.309.6949.279			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NZ180	11644574	Green Published			2022-12-28	WOS:A1994NZ18000070
J	SLOAN, FA				SLOAN, FA			ORGAN PROCUREMENT - EXPENDITURES AND FINANCIAL INCENTIVES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									DUKE UNIV,DEPT ECON,DURHAM,NC 27708	Duke University	SLOAN, FA (corresponding author), DUKE UNIV,CTR HLTH POLICY RES & EDUC,BOX 90253,DURHAM,NC 27708, USA.							Blair Roger D, 1991, Yale J Regul, V8, P403; COHEN LR, 1989, GEORGE WASH LAW REV, V58, P1; Danzon P M, 1982, J Health Econ, V1, P29, DOI 10.1016/0167-6296(82)90020-0; EVANS RW, 1993, JAMA-J AM MED ASSOC, V269, P3113, DOI 10.1001/jama.269.24.3113; SHLEIFER A, 1985, RAND J ECON, V16, P319, DOI 10.2307/2555560; 1993, GAOHRD9356 US GEN AC	6	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	1993	269	24					3155	3156		10.1001/jama.269.24.3155	http://dx.doi.org/10.1001/jama.269.24.3155			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LH145	11652640				2022-12-28	WOS:A1993LH14500032
J	Doyal, L				Doyal, L			Sex, gender, and health: the need for a new approach	BRITISH MEDICAL JOURNAL			English	Article							MENS HEALTH		Univ Bristol, Sch Policy Studies, Bristol BS8 1TZ, Avon, England	University of Bristol	Doyal, L (corresponding author), Univ Bristol, Sch Policy Studies, Bristol BS8 1TZ, Avon, England.		Sandall, Jane/D-4146-2009	Sandall, Jane/0000-0003-2000-743X				Annandale E., 2000, GENDER INEQUALITIES; [Anonymous], 1995, WORLD MENTAL HLTH PR; BUSFIELD J, 2000, MEN WOMEN MADNESS UN; CAMERON C, 1998, SOCIOLOGY HLTH ILLNE, V18, P673; CANAAN J, 1996, UNDERSTANDING MASCUL; Daykin N., 1995, SOCIOLOGY HLTH PROMO; Doyal L, 2000, SOC SCI MED, V51, P931, DOI 10.1016/S0277-9536(00)00072-1; Doyal L., 1995, WHAT MAKES WOMEN SIC; DOYAL L, 1998, WOMEN HLTH SERVICES; *FAM HLTH INT, 1998, MEN REPR HLTH; GARENNE M, 1998, PERSPECTIVES BIOL ME, V42, P773; Griffiths S, 1996, BRIT MED J, V312, P69; HARRISON J, 1992, MENS LIVES; Huggins ALB, 1992, SOCIAL PERSPECTIVES; Kraemer S, 2000, BRIT MED J, V321, P1609, DOI 10.1136/bmj.321.7276.1609; MASTROIANNI A, 1994, WOMEN HLTH ETHICAL L, V1; MASTROIANNI A, 1994, WOMEN HLTH ETHICAL L, V2; Moynihan C, 1998, BRIT MED J, V317, P1072; *NHS EX, 1998, NAT SURV NHS PAT GEN; Raine R, 2000, J Health Serv Res Policy, V5, P237; RINGHEIM K, 1999, REPROD HEALTH MATTER, V14, P83; SABO D, 1993, MENS HLTH ILLNESS GE; Schofield T, 2000, J AM COLL HEALTH, V48, P247, DOI 10.1080/07448480009596266; United Nations Development Program, 1995, HUM DEV REP 1995; WALDRON I, 1995, MENS HLTH ILLNESS GE; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, 2001, GLOB EST MAT MORT 19	27	234	250	0	24	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 3	2001	323	7320					1061	1063		10.1136/bmj.323.7320.1061	http://dx.doi.org/10.1136/bmj.323.7320.1061			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MP	11691769	Green Published			2022-12-28	WOS:000172055900026
J	Balistreri, MLM; Gersen, H; Korterik, JP; Kuipers, L; van Hulst, NF				Balistreri, MLM; Gersen, H; Korterik, JP; Kuipers, L; van Hulst, NF			Tracking femtosecond laser pulses in space and time	SCIENCE			English	Article							OPTICAL MICROSCOPY	We show that the propagation of a femtosecond laser pulse inside a photonic structure can be directly visualized and tracked as it propagates using a time-resolved photon scanning tunneling microscope. From the time-dependent and phase-sensitive measurements, both the group velocity and the phase velocity are unambiguously and simultaneously determined. It is expected that this technique wilt find applications in the investigation of the local dynamic behavior of photonic crystals and integrated optical circuits.	Univ Twente, Dept Appl Phys, Appl Opt Grp, NL-7500 AE Enschede, Netherlands; Univ Twente, MESA, Res Inst, NL-7500 AE Enschede, Netherlands	University of Twente; University of Twente	van Hulst, NF (corresponding author), Univ Twente, Dept Appl Phys, Appl Opt Grp, POB 217, NL-7500 AE Enschede, Netherlands.		van Hulst, Niek/J-2121-2012; gersen, henkjan/B-3735-2011; Kuipers, Laurens/A-9378-2014	van Hulst, Niek/0000-0003-4630-1776; gersen, henkjan/0000-0002-9253-7555; 				Achermann M, 2000, APPL PHYS LETT, V76, P2695, DOI 10.1063/1.126446; Balistreri MLM, 2000, PHYS REV LETT, V85, P294, DOI 10.1103/PhysRevLett.85.294; Balistreri MLM, 1999, OPT LETT, V24, P1829, DOI 10.1364/OL.24.001829; Balistreri MLM, 2001, J LIGHTWAVE TECHNOL, V19, P1169, DOI 10.1109/50.939798; BETZIG E, 1991, SCIENCE, V251, P1468, DOI 10.1126/science.251.5000.1468; Bozhevolnyi SI, 2001, PHYS REV LETT, V86, P3008, DOI 10.1103/PhysRevLett.86.3008; Diels J. C., 1996, ULTRASHORT LASER PUL; Emiliani V, 2000, PHYS REV B, V61, P10583, DOI 10.1103/PhysRevB.61.R10583; Guest JR, 2001, SCIENCE, V293, P2224, DOI 10.1126/science.1063696; Hsu JWP, 2001, MAT SCI ENG R, V33, P1, DOI 10.1016/S0927-796X(00)00031-0; JOHN S, 1993, PHYS REV LETT, V71, P1168, DOI 10.1103/PhysRevLett.71.1168; Krenn JR, 1999, PHYS REV LETT, V82, P2590, DOI 10.1103/PhysRevLett.82.2590; Nesci A, 2001, OPT LETT, V26, P208, DOI 10.1364/OL.26.000208; REDDICK RC, 1989, PHYS REV B, V39, P767, DOI 10.1103/PhysRevB.39.767; SMITH K, 1989, OPT LETT, V14, P1284, DOI 10.1364/OL.14.001284; SOUKOULIS CM, 2001, PHOTONIC CRYSTALS LI; SPIELMANN C, 1994, PHYS REV LETT, V73, P2308, DOI 10.1103/PhysRevLett.73.2308; STEINBERG AM, 1993, PHYS REV LETT, V71, P708, DOI 10.1103/PhysRevLett.71.708; XIE XS, 1994, SCIENCE, V265, P361, DOI 10.1126/science.265.5170.361	19	139	140	4	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1080	1082		10.1126/science.1065163	http://dx.doi.org/10.1126/science.1065163			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691986				2022-12-28	WOS:000172013800043
J	Lu, Z; Klem, AM; Ramu, Y				Lu, Z; Klem, AM; Ramu, Y			Ion conduction pore is conserved among potassium channels	NATURE			English	Article							RECTIFIER K+ CHANNEL; VOLTAGE-SENSING RESIDUES; INWARD-RECTIFIER; STREPTOMYCES-LIVIDANS; FUNCTIONAL EXPRESSION; MOLECULAR-BASIS; GATING CHARGE; C-TERMINUS; RECTIFICATION; INACTIVATION	Potassium channels, a group of specialized membrane proteins, enable K+ ions to flow selectively across cell membranes. Transmembrane K+ currents underlie electrical signalling in neurons and other excitable cells. The atomic structure of a bacterial K+ channel pore has been solved by means of X-ray crystallography. To the extent that the prokaryotic pore is representative of other K+ channels, this landmark achievement has profound implications for our general understanding of K+ channels. But serious doubts have been raised concerning whether the prokaryotic K+ channel pore does actually represent those of eukaryotes. Here we have addressed this fundamental issue by substituting the prokaryotic pore into eukaryotic voltage-gated and inward-rectifier K+ channels. The resulting chimaeras retain the respective functional hallmarks of the eukaryotic channels, which indicates that the ion conduction pore is indeed conserved among K+ channels.	Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Lu, Z (corresponding author), Univ Penn, Dept Physiol, 3700 Hamilton Walk, Philadelphia, PA 19104 USA.							Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; BOND CT, 1994, RECEPTOR CHANNEL, V2, P183; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; Caprini M, 2001, J BIOL CHEM, V276, P21070, DOI 10.1074/jbc.M100487200; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; Guo DL, 2000, J GEN PHYSIOL, V116, P561, DOI 10.1085/jgp.116.4.561; Hackos DH, 2001, BIOPHYS J, V80, p182A; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; Lu Z, 1997, BIOCHEMISTRY-US, V36, P6936, DOI 10.1021/bi9702849; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Spassova MA, 1998, J GEN PHYSIOL, V112, P211, DOI 10.1085/jgp.112.2.211; STANFIELD PR, 1994, J PHYSIOL-LONDON, V478, P1; TAGLIALATELA M, 1995, EMBO J, V14, P5532, DOI 10.1002/j.1460-2075.1995.tb00240.x; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4	50	266	273	1	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					809	813		10.1038/35101535	http://dx.doi.org/10.1038/35101535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677598				2022-12-28	WOS:000171750200037
J	Hayes, PC; Lee, A				Hayes, PC; Lee, A			What progress with artificial livers?	LANCET			English	Editorial Material							FULMINANT HEPATIC-FAILURE; BIOARTIFICIAL LIVER; CHARCOAL HEMOPERFUSION; TRIAL		Royal Infirm, Dept Med & Anaesthet, Edinburgh EH3 9YW, Midlothian, Scotland	Royal Infirmary of Edinburgh	Hayes, PC (corresponding author), Royal Infirm, Dept Med & Anaesthet, Edinburgh EH3 9YW, Midlothian, Scotland.	phayes@srv1.med.ed.ac.uk						Clemmensen JO, 1997, EUR J GASTROEN HEPAT, V9, P55, DOI 10.1097/00042737-199701000-00014; Ellis AJ, 1996, HEPATOLOGY, V24, P1446, DOI 10.1002/hep.510240625; GAZZARD BG, 1974, LANCET, V1, P1301; GERLACH JC, 1994, TRANSPLANTATION, V58, P984, DOI 10.1097/00007890-199411150-00002; KOBAYASHI N, 2000, SCIENCE, V287, P1185; Mitzner SR, 2000, LIVER TRANSPLANT, V6, P277, DOI 10.1053/lv.2000.6355; NYBERG SL, 1993, CELL TRANSPLANT, V2, P441, DOI 10.1177/096368979300200602; OGRADY JG, 1988, GASTROENTEROLOGY, V94, P1186, DOI 10.1016/0016-5085(88)90011-X; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; Patzer JF, 1999, ANN NY ACAD SCI, V875, P340, DOI 10.1111/j.1749-6632.1999.tb08516.x; ROZGA J, 1994, ANN SURG, V219, P538, DOI 10.1097/00000658-199405000-00012; Sorkine P, 2001, CRIT CARE MED, V29, P1332, DOI 10.1097/00003246-200107000-00006; Tisaoussis J, 2001, LIVER TRANSPLANT, V7, P2, DOI 10.1053/jlts.2001.20845	13	7	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2001	358	9290					1286	1287		10.1016/S0140-6736(01)06454-6	http://dx.doi.org/10.1016/S0140-6736(01)06454-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684205				2022-12-28	WOS:000171702500004
J	Little, P; Everitt, H; Williamson, I; Warner, G; Moore, M; Gould, C; Ferrier, K; Payne, S				Little, P; Everitt, H; Williamson, I; Warner, G; Moore, M; Gould, C; Ferrier, K; Payne, S			Observational study of effect of patient centredness and positive approach on outcomes of general practice consultations	BRITISH MEDICAL JOURNAL			English	Article							PATIENTS SATISFACTION; DECISION-MAKING; PRIMARY-CARE; CENTEREDNESS; QUESTIONNAIRE; COMMUNICATION; DOCTORS; CANCER	Objective To measure patients' perceptions of patient centredness and the relation of these perceptions to outcomes. Design Observational study using questionnaires. Setting Three general practices. Participants 865 consecutive patients attending the practices. Main outcome measures Patients' enablement, satisfaction, and burden of symptoms. Results Factor analysis identified five components. These were communication and partnership (a sympathetic doctor interested in patients' worries and expectations and who discusses and agrees the problem and treatment, Cronbach's alpha = 0.96); personal relationship (a doctor who knows die patient and their emotional needs, alpha = 0.89); health promotion (alpha = 0.87); positive approach (being definite about the problem and when it would settle, alpha = 0.84); and interest in effect on patient's life (alpha = 0.89). Satisfaction was related to communication and partnership (adjusted beta = 19.1; 95% confidence interval 17.7 to 20.7) and a positive approach (4.28; 2.96 to 5.60). Enablement was greater with interest in die effect on life (0.55; 0.25 to 0.86), health promotion (0.57; 0.30 to 0.85), and a positive approach (0.82; 0.52 to 1.11). A positive approach was also associated with reduced symptom burden at one month (beta = -0.25; -0.41 to -0.10). Referrals were fewer if patients felt they had a personal relationship with their doctor (odds ratio 0.70; 0.54 to 0.90). Conclusions Components of patients' perceptions can be measured reliably and predict different outcomes. If doctors don't provide a positive, patient centred approach patients will be less satisfied, less enabled, and may have greater symptom burden and higher rates of referral.	Univ Southampton, Aldermoor Hlth Ctr,Fac Med Hlth & Biol Sci, Community Clin Sci Div, Primary Med Care Grp, Southampton SO16 5ST, Hants, England; Nightingale Surg, Romsey SO51 7QM, Hants, England; Three Swans Surg, Salisbury SP1 1DX, Wilts, England; Univ Sheffield, Sheffield Palliat Care Studies, Sheffield S11 9NE, S Yorkshire, England	University of Southampton; University of Sheffield	Little, P (corresponding author), Univ Southampton, Aldermoor Hlth Ctr,Fac Med Hlth & Biol Sci, Community Clin Sci Div, Primary Med Care Grp, Southampton SO16 5ST, Hants, England.		Moore, Michael/C-3447-2011; Harding, Richard/G-9729-2012	Moore, Michael/0000-0002-5127-4509; Everitt, Hazel/0000-0001-7362-8403; Payne, Sheila/0000-0001-6982-9181; Little, Paul/0000-0003-3664-1873				BAKER R, 1990, BRIT J GEN PRACT, V40, P487; Barry CA, 2000, BRIT MED J, V320, P1246, DOI 10.1136/bmj.320.7244.1246; Britten N, 1997, BRIT MED J, V315, P1506, DOI 10.1136/bmj.315.7121.1506; Britten N, 2000, BMJ-BRIT MED J, V320, P484, DOI 10.1136/bmj.320.7233.484; BROWN JB, 1995, WORKING PAPER SERIES, V952; Charles C, 1998, SOCIOL HEALTH ILL, V20, P71, DOI 10.1111/1467-9566.00081; Dowsett SM, 2000, PSYCHO-ONCOL, V9, P147, DOI 10.1002/(SICI)1099-1611(200003/04)9:2<147::AID-PON443>3.0.CO;2-X; Fitzpatrick R.M., 1991, SOCIOLOGY APPL MED, P261; Guadagnoli E, 1998, SOC SCI MED, V47, P329, DOI 10.1016/S0277-9536(98)00059-8; HENBEST RJ, 1992, FAM PRACT, V9, P311, DOI 10.1093/fampra/9.3.311; HENBEST RJ, 1990, FAM PRACT, V7, P28, DOI 10.1093/fampra/7.1.28; HJORTDAHL P, 1992, BRIT MED J, V304, P1287, DOI 10.1136/bmj.304.6837.1287; Howie JGR, 1999, BMJ-BRIT MED J, V319, P738, DOI 10.1136/bmj.319.7212.738; Jung HP, 1997, BRIT J GEN PRACT, V47, P805; Kinnersley P, 1999, BRIT J GEN PRACT, V49, P711; LAW SAT, 1995, BRIT J GEN PRACT, V45, P520; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Little P, 2001, BMJ-BRIT MED J, V322, P468, DOI 10.1136/bmj.322.7284.468; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; MERYN S, 1998, BRIT MED J, V316, P19; Paterson C, 1996, BRIT MED J, V312, P1016; SAVAGE R, 1990, BRIT MED J, V301, P968, DOI 10.1136/bmj.301.6758.968; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Streiner DL., 1995, HLTH MEASUREMENT SCA, V2nd ed.; THOMAS KB, 1987, BRIT MED J, V294, P1200, DOI 10.1136/bmj.294.6581.1200; WILKIN D, 1992, MEASURES NEED OUTCOM; WILLIAMS S, 1995, FAM PRACT, V12, P193, DOI 10.1093/fampra/12.2.193	27	540	550	0	35	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 20	2001	323	7318					908	911		10.1136/bmj.323.7318.908	http://dx.doi.org/10.1136/bmj.323.7318.908			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486BH	11668137	Green Published, Bronze			2022-12-28	WOS:000171798200023
J	Ram, FSF; Wright, J; Brocklebank, D; White, JES				Ram, FSF; Wright, J; Brocklebank, D; White, JES		Natl Hlth Technology Assessment In	Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering beta(2) agonist bronchodilators in asthma	BMJ-BRITISH MEDICAL JOURNAL			English	Review							FENOTEROL INHALATION POWDER; SALBUTAMOL POWDER; CFC ALBUTEROL; AEROSOL; TURBUHALER; TERBUTALINE; CHILDREN; SULFATE; MDI; EFFICACY	Objectives To determine the clinical effectiveness of pressurised metered dose inhalers compared with other hand held inhaler devices for delivering short acting beta (2) agonists in stable asthma. Design Systematic review of randomised controlled trials. Data sources Cochrane Airways Group specialised trials database (which includes hand searching of 20 relevant journals), Medline, Embase, Cochrane controlled clinical trials register, pharmaceutical companies, and bibliographies of included trials. Trials All trials in children or adults with stable asthma that compared the pressurised metered dose inhaler (with or without a spacer device) against any other hand held inhaler device containing the same beta (2) agonist. Results 84 randomised controlled trials were included. No differences were found between the pressurised metered dose inhaler and any other hand held inhaler device for lung function, blood pressure, symptoms, bronchial hyperreactivity systemic bioavailability, inhaled steroid requirement serum potassium concentration, and use of additional relief bronchodilators. In adults, pulse rate was lower in those using the pressurised metered dose inhaler compared with those using Turbohaler (standardised mean difference 0.44, 95% confidence interval 0.05 to 0.84); patients preferred the pressurised metered dose inhaler to the Rotahaler (relative risk 0.53, 95% confidence interval 0.36 to 0.78); hydrofluoroalkane pressurised metered dose inhalers reduced the requirement for rescue short course oral steroids (relative risk 0.67, 0.49 to 0.91). Conclusions No evidence was found to show that alternative inhaler devices are more effective than standard pressurised metered dose inhalers for delivering acting beta (2) agonist bronchodilators in asthma. Pressurised metered dose inhalers remain the most cost effective delivery devices.	Bradford Royal Infirm, Bradford Hosp NHS Trust, Bradford BD9 6RJ, W Yorkshire, England; York Dist Gen Hosp, Dept Resp Med, York Hlth Serv NHS Trust, York YO3 7HE, N Yorkshire, England	Bradford Royal Infirmary	Wright, J (corresponding author), Bradford Royal Infirm, Bradford Hosp NHS Trust, Bradford BD9 6RJ, W Yorkshire, England.	john.wright@bradford.hospitals.nhs.uk	Wright, John/H-1624-2012	Wright, John/0000-0001-9572-7293; Ram, Felix Simon Francis/0000-0002-5437-4089				*3M HLTH CAR, UNPUB 4 WEEK SAF EFF; ANDERSON PB, 1998, J CLIN RES, V1, P49; Bondesson E, 1998, RESP MED, V92, P325, DOI 10.1016/S0954-6111(98)90116-0; Borgstrom L, 1996, AM J RESP CRIT CARE, V153, P1636, DOI 10.1164/ajrccm.153.5.8630614; BOYE NP, 1983, EUR J RESPIR DIS, V64, P9; Bronsky E, 1999, J ASTHMA, V36, P107, DOI 10.3109/02770909909065154; BRONSKY E, 1987, J ALLERGY CLIN IMMUN, V79, P741, DOI 10.1016/0091-6749(87)90205-3; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; Chapman KR, 1997, ANN ALLERG ASTHMA IM, V78, P59, DOI 10.1016/S1081-1206(10)63373-X; CLARKE M, 1999, REV MANAGER REVMAN C; CUSTOVIC A, 1995, J PHARM MED, V5, P161; DIRKSEN H, 1983, EUR J RESPIR DIS, V64, P48; DOCKHORN R, 1995, J ALLERGY CLIN IMMUN, V96, P50, DOI 10.1016/S0091-6749(95)70032-3; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EKSTROM T, 1995, ANN ALLERG ASTHMA IM, V74, P328; Geoffroy P, 1999, ANN ALLERG ASTHMA IM, V82, P377, DOI 10.1016/S1081-1206(10)63287-5; Giannini D, 2000, CHEST, V117, P1319, DOI 10.1378/chest.117.5.1319; Golish J, 1998, J ASTHMA, V35, P373, DOI 10.3109/02770909809075671; Guyatt GH, 1998, BRIT MED J, V316, P690, DOI 10.1136/bmj.316.7132.690; HAAHTELA T, 1994, ANN ALLERGY, V72, P178; HARTLEY JPR, 1977, BRIT J CLIN PHARMACO, V4, P673, DOI 10.1111/j.1365-2125.1977.tb00429.x; HARTLEY JPR, 1979, BRIT J DIS CHEST, V73, P271, DOI 10.1016/0007-0971(79)90051-2; HETZEL MR, 1977, CLIN ALLERGY, V7, P563, DOI 10.1111/j.1365-2222.1977.tb01486.x; HULTQUIST C, 1989, ALLERGY, V44, P467, DOI 10.1111/j.1398-9995.1989.tb04184.x; JOHNSEN CR, 1988, ALLERGY, V43, P392, DOI 10.1111/j.1398-9995.1988.tb00434.x; KEMP JP, 1989, J ALLERGY CLIN IMMUN, V83, P697, DOI 10.1016/0091-6749(89)90085-7; KIVIRANTA K, 1985, ALLERGY, V40, P305, DOI 10.1111/j.1398-9995.1985.tb00237.x; Kleerup EC, 1996, CHEST, V109, P702, DOI 10.1378/chest.109.3.702; Kou M, 1998, J ASTHMA, V35, P505, DOI 10.3109/02770909809071004; LABERGE S, 1994, J PEDIATR-US, V124, P815, DOI 10.1016/S0022-3476(05)81381-2; Langley S. J., 1998, European Respiratory Journal, V12, p67S; MATHIEU M, 1992, EUR J CLIN PHARMACOL, V42, P435; Mellen A, 1999, AM J RESP CRIT CARE, V159, P1663, DOI 10.1164/ajrccm.159.5.9801061; Morice AH, 1996, BRIT J CLIN PHARMACO, V42, pP658; Neville RG, 1999, EUR RESPIR J, V14, P605, DOI 10.1034/j.1399-3003.1999.14c20.x; OSTERMAN K, 1991, EUR RESPIR J, V4, P175; Parameswaran KN, 1999, AM J RESP CRIT CARE, V160, P354, DOI 10.1164/ajrccm.160.1.9812035; Pearson MG, 1997, THORAX, V52, pS1; PERSSON G, 1988, EUR RESPIR J, V1, P681; POVER GM, 1988, J INT MED RES, V16, P201, DOI 10.1177/030006058801600306; Ramsdell JW, 1999, CHEST, V115, P945, DOI 10.1378/chest.115.4.945; Ramsdell JW, 1998, ANN ALLERG ASTHMA IM, V81, P593, DOI 10.1016/S1081-1206(10)62711-1; RUFFIN R, 1995, AM J RESP CRIT CARE, V151, pA58; SELROOS O, 1994, THORAX, V49, P1228, DOI 10.1136/thx.49.12.1228; Selroos O, 1996, CLIN IMMUNOTHER, V6, P273, DOI 10.1007/BF03259089; Seppala OP, 1998, ARZNEIMITTEL-FORSCH, V48, P919; SILVASTI M, 1993, ACTA THERAP, V19, P125; SVEDMYR N, 1982, EUR J RESPIR DIS, V63, P81; THOMPSON P, 1995, BRIT J CLIN PRACT, P31; TUKIAINEN H, 1985, EUR J CLIN PHARMACOL, V27, P645, DOI 10.1007/BF00547042	50	22	26	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2001	323	7318					901	905		10.1136/bmj.323.7318.901	http://dx.doi.org/10.1136/bmj.323.7318.901			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486BH	11668134	Green Published, Bronze			2022-12-28	WOS:000171798200020
J	Karsenti, E; Vernos, I				Karsenti, E; Vernos, I			Cell cycle - The mitotic spindle: A self-made machine	SCIENCE			English	Review							NUCLEAR-ENVELOPE BREAKDOWN; MICROTUBULE DYNAMICS; CHROMOSOME CONDENSATION; RESPECTIVE ROLES; RAN-GTP; ORGANIZATION; CENTROSOMES; TRANSPORT; CHROMATIN; INTERPHASE	The mitotic spindle is a highly dynamic molecular machine composed of tubulin, motors, and other molecules. It assembles around the chromosomes and distributes the duplicated genome to the daughter cells during mitosis. The biochemical and physical principles that govern the assembly of this machine are still unclear. However, accumulated discoveries indicate that chromosomes play a key role. Apparently, they generate a local cytoplasmic state that supports the nucleation and growth of microtubules. Then soluble and chromosome-associated molecular motors sort them into a bipolar array. The emerging picture is that spindle assembly is governed by a combination of modular principles and that their relative contribution may vary in different cell types and in various organisms.	European Mol Biol Lab, Cell Biol & Biophys Program, D-69117 Heidelberg, Germany; Univ Paris 06, CNRS, Inst Jacques Monod, Paris, France; Univ Paris 07, Paris, France	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Karsenti, E (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Program, Meyerhofstr 1, D-69117 Heidelberg, Germany.	karsenti@embl-heidelberg.de; vernos@embl-heidelberg.de	Vernos, Isabelle/C-1687-2015	Vernos, Isabelle/0000-0003-1469-9214				Andersen SSL, 2000, TRENDS CELL BIOL, V10, P261, DOI 10.1016/S0962-8924(00)01786-4; Andersen SSL, 1997, NATURE, V389, P640, DOI 10.1038/39382; BATAILLON E, 1912, ANN SCI NAT ZOOL, V9, P249; BLOOM GS, 1994, PROTEIN PROFILE SERI, V2; BOVERI T, 1901, JENA Z MED NATURWISS, V28, P1; Budde PP, 2001, J CELL BIOL, V153, P149, DOI 10.1083/jcb.153.1.149; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Dasso M, 2001, CELL, V104, P321, DOI 10.1016/S0092-8674(01)00218-5; DEMEY J, 1982, P NATL ACAD SCI-BIOL, V79, P1898; Dogterom M, 1996, J CELL BIOL, V133, P125, DOI 10.1083/jcb.133.1.125; DOGTEROM M, 1994, THESIS U PARIS 11; FORBES DJ, 1983, CELL, V34, P13, DOI 10.1016/0092-8674(83)90132-0; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; GURDON JB, 1986, J CELL SCI, P287; GURDON JB, 1967, P NATL ACAD SCI USA, V58, P545, DOI 10.1073/pnas.58.2.545; Hagan IM, 1998, J CELL SCI, V111, P1603; Heald R, 1997, J CELL BIOL, V138, P615, DOI 10.1083/jcb.138.3.615; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Heald R, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P326; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Kahana JA, 1999, J CELL BIOL, V146, P1205, DOI 10.1083/jcb.146.6.1205; KARSENTI E, 1984, J CELL BIOL, V99, pS47, DOI 10.1083/jcb.99.1.47s; KARSENTI E, 1984, J CELL BIOL, V98, P1730, DOI 10.1083/jcb.98.5.1730; KARSENTI E, 1991, ADV PROTEIN PHOSPHAT, V6, P453; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; KIRSCHNER M, 1985, TRENDS GENET, V1, P41, DOI 10.1016/0168-9525(85)90021-6; Kuntziger T, 2001, MOL BIOL CELL, V12, P437, DOI 10.1091/mbc.12.2.437; LOHKA MJ, 1985, J CELL BIOL, V101, P518, DOI 10.1083/jcb.101.2.518; LOHKA MJ, 1983, EXP CELL RES, V148, P481, DOI 10.1016/0014-4827(83)90169-6; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; MAZIA D, 1987, INT REV CYTOL, V100, P49; Mitchison TJ, 2001, NAT CELL BIOL, V3, pE17, DOI 10.1038/35050656; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; NEWPORT J, 1987, CELL, V48, P205, DOI 10.1016/0092-8674(87)90424-7; NICKLAS RB, 1985, J CELL BIOL, V100, P1, DOI 10.1083/jcb.100.1.1; Raff JW, 2001, CURR BIOL, V11, pR159, DOI 10.1016/S0960-9822(01)00082-3; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; STEFFEN W, 1986, J CELL BIOL, V102, P1679, DOI 10.1083/jcb.102.5.1679; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; VERDE F, 1991, J CELL BIOL, V112, P1177, DOI 10.1083/jcb.112.6.1177; VERDE F, 1990, NATURE, V343, P233, DOI 10.1038/343233a0; VERNOS I, 1995, TRENDS CELL BIOL, V5, P297, DOI 10.1016/S0962-8924(00)89045-5; VERNOS I, 1995, CELL, V81, P117, DOI 10.1016/0092-8674(95)90376-3; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; WATERS JC, 1995, BIOESSAYS, V17, P911, DOI 10.1002/bies.950171102; Waters JC, 1997, CURR OPIN CELL BIOL, V9, P37, DOI 10.1016/S0955-0674(97)80149-4; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Wilson EB., 1925, CELL DEV HEREDITY, V3rd edition; Winey M, 2001, NAT CELL BIOL, V3, pE23, DOI 10.1038/35050663; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Zhai Y, 1996, J CELL BIOL, V135, P201, DOI 10.1083/jcb.135.1.201; ZIEGLER D, 1973, DEV BIOL, V35, P283, DOI 10.1016/0012-1606(73)90024-9	63	363	371	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					543	547		10.1126/science.1063488	http://dx.doi.org/10.1126/science.1063488			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641489				2022-12-28	WOS:000171695600035
J	Scodeggio, M				Scodeggio, M			Astronomy - Toward resolving the mystery of galaxy formation	SCIENCE			English	Editorial Material							STAR-FORMATION; HIGH-REDSHIFT; DEEP FIELD		CNR, Ist Fis Cosm G Occhialini, I-20133 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR)	Scodeggio, M (corresponding author), CNR, Ist Fis Cosm G Occhialini, Via Bassini 15, I-20133 Milan, Italy.	marcos@ifctr.mi.cnr.it		Scodeggio, Marco/0000-0002-2282-5850				Barger AJ, 1998, NATURE, V394, P248, DOI 10.1038/28338; Cimatti A, 1998, NATURE, V392, P895, DOI 10.1038/31872; COLE S, 1994, MON NOT R ASTRON SOC, V271, P781, DOI 10.1093/mnras/271.4.781; EGGEN OJ, 1962, ASTROPHYS J, V136, P748, DOI 10.1086/147433; Hughes DH, 1998, NATURE, V394, P241, DOI 10.1038/28328; LARSON RB, 1974, MON NOT R ASTRON SOC, V166, P585, DOI 10.1093/mnras/166.3.585; Maihara T, 2001, PUBL ASTRON SOC JPN, V53, P25, DOI 10.1093/pasj/53.1.25; ROBERTS MS, 1994, ANNU REV ASTRON ASTR, V32, P115; Scodeggio M, 2000, ASTRON ASTROPHYS, V359, P953	10	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					537	538		10.1126/science.1065709	http://dx.doi.org/10.1126/science.1065709			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641488				2022-12-28	WOS:000171695600034
J	Wong, K; Ren, XR; Huang, YZ; Xie, Y; Liu, GF; Saito, H; Tang, H; Wen, L; Brady-Kalnay, SM; Mei, L; Wu, JY; Xiong, WC; Rao, Y				Wong, K; Ren, XR; Huang, YZ; Xie, Y; Liu, GF; Saito, H; Tang, H; Wen, L; Brady-Kalnay, SM; Mei, L; Wu, JY; Xiong, WC; Rao, Y			Signal transduction in neuronal migration: Roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway	CELL			English	Article							ACTIN-DEPOLYMERIZING PROTEIN; PHOTORECEPTOR AXON GUIDANCE; ALDRICH-SYNDROME PROTEIN; GROWTH-CONE COLLAPSE; ARP2/3 COMPLEX; N-WASP; DROSOPHILA-MELANOGASTER; CELL-ADHESION; RHO GTPASES; REPELLENT	The Slit protein guides neuronal and leukocyte migration through the transmembrane receptor Roundabout (Robo). We report here that the intracellular domain of Robo interacts with a novel family of Rho GTPase activating proteins (GAPs). Two of the Slit-Robo GAPs (srGAPs) are expressed in regions responsive to Slit. Slit increased srGAP1-Robo1 interaction and inactivated Cdc42. A dominant negative srGAP1 blocked Slit inactivation of Cdc42 and Slit repulsion of migratory cells from the anterior subventricular zone (SVZa) of the forebrain. A constitutively active Cdc42 blocked the repulsive effect of Slit. These results have demonstrated important roles for GAPs and Cdc42 in neuronal migration. We propose a signal transduction pathway from the extracellular guidance cue to intracellular actin polymerization.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Univ Alabama Birmingham, Sch Med, Dept Pathol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Sch Med, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Sch Med, Dept Phys Med & Rehabil, Birmingham, AL 35294 USA; Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Case Western Reserve University	Rao, Y (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	wxiong@path.uab.edu; raoyi@thalamus.wustl.edu	Tang, Hao/G-9841-2011; Mei, Lin/G-8755-2012		NATIONAL CANCER INSTITUTE [R01CA114197] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070967] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA114197-01A2] Funding Source: Medline; NEI NIH HHS [R01 EY014576-03] Funding Source: Medline; NIGMS NIH HHS [R01 GM070967-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ba-Charvet KTN, 2001, J NEUROSCI, V21, P4281; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Battye R, 1999, DEVELOPMENT, V126, P2475; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Burden-Gulley SM, 1999, J CELL BIOL, V144, P1323, DOI 10.1083/jcb.144.6.1323; Chen JH, 2001, J NEUROSCI, V21, P1548, DOI 10.1523/JNEUROSCI.21-05-01548.2001; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Erskine L, 2000, J NEUROSCI, V20, P4975; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Jin Z, 1997, J NEUROSCI, V17, P6256; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kuhn TB, 1999, J NEUROSCI, V19, P1965; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Lin MZ, 2000, CELL, V101, P239, DOI 10.1016/S0092-8674(00)80833-8; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Ma L, 1998, P NATL ACAD SCI USA, V95, P15362, DOI 10.1073/pnas.95.26.15362; Machesky LM, 1999, J CELL BIOL, V146, P267, DOI 10.1083/jcb.146.2.267; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Mullins RD, 1999, CURR BIOL, V9, P405, DOI 10.1016/S0960-9822(99)80187-0; Niclou SP, 2000, J NEUROSCI, V20, P4962; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; O'Brien SP, 2000, P NATL ACAD SCI USA, V97, P12074, DOI 10.1073/pnas.97.22.12074; Paulus W, 1996, J VIROL, V70, P62, DOI 10.1128/JVI.70.1.62-67.1996; Pear Warren S., 1997, P41; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; Ruan WJ, 1999, NEURON, V24, P595, DOI 10.1016/S0896-6273(00)81115-0; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; SWIFT S, 1999, CURRENT PROTOCOL S31, V28; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Vastrik I, 1999, CURR BIOL, V9, P991, DOI 10.1016/S0960-9822(99)80447-3; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6; Zigmond SH, 1997, J CELL BIOL, V138, P363, DOI 10.1083/jcb.138.2.363	61	429	459	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2001	107	2					209	221		10.1016/S0092-8674(01)00530-X	http://dx.doi.org/10.1016/S0092-8674(01)00530-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672528	Bronze			2022-12-28	WOS:000171694800010
J	Hopkins, KD				Hopkins, KD			Reminders unscrambled from Ig Nobel awards	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		Hopkins, KD (corresponding author), Lancet, London WC1X 8RR, England.							ABRAHAMS M, WHAT IS THIS IG; BARSS P, 1984, J TRAUMA, V24, P990, DOI 10.1097/00005373-198411000-00012	2	0	0	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1202	1202		10.1016/S0140-6736(01)06340-1	http://dx.doi.org/10.1016/S0140-6736(01)06340-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675054				2022-12-28	WOS:000171527000006
J	Yokoyama, T; Yokoyama, S; Kamikado, T; Okuno, Y; Mashiko, S				Yokoyama, T; Yokoyama, S; Kamikado, T; Okuno, Y; Mashiko, S			Selective assembly on a surface of supramolecular aggregates with controlled size and shape	NATURE			English	Article							MOLECULES; AU(111); NANOSTRUCTURES; MANIPULATION; DEVICES	The realization of molecule-based miniature devices with advanced functions requires the development of new and efficient approaches for combining molecular building blocks into desired functional structures, ideally with these structures supported on suitable substrates(1-4). Supramolecular aggregation occurs spontaneously and can lead to controlled structures if selective and directional non-covalent interactions are exploited. But such selective supramolecular assembly has yielded almost exclusively crystals or dissolved structures(5); the self-assembly of absorbed molecules into larger structures(6-8), in contrast, has not yet been directed by controlling selective intermolecular interactions. Here we report the formation of surface-supported supramolecular structures whose size and aggregation pattern are rationally controlled by tuning the non-covalent interactions between individual absorbed molecules. Using low-temperature scanning tunnelling microscopy, we show that substituted porphyrin molecules adsorbed on a gold surface form monomers, trimers, tetramers or extended wire-like structures. We rnd that each structure corresponds in a predictable fashion to the geometric and chemical nature of the porphyrin substituents that mediate the interactions between individual adsorbed molecules. Our findings suggest that careful placement of functional groups that are able to participate in directed noncovalent interactions will allow the rational design and construction of a wide range of supramolecular architectures absorbed to surfaces.	Natl Inst Mat Sci, Moriyama Ku, Nagoya, Aichi 4630003, Japan; Commun Res Labs, Nishi Ku, Kobe, Hyogo 6512401, Japan	National Institute for Materials Science; National Institute of Information & Communications Technology (NICT) - Japan	Yokoyama, T (corresponding author), Natl Inst Mat Sci, Moriyama Ku, 2268-1 Shimo Shidami, Nagoya, Aichi 4630003, Japan.	Yokoyama.takashi@nims.go.jp	Yokoyama, Takashi/B-9845-2011					BARTH JV, 1990, PHYS REV B, V42, P9307, DOI 10.1103/PhysRevB.42.9307; Barth JV, 2000, ANGEW CHEM INT EDIT, V39, P1230, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1230::AID-ANIE1230>3.0.CO;2-I; Bohringer M, 1999, PHYS REV LETT, V83, P324, DOI 10.1103/PhysRevLett.83.324; Cai LT, 2000, APPL PHYS LETT, V77, P3105, DOI 10.1063/1.1323546; CHAMBLISS DD, 1991, PHYS REV LETT, V66, P1721, DOI 10.1103/PhysRevLett.66.1721; Collier CP, 1999, SCIENCE, V285, P391, DOI 10.1126/science.285.5426.391; DEREGE PJF, 1995, SCIENCE, V269, P1409, DOI 10.1126/science.7660123; FIND HW, 1999, NATURE, V398, P407; Furukawa M, 2000, SURF SCI, V445, pL58, DOI 10.1016/S0039-6028(99)01068-7; Joachim C, 2000, NATURE, V408, P541, DOI 10.1038/35046000; Jung TA, 1996, SCIENCE, V271, P181, DOI 10.1126/science.271.5246.181; Jung TA, 1997, NATURE, V386, P696, DOI 10.1038/386696a0; Lehn J.-M., 1995, SUPRAMOLECULAR CHEM; Lopinski GP, 2000, NATURE, V406, P48, DOI 10.1038/35017519; Moresco F, 2001, PHYS REV LETT, V86, P672, DOI 10.1103/PhysRevLett.86.672; Moresco F, 2001, APPL PHYS LETT, V78, P306, DOI 10.1063/1.1339251; Sugiura K, 1999, CHEM LETT, P841, DOI 10.1246/cl.1999.841; Wada Y, 2000, JPN J APPL PHYS 1, V39, P3835, DOI 10.1143/JJAP.39.3835; Yokoyama T, 2001, J CHEM PHYS, V115, P3814, DOI 10.1063/1.1389276; Yokoyama T, 1999, PHYS REV B, V59, P12232, DOI 10.1103/PhysRevB.59.12232	20	742	749	8	298	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2001	413	6856					619	621		10.1038/35098059	http://dx.doi.org/10.1038/35098059			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675782				2022-12-28	WOS:000171485700045
J	Adshead, G				Adshead, G			Personal view - Time flies ...	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Esmail A, 1998, BRIT MED J, V316, P193; 1997, BRIT MED J, V314, P1619	2	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 14	1999	319	7207					458	458		10.1136/bmj.319.7207.458b	http://dx.doi.org/10.1136/bmj.319.7207.458b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227UT	11682722	Green Published			2022-12-28	WOS:000082098900050
J	Smith, O				Smith, O			Nota Bene, theater - A gamete gambol	SCIENCE			English	News Item																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	1999	285	5424					56	56						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212CY	11645159				2022-12-28	WOS:000081199800044
J	Zwart, F				Zwart, F			A very special day	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 26	1997	315	7102					260	260		10.1136/bmj.315.7102.260	http://dx.doi.org/10.1136/bmj.315.7102.260			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XN517	11644985	Green Published			2022-12-28	WOS:A1997XN51700077
J	Rabinowitz, B				Rabinowitz, B			The great hijack	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 28	1996	313	7060					826	826						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VK566	11644828				2022-12-28	WOS:A1996VK56600087
J	BEWLEY, S				BEWLEY, S			AN ETHICAL DEBATE - SHOULD OLDER WOMEN BE OFFERED IN-VITRO FERTILIZATION - IN-VITRO FERTILIZATION IS RARELY SUCCESSFUL IN OLDER WOMEN	BRITISH MEDICAL JOURNAL			English	Article											BEWLEY, S (corresponding author), GUYS & ST THOMAS HOSP,DEPT OBSTET & GYNAECOL,LONDON SE1 7EM,ENGLAND.			bewley, susan/0000-0001-8064-652X					0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 3	1995	310	6992					1457	1457		10.1136/bmj.310.6992.1457	http://dx.doi.org/10.1136/bmj.310.6992.1457			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RC105	11644710	Green Published			2022-12-28	WOS:A1995RC10500031
J	CRAWSHAW, R				CRAWSHAW, R			GREED AND THE MEDICAL-PROFESSION	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 9	1993	306	6870					151	151		10.1136/bmj.306.6870.151	http://dx.doi.org/10.1136/bmj.306.6870.151			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KG465	11643094	Green Published, Bronze			2022-12-28	WOS:A1993KG46500090
J	DUNEA, G				DUNEA, G			EDITORS IN DISTRESS	BRITISH MEDICAL JOURNAL			English	Editorial Material																		1988, BR MED J, V296, P307; 1988, JAMA            0108, P272	2	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	AUG 6	1988	297	6645					430	430		10.1136/bmj.297.6645.430	http://dx.doi.org/10.1136/bmj.297.6645.430			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P5450	11644468	Green Published, Bronze			2022-12-28	WOS:A1988P545000065
J	Sereno, PC; Larsson, HCE; Sidor, CA; Gado, B				Sereno, PC; Larsson, HCE; Sidor, CA; Gado, B			The giant crocodyliform Sarcosuchus from the Cretaceous of Africa	SCIENCE			English	Article								New fossils of the giant African crocodyliform Sarcosuchus imperator clarify its skeletal anatomy, growth patterns, size, longevity, and phylogenetic position. The skull has an expansive narial bulla and elongate jaws studded with stout, smooth crowns that do not interlock. The jaw form suggests a generalized diet of large vertebrates, including fish and dinosaurs. S. imperator is estimated to have grown to a maximum body length of at least 11 to 12 meters and body weight of about 8 metric tons over a life-span of 50 to 60 years. Unlike its closest relatives, which lived as specialized piscivores in marginal marine habitats, S. imperator thrived in fluvial environments.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06511 USA; New York Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA; Inst Rech Sci Humaines, Niamey, Niger	University of Chicago; Yale University; New York Institute Technology	Sereno, PC (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA.		Larsson, Hans/AAD-4579-2019	Larsson, Hans/0000-0002-6377-4770				Andrews C. W., 1913, Annals & Magazine of Natural History, V11; Buffetau E., 1981, MEMOIRES SOC GEOLOGI, V60, P1; BUFFETAUT E, 1977, Palaeontology (Oxford), V20, P203; Erickson GM, 1999, NATURE, V398, P205, DOI 10.1038/18343; Greer A.E., 1974, Journal Herpet, V8, P381, DOI 10.2307/1562913; Grenard S., 1991, HDB ALLIGATORS CROCO; Headden Jaime A., 2001, Journal of Vertebrate Paleontology, V21, p59A; HOOLEY RW, 1907, J GEOL SOC LONDON, V63, P50; LARSSON HC, 2000, THESIS U CHICAGO; Maisey J.G., 1991, SANTANA FOSSILS ILLU, P342; Pooley A.C., 1989, P76; Ross F.D., 1983, P305; Schwimmer David R., 1999, Journal of Vertebrate Paleontology, V19, p74A; Sereno PC, 1999, SYST BIOL, V48, P329, DOI 10.1080/106351599260328; Singh L.A.K., 1982, British Journal of Herpetology, V6, P253; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; SWOFFORD DL, 1993, PAUP 3 1; TAQUET P, 1975, CAH PALEONTOL, V1, P1; Taquet P., 1966, CR HEBD ACAD SCI, V262, P2326; WEBB GJW, 1983, AUST WILDLIFE RES, V10, P383, DOI 10.1071/WR9830383; WEBB GJW, 1978, AUST J ZOOL, V26, P1; WERMUTH HEINZ, 1964, SENCKENBERG BIOL, V45, P369; Woodward AR, 1995, J HERPETOL, V29, P507, DOI 10.2307/1564733; Wu XC, 2001, J VERTEBR PALEONTOL, V21, P492, DOI 10.1671/0272-4634(2001)021[0492:TACNMF]2.0.CO;2; Wu XC, 1996, CAN J EARTH SCI, V33, P606, DOI 10.1139/e96-045	25	216	226	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1516	1519		10.1126/science.1066521	http://dx.doi.org/10.1126/science.1066521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11679634	Green Published			2022-12-28	WOS:000172240500045
J	Bellini, T; Radzihovsky, L; Toner, J; Clark, NA				Bellini, T; Radzihovsky, L; Toner, J; Clark, NA			Universality and scaling in the disordering of a smectic liquid crystal	SCIENCE			English	Article							NEMATIC PHASE-TRANSITION; LONG-RANGE ORDER; CRITICAL-BEHAVIOR; SILICA AEROGEL; II SUPERCONDUCTORS; QUENCHED DISORDER; RANDOM-FIELDS; POROUS-MEDIA; SCATTERING; LATTICES	We present experimental and theoretical studies of the effects of quenched disorder on one-dimensional crystal ordering in three dimensions. This fragile smectic liquid crystal layering, the material with the simplest positional order, is also the most easily deformed periodic structure and is, therefore, profoundly affected by disorder, introduced here by confinement in silica aerogel. Theory and experiment combine to characterize this system to an extraordinary degree, their close accord producing a coherent picture: crystal ordering is lost, giving way to extended short-range correlations that exhibit universal structure and scaling, anomalous layer elasticity, and glassy dynamics.	Univ Colorado, Dept Phys, Boulder, CO 80309 USA; Univ Milan, Dipartimento Chim & Biochim Med, INFM, Milan, Italy; Univ Oregon, Dept Phys, Inst Mat Sci, Eugene, OR 97403 USA; Univ Oregon, Inst Theoret Sci, Eugene, OR 97403 USA	University of Colorado System; University of Colorado Boulder; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Milan; University of Oregon; University of Oregon	Bellini, T (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.		Clark, Noel A./E-9011-2010; Bellini, Tommaso/M-5510-2014; Toner, John/G-9470-2015; Clark, Noel A/AAP-9116-2020	Clark, Noel A./0000-0001-9301-5540; Bellini, Tommaso/0000-0003-4898-4400; 				AHARONY A, 1976, PHYS REV LETT, V37, P1364, DOI 10.1103/PhysRevLett.37.1364; BALENTS L, COMMUNICATION; BELLINI T, 1995, PHYS REV LETT, V74, P2740, DOI 10.1103/PhysRevLett.74.2740; Bellini T, 2000, PHYS REV LETT, V85, P1008, DOI 10.1103/PhysRevLett.85.1008; BELLINI T, 1992, PHYS REV LETT, V69, P788, DOI 10.1103/PhysRevLett.69.788; BELLINI T, 1996, LIQUID CRYSTALS COMP, pCH19; BENZEKRI M, 1990, PHYS REV B, V41, P9032, DOI 10.1103/PhysRevB.41.9032; BINDER K, 1986, REV MOD PHYS, V58, P801, DOI 10.1103/RevModPhys.58.801; Chan M, 1996, PHYS TODAY, V49, P30, DOI 10.1063/1.881509; CLARK NA, 1973, APPL PHYS LETT, V22, P493, DOI 10.1063/1.1654481; CLARK NA, 1993, PHYS REV LETT, V71, P3505, DOI 10.1103/PhysRevLett.71.3505; Crawford G. P., 1996, LIQUID CRYSTALS COMP; DEGENNES PG, 1972, SOLID STATE COMMUN, V10, P753, DOI 10.1016/0038-1098(72)90186-X; DEGENNES PG, 1993, PHYSICS LIQUID CRYST, pCH7; Feldman DE, 2000, PHYS REV LETT, V84, P4886, DOI 10.1103/PhysRevLett.84.4886; Fisher DS, 1997, PHYS REV LETT, V78, P1964, DOI 10.1103/PhysRevLett.78.1964; FISHER DS, 1986, PHYS REV LETT, V56, P416, DOI 10.1103/PhysRevLett.56.416; FISHER DS, 1985, PHYS REV B, V31, P7233, DOI 10.1103/PhysRevB.31.7233; FISHER DS, 1991, PHYS REV B, V43, P130, DOI 10.1103/PhysRevB.43.130; FISHER DS, 1988, PHYS TODAY       DEC, P56; FISHER ME, 1967, PHYS REV LETT, V19, P169, DOI 10.1103/PhysRevLett.19.169; FISHER ME, 1972, PHYS REV LETT, V28, P1516, DOI 10.1103/PhysRevLett.28.1516; FISHER MPA, 1989, PHYS REV LETT, V62, P1415, DOI 10.1103/PhysRevLett.62.1415; FRISKEN BJ, 1995, PHYS REV E, V51, P5922, DOI 10.1103/PhysRevE.51.5922; GARLAND CW, 1994, PHYS REV E, V49, P2964, DOI 10.1103/PhysRevE.49.2964; GIAMARCHI T, 1994, PHYS REV LETT, V72, P1530, DOI 10.1103/PhysRevLett.72.1530; GRINGAS MJP, 1996, PHYS REV B, V53, P15193; GRINSTEIN G, 1976, PHYS REV LETT, V37, P944, DOI 10.1103/PhysRevLett.37.944; GRINSTEIN G, 1981, PHYS REV LETT, V47, P856, DOI 10.1103/PhysRevLett.47.856; LUBENSKY TC, 1978, PHYS REV B, V17, P366, DOI 10.1103/PhysRevB.17.366; MARITAN A, 1994, PHYS REV LETT, V72, P4113, DOI 10.1103/PhysRevLett.72.4113; MENON N, 1995, PHYS REV LETT, V74, P1230, DOI 10.1103/PhysRevLett.74.1230; MOON K, 1995, PHYS REV LETT, V75, P1328, DOI 10.1103/PhysRevLett.75.1328; NELSON DR, 1981, PHYS REV B, V24, P363, DOI 10.1103/PhysRevB.24.363; OGIELSKI AT, 1986, PHYS REV LETT, V56, P1298, DOI 10.1103/PhysRevLett.56.1298; Park S.C., UNPUB; PATTON BR, 1992, PHYS REV LETT, V69, P1556, DOI 10.1103/PhysRevLett.69.1556; Radzihovsky L, 1997, PHYS REV LETT, V79, P4214, DOI 10.1103/PhysRevLett.79.4214; Radzihovsky L, 1999, PHYS REV B, V60, P206, DOI 10.1103/PhysRevB.60.206; Radzihovsky L, 1997, PHYS REV LETT, V78, P4414, DOI 10.1103/PhysRevLett.78.4414; Radzihovsky L., UNPUB; RADZIHOVSKY L, 1998, B AM PHYS SOC, V43, P193; RAPPAPORT AG, 1996, LIQUID CRYSTALS COMP, pCH20; RICARD L, 1981, J PHYS-PARIS, V42, P861, DOI 10.1051/jphys:01981004206086100; RICARD L, 1979, J PHYS, V40, pC3; TONER J, 1982, PHYS REV B, V26, P462, DOI 10.1103/PhysRevB.26.462; WARD B, 1999, THESIS U COLORADO; WU L, 1995, PHYS REV E, V51, P2157, DOI 10.1103/PhysRevE.51.2157	50	174	174	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1074	1079		10.1126/science.1057480	http://dx.doi.org/10.1126/science.1057480			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691985				2022-12-28	WOS:000172013800042
J	Guthohrlein, GR; Keller, M; Hayasaka, K; Lange, W; Walther, H				Guthohrlein, GR; Keller, M; Hayasaka, K; Lange, W; Walther, H			A single ion as a nanoscopic probe of an optical field	NATURE			English	Article							CAVITY; ATOM; MICROSCOPY; MOLECULE; GENERATION; PHOTONS	In near-field imaging, resolution beyond the diffraction limit of optical microscopy is obtained by scanning the sampling region with a probe of subwavelength size(1). In recent experiments, single molecules were used as nanoscopic probes to attain a resolution of a few tens of nanometres(2,3). Positional control of the molecular probe was typically achieved by embedding it in a crystal attached to a substrate on a translation stage. However, the presence of the host crystal inevitably led to a disturbance of the light field that was to be measured. Here we report a near-field probe with atomic-scale resolution-a single calcium ion in a radiofrequency trap-that causes minimal perturbation of the optical field. We measure the three-dimensional spatial structure of an optical field with a spatial resolution as high as 60 nm (determined by the residual thermal motion of the trapped ion), and scan the modes of a low-loss optical cavity over a range of up to 100 mum. The precise positioning we achieve implies a deterministic control of the coupling between ion and field. At the same time, the field and the internal states of the ion are not affected by the trapping potential. Our set-up is therefore an ideal system for performing cavity quantum electrodynamics(4,5) experiments with a single particle.	Max Planck Inst Quantum Opt, D-85748 Garching, Germany; Commun Res Labs, Nishi Ku, Kobe, Hyogo 65124, Japan	Max Planck Society; National Institute of Information & Communications Technology (NICT) - Japan	Lange, W (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.							BETZIG E, 1993, SCIENCE, V262, P1422, DOI 10.1126/science.262.5138.1422; DIEDRICH F, 1987, PHYS REV LETT, V58, P203, DOI 10.1103/PhysRevLett.58.203; Gotzinger S, 2001, J MICROSC-OXFORD, V202, P117, DOI 10.1046/j.1365-2818.2001.00865.x; Hennrich M, 2000, PHYS REV LETT, V85, P4872, DOI 10.1103/PhysRevLett.85.4872; HOEFFGES JT, 1997, OPT COMMUN, V133, P170; Hoffges JT, 1997, J MOD OPTIC, V44, P1999, DOI 10.1080/09500349708231861; Hood CJ, 2000, SCIENCE, V287, P1447, DOI 10.1126/science.287.5457.1447; Law CK, 1997, J MOD OPTIC, V44, P2067, DOI 10.1080/095003497152357; Meekhof DM, 1996, PHYS REV LETT, V76, P1796, DOI 10.1103/PhysRevLett.76.1796; Meyer GM, 1997, EUROPHYS LETT, V37, P317, DOI 10.1209/epl/i1997-00150-y; Michaelis J, 1999, OPT LETT, V24, P581, DOI 10.1364/OL.24.000581; Michaelis J, 2000, NATURE, V405, P325, DOI 10.1038/35012545; MONROE C, 1995, PHYS REV LETT, V75, P4011, DOI 10.1103/PhysRevLett.75.4011; Peik E, 1999, PHYS REV A, V60, P439, DOI 10.1103/PhysRevA.60.439; PELLIZZARI T, 1995, PHYS REV LETT, V75, P3788, DOI 10.1103/PhysRevLett.75.3788; Pinkse PWH, 2000, NATURE, V404, P365, DOI 10.1038/35006006; POHL DW, 1984, APPL PHYS LETT, V44, P651, DOI 10.1063/1.94865; Roos CF, 2000, PHYS REV LETT, V85, P5547, DOI 10.1103/PhysRevLett.85.5547; Sick B, 2001, J MICROSC-OXFORD, V202, P365, DOI 10.1046/j.1365-2818.2001.00795.x; Veerman JA, 1999, J MICROSC-OXFORD, V194, P477, DOI 10.1046/j.1365-2818.1999.00520.x; Zheng SB, 2000, PHYS REV LETT, V85, P2392, DOI 10.1103/PhysRevLett.85.2392	21	309	314	1	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 01	2001	414	6859					49	51		10.1038/35102129	http://dx.doi.org/10.1038/35102129			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689937				2022-12-28	WOS:000171898900036
J	Boorum, MM; Vasil'ev, YV; Drewello, T; Scott, LT				Boorum, MM; Vasil'ev, YV; Drewello, T; Scott, LT			Groundwork for a rational synthesis of C-60: Cyclodehydrogenation of a C60H30 polyarene	SCIENCE			English	Article							FULLERENE FORMATION; MASS-SPECTROMETRY; COALESCENCE; IONIZATION	A C60H30 polycyctic aromatic hydrocarbon (PAH) that incorporates all 60 carbon atoms and 75 of the 90 carbon-carbon bonds required to form the fullerene C-60 has been synthesized in nine steps by conventional laboratory methods. Laser irradiation of this C60H30 PAH at 337 nanometers induces hydrogen loss and the formation of C-60, as detected by mass spectrometry. A specifically labeled [C-13(3)] C60H30 retains all three C-13 atoms during the cage formation process. A structurally related C48H24 PAH that lacks the three peripheral benzene rings cannot be transformed into C-60, whereas the next higher homolog, a C80H40 PAH, degrades to the C60H30 PAH, which then loses hydrogen to give [60]fullerene. These control experiments verify that the C-60 is formed by a molecular transformation directly from the C60H30 PAH and not by fragmentation and recombination in the gas phase.	Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA	University of Warwick; Boston College	Drewello, T (corresponding author), Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.		Scott, Lawrence T./G-5020-2018	Scott, Lawrence T./0000-0003-3496-8506				Ansems RBM, 2000, J AM CHEM SOC, V122, P2719, DOI 10.1021/ja993028n; BOORUM MM, 2001, THESIS BOSTON COLL; CAMPBELL EEB, 1994, INT J MASS SPECTROM, V136, P209, DOI 10.1016/0168-1176(94)04050-8; CHANG TM, 1992, J AM CHEM SOC, V114, P760; CHOWDHURY S, 1994, POLYCYCL AROMAT COMP, V5, P27, DOI 10.1080/10406639408015152; CLAR E, 1964, POLYCYCLIC HYDROCARB, pCH43; Clipston NL, 2000, J PHYS CHEM A, V104, P9171, DOI 10.1021/jp001837j; de Frutos O, 1999, ANGEW CHEM INT EDIT, V38, P204, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<204::AID-ANIE204>3.0.CO;2-5; Gomez-Lor B, 1999, CHEM COMMUN, P2431, DOI 10.1039/a906990i; Goroff NS, 1996, ACCOUNTS CHEM RES, V29, P77, DOI 10.1021/ar950162d; Jinno K, 1998, J MICROCOLUMN SEP, V10, P79, DOI 10.1002/(SICI)1520-667X(1998)10:1<79::AID-MCS11>3.0.CO;2-H; KIPPING FS, 1894, J CHEM SOC, V65, P259; LIU LB, 1991, J ORG CHEM, V56, P3769, DOI 10.1021/jo00012a005; MCELVANY SW, 1993, SCIENCE, V259, P1594, DOI 10.1126/science.259.5101.1594; MCMAHON BJ, 1997, THESIS BOSTON COLL; MODER M, 2000, J CHEM SOC, V195, P599; MULLER D, 1968, B SOC CHIM FR, P334; NAGEL DL, 1977, J ORG CHEM, V42, P3626, DOI 10.1021/jo00442a041; Prinzbach H, 2000, NATURE, V407, P60, DOI 10.1038/35024037; Rubin Y, 1998, ANGEW CHEM INT EDIT, V37, P1226, DOI 10.1002/(SICI)1521-3773(19980518)37:9<1226::AID-ANIE1226>3.0.CO;2-H; Sarobe M, 1999, CHEM PHYS LETT, V313, P31, DOI 10.1016/S0009-2614(99)00929-X; Scott LT, 1996, J AM CHEM SOC, V118, P8743, DOI 10.1021/ja9621511; Taylor R., 1999, LECT NOTES FULLERENE; Tobe Y, 1999, ELEC SOC S, V99, P146; Tobe Y, 1998, J AM CHEM SOC, V120, P4544, DOI 10.1021/ja9803308; Tobe Y, 2001, TETRAHEDRON, V57, P3629, DOI 10.1016/S0040-4020(01)00250-2; Vasil'ev Y, 2000, CHEM COMMUN, P1233, DOI 10.1039/b003882m; Vasil'ev YV, 2001, J PHYS CHEM A, V105, P661, DOI 10.1021/jp002890a; WANG L, 1996, 212 NAT M AM CHEM SO	29	155	156	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2001	294	5543					828	831		10.1126/science.1064250	http://dx.doi.org/10.1126/science.1064250			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679663				2022-12-28	WOS:000171851800039
J	Gizis, JE				Gizis, JE			Astronomy - Brown dwarfs	SCIENCE			English	Editorial Material							2MASS		Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA	University of Delaware	Gizis, JE (corresponding author), Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA.							Bailer-Jones CAL, 2001, ASTRON ASTROPHYS, V367, P218, DOI 10.1051/0004-6361:20000416; Bejar VJS, 2001, ASTROPHYS J, V556, P830, DOI 10.1086/321621; Berger E, 2001, NATURE, V410, P338, DOI 10.1038/35066514; BURGASSER AJ, IN PRESS ASTROPHYS J; Comeron F, 2000, ASTRON ASTROPHYS, V359, P269; GEBALLE TR, IN PRESS ASTROPHYS J; Gizis JE, 2000, ASTRON J, V120, P1085, DOI 10.1086/301456; HILLENBRAND L, AM ASTR SOC C 3 7 JU; Kirkpatrick JD, 1999, ASTROPHYS J, V519, P802, DOI 10.1086/307414; Lucas PW, 2001, MON NOT R ASTRON SOC, V326, P695, DOI 10.1046/j.1365-8711.2001.04666.x; Martin EL, 1999, ASTRON J, V118, P2466, DOI 10.1086/301107; Muench AA, 2001, ASTROPHYS J, V558, pL51, DOI 10.1086/323420; Reid IN, 2001, ASTRON J, V121, P489, DOI 10.1086/318023; Rutledge RE, 2000, ASTROPHYS J, V538, pL141, DOI 10.1086/312817	15	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2001	294	5543					801	802		10.1126/science.1066316	http://dx.doi.org/10.1126/science.1066316			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679656				2022-12-28	WOS:000171851800031
J	Kohguchi, H; Suzuki, T; Alexander, MH				Kohguchi, H; Suzuki, T; Alexander, MH			Fully state-resolved differential cross sections for the inelastic scattering of the open-shell NO molecule by Ar	SCIENCE			English	Article							COLLISIONS INVOLVING MOLECULES; PI-ELECTRONIC STATES; ROTATIONAL-EXCITATION; DERIVATION; RESOLUTION; SURFACES; QUANTUM	State-resolved differential cross sections (DCSs) for the inelastic scattering of NO(j" = 0.5, Omega" = 1/2) + Ar --> NO(j', Omega' = 1/2, 3/2) + Ar were obtained at a collision energy of 516 cm(-1), both experimentally and theoretically. A crossed molecular beam ion-imaging apparatus was used to measure DCSs for 20 final (j', Omega') states, including spin-orbit conserving (Delta Omega = 0) and changing (Delta Omega = 1) transitions. Quantum close-coupling scattering calculations on ab initio coupled-cluster CCSD(T) and CEPA (correlated electron pair approximation) potential energy surfaces were also performed. Although small discrepancies were found for the Delta Omega = 1 transitions, we find marked agreement between theory and experiment for the collision dynamics of this system, which is the paradigm for the collisional relaxation of a molecular radical.	Inst Mol Sci, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Okazaki, Aichi 4448585, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Japan; Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); University System of Maryland; University of Maryland College Park	Suzuki, T (corresponding author), Inst Mol Sci, Okazaki, Aichi 4448585, Japan.		Kohguchi, Hiroshi/J-7799-2015	Kohguchi, Hiroshi/0000-0001-9684-1258				Alexander MH, 1999, J CHEM PHYS, V111, P7426, DOI 10.1063/1.480066; ALEXANDER MH, 1985, CHEM PHYS, V92, P337, DOI 10.1016/0301-0104(85)85029-1; ALEXANDER MH, 1982, J CHEM PHYS, V76, P5974, DOI 10.1063/1.442951; ALEXANDER MH, 1993, J CHEM PHYS, V99, P7725, DOI 10.1063/1.465702; ALEXANDER MH, HIBRIDON PROGRAM SUI; ANDRESEN P, 1982, J CHEM PHYS, V77, P2204, DOI 10.1063/1.444027; BIELER CR, 1995, CHEM PHYS LETT, V235, P175, DOI 10.1016/0009-2614(95)00118-N; BONTUYAN LS, 1993, J PHYS CHEM-US, V97, P6342, DOI 10.1021/j100126a006; BROWN JM, 1983, ADV CHEM PHYS, V52; COREY GC, 1986, J CHEM PHYS, V85, P5652, DOI 10.1063/1.451578; de Lange MJL, 1999, CHEM PHYS LETT, V313, P491, DOI 10.1016/S0009-2614(99)01065-9; HERZBERG G, 1968, MOL SPECTRA MOL STRU, V1; Jons SD, 1996, J CHEM PHYS, V105, P5397, DOI 10.1063/1.472381; Kim Y, 2000, CHEM PHYS LETT, V318, P522, DOI 10.1016/S0009-2614(00)00055-5; KORSCH HJ, 1981, J CHEM PHYS, V75, P3850, DOI 10.1063/1.442540; LEVINE RD, 1987, MOL REACTION DYNAMIC; Lin A, 1999, J PHYS CHEM A, V103, P1198, DOI 10.1021/jp984119u; Lorenz KT, 2001, SCIENCE, V293, P2063, DOI 10.1126/science.1062754; MACDONALD RG, 1989, J CHEM PHYS, V91, P821, DOI 10.1063/1.457134; NIELSON GC, 1977, J CHEM PHYS, V66, P1396, DOI 10.1063/1.434124; ORLIKOWSKI T, 1983, J CHEM PHYS, V79, P6006, DOI 10.1063/1.445783; SUZUKI T, 1999, FARADAY DISCUSS, V113, P485; Tan XF, 2001, J CHEM PHYS, V114, P8938, DOI 10.1063/1.1368387; VANDENBERGH H, 1973, FARADAY DISCUSS, P203; Yonekura N, 1999, REV SCI INSTRUM, V70, P3265, DOI 10.1063/1.1149902	25	88	90	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2001	294	5543					832	834		10.1126/science.1063774	http://dx.doi.org/10.1126/science.1063774			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679664				2022-12-28	WOS:000171851800040
J	Giebink, GS				Giebink, GS			Current concepts: The prevention of pneumococcal disease in children.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RESISTANT STREPTOCOCCUS-PNEUMONIAE; ACUTE OTITIS-MEDIA; CONJUGATE VACCINE FORMULATION; COMMUNITY-ACQUIRED PNEUMONIA; RESPIRATORY SYNCYTIAL VIRUS; NASOPHARYNGEAL CARRIAGE; COST-EFFECTIVENESS; HEALTHY INFANTS; UNITED-STATES; RISK-FACTORS		Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Giebink, GS (corresponding author), Univ Minnesota, Sch Med, Dept Pediat, MMC-296,420 Delaware St SE, Minneapolis, MN 55455 USA.	giebi001@umn.edu						Abramson JS, 2000, PEDIATRICS, V106, P362; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 1999, Wkly Epidemiol Rec, V74, P177; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; Barnett ED, 1999, CLIN INFECT DIS, V29, P191, DOI 10.1086/520151; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; BERMAN S, 1995, NEW ENGL J MED, V332, P1560, DOI 10.1056/NEJM199506083322307; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Block SL, 1997, PEDIATR INFECT DIS J, V16, P449, DOI 10.1097/00006454-199704000-00029; BLOCK SL, 1995, PEDIATR INFECT DIS J, V14, P751, DOI 10.1097/00006454-199509000-00005; Boken DJ, 1996, PEDIATR INFECT DIS J, V15, P667, DOI 10.1097/00006454-199608000-00006; BOKEN DJ, 1995, PEDIATR INFECT DIS J, V14, P879, DOI 10.1097/00006454-199510000-00012; BREIMAN RF, 1994, JAMA-J AM MED ASSOC, V271, P1831, DOI 10.1001/jama.271.23.1831; Briles DE, 2000, VACCINE, V19, pS87, DOI 10.1016/S0264-410X(00)00285-1; Butler JC, 1996, J INFECT DIS, V174, P986, DOI 10.1093/infdis/174.5.986; CLEMENTS DA, 1995, ARCH PEDIAT ADOL MED, V149, P1113, DOI 10.1001/archpedi.1995.02170230067009; Coffey TJ, 1999, MICROBIOL-SGM, V145, P2023, DOI 10.1099/13500872-145-8-2023; Coffey TJ, 1998, MOL MICROBIOL, V27, P73, DOI 10.1046/j.1365-2958.1998.00658.x; Connor E, 1997, PEDIATRICS, V99, P93; Dagan R, 1998, PEDIATR INFECT DIS J, V17, P880, DOI 10.1097/00006454-199810000-00006; Dagan R, 1996, J INFECT DIS, V174, P1271, DOI 10.1093/infdis/174.6.1271; Dagan R, 2000, PEDIATR INFECT DIS J, V19, pS79, DOI 10.1097/00006454-200005001-00012; Daly KA, 1999, PEDIATRICS, V103, P1158, DOI 10.1542/peds.103.6.1158; Dowell SF, 1999, PEDIATR INFECT DIS J, V18, P341, DOI 10.1097/00006454-199904000-00006; Dowell SF, 1997, AM FAM PHYSICIAN, V55, P1647; Dowell SF, 1999, PEDIATR INFECT DIS J, V18, P1, DOI 10.1097/00006454-199901000-00002; DUCHIN JS, 1995, PEDIATR INFECT DIS J, V14, P745, DOI 10.1097/00006454-199509000-00004; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; FREID VM, 1998, VITAL HLTH STATISTIC, V13; Gates GA, 1996, OTOLARYNG HEAD NECK, V114, P525, DOI 10.1016/S0194-5998(96)70243-7; Gendrel D, 1997, EUR J CLIN MICROBIOL, V16, P388, DOI 10.1007/BF01726370; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P122, DOI 10.1086/313609; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; HEIKKINEN T, 1991, AM J DIS CHILD, V145, P445, DOI 10.1001/archpedi.1991.02160040103017; Jacobs MR, 1998, ANTIMICROB AGENTS CH, V42, P589, DOI 10.1128/AAC.42.3.589; Jacobs MR, 1999, ANTIMICROB AGENTS CH, V43, P1901, DOI 10.1128/AAC.43.8.1901; JOLOBA ML, 2000, 40 INT C ANT AG CHEM, P235; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; KALEIDA PH, 1991, PEDIATRICS, V87, P466; KARRON RA, 1995, J INFECT DIS, V172, P1445, DOI 10.1093/infdis/172.6.1445; KARRON RA, 1995, J INFECT DIS, V171, P1107, DOI 10.1093/infdis/171.5.1107; Kilpi T, 2001, NEW ENGL J MED, V344, P1720; KILPI T, 2000, 40 INT C ANT AG CHEM, P245; Klein DL, 1995, MICROB DRUG RESIST, V1, P49, DOI 10.1089/mdr.1995.1.49; Levine OS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e28; Lieu TA, 2000, JAMA-J AM MED ASSOC, V283, P1460, DOI 10.1001/jama.283.11.1460; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; Miernyk KM, 2000, CLIN INFECT DIS, V31, P34, DOI 10.1086/313907; Paradise JL, 1997, PEDIATRICS, V99, P318, DOI 10.1542/peds.99.3.318; Pitkaranta A, 1998, PEDIATRICS, V102, P291, DOI 10.1542/peds.102.2.291; Rennels MB, 1998, PEDIATRICS, V101, P604, DOI 10.1542/peds.101.4.604; Simoes EAF, 1996, J PEDIATR-US, V129, P214, DOI 10.1016/S0022-3476(96)70245-7; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; ZENNI MK, 1995, J PEDIATR-US, V127, P533, DOI 10.1016/S0022-3476(95)70108-7	56	67	69	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2001	345	16					1177	1183		10.1056/NEJMra010462	http://dx.doi.org/10.1056/NEJMra010462			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482YX	11642234				2022-12-28	WOS:000171605800006
J	Knudsen, BM; Andersen, SB				Knudsen, BM; Andersen, SB			Geophysics - Longitudinal variation in springtime ozone trends	NATURE			English	Article							DEPLETION		Danish Meteorol Inst, DK-2100 Copenhagen, Denmark	Danish Meteorological Institute DMI	Knudsen, BM (corresponding author), Danish Meteorol Inst, Lyngbyvej 100, DK-2100 Copenhagen, Denmark.	bk@dmi.dk	andersen, signe/C-4809-2013	andersen, signe/0000-0002-8216-0141				ENTZIAN G, 2000, P QUAD OZ S SAPP 3 8; Hood L, 1999, J GEOPHYS RES-ATMOS, V104, P24321, DOI 10.1029/1999JD900401; Knudsen BM, 1998, GEOPHYS RES LETT, V25, P627, DOI 10.1029/98GL00300; Knudsen BM, 2000, J GEOPHYS RES-ATMOS, V105, P6885, DOI 10.1029/1999JD901076; LARSEN N, 1994, GEOPHYS RES LETT, V21, P1611, DOI 10.1029/94GL01394; McPeters RD, 1996, GEOPHYS RES LETT, V23, P3699, DOI 10.1029/96GL03540; MORCRETTE JJ, 1991, J GEOPHYS RES-ATMOS, V96, P9121, DOI 10.1029/89JD01597; Muller R, 1997, NATURE, V389, P709, DOI 10.1038/39564; *WORLD MET ORG, 1999, 44 WORLD MET ORG, pCH4; ZEREFOS CS, 1992, J GEOPHYS RES-ATMOS, V97, P10135, DOI 10.1029/92JD00508	10	20	20	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					699	700		10.1038/35099677	http://dx.doi.org/10.1038/35099677			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607021				2022-12-28	WOS:000171608000033
J	Domning, DP				Domning, DP			The earliest known fully quadrupedal sirenian	NATURE			English	Article							EOCENE; JAMAICA; ORIGIN	Modern seacows (manatees and dugongs; Mammalia, Sirenia) are completely aquatic, with flipperlike forelimbs and no hindlimbs(1,2). Here I describe Eocene fossils from Jamaica that represent nearly the entire skeleton of a new genus and species of sirenian-the most primitive for which extensive postcranial remains are known. This animal was fully capable of locomotion on land, with four well-developed legs, a multivertebral sacrum, and a strong sacroiliac articulation that could support the weight of the body out of water as in land mammals. Aquatic adaptations show, however, that it probably spent most of its time in the water. Its intermediate form thus illustrates the evolutionary transition between terrestrial and aquatic life. Similar to contemporary primitive cetaceans(3), it probably swam by spinal extension with simultaneous pelvic paddling, unlike later sirenians and cetaceans, which lost the hindlimbs and enlarged the tail to serve as the main propulsive organ. Together with fossils of later sirenians elsewhere in the world(1,4-7), these new specimens document one of the most marked examples of morphological evolution in the vertebrate fossil record.	Howard Univ, Dept Anat, Washington, DC 20059 USA	Howard University	Domning, DP (corresponding author), Howard Univ, Dept Anat, Washington, DC 20059 USA.	ddomning@fac.howard.edu						Abel O, 1904, ABHANDLUNGEN KAISERL, V19, P1; Domning Daryl P., 2000, Historical Biology, V14, P115; Domning Daryl P., 2001, P151; Domning Daryl P., 1994, Contributions from the Museum of Paleontology University of Michigan, V29, P69; Domning Daryl P., 1994, Proceedings of the San Diego Society of Natural History, V29, P177; DOMNING DP, 1991, MAR MAMMAL SCI, V7, P331, DOI 10.1111/j.1748-7692.1991.tb00111.x; Domning DP, 1997, J VERTEBR PALEONTOL, V17, P638, DOI 10.1080/02724634.1997.10011013; DOMNING DP, 1982, SMITHSONIAN CONTRIBU, V52, P1; DOMNING DP, 2001, B ASHORO MUS PALEONT, V2, P39; Fish FE, 1996, AM ZOOL, V36, P628, DOI 10.1093/icb/36.6.628; GINGERICH PD, 1994, NATURE, V368, P844, DOI 10.1038/368844a0; Lepsius G.R., 1882, ABHANDLUNGEN MITTELR, V1, P1; Liu FGR, 1999, SYST BIOL, V48, P54, DOI 10.1080/106351599260436; MacPhee R. D. E., 1999, Journal of Vertebrate Paleontology, V19, p61A; Matthew W. D., 1937, Transactions of the American Philosophical Society Philadelphia NS, V30, P1; Pregill GK, 1999, HERPETOLOGICA, V55, P157; SAVAGE RJG, 1994, J VERTEBR PALEONTOL, V14, P427, DOI 10.1080/02724634.1994.10011569; Siegfried P., 1967, Palaeontologische Zeitschrift, V41, P165; Taylor Michael A., 2000, Historical Biology, V14, P15; Thewissen J.G.M., 1996, Courier Forschungsinstitut Senckenberg, V191, P1; Thewissen J.G.M., 1992, Journal of Vertebrate Paleontology, V12, P494; THEWISSEN JGM, 1994, SCIENCE, V263, P210, DOI 10.1126/science.263.5144.210	22	114	121	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2001	413	6856					625	627		10.1038/35098072	http://dx.doi.org/10.1038/35098072			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675784				2022-12-28	WOS:000171485700047
J	[Anonymous]				[Anonymous]			DECLARATION ON ANIMALS IN MEDICAL-RESEARCH	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 8	1990	301	6750					460	460						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DX630	11642792				2022-12-28	WOS:A1990DX63000014
J	MOURIN, K				MOURIN, K			INSURANCE REPORT INSTRUCTIONS - ARE THEY ETHICAL	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 12	1990	300	6734					1278	1279						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD181	11642776				2022-12-28	WOS:A1990DD18100052
J	Kawakita, H; Watanabe, J; Ando, H; Aoki, W; Fuse, T; Honda, S; Izumiura, H; Kajino, T; Kambe, E; Kawanomoto, S; Noguchi, K; Okita, K; Sadakane, K; Sato, B; Takada-Hidai, M; Takeda, Y; Usuda, T; Watanabe, E; Yoshida, M				Kawakita, H; Watanabe, J; Ando, H; Aoki, W; Fuse, T; Honda, S; Izumiura, H; Kajino, T; Kambe, E; Kawanomoto, S; Noguchi, K; Okita, K; Sadakane, K; Sato, B; Takada-Hidai, M; Takeda, Y; Usuda, T; Watanabe, E; Yoshida, M			The spin temperature of NH3 in Comet C/1999S4 (LINEAR)	SCIENCE			English	Article							O1 HALE-BOPP; DISPERSION SPECTRA; AMMONIA; DEUTERIUM; CATALOG; RATIO; C2	A high-dispersion spectrum of Comet C/1999S4 (LINEAR) was obtained in the optical region with the high-dispersion spectrograph on the Subaru telescope when the comet was 0.863 astronomical units from the Sun before its disintegration. We obtained high signal-to-noise ratio emission tines of the cometary NH2 bands from which an ortho-to-para ratio (OPR) of 3.33 +/- 0.07 was derived on the basis of a fluorescence excitation model. Assuming that cometary NH2 mainly originates from ammonia through photodissociation, the derived OPR of NH2, molecules should reflect that of ammonia, which provides information on the environment of molecular formation or condensation and of the thermal history of cometary ices. Assuming that the OPR of ammonia in comets was unchanged in the nucleus, the derived spin temperature of ammonia (28 +/- 2 kelvin) suggests that a formation region of the cometary ammonia ice was between the orbit of Saturn and that of Uranus in the solar nebula.	Gunma Astron Observ, Gunma 3770702, Japan; Natl Astron Observ Japan, Tokyo 1818588, Japan; Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; Natl Astron Observ Japan, Okayama Astrophys Observ, Okayama 7190232, Japan; Natl Def Acad, Dept Earth & Ocean Sci, Kanagawa 2398686, Japan; Osaka Kyoiku Univ, Astron Inst, Kashiwara, Osaka 5828582, Japan; Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; Tokai Univ, Liberal Arts Educ Ctr, Hiratsuka, Kanagawa 2591292, Japan; Komazawa Univ, Setagaya Ku, Tokyo 1548525, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Defence Academy - Japan; Osaka University of Education; University of Tokyo; Tokai University	Kawakita, H (corresponding author), Gunma Astron Observ, 6860-86 Nakayama, Gunma 3770702, Japan.	kawakita@astron.pref.gunma.jp						AHEARN MF, 1978, ASTROPHYS J, V219, P768, DOI 10.1086/155837; Aikawa Y, 1999, ASTROPHYS J, V526, P314, DOI 10.1086/307973; Aikawa Y, 1999, ASTROPHYS J, V519, P705, DOI 10.1086/307400; Bachir IH, 1999, J MOL SPECTROSC, V193, P326, DOI 10.1006/jmsp.1998.7752; Bird MK, 1997, ASTRON ASTROPHYS, V325, pL5; Bird MK, 1997, EARTH MOON PLANETS, V78, P21, DOI 10.1023/A:1006246606131; BIRSS FW, 1985, COMPUT PHYS COMMUN, V38, P83, DOI 10.1016/0010-4655(85)90048-7; Blake GA, 1999, NATURE, V398, P213, DOI 10.1038/18372; Bockelee-Morvan D, 2001, SCIENCE, V292, P1339, DOI 10.1126/science.1058512; Brown ME, 1996, ASTRON J, V112, P1197, DOI 10.1086/118090; BUENKER RJ, 1981, MOL PHYS, V43, P987, DOI 10.1080/00268978100101821; Crovisier J, 1999, NATO ADV SCI I C-MAT, V523, P389; FINK U, 1991, ASTROPHYS J, V383, P356, DOI 10.1086/170794; FUJII M, UNPUB; HIRAOKA K, 1995, ASTROPHYS J, V443, P363, DOI 10.1086/175531; Irvine W. M., 2000, Protostars and planets 4, P1159; Kawakita H, 2000, PUBL ASTRON SOC JPN, V52, P925, DOI 10.1093/pasj/52.5.925; Kawakita H, 1998, ASTROPHYS J, V495, P946, DOI 10.1086/305318; Kawakita H, 2001, PUBL ASTRON SOC JPN, V53, pL5, DOI 10.1093/pasj/53.1.L5; KURUCZ RL, 1984, 1 HARV U NAT SOL OBS; KURUCZ RL, 1984, 1 NAT SOL OBS; Meier R, 1998, SCIENCE, V279, P842, DOI 10.1126/science.279.5352.842; Meier R, 1998, SCIENCE, V279, P1707, DOI 10.1126/science.279.5357.1707; Mousis O, 2000, ICARUS, V148, P513, DOI 10.1006/icar.2000.6499; Mumma M. J., 1993, PROTOSTARS PLANETS, P1177; Mumma MJ, 2001, SCIENCE, V292, P1334, DOI 10.1126/science.1058929; MUMMA MJ, 1987, ASTRON ASTROPHYS, V187, P419; NOGUCHI K, 1999, SPIE, V3355, P354; QUACK M, 1977, MOL PHYS, V34, P477, DOI 10.1080/00268977700101861; Stern SA, 2000, ASTROPHYS J, V544, pL169, DOI 10.1086/317312; Takano S, 2000, PUBL ASTRON SOC JPN, V52, pL67, DOI 10.1093/pasj/52.6.L67; TEGLER S, 1989, ASTROPHYS J, V343, P445, DOI 10.1086/167717; TEGLER SC, 1992, ASTROPHYS J, V384, P292, DOI 10.1086/170872; THEKAEKARA MP, 1974, APPL OPTICS, V13, P518, DOI 10.1364/AO.13.000518; Weaver HA, 2001, SCIENCE, V292, P1329, DOI 10.1126/science.1058606; Willacy K, 1998, ASTRON ASTROPHYS, V338, P995; WOMACK M, 1997, 7474 IAU; Zhang HW, 2001, ASTRON ASTROPHYS, V367, P1049, DOI 10.1051/0004-6361:20010008	39	55	56	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2001	294	5544					1089	1091		10.1126/science.1064339	http://dx.doi.org/10.1126/science.1064339			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691989				2022-12-28	WOS:000172013800046
J	Farooqi, IS; Keogh, JM; Kamath, S; Jones, S; Gibson, WT; Trussell, R; Jebb, SA; Lip, GYH; O'Rahilly, S				Farooqi, IS; Keogh, JM; Kamath, S; Jones, S; Gibson, WT; Trussell, R; Jebb, SA; Lip, GYH; O'Rahilly, S			Metabolism - Partial leptin deficiency and human adiposity	NATURE			English	Article							RECOMBINANT LEPTIN; OBESE		Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QQ, England; City Hosp, Univ Dept Med, Birmingham B18 7QH, W Midlands, England; MRC Human Nutr Res, Cambridge CB1 9NL, England; Alberta Childrens Prov Gen Hosp, Dept Med Genet, Calgary, AB T2T 5C7, Canada; Alberta Childrens Prov Gen Hosp, Dept Paediat Endocrinol, Calgary, AB T2T 5C7, Canada	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Birmingham; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary	Farooqi, IS (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Hills Rd, Cambridge CB2 2QQ, England.	sorahill@hgmp.mrc.ac.uk	O'Rahilly, Stephen/ABF-6509-2020; Farooqi, Ismaa Sadaf/AAZ-3046-2020; Gibson, William/AFL-3634-2022	O'Rahilly, Stephen/0000-0003-2199-4449; Gibson, William/0000-0002-6552-402X; Farooqi, Sadaf/0000-0001-7609-3504; Jebb, Susan/0000-0001-9190-2920				Chung WK, 1998, AM J PHYSIOL-REG I, V274, pR985, DOI 10.1152/ajpregu.1998.274.4.R985; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Flier JS, 1998, J CLIN ENDOCR METAB, V83, P1407, DOI 10.1210/jc.83.5.1407; Havel PJ, 2000, P NUTR SOC, V59, P359, DOI 10.1017/S0029665100000410; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Ravussin E, 1997, NAT MED, V3, P238, DOI 10.1038/nm0297-238; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	9	285	291	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					34	35		10.1038/35102112	http://dx.doi.org/10.1038/35102112			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689931				2022-12-28	WOS:000171898900030
J	Chalmers, J; Capewell, S				Chalmers, J; Capewell, S			Deprivation, disease, and death in Scotland: graphical display of survival of a cohort	BRITISH MEDICAL JOURNAL			English	Article									NHS Scotland, Informat & Stat Div, Edinburgh EH5 3SQ, Midlothian, Scotland; Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England	NHS National Services Scotland; University of Liverpool	Chalmers, J (corresponding author), NHS Scotland, Informat & Stat Div, Edinburgh EH5 3SQ, Midlothian, Scotland.							Carstairs V., 1991, DEPRIVATION HLTH SCO; Hart CL, 1998, SOC SCI MED, V47, P1121, DOI 10.1016/S0277-9536(98)00061-6; LANGMUIR AD, 1976, INT J EPIDEMIOL, V5, P13, DOI 10.1093/ije/5.1.13; LOEVINSOHN BP, 1994, INT J EPIDEMIOL, V23, P194, DOI 10.1093/ije/23.1.194	4	9	9	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2001	323	7319					967	968		10.1136/bmj.323.7319.967	http://dx.doi.org/10.1136/bmj.323.7319.967			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488CU	11679385	Green Published, Bronze			2022-12-28	WOS:000171918500016
J	Vrijhoef, HJM; Spreeuwenberg, C; Eijkelberg, IMJG; Wolffenbuttel, BHR; van Merode, GG				Vrijhoef, HJM; Spreeuwenberg, C; Eijkelberg, IMJG; Wolffenbuttel, BHR; van Merode, GG			Adoption of disease management model for diabetes in region of Maastricht	BRITISH MEDICAL JOURNAL			English	Article							CARE; TECHNOLOGY; QUALITY		Univ Maastricht, Fac Hlth Sci, Dept Hlth Care Studies, NL-6200 MD Maastricht, Netherlands; Univ Maastricht, Fac Hlth Sci, Dept Hlth Org Policy & Econ, NL-6200 MD Maastricht, Netherlands; Univ Hosp Maastricht, Dept Endocrinol, NL-6202 AZ Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Vrijhoef, HJM (corresponding author), Univ Maastricht, Fac Hlth Sci, Dept Hlth Care Studies, POB 616, NL-6200 MD Maastricht, Netherlands.		Wolffenbuttel, Bruce/A-8419-2011; Vrijhoef, Hubertus/AAR-2387-2020	Wolffenbuttel, Bruce/0000-0001-9262-6921; Vrijhoef, Hubertus/0000-0002-5539-4671				Davis RM, 1999, BRIT MED J, V318, P1090, DOI 10.1136/bmj.318.7191.1090; Drummond M, 2000, INT J TECHNOL ASSESS, V16, P1, DOI 10.1017/S0266462300016111; EIJKELBERG I, 2000, HDB TRANSMURALE ZORG, P37; EIJKELBERG IMJ, 2001, INT J INTEGRATED CAR, V1; Eisenberg JM, 1999, JAMA-J AM MED ASSOC, V282, P1865, DOI 10.1001/jama.282.19.1865; Ellrodt G, 1997, JAMA-J AM MED ASSOC, V278, P1687, DOI 10.1001/jama.278.20.1687; Epstein RS, 1996, ANN INTERN MED, V124, P832, DOI 10.7326/0003-4819-124-9-199605010-00008; Grol R, 2000, INT J QUAL HEALTH C, V12, P297, DOI 10.1093/intqhc/12.4.297; Hampson JP, 1996, FAM PRACT, V13, P264, DOI 10.1093/fampra/13.3.264; Hunter DJ, 1997, BRIT MED J, V315, P50, DOI 10.1136/bmj.315.7099.50; Hunter DJ, 2000, BRIT MED J, V320, P530, DOI 10.1136/bmj.320.7234.530; Kesteloot K, 1999, INT J TECHNOL ASSESS, V15, P506, DOI 10.1017/S0266462399015366; Richards T, 1998, BRIT MED J, V317, P426; Vrijhoef HJM, 2000, PATIENT EDUC COUNS, V41, P243, DOI 10.1016/S0738-3991(99)00104-4; VRIJHOEF HJM, IN PRESS J ADV NURS; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Yin R.K., 1994, CASE STUDY RES	17	35	36	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2001	323	7319					983	985		10.1136/bmj.323.7319.983	http://dx.doi.org/10.1136/bmj.323.7319.983			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	488CU	11679390	Green Published			2022-12-28	WOS:000171918500021
J	Vanag, VK; Epstein, IR				Vanag, VK; Epstein, IR			Inwardly rotating spiral waves in a reaction-diffusion system	SCIENCE			English	Article							BELOUSOV-ZHABOTINSKII REACTION; AEROSOL OT; PROPAGATION; TURBULENCE; DYNAMICS; PATTERNS; MUSCLE	Almost 30 years have passed since the discovery of concentric (target) and spiral waves in the spatially extended Belousov-Zhabotinsky (BZ) reaction. Since then, rotating spirals and target waves have been observed in a variety of physical, chemical, and biological reaction-diffusion systems. AR of these waves propagate out from the spiral center or pacemaker. We report observations of inwardly rotating spirals found in the BZ system dispersed in water droplets of a water-in-oil microemulsion. These "antispirals" were also generated in computer simulations.	Brandeis Univ, Dept Chem, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Epstein, IR (corresponding author), Brandeis Univ, Dept Chem, Waltham, MA 02454 USA.	epstein@brandeis.edu		Vanag, Vladimir/0000-0002-9521-6650				AGLADZE K, 1994, SCIENCE, V264, P1746, DOI 10.1126/science.264.5166.1746; AGLADZE KI, 1982, NATURE, V296, P424, DOI 10.1038/296424a0; BALASUBRAMANIAN D, 1988, J PHYS CHEM-US, V92, P5995, DOI 10.1021/j100332a032; BUDRENE EO, 1995, NATURE, V376, P49, DOI 10.1038/376049a0; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; DE TK, 1995, ADV COLLOID INTERFAC, V59, P95, DOI 10.1016/0001-8686(95)80005-N; ERTL G, 1991, SCIENCE, V254, P1750, DOI 10.1126/science.254.5039.1750; GERHARDT M, 1990, SCIENCE, V247, P1563, DOI 10.1126/science.2321017; Hamik CT, 2001, J PHYS CHEM A, V105, P6144, DOI 10.1021/jp010270j; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; KEENER JP, 1986, PHYSICA D, V21, P307, DOI 10.1016/0167-2789(86)90007-2; LECHLEITER J, 1991, SCIENCE, V252, P123, DOI 10.1126/science.2011747; Lee KJ, 1997, PHYS REV LETT, V79, P2907, DOI 10.1103/PhysRevLett.79.2907; Lee KJ, 1996, PHYS REV LETT, V76, P1174, DOI 10.1103/PhysRevLett.76.1174; Leung KT, 2001, NATURE, V410, P166, DOI 10.1038/35065517; MAREK M, 1994, J PHYS CHEM-US, V98, P7452, DOI 10.1021/j100082a010; MULLER SC, 1985, SCIENCE, V230, P661, DOI 10.1126/science.230.4726.661; Ouyang Q, 1996, NATURE, V379, P143, DOI 10.1038/379143a0; PEREZMUNUZURI V, 1991, NATURE, V353, P740, DOI 10.1038/353740a0; VANAG VK, 1995, J PHYS CHEM-US, V99, P6944, DOI 10.1021/j100018a028; VANAG VK, IN PRESS PHYS REV LE; WINFREE AT, 1972, SCIENCE, V175, P634, DOI 10.1126/science.175.4022.634; WINFREE AT, 1994, SCIENCE, V266, P1003, DOI 10.1126/science.7973648; Witkowski FX, 1998, NATURE, V392, P78, DOI 10.1038/32170; ZAIKIN AN, 1970, NATURE, V225, P535, DOI 10.1038/225535b0; Zarnitsina VI, 2001, CHAOS, V11, P57, DOI 10.1063/1.1345728; Zykov V. S., 1980, Biophysics, V25, P906	27	240	243	0	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					835	837		10.1126/science.1064167	http://dx.doi.org/10.1126/science.1064167			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679665				2022-12-28	WOS:000171851800041
J	Brinker, A; Pfeifer, G; Kerner, MJ; Naylor, DJ; Hartl, FU; Hayer-Hartl, M				Brinker, A; Pfeifer, G; Kerner, MJ; Naylor, DJ; Hartl, FU; Hayer-Hartl, M			Dual function of protein confinement in chaperonin-assisted protein folding	CELL			English	Article							RIBULOSEBISPHOSPHATE CARBOXYLASE; MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ATPASE CYCLE; IN-VIVO; RHODOSPIRILLUM-RUBRUM; NONNATIVE FORMS; CENTRAL CAVITY; GROEL	The GroEL/GroES chaperonin system mediates the folding of a range of newly synthesized polypeptides in the bacterial cytosol. Using a rapid biotin-streptavidin-based inhibition of chaperonin function, we show that the cage formed by GroEL and its cofactor GroES can have a dual role in promoting folding. First, enclosure of nonnative protein in the GroEL:GroES complex is essential for folding to proceed unimpaired by aggregation. Second, folding inside the cage can be significantly faster than folding in free solution, independently of ATP-driven cycles of GroES binding and release. This suggests that confinement of unfolded protein in the narrow hydrophilic space of the chaperonin cage smoothes the energy landscape for the folding of some proteins, increasing the flux of folding intermediates toward the native state.	Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany	Max Planck Society; Max Planck Society	Hayer-Hartl, M (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.		Hartl, F. Ulrich/Y-8206-2019; Hayer-Hartl, Manajit/V-8078-2017	Hayer-Hartl, Manajit/0000-0001-8213-6742				AGARD DA, 1993, SCIENCE, V260, P1903, DOI 10.1126/science.8100365; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Chen JW, 2001, NAT STRUCT BIOL, V8, P721, DOI 10.1038/90443; CORRALES FJ, 1995, P NATL ACAD SCI USA, V92, P5326, DOI 10.1073/pnas.92.12.5326; Corrales FJ, 1996, P NATL ACAD SCI USA, V93, P4509, DOI 10.1073/pnas.93.9.4509; Coyle JE, 1999, NAT STRUCT BIOL, V6, P683; COYLE JE, 1997, FOLD DES, V2, P93; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Ellis R. John, 1999, Current Opinion in Structural Biology, V9, P102, DOI 10.1016/S0959-440X(99)80013-X; Ellis RJ, 1996, FASEB J, V10, P20, DOI 10.1096/fasebj.10.1.8566542; ELLIS RJ, 1994, CURR BIOL, V4, P633; ENGEL A, 1995, SCIENCE, V269, P832, DOI 10.1126/science.7638600; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; Farr GW, 1997, CELL, V89, P927, DOI 10.1016/S0092-8674(00)80278-0; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Feltham JL, 2000, CELL, V100, P193, DOI 10.1016/S0092-8674(00)81557-3; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HAYERHARTL MK, 1995, SCIENCE, V269, P836, DOI 10.1126/science.7638601; HAYERHARTL MK, 1994, EMBO J, V13, P3192, DOI 10.1002/j.1460-2075.1994.tb06618.x; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; HORWICH AL, 1993, CELL, V74, P909, DOI 10.1016/0092-8674(93)90470-B; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; Luo S, 2001, J BIOL CHEM, V276, P7023, DOI 10.1074/jbc.M006838200; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Martin J, 1997, P NATL ACAD SCI USA, V94, P1107, DOI 10.1073/pnas.94.4.1107; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MINTON AP, 1992, BIOPHYS J, V63, P1090, DOI 10.1016/S0006-3495(92)81663-6; MURAL RJ, 1990, J BIOL CHEM, V265, P6501; Ranson NA, 1997, J MOL BIOL, V266, P656, DOI 10.1006/jmbi.1996.0815; Richardson A, 1998, TRENDS BIOCHEM SCI, V23, P138, DOI 10.1016/S0968-0004(98)01193-1; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Saibil H, 2000, CURR OPIN STRUC BIOL, V10, P251, DOI 10.1016/S0959-440X(00)00074-9; SCHLOSS JV, 1979, J BACTERIOL, V137, P490, DOI 10.1128/JB.137.1.490-501.1979; SCHMIDT M, 1994, J BIOL CHEM, V269, P10304; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; SOMERVILLE CR, 1984, MOL GEN GENET, V193, P214, DOI 10.1007/BF00330670; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Todd MJ, 1996, P NATL ACAD SCI USA, V93, P4030, DOI 10.1073/pnas.93.9.4030; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; VANDERVIES SM, 1992, BIOCHEMISTRY-US, V31, P3635, DOI 10.1021/bi00129a012; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; Wang JD, 1999, NAT STRUCT BIOL, V6, P597; Weber F, 1998, NAT STRUCT BIOL, V5, P977, DOI 10.1038/2952; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	58	238	241	0	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					223	233		10.1016/S0092-8674(01)00517-7	http://dx.doi.org/10.1016/S0092-8674(01)00517-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672529	Bronze			2022-12-28	WOS:000171694800011
J	Richter, C; Wunsch, M; Rasheed, M; Kotter, I; Badran, MI				Richter, C; Wunsch, M; Rasheed, M; Kotter, I; Badran, MI			Endoscopic exploration of Red Sea coral reefs reveals dense populations of cavity-dwelling sponges	NATURE			English	Article							PHYTOPLANKTON; ABUNDANCE; DEPLETION; PLANKTON	Framework cavities are the largest but least explored coral reef habitat(1). Previous dive studies of caverns, spaces below plate corals, rubble and artificial cavities(1-3) suggest that cavity-dwelling (coelobite) filter-feeders are important in the trophodynamics of reefs(2,4,5). Quantitative community data are lacking, however, as the bulk of the narrow crevices interlacing the reef framework are inaccessible to conventional analysis methods(6). Here we have developed endoscopic techniques to explore Red Sea framework crevices up to 4 m into the carbonate rock, revealing a large internal surface (2.5-7.4 m(2) per projected m(2) reef) dominated by encrusting filter-feeders. Sponges alone provided up to 60% of coelobite cover, outweighing epi-reefal filter-feeder biomass by two orders of magnitude. Coelobite community filtration removed more than 60% of the phytoplankton in the course of its less than 5-minute passage through the crevices, corresponding to an uptake of roughly 0.9 g carbon m(-2) d(-1). Mineralization of the largely allochthonous organic material is a principal source of nutrients supporting coral and algal growth. The supply of new material by coelobites may provide a key to understanding the 'coral reef paradox'-a rich ecosystem thriving in nutrient-poor water.	Zentrum Marine Trop Okol, D-28359 Bremen, Germany; Univ Jordan, Marine Sci Stn, Aqaba, Jordan; Yarmouk Univ, Aqaba, Jordan; Max Planck Inst Marien Mikrobiol, D-28359 Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of Bremen; University of Jordan; Yarmouk University; Max Planck Society	Richter, C (corresponding author), Zentrum Marine Trop Okol, Fahrenheitstr 6, D-28359 Bremen, Germany.	crichter@uni-bremen.de	Koetter, Ina/O-3121-2019; Richter, Claudio/AAT-1212-2020	Koetter, Ina/0000-0002-9262-005X; Richter, Claudio/0000-0002-8182-6896; Rasheed, Mohammed/0000-0002-6131-368X				ANDREWS JC, 1983, LIMNOL OCEANOGR, V28, P215, DOI 10.4319/lo.1983.28.2.0215; ATKINSON MJ, 1983, LIMNOL OCEANOGR, V28, P568, DOI 10.4319/lo.1983.28.3.0568; AYUKAI T, 1995, CORAL REEFS, V14, P141, DOI 10.1007/BF00367231; BUSS LW, 1981, J EXP MAR BIOL ECOL, V49, P151, DOI 10.1016/0022-0981(81)90067-8; D'Elia CF, 1988, CONCEPTS ECOSYSTEM E, P195; Darwin C., 1842, STRUCTURE DISTRIBUTI; Ferrier-Pages C, 1998, MICROBIAL ECOL, V35, P46, DOI 10.1007/s002489900059; Gast GJ, 1998, MAR ECOL PROG SER, V167, P37, DOI 10.3354/meps167037; Ginsburg R.N, 1983, PERSPECTIVES CORAL R, P148; GLYNN PW, 1973, MAR BIOL, V22, P1, DOI 10.1007/BF00388905; JACKSON JBC, 1971, SCIENCE, V173, P623, DOI 10.1126/science.173.3997.623; JOKIEL PL, 1993, MAR ECOL PROG SER, V93, P175, DOI 10.3354/meps093175; KOBLUK D R, 1988, Palaios, V3, P379, DOI 10.2307/3514784; Mergner H., 1985, P 5 INT COR REEF C, V6, P243; MERGNER H, 1980, P S COAST MAR ENV RE, P39; MEYER JL, 1983, SCIENCE, V220, P1047, DOI 10.1126/science.220.4601.1047; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Pawlik JR, 1998, LIMNOL OCEANOGR, V43, P1396, DOI 10.4319/lo.1998.43.6.1396; Pile AJ, 1997, LIMNOL OCEANOGR, V42, P178, DOI 10.4319/lo.1997.42.1.0178; REISWIG HM, 1971, BIOL BULL, V141, P568, DOI 10.2307/1540270; Richter C, 1999, MAR ECOL PROG SER, V188, P105, DOI 10.3354/meps188105; ROUGERIE F, 1995, OCEANOL ACTA, V18, P61; SHASHAR N, 1994, CORAL REEFS, V13, P171, DOI 10.1007/BF00301195; Sorokin Y. I., 1995, CORAL REEF ECOLOGY; Tribble G.W., 1988, P 6 INT CORAL REEF S, P577; Wulff JL, 1997, MAR BIOL, V129, P41, DOI 10.1007/s002270050144; Wunsch M, 1998, MAR ECOL PROG SER, V169, P277, DOI 10.3354/meps169277; Yahel G, 1998, LIMNOL OCEANOGR, V43, P551, DOI 10.4319/lo.1998.43.4.0551; [No title captured]; [No title captured]	30	159	163	0	32	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					726	730		10.1038/35099547	http://dx.doi.org/10.1038/35099547			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607030				2022-12-28	WOS:000171608000042
J	Jaffery, JB; Aggarwal, A; Ades, PA; Weise, WJ				Jaffery, JB; Aggarwal, A; Ades, PA; Weise, WJ			A long sweet sleep with sour consequences	LANCET			English	Editorial Material									Univ Vermont, Coll Med, Dept Med, Burlington, VT 05401 USA	University of Vermont	Weise, WJ (corresponding author), Univ Vermont, Coll Med, Dept Med, Burlington, VT 05401 USA.							DENNING DW, 1988, POSTGRAD MED J, V64, P867, DOI 10.1136/pgmj.64.757.867; Lewis LD, 1997, CLIN PHARMACOL THER, V61, P692, DOI 10.1016/S0009-9236(97)90105-3; Litovitz TL, 1998, AM J EMERG MED, V16, P443, DOI 10.1016/S0735-6757(98)90000-6; RZEPECKI J, 1998, POL MERK LEK, V26, P74	4	4	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1236	1236		10.1016/S0140-6736(01)06349-8	http://dx.doi.org/10.1016/S0140-6736(01)06349-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675063				2022-12-28	WOS:000171527000015
J	Jonsson, B				Jonsson, B			Economics of drug treatment: for which patients is it costeffective to lower cholesterol?	LANCET			English	Article							CORONARY-HEART-DISEASE; COST-EFFECTIVENESS ANALYSIS; PRIMARY PREVENTION; MYOCARDIAL-INFARCTION; FUTURE COSTS; TASK-FORCE; HEALTH; PRAVASTATIN; UTILITIES; STATEMENT	Today's society places a great emphasis on value for money, so medical interventions must not only be shown to be effective but also be proved to be costeffective. Drug treatment is no exception. In health economics, costeffectiveness is calculated differently depending on the indication and the perspective. For cholesterol-lowering drugs (as an example) there is a difference between primary and secondary intervention. In primary prevention, the cut off value for absolute risk when treatment is costeffective varies with age and sex, but in secondary prevention, although treatment is costeffective for all groups of patients, costeffectiveness varies with age, sex, cholesterol concentration, and other risk factors. There are three complementary approaches to economic assessment of secondary prevention-analysis of the whole population, subgroup analysis, and modelling.	Stockholm Sch Econ, Ctr Hlth Econ, S-11383 Stockholm, Sweden	Stockholm School of Economics	Jonsson, B (corresponding author), Stockholm Sch Econ, Ctr Hlth Econ, Box 6501, S-11383 Stockholm, Sweden.	hebj@hhs.se						ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Cutler DM, 1998, AM ECON REV, V88, P97; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; GLASZIOU PP, 1994, MED J AUSTRALIA, V161, P532, DOI 10.5694/j.1326-5377.1994.tb127596.x; Grundy SM, 1998, CIRCULATION, V97, P1876, DOI 10.1161/01.CIR.97.18.1876; Johannesson M, 1998, HEALTH ECON, V7, P1, DOI 10.1002/(SICI)1099-1050(199802)7:1<1::AID-HEC327>3.0.CO;2-U; Johannesson M, 1997, MED DECIS MAKING, V17, P382, DOI 10.1177/0272989X9701700403; Johannesson M, 1997, NEW ENGL J MED, V336, P332, DOI 10.1056/NEJM199701303360503; Johannesson M, 1996, J INTERN MED, V240, P23, DOI 10.1046/j.1365-2796.1996.491830000.x; Johannesson M, 2001, EUR HEART J, V22, P919, DOI 10.1053/euhj.2000.2484; JOHANNESSON M, 1991, MED INFORM, V16, P355, DOI 10.3109/14639239109067657; Johannsson B., 1993, FJOLRIT NATTURUFRAED, V24, P1; Jonsson B, 1999, DIABETOLOGIA, V42, P1293, DOI 10.1007/s001250051441; Jonsson B, 1996, EUR HEART J, V17, P1001; LAROSA JC, 1990, CIRCULATION, V81, P1721, DOI 10.1161/01.CIR.81.5.1721; Lundberg L, 1999, EUR J PUBLIC HEALTH, V9, P211, DOI 10.1093/eurpub/9.3.211; Meltzer D, 1997, J HEALTH ECON, V16, P33, DOI 10.1016/S0167-6296(96)00507-3; Newhouse JP, 1998, HEALTH ECON, V7, pS79, DOI 10.1002/hec.4730070907; PEDERSEN TR, 1994, LANCET, V344, P1383; Ramsay LE, 1996, LANCET, V348, P387, DOI 10.1016/S0140-6736(96)05516-X; Ramsay LE, 1996, LANCET, V348, P1251, DOI 10.1016/S0140-6736(05)65536-5; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X; Zethraeus N, 1999, J INTERN MED, V246, P151, DOI 10.1046/j.1365-2796.1999.00546.x	27	20	20	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2001	358	9289					1251	1256		10.1016/S0140-6736(01)06350-4	http://dx.doi.org/10.1016/S0140-6736(01)06350-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481NX	11675082				2022-12-28	WOS:000171527000032
J	Skegg, DCG				Skegg, DCG			Hormone therapy and heart disease after the menopause	LANCET			English	Editorial Material							POSTMENOPAUSAL WOMEN; REPLACEMENT THERAPY; ESTROGEN; PREVENTION		Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand	University of Otago	Skegg, DCG (corresponding author), Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand.							Barrett-Connor E, 2001, INT J EPIDEMIOL, V30, P423, DOI 10.1093/ije/30.3.423; Barrett-Connor E, 1998, ANNU REV PUBL HEALTH, V19, P55, DOI 10.1146/annurev.publhealth.19.1.55; BARRETTCONNOR E, 1991, ANN INTERN MED, V115, P455, DOI 10.7326/0003-4819-115-6-455; GRADY D, 1992, ANN INTERN MED, V117, P1038; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Mosca L, 2001, CIRCULATION, V104, P499, DOI 10.1161/hc2901.092200; North FM, 2001, NEW ZEAL MED J, V114, P250; Petitti Diana B., 1994, Annals of Epidemiology, V4, P115; Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511; POSTHUMA WFM, 1994, BRIT MED J, V308, P1268; Rosano GMC, 2001, EUR HEART J, V22, P439, DOI 10.1053/euhj.2000.2298; Rossouw JE, 1996, CIRCULATION, V94, P2982, DOI 10.1161/01.CIR.94.11.2982; STURGEON SR, 1995, EPIDEMIOLOGY, V6, P227, DOI 10.1097/00001648-199505000-00006	15	17	17	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1196	1197		10.1016/S0140-6736(01)06336-X	http://dx.doi.org/10.1016/S0140-6736(01)06336-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675050				2022-12-28	WOS:000171527000002
J	Kinghorn, W				Kinghorn, W			Indecision	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University	Kinghorn, W (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 4	1998	280	17					1538	1538		10.1001/jama.280.17.1538	http://dx.doi.org/10.1001/jama.280.17.1538			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134RR	11645112	hybrid			2022-12-28	WOS:000076757200034
J	LEWIS, W				LEWIS, W			A PAPER THAT CHANGED MY PRACTICE - LIGHT IN THE DARKNESS	BRITISH MEDICAL JOURNAL			English	Note																		GILLON R, 1994, BRIT MED J, V309, P184, DOI 10.1136/bmj.309.6948.184	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 14	1995	311	7011					994	994						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TA079	11644730				2022-12-28	WOS:A1995TA07900028
J	BRAHAMS, D				BRAHAMS, D			FRAUD IN DRUG RESEARCH	LANCET			English	Editorial Material																			0	0	0	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	AUG 22	1992	340	8817					477	478		10.1016/0140-6736(92)91788-A	http://dx.doi.org/10.1016/0140-6736(92)91788-A			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JJ877	11643085				2022-12-28	WOS:A1992JJ87700018
J	GABRIEL, R				GABRIEL, R			ETHICS, JUSTICE, AND COMMERCE IN ORGAN REPLACEMENT	LANCET			English	Editorial Material																			0	3	3	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 12	1991	337	8733					104	104		10.1016/0140-6736(91)90755-E	http://dx.doi.org/10.1016/0140-6736(91)90755-E			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER477	11642970				2022-12-28	WOS:A1991ER47700017
J	[Anonymous]				[Anonymous]			EUTHANASIA - CONCLUSIONS OF A BMA WORKING PARTY SET UP TO REVIEW THE ASSOCIATIONS GUIDANCE ON EUTHANASIA	BRITISH MEDICAL JOURNAL			English	Editorial Material																		1988, EUTHANASIA REPORT	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 14	1988	296	6633					1376	1377						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	N4544	11652526				2022-12-28	WOS:A1988N454400020
J	Spradling, A; Drummond-Barbosa, D; Kai, T				Spradling, A; Drummond-Barbosa, D; Kai, T			Stem cells find their niche	NATURE			English	Review							HAIR FOLLICLE MORPHOGENESIS; PRIMORDIAL GERM-CELLS; CONDITIONAL ABLATION; SMALL-INTESTINE; BETA-CATENIN; MICE LACKING; PROLIFERATION; DIFFERENTIATION; DIVISION; HEDGEHOG	The concept that stem cells are controlled by particular microenvironments known as 'riches' has been widely invoked. But niches have remained largely a theoretical construct because of the difficulty of identifying and manipulating individual stem cells and their surroundings. Technical advances now make it possible to characterize small zones that maintain and control stem cell activity in several organs, including gonads, skin and gut. These studies are beginning to unify our understanding of stem cell regulation at the cellular and molecular levels, and promise to advance efforts to use stem cells therapeutically.	Carnegie Inst Sci, Dept Embryol, HHMI, Baltimore, MD 21210 USA	Carnegie Institution for Science; Howard Hughes Medical Institute	Spradling, A (corresponding author), Carnegie Inst Sci, Dept Embryol, HHMI, 115 W Univ Pkwy, Baltimore, MD 21210 USA.				Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; Berry LW, 1997, DEVELOPMENT, V124, P925; Bjerknes M, 1997, AM J PATHOL, V150, P833; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; DasGupta R, 1999, DEVELOPMENT, V126, P4557; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; de Rooij DG, 1998, CURR OPIN CELL BIOL, V10, P694, DOI 10.1016/S0955-0674(98)80109-9; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Dobrinski I, 1999, MOL REPROD DEV, V53, P142, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;142::AID-MRD3&gt;3.0.CO;2-O; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; Forbes A, 1998, DEVELOPMENT, V125, P679; Forbes AJ, 1996, DEVELOPMENT, V122, P3283; Forbes AJ, 1996, DEVELOPMENT, V122, P1125; Gambardella L, 2000, MECH DEVELOP, V96, P215, DOI 10.1016/S0925-4773(00)00398-1; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Gonczy P, 1997, DEVELOPMENT, V124, P4361; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; HENDERSON ST, 1994, DEVELOPMENT, V120, P2913; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; Kadyk LC, 1998, DEVELOPMENT, V125, P1803; Kaestner KH, 1997, GENE DEV, V11, P1583, DOI 10.1101/gad.11.12.1583; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, COLD SPRING HARBOR M, P149; King FJ, 2001, MOL CELL, V7, P497, DOI 10.1016/S1097-2765(01)00197-6; Kishimoto J, 2000, GENE DEV, V14, P1181; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kulessa H, 2000, EMBO J, V19, P6664, DOI 10.1093/emboj/19.24.6664; LAVKER RM, 1982, SCIENCE, V215, P1239, DOI 10.1126/science.7058342; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; LIN H, 1993, DEV BIOL, V159, P140, DOI 10.1006/dbio.1993.1228; Lin HF, 1997, DEVELOPMENT, V124, P2463; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Novelli MR, 1996, SCIENCE, V272, P1187, DOI 10.1126/science.272.5265.1187; Ohlstein B, 2000, GENETICS, V155, P1809; Ohta H, 2000, DEVELOPMENT, V127, P2125; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Panteleyev AA, 1998, J INVEST DERMATOL, V110, P902, DOI 10.1046/j.1523-1747.1998.00219.x; Parreira GG, 1998, BIOL REPROD, V59, P1360, DOI 10.1095/biolreprod59.6.1360; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Rindi G, 1999, DEVELOPMENT, V126, P4149; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; SAHUTBARNOLA I, 1995, DEV BIOL, V170, P127, DOI 10.1006/dbio.1995.1201; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Tanaka SS, 2000, GENE DEV, V14, P841; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; TILL J, 1961, RADIAT RES, V14, P1419; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Twombly V, 1996, DEVELOPMENT, V122, P1555; VANBEEK MEAB, 1990, CELL TISSUE KINET, V23, P1; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Wang RA, 1999, BIOL REPROD, V61, P999, DOI 10.1095/biolreprod61.4.999; Watt FM, 2001, COLD SPRING HARBOR M, P439; Wong MH, 2000, P NATL ACAD SCI USA, V97, P12601, DOI 10.1073/pnas.230237997; Wright NA, 2000, INT J EXP PATHOL, V81, P117, DOI 10.1046/j.1365-2613.2000.00146.x; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099; Zhang Y, 2000, DEVELOPMENT, V127, P2165	83	1069	1200	2	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					98	104		10.1038/35102160	http://dx.doi.org/10.1038/35102160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689954				2022-12-28	WOS:000171898900053
J	Cheng, E; Myers, L; Wolf, S; Shatin, D; Cui, XP; Ellison, G; Belin, T; Vickrey, B				Cheng, E; Myers, L; Wolf, S; Shatin, D; Cui, XP; Ellison, G; Belin, T; Vickrey, B			Mobility impairments and use of preventive services in women with multiple sclerosis: observational study	BRITISH MEDICAL JOURNAL			English	Article									Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; Ctr Hlth Care Policy & Evaluat, Minnetonka, MN USA; Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Cheng, E (corresponding author), Univ Calif Los Angeles, Dept Neurol, 650 Charles Young Dr S, Los Angeles, CA 90095 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS081764] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Becker H, 1997, ARCH PHYS MED REHAB, V78, pS26, DOI 10.1016/S0003-9993(97)90218-5; FRAME PS, 1992, AM FAM PHYSICIAN, V45, P1192; Iezzoni LI, 2000, AM J PUBLIC HEALTH, V90, P955, DOI 10.2105/AJPH.90.6.955; US Department of Health and Human Services, 1995, HLTH PEOPL 2000 NAT; Vickrey BG, 2000, NEUROLOGY, V55, P1341, DOI 10.1212/WNL.55.9.1341	5	36	37	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2001	323	7319					968	969		10.1136/bmj.323.7319.968	http://dx.doi.org/10.1136/bmj.323.7319.968			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488CU	11679386	Green Published, Bronze			2022-12-28	WOS:000171918500017
J	Griffiths, C; Kaur, G; Gantley, M; Feder, G; Hillier, S; Goddard, J; Packe, G				Griffiths, C; Kaur, G; Gantley, M; Feder, G; Hillier, S; Goddard, J; Packe, G			Influences on hospital admission for asthma in south Asian and white adults: qualitative interview study	BRITISH MEDICAL JOURNAL			English	Article							SOCIOECONOMICALLY DEPRIVED AREAS; SUBCONTINENT ETHNIC-GROUPS; OUTCOMES; RATES; POPULATION; BIRMINGHAM; EDUCATION; IMPACT; CITY; UK	Objective To explore reasons for increased risk of hospital admission among south Asian patients with asthma. Design Qualitative interview study using modified critical incident technique and framework analysis. Setting Newham, east London, a deprived area with a large mixed south Asian population. Participants 58 south Asian and white adults With asthma (49 admitted to hospital with asthma, 9 not admitted); 17 general practitioners; 5 accident and emergency doctors; 2 out of hours general practitioners; 1 asthma specialist nurse. Main outcome measures Patients' and health professionals' views on influences on admission, events leading to admission, general practices' organisation and asthma strategies, doctor-patient relationship, and cultural attitudes to asthma. Results South Asian and white patients admitted to hospital coped differently with asthma. South Asians described less confidence in controlling their asthma, were unfamiliar with the concept of preventive medication, and often expressed less confidence in their general practitioner. South Asians managed asthma exacerbations with family advocacy, without systematic changes in prophylaxis, and without systemic corticosteroids. Patients describing difficulty accessing primary care during asthma exacerbations were registered with practices with weak strategies for asthma care and were often south Asian. Patients with easy access described care suggesting partnerships with their general practitioner, had better confidence to control asthma, and were registered with practices with Well developed asthma strategies that included policies low avoiding hospital admission. Conclusions The different ways of coping with asd)ina exacerbations and accessing care may partly explain the increased risk of hospital admission in south Asian patients. Interventions that increase confidence to control asthma, confidence in the general practitioner, understanding of preventive treatment, and use of systemic corticosteroids in exacerbations may reduce hospital admissions. Development of more sophisticated asthma strategies by practices with better access and partnerships with patients tray also achieve this.	Queen Marys Sch Med & Dent, St Bartholomews & Royal London Sch Med & Dent, Dept Gen Practice & Primary Care, London E1 4NS, England; Royal London Hosp, Dept Human Sci & Med Eth, London E1 2AD, England; Newham Dist Gen Hosp, London, England	University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital	Griffiths, C (corresponding author), Queen Marys Sch Med & Dent, St Bartholomews & Royal London Sch Med & Dent, Dept Gen Practice & Primary Care, London E1 4NS, England.			Feder, Gene/0000-0002-7890-3926				[Anonymous], 1997, SELF EFFICACY; AYRES JG, 1986, BRIT J DIS CHEST, V80, P242, DOI 10.1016/0007-0971(86)90059-8; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; BRADLEY CP, 1992, FAM PRACT, V9, P98, DOI 10.1093/fampra/9.1.98; Clark NM, 1998, PEDIATRICS, V101, P831, DOI 10.1542/peds.101.5.831; *COMM HLTH SCI RES, 2000, SYST REV ACC TREATM; DEPALO VA, 1994, CHEST, V106, P447, DOI 10.1378/chest.106.2.447; *E LOND CIT HLTH A, 2000, HLTH E END ANN PUBL; GIBSON PG, 2000, COCHRANE DATABASE SY; Gilthorpe MS, 1998, RESP MED, V92, P642, DOI 10.1016/S0954-6111(98)90511-X; Green J, 1998, BMJ-BRIT MED J, V316, P1064; Howie JGR, 1999, BMJ-BRIT MED J, V319, P738, DOI 10.1136/bmj.319.7212.738; KELSO TM, 1995, AM J EMERG MED, V13, P632, DOI 10.1016/0735-6757(95)90046-2; Moudgil H, 1998, THORAX, V53, P490, DOI 10.1136/thx.53.6.490; Moudgil H, 2000, THORAX, V55, P177, DOI 10.1136/thorax.55.3.177; MYERS P, 1992, RESP MED, V86, P297, DOI 10.1016/S0954-6111(06)80027-2; Norman P., 1996, PREDICTING HLTH BEHA, P197; ORMEROD LP, 1995, RESP MED, V89, P415, DOI 10.1016/0954-6111(95)90209-0; ORMEROD LP, 1995, RESP MED, V89, P115; Partridge MR, 2000, THORAX, V55, P175, DOI 10.1136/thorax.55.3.175; PATTEN MQ, 1990, QUALITATIVE EVALUATI; Ritchie J, 2002, ANAL QUALITATIVE DAT, P187; Rona RJ, 2000, THORAX, V55, P239, DOI 10.1136/thorax.55.3.239; ROWE BH, 1992, AM J EMERG MED, V10, P301, DOI 10.1016/0735-6757(92)90007-K; SPERBER K, 1995, J ASTHMA, V32, P335, DOI 10.3109/02770909509082758; [No title captured], DOI DOI 10.1136/THX.52.2008.S1]	26	55	55	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2001	323	7319					962	966A		10.1136/bmj.323.7319.962	http://dx.doi.org/10.1136/bmj.323.7319.962			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488CU	11679384	Green Published, Bronze			2022-12-28	WOS:000171918500015
J	McAlister, FA; Lawson, FME; Teo, KK; Armstrong, PW				McAlister, FA; Lawson, FME; Teo, KK; Armstrong, PW			Randomised trials of secondary prevention programmes in coronary heart disease: systematic review	BRITISH MEDICAL JOURNAL			English	Review							ACUTE MYOCARDIAL-INFARCTION; MULTIFACTORIAL INTERVENTION PROGRAM; CARDIAC REHABILITATION; SUDDEN DEATHS; FOLLOW-UP; GENERAL-PRACTICE; CLINICAL-TRIALS; REDUCTION; CARE; RISK	Objective To determine whether multidisciplinary disease management programmes for patients with coronary heart disease improve processes of care and reduce morbidity and mortality. Data sources Randomised clinical trials of disease management programmes in patients with coronary heart disease were identified by searching Medline 1966-2000, Embase 1980-99, CINAHL 1982-99, SIGLE 1980-99, the Cochrane controlled trial register, the Cochrane effective practice and organisation of care study register, and bibliographies of published studies. Data extraction Studies were selected and data were extracted independently by two investigators, and summary risk ratios were calculated by using both the random effects model anti the fixed effects model. Data synthesis A total of 12 trials (9803 patients with coronary heart disease) were identified. Disease management programmes had positive impacts on processes of care. Patients randomised to these programmes were more likely to be prescribed efficacious drugs (risk ratio 2.14 (95% confidence interval 1.92 to 2.38) for lipid lowering drugs, 1.19 (1.07 to 1.32) for beta blockers, and 1.07 (1.03 to 1.11) for antiplatelet agents). Five out of seven trials evaluating risk factor profiles showed significantly greater improvements with these programmes in comparison With usual care (with effect sizes in the moderate range). Summary risk ratios were 0.91 (0.79 to 1.04) for all cause mortality, 0.94 (0.80 to 1.10) for recurrent myocardial infarction, and 0.84 (0.76 to 0.94) for admission to hospital. Five of the eight trials evaluating quality of life or functional status reported better outcomes in the intervention arms. Only three of these trials reported the costs of the intervention-the interventions were cost saving in two cases. Conclusions Disease management programmes improve processes of care, reduce admissions to hospital, and enhance duality of life or functional status in patients with coronary heart disease. The programmes' impact on survival and recurrent infarctions, their cost effectiveness, and the optimal mix of components remain uncertain.	Univ Alberta Hosp, Div Gen Internal Med, Edmonton, AB T6G 2R7, Canada; Univ Alberta, Div Geriatr Med, Edmonton, AB T6G 2R7, Canada; Univ Alberta, Div Cardiol, Edmonton, AB T6G 2M7, Canada; McMaster Univ, Div Cardiol, Hamilton, ON L8S 4L8, Canada	University of Alberta; University of Alberta; University of Alberta; McMaster University	McAlister, FA (corresponding author), Univ Alberta Hosp, Div Gen Internal Med, 2E3-24 WMC,8440 112 St, Edmonton, AB T6G 2R7, Canada.		McAlister, Finlay/C-4151-2013	McAlister, Finlay/0000-0001-7435-3341; Armstrong, Paul/0000-0002-0460-3445				BEDFORD A, 1976, BRIT J SOC CLIN PSYC, V15, P387, DOI 10.1111/j.2044-8260.1976.tb00050.x; BONNEUX L, 1994, AM J PUBLIC HEALTH, V84, P20, DOI 10.2105/AJPH.84.1.20; Campbell NC, 1998, HEART, V80, P447, DOI 10.1136/hrt.80.5.447; Campbell NC, 1998, BMJ-BRIT MED J, V316, P1434, DOI 10.1136/bmj.316.7142.1434; Cohen JD, 2001, LANCET, V357, P972, DOI 10.1016/S0140-6736(00)04252-5; CUPPLES ME, 1994, BRIT MED J, V309, P993, DOI 10.1136/bmj.309.6960.993; DEBUSK RF, 1994, ANN INTERN MED, V120, P721, DOI 10.7326/0003-4819-120-9-199405010-00001; Dinnes J, 1999, QUAL HEALTH CARE, V8, P65, DOI 10.1136/qshc.8.1.65; FITZGERALD JF, 1994, ARCH INTERN MED, V154, P1721, DOI 10.1001/archinte.154.15.1721; FrasureSmith N, 1997, LANCET, V350, P473, DOI 10.1016/S0140-6736(97)02142-9; Greenland Philip, 1996, American Journal of Medicine, V101, p76S, DOI 10.1016/S0002-9343(96)00324-5; HAMALAINEN H, 1989, EUR HEART J, V10, P55; Hamalainen H, 1995, EUR HEART J, V16, P1839; HASKELL WL, 1994, CIRCULATION, V89, P975, DOI 10.1161/01.CIR.89.3.975; Hunter DJ, 1997, BRIT MED J, V315, P50, DOI 10.1136/bmj.315.7099.50; Jolly K, 1999, BMJ-BRIT MED J, V318, P706; Jones DA, 1996, BRIT MED J, V313, P1517, DOI 10.1136/bmj.313.7071.1517; KALLIO V, 1979, LANCET, V2, P1091; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Kotseva K, 2001, LANCET, V357, P995, DOI 10.1016/S0140-6736(00)04235-5; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; NAYLOR M, 1994, ANN INTERN MED, V120, P999, DOI 10.7326/0003-4819-120-12-199406150-00005; Naylor M D, 1999, J Cardiovasc Nurs, V14, P44; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; OCONNOR GT, 1989, CIRCULATION, V80, P234, DOI 10.1161/01.CIR.80.2.234; OLDRIDGE NB, 1988, JAMA-J AM MED ASSOC, V260, P945, DOI 10.1001/jama.260.7.945; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Shephard RJ, 1999, CIRCULATION, V99, P963, DOI 10.1161/01.CIR.99.7.963; VERMEULEN A, 1983, AM HEART J, V105, P798, DOI 10.1016/0002-8703(83)90243-0; *WHO, 1983, 84 WHO, P1; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2088, DOI 10.1001/jama.260.14.2088	32	247	250	0	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2001	323	7319					957	962		10.1136/bmj.323.7319.957	http://dx.doi.org/10.1136/bmj.323.7319.957			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488CU	11679383	Green Published, Bronze			2022-12-28	WOS:000171918500014
J	Ueda, M; Sako, Y; Tanaka, T; Devreotes, P; Yanagida, T				Ueda, M; Sako, Y; Tanaka, T; Devreotes, P; Yanagida, T			Single-molecule analysis of chemotactic signaling in Dictyostelium cells	SCIENCE			English	Article							SURFACE CAMP RECEPTOR; LIVING CELLS; TRANSDUCTION; DISCOIDEUM; LOCALIZATION; DESENSITIZATION; ACTIVATION; AFFINITY; CYCLASE; BINDING	Single-molecule imaging techniques were used to reveal the binding of individual cyclic adenosine 3',5'-monophosphate molecules to heterotrimeric guanine nucleotide-binding protein coupled receptors on the surface of living Dictyostelium discoideum cells, The binding sites were uniformly distributed and diffused rapidly in the plane of the membrane. The probabilities of individual association and dissociation events were greater for receptors at the anterior end of the cell. Agonist-induced receptor phosphorylation had little effect on any of the monitored properties, whereas G protein coupling influenced the binding kinetics. These observations illustrate the dynamic properties of receptors involved in gradient sensing and suggest that these may be polarized in chemotactic cells.	Japan Sci & Technol Corp, Recognit & Format, Tokyo, Japan; Japan Sci & Technol Corp, PRESTO, Times Arrow & Biosignaling, Kawaguchi, Japan; JST, ICORP, Single Mol Proc Project, Osaka 5620035, Japan; Biomol Engn Res Inst, Osaka 5650874, Japan; Johns Hopkins Med Inst, Dept Cell Biol, Baltimore, MD 21205 USA; Osaka Univ, Grad Sch Med, Dept Physiol & Biosignalling, Suita, Osaka 5650871, Japan	Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Johns Hopkins University; Johns Hopkins Medicine; Osaka University	Ueda, M (corresponding author), Japan Sci & Technol Corp, Recognit & Format, Tokyo, Japan.		Sako, Yasushi/B-3253-2015	Sako, Yasushi/0000-0002-5707-5455				CLAVIEZ M, 1982, EMBO J, V1, P1017, DOI 10.1002/j.1460-2075.1982.tb01287.x; DEVREOTES P, 1987, METHOD CELL BIOL, V28, P299; HALL AL, 1988, J CELL BIOCHEM, V37, P285, DOI 10.1002/jcb.240370304; Ishijima A, 2001, TRENDS BIOCHEM SCI, V26, P438, DOI 10.1016/S0968-0004(01)01860-6; JANS DA, 1992, BIOCHIM BIOPHYS ACTA, V1113, P271, DOI 10.1016/0304-4157(92)90001-Q; JANSSENS PMW, 1987, MICROBIOL REV, V51, P396, DOI 10.1128/MMBR.51.4.396-418.1987; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; KONIJN TM, 1987, METHOD CELL BIOL, V28, P283; LEVITZKI A, 1993, LIFE SCI, V52, P2093, DOI 10.1016/0024-3205(93)90724-H; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Parent CA, 1996, ANNU REV BIOCHEM, V65, P411; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; VANHAASTERT PJM, 1984, J BIOL CHEM, V259, P3321; VANHAASTERT PJM, 1986, J BIOL CHEM, V261, P6904; VANHAASTERT PJM, 1983, J BIOL CHEM, V258, P9636; WU LJ, 1995, J CELL BIOL, V129, P1667, DOI 10.1083/jcb.129.6.1667; Xiao Z, 1999, J BIOL CHEM, V274, P1440, DOI 10.1074/jbc.274.3.1440; Xiao Z, 1997, J CELL BIOL, V139, P365, DOI 10.1083/jcb.139.2.365; YUMURA S, 1984, J CELL BIOL, V99, P894, DOI 10.1083/jcb.99.3.894	22	266	287	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2001	294	5543					864	867		10.1126/science.1063951	http://dx.doi.org/10.1126/science.1063951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679673				2022-12-28	WOS:000171851800050
J	Thompson, DC; McPhillips, H; Davis, RL; Lieu, TL; Homer, CJ; Helfand, M				Thompson, DC; McPhillips, H; Davis, RL; Lieu, TL; Homer, CJ; Helfand, M			Universal newborn hearing screening - Summary of evidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HARD-OF-HEARING; DEMONSTRATION PROJECT; EARLY IDENTIFICATION; LANGUAGE-DEVELOPMENT; CHILDREN; IMPAIRMENT; INFANTS; DEAF; AGE; INTERVENTION	Context Each year, approximately 5000 infants are born in the United States with moderate-to-profound, bilateral permanent hearing loss (PHL). Universal newborn hearing screening (UNHS) has been proposed as a means to speed diagnosis and treatment and thereby improve language outcomes in these children. Objectives To identify strengths, weaknesses, and gaps in the evidence supporting UNHS and to compare the additional benefits and harms of UNHS with those of selective screening of high-risk newborns. Data Sources We searched the MEDLINE, CINAHL, and PsychINFO databases for relevant articles published from 1994 to August 2001, using terms for hearing disorders, infants or newborns, screening, and relevant treatments. We contacted experts and reviewed reference lists to identify additional articles, including those published before 1994. Study Selection We included controlled and observational studies of (1) the accuracy, yield, and harms of screening using otoacoustic emissions (OAEs), auditory brainstem response (ABR), or both in the general newborn population and (2) the effects of screening or early identification and treatment on language outcomes. Of an original 340 articles identified, 19 articles, including 1 controlled trial, met these inclusion criteria. Data Extraction Data on population, test performance, outcomes, and methodological quality were extracted by 2 authors (D.C.T., H.M.) using prespecified criteria developed by the US Preventive Services Task Force. We queried authors when information needed to assess study quality was missing. Data Synthesis Good-quality studies show that from 2041 to 2794 low-risk and 86 to 208 high-risk newborns were screened to find 1 case of moderate-to-profound PHL. The best estimate of positive predictive value was 6.7%. Six percent to 15% of infants who are missed by the screening tests are subsequently diagnosed with bilateral PHL. In a trial of UNHS vs clinical screening at age 8 months, UN HS increased the proportion of infants with moderate-to-severe hearing loss diagnosed by age 10 months (57% vs 14%) but did not reduce the rate of diagnosis after age 18 months. No good-quality controlled study has compared UNHS with selective screening of high-risk new. borns. In fair- to poor-quality cohort studies, intervention before age 6 months was associated with improved language and communication skills by ages 2 to 5 years. These studies had unclear criteria for selecting subjects, and none compared an inception cohort of low-risk newborns identified by screening with those identified in usual care, making it impossible to exclude selection bias as an explanation for the results. In a mathematical model based on the literature review, we estimated that extending screening to low-risk infants would detect 1 additional case before age 10 months for every 1441 low-risk infants screened, and result in treatment before 10 months of 1 additional case for every 2401 low-risk infants screened. With UNHS, 254 newborns would be referred for audiological evaluation because of false-positive second-stage screening test results vs 48 for selective screening. Conclusions Modern screening tests for hearing Impairment can improve identification of newborns with PHL, but the efficacy of UNHS to improve long-term language outcomes remains uncertain.	Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; Harvard Pilgrim Hlth Care, Seattle, WA USA; Natl Initiat Childrens Healthcare Qual, Boston, MA USA; Oregon Hlth & Sci Univ, Portland VA Med Ctr, Portland, OR 97201 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center	Thompson, DC (corresponding author), Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, 325 9th Ave,Box 359960, Seattle, WA 98104 USA.	dct@uwashington.edu						Aidan D, 1999, ANN OTO RHINOL LARYN, V108, P525, DOI 10.1177/000348949910800601; Allen T., 1986, DEAF CHILDREN AM, P161, DOI DOI 10.1177/15257401050270010201; Apuzzo Mah-Rya L., 1995, Seminars in Hearing, V16, P124, DOI 10.1055/s-0028-1083710; BARRINGER DG, 1997, AUDIOLOGY TODAY, V9, P18; BarskyFirkser L, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.6.e4; Boyle C A, 1996, MMWR CDC Surveill Summ, V45, P1; Brookhouser PE, 1996, PEDIATR CLIN N AM, V43, P1195, DOI 10.1016/S0031-3955(05)70514-9; Calderon R, 1998, VOLTA REV, V100, P53; Carney AE, 1998, J SPEECH LANG HEAR R, V41, pS61, DOI 10.1044/jslhr.4101.s61; Clemens CJ, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.1.e7; Dalzell L, 2000, EAR HEARING, V21, P118, DOI 10.1097/00003446-200004000-00006; DAVIS A, 1997, HEALTH TECHNOL ASSES, V1, P1, DOI DOI 10.3310/HTA1100; Eilers R E, 1995, Curr Probl Pediatr, V25, P60, DOI 10.1016/S0045-9380(06)80024-1; Erenberg A, 1999, PEDIATRICS, V103, P527; Fenson L., 1993, MACARTHUR COMMUNICAT; Finitzo T, 1998, PEDIATRICS, V102, P1452, DOI 10.1542/peds.102.6.1452; Finitzo T, 1999, PEDIATR CLIN N AM, V46, P15, DOI 10.1016/S0031-3955(05)70078-X; FINITZO T, 1997, AM J AUDIOL, V6, P91; Folsom RC, 1999, PEDIATR CLIN N AM, V46, P107, DOI 10.1016/S0031-3955(05)70085-7; Fonseca S, 1999, BRIT J AUDIOL, V33, P135, DOI 10.3109/03005369909090093; FORNUM H, 2001, BMJ-BRIT MED J, V323, P536; Fortnum H, 1997, BRIT J AUDIOL, V31, P409, DOI 10.3109/03005364000000037; GERBER S E, 1990, British Journal of Audiology, V24, P347, DOI 10.3109/03005369009076575; Gopnik A., 1999, SCI CRIB MINDS BRAIN; Grandori F, 1998, Int J Pediatr Otorhinolaryngol, V44, P309; Grandori F, 1999, Am J Audiol, V8, P19, DOI 10.1044/1059-0889(1999/004); Green GE, 1999, JAMA-J AM MED ASSOC, V281, P2211, DOI 10.1001/jama.281.23.2211; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Harrison M, 1996, EAR HEARING, V17, P55, DOI 10.1097/00003446-199602000-00007; Holt JA., 1993, AM ANN DEAF, V138, P172, DOI DOI 10.1353/AAD.2012.0684; Hyde M L, 1990, J Am Acad Audiol, V1, P59; IRETON H, 1974, MINNESOTA CHILD DEV; *JOINT COMM INF HE, 2001, JOINT COMM INF HEAR; Karikoski JO, 1995, SCAND AUDIOL, V24, P237, DOI 10.3109/01050399509047542; Kennedy CR, 1999, ACTA PAEDIATR, V88, P73, DOI 10.1080/080352599750029448; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Maki-Torkko EM, 1998, SCAND AUDIOL, V27, P95, DOI 10.1080/010503998420333; MARTIN WH, 1994, OTOLARYNG CLIN N AM, V27, P487; Mason JA, 1998, PEDIATRICS, V101, P221, DOI 10.1542/peds.101.2.221; MAUK GW, 1991, EAR HEARING, V12, P312, DOI 10.1097/00003446-199110000-00003; MAYNE A, 2000, VOLTA REV, V0100; Meadow-Orlans KP, 1997, AM ANN DEAF, V142, P278, DOI 10.1353/aad.2012.0221; Mehl AL, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e4; Moeller M P, 1986, ASHA Monogr, P41; Moeller MP, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.3.e43; MOORE JM, 1992, EAR HEARING, V13, P187, DOI 10.1097/00003446-199206000-00008; *NIH, 1993, EARL ID HEAR IMP INF; Norton SJ, 2000, EAR HEARING, V21, P508, DOI 10.1097/00003446-200010000-00013; OudesluysMurphy AM, 1996, EUR J PEDIATR, V155, P429, DOI 10.1007/BF01955176; PARVING A, 1998, J AUDIOL MED, V7, P100; Preisler G, 1999, INT J PEDIATR OTORHI, V49, pS39, DOI 10.1016/S0165-5876(99)00130-5; Prieve B, 2000, EAR HEARING, V21, P104, DOI 10.1097/00003446-200004000-00005; Prieve BA, 2000, EAR HEARING, V21, P85, DOI 10.1097/00003446-200004000-00003; RACH GH, 1988, INT J PEDIATR OTORHI, V15, P253, DOI 10.1016/0165-5876(88)90080-8; RUBEN RJ, 1991, ACTA OTO-LARYNGOL, P127; Silverman CA, 1998, PRIMARY CARE, V25, P545, DOI 10.1016/S0095-4543(15)30003-8; Sininger YS, 1999, PEDIATR CLIN N AM, V46, P1, DOI 10.1016/S0031-3955(05)70077-8; Stein LK, 1999, PEDIATR CLIN N AM, V46, P95, DOI 10.1016/S0031-3955(05)70084-5; STREDLERBROWN A, IN PRESS VOLTA REV; THOMSON V, 1997, AM J AUDIOL, V6, P74; Thomson Vickie, 1998, Seminars in Hearing, V19, P287, DOI 10.1055/s-0028-1082977; *US PREV SERV TASK, 1996, US PREV SERV TASK FO, P393; Van Naarden K, 1999, PEDIATRICS, V103, P570, DOI 10.1542/peds.103.3.570; Vohr BR, 1998, J PEDIATR-US, V133, P353, DOI 10.1016/S0022-3476(98)70268-9; Watkin PM, 1996, ARCH DIS CHILD-FETAL, V75, pF158, DOI 10.1136/fn.75.3.F158; Watkin PM, 1998, BRIT J AUDIOL, V32, P27, DOI 10.3109/03005364000000048; WATKIN PM, 1991, ARCH DIS CHILD-FETAL, V66, P1130, DOI 10.1136/adc.66.10_Spec_No.1130; Watkins V, 1996, T I MET FINISH, V74, P6; *WESS UNIV NEON HE, 1998, LANCET, V351, P1957; White Karl R., 1993, Seminars in Hearing, V14, P18; Widen JE, 2000, EAR HEARING, V21, P471, DOI 10.1097/00003446-200010000-00011; Yoshinaga-Itano C, 1998, AM ANN DEAF, V143, P380, DOI 10.1353/aad.2012.0151; Yoshinaga-Itano C, 1998, AM ANN DEAF, V143, P416, DOI 10.1353/aad.2012.0118; Yoshinaga-Itano C, 1998, PEDIATRICS, V102, P1161, DOI 10.1542/peds.102.5.1161; Yoshinaga-Itano C, 2000, J Perinatol, V20, pS132; ZINKUS PW, 1980, PEDIATRICS, V66, P246	76	247	261	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2001	286	16					2000	2010		10.1001/jama.286.16.2000	http://dx.doi.org/10.1001/jama.286.16.2000			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	485JD	11667937				2022-12-28	WOS:000171750500024
J	Knust, E				Knust, E			G protein signaling and asymmetric cell division	CELL			English	Review							DROSOPHILA		Univ Dusseldorf, Inst Genet, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Knust, E (corresponding author), Univ Dusseldorf, Inst Genet, Univ Str 1, D-40225 Dusseldorf, Germany.		Knust, Elisabeth/B-4338-2017					BAHLER J, 2000, FRONTIERS MOL BIOL, V28; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; PIANO F, 2000, FRONTIERS MOL BIOL, V28; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; WEINER OD, 2000, FRONTIERS MOL BIOL, V28; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5	13	23	23	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					125	128		10.1016/S0092-8674(01)00534-7	http://dx.doi.org/10.1016/S0092-8674(01)00534-7			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672519	Bronze			2022-12-28	WOS:000171694800001
J	Dequeker, J; Luyten, FP				Dequeker, J; Luyten, FP			For and against - Bone densitometry is not a good predictor of hip fracture - Against	BRITISH MEDICAL JOURNAL			English	Article							DENSITY; WOMEN; RISK; OSTEOPOROSIS; INCREASES; CALCIUM; SPINE; MEN		Univ Ziekenhuizen KU Leuven, Dept Rheumatol, B-3000 Louvain, Belgium	KU Leuven; University Hospital Leuven	Dequeker, J (corresponding author), Univ Ziekenhuizen KU Leuven, Dept Rheumatol, B-3000 Louvain, Belgium.		Luyten, Frank/GPS-7793-2022					Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663; Aerssens J, 1996, ENDOCRINOLOGY, V137, P1358, DOI 10.1210/en.137.4.1358; CHAPUY MC, 1994, BRIT MED J, V308, P1081, DOI 10.1136/bmj.308.6936.1081; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; DeLaet CEDH, 1997, BRIT MED J, V315, P221, DOI 10.1136/bmj.315.7102.221; DEQUEKER J, 1987, BONE, V8, P207, DOI 10.1016/8756-3282(87)90166-9; Dequeker J, 2000, CLIN RHEUMATOL, V19, P171, DOI 10.1007/s100670050150; Faulkner KG, 2000, J BONE MINER RES, V15, P183, DOI 10.1359/jbmr.2000.15.2.183; Genant HK, 1999, OSTEOPOROSIS INT, V10, P259, DOI 10.1007/s001980050224; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Huopio J, 2000, OSTEOPOROSIS INT, V11, P219, DOI 10.1007/s001980050284; JONES G, 1995, J BONE MINER RES, V10, P106; Mashiba T, 2000, J BONE MINER RES, V15, P613, DOI 10.1359/jbmr.2000.15.4.613; ONEILL TW, 1995, OSTEOPOROSIS INT, V5, P327, DOI 10.1007/BF01622254	15	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 6	2001	323	7316					797	799						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481LK	11642251				2022-12-28	WOS:000171520600035
J	Dowey, JA				Dowey, JA			Child B: A personal view	BRITISH MEDICAL JOURNAL			English	Article																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 18	1997	314	7075					200	200						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WD911	11644899				2022-12-28	WOS:A1997WD91100034
J	ROBIN, ED				ROBIN, ED			FOR DEBATE - THE HIPPOCRATIC OATH UPDATED	BRITISH MEDICAL JOURNAL			English	Note																			0	9	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 9	1994	309	6947					96	96						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NW716	11644560				2022-12-28	WOS:A1994NW71600020
J	DOROZYNSKI, A				DOROZYNSKI, A			FRENCH DOCTORS PUZZLE OVER GENE OWNERSHIP	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	APR 2	1994	308	6933					873	874		10.1136/bmj.308.6933.873a	http://dx.doi.org/10.1136/bmj.308.6933.873a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE600	11644527	Green Published			2022-12-28	WOS:A1994NE60000008
J	WARD, E				WARD, E			A TRAGIC AND WICKED WASTE OF LIFE	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 5	1991	302	6767					57	57		10.1136/bmj.302.6767.57	http://dx.doi.org/10.1136/bmj.302.6767.57			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER372	11642869	Green Published, Bronze			2022-12-28	WOS:A1991ER37200061
J	RICHARDS, J				RICHARDS, J			TODAY I LAID HANDS ON A BABY CONDEMNED TO DEATH	BRITISH MEDICAL JOURNAL			English	Editorial Material																		1988, BRIT MED J, V296, P446	1	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	NOV 25	1989	299	6711					1345	1345						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB425	11644422				2022-12-28	WOS:A1989CB42500056
J	DRIFE, JO				DRIFE, JO			LOOKING CAROL IN THE FACE	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 2	1988	297	6640					80	80		10.1136/bmj.297.6640.80	http://dx.doi.org/10.1136/bmj.297.6640.80			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P1000	11644346	Green Published, Bronze			2022-12-28	WOS:A1988P100000081
J	Sahota, P; Rudolf, MCJ; Dixey, R; Hill, AJ; Barth, JH; Barth, J				Sahota, P; Rudolf, MCJ; Dixey, R; Hill, AJ; Barth, JH; Barth, J			Evaluation of implementation and effect of primary school based intervention to reduce risk factors for obesity	BRITISH MEDICAL JOURNAL			English	Article							HEALTH	Objectives To implement a school based health promotion programme aimed at reducing risk factors for obesity and to evaluate the implementation process and its effect on the school. Design Data from 10 schools participating in a group randomised controlled crossover trial were pooled and analysed. Setting 10 primary schools in Leeds. Participants 634 children (350 boys and 284 girls) aged 7-11 years. Main outcome measures Response rates to questionnaires, teachers' evaluation of training and input, success of school action plans, content of school meals, and children's knowledge of healthy living and self reported behaviour. Results All 10 schools participated throughout the study. 76 (89%) of the action points determined by schools in their school action plans were achieved, along with positive changes in school meals. A high level of support for nutrition education and promotion of physical activity was expressed by both teachers and parents. 410 (64%) parents responded to the questionnaire concerning changes they would like to see implemented in school. 19 out of 20 teachers attended the training, and all reported satisfaction with the training, resources, and support. Intervention children showed a higher score for knowledge, attitudes, and self reported behaviour for healthy eating and physical activity. Conclusion This programme was successfully implemented and produced changes at school level that tackled risk factors for obesity.	Leeds Community & Mental Hlth Trust, Leeds LS2 9DE, W Yorkshire, England; Leeds Metropolitan Univ, Sch Hlth Sci, Leeds LS1 3HE, W Yorkshire, England; Univ Leeds, Sch Med, Leeds LS2 9LT, W Yorkshire, England; Gen Infirm, Leeds LS1 3EX, W Yorkshire, England; Nuffield Inst Hlth, Leeds LS2 9PL, W Yorkshire, England	Leeds Beckett University; University of Leeds; Leeds General Infirmary; University of Leeds	Rudolf, MCJ (corresponding author), Leeds Community & Mental Hlth Trust, Belmont House, Leeds LS2 9DE, W Yorkshire, England.		Barth, Julian H/F-6028-2010; Cade, Janet E/G-4250-2016	Cade, Janet E/0000-0003-3421-0121				DIETZ WH, 1992, OBESITY, P606; Fruhbeck G, 2000, BRIT MED J, V320, P328, DOI 10.1136/bmj.320.7231.328; GARROW J, 1991, BRIT MED J, V303, P704, DOI 10.1136/bmj.303.6804.704; NHS Centre for Reviews and Dissemination, 1997, EFFECTIVE HLTH CARE, V3; Parcel GS, 1988, CHILDHOOD OBESITY BI, P143; Power C, 1997, INT J OBESITY, V21, P507, DOI 10.1038/sj.ijo.0800454; Reilly JJ, 1999, BRIT MED J, V319, P1039, DOI 10.1136/bmj.319.7216.1039; RENISCOW K, 1993, ANN NY ACAD SCI, V699, P154; Rudolf MCJ, 2001, BRIT MED J, V322, P1094, DOI 10.1136/bmj.322.7294.1094; Sahota P, 2001, BMJ-BRIT MED J, V323, P1029, DOI 10.1136/bmj.323.7320.1029; Story M, 1999, INT J OBESITY, V23, pS43, DOI 10.1038/sj.ijo.0800859; Tones K, 1996, HEALTH EDUC RES, V11, pR1; WHO, 1997, PREV MAN GLOB EP; Young I, 1989, HLTH SCH	14	99	103	0	32	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 3	2001	323	7320					1027	1029		10.1136/bmj.323.7320.1027	http://dx.doi.org/10.1136/bmj.323.7320.1027			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MP	11691758	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000172055900014
J	Temple, S				Temple, S			The development of neural stem cells	NATURE			English	Review							CENTRAL-NERVOUS-SYSTEM; ADULT MAMMALIAN BRAIN; PROGENITOR CELLS; SPINAL-CORD; NEURONAL DIFFERENTIATION; PATTERN-FORMATION; GENE-EXPRESSION; PRECURSORS; CNS; MULTIPOTENT	The discovery of stem cells that can generate neural tissue has raised new possibilities for repairing the nervous system. A rush of papers proclaiming adult stem cell plasticity has fostered the notion that there is essentially one stem cell type that, with the right impetus, can create whatever progeny our heart, liver or other vital organ desires. But studies aimed at understanding the role of stem cells during development have led to a different view-that stem cells are restricted regionally and temporally, and thus not all stem cells are equivalent. Can these views be reconciled?.	Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA	Albany Medical College	Temple, S (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, 47 New Scotland Ave, Albany, NY 12208 USA.							Altmann CR, 2001, INT REV CYTOL, V203, P447; Alvarez-Buylla A, 2000, Prog Brain Res, V127, P1; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Anderson DJ, 1997, COLD SPRING HARB SYM, V62, P493; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; BARBE MF, 1991, J NEUROSCI, V11, P519; Betarbet R, 1996, CELL TRANSPLANT, V5, P165, DOI 10.1016/0963-6897(95)02042-X; Brody T, 2000, DEV BIOL, V226, P34, DOI 10.1006/dbio.2000.9829; Brustle O, 1997, P NATL ACAD SCI USA, V94, P14809, DOI 10.1073/pnas.94.26.14809; Brustle O, 1995, NEURON, V15, P1275, DOI 10.1016/0896-6273(95)90007-1; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; CAPELA A, 2000, SOC NEUR ABSTR; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Desai AR, 2000, DEVELOPMENT, V127, P2863; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; DOETSCH F, 2001, SOC NEUR ABSTR; Durbec P, 2001, MOL CELL NEUROSCI, V17, P561, DOI 10.1006/mcne.2000.0951; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GOLDOWITZ D, 1989, NEURON, V3, P705, DOI 10.1016/0896-6273(89)90239-0; Gritti A, 1999, J NEUROSCI, V19, P3287; HE W, IN PRESS J NEUROSCI; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Kalyani A, 1997, DEV BIOL, V186, P202, DOI 10.1006/dbio.1997.8592; Kalyani AJ, 1998, J NEUROSCI, V18, P7856; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; KILPATRICK TJ, 1993, NEURON, V10, P255, DOI 10.1016/0896-6273(93)90316-J; Kirschstein RL, 2001, STEM CELLS SCI PROGR; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Li WW, 2000, DEV NEUROSCI-BASEL, V22, P68, DOI 10.1159/000017428; Li WW, 1998, J NEUROSCI, V18, P8853; Lillien L, 2000, DEVELOPMENT, V127, P4993; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Lim DA, 1997, P NATL ACAD SCI USA, V94, P14832, DOI 10.1073/pnas.94.26.14832; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Mujtaba T, 1998, DEV BIOL, V200, P1, DOI 10.1006/dbio.1998.8913; Olsson M, 1997, NEURON, V19, P761, DOI 10.1016/S0896-6273(00)80959-9; Pagano SF, 2000, STEM CELLS, V18, P295, DOI 10.1634/stemcells.18-4-295; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; Rao MS, 1999, ANAT RECORD, V257, P137; Reh TA, 1998, J NEUROBIOL, V36, P206, DOI 10.1002/(SICI)1097-4695(199808)36:2<206::AID-NEU8>3.3.CO;2-4; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Shen Q, 1998, J NEUROBIOL, V36, P162, DOI 10.1002/(SICI)1097-4695(199808)36:2<162::AID-NEU5>3.0.CO;2-#; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Skeath JB, 1999, BIOESSAYS, V21, P922, DOI 10.1002/(SICI)1521-1878(199911)21:11<922::AID-BIES4>3.0.CO;2-T; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; Temple S, 2001, NAT REV NEUROSCI, V2, P513, DOI 10.1038/35081577; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; TOPEPE V, 2001, NEURON, V30, P65; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; TROPEPE V, 2000, SOC NEUR ABSTR; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; White PM, 2001, NEURON, V29, P57, DOI 10.1016/S0896-6273(01)00180-5; Winkler C, 1998, MOL CELL NEUROSCI, V11, P99, DOI 10.1006/mcne.1998.0674; WOLPERT L, 1994, DEV GENET, V15, P485, DOI 10.1002/dvg.1020150607; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zhu G, 1999, J NEUROSCI RES, V56, P131, DOI 10.1002/(SICI)1097-4547(19990415)56:2<131::AID-JNR3>3.0.CO;2-I	75	1155	1277	8	205	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 01	2001	414	6859					112	117		10.1038/35102174	http://dx.doi.org/10.1038/35102174			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689956				2022-12-28	WOS:000171898900055
J	Cobb, M				Cobb, M			Wondrous order	NATURE			English	Editorial Material									Univ Paris 06, Ecol Lab, F-75005 Paris, France	UDICE-French Research Universities; Sorbonne Universite	Cobb, M (corresponding author), Univ Paris 06, Ecol Lab, 7 Quai St Bernard, F-75005 Paris, France.								0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					779	779		10.1038/35101666	http://dx.doi.org/10.1038/35101666			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677583	Bronze			2022-12-28	WOS:000171750200024
J	DeCamp, MF; Reis, DA; Bucksbaum, PH; Adams, B; Caraher, JM; Clarke, R; Conover, CWS; Dufresne, EM; Merlin, R; Stoica, V; Wahlstrand, JK				DeCamp, MF; Reis, DA; Bucksbaum, PH; Adams, B; Caraher, JM; Clarke, R; Conover, CWS; Dufresne, EM; Merlin, R; Stoica, V; Wahlstrand, JK			Coherent control of pulsed X-ray beams	NATURE			English	Article							LASER-PRODUCED PLASMAS; DIFFRACTION; PHONONS; GENERATION; DYNAMICS	Synchrotrons produce continuous trains of closely spaced X-ray pulses. Application of such sources to the study of atomic-scale motion requires efficient modulation of these beams on timescales ranging from nanoseconds to femtoseconds. However, ultrafast X-ray modulators are not generally available. Here we report efficient subnanosecond coherent switching of synchrotron beams by using acoustic pulses in a crystal to modulate the anomalous low-loss transmission of X-ray pulses. The acoustic excitation transfers energy between two X-ray beams in a time shorter than the synchrotron pulse width of about 100 ps. Gigahertz modulation of the diffracted X-rays is also observed. We report different geometric arrangements, such as a switch based on the collision of two counter-propagating acoustic pulses: this doubles the X-ray modulation frequency, and also provides a means of observing a localized transient strain inside an opaque material. We expect that these techniques could be scaled to produce subpicosecond pulses, through laser-generated coherent optical phonon modulation of X-ray diffraction in crystals. Such ultrafast capabilities have been demonstrated thus far only in laser-generated X-ray sources, or through the use of X-ray streak cameras(1-6).	Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; Univ Michigan, FOCUS Ctr, Ann Arbor, MI 48109 USA; Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; Colby Coll, Waterville, ME 04901 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; United States Department of Energy (DOE); Argonne National Laboratory; Colby College	DeCamp, MF (corresponding author), Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA.		Adams, Bernhard/F-7195-2017	Conover, Charles/0000-0003-3170-4548; Bucksbaum, Philip/0000-0003-1258-5571; Dufresne, Eric/0000-0002-2077-4754; Adams, Bernhard/0000-0003-4725-6583; Merlin, Roberto/0000-0002-5584-0248				Akhmanov S. A., 1992, Soviet Physics - Uspekhi, V35, P153, DOI 10.1070/PU1992v035n03ABEH002221; AUSTON DH, 1974, PHYS REV LETT, V32, P1120, DOI 10.1103/PhysRevLett.32.1120; Authier A., 1996, XRAY NEUTRON DYNAMIC; BATTERMAN BW, 1964, REV MOD PHYS, V36, P681, DOI 10.1103/RevModPhys.36.681; BORRMANN G, 1956, Z NATURFORSCH PT A, V11, P585; CHAPMAN LD, 1983, PHYS REV B, V27, P2264, DOI 10.1103/PhysRevB.27.2264; Entin I. R., 1978, Soviet Physics - Solid State, V20, P754; HAUER A, 1975, APPL PHYS LETT, V27, P524, DOI 10.1063/1.88293; KIEFFER JC, 1993, PHYS FLUIDS B-PLASMA, V5, P2676, DOI 10.1063/1.860705; Larsson J, 1997, OPT LETT, V22, P1012, DOI 10.1364/OL.22.001012; LEROUX SD, 1975, PHYS REV LETT, V35, P230, DOI 10.1103/PhysRevLett.35.230; Lindenberg AM, 2000, PHYS REV LETT, V84, P111, DOI 10.1103/PhysRevLett.84.111; MURNANE MM, 1991, SCIENCE, V251, P531, DOI 10.1126/science.251.4993.531; Reis DA, 2001, PHYS REV LETT, V86, P3072, DOI 10.1103/PhysRevLett.86.3072; Rose-Petruck C, 1999, NATURE, V398, P310, DOI 10.1038/18631; ROUSSE A, 1994, PHYS REV E, V50, P2200, DOI 10.1103/PhysRevE.50.2200; Schoenlein RW, 1996, SCIENCE, V274, P236, DOI 10.1126/science.274.5285.236; Schoenlein RW, 2000, SCIENCE, V287, P2237, DOI 10.1126/science.287.5461.2237; THOMSEN C, 1986, PHYS REV B, V34, P4129, DOI 10.1103/PhysRevB.34.4129; Warren B, 1990, XRAY DIFFRACTION, P253; YOUNG JF, 1982, PHYS REV B, V26, P2145, DOI 10.1103/PhysRevB.26.2147; Zachariasen W. H., 1945, THEORY XRAY DIFFRACT	22	59	60	0	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					825	828		10.1038/35101560	http://dx.doi.org/10.1038/35101560			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677601	Green Published			2022-12-28	WOS:000171750200040
J	McCormick, BB; Tomlinson, G; Brill-Edwards, P; Detsky, AS				McCormick, BB; Tomlinson, G; Brill-Edwards, P; Detsky, AS			Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DRUG COMPANIES; PHYSICIANS; INDUSTRY; INFORMATION; FACULTY	Context The long-term effect of policies restricting contact between residents and pharmaceutical company representatives (PCRs) during internal medicine training is Unknown. The McMaster University Department of Medicine in Hamilton, Ontario, implemented a policy restricting PCR contact with trainees in 1992, whereas the Department of Medicine at the University of Toronto, Toronto, Ontario, has no such policy. Objective To determine if the presence of a restrictive policy and the frequency of contact with PCRs during internal medicine training predict attitudes and behavior several years after completion of training. Design, Setting, and Participants Retrospective analysis of the attitudes and behavior of 3 cohorts of physicians: University of Toronto trainees, prepolicy McMaster trainees, and postpolicy McMaster trainees. Surveys were mailed to 242 former University of Toronto and 57 former McMaster trainees who completed their internal medicine training between 1990 and 1996, with response rates of 163 (67%) and 42 (74%), respectively. Main Outcome Measures Physician attitude, assessed by a question about the perceived helpfulness of PCR information, and behavior, assessed by whether physicians met with PCRs in the office and the frequency of contacts with PCRs (current contact score, consisting of conversations with PCRs, PCR-sponsored events attended, gifts, honoraria, and consulting fees received). Results In both the unadjusted and multiple regression analyses, postpolicy McMaster trainees were less likely to find information from PCRs beneficial in guiding their practice compared with Toronto and prepolicy McMaster trainees, with unadjusted odds ratios (ORs) of 0.44 (95% confidence interval [CI], 0.20-0.94) and 0.39 (95% CI, 0.13-1.22), respectively. All 3 groups were equally likely to report that they met with PCRs in their off ice in the past year (88%). Postpolicy McMaster trainees had a lower current contact score compared with Toronto (9.3 vs 10.9; P=.04) and prepolicy McMaster trainees (9.3 vs 10.8; P=.18). In multiple regression models, greater frequency of contact with PCRs during training was a predictor of increased perceived benefit of PCR information (OR, 1.29; 95% CI, 1.13-1.47) and was positively correlated with the current contact score (partial r=0.49; P<.001). Number of PCR-sponsored rounds attended during training was not a consistent predictor of attitudes or behavior. Conclusions Policies restricting PCR access to internal medicine trainees and the amount of contact during residency appear to affect future attitudes and behavior of physicians.	Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Univ Hlth Network, Toronto, ON, Canada; McMaster Univ, Dept Med, Hamilton, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; McMaster University	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Room 427, Toronto, ON M5G 1X5, Canada.	detsky@utstat.toronto.edu	Tomlinson, George A/L-5432-2016	Tomlinson, George A/0000-0002-9328-6399				ANDALEEB SS, 1995, HEALTH CARE MANAGE R, V20, P68; BANKS JW, 1992, ACAD MED, V67, P610, DOI 10.1097/00001888-199209000-00017; BRONTZMAN GL, 1993, J GEN INTERNAL MED, V8, P130; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; EROLA JA, 1994, CAN MED ASSOC J, V150, P955; Ferguson RP, 1999, AM J MED, V107, P149, DOI 10.1016/S0002-9343(99)00192-8; GUYATT G, 1993, CAN MED ASSOC J, V149, P405; GUYATT G, 1994, CAN MED ASSOC J, V150, P951; Hopper JA, 1997, J GEN INTERN MED, V12, P639, DOI 10.1046/j.1525-1497.1997.07126.x; Lexchin J, 1997, CAN FAM PHYSICIAN, V43, P941; LEXCHIN J, 1993, CAN MED ASSOC J, V149, P1401; LICHSTEIN PR, 1992, ARCH INTERN MED, V152, P1009, DOI 10.1001/archinte.152.5.1009; LURIE N, 1990, J GEN INTERN MED, V5, P240, DOI 10.1007/BF02600542; ORLOWSKI JP, 1992, CHEST, V102, P270, DOI 10.1378/chest.102.1.270; Sergeant MD, 1996, CAN MED ASSOC J, V155, P1243; *SOUTH INF PROD LT, 1998, CAN MED DIR 1998 ED; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Stryer D, 1996, J GEN INTERN MED, V11, P575, DOI 10.1007/BF02599024; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; Williams A., 1990, PRESCRIPTIONS HLTH R, P1; ZIEGLER MG, 1995, JAMA-J AM MED ASSOC, V273, P1296, DOI 10.1001/jama.273.16.1296	21	121	123	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2001	286	16					1994	+		10.1001/jama.286.16.1994	http://dx.doi.org/10.1001/jama.286.16.1994			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485JD	11667936	Bronze			2022-12-28	WOS:000171750500023
J	Begbie, J; Graham, A				Begbie, J; Graham, A			Integration between the epibranchial placodes and the hindbrain	SCIENCE			English	Article							NEURAL CREST CELLS; CHICK HINDBRAIN; MIGRATION; GANGLIA; EMBRYO; INDUCTION; ENDODERM; MESODERM; ABSENCE; REGION	Developmental integration results from coordination among components of different embryonic fields to realize the later anatomical and functional relationships. We demonstrate that in the chick head, integration between the epibranchial placodes and the hindbrain is achieved as the neuroglial hindbrain crest cells guide the epibranchial neuronal. cells inward to establish their central connections. This work defines a role for the neuroglial hindbrain crest in organizing the afferent innervation of the hindbrain.	UCL, MRC, Ctr Dev Neurobiol, London SE1 9RT, England	University of London; University College London	Graham, A (corresponding author), UCL, MRC, Ctr Dev Neurobiol, 4th Floor,New Hunts House,Guys Campus, London SE1 9RT, England.	anthony.graham@kcl.ac.uk	graham, anthony/B-1864-2008	graham, anthony/0000-0003-2011-7188				Ariens Kappers C. N., 1960, COMP ANATOMY NERVOUS; AYERLELIEVRE CS, 1982, DEV BIOL, V94, P291, DOI 10.1016/0012-1606(82)90349-9; Baker CVH, 1997, DEVELOPMENT, V124, P3077; Barlow LA, 1997, DEVELOPMENT, V124, P949; Begbie J, 1999, DEVELOPMENT, V126, P895; BIRTSCH S, 2001, GENE DEV, V15, P66; DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406; GRAHAM A, 1993, DEVELOPMENT, V119, P233; Graham A, 2001, BIOESSAYS, V23, P54, DOI 10.1002/1521-1878(200101)23:1<54::AID-BIES1007>3.0.CO;2-5; Horigome N, 1999, DEV BIOL, V207, P287, DOI 10.1006/dbio.1998.9175; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Piotrowski T, 2000, DEV BIOL, V225, P339, DOI 10.1006/dbio.2000.9842; SIMON H, 1994, J NEUROBIOL, V25, P1129, DOI 10.1002/neu.480250908; TOSNEY KW, 1982, DEV BIOL, V89, P13, DOI 10.1016/0012-1606(82)90289-5; Trainor P, 2000, NAT CELL BIOL, V2, P96, DOI 10.1038/35000051; Veitch E, 1999, CURR BIOL, V9, P1481, DOI 10.1016/S0960-9822(00)80118-9	20	77	78	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					595	598		10.1126/science.1062028	http://dx.doi.org/10.1126/science.1062028			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641498				2022-12-28	WOS:000171695600047
J	Urban, S; Lee, JR; Freeman, M				Urban, S; Lee, JR; Freeman, M			Drosophila Rhomboid-1 defines a family of putative intramembrane serine proteases	CELL			English	Article							EGF RECEPTOR; SIGNALING PATHWAY; ALZHEIMERS-DISEASE; GXXXG MOTIF; GENE; STAR; PROTEINS; SPITZ; PROVIDENCIA; ASSOCIATION	The polytopic membrane protein Rhomboid-1 promotes the cleavage of the membrane-anchored TGF alpha -like growth factor Spitz, allowing it to activate the Drosophila EGF receptor. Until now, the mechanism of this key signaling regulator has been obscure, but our analysis suggests that Rhomboid-1 is a novel intramembrane serine protease that directly cleaves Spitz. In accordance with the putative Rhomboid active site being in the membrane bilayer, Spitz is cleaved within its transmembrane domain, and thus is, to our knowledge, the first example of a growth factor activated by regulated intramembrane proteolysis. Rhomboid-1 is conserved throughout evolution from archaea to humans, and our results show that a human Rhomboid promotes Spitz cleavage by a similar mechanism. This growth factor activation mechanism may therefore be widespread.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Freeman, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.			Freeman, Matthew/0000-0003-0410-5451				Arribas J, 1997, J BIOL CHEM, V272, P17160, DOI 10.1074/jbc.272.27.17160; Bang AG, 2000, GENE DEV, V14, P177; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; BOEL E, 1988, LIPIDS, V23, P701, DOI 10.1007/BF02535672; BRENNER S, 1988, NATURE, V334, P528, DOI 10.1038/334528a0; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; DATTA S, 1988, J BIOL CHEM, V263, P1107; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; FERSHT AR, 1973, BIOCHEMISTRY-US, V12, P2035, DOI 10.1021/bi00735a002; FREEMAN M, 1992, DEVELOPMENT, V116, P335; Gallio M, 2000, CURR BIOL, V10, pR693, DOI 10.1016/S0960-9822(00)00722-3; GOLEMBO M, 1996, DEVELOPMENT, V122, P3360; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Guichard A, 2000, DEV BIOL, V226, P255, DOI 10.1006/dbio.2000.9851; Guichard A, 1999, DEVELOPMENT, V126, P2663; HARTLEY BS, 1960, ANNU REV BIOCHEM, V29, P45, DOI 10.1146/annurev.bi.29.070160.000401; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; HEBERLEIN U, 1993, DEV BIOL, V160, P51, DOI 10.1006/dbio.1993.1285; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; KOLODKIN AL, 1994, DEVELOPMENT, V120, P1731; Kopan R, 2000, GENE DEV, V14, P2799, DOI 10.1101/gad.836900; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Paetzel M, 1997, TRENDS BIOCHEM SCI, V22, P28, DOI 10.1016/S0968-0004(96)10065-7; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Pickup AT, 1999, DEV BIOL, V205, P254, DOI 10.1006/dbio.1998.9119; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Rather PN, 1999, J BACTERIOL, V181, P7185, DOI 10.1128/JB.181.23.7185-7191.1999; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; RUTLEDGE BJ, 1992, GENE DEV, V6, P1503, DOI 10.1101/gad.6.8.1503; Salvesen G.S., 2001, PROTEOLYTIC ENZYMES; Schauder S, 2001, GENE DEV, V15, P1468, DOI 10.1101/gad.899601; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; VERNET T, 1995, J BIOL CHEM, V270, P16645, DOI 10.1074/jbc.270.28.16645; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Wasserman JD, 2000, GENE DEV, V14, P1651; Wasserman JD, 1997, TRENDS CELL BIOL, V7, P431, DOI 10.1016/S0962-8924(97)01143-4; zurLage P, 1997, CURR BIOL, V7, P166, DOI 10.1016/S0960-9822(97)70087-3	46	462	484	0	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					173	182		10.1016/S0092-8674(01)00525-6	http://dx.doi.org/10.1016/S0092-8674(01)00525-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672525	Bronze			2022-12-28	WOS:000171694800007
J	Pravdo, SH; Feigelson, ED; Garmire, G; Maeda, Y; Tsuboi, Y; Bally, J				Pravdo, SH; Feigelson, ED; Garmire, G; Maeda, Y; Tsuboi, Y; Bally, J			Discovery of X-rays from the protostellar outflow object HH2	NATURE			English	Article							HERBIG-HARO OBJECTS; EMISSION; SHOCK	Herbig-Haro (HH) objects have been known(1,2) for 50 years to be luminous condensations of gas in star-forming regions, but their underlying physical nature is still being elucidated. Previously suggested models encompass newborn stars(3), stellar winds clashing with nebular material(4), dense pockets of interstellar gas excited by shocks from outflows(5), and interstellar 'bullets' (ref. 6). Recent progress has been made with the jet-induced shock model(7), in which material streams out of young stellar objects and collides with the surrounding interstellar medium. A clear prediction of this model is that the most energetic Herbig-Haro objects will emit X-rays, although they have not hitherto been detected(8). Here we report the discovery of X-ray emission from one of the brightest and closest Herbig-Haro objects, HH2, at a level consistent with the model predictions. We conclude that this Herbig-Haro object contains shock-heated material located at or near its leading edge with a temperature of about 10(6) K.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Penn State Univ, Dept Astron & Astrophys, DAvey Lab 525, University Pk, PA 16802 USA; Univ Colorado, Boulder, CO 80309 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Colorado System; University of Colorado Boulder	Pravdo, SH (corresponding author), CALTECH, Jet Prop Lab, Mail Stop 306-438,4800 Oak Grove Dr, Pasadena, CA 91109 USA.							AMBARTSUMIAN VA, 1954, COMM BYURAKAN OBSERV, V13, P3; Bautz M, 1998, P SOC PHOTO-OPT INS, V3444, P210, DOI 10.1117/12.331238; BOHM KH, 1979, ASTRON ASTROPHYS, V74, P297; BOHMVITENSE E, 1982, ASTROPHYS J, V262, P224, DOI 10.1086/160413; CANTO J, 1980, ASTROPHYS J, V239, P982, DOI 10.1086/158186; *CHANDR INT AN OBS, CIAO 2 SCI THREADS D; COX DP, 1971, ASTROPHYS J, V167, P113, DOI 10.1086/151009; EISLOFFEL J, 1994, ASTRON J, V108, P1042, DOI 10.1086/117133; *EUR SPAC AG, 1997, ESA, V1; HARO G, 1952, ASTROPHYS J, V115, P572, DOI 10.1086/145576; HARTIGAN P, 1987, ASTROPHYS J, V316, P323, DOI 10.1086/165204; HERBIG GH, 1951, ASTROPHYS J, V113, P697, DOI 10.1086/145440; Hog E, 2000, ASTRON ASTROPHYS, V355, pL27; MCKEE CF, 1974, ASTROPHYS J, V188, P335, DOI 10.1086/152721; Mewe R., 1985, Astronomy & Astrophysics Supplement Series, V62, P197; MONET DG, 1998, AAS M, V193; NORMAN C, 1979, ASTROPHYS J, V228, P197, DOI 10.1086/156836; ORTALINI S, 1980, ASTRON ASTROPHYS, V83, pL8; PRAVDO SH, 1985, ASTROPHYS J, V293, pL35, DOI 10.1086/184486; PRAVDO SH, 1981, ASTROPHYS J, V248, P591, DOI 10.1086/159184; REIPURTH B, 1997, IAU S, V182; Rodriguez LF, 2000, ASTRON J, V119, P882, DOI 10.1086/301231; SCHWARTZ RD, 1978, ASTROPHYS J, V223, P884, DOI 10.1086/156321	23	104	104	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					708	711		10.1038/35099508	http://dx.doi.org/10.1038/35099508			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607024				2022-12-28	WOS:000171608000036
J	Heller, D				Heller, D			Validity of the evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MMR VACCINATION; AUTISM 1998; CAUSAL		Univ Manchester, Sch Med, Sch Epidemiol & Hlth Sci, Evidence Populat Hlth Unit, Manchester M13 9PT, Lancs, England	University of Manchester	Heller, D (corresponding author), Univ Manchester, Sch Med, Sch Epidemiol & Hlth Sci, Evidence Populat Hlth Unit, Manchester M13 9PT, Lancs, England.	Dick.Heller@man.ac.uk						Dales L, 2001, JAMA-J AM MED ASSOC, V285, P1183, DOI 10.1001/jama.285.9.1183; Gellin BG, 2001, NEW ENGL J MED, V344, P372, DOI 10.1056/NEJM200102013440509; HELLER RC, IN PRESS J EPIDEMIOL; *I MED, 2001, IMM SAF REV MEASL MU; Kaye JA, 2001, BRIT MED J, V322, P460, DOI 10.1136/bmj.322.7284.460; Nicoll A, 1998, BMJ-BRIT MED J, V316, P715, DOI 10.1136/bmj.316.7133.715; Patja A, 2000, PEDIATR INFECT DIS J, V19, P1127, DOI 10.1097/00006454-200012000-00002; Roberts R, 1998, BRIT MED J, V316, P1824, DOI 10.1136/bmj.316.7147.1824; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; Wakefield AJ, 1998, LANCET, V351, P1356, DOI 10.1016/S0140-6736(05)79083-8; Watson J C, 1998, MMWR Recomm Rep, V47, P1; Wise Jacqui, 2001, BMJ-BRIT MED J, V322, P130	12	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2001	323	7317					839	840						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483RW	11683152				2022-12-28	WOS:000171650500027
J	West, GB; Brown, JH; Enquist, BJ				West, GB; Brown, JH; Enquist, BJ			A general model for ontogenetic growth	NATURE			English	Article							BODY-SIZE; LIFE; LAWS	Several equations have been proposed to describe ontogenetic growth trajectories for organisms justified primarily on the goodness of rt rather than on any biological mechanism(1-6). Here, we derive a general quantitative model based on fundamental principles(7-9) for the allocation of metabolic energy between maintenance of existing tissue and the production of new biomass. We thus predict the parameters governing growth curves from basic cellular properties(10) and derive a single parameterless universal curve that describes the growth of many diverse species. The model provides the basis for deriving allometric relationships for growth rates and the timing of life history events(2,11,12).	Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; Santa Fe Inst, Santa Fe, NM 87501 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute; University of New Mexico; University of Arizona	West, GB (corresponding author), Los Alamos Natl Lab, Div Theoret, MS B285, Los Alamos, NM 87545 USA.	gbw@lanl.gov	Enquist, Brian J/B-6436-2008	Enquist, Brian J/0000-0002-6124-7096				ALBERTS M, 1994, MOL BIOL CELL; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; BRETT JR, 1989, J FISH RES BOARD CAN, V22, P1491; Brody S, 1964, BIOENERGETICS GROWTH; Brown J., 2000, SCALING BIOL; Calder WA., 1984, SIZE FUNCTION LIFE H; Charnov Eric L., 1993, P1; Cummins K. W, 1971, Mitt int Verein theor angew Limnol, VNo. 18, P1; Day T, 1997, AM NAT, V149, P381, DOI 10.1086/285995; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; HAMBURGER K, 1983, MAR BIOL, V75, P303, DOI 10.1007/BF00406016; KOHLER AC, 1964, J FISH RES BOARD CAN, V21, P57, DOI 10.1139/f64-007; Kozlowski J, 1996, P ROY SOC B-BIOL SCI, V263, P559, DOI 10.1098/rspb.1996.0084; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Reiss M.J., 1989, ALLOMETRY GROWTH REP; Ricker W.E., 1979, BIOENERGETICS GROWTH, VVIII, P677, DOI DOI 10.1016/S1546-5098(08)60034-5; ROGERS DM, 1995, J APPL PHYSIOL, V79, P958, DOI 10.1152/jappl.1995.79.3.958; Stearns S.C., 1992, pi; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; WEATHERS WW, 1995, IBIS, V137, P532, DOI 10.1111/j.1474-919X.1995.tb03263.x; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; XIAOJUN X, 1990, Physiological Zoology, V63, P1181	24	771	808	10	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2001	413	6856					628	631		10.1038/35098076	http://dx.doi.org/10.1038/35098076			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675785				2022-12-28	WOS:000171485700048
J	ROBERTSON, I				ROBERTSON, I			GENE GENIES	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	1995	310	6995					1679	1679		10.1136/bmj.310.6995.1679a	http://dx.doi.org/10.1136/bmj.310.6995.1679a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RF698	11644705	Green Published			2022-12-28	WOS:A1995RF69800096
J	[Anonymous]				[Anonymous]			THE RIGHT-TO-DIE	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 1	1994	308	6920					66	66						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ096	11644505				2022-12-28	WOS:A1994MQ09600081
J	PEARSON, GS				PEARSON, GS			VETERANS AT RISK - THE HEALTH-EFFECTS OF MUSTARD GAS AND LEWISITE - PECHURA,CM, RALL,DP	NATURE			English	Book Review											PEARSON, GS (corresponding author), MINIST DEF,CHEM & BIOL DEF ESTAB,PORTON DOWN,SALISBURY SP4 0QJ,WILTS,ENGLAND.							Pechura C., 1993, VETERANS RISK HLTH E	1	7	8	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 16	1993	365	6443					218	218		10.1038/365218a0	http://dx.doi.org/10.1038/365218a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LX471	11643154				2022-12-28	WOS:A1993LX47100040
J	BURKHART, J				BURKHART, J			AMA POLICY FOR TESTING HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											BURKHART, J (corresponding author), AMER MED ASSOC,DEPT RESIDENT PHYSICIAN SERV,515 N STATE ST,CHICAGO,IL 60610, USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	1992	267	6					792	792						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HC484	11642977				2022-12-28	WOS:A1992HC48400008
J	d'Aignaux, JNH; Cousens, SN; Smith, PG				d'Aignaux, JNH; Cousens, SN; Smith, PG			Predictability of the UK variant Creutzfeldt-Jakob disease epidemic	SCIENCE			English	Article							VCJD MORTALITY; AIDS EPIDEMIC; UNITED-STATES; GREAT-BRITAIN; SCRAPIE; GENOTYPE	Back-calculation analysis of the variant Creutzfeldt-Jakob disease epidemic in the United Kingdom is used to estimate the number of infected individuals and future disease incidence. The model assumes a hazard of infection proportional to the incidence of bovine spongiform encephalopathy in the United Kingdom and accounts for precautionary control measures and very wide ranges of incubation periods. The model indicates that current case data are compatible with numbers of infections ranging from a few hundred to several millions. In the tatter case, the model suggests that the mean incubation period must be well beyond the human life-span, resulting in disease epidemics of at most several thousand cases.	Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	d'Aignaux, JNH (corresponding author), Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, Keppel St, London WC1E 7HT, England.		smith, peter/ABH-9627-2020	smith, peter/0000-0003-0080-7560				ANDERSON RM, 1996, NATURE, V382, P943; Balter M, 2000, SCIENCE, V289, P1663; Bonn D, 2000, LANCET, V356, P570; Bossers A, 1996, J GEN VIROL, V77, P2669, DOI 10.1099/0022-1317-77-10-2669; BROOKMEYER R, 1991, SCIENCE, V253, P37, DOI 10.1126/science.2063206; BROOKMEYER R, 1986, LANCET, V2, P1320; CARP RI, 1987, J GEN VIROL, V68, P401, DOI 10.1099/0022-1317-68-2-401; Cervenakova L, 1998, P NATL ACAD SCI USA, V95, P13239, DOI 10.1073/pnas.95.22.13239; Cooper J D, 2000, J Epidemiol Biostat, V5, P209; Cousens SN, 1997, NATURE, V385, P197, DOI 10.1038/385197a0; Frosh A, 2001, BRIT MED J, V322, P1558, DOI 10.1136/bmj.322.7302.1558; Ghani AC, 2000, NATURE, V406, P583, DOI 10.1038/35020688; Ghani AC, 1998, P ROY SOC B-BIOL SCI, V265, P2443, DOI 10.1098/rspb.1998.0596; JONES J, 2000, BRIT MED J, V321, pB469; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; Manolakou K, 2001, P NATL ACAD SCI USA, V98, P7402, DOI 10.1073/pnas.121172098; McLean AR, 2000, PHILOS T ROY SOC B, V355, P1043, DOI 10.1098/rstb.2000.0641	18	72	74	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2001	294	5547					1729	1731		10.1126/science.1064748	http://dx.doi.org/10.1126/science.1064748			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11679631				2022-12-28	WOS:000172307400048
J	Greengard, P				Greengard, P			Neuroscience - The neurobiology of slow synaptic transmission	SCIENCE			English	Review							CAMP-REGULATED PHOSPHOPROTEIN; DEPENDENT PROTEIN-KINASE; SQUID GIANT SYNAPSE; INNERVATED BRAIN-REGIONS; MAMMALIAN BRAIN; IN-VIVO; IMMUNOCYTOCHEMICAL LOCALIZATION; PHOSPHORYLATION SYSTEMS; TRANSMITTER RELEASE; HIPPOCAMPAL-NEURONS	Nerve cells communicate with each other through two mechanisms, referred to as fast and slow synaptic transmission. Fast-acting neurotransmitters, e.g., glutamate (excitatory) and gamma -aminobutyric add (GABA) (inhibitory), achieve effects on their target cells within one millisecond by virtue of opening ligand-operated ion channels. In contrast all of the effects of the biogenic amine and peptide neurotransmitters, as well as many of the effects of glutamate and GABA are achieved over hundreds of milliseconds to minutes by slow synaptic transmission. This latter process is mediated through an enormously more complicated sequence of biochemical steps, involving second messengers, protein kinases, and protein phosphatases. Slow-acting neurotransmitters control the efficacy of fast synaptic transmission by regulating the efficiency of neurotransmitter release from presynaptic terminals and by regulating the efficiency with which fast-acting neurotransmitters produce their effects on postsynaptic receptors.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	Rockefeller University	Greengard, P (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10021 USA.							Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; CARLSSON A, 2000, PRIX NOBEL 2000, P237; CASTELLUCCI VF, 1982, J NEUROSCI, V2, P1673; CASTELLUCCI VF, 1980, P NATL ACAD SCI-BIOL, V77, P7492, DOI 10.1073/pnas.77.12.7492; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; DESDOUITS F, 1995, P NATL ACAD SCI USA, V92, P2682, DOI 10.1073/pnas.92.7.2682; DESDOUITS F, 1995, J BIOL CHEM, V270, P8772, DOI 10.1074/jbc.270.15.8772; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Fienberg AA, 2000, BRAIN RES REV, V31, P313, DOI 10.1016/S0165-0173(99)00047-8; GIRAULT JA, 1988, P NATL ACAD SCI USA, V85, P7790, DOI 10.1073/pnas.85.20.7790; GIRAULT JA, 1989, J BIOL CHEM, V264, P21748; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; HSIEHWILSON L, UNPUB; KANDEL ER, 2000, PRIX NOBEL 2000, P326; KEBABIAN JW, 1971, SCIENCE, V174, P1346, DOI 10.1126/science.174.4016.1346; KREBS EG, 1992, PRIX NOBEL 1992, P98; KUO JF, 1970, J BIOL CHEM, V245, P2493; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; MIYAMOTO E, 1969, SCIENCE, V165, P63, DOI 10.1126/science.165.3888.63; NAIRN AC, 1982, NATURE, V299, P734, DOI 10.1038/299734a0; Nestler E. J., 1984, PROTEIN PHOSPHORYLAT; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; Nishi A, 1999, J NEUROCHEM, V72, P2015, DOI 10.1046/j.1471-4159.1999.0722015.x; Nishi A, 1997, J NEUROSCI, V17, P8147; OUIMET CC, 1984, J NEUROSCI, V4, P111; OUIMET CC, 1992, J COMP NEUROL, V323, P209, DOI 10.1002/cne.903230206; OUIMET CC, 1988, CENTRAL D1 DOPAMINE, V235, P1; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; SCHULMAN H, 1978, NATURE, V271, P478, DOI 10.1038/271478a0; SILVA EFDE, 1995, J NEUROSCI, V15, P3375; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; SNYDER GL, 1994, J NEUROCHEM, V63, P1766; SNYDER GL, 1993, P NATL ACAD SCI USA, V90, P11277, DOI 10.1073/pnas.90.23.11277; Snyder GL, 1998, J NEUROSCI, V18, P10297; SUTHERLAND EW, 1972, PRIX NOBEL 1971, P240; Svenningsson P, 1998, NEUROSCIENCE, V84, P223, DOI 10.1016/S0306-4522(97)00510-1; Svenningsson P, 2000, P NATL ACAD SCI USA, V97, P1856, DOI 10.1073/pnas.97.4.1856; Svenningsson P, 2000, J NEUROCHEM, V75, P248, DOI 10.1046/j.1471-4159.2000.0750248.x; WALAAS SI, 1983, J NEUROSCI, V3, P302; WALAAS SI, 1983, J NEUROSCI, V3, P291; WALAAS SI, 1983, NATURE, V301, P69; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516	50	656	680	4	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1024	1030		10.1126/science.294.5544.1024	http://dx.doi.org/10.1126/science.294.5544.1024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691979				2022-12-28	WOS:000172013800035
J	Segura-Totten, M; Wilson, KL				Segura-Totten, M; Wilson, KL			Virology - HIV - Breaking the rules for nuclear entry	SCIENCE			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; CELL-CYCLE; PROTEIN; AUTOINTEGRATION; ORGANIZATION; COMPLEXES; ENVELOPE; MITOSIS; GENE; VPR		Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Segura-Totten, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.							Cai ML, 2001, EMBO J, V20, P4399, DOI 10.1093/emboj/20.16.4399; Chen HM, 1998, P NATL ACAD SCI USA, V95, P15270, DOI 10.1073/pnas.95.26.15270; Cohen M, 2001, TRENDS BIOCHEM SCI, V26, P41, DOI 10.1016/S0968-0004(00)01727-8; de Noronha CMC, 2001, SCIENCE, V294, P1105, DOI 10.1126/science.1063957; Furukawa K, 1999, J CELL SCI, V112, P2485; Henklein P, 2000, J BIOL CHEM, V275, P32016, DOI 10.1074/jbc.M004044200; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Laguri C, 2001, STRUCTURE, V9, P503, DOI 10.1016/S0969-2126(01)00611-6; Lee MS, 1998, P NATL ACAD SCI USA, V95, P1528, DOI 10.1073/pnas.95.4.1528; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Lin F, 2000, J BIOL CHEM, V275, P4840, DOI 10.1074/jbc.275.7.4840; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; Scott ES, 2001, J VIROL, V75, P8818, DOI 10.1128/JVI.75.18.8818-8830.2001; Sherman MP, 2001, J VIROL, V75, P1522, DOI 10.1128/JVI.75.3.1522-1532.2001; Steen RL, 2000, J CELL BIOL, V150, P1251, DOI 10.1083/jcb.150.6.1251; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Vasu SK, 2001, CURR OPIN CELL BIOL, V13, P363, DOI 10.1016/S0955-0674(00)00221-0	21	18	18	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1016	1017		10.1126/science.1066729	http://dx.doi.org/10.1126/science.1066729			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691977				2022-12-28	WOS:000172013800033
J	Berneche, S; Roux, B				Berneche, S; Roux, B			Energetics of ion conduction through the K+ channel	NATURE			English	Article							FREE-ENERGY CALCULATIONS; MOLECULAR-DYNAMICS; POTASSIUM CHANNEL; SIMULATIONS; PERMEATION; KCSA; SELECTIVITY; MECHANISM; BILAYER; WATER	K+ channels are transmembrane proteins that are essential for the transmission of nerve impulses. The ability of these proteins to conduct K+ ions at levels near the limit of diffusion is traditionally described in terms of concerted mechanisms in which ion-channel attraction and ion-ion repulsion have compensating effects, as several ions are moving simultaneously in single file through the narrow pore(1-4). The efficiency of such a mechanism, however, relies on a delicate energy balance-the strong ion-channel attraction must be perfectly counterbalanced by the electrostatic ion-ion repulsion. To elucidate the mechanism of ion conduction at the atomic level, we performed molecular dynamics free energy simulations on the basis of the X-ray structure of the KcsA K+ channel(4). Here we rnd that ion conduction involves transitions between two main states, with two and three K+ ions occupying the selectivity filter, respectively; this process is reminiscent of the 'knock-on' mechanism proposed by Hodgkin and Keynes in 1955(1). The largest free energy barrier is on the order of 2-3 kcal mol(-1), implying that the process of ion conduction is limited by diffusion. Ion-ion repulsion, although essential for rapid conduction, is shown to act only at very short distances. The calculations show also that the rapidly conducting pore is selective.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada	Cornell University; Universite de Montreal	Roux, B (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.	benoit.roux@med.cornell.edu	Bernèche, Simon/L-6389-2013	Bernèche, Simon/0000-0002-6274-4094				ALCAYAGA C, 1989, BIOPHYS J, V55, P367, DOI 10.1016/S0006-3495(89)82814-0; Allen TW, 2000, J CHEM PHYS, V112, P8191, DOI 10.1063/1.481420; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; ARMSTRON.CM, 1968, NATURE, V219, P1262, DOI 10.1038/2191262a0; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Berneche S, 2000, BIOPHYS J, V78, P2900, DOI 10.1016/S0006-3495(00)76831-7; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Crouzy S, 2001, J GEN PHYSIOL, V118, P207, DOI 10.1085/jgp.118.2.207; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EISENMAN G, 1962, Biophys J, V2, P259; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Guidoni L, 1999, BIOCHEMISTRY-US, V38, P8599, DOI 10.1021/bi990540c; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LAUGER P, 1979, BIOCHIM BIOPHYS ACTA, V552, P143, DOI 10.1016/0005-2736(79)90253-0; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Roux B, 1999, BIOPHYS J, V77, P139, DOI 10.1016/S0006-3495(99)76878-5; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Schlenkrich Michael, 1996, P31; SCHUMAKER MF, 1990, BIOPHYS J, V58, P975, DOI 10.1016/S0006-3495(90)82442-5; Shrivastava IH, 2000, BIOPHYS J, V78, P557, DOI 10.1016/S0006-3495(00)76616-1; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8	30	624	635	0	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					73	77		10.1038/35102067	http://dx.doi.org/10.1038/35102067			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689945				2022-12-28	WOS:000171898900044
J	Salehi-Ashtiani, K; Szostak, JW				Salehi-Ashtiani, K; Szostak, JW			In vitro evolution suggests multiple origins for the hammerhead ribozyme	NATURE			English	Article							HEPATITIS-DELTA-VIRUS; RNA; TRANSCRIPTS	The hammerhead ribozyme was originally discovered in a group of RNAs associated with plant viruses, and has subsequently been identified in the genome of the newt (Notophthalamus viridescens)(1,2), in schistosomes(3) and in cave crickets (Dolichopoda species)(4). The sporadic occurrence of this self-cleaving RNA motif in highly divergent organisms could be a consequence of the very early evolution of the hammerhead ribozyme(4,5), with all extant examples being descended from a single ancestral progenitor. Alternatively, the hammerhead ribozyme may have evolved independently many times. To better understand the observed distribution of hammerhead ribozymes, we used in vitro selection to search an unbiased sample of random sequences for comparably active self-cleaving motifs. Here we show that, under near-physiological conditions, the hammerhead ribozyme motif is the most common (and thus the simplest) RNA structure capable of self-cleavage at biologically observed rates. Our results suggest that the evolutionary process may have been channelled, in nature as in the laboratory, towards repeated selection of the simplest solution to a biochemical problem.	Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.			Salehi-Ashtiani, Kourosh/0000-0002-6521-5243				BEATTIE TL, 1995, P NATL ACAD SCI USA, V92, P4686, DOI 10.1073/pnas.92.10.4686; BEEN MD, 1994, TRENDS BIOCHEM SCI, V19, P251, DOI 10.1016/0968-0004(94)90151-1; Conaty J, 1999, NUCLEIC ACIDS RES, V27, P2400, DOI 10.1093/nar/27.11.2400; DIENER TO, 1989, P NATL ACAD SCI USA, V86, P9370, DOI 10.1073/pnas.86.23.9370; Ferbeyre G, 1998, MOL CELL BIOL, V18, P3880, DOI 10.1128/MCB.18.7.3880; GOULD SJ, 1989, WONDERFUL LIFE BURGE, P292; HAMPEL N, 1998, PROGR NUCL ACIDS RES, P1; LONG DM, 1993, FASEB J, V7, P25, DOI 10.1096/fasebj.7.1.8422971; PABONPENA LM, 1991, MOL CELL BIOL, V11, P6109, DOI 10.1128/MCB.11.12.6109; Rojas AA, 2000, NUCLEIC ACIDS RES, V28, P4037, DOI 10.1093/nar/28.20.4037; RUFFNER DE, 1990, BIOCHEMISTRY-US, V29, P10695, DOI 10.1021/bi00499a018; Tang J, 2000, P NATL ACAD SCI USA, V97, P5784, DOI 10.1073/pnas.97.11.5784; THILL G, 1993, BIOCHEMISTRY-US, V32, P4254, DOI 10.1021/bi00067a013; THOMSON JB, 1997, CATALYTIC RNA, P173; WILLS G, 1995, LEARNING ORG, V2, P14; Zhang Y, 1996, GENE, V172, P183, DOI 10.1016/0378-1119(96)00126-6	16	129	143	2	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 01	2001	414	6859					82	84		10.1038/35102081	http://dx.doi.org/10.1038/35102081			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689947				2022-12-28	WOS:000171898900046
J	Angel, CA; Ehlers, RA				Angel, CA; Ehlers, RA			Atloido-occipital dislocation in a small child after air-bag deployment.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Texas, Med Branch, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Angel, CA (corresponding author), Univ Texas, Med Branch, Galveston, TX 77555 USA.								0	3	3	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2001	345	17					1256	1256		10.1056/NEJMicm070559	http://dx.doi.org/10.1056/NEJMicm070559			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485RU	11680446				2022-12-28	WOS:000171773100006
J	Schlunzen, F; Zarivach, R; Harms, J; Bashan, A; Tocilj, A; Albrecht, R; Yonath, A; Franceschi, F				Schlunzen, F; Zarivach, R; Harms, J; Bashan, A; Tocilj, A; Albrecht, R; Yonath, A; Franceschi, F			Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria	NATURE			English	Article							23S RIBOSOMAL-RNA; ESCHERICHIA-COLI; BINDING-SITE; ERYTHROMYCIN RESISTANCE; CRYSTAL-STRUCTURES; CHLORAMPHENICOL; MUTATIONS; SUBUNIT; CONFORMATION; RECOGNITION	Ribosomes, the site of protein synthesis, are a major target for natural and synthetic antibiotics. Detailed knowledge of antibiotic binding sites is central to understanding the mechanisms of drug action. Conversely, drugs are excellent tools for studying the ribosome function. To elucidate the structural basis of ribosome-antibiotic interactions, we determined the high-resolution X-ray structures of the 50S ribosomal subunit of the eubacterium Deinococcus radiodurans, complexed with the clinically relevant antibiotics chloramphenicol, clindamycin and the three macrolides erythromycin, clarithromycin and roxithromycin. We found that antibiotic binding sites are composed exclusively of segments of 23S ribosomal RNA at the peptidyl transferase cavity and do not involve any interaction of the drugs with ribosomal proteins. Here we report the details fo antibiotic interactions with the components of their binding sites. Our results also show the importance of putative Mg+2 ions for the binding of some drugs. This structural analysis should facilitate rational drug design.	Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Max Planck Res, Unit Ribosomal Struct, D-22603 Hamburg, Germany; Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel	Max Planck Society; Max Planck Society; Weizmann Institute of Science	Franceschi, F (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	Franceschi@molgen.mpg.de	Schluenzen, Frank/P-9177-2019; Harms, Joerg/K-8786-2012; Schluenzen, Frank/H-6274-2014; ZARIVACH, RAZ/F-1671-2012; Franceschi, Francois/AAF-5860-2021	Schluenzen, Frank/0000-0003-2849-0542; Harms, Joerg/0000-0002-9442-8264; Schluenzen, Frank/0000-0003-2849-0542; ZARIVACH, RAZ/0000-0001-6543-0296; Franceschi, Francois/0000-0002-1554-7944				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Barta A., 2001, SCIENCE, V291, p203a, DOI [10.1126/science.291.5502.203a, DOI 10.1126/SCIENCE.291.5502.203A]; Bottger EC, 2001, EMBO REP, V2, P318, DOI 10.1093/embo-reports/kve062; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CUNDLIFFE E, 1990, RIBOSOME, P479; DOUTHWAITE S, 1992, NUCLEIC ACIDS RES, V20, P4717, DOI 10.1093/nar/20.18.4717; GASC JC, 1991, J ANTIBIOT, V44, P313, DOI 10.7164/antibiotics.44.313; GOLDMAN RC, 1990, ANTIMICROB AGENTS CH, V34, P426, DOI 10.1128/AAC.34.3.426; Gregory ST, 1999, J MOL BIOL, V289, P827, DOI 10.1006/jmbi.1999.2839; Hansen LH, 1999, MOL MICROBIOL, V31, P623, DOI 10.1046/j.1365-2958.1999.01202.x; HARMS J, IN PRESS CELL; Izard T, 2000, EMBO J, V19, P2690, DOI 10.1093/emboj/19.11.2690; KALLIARAFTOPOULOS S, 1994, MOL PHARMACOL, V46, P1009; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MANKIN AS, 1991, J BACTERIOL, V173, P3559, DOI 10.1128/jb.173.11.3559-3563.1991; MAO JCH, 1969, J MOL BIOL, V44, P347, DOI 10.1016/0022-2836(69)90180-6; MILLER KD, 1993, J AM HIST, V80, P319, DOI 10.2307/2079816; MOAZED D, 1991, P NATL ACAD SCI USA, V88, P3725, DOI 10.1073/pnas.88.9.3725; MOAZED D, 1987, BIOCHIMIE, V69, P879, DOI 10.1016/0300-9084(87)90215-X; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; NOLL M, 1973, J MOL BIOL, V75, P281, DOI 10.1016/0022-2836(73)90021-1; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; Polacek N, 2001, NATURE, V411, P498, DOI 10.1038/35078113; POLACEK N, 2000, RNA BINDING ANTIBIOT, P1; Poulsen SM, 2000, J MOL BIOL, V304, P471, DOI 10.1006/jmbi.2000.4229; RODRIGUEZFONSECA C, 1995, J MOL BIOL, V247, P224, DOI 10.1006/jmbi.1994.0135; Ross JI, 1997, ANTIMICROB AGENTS CH, V41, P1162, DOI 10.1128/AAC.41.5.1162; Saarma U, 1998, RNA, V4, P189; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; SHAW WV, 1991, ANNU REV BIOPHYS BIO, V20, P363, DOI 10.1146/annurev.biophys.20.1.363; SIGMUND CD, 1984, NUCLEIC ACIDS RES, V12, P4653, DOI 10.1093/nar/12.11.4653; Spahn CMT, 1996, J MOL MED, V74, P423, DOI 10.1007/s001090050044; STEINER G, 1988, EMBO J, V7, P3949, DOI 10.1002/j.1460-2075.1988.tb03281.x; STEINMETZ WE, 1992, J MED CHEM, V35, P4842, DOI 10.1021/jm00104a009; Tenson T, 1996, P NATL ACAD SCI USA, V93, P5641, DOI 10.1073/pnas.93.11.5641; Thompson J, 2001, P NATL ACAD SCI USA, V98, P9002, DOI 10.1073/pnas.151257098; VAZQUEZ D, 1975, INHIBITORS PROTEIN S; VESTER B, 1988, EMBO J, V7, P3577, DOI 10.1002/j.1460-2075.1988.tb03235.x; VESTER B, 1995, RNA, V1, P501; Vester B, 2001, ANTIMICROB AGENTS CH, V45, P1, DOI 10.1128/AAC.45.1.1-12.2001; VINCE R, 1975, ANTIMICROB AGENTS CH, V8, P439, DOI 10.1128/AAC.8.4.439; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WITTMANN HG, 1973, MOL GEN GENET, V127, P175, DOI 10.1007/BF00333665; Xiong LQ, 1999, MOL MICROBIOL, V31, P633, DOI 10.1046/j.1365-2958.1999.01203.x; YONATH A, 1987, SCIENCE, V236, P813, DOI 10.1126/science.3576200; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	51	806	873	6	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2001	413	6858					814	821		10.1038/35101544	http://dx.doi.org/10.1038/35101544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677599				2022-12-28	WOS:000171750200038
J	Watanabe, T; Nanez, JE; Sasaki, Y				Watanabe, T; Nanez, JE; Sasaki, Y			Perceptual learning without perception	NATURE			English	Article							PRIMARY VISUAL-CORTEX; ATTENTIONAL MODULATION; ORIENTATION; MOTION; IMPROVEMENT; DISCRIMINATION; PLASTICITY; TASK; MT	The brain is able to adapt rapidly and continually to the surrounding environment, becoming increasingly sensitive to important and frequently encountered stimuli(1-4). It is often claimed that this adaptive learning is highly task-specific, that is, we become more sensitive to the critical signals in the tasks we attend to(5-15). Here, we show a new type of perceptual learning, which occurs without attention, without awareness and without any task relevance. Subjects were repeatedly presented with a background motion signal so weak that its direction was not visible; the invisible motion was an irrelevant background to the central task that engaged the subject's attention. Despite being below the threshold of visibility and being irrelevant to the central task, the repetitive exposure improved performance specifically for the direction of the exposed motion when tested in a subsequent suprathreshold test. These results suggest that a frequently presented feature sensitizes the visual system merely owing to its frequency, not its relevance or salience.	Boston Univ, Dept Psychol, Boston, MA 02215 USA; Arizona State Univ W, Dept Social & Behav Sci, Phoenix, AZ 85069 USA; Massachusetts Gen Hosp, NMR Ctr, Charlestown, MA 02129 USA	Boston University; Arizona State University; Arizona State University-Downtown Phoenix; Harvard University; Massachusetts General Hospital	Watanabe, T (corresponding author), Boston Univ, Dept Psychol, 64 Cummington St, Boston, MA 02215 USA.			Sasaki, Yuka/0000-0002-0061-0250				AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; Albert MK, 2000, PERCEPTION, V29, P303; BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; Bar M, 1998, PSYCHOL SCI, V9, P464, DOI 10.1111/1467-9280.00086; BARLOW HB, 1989, VISION CODING EFFICI; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; FAHLE M, 1993, VISION RES, V33, P397, DOI 10.1016/0042-6989(93)90094-D; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Gilbert CD, 1996, CURR OPIN NEUROBIOL, V6, P269, DOI 10.1016/S0959-4388(96)80083-3; Grossberg S, 1999, SPATIAL VISION, V12, P163, DOI 10.1163/156856899X00102; Ito M, 1998, NEURON, V20, P1191, DOI 10.1016/S0896-6273(00)80499-7; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KOYAMA S, IN PRESS J VIS S; NAKAYAMA K, 1992, SCIENCE, V257, P1357, DOI 10.1126/science.1529336; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; RAMACHANDRAN VS, 1973, PERCEPTION, V2, P371, DOI 10.1068/p020371; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; SAGI D, 1994, CURR OPIN NEUROBIOL, V4, P195, DOI 10.1016/0959-4388(94)90072-8; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; SLEMMER JA, IN PRESS J VIS S; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Vaina LM, 1998, P NATL ACAD SCI USA, V95, P12657, DOI 10.1073/pnas.95.21.12657; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; Watanabe T, 1998, J NEUROPHYSIOL, V79, P2218, DOI 10.1152/jn.1998.79.4.2218; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114	29	356	361	2	47	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					844	848		10.1038/35101601	http://dx.doi.org/10.1038/35101601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	485JA	11677607				2022-12-28	WOS:000171750200046
J	Luo, JY; Nikolaev, AY; Imai, S; Chen, DL; Su, F; Shiloh, A; Guarente, L; Gu, W				Luo, JY; Nikolaev, AY; Imai, S; Chen, DL; Su, F; Shiloh, A; Guarente, L; Gu, W			Negative control of p53 by Sir2 alpha promotes cell survival under stress	CELL			English	Article							DNA-DAMAGE; HISTONE DEACETYLASE; SIR2-LIKE PROTEINS; P53-DEPENDENT APOPTOSIS; PREMATURE SENESCENCE; OXIDATIVE STRESS; ONCOGENIC RAS; LIFE-SPAN; SIR2; ACETYLATION	The NAD-dependent histone deacetylation of Sir2 connects cellular metabolism with gene silencing as well as aging in yeast. Here, we show that mammalian Sir2 alpha physically interacts with p53 and attenuates p53-mediated functions. Nicotinamide (Vitamin B3) inhibits an NAD-dependent p53 deacetylation induced by Sir2 alpha, and also enhances the p53 acetylation levels in vivo. Furthermore, Sir2 alpha represses p53-dependent apoptosis in response to DNA damage and oxidative stress, whereas expression of a Sir2 alpha point mutant increases the sensitivity of cells in the stress response. Thus, our findings implicate a p53 regulatory pathway mediated by mammalian Sir2 alpha. These results have significant implications regarding an important role for Sir2 alpha in modulating the sensitivity of cells in p53-dependent apoptotic response and the possible effect in cancer therapy.	Columbia Univ Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Columbia University; Columbia University; Massachusetts Institute of Technology (MIT)	Gu, W (corresponding author), Columbia Univ Coll Phys & Surg, Inst Canc Genet, 1150 St Nicholas Ave, New York, NY 10032 USA.		Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914; Nikolaev, Anatoly/0000-0003-2818-5839	NATIONAL CANCER INSTITUTE [R01CA085533] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA85533] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Appella E, 2000, PATHOL BIOL, V48, P227; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Butler LM, 2000, CANCER RES, V60, P5165; Campisi J, 2000, SCIENCE, V289, P2062, DOI 10.1126/science.289.5487.2062; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; Chen QM, 2000, BIOCHEM J, V347, P543, DOI 10.1042/0264-6021:3470543; Chresta CM, 1996, NAT MED, V2, P745, DOI 10.1038/nm0796-745; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Ferbeyre G, 2000, GENE DEV, V14, P2015; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guarente L, 2000, GENE DEV, V14, P1021; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Lutzker SG, 1996, NAT MED, V2, P804, DOI 10.1038/nm0796-804; Marks PA, 2001, CLIN CANCER RES, V7, P759; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Prives C, 1999, J PATHOL, V187, P112; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shore D, 2000, P NATL ACAD SCI USA, V97, P14030, DOI 10.1073/pnas.011506198; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vaziri H, 1997, EMBO J, V16, P6018, DOI 10.1093/emboj/16.19.6018; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Yin YX, 1998, NATURE, V391, P707, DOI 10.1038/35648; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Yu AD, 2000, MOL CELL, V5, P801, DOI 10.1016/S1097-2765(00)80320-2; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	50	1771	1885	1	124	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					137	148		10.1016/S0092-8674(01)00524-4	http://dx.doi.org/10.1016/S0092-8674(01)00524-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672522	Bronze			2022-12-28	WOS:000171694800004
J	Simonsen, L; Morens, DM; Elixhauser, A; Gerber, M; Van Raden, M; Blackwelder, WC				Simonsen, L; Morens, DM; Elixhauser, A; Gerber, M; Van Raden, M; Blackwelder, WC			Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception	LANCET			English	Article							DEVELOPING-COUNTRIES; UNITED-STATES; IMMUNIZATION; INFECTION; CHILDREN; FUTURE	Background Studies have reported a temporal association between a first dose of rotavirus vaccine (Rotashield) and infant intussusception. We investigated the effect of Rotashield vaccination use on intussusception admissions in ten US states. Methods We analysed electronic databases containing 100% hospital discharge records for 1993-99 from ten US states, where an estimated 28% of the birth cohort had received Rotashield (based on manufacturer's net sales data). We examined records of infants admitted to hospital (<365 days old) with any mention of intussusception (international Classification of Diseases, ninth revision. clinical modification code 560.0). Excess admissions for intussusception during the period of Rotashield availability (October 1998 to June 1999) were estimated by direct comparison with the corresponding period of October 1997 to June 1998 (before Rotashield was available) and with adjustment for secular trends during 1993-98 by Poisson regression. Findings Hospital admission for intussusception among infants younger than 365 days of age during the Rotashield period compared with previously was 4% lower (10 cases) by direct comparison and 10% lower (27 cases) by trend comparison, corresponding to a negative population attributable risk. Among infants aged 45-210 days (target age range for a first Rotashield dose), we estimated an increase in intussusception admissions of 1% (one excess admission) by direct comparison and 4% (4.6 excess admissions) by trend comparison, corresponding to a population attributable risk range of one excess admission in 66 000-302 000. Interpretation We found no evidence of increased infant intussusception admissions during the period of Rotashield availability. The total intussusception admission risk attributable to Rotashield was substantially lower than previous estimates based on studies focusing on the immediate postvaccination weeks.	NIAID, NIH, Bethesda, MD 20892 USA; Agcy Healthcare Res & Qual, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Agency for Healthcare Research & Quality	Simonsen, L (corresponding author), 6700-B Rockledge Dr,Room 3153, Bethesda, MD 20892 USA.		Simonsen, Lone/K-4531-2014	Simonsen, Lone/0000-0003-1535-8526				*ADV COMM IMM PRAC, 1999, ACIP C ATL OCT 22 19, P1; [Anonymous], M FUT DIR ROT VACC R; Bresee JS, 1999, VACCINE, V17, P2207, DOI 10.1016/S0264-410X(98)00376-4; *CDCP, 1999, MMWR MORB MORTAL WKL, V48; CHANG HGH, IN PRESS PEDIATRICS; DEZOYSA I, 1985, B WORLD HEALTH ORGAN, V63, P569; Ehresman K., 1999, Morbidity and Mortality Weekly Report, V48, P577; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Gay N, 1999, LANCET, V354, P956, DOI 10.1016/S0140-6736(05)75710-X; Glass RI, 1996, J INFECT DIS, V174, pS5, DOI 10.1093/infdis/174.Supplement_1.S5; *I MED, 1986, NEW VACC DEV DIS IMP, V2; Kramarz P, 2001, PEDIATR INFECT DIS J, V20, P410, DOI 10.1097/00006454-200104000-00008; Levin A, 2000, ANN INTERN MED, V133, P661, DOI 10.7326/0003-4819-133-8-200010170-00102; Melton L, 2000, LANCET, V356, P318, DOI 10.1016/S0140-6736(05)73604-7; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Nakagomi T, 2000, MICROBIOL IMMUNOL, V44, P619, DOI 10.1111/j.1348-0421.2000.tb02542.x; Parashar UD, 2000, PEDIATRICS, V106, P1413, DOI 10.1542/peds.106.6.1413; Rennels MB, 1998, PEDIATR INFECT DIS J, V17, P924, DOI 10.1097/00006454-199810000-00018; Tucker AW, 1998, JAMA-J AM MED ASSOC, V279, P1371, DOI 10.1001/jama.279.17.1371; Weijer C, 2000, BRIT MED J, V321, P525, DOI 10.1136/bmj.321.7260.525	20	92	94	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1224	1229		10.1016/S0140-6736(01)06346-2	http://dx.doi.org/10.1016/S0140-6736(01)06346-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675060				2022-12-28	WOS:000171527000012
J	BENDITT, J				BENDITT, J			CONDUCT IN SCIENCE	SCIENCE			English	Editorial Material																			0	3	3	0	1	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 23	1995	268	5218					1705	1705		10.1126/science.11644751	http://dx.doi.org/10.1126/science.11644751			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RE668	11644751				2022-12-28	WOS:A1995RE66800022
J	DUNEA, G				DUNEA, G			TELLING THE PATIENT	BRITISH MEDICAL JOURNAL			English	Editorial Material											DUNEA, G (corresponding author), COOK CTY HOSP,CHICAGO,IL 60612, USA.								0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 3	1995	310	6992					1474	1474		10.1136/bmj.310.6992.1474	http://dx.doi.org/10.1136/bmj.310.6992.1474			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC105	11644712	Green Published			2022-12-28	WOS:A1995RC10500071
J	CHARLTON, R				CHARLTON, R			WORDS OF SORROW	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	DEC 4	1993	307	6917					1502	1502		10.1136/bmj.307.6917.1502	http://dx.doi.org/10.1136/bmj.307.6917.1502			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MK797	11643200	Bronze, Green Published			2022-12-28	WOS:A1993MK79700081
J	Hermanson, KD; Lumsdon, SO; Williams, JP; Kaler, EW; Velev, OD				Hermanson, KD; Lumsdon, SO; Williams, JP; Kaler, EW; Velev, OD			Dielectrophoretic assembly of electrically functional microwires from nanoparticle suspensions	SCIENCE			English	Article							COLLOIDAL PARTICLES; FIELDS	A new class of microwires can be assembled by dielectrophoresis from suspensions of metallic nanoparticles. The wires are formed in the gaps between planar electrodes and can grow faster than 50 micrometers per second to lengths exceeding 5 millimeters. They have good ohmic conductance and automatically form electrical connections to conductive islands or particles. The thickness and the fractal dimension of the wires can be controlled, and composite wires with a metallic core surrounded by a latex shell can be assembled. The simple assembly process and their high surface-to-volume ratio make these structures promising for wet electronic and bioelectronic circuits.	Univ Delaware, Dept Chem Engn, Ctr Mol & Engn Thermodynam, Newark, DE 19716 USA	University of Delaware	Velev, OD (corresponding author), N Carolina State Univ, Dept Chem Engn, Riddick Hall, Raleigh, NC 27695 USA.	odvelev@unity.ncsu.edu	Velev, Orlin D/A-2853-2008; Kaler, Eric/AAR-9561-2020	Velev, Orlin D/0000-0003-0473-8056; 				BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049; Bowden N, 1997, SCIENCE, V276, P233, DOI 10.1126/science.276.5310.233; Bradley JC, 1997, NATURE, V389, P268, DOI 10.1038/38464; Bradley JC, 1999, ADV MATER, V11, P374, DOI 10.1002/(SICI)1521-4095(199903)11:5<374::AID-ADMA374>3.3.CO;2-H; Breen TL, 1999, SCIENCE, V284, P948, DOI 10.1126/science.284.5416.948; Cassagneau TP, 2000, MRS BULL, V25, P40, DOI 10.1557/mrs2000.178; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Decher G, 1998, CURR OPIN COLLOID IN, V3, P32, DOI 10.1016/S1359-0294(98)80039-3; Dueweke M, 1996, PHYS REV E, V54, P496, DOI 10.1103/PhysRevE.54.496; FUHR G, 1994, NATURWISSENSCHAFTEN, V81, P528; GAST AP, 1989, ADV COLLOID INTERFAC, V30, P153, DOI 10.1016/0001-8686(89)80006-5; Holmes JD, 2000, SCIENCE, V287, P1471, DOI 10.1126/science.287.5457.1471; Huang Y, 2001, SCIENCE, V291, P630, DOI 10.1126/science.291.5504.630; Jones T. B., 1995, ELECTROMECHANICS PAR; Kenis PJA, 1999, SCIENCE, V285, P83, DOI 10.1126/science.285.5424.83; Li CZ, 1998, PHYS REV B, V58, P6775, DOI 10.1103/PhysRevB.58.6775; MATSUSHITA M, 1984, PHYS REV LETT, V53, P286, DOI 10.1103/PhysRevLett.53.286; Mbindyo JKN, 2001, ADV MATER, V13, P249, DOI 10.1002/1521-4095(200102)13:4<249::AID-ADMA249>3.0.CO;2-9; Muller T, 1996, J PHYS D APPL PHYS, V29, P340, DOI 10.1088/0022-3727/29/2/010; PETHIG R, 1992, J PHYS D APPL PHYS, V25, P881, DOI 10.1088/0022-3727/25/5/022; Pethig R, 1996, CRIT REV BIOTECHNOL, V16, P331, DOI 10.3109/07388559609147425; Pohl H., 1978, DIELECTROPHORESIS; Shah RR, 2001, SCIENCE, V293, P1296, DOI 10.1126/science.1062293; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; Smith PA, 2000, APPL PHYS LETT, V77, P1399, DOI 10.1063/1.1290272; Thurn-Albrecht T, 2000, SCIENCE, V290, P2126, DOI 10.1126/science.290.5499.2126; TRAU M, 1995, NATURE, V374, P437, DOI 10.1038/374437a0; Velev OD, 1999, LANGMUIR, V15, P3693, DOI 10.1021/la981729c; Wen WJ, 1997, PHYS REV E, V55, pR2100, DOI 10.1103/PhysRevE.55.R2100; Yu JS, 2000, CHEM COMMUN, P2445, DOI 10.1039/b007999p	30	497	527	1	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2001	294	5544					1082	1086		10.1126/science.1063821	http://dx.doi.org/10.1126/science.1063821			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691987				2022-12-28	WOS:000172013800044
J	Lagos-Quintana, M; Rauhut, R; Lendeckel, W; Tuschl, T				Lagos-Quintana, M; Rauhut, R; Lendeckel, W; Tuschl, T			Identification of novel genes coding for small expressed RNAs	SCIENCE			English	Article							INTERFERENCE; SEQUENCE; RDE-1	In Caenorhabditis elegans, lin-4 and let-7 encode 22- and 21-nucleotide (nt) RNAs, respectively, which function as key regulators of developmental timing. Because the appearance of these short RNAs is regulated during development, they are also referred to as small temporal RNAs (stRNAs). We show that many 21- and 22-nt expressed RNAs, termed microRNAs, exist in invertebrates and vertebrates and that some of these novel RNAs, similar to let-7 stRNA, are highly conserved. This suggests that sequence-specific, posttranscriptional regulatory mechanisms mediated by small RNAs are more general than previously appreciated.	Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany	Max Planck Society	Tuschl, T (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Biochem, Fassberg 11, D-37077 Gottingen, Germany.	ttuschl@mpibpc.gwdg.de	Quintana, Mariana Lagos/A-7919-2010					Ambros V, 2000, CURR OPIN GENET DEV, V10, P428, DOI 10.1016/S0959-437X(00)00108-8; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Eddy SR, 1999, CURR OPIN GENET DEV, V9, P695, DOI 10.1016/S0959-437X(99)00022-2; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Feinbaum R, 1999, DEV BIOL, V210, P87, DOI 10.1006/dbio.1999.9272; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Moss EG, 2000, CURR BIOL, V10, pR436, DOI 10.1016/S0960-9822(00)00528-5; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Slack F, 1997, ANNU REV GENET, V31, P611, DOI 10.1146/annurev.genet.31.1.611; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	29	3664	4290	10	405	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					853	858		10.1126/science.1064921	http://dx.doi.org/10.1126/science.1064921			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679670	Green Submitted			2022-12-28	WOS:000171851800047
J	Sagarin, R; Micheli, F				Sagarin, R; Micheli, F			Climate change - Climate change in nontraditional data sets	SCIENCE			English	Article							LAKE		Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA	Stanford University	Sagarin, R (corresponding author), Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA.			Micheli, Fiorenza/0000-0002-6865-1438				ASSEL RA, 1995, LIMNOL OCEANOGR, V40, P165, DOI 10.4319/lo.1995.40.1.0165; COGHILL J, COMMUNICATION; Inouye DW, 2000, P NATL ACAD SCI USA, V97, P1630, DOI 10.1073/pnas.97.4.1630; Magnuson JJ, 2000, SCIENCE, V289, P1743, DOI 10.1126/science.289.5485.1743; SCRIMGEOUR GJ, 1994, FRESHWATER BIOL, V32, P261, DOI 10.1111/j.1365-2427.1994.tb01125.x; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923	6	55	57	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2001	294	5543					811	811		10.1126/science.1064218	http://dx.doi.org/10.1126/science.1064218			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679659				2022-12-28	WOS:000171851800034
J	Klaassen, M; Lindstrom, A; Meltofte, H; Piersma, T				Klaassen, M; Lindstrom, A; Meltofte, H; Piersma, T			Ornithology - Arctic waders are not capital breeders	NATURE			English	Article							STABLE ISOTOPES		Netherlands Inst Ecol, Ctr Limnol, NL-3600 BG Maarssen, Netherlands; Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; Netherlands Inst Sea Res, NL-1790 AB Den Burg, Netherlands; Univ Groningen, Ctr Ecol & Evolutionary Studies, NL-9750 AA Haren, Netherlands; Natl Environm Res Inst, Dept Arctic Environm, DK-4000 Roskilde, Denmark	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Lund University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Groningen; Aarhus University	Klaassen, M (corresponding author), Netherlands Inst Ecol, Ctr Limnol, POB 1299, NL-3600 BG Maarssen, Netherlands.		Piersma, Theunis/D-1871-2012; Bond, Alexander L/A-3786-2010; Klaassen, Marcel/B-4325-2008	Klaassen, Marcel/0000-0003-3907-9599				Cramp S., 1980, BIRDS W PALEARCTIC, V2; Davidson N.C., 1988, P342; DRENT RH, 1980, ARDEA, V68, P225; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Newton I., 1977, P113; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Stettenheim P., 1972, AVIAN BIOL, V2, P1; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050	8	169	179	0	33	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					794	794		10.1038/35101654	http://dx.doi.org/10.1038/35101654			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677593	Green Published			2022-12-28	WOS:000171750200032
J	Finlayson, B; Dewar, S				Finlayson, B; Dewar, S			Reforming complaints systems: UK and New Zealand	LANCET			English	Editorial Material									Kings Fund, Hlth Care Policy Programme, London W1G OAN, England		Finlayson, B (corresponding author), Kings Fund, Hlth Care Policy Programme, London W1G OAN, England.							*COMM HLTH IMPR, 2001, INV ISS AR CAS LOUGH; CULL H, 2001, REV PROCESSES ADVERS; *DEP HLTH, 2001, ASS QUAL MED PRACT I; *DEP HLTH, 2000, REG PRIV VOL HEALTHC; Department of Health, 2001, BUILD SAF NHS PAT IM; Department of Health, 2001, REF NHS COMPL PROC L; *NHS, 2001, NHS COMPL PROC NAT E; STACEY M, 1992, REGULATING BRIT MED, P252; 2001, CMND5207	9	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 20	2001	358	9290					1290	1290		10.1016/S0140-6736(01)06457-1	http://dx.doi.org/10.1016/S0140-6736(01)06457-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684208				2022-12-28	WOS:000171702500007
J	Barnett, RN; Cleveland, CL; Joy, A; Landman, U; Schuster, GB				Barnett, RN; Cleveland, CL; Joy, A; Landman, U; Schuster, GB			Charge migration in DNA: Ion-gated transport	SCIENCE			English	Article							HOLE TRANSPORT; POTENTIALS; DYNAMICS; BASES	Electron hole (radical cation) migration in DNA, where the quantum transport of an injected charge is gated in a correlated manner by the thermal motions of the hydrated counterions, is described here. Classical molecular dynamics simulations in conjunction with large-scale first-principles electronic structure calculations reveal that different counterion configurations Lead to formation of states characterized by varying spatial distributions and degrees of charge localization. Stochastic dynamic fluctuations between such ionic configurations can induce correlated changes in the spatial distribution of the hole, with concomitant transport along the DNA double helix. Comparative ultraviolet tight-induced cleavage experiments on native B DNA oligomers and on ones modified to contain counterion (Na+)-starved bridges between damage-susceptible hole-trapping sites called GG steps show in the Latter a reduction in damage at the distal step. This reduction indicates a reduced mobility of the hole across the modified bridge as predicted theoretically.	Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Landman, U (corresponding author), Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.	gary.schuster@cos.gatech.edu						ARNOTT S, 1977, HDB BIOCH MOL BIOL, P411; BARNETT RN, 1993, PHYS REV B, V48, P2081, DOI 10.1103/PhysRevB.48.2081; Berlin YA, 2001, J AM CHEM SOC, V123, P260, DOI 10.1021/ja001496n; Beveridge DL, 2000, CURR OPIN STRUC BIOL, V10, P182, DOI 10.1016/S0959-440X(00)00076-2; Boudaiffa B, 2000, SCIENCE, V287, P1658, DOI 10.1126/science.287.5458.1658; Fink HW, 2001, CELL MOL LIFE SCI, V58, P1, DOI 10.1007/PL00000770; Giese B, 2000, ACCOUNTS CHEM RES, V33, P631, DOI 10.1021/ar990040b; Grozema FC, 2000, J AM CHEM SOC, V122, P10903, DOI 10.1021/ja001497f; Heller A, 2000, FARADAY DISCUSS, V116, P1, DOI 10.1039/b006196o; Henderson PT, 1999, P NATL ACAD SCI USA, V96, P8353, DOI 10.1073/pnas.96.15.8353; Hud NV, 2001, CURR OPIN STRUC BIOL, V11, P293, DOI 10.1016/S0959-440X(00)00205-0; HUSH NS, 1975, CHEM PHYS LETT, V34, P11, DOI 10.1016/0009-2614(75)80190-4; Jackson NM, 2001, CURR OPIN CHEM BIOL, V5, P209, DOI 10.1016/S1367-5931(00)00192-7; Jortner J, 1998, P NATL ACAD SCI USA, V95, P12759, DOI 10.1073/pnas.95.22.12759; Lewis FD, 2001, ACCOUNTS CHEM RES, V34, P159, DOI 10.1021/ar0000197; LIAS SG, 1988, J PHYS CHEM REF DATA, V17, P1; Marcus RA, 1998, J PHYS CHEM B, V102, P10071, DOI 10.1021/jp9834457; McFail-Isom L, 1999, CURR OPIN STRUC BIOL, V9, P298, DOI 10.1016/S0959-440X(99)80040-2; Meggers E, 1998, J AM CHEM SOC, V120, P12950, DOI 10.1021/ja983092p; ORLOV VM, 1976, TETRAHEDRON LETT, P4377; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Ratner MA, 2001, P NATL ACAD SCI USA, V98, P387, DOI 10.1073/pnas.98.2.387; Schuster GB, 2000, ACCOUNTS CHEM RES, V33, P253, DOI 10.1021/ar980059z; Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Wan CZ, 2000, P NATL ACAD SCI USA, V97, P14052, DOI 10.1073/pnas.250483297; Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9; [No title captured]	29	338	347	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					567	571		10.1126/science.1062864	http://dx.doi.org/10.1126/science.1062864			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641491				2022-12-28	WOS:000171695600039
J	Murphy, DJ; Liebling, RE; Verity, L; Swingler, R; Patel, R				Murphy, DJ; Liebling, RE; Verity, L; Swingler, R; Patel, R			Early maternal and neonatal morbidity associated with operative delivery in second stage of labour: a cohort study	LANCET			English	Article							CESAREAN-SECTION; VAGINAL DELIVERY; TRIAL; MIDFORCEPS; FORCEPS	Background A frequent dilemma for obstetricians is how to keep morbidity to a minimum when faced with arrested progress at full dilatation of the cervix. Our aim was to examine maternal and neonatal morbidity associated with vaginal instrumental delivery in theatre and caesarean section, at full dilatation. Methods We did a prospective cohort study of 393 women, who had term, singleton, liveborn, cephalic pregnancies requiring operative delivery in theatre at full dilatation for 1 year. Findings Factors increasing the likelihood of caesarean section included maternal body-mass index greater than 30 (adjusted odds ratio 2.4, 95% CI 1.2-4.9), neonatal birthweight greater than 4.0 kg (2.3, 1.3-3.8), and occipitoposterior position (2.5, 1.6-3.9). Women undergoing caesarean section were more likely to have a major haemorrhage (>1 L; 2.8, 1.1-7.6) and extended hospital stay (greater than or equal to6 days; 3.5, 1.6-7.6) than those with vaginal delivery. Babies delivered by caesarean section were more likely to require admission for intensive care (2.6, 1.2-6.0) but less likely to have trauma (0.4, 0.2-0.7) than babies delivered by forceps. Overall neonatal morbidity was low, but a few babies in each group had serious complications (serious trauma, eight vs three; sepsis, six vs 13; and jaundice, ten vs 12 after vaginal delivery and caesarean section, respectively). Major haemorrhage was less likely after delivery by a skilled obstetrician (0.5, 0.3-0.9). Interpretation The data lend support to an aim to deliver women vaginally, unless there are clear signs of cephalopelvic disproportion, and underline the importance of skilled obstetricians supervising complex operative deliveries.	Univ Bristol, St Michaels Hosp, Div Obstet & Gynecol, Bristol BS2 8EG, Avon, England; Southmead Gen Hosp, N Bristol NHS Trust, Bristol, Avon, England	University of Bristol; North Bristol NHS Trust; Southmead Hospital	Murphy, DJ (corresponding author), Univ Bristol, St Michaels Hosp, Div Obstet & Gynecol, Southwell St, Bristol BS2 8EG, Avon, England.			Murphy, Deirdre/0000-0001-6074-6718; Patel, Roshni/0000-0002-1399-3131				AlMufti R, 1996, LANCET, V347, P544, DOI 10.1016/S0140-6736(96)91176-9; *ASS IMPR MAT SERV, 1997, CHART ETH RES MAT CA; BASHORE RA, 1990, AM J OBSTET GYNECOL, V162, P1428, DOI 10.1016/0002-9378(90)90902-J; CHISWICK ML, 1979, BRIT MED J, V1, P7, DOI 10.1136/bmj.1.6155.7; CIBILS LA, 1990, J PERINAT MED, V18, P5, DOI 10.1515/jpme.1990.18.1.5; CLARK SL, 1984, OBSTET GYNECOL, V64, P376; DIERKER LJ, 1985, AM J OBSTET GYNECOL, V152, P176, DOI 10.1016/S0002-9378(85)80019-3; *EXP MAT GROUP, 1993, CHANG CHILDB 1; Fynes M, 1999, LANCET, V354, P983, DOI 10.1016/S0140-6736(98)11205-9; Fynes M, 1998, OBSTET GYNECOL, V92, P496, DOI 10.1016/S0029-7844(98)00256-7; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; Johanson RB, 1999, BRIT J OBSTET GYNAEC, V106, P544, DOI 10.1111/j.1471-0528.1999.tb08322.x; LOMAS J, 1989, EFFECTIVE CARE PREGN, P1189; LOWE B, 1987, BRIT J OBSTET GYNAEC, V94, P60, DOI 10.1111/j.1471-0528.1987.tb02254.x; Penn ZJ, 1996, BRIT J OBSTET GYNAEC, V103, P684, DOI 10.1111/j.1471-0528.1996.tb09838.x; REPKE JT, 1984, SURG GYNECOL OBSTET, V158, P112; Revah A, 1997, AM J OBSTET GYNECOL, V176, P200, DOI 10.1016/S0002-9378(97)80036-1; ROBERTSON PA, 1990, AM J OBSTET GYNECOL, V162, P1436, DOI 10.1016/0002-9378(90)90903-K; RODRIGUEZ AI, 1994, AM J OBSTET GYNECOL, V171, P1022, DOI 10.1016/0002-9378(94)90026-4; Sachs BP, 1999, NEW ENGL J MED, V340, P54, DOI 10.1056/NEJM199901073400112; Wagner M, 2000, LANCET, V356, P1677, DOI 10.1016/S0140-6736(00)03169-X	21	217	225	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1203	1207		10.1016/S0140-6736(01)06341-3	http://dx.doi.org/10.1016/S0140-6736(01)06341-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675055				2022-12-28	WOS:000171527000007
J	Cobb, A				Cobb, A			Was it wrong to want a baby?	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	DEC 16	1995	311	7020					1647	1648		10.1136/bmj.311.7020.1647a	http://dx.doi.org/10.1136/bmj.311.7020.1647a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TL422	11644743	Green Published			2022-12-28	WOS:A1995TL42200081
J	BRENNER, S				BRENNER, S			THE CODE OF CODES - SCIENTIFIC AND SOCIAL-ISSUES IN THE HUMAN GENOME PROJECT - KEVLES,DJ, HOOD,L	NATURE			English	Book Review											BRENNER, S (corresponding author), MRC,MOLEC GENET UNIT,HILLS RD,CAMBRIDGE CB2 2QH,ENGLAND.							Kevles D., 1992, CODE CODESCI SOCIA, P136	1	0	0	0	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUL 2	1992	358	6381					27	28		10.1038/358027a0	http://dx.doi.org/10.1038/358027a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JB341	11643003	Bronze			2022-12-28	WOS:A1992JB34100039
J	Ni, CY; Murphy, MP; Golde, TE; Carpenter, G				Ni, CY; Murphy, MP; Golde, TE; Carpenter, G			gamma-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase	SCIENCE			English	Article							INTRAMEMBRANE PROTEOLYSIS; MECHANISM	ErbB-4 is a transmembrane receptor tyrosine kinase that regulates cell proliferation and differentiation. After binding of its ligand heregulin (HRG) or activation of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA), the ErbB-4 ectodomain is cleaved by a metalloprotease. We now report a subsequent cleavage by gamma -secretase that releases the ErbB-4 intracellular domain from the membrane and facilitates its translocation to the nucleus. gamma -Secretase cleavage was prevented by chemical inhibitors or a dominant negative presenilin. Inhibition of gamma -secretase also prevented growth inhibition by HRG. gamma -Secretase cleavage of ErbB-4 may represent another mechanism for receptor tyrosine kinase-mediated signaling.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Mayo Clin Jacksonville, Dept Neurosci & Pharmacol, Jacksonville, FL 32224 USA	Vanderbilt University; Vanderbilt University; Mayo Clinic	Carpenter, G (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37232 USA.				NCI NIH HHS [CA68485, CA24071] Funding Source: Medline; NIDDK NIH HHS [DK20593] Funding Source: Medline; NINDS NIH HHS [NS39072] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA068485, R01CA024071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, P30DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039072] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bae SS, 2001, FEBS LETT, V491, P16, DOI 10.1016/S0014-5793(01)02167-6; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; McLendon C, 2000, FASEB J, V14, P2383; Murphy MP, 2000, J BIOL CHEM, V275, P26277, DOI 10.1074/jbc.M002812200; NI CB, UNPUB; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Sartor CI, 2001, MOL CELL BIOL, V21, P4265, DOI 10.1128/MCB.21.13.4265-4275.2001; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Srinivasan R, 2000, CANCER RES, V60, P1483; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065; Vecchi M, 1997, J CELL BIOL, V139, P995, DOI 10.1083/jcb.139.4.995; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhou WL, 2000, J BIOL CHEM, V275, P34737, DOI 10.1074/jbc.M003756200	18	713	731	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2179	2181		10.1126/science.1065412	http://dx.doi.org/10.1126/science.1065412			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11679632				2022-12-28	WOS:000172647700055
J	Kidwell, SM				Kidwell, SM			Preservation of species abundance in marine death assemblages	SCIENCE			English	Article							FOSSIL RECORD; AMAZON-SHELF; CORAL-REEFS; COMMUNITY; SEDIMENTS; POPULATIONS; DISSOLUTION; PLEISTOCENE; TEXAS	Fossil assemblages of skeletal material are thought to differ from their source live communities, particularly in relative abundance of species, owing to potential bias from postmortem transport and time-averaging of multiple generations. However, statistical meta-analysis of 85 marine molluscan data sets indicates that, although sensitive to sieve mesh-size and environment, time-averaged death assemblages retain a strong signal of species' original rank orders. Naturally accumulated death assemblages thus provide a reliable means of acquiring the abundance data that are key to a new generation of paleobiologic and macroecologic questions and to extending ecological time-series via sedimentary cores.	Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Chicago	Kidwell, SM (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.							Aller JY, 1996, CONT SHELF RES, V16, P717, DOI 10.1016/0278-4343(96)88778-4; ALLER JY, 1995, PALAEOGEOGR PALAEOCL, V118, P181, DOI 10.1016/0031-0182(95)00003-4; BACHELET G, 1990, MAR ENVIRON RES, V30, P21, DOI 10.1016/0141-1136(90)90008-C; BARNBACH RK, 1996, EVOLUTIONARY PALEOBI, P123; CARTHEW R, 1986, PALAEONTOLOGY, V29, P243; CUMMINS H, 1986, PALAEOGEOGR PALAEOCL, V52, P291, DOI 10.1016/0031-0182(86)90052-0; Davis MB, 2000, ANNU REV EARTH PL SC, V28, P1, DOI 10.1146/annurev.earth.28.1.1; FLESSA KW, 1994, LETHAIA, V27, P153, DOI 10.1111/j.1502-3931.1994.tb01570.x; GREEN MA, 1993, LIMNOL OCEANOGR, V38, P331, DOI 10.4319/lo.1993.38.2.0331; Greenstein BJ, 1997, B MAR SCI, V61, P431; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JOHNSON RALPH GORDON, 1965, J PALEONTOL, V39, P80; KIDWELL SM, 1995, ANNU REV ECOL SYST, V26, P269, DOI 10.1146/annurev.es.26.110195.001413; KIDWELL SM, IN PRESS 1998 BELL B; McKinney FK, 1998, SCIENCE, V281, P807, DOI 10.1126/science.281.5378.807; McKinney M.L., 1997, BIOL RARITY CAUSES C, P110, DOI [10.1007/978-94-011-5874-9_7, DOI 10.1007/978-94-011-5874-9_7]; MELDAHL KH, 1998, PALEOBIOLOGY, V24, P287; Miller A.I, 1981, THESIS VIRGINIA POLY; Pandolfi JM, 1999, AM ZOOL, V39, P113; PETERSON CH, 1972, THESIS U CALIFORNIA; POWELL EN, 1992, PALAEOGEOGR PALAEOCL, V95, P209, DOI 10.1016/0031-0182(92)90142-R; REISH DJ, 1959, ECOLOGY, V40, P307, DOI 10.2307/1930047; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; STAFF GM, 1986, GEOL SOC AM BULL, V97, P428, DOI 10.1130/0016-7606(1986)97<428:TTATIO>2.0.CO;2; VALENTINE JW, 1989, PALEOBIOLOGY, V15, P83, DOI 10.1017/S0094837300009295; WALTER LM, 1990, AM J SCI, V290, P601, DOI 10.2475/ajs.290.6.601; WARME JE, 1976, STRUCTURE CLASSIFICA, P143; [No title captured]	28	228	239	3	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1091	1094		10.1126/science.1064539	http://dx.doi.org/10.1126/science.1064539			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691990				2022-12-28	WOS:000172013800047
J	Calam, J; Baron, JH				Calam, J; Baron, JH			ABC of the upper gastrointestinal tract - Pathophysiology of duodenal and gastric ulcer and gastric cancer	BRITISH MEDICAL JOURNAL			English	Review							HELICOBACTER-PYLORI		Hammersmith Hosp, Imperial Coll Sch Med, London, England; Mt Sinai Sch Med, New York, NY USA; St Marys Hosp, London, England	Imperial College London; Icahn School of Medicine at Mount Sinai; Imperial College London	Calam, J (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, London, England.							Calam J, 1996, CLIN GUIDE HELICOBAC; ELOMAR EM, 1995, GASTROENTEROLOGY, V109, P681, DOI 10.1016/0016-5085(95)90374-7; Harris AW, 1996, GUT, V38, P663, DOI 10.1136/gut.38.5.663; LOGAN RPH, 1995, GUT, V36, P12, DOI 10.1136/gut.36.1.12; SAPONIN P, 1996, J PHYSIOL PHARMACOL, V47, P151	5	63	69	2	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2001	323	7319					980	982		10.1136/bmj.323.7319.980	http://dx.doi.org/10.1136/bmj.323.7319.980			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488CU	11679389	Green Published			2022-12-28	WOS:000171918500020
J	Lee, RC; Ambros, V				Lee, RC; Ambros, V			An extensive class of small RNAs in Caenorhabditis elegans	SCIENCE			English	Article							INTERFERENCE; CONSERVATION; EXPRESSION; SEQUENCE; GENES	The lin-4 and let-7 antisense RNAs are temporal regulators that control the timing of developmental events in Caenorhabditis elegans by inhibiting translation of target mRNAs. let-7 RNA is conserved among bilaterian animals, suggesting that this class of small RNAs [microRNAs (miRNAs)] is evolutionarily ancient. Using bioinformatics and cDNA cloning, we found 15 new miRNA genes in C. elegans. Several of these genes express small transcripts that vary In abundance during C. elegans larval development, and three of them have apparent homologs in mammals and/or insects. Small noncoding RNAs of the miRNA class appear to be numerous and diverse.	Dartmouth Coll Sch Med, Dept Genet, Hanover, NH 03755 USA	Dartmouth College	Ambros, V (corresponding author), Dartmouth Coll Sch Med, Dept Genet, Hanover, NH 03755 USA.	vambros@dartmouth.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034028] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM-34028] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ERDMANN VA, 1908, NUCLEIC ACIDS RES, V29, P189; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kent WJ, 2000, GENOME RES, V10, P1115, DOI 10.1101/gr.10.8.1115; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	13	2161	2521	9	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					862	864		10.1126/science.1065329	http://dx.doi.org/10.1126/science.1065329			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679672				2022-12-28	WOS:000171851800049
J	Damasio, A				Damasio, A			Fundamental feelings	NATURE			English	Editorial Material									Univ Iowa, Coll Med, Dept Neurol, Iowa City, IA 52242 USA	University of Iowa	Damasio, A (corresponding author), Univ Iowa, Coll Med, Dept Neurol, 200 Hawkins Dr, Iowa City, IA 52242 USA.		Damasio, Antonio/AAD-1342-2019					Damasio A.R., 2000, FEELING WHAT HAPPENS; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2	4	110	115	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2001	413	6858					781	781		10.1038/35101669	http://dx.doi.org/10.1038/35101669			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677584	Bronze			2022-12-28	WOS:000171750200025
J	Jayaraman, KS; Weis, P				Jayaraman, KS; Weis, P			Fallout from terrorism hits summits on developing world	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					759	759		10.1038/35101727	http://dx.doi.org/10.1038/35101727			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677559	Bronze			2022-12-28	WOS:000171750200004
J	Minsky, BD				Minsky, BD			Adjuvant radiation therapy for rectal cancer: is there finally an answer?	LANCET			English	Editorial Material									Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Minsky, BD (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA.	minskyb@mskcc.org						Camma C, 2000, JAMA-J AM MED ASSOC, V284, P1008, DOI 10.1001/jama.284.8.1008; Grann A, 2001, INT J RADIAT ONCOL, V49, P987, DOI 10.1016/S0360-3016(00)01529-7; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Pahlman L, 1997, NEW ENGL J MED, V336, P980; ROH MS, 2001, P AN M AM SOC CLIN, V20, pA123; Sauer R., 2000, International Journal of Radiation Oncology Biology Physics, V48, P119, DOI 10.1016/S0360-3016(00)80034-6; SKIBBER JM, 2001, CANC PRINCIPLES PRAC, P1271	8	14	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2001	358	9290					1285	1286		10.1016/S0140-6736(01)06453-4	http://dx.doi.org/10.1016/S0140-6736(01)06453-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684204				2022-12-28	WOS:000171702500003
J	Lee, JR; Urban, S; Garvey, CF; Freeman, M				Lee, JR; Urban, S; Garvey, CF; Freeman, M			Regulated intracellular ligand transport and proteolysis control EGF signal activation in Drosophila	CELL			English	Article							ALPHA HOMOLOG SPITZ; DORSAL-VENTRAL AXIS; GROWTH-FACTOR-ALPHA; CELL-SURFACE; EYE DEVELOPMENT; PROTGF-ALPHA; RECEPTOR; PROTEIN; PATHWAY; GENE	The membrane proteins Star and Rhomboid-1 have been genetically defined as the primary regulators of EGF receptor activation in Drosophila, but their molecular mechanisms have been elusive. Both Star and Rhomboid-1 have been assumed to work at the cell surface to control ligand activation. Here, we demonstrate that they control receptor signaling by regulating intracellular trafficking and proteolysis of the ligand Spitz. Star is present throughout the secretory pathway and is required to export Spitz from the endoplasmic reticulum to the Golgi apparatus. Rhomboid-1 is localized in the Golgi, where it promotes the cleavage of Spitz. This defines a novel growth factor release mechanism that is distinct from metalloprotease-dependent shedding from the cell surface.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Freeman, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.			Freeman, Matthew/0000-0003-0410-5451				Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; Bang AG, 2000, GENE DEV, V14, P177; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Casci T, 1999, CANCER METAST REV, V18, P181, DOI 10.1023/A:1006313122373; Dominguez M, 1998, CURR BIOL, V8, P1039, DOI 10.1016/S0960-9822(98)70441-5; Fernandez-Larrea J, 1999, MOL CELL, V3, P423, DOI 10.1016/S1097-2765(00)80470-0; FREEMAN M, 1992, DEVELOPMENT, V116, P335; FREEMAN M, 1994, MECH DEVELOP, V48, P25, DOI 10.1016/0925-4773(94)90003-5; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Golembo M, 1996, DEVELOPMENT, V122, P3363; Guichard A, 1999, DEVELOPMENT, V126, P2663; HEBERLEIN U, 1993, DEV BIOL, V160, P51, DOI 10.1006/dbio.1993.1285; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Klambt C, 2000, CURR BIOL, V10, pR388, DOI 10.1016/S0960-9822(00)00485-1; KOLODKIN AL, 1994, DEVELOPMENT, V120, P1731; Kuo A, 2000, EMBO J, V19, P6427, DOI 10.1093/emboj/19.23.6427; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; PANDIELLA A, 1992, J BIOL CHEM, V267, P24028; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Pickup AT, 1999, DEV BIOL, V205, P254, DOI 10.1006/dbio.1998.9119; RUOHOLABAKER H, 1993, CELL, V73, P953, DOI 10.1016/0092-8674(93)90273-S; RUTLEDGE BJ, 1992, GENE DEV, V6, P1503, DOI 10.1101/gad.6.8.1503; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; SEELIG HP, 1994, J AUTOIMMUN, V7, P67, DOI 10.1006/jaut.1994.1006; Sturtevant MA, 1996, DEV BIOL, V174, P298, DOI 10.1006/dbio.1996.0075; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; TEIXIDO J, 1990, J BIOL CHEM, V265, P6410; Tio M, 1997, DEVELOPMENT, V124, P343; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Urena JM, 1999, J CELL SCI, V112, P773; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Wasserman JD, 2000, GENE DEV, V14, P1651; Wasserman JD, 1997, TRENDS CELL BIOL, V7, P431, DOI 10.1016/S0962-8924(97)01143-4; Wasserman JD, 1998, CELL, V95, P355, DOI 10.1016/S0092-8674(00)81767-5; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; zurLage P, 1997, CURR BIOL, V7, P166, DOI 10.1016/S0960-9822(97)70087-3	40	309	319	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					161	171		10.1016/S0092-8674(01)00526-8	http://dx.doi.org/10.1016/S0092-8674(01)00526-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672524	Bronze			2022-12-28	WOS:000171694800006
J	Smith, DE; Tans, SJ; Smith, SB; Grimes, S; Anderson, DL; Bustamante, C				Smith, DE; Tans, SJ; Smith, SB; Grimes, S; Anderson, DL; Bustamante, C			The bacteriophage phi 29 portal motor can package DNA against a large internal force	NATURE			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; MOLECULES; PROTEIN-GP3; PROHEAD	As part of the viral infection cycle, viruses must package their newly replicated genomes for delivery to other host cells. Bacteriophage phi 29 packages its 6.6-mum long, double-stranded DNA into a 42x54 nm capsid(1) by means of a portal complex that hydrolyses ATP(2). This process is remarkable because entropic, electrostatic and bending energies of the DNA must be overcome to package the DNA to near-crystalline density. Here we use optical tweezers to pull on single DNA molecules as they are packaged, thus demonstrating that the portal complex is a force-generating motor. This motor can work against loads of up to 57 pN on average, making it one of the strongest molecular motors reported to date. Movements of over 5 mum are observed, indicating high processivity. Pauses and slips also occur, particularly at higher forces. We establish the force-velocity relationship of the motor and find that the rate-limiting step of the motor's cycle is force dependent even at low loads. Notably, the packaging rate decreases as the prohead is filled, indicating that an internal force builds up to similar to 50 pN owing to DNA confinement. Our data suggest that this force may be available for initiating the ejection of the DNA from the capsid during infection.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Oral Sci, Minneapolis, MN 55455 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.		Tans, Sander/AAS-2901-2020; Smith, Douglas E/A-3131-2017	Smith, Douglas E/0000-0002-8206-3632; Bustamante, Carlos/0000-0002-2970-0073				Anderson Dwight, 1993, P859; BARLOW R, 1989, STAT GUIDE USE STAT, P15; Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; BERG HC, 1993, BIOPHYS J, V65, P2201, DOI 10.1016/S0006-3495(93)81278-5; BJORNSTI MA, 1983, J VIROL, V45, P383, DOI 10.1128/JVI.45.1.383-396.1983; Coppin CM, 1997, P NATL ACAD SCI USA, V94, P8539, DOI 10.1073/pnas.94.16.8539; EARNSHAW WC, 1980, CELL, V21, P319, DOI 10.1016/0092-8674(80)90468-7; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Garcia LR, 1996, J BACTERIOL, V178, P6921, DOI 10.1128/jb.178.23.6921-6929.1996; GRIMES S, 1989, J MOL BIOL, V209, P91, DOI 10.1016/0022-2836(89)90172-1; Grimes S, 1997, J MOL BIOL, V266, P901, DOI 10.1006/jmbi.1996.0843; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; GUO PX, 1986, P NATL ACAD SCI USA, V83, P3505, DOI 10.1073/pnas.83.10.3505; Ibarra B, 2000, J MOL BIOL, V298, P807, DOI 10.1006/jmbi.2000.3712; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; LEHNINGER AL, 1993, PRINCIPLES BIOCH, P375; NOVICK SL, 1988, BIOCHEMISTRY-US, V27, P7919, DOI 10.1021/bi00420a050; Odijk T, 1998, BIOPHYS J, V75, P1223, DOI 10.1016/S0006-3495(98)74041-X; RAU DC, 1984, P NATL ACAD SCI-BIOL, V81, P2621, DOI 10.1073/pnas.81.9.2621; RIEMER SC, 1978, BIOPOLYMERS, V17, P785, DOI 10.1002/bip.1978.360170317; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Tao YZ, 1998, CELL, V95, P431, DOI 10.1016/S0092-8674(00)81773-0; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902	25	829	851	1	118	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					748	752		10.1038/35099581	http://dx.doi.org/10.1038/35099581			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607035				2022-12-28	WOS:000171608000047
J	Breedveld, FC				Breedveld, FC			Is there a place for leflunomide in the treatment of rheumatoid arthritis?	LANCET			English	Editorial Material							METHOTREXATE; SAFETY; EFFICACY; SULFASALAZINE		Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Breedveld, FC (corresponding author), Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands.							Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Drossaers-Bakker KW, 1999, ARTHRITIS RHEUM, V42, P1854, DOI 10.1002/1529-0131(199909)42:9<1854::AID-ANR9>3.0.CO;2-F; Emery P, 2000, RHEUMATOLOGY, V39, P655, DOI 10.1093/rheumatology/39.6.655; FRIES JF, 1993, ARTHRITIS RHEUM, V36, P297, DOI 10.1002/art.1780360303; Herrmann ML, 2000, IMMUNOPHARMACOLOGY, V47, P273, DOI 10.1016/S0162-3109(00)00191-0; MLADENOVIC V, 1995, ARTHRITIS RHEUM-US, V38, P1595, DOI 10.1002/art.1780381111; Smolen JS, 1999, LANCET, V353, P259, DOI 10.1016/S0140-6736(98)09403-3; Strand V, 1999, ARCH INTERN MED, V159, P2542, DOI 10.1001/archinte.159.21.2542; Weinblatt ME, 1999, ARTHRITIS RHEUM-US, V42, P1322, DOI 10.1002/1529-0131(199907)42:7<1322::AID-ANR4>3.0.CO;2-P	9	10	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1198	1200		10.1016/S0140-6736(01)06338-3	http://dx.doi.org/10.1016/S0140-6736(01)06338-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675052				2022-12-28	WOS:000171527000004
J	Warnock, M				Warnock, M			Informed consent - a publisher's duty	BRITISH MEDICAL JOURNAL			English	Article																			0	15	16	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 28	1998	316	7136					1002	1003						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZF034	11645039				2022-12-28	WOS:000072856100031
J	DeWildt, G; Sweeney, H				DeWildt, G; Sweeney, H			Moving away from rational medicine?	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 25	1996	312	7042					1367	1367		10.1136/bmj.312.7042.1367	http://dx.doi.org/10.1136/bmj.312.7042.1367			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UN476	11644783	Green Published			2022-12-28	WOS:A1996UN47600079
J	Maun, AR				Maun, AR			Advance directives	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											Maun, AR (corresponding author), YALE NEW HAVEN MED CTR,20 YORK ST,NEW HAVEN,CT 06504, USA.							1995, JAMA-J AM MED ASSOC, V274, P1591	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	1996	275	12					950	950						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UA563	11644768				2022-12-28	WOS:A1996UA56300037
J	KAHTAN, S; FITTON, P				KAHTAN, S; FITTON, P			LISTEN TO ME	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	AUG 28	1993	307	6903					571	571		10.1136/bmj.307.6903.571	http://dx.doi.org/10.1136/bmj.307.6903.571			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LV180	11643162	Bronze, Green Published			2022-12-28	WOS:A1993LV18000081
J	RANDAL, J				RANDAL, J			THE HUMAN GENOME PROJECT	LANCET			English	Editorial Material																			0	6	6	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 23	1989	2	8678-9					1535	1536						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE966	11659182				2022-12-28	WOS:A1989CE96600065
J	[Anonymous]				[Anonymous]			NUCLEAR DECISIONS	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	1989	1	8645					1030	1030						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	U4448	11644430				2022-12-28	WOS:A1989U444800058
J	CARVEL, J				CARVEL, J			EMBRYO RESEARCH	LANCET			English	Editorial Material																			0	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 13	1988	1	8581					368	369						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	M0211	11644347				2022-12-28	WOS:A1988M021100063
J	Priest, P; Yudkin, P; McNulty, C; Mant, D				Priest, P; Yudkin, P; McNulty, C; Mant, D			Antibacterial prescribing and antibacterial resistance in English general practice: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To quantify the relation between community based antibacterial prescribing and antibacterial resistance in community acquired disease. Design Cross sectional study of antibacterial prescribing and antibacterial resistance of routine isolates within individual practices and primary care groups. Setting 405 general practices (38 groups) in south west and north west England. Main outcome measures Correlation between antibacterial prescribing and resistance for urinary coliforms and Streptococcus pneumoniae. Results Antibacterial resistance in urinary coliform isolates is common but the Correlation with prescribing rates was relatively low for individual practices (ampicillin and amoxicillin r(s) = 0.20, P = 0.001; trimethoprim. r(e) = 0.24, P = 0.0001) and primary care groups (ampicillin and amoxicillin r(s) = 0.44, P = 0.05; trimethoprim r(s) = 0.31, P = 0.09). Regression coefficients were also low; a practice prescribing 20% less ampicillin and amoxicillin than average would have about 1% fewer resistant isolates (0.94/100; 95% confidence interval 0.02 to 1.85). Resistance of S pneumoniae to both penicillin and erythromycin remains uncommon, and no clear relation with prescribing was found. Conclusions Routine microbiological isolates should not be used for surveillance of antibacterial resistance in the community or for monitoring the outcome of any change in antibacterial prescribing by general practitioners. Trying to reduce the overall level of antibiotic prescribing in UK general practice may not be the most effective strategy for reducing resistance in the community.	Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; Gloucestershire Royal Hosp, Gloucester Publ Hlth Lab, Gloucester GL1 3NN, England	University of Oxford; Gloucestershire Royal Hospital	Priest, P (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	patricia.priest@dphpc.ox.ac.uk	Mant, David CA/C-7763-2009					Arason VA, 1996, BMJ-BRIT MED J, V313, P387; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; Carbon C, 1998, BRIT MED J, V317, P663, DOI 10.1136/bmj.317.7159.663; DARDAMISSIS E, ANTIBIOTIC PRESCRIBI; Department of Health and Social Care (DHSC), 2000, UK ANT RES STRAT ACT; DONNER A, 1994, AM J EPIDEMIOL, V140, P279, DOI 10.1093/oxfordjournals.aje.a117247; Huovinen P, 1998, BRIT MED J, V317, P613, DOI 10.1136/bmj.317.7159.613; Lindbaek M, 1998, BRIT MED J, V317, P1521; Magee JT, 1999, BMJ-BRIT MED J, V319, P1239, DOI 10.1136/bmj.319.7219.1239; Seppala H, 1995, CLIN INFECT DIS, V21, P1378, DOI 10.1093/clinids/21.6.1378; Steinke DT, 2001, J ANTIMICROB CHEMOTH, V47, P781, DOI 10.1093/jac/47.6.781; van Weel C, 1999, LANCET, V354, P1052, DOI 10.1016/S0140-6736(99)90107-1; Wise R, 1998, BMJ-BRIT MED J, V317, P609, DOI 10.1136/bmj.317.7159.609	13	40	41	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2001	323	7320					1037	1041		10.1136/bmj.323.7320.1037	http://dx.doi.org/10.1136/bmj.323.7320.1037			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MP	11691763	Green Published, Bronze			2022-12-28	WOS:000172055900019
J	Gray, R; Hills, R; Stowe, R; Clarke, M; Peto, R; Buyse, M; Piedbois, P				Gray, R; Hills, R; Stowe, R; Clarke, M; Peto, R; Buyse, M; Piedbois, P		Colorectal Canc Collaborative Grp	Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials	LANCET			English	Article							TOTAL MESORECTAL EXCISION; PREOPERATIVE RADIOTHERAPY; RADIATION-THERAPY; MULTICENTER TRIAL; CARCINOMA; CHEMOTHERAPY; TUMOR; ADENOCARCINOMA; IRRADIATION; RECURRENCE	Background At least 28 randomised, controlled trials have compared outcomes of surgery for rectal cancer combined with preoperative or postoperative radiotherapy with those of surgery alone. We have done a collaborative metaanalysis of these results to give a more balanced view of the total evidence and to increase statistical precision. Methods We centrally checked and analysed individual patient data from 22 randomised comparisons between preoperative (6350 patients in 14 trials) or postoperative (2157 in eight trials) radiotherapy and no radiotherapy for rectal cancer. Findings Overall survival was only marginally better in patients who were allocated to radiotherapy than in those allocated to surgery alone (62% vs 63% died; p=0.06). Rates of apparently curative resection were not improved by preoperative radiotherapy (85% radiotherapy vs 86% control). Yearly risk of local recurrence was 46% (SE 6) lower in those who had preoperative radiotherapy than in those who had surgery alone (p=0.00001), and 37% (10) lower in those who had postoperative treatment than those who had surgery alone (p=0.002). Fewer patients who had preoperative radiotherapy died from rectal cancer than did those who had surgery alone (45% vs 50%, respectively, p=0.0003), but early (less than or equal to1 year after treatment) deaths from other causes increased (8% vs 4% died, p<0.0001). Interpretation Preoperative radiotherapy (at biologically effective doses <greater than or equal to>30 Gy) reduces risk of local recurrence and death from rectal cancer. If safety can be improved without compromising effectiveness, then overall survival would be moderately improved by use of preoperative radiotherapy, especially for young, high risk patients. Postoperative radiotherapy also reduces local recurrence, but short preoperative radiation schedules seem to be at least as effective as longer schedules.	Univ Birmingham, Clin Trials Unit, CCCG Secretariat, Birmingham B15 2RR, W Midlands, England	University of Birmingham	Gray, R (corresponding author), Univ Birmingham, Clin Trials Unit, CCCG Secretariat, Park Grange,1 Somerset Rd, Birmingham B15 2RR, W Midlands, England.			Buyse, Marc/0000-0002-4559-0994; Gray, Richard/0000-0003-4440-574X; Hills, Robert/0000-0003-0166-0062; STOWE, REBECCA/0000-0003-4007-6723				ABE O, 1992, LANCET, V339, P71; ABE O, 1995, NEW ENGL J MED, V333, P1444; [Anonymous], 1992, Lancet, V339, P1; Arnott SJ, 1996, LANCET, V348, P1610; BALSLEV IB, 1986, CANCER-AM CANCER SOC, V58, P22, DOI 10.1002/1097-0142(19860701)58:1<22::AID-CNCR2820580106>3.0.CO;2-Q; Boulis-Wassif S, 1979, ADJUVANT THERAPY CAN, VII, P613; BUYSE M, 1996, EORTC STUDIES RECTAL, P53; *CANC GUID SUBGR C, 1997, IMPR OUTC COL CANC R; Cedermark B, 1996, ANN SURG ONCOL, V3, P423; CEDERMARK B, 1995, CANCER-AM CANCER SOC, V75, P2269, DOI 10.1002/1097-0142(19950501)75:9<2269::AID-CNCR2820750913>3.0.CO;2-I; CUMMINGS BJ, 1985, BRIT J SURG, V72, pS64, DOI 10.1002/bjs.1800721335; DAHL O, 1990, CANCER-AM CANCER SOC, V66, P2286, DOI 10.1002/1097-0142(19901201)66:11<2286::AID-CNCR2820661106>3.0.CO;2-T; FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604, DOI 10.1056/NEJM198506203122504; FISHER B, 1988, JNCI-J NATL CANCER I, V80, P21, DOI 10.1093/jnci/80.1.21; FOWLER JF, 1989, BRIT J RADIOL, V62, P679, DOI 10.1259/0007-1285-62-740-679; FRYKHOLM GJ, 1993, DIS COLON RECTUM, V36, P564, DOI 10.1007/BF02049863; GELMAN R, 1990, J CLIN ONCOL, V8, P548, DOI 10.1200/JCO.1990.8.3.548; GERARD A, 1988, ANN SURG, V208, P606, DOI 10.1097/00000658-198811000-00011; GOLDBERG PA, 1994, EUR J CANCER, V30A, P1602, DOI 10.1016/0959-8049(94)00312-S; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; HEALD RJ, 1986, LANCET, V1, P1479; HIGGINS GA, 1975, ANN SURG, V181, P624, DOI 10.1097/00000658-197505000-00017; HIGGINS GA, 1986, CANCER, V58, P352, DOI 10.1002/1097-0142(19860715)58:2<352::AID-CNCR2820580226>3.0.CO;2-D; Holm T, 1996, CANCER, V78, P968, DOI 10.1002/(SICI)1097-0142(19960901)78:5<968::AID-CNCR5>3.0.CO;2-8; Jones B, 1999, ACTA ONCOL, V38, P883, DOI 10.1080/028418699432572; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Kimura K, 1989, JPN J CANC CHEMOTHER, V16, P3161; KLIGERMAN MM, 1975, CANCER, V36, P691, DOI 10.1002/1097-0142(197508)36:2+<691::AID-CNCR2820360812>3.0.CO;2-E; LINDMARK G, 1992, INT J COLORECTAL DIS, V7, P162, DOI 10.1007/BF00360359; MANSOUR EG, 1991, P AN M AM SOC CLIN, V10, P154; MARNEGHAN H, 1991, AUSTRALAS RADIOL, V35, P61; MARSH PJ, 1994, DIS COLON RECTUM, V37, P1205, DOI 10.1007/BF02257783; NETO JAR, 1989, DIS COLON RECTUM, V32, P702, DOI 10.1007/BF02555778; Niebel W, 1988, Recent Results Cancer Res, V110, P111; Oates GD, 1996, LANCET, V348, P1605; Pahlman L, 1997, NEW ENGL J MED, V336, P980; PAHLMAN L, 1993, BRIT J SURG, V80, P1333, DOI 10.1002/bjs.1800801040; QUIRKE P, 1986, LANCET, V2, P996, DOI 10.1016/s0140-6736(86)92612-7; *RAD THER ONC GROU, 1997, PREOP IRR POT CUR AD; *RAD THER ONC GROU, 1977, VAL POST RAD CHEM AL; RIDER WD, 1977, CAN J SURG, V20, P335; SAUSE WT, 1990, INT J RADIAT ONCOL, V18, P1011, DOI 10.1016/0360-3016(90)90435-M; SMITH AN, 1984, BRIT J SURG, V71, P21; THOMAS PRM, 1988, RADIOTHER ONCOL, V13, P245, DOI 10.1016/0167-8140(88)90219-8; TREURNIETDONKER AD, 1991, CANCER-AM CANCER SOC, V67, P2042, DOI 10.1002/1097-0142(19910415)67:8<2042::AID-CNCR2820670806>3.0.CO;2-4; WITHERS HR, 1995, INT J RADIAT ONCOL, V31, P353, DOI 10.1016/0360-3016(94)00354-N; Wolmark N, 2000, JNCI-J NATL CANCER I, V92, P388, DOI 10.1093/jnci/92.5.388	47	721	738	2	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2001	358	9290					1291	1304						14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684209				2022-12-28	WOS:000171702500008
J	Sorensen, HT; Pedersen, L; Nogard, L; Fonager, K; Rothman, KJ				Sorensen, HT; Pedersen, L; Nogard, L; Fonager, K; Rothman, KJ			Does month of birth affect risk of Crohn's disease in childhood and adolescence?	BRITISH MEDICAL JOURNAL			English	Article							IN-UTERO; MEASLES; EXPOSURE		Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus C, Denmark; Aalborg Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; Aarhus Univ, Inst Epidemiol & Social Med, DK-8000 Aarhus C, Denmark; Boston Univ, Sch Med, Prevent Med & Epidemiol Sect, Boston, MA 02118 USA	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University; Boston University	Sorensen, HT (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Vennelyst Blvd 6, DK-8000 Aarhus C, Denmark.		Sorensen, Henrik Toft/Z-6181-2019; Nørgård, Bente M/F-9563-2013	Sorensen, Henrik Toft/0000-0003-4299-7040; Nørgård, Bente M/0000-0002-9514-3033; Rothman, Kenneth/0000-0003-2398-1705; Fonager, Kirsten/0000-0001-9641-992X				Ekbom A, 1996, LANCET, V348, P515, DOI 10.1016/S0140-6736(96)04429-7; Haslam N, 2000, GUT, V47, P801, DOI 10.1136/gut.47.6.801; Nielsen LLW, 1998, BRIT MED J, V316, P196, DOI 10.1136/bmj.316.7126.196	3	24	24	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 20	2001	323	7318					907	907		10.1136/bmj.323.7318.907	http://dx.doi.org/10.1136/bmj.323.7318.907			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486BH	11668136	Bronze, Green Published			2022-12-28	WOS:000171798200022
J	Cui, XD; Primak, A; Zarate, X; Tomfohr, J; Sankey, OF; Moore, AL; Moore, TA; Gust, D; Harris, G; Lindsay, SM				Cui, XD; Primak, A; Zarate, X; Tomfohr, J; Sankey, OF; Moore, AL; Moore, TA; Gust, D; Harris, G; Lindsay, SM			Reproducible measurement of single-molecule conductivity	SCIENCE			English	Article							ASSEMBLED ALKANETHIOL MONOLAYERS; METAL JUNCTIONS; TRANSPORT	A reliable method has been developed for making through-bond electrical contacts to molecules. Current-voltage curves are quantized as integer multiples of one fundamental curve, an observation used to identify single-molecule contacts. The resistance of a single octanedithiol molecule was 900 +/- 50 megohms, based on measurements on more than 1000 single molecules. In contrast, nonbonded contacts to octanethiol monolayers were at least four orders of magnitude more resistive, less reproducible, and had a different voltage dependence, demonstrating that the measurement of intrinsic molecular properties requires chemically bonded contacts.	Arizona State Univ, Dept Phys & Astron, Tempe, AZ 85287 USA; Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; Motorola Inc, Tempe, AZ 85284 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Cui, XD (corresponding author), Arizona State Univ, Dept Phys & Astron, Tempe, AZ 85287 USA.		Zarate, Xristo/AAH-1463-2020; Cui, Xiaodong/C-2023-2009	Zarate, Xristo/0000-0002-9824-3961; Cui, Xiaodong/0000-0002-2013-8336				Cygan MT, 1998, J AM CHEM SOC, V120, P2721, DOI 10.1021/ja973448h; Datta S, 1997, PHYS REV LETT, V79, P2530, DOI 10.1103/PhysRevLett.79.2530; DEMKOV AA, 1995, PHYS REV B, V52, P1618, DOI 10.1103/PhysRevB.52.1618; DEROSE JA, 1991, SURF SCI, V256, P102, DOI 10.1016/0039-6028(91)91204-B; Di Ventra M, 2000, PHYS REV LETT, V84, P979, DOI 10.1103/PhysRevLett.84.979; DOROGI M, 1995, PHYS REV B, V52, P9071, DOI 10.1103/PhysRevB.52.9071; Fink HW, 1999, NATURE, V398, P407, DOI 10.1038/18855; Frank S, 1998, SCIENCE, V280, P1744, DOI 10.1126/science.280.5370.1744; Gittins DI, 2000, NATURE, V408, P67, DOI 10.1038/35040518; Holmlin RE, 2001, J AM CHEM SOC, V123, P5075, DOI 10.1021/ja004055c; Leatherman G, 1999, J PHYS CHEM B, V103, P4006, DOI 10.1021/jp9831278; MUJICA V, 1994, J CHEM PHYS, V101, P6849, DOI 10.1063/1.468314; Porath D, 2000, NATURE, V403, P635, DOI 10.1038/35001029; Reed MA, 1997, SCIENCE, V278, P252, DOI 10.1126/science.278.5336.252; Schlenoff JB, 1995, J AM CHEM SOC, V117, P12528, DOI 10.1021/ja00155a016; SIEPMANN JI, 1993, PHYS REV LETT, V70, P453, DOI 10.1103/PhysRevLett.70.453; Son KA, 2001, PHYS REV LETT, V86, P5357, DOI 10.1103/PhysRevLett.86.5357; Weare WW, 2000, J AM CHEM SOC, V122, P12890, DOI 10.1021/ja002673n; Wold DJ, 2001, J AM CHEM SOC, V123, P5549, DOI 10.1021/ja0101532; Yang JS, 2000, J ORG CHEM, V65, P871, DOI 10.1021/jo991339a	20	1194	1224	14	259	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					571	574		10.1126/science.1064354	http://dx.doi.org/10.1126/science.1064354			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641492				2022-12-28	WOS:000171695600040
J	Valadkhan, S; Manley, JL				Valadkhan, S; Manley, JL			Splicing-related catalysis by protein-free snRNAs	NATURE			English	Article							SMALL NUCLEAR-RNA; METAL-ION CATALYSIS; U6 SNRNA; TERTIARY INTERACTION; IN-VITRO; SPLICEOSOME; SELECTION; STEP; DNA; SEQUENCE	Removal of intervening sequences from eukaryotic messenger RNA precursors is carried out by the spliceosome, a complex assembly of five small nuclear RNAs (snRNAs) and a large number of proteins. Although it has been suggested that the spliceosome might be an RNA enzyme, direct evidence for this has been lacking, and the identity of the catalytic domain of the spliceosome is unknown. Here we show that a protein-free complex of two snRNAs, U2 and U6, can bind and position a small RNA containing the sequence of the intron branch site, and activate the branch adenosine to attack a catalytically critical domain of U6 in a reaction that is related to the first step of splicing. Our data provide direct evidence for the catalytic potential of spliceosomal snRNAs.	Columbia Univ, Sherman Fairchild Ctr Life Sci, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Manley, JL (corresponding author), Columbia Univ, Sherman Fairchild Ctr Life Sci, Dept Biol Sci, New York, NY 10027 USA.	jlm2@columbia.edu	Valadkhan, Saba/G-5561-2010; Valadkhan, Saba/G-7271-2012	Manley, James/0000-0002-8341-1459				Boudvillain M, 1998, EMBO J, V17, P7091, DOI 10.1093/emboj/17.23.7091; BURGE CB, 1998, RNA WORLD, V2, P525; BURN AJ, 1961, J CHEM SOC, P5532, DOI 10.1039/jr9610005532; Collins CA, 2000, NAT STRUCT BIOL, V7, P850; Collins CA, 1999, GENE DEV, V13, P1970, DOI 10.1101/gad.13.15.1970; DATTA B, 1993, MOL CELL BIOL, V13, P5377, DOI 10.1128/MCB.13.9.5377; FABRIZIO P, 1992, NUCLEIC ACIDS RES, V20, P3659, DOI 10.1093/nar/20.14.3659; FABRIZIO P, 1990, SCIENCE, V250, P404, DOI 10.1126/science.2145630; GISH G, 1988, SCIENCE, V240, P1520, DOI 10.1126/science.2453926; Gordon PM, 2000, RNA, V6, P199, DOI 10.1017/S1355838200992069; Hetzer M, 1997, NATURE, V386, P417, DOI 10.1038/386417a0; Huang Z, 1996, NUCLEIC ACIDS RES, V24, P4360, DOI 10.1093/nar/24.21.4360; KOOLE LH, 1991, TETRAHEDRON, V47, P3183, DOI 10.1016/S0040-4020(01)96043-0; LEHMAN IR, 1974, SCIENCE, V186, P790; MADHANI HD, 1994, GENE DEV, V8, P1071, DOI 10.1101/gad.8.9.1071; MADHANI HD, 1990, GENE DEV, V4, P2264, DOI 10.1101/gad.4.12b.2264; Newman A, 1997, CURR BIOL, V7, pR418, DOI 10.1016/S0960-9822(06)00206-5; Nilsen TW, 1998, COLD SPRING HARBOR M, P279; OKeefe RT, 1996, CELL, V86, P679, DOI 10.1016/S0092-8674(00)80140-3; QUERY CC, 1994, GENE DEV, V8, P587, DOI 10.1101/gad.8.5.587; Query CC, 1996, EMBO J, V15, P1392, DOI 10.1002/j.1460-2075.1996.tb00481.x; Saenger W., 1984, PRINCIPLES NUCL ACID, P116, DOI DOI 10.1007/978-1-4612-5190-3_6; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Segault V, 1999, MOL CELL BIOL, V19, P2782; Siatecka M, 1999, GENE DEV, V13, P1983, DOI 10.1101/gad.13.15.1983; Sontheimer EJ, 1997, NATURE, V388, P801, DOI 10.1038/42068; SUN JS, 1995, GENE DEV, V9, P843, DOI 10.1101/gad.9.7.843; TANI T, 1991, GENE DEV, V5, P1022, DOI 10.1101/gad.5.6.1022; Tarn WY, 1996, SCIENCE, V273, P1824, DOI 10.1126/science.273.5283.1824; Tarn WY, 1997, TRENDS BIOCHEM SCI, V22, P132, DOI 10.1016/S0968-0004(97)01018-9; Tuschl T, 2001, RNA, V7, P29, DOI 10.1017/S1355838201001510; Tuschl T, 1998, EMBO J, V17, P2637, DOI 10.1093/emboj/17.9.2637; Valadkhan S, 2000, RNA, V6, P206, DOI 10.1017/S1355838200992197; WOLFF T, 1994, P NATL ACAD SCI USA, V91, P903, DOI 10.1073/pnas.91.3.903; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; YU YT, 1995, RNA, V1, P46; YU YT, 1993, CELL, V75, P1049, DOI 10.1016/0092-8674(93)90315-H	37	170	185	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					701	707		10.1038/35099500	http://dx.doi.org/10.1038/35099500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607023				2022-12-28	WOS:000171608000035
J	Ouriel, K				Ouriel, K			Peripheral arterial disease	LANCET			English	Article							PRIMARY STENT PLACEMENT; VASCULAR SMOOTH-MUSCLE; INTERMITTENT CLAUDICATION; GENE-TRANSFER; FOLLOW-UP; FEMOROPOPLITEAL ANGIOPLASTY; THROMBOLYTIC THERAPY; OCCLUSIVE DISEASE; HYPERBARIC-OXYGEN; SECONDARY PATENCY	Lower extremity peripheral arterial disease (PAD) most frequently presents with pain during ambulation, which is known as "intermittent claudication". Some relief of symptoms is possible with exercise, pharmacotherapy, and cessation of smoking. The risk of limb-loss is overshadowed by the risk of mortality from coexistent coronary artery and cerebrovascular atherosclerosis. Primary therapy should be directed at treating the generalised atherosclerotic process, managing lipids, blood sugar, and blood pressure. By contrast, the risk of limb-loss becomes substantial when there is pain at rest, ischaemic ulceration, or gangrene. Interventions such as balloon angioplasty, stenting, and surgical revascularisation should be considered in these patients with so-called "critical limb ischaemia". The choice of the intervention is dependent on the anatomy of the stenotic or occlusive lesion; percutaneous interventions are appropriate when the lesion is focal and short but longer lesions must be treated with surgical revascularisation to achieve acceptable long-term outcome.	Cleveland Clin Fdn, Dept Vasc Surg, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Ouriel, K (corresponding author), Cleveland Clin Fdn, Dept Vasc Surg, 9500 Euclid Ave, Cleveland, OH 44195 USA.	ourielk@ccf.org						ADHOUTE G, 1986, ANGIOLOGY, V37, P160, DOI 10.1177/000331978603700304; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; BAINTON D, 1994, BRIT HEART J, V72, P128; Baumgartner I, 2000, ANN INTERN MED, V132, P880, DOI 10.7326/0003-4819-132-11-200006060-00005; Baumgartner I, 1998, CIRCULATION, V97, P1114, DOI 10.1161/01.CIR.97.12.1114; Beebe HG, 1999, ARCH INTERN MED, V159, P2041, DOI 10.1001/archinte.159.17.2041; Belkin M, 1996, J VASC SURG, V24, P957, DOI 10.1016/S0741-5214(96)70041-1; Bertel V, 1997, EUR J VASC ENDOVASC, V14, P91; BLAISDELL FW, 1978, SURGERY, V84, P822; Bloor K, 1961, Ann R Coll Surg Engl, V28, P36; Bosch JL, 1997, RADIOLOGY, V204, P87, DOI 10.1148/radiology.204.1.9205227; BRAY AE, 1995, J ENDOVASC SURG, V2, P150, DOI 10.1583/1074-6218(1995)002<0150:SSITFA>2.0.CO;2; BREWSTER DC, 1978, SURGERY, V84, P739; CARUANA JA, 1981, ARCH SURG-CHICAGO, V116, P423; Cheng SWK, 1997, EUR J VASC ENDOVASC, V14, P17, DOI 10.1016/S1078-5884(97)80220-1; Ciaravino ME, 1996, ANN VASC SURG, V10, P558, DOI 10.1007/BF02000444; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; DASILVA A, 1979, J CHRON DIS, V32, P797, DOI 10.1016/0021-9681(79)90059-6; Dechend R, 1999, CIRCULATION, V100, P1369, DOI 10.1161/01.CIR.100.13.1369; Diehm C, 1988, PROSTAGLANDIN E1 WIR, P133; DOTTER CT, 1964, CIRCULATION, V30, P654, DOI 10.1161/01.CIR.30.5.654; Erb W., 1911, MUNCH MED WOCHENSCHR, V2, P2487; Faglia E, 1996, DIABETES CARE, V19, P1338, DOI 10.2337/diacare.19.12.1338; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; FOWKES FGR, 1992, AM J EPIDEMIOL, V135, P331; Geerts WH, 2001, CHEST, V119, p132S, DOI 10.1378/chest.119.1_suppl.132S; Geng YJ, 1996, ARTERIOSCL THROM VAS, V16, P19, DOI 10.1161/01.ATV.16.1.19; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; GIAMBRONE MA, 1997, J CLIN INVEST S, V100, P61; Gimbrone Jr, 1999, J Vasc Surg, V29, P1104, DOI 10.1016/S0741-5214(99)70252-1; GORMAN JF, 1965, CIRCULATION, V32, P936, DOI 10.1161/01.CIR.32.6.936; GRAOR RA, 1994, ANN SURG, V220, P251; Gray B H, 1997, Semin Vasc Surg, V10, P8; Handa K, 1996, ANGIOLOGY, V47, P543, DOI 10.1177/000331979604700602; HENRY M, 1995, RADIOLOGY, V197, P167, DOI 10.1148/radiology.197.1.7568818; HERTZER NR, 1984, ANN SURG, V199, P223, DOI 10.1097/00000658-198402000-00016; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; HOLM J, 1972, ACTA CHIR SCAND, V138, P683; INGOLFSSON IO, 1994, J CLIN EPIDEMIOL, V47, P1237, DOI 10.1016/0895-4356(94)90128-7; Isner JM, 1996, LANCET, V348, P370, DOI 10.1016/S0140-6736(96)03361-2; Jackson MR, 2001, CHEST, V119, p283S, DOI 10.1378/chest.119.1_suppl.283S; JIVEGARD L, 1988, J CARDIOVASC SURG, V29, P32; JUERGENS JL, 1960, CIRCULATION, V21, P188, DOI 10.1161/01.CIR.21.2.188; Kannel W B, 1992, Ann Epidemiol, V2, P457; KANNEL WB, 1985, J AM GERIATR SOC, V33, P13, DOI 10.1111/j.1532-5415.1985.tb02853.x; KANNEL WB, 1970, CIRCULATION, V41, P875, DOI 10.1161/01.CIR.41.5.875; Lee RJ, 2000, CIRCULATION, V102, P898; LEFER AM, 1993, ARTERIOSCLER THROMB, V13, P771, DOI 10.1161/01.ATV.13.6.771; Libby P, 2000, J INTERN MED, V247, P349, DOI 10.1046/j.1365-2796.2000.00654.x; LINDGARDE F, 1989, CIRCULATION, V80, P1549, DOI 10.1161/01.CIR.80.6.1549; Luther M, 1996, BRIT J SURG, V83, P241, DOI 10.1002/bjs.1800830229; Martin EC, 1995, J VASC INTERV RADIOL, V6, P843, DOI 10.1016/S1051-0443(95)71198-8; MATSI PJ, 1994, RADIOLOGY, V191, P727, DOI 10.1148/radiology.191.3.8184053; MCNAMARA TO, 1985, AM J ROENTGENOL, V144, P769, DOI 10.2214/ajr.144.4.769; MCNAMARA TO, 1995, THROMBOLYTIC THERAPY, P253; Meijer WT, 1998, ARTERIOSCL THROM VAS, V18, P185, DOI 10.1161/01.ATV.18.2.185; Mlot C, 1996, SCIENCE, V272, P1422, DOI 10.1126/science.272.5267.1422; Murphy TP, 1996, J VASC INTERV RADIOL, V7, P21, DOI 10.1016/S1051-0443(96)70727-3; MURRAY JG, 1995, RADIOLOGY, V195, P158, DOI 10.1148/radiology.195.1.7892459; NEWMAN AB, 1993, JAMA-J AM MED ASSOC, V270, P487, DOI 10.1001/jama.270.4.487; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; OURIEL K, 1994, RADIOLOGY, V193, P561, DOI 10.1148/radiology.193.2.7972780; OURIEL K, 1994, J VASC SURG, V19, P1021, DOI 10.1016/S0741-5214(94)70214-4; OURIEL K, 1982, ARCH SURG-CHICAGO, V117, P1297; Ouriel K, 1998, NEW ENGL J MED, V338, P1105, DOI 10.1056/NEJM199804163381603; Ouriel K, 2000, J VASC INTERV RADIOL, V11, P849, DOI 10.1016/S1051-0443(07)61799-0; Padberg FT, 1996, J SURG RES, V60, P365; PORTER JM, 1982, AM HEART J, V104, P66, DOI 10.1016/0002-8703(82)90642-1; PUJIA A, 1993, MINERVA CARDIOANGIOL, V41, P130; Sarac TP, 1998, J VASC SURG, V28, P446, DOI 10.1016/S0741-5214(98)70130-2; Semba CP, 2000, J VASC INTERV RADIOL, V11, P149, DOI 10.1016/S1051-0443(07)61459-6; Smith I, 1996, EUR J VASC ENDOVASC, V11, P402, DOI 10.1016/S1078-5884(96)80170-5; Stoffers HE, 1991, EPIDEMIOLOGY PERIPHE, P109; Stoffers HEJH, 1996, INT J EPIDEMIOL, V25, P282, DOI 10.1093/ije/25.2.282; Strecker EPK, 1997, RADIOLOGY, V205, P375, DOI 10.1148/radiology.205.2.9356617; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Tangelder MJD, 2000, LANCET, V355, P346; TAYLOR LM, 1990, J VASC SURG, V11, P193, DOI 10.1067/mva.1990.17235; Tetteroo E, 1998, LANCET, V351, P1153, DOI 10.1016/S0140-6736(97)09508-1; *TRANS INT CONS, 2000, J VASC SURG S, V1, P1; TRUBESTEIN G, 1984, ANGIOLOGY, V35, P701, DOI 10.1177/000331978403501103; TRUBESTEIN G, 1984, ANGIOLOGY, V35, P500, DOI 10.1177/000331978403500805; Ubbink DT, 1997, EUR J VASC ENDOVASC, V13, P296, DOI 10.1016/S1078-5884(97)80101-3; UK Severe Limb-Ischaemia Study Group, 1991, EUR J VASCULAR SURG, V5, P511; VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36; VEITH FJ, 1986, J VASC SURG, V3, P104; Visser K, 2000, RADIOLOGY, V216, P67, DOI 10.1148/radiology.216.1.r00jl0367; Vorwerk D, 1996, RADIOLOGY, V198, P45, DOI 10.1148/radiology.198.1.8539403; VORWERK D, 1995, RADIOLOGY, V194, P745, DOI 10.1148/radiology.194.3.7862973; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; WHITE GH, 1995, J VASC SURG, V21, P270, DOI 10.1016/S0741-5214(95)70268-7; WOLFE JHN, 1986, BRIT J SURG, V73, P321; WYSS CR, 1987, SURGERY, V101, P56; ZIMMERMAN BR, 1981, MAYO CLIN PROC, V56, P233	95	477	519	0	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2001	358	9289					1257	1264		10.1016/S0140-6736(01)06351-6	http://dx.doi.org/10.1016/S0140-6736(01)06351-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675083				2022-12-28	WOS:000171527000033
J	Labrecque, M; Eason, E; Marcoux, S				Labrecque, M; Eason, E; Marcoux, S			Perineal massage in pregnancy - Such massage significantly decreases perineal trauma at birth	BRITISH MEDICAL JOURNAL			English	Letter									Univ Laval, Dept Family Med, Quebec City, PQ G1K 7P4, Canada; Univ Ottawa, Dept Obstet & Gynaecol, Ottawa, ON, Canada; Univ Laval, Dept Social & Prevent Med, Quebec City, PQ G1K 7P4, Canada	Laval University; University of Ottawa; Laval University	Labrecque, M (corresponding author), Univ Laval, Dept Family Med, Quebec City, PQ G1K 7P4, Canada.			Halligan, Steve/0000-0003-0632-5108				Labrecque M, 1999, AM J OBSTET GYNECOL, V180, P593, DOI 10.1016/S0002-9378(99)70260-7; Stamp G, 2001, BMJ-BRIT MED J, V322, P1277, DOI 10.1136/bmj.322.7297.1277	2	2	2	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 29	2001	323	7315					753	754		10.1136/bmj.323.7315.753b	http://dx.doi.org/10.1136/bmj.323.7315.753b			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478HJ	11675731				2022-12-28	WOS:000171340700039
J	Tobias, JS				Tobias, JS			Changing the BMJ's position on informed consent would be counterproductive	BRITISH MEDICAL JOURNAL			English	Article									Middlesex Hosp, Meyerstein Inst Oncol, London W1N 8AA, England	University of London; University College London	Tobias, JS (corresponding author), Middlesex Hosp, Meyerstein Inst Oncol, London W1N 8AA, England.							Bland M, 1997, BRIT MED J, V314, P1477; Bratt DE, 1997, BRIT MED J, V314, P1477, DOI 10.1136/bmj.314.7092.1477; Brewin T, 1997, BRIT MED J, V315, P253; Chanter DO, 1997, BRIT MED J, V314, P1478; Little P, 1997, BRIT MED J, V314, P1478; Montgomery C, 1997, BRIT MED J, V314, P1482; Morley C, 1997, BRIT MED J, V314, P1480; Sikorski J, 1997, BRIT MED J, V315, P250; Soutter P, 1997, BRIT MED J, V314, P1477; Thornton H, 1997, BRIT MED J, V314, P1479; TOBIAS JS, 1993, BRIT MED J, V307, P1199, DOI 10.1136/bmj.307.6913.1199	11	16	16	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 28	1998	316	7136					1001	1002						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZF034	11645038				2022-12-28	WOS:000072856100030
J	DYER, J				DYER, J			NO MORE HIROSHIMAS	LANCET			English	Editorial Material											DYER, J (corresponding author), ROYAL EDINBURGH & ASSOC HOSP,EDINBURGH EH10 5HF,SCOTLAND.								0	1	1	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 28	1989	2	8670					1051	1053						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX046	11644435				2022-12-28	WOS:A1989AX04600065
J	Parker, AR; Lawrence, CR				Parker, AR; Lawrence, CR			Water capture by a desert beetle	NATURE			English	Article									Univ Oxford, Dept Zool, Oxford OX1 3PS, England; QinetiQ, Mech Sci Sector, Farnborough GU14 0LX, Hants, England	University of Oxford; Qinetiq Group Plc	Parker, AR (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.							Crawford C.S., 1981, BIOL DESERT INVERTEB; HAMILTON WJ, 1976, NATURE, V262, P284, DOI 10.1038/262284a0; KOCH C., 1962, ANN TRANSVAAL MUS, V24, P61; Louw G.N., 1972, Symposia Zool Soc Lond, VNo. 31, P297; MACHIN J, 1970, J EXP BIOL, V53, P753; MCGILL DJ, 1989, STAT INTRO DYNAMICS; ROBERTS CS, 1991, PHYSIOL ENTOMOL, V16, P463, DOI 10.1111/j.1365-3032.1991.tb00586.x; Watanabe K, 2000, J JPN SOC TRIBOLOGIS, V45, P354; 01098144	9	1423	1497	106	1125	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 01	2001	414	6859					33	34		10.1038/35102108	http://dx.doi.org/10.1038/35102108			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689930				2022-12-28	WOS:000171898900029
J	Ruvkun, G				Ruvkun, G			Molecular biology - Glimpses of a tiny RNA world	SCIENCE			English	Editorial Material							GENE; INTERFERENCE; EXPRESSION; RDE-1; ALPHA; ACTS		Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.							Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lynn K, 1999, DEVELOPMENT, V126, P469; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Mori Y, 2000, NAT NEUROSCI, V3, P1079, DOI 10.1038/80591; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	20	242	330	4	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					797	799		10.1126/science.1066315	http://dx.doi.org/10.1126/science.1066315			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679654				2022-12-28	WOS:000171851800029
J	Bamforth, I				Bamforth, I			Literature, medicine, and the culture wars	LANCET			English	Editorial Material											Bamforth, I (corresponding author), 86 Rue Kempf, F-67000 Strasbourg, France.	IainBAMFORTH@wanadoo.fr						Bolton G, 1999, LANCET, V354, P243, DOI 10.1016/S0140-6736(98)06443-5; COUSER GT, 1998, RECOVERIG BODIES ILL; DANIELS AM, 1998, TIMES LIT SUPPL 0424; Eagleton T, 1998, TLS-TIMES LIT SUPPL, P6; EMERSON RW, 1982, SELECTED ESSAYS, P304; HELLER E, 1984, AGE PROSE LIT PHILOS, P218; Hughes R., 1993, CULTURE COMPLAINT FR; Hurwitz, 1998, NARRATIVE BASED MED; MCWHINNEY IR, 1997, TXB FAMILY MED, P25; STAROBINSKI J, 1990, MAGAZINE LIT     SEP, V280; STEIGMOLLER F, 1981, LETT G FLAUBERT 1830; STEINER G, 1978, DIFFICULTY OTHER ESS, P11; TALLIS R, 1995, NEWTONS SLEEP 2 CULT, P27; Zeiger Melissa, 1997, CONSOLATION DEATH SE, P135	14	7	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2001	358	9290					1361	1364		10.1016/S0140-6736(01)06419-4	http://dx.doi.org/10.1016/S0140-6736(01)06419-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684237				2022-12-28	WOS:000171702500034
J	Dumont, A; de Bernis, L; Bouvier-Colle, MH; Breart, G				Dumont, A; de Bernis, L; Bouvier-Colle, MH; Breart, G		MOMA Study Grp	Caesarean section rate for maternal indication in sub-Saharan Africa: a systematic review	LANCET			English	Article							ABRUPTIO PLACENTAE; VAGINAL DELIVERY; ACTIVE MANAGEMENT; CASE-FATALITY; WEST-AFRICA; ACTION LINE; LABOR; ECLAMPSIA; BIRTH; MORTALITY	Introduction Rates of caesarean sections in more-developed countries have been rising since 1970, and vary greatly between less-developed countries. Present estimates, based on data from more-developed countries need to be validated with data from less-developed countries. We estimated the need for caesarean section for maternal indication in a population of pregnant women in west Africa (MOMA survey). Methods The expected caesarean section rate was calculated from the rate of obstetric risk in the MOMA population, and rates of caesarean section in published work. Findings Three-quarters of women from hospitals of sub-Saharan Africa were delivered by caesarean section for maternal reasons. Such intervention was needed for six main reasons, protracted labour, abruptio placentae, previous caesarean section, eclampsia, placenta praevia, and malpresentation. Although the observed rate of caesarean section in west African women is 1.3%, our results, combined with those of published work suggest a range of 3.6-6.5% (median, 5.4%). Interpretation Our method might not be strictly accurate, but it is simple and provides informative findings that can help policy makers and health planners in sub-Saharan Africa to design and follow up programmes to reach the optimum caesarean section rate. Moreover, application of this method to hospital data could improve practitioners' assessments in these countries.	Natl Inst Hlth & Med Res, INSERM, Epidemiol Res Unit Womens & Childrens Hlth, Paris, France; Hlth Senegal, French Cooperat Off, Dakar, Senegal; Hlth Senegal, Natl Unit Reprod, Dakar, Senegal; WHO, Dept Reprod Hlth & Res, Geneva, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); World Health Organization	Dumont, A (corresponding author), Minist Sante, Serv Natl Sante Reprod, BP 11 574, Dakar, Senegal.	adumont@sentoo.sn	Dumont, Alexandre/I-9429-2016	Dumont, Alexandre/0000-0003-3826-0193; breart, gerard/0000-0003-3142-9128				ALI Y, 1995, E AFR MED J, V72, P60; [Anonymous], 1985, LANCET, V2, P436; BASSAW B, 1994, W INDIAN MED J, V43, P18; BATUNGWANAYOC C, 1995, MED AFR NOIRE, V42, P628; BIRD GC, 1978, TROP DOCT, V8, P78, DOI 10.1177/004947557800800213; BLAIR RG, 1973, J OBSTET GYN BR COMM, V80, P242; Blanch G, 1998, BRIT J OBSTET GYNAEC, V105, P117, DOI 10.1111/j.1471-0528.1998.tb09362.x; BOISSELIER P, 1987, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V16, P251; Bouvier-Colle MH, 2001, ACTA OBSTET GYN SCAN, V80, P113; Cisse C. T., 1998, Cahiers d'Etudes et de Recherches Francophones/Sante, V8, P369; Cisse C. T., 1995, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V24, P194; DeBrouwere V, 1996, REV EPIDEMIOL SANTE, V44, P111; DEJONG P, 1987, INT J GYNECOL OBSTET, V25, P405, DOI 10.1016/0020-7292(87)90348-1; DEMUYLDER X, 1990, OBSTET GYNECOL, V75, P360; DEMUYLDER X, 1988, AUST NZ J OBSTET GYN, V28, P99; DIALLO F, 1998, MED AFR NOIRE, V45, P259; DOH AS, 1991, CENT AFR J MED, V37, P326; DOUGLAS KA, 1994, BMJ-BRIT MED J, V309, P1395, DOI 10.1136/bmj.309.6966.1395; DROUIN P, 1979, OBSTET GYNECOL, V53, P741; DULEY L, 1995, LANCET, V345, P1455; DUMONT A, 1996, MED AFR NOIRE, V46, P332; EGWUATU VE, 1990, INT J GYNECOL OBSTET, V32, P1, DOI 10.1016/0020-7292(90)90973-O; Ekholm E, 1999, ACTA OBSTET GYN SCAN, V78, P877, DOI 10.1034/j.1600-0412.1999.781008.x; Elliott JP, 1997, AM J OBSTET GYNECOL, V177, P139, DOI 10.1016/S0002-9378(97)70452-6; FOURN L, 1994, REV EPIDEMIOL SANTE, V42, P5; FRANCOME C, 1993, SOC SCI MED, V37, P1199, DOI 10.1016/0277-9536(93)90332-X; GILABERT J, 1985, ACTA OBSTET GYN SCAN, V64, P35, DOI 10.3109/00016348509154685; GOLDITCH I, JAMA, V212, P288; Granja A, 1991, Clin Exp Obstet Gynecol, V18, P47; HARRISON KA, 1985, BRIT J OBSTET GYNAEC, V92, P1; HUNTER DJS, 1983, AM J OBSTET GYNECOL, V145, P189, DOI 10.1016/0002-9378(83)90489-1; HURD WW, 1983, OBSTET GYNECOL, V61, P467; KLUFIO CA, 1973, GHANA MED J, V12, P426; KNAB DR, 1978, OBSTET GYNECOL, V52, P625; KWAST BE, 1994, LANCET, V343, P1399; Kwast BE, 1998, MIDWIFERY, V14, P66; KWAST BE, 1988, WHOMCH883; LANKOANDE J, 1997, CAHIER SANTE, V7, P231; Lavender T, 1998, BRIT J OBSTET GYNAEC, V105, P976, DOI 10.1111/j.1471-0528.1998.tb10260.x; LENNOX CE, 1981, PAPUA NEW GUINEA MED, V24, P286; LOPEZLLERA M, 1992, AM J OBSTET GYNECOL, V166, P4, DOI 10.1016/0002-9378(92)91816-S; Love CDB, 1996, BRIT J OBSTET GYNAEC, V103, P864, DOI 10.1111/j.1471-0528.1996.tb09903.x; LUNAN CB, 1973, J OBSTET GYN BR COMM, V80, P120; Malone FD, 1996, OBSTET GYNECOL, V88, P211, DOI 10.1016/0029-7844(96)00185-8; MOCK CN, 1991, INT J GYNECOL OBSTET, V36, P187, DOI 10.1016/0020-7292(91)90712-E; MOODLEY J, 1983, S AFR MED J, V63, P530; MOORE PJ, 1985, S AFR MED J, V67, P597; Mwinyoglee J, 1996, S AFR MED J, V86, P1536; NYIRJESY P, 1992, J REPROD MED, V37, P457; OBED SA, 1994, INT J GYNECOL OBSTET, V45, P97, DOI 10.1016/0020-7292(94)90115-5; ODENDAAL HJ, 1978, S AFR MED J, V54, P476; ODRISCOLL K, 1984, OBSTET GYNECOL, V63, P485; Ojo V A, 1988, Asia Oceania J Obstet Gynaecol, V14, P185; Ojo V A, 1989, Asia Oceania J Obstet Gynaecol, V15, P121; OKPERE EE, 1982, TROP J OBSTET GYNAEC, V3, P45; Omu A E, 1981, Int J Gynaecol Obstet, V19, P205, DOI 10.1016/0020-7292(81)90063-1; OTOLORIN EO, 1988, INT J GYNECOL OBSTET, V26, P367, DOI 10.1016/0020-7292(88)90331-1; PHILPOTT RH, 1972, J OBSTET GYN BR COMM, V79, P599; Picaud A, 1990, Rev Fr Gynecol Obstet, V85, P387; PORAPAKKHAM S, 1979, OBSTET GYNECOL, V54, P26, DOI 10.1097/00006250-197907000-00007; Prual A, 2000, B WORLD HEALTH ORGAN, V78, P593; Rasmussen S, 1996, ACTA OBSTET GYN SCAN, V75, P229, DOI 10.3109/00016349609047092; ROSEN MG, 1991, OBSTET GYNECOL, V77, P465; SAFTLAS AF, 1991, OBSTET GYNECOL, V78, P1081; Saito H, 1982, Nihon Sanka Fujinka Gakkai Zasshi, V34, P529; SOKOL RJ, 1982, OBSTET GYNECOL, V59, P340; Spaans WA, 1997, EUR J OBSTET GYN R B, V72, P9, DOI 10.1016/S0301-2115(96)02646-2; Tadesse E, 1996, E AFR MED J, V73, P619; Taner CE, 1996, INT J GYNECOL OBSTET, V53, P11, DOI 10.1016/S0020-7292(96)80003-8; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; TSHIBANGU K, 1991, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V20, P69; TSHILOMBO K M, 1991, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V20, P568; VANDENBROEK N, 1989, INT J GYNECOL OBSTET, V28, P337, DOI 10.1016/0020-7292(89)90605-X; VANDERWALT WA, 1994, INT J GYNECOL OBSTET, V46, P271, DOI 10.1016/0020-7292(94)90405-7; VANDERWIJDEN CL, 1993, INT J GYNECOL OBSTET, V41, P183, DOI 10.1016/0020-7292(93)90704-Z; VANROOSMALEN J, 1991, INT J GYNECOL OBSTET, V34, P211, DOI 10.1016/0020-7292(91)90351-5; WADHAWAN S, 1983, INT J GYNECOL OBSTET, V21, P7, DOI 10.1016/0020-7292(83)90063-2; WALTON SM, 1978, E AFR MED J, V55, P1; Weil O, 1999, LANCET, V354, P940, DOI 10.1016/S0140-6736(99)02369-7	79	119	120	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2001	358	9290					1328	1333		10.1016/S0140-6736(01)06414-5	http://dx.doi.org/10.1016/S0140-6736(01)06414-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684214				2022-12-28	WOS:000171702500013
J	Luo, MJ; Zhou, ZL; Magni, K; Christoforides, C; Rappsilber, J; Mann, M; Reed, R				Luo, MJ; Zhou, ZL; Magni, K; Christoforides, C; Rappsilber, J; Mann, M; Reed, R			Pre-mRNA splicing and mRNA export linked by direct interactions between UAP56 and Aly	NATURE			English	Article							MESSENGER-RNA EXPORT; BINDING PROTEIN; U2 SNRNP; NUCLEUS; METAZOANS; COMPLEX	Recent studies indicate that splicing of pre-messenger RNA and export of mRNA are normally coupled in vivo(1-6). During splicing, the conserved mRNA export factor Aly is recruited to the spliced mRNA-protein complex (mRNP), which targets the mRNA for export. At present, it is not known how Aly is recruited to the spliced mRNP. Here we show that the conserved DEAD-box helicase UAP56, which functions during spliceosome assembly(7-10), interacts directly and highly specifically with Aly. Moreover, UAP56 is present together with Aly in the spliced mRNP. Significantly, excess UAP56 is a potent dominant negative inhibitor of mRNA export. Excess UAP56 also inhibits the recruitment of Aly to the spliced mRNP. Furthermore, a mutation in Aly that blocks its interaction with UAP56 prevents recruitment of Aly to the spliced mRNP. These data suggest that the splicing factor UAP56 functions in coupling the splicing and export machineries by recruiting Aly to the spliced mRNP.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ So Denmark, Prot Interact Lab, Ctr Expt Bioinformat, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	Harvard University; Harvard Medical School; University of Southern Denmark	Reed, R (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	rreed@hms.harvard.edu	Rappsilber, Juri/ABF-3328-2020; Rappsilber, Juri/B-7265-2015; Mann, Matthias/A-3454-2013	Rappsilber, Juri/0000-0001-5999-1310; Mann, Matthias/0000-0003-1292-4799				Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Das R, 2000, MOL CELL, V5, P779, DOI 10.1016/S1097-2765(00)80318-4; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; HAMM J, 1990, CELL, V63, P109, DOI 10.1016/0092-8674(90)90292-M; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Libri D, 2001, GENE DEV, V15, P36, DOI 10.1101/gad.852101; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Moazed D, 1997, P NATL ACAD SCI USA, V94, P2186, DOI 10.1073/pnas.94.6.2186; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Virbasius CMA, 1999, MOL CELL, V4, P219, DOI 10.1016/S1097-2765(00)80369-X; VORM O, 1994, ANAL CHEM, V66, P3281, DOI 10.1021/ac00091a044; Wichmann I, 1999, HUM IMMUNOL, V60, P57, DOI 10.1016/S0198-8859(98)00085-8; Zhang M, 2001, GENE DEV, V15, P30, DOI 10.1101/gad.851701; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	23	299	305	3	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2001	413	6856					644	647		10.1038/35098106	http://dx.doi.org/10.1038/35098106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675789				2022-12-28	WOS:000171485700052
J	Luo, YQ; Wan, SQ; Hui, DF; Wallace, LL				Luo, YQ; Wan, SQ; Hui, DF; Wallace, LL			Acclimatization of soil respiration to warming in a tall grass prairie	NATURE			English	Article							TRACE GAS FLUXES; TEMPERATURE-DEPENDENCE; ORGANIC-CARBON; CO2 EMISSIONS; DECOMPOSITION; CLIMATE; FEEDBACKS; FOREST; MATTER; CH4	The latest report by the Intergovernmental Panel on Climate Change (IPCC) predicts a 1.4-5.8 degreesC average increase in the global surface temperature over the period 1990 to 2100 (ref. 1). These estimates of future warming are greater than earlier projections, which is partly due to incorporation of a positive feedback. This feedback results from further release of greenhouse gases from terrestrial ecosystems in response to climatic warming(2-4). The feedback mechanism is usually based on the assumption that observed sensitivity of soil respiration to temperature under current climate conditions would hold in a warmer climate(5). However, this assumption has not been carefully examined. We have therefore conducted an experiment in a tall grass prairie ecosystem in the US Great Plains to study the response of soil respiration (the sum of root and heterotrophic respiration) to artificial warming of about 2 degreesC. Our observations indicate that the temperature sensitivity of soil respiration decreases-or acclimatizes-under warming and that the acclimatization is greater at high temperatures. This acclimatization of soil respiration to warming may therefore weaken the positive feedback between the terrestrial carbon cycle and climate.	Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Luo, YQ (corresponding author), Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA.	yluo@ou.edu	Wan, Shiqiang/B-5799-2009; Wan, Shiqiang/L-9166-2019	Wan, Shiqiang/0000-0003-0631-1232; Wan, Shiqiang/0000-0003-0631-1232; Hui, Dafeng/0000-0002-5284-2897				Atkin OK, 2000, NEW PHYTOL, V147, P141, DOI 10.1046/j.1469-8137.2000.00683.x; Cheng WX, 1996, SOIL BIOL BIOCHEM, V28, P1283, DOI 10.1016/S0038-0717(96)00138-1; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; *IPCC, 2001, CLIM CHANG 2001 SYNT; JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; Lenton TM, 2000, TELLUS B, V52, P1159, DOI 10.1034/j.1600-0889.2000.01104.x; Lin GH, 1999, GLOB CHANGE BIOL, V5, P157, DOI 10.1046/j.1365-2486.1999.00211.x; Liski J, 1999, AMBIO, V28, P171; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; McHale PJ, 1998, CAN J FOREST RES, V28, P1365, DOI 10.1139/cjfr-28-9-1365; Oechel WC, 2000, NATURE, V406, P978, DOI 10.1038/35023137; PETERJOHN WT, 1994, ECOL APPL, V4, P617, DOI 10.2307/1941962; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Rustad LE, 1998, GLOB CHANGE BIOL, V4, P597, DOI 10.1046/j.1365-2486.1998.00169.x; Saleska SR, 1999, GLOB CHANGE BIOL, V5, P125, DOI 10.1046/j.1365-2486.1999.00216.x; Sarmiento J, 2000, NATURE, V408, P155, DOI 10.1038/35041676; Schimel DS, 1996, GLOBAL BIOGEOCHEM CY, V10, P677, DOI 10.1029/96GB01524; Shaver GR, 2000, BIOSCIENCE, V50, P871, DOI 10.1641/0006-3568(2000)050[0871:GWATEA]2.0.CO;2; Striegl RG, 1998, CAN J FOREST RES, V28, P534, DOI 10.1139/cjfr-28-4-534; TARR J, 1980, Proceedings of the Oklahoma Academy of Science, V60, P39; *USDA, 1963, NAT COOP SOIL SURV, P1; Verville JH, 1998, BIOGEOCHEMISTRY, V41, P215, DOI 10.1023/A:1005984701775; Woodwell GM, 1998, CLIMATIC CHANGE, V40, P495, DOI 10.1023/A:1005345429236; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	28	892	1218	26	647	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2001	413	6856					622	625		10.1038/35098065	http://dx.doi.org/10.1038/35098065			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675783				2022-12-28	WOS:000171485700046
J	Rogers, A				Rogers, A			European regulations set to protect research	LANCET			English	News Item																			0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 18	1999	354	9183					1011	1011		10.1016/S0140-6736(05)76625-3	http://dx.doi.org/10.1016/S0140-6736(05)76625-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	236JG	11657501				2022-12-28	WOS:000082596000037
J	Birmingham, L				Birmingham, L			Personal views - Should prisoners have a say in prison health care?	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	2	3	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 5	1997	315	7099					65	66		10.1136/bmj.315.7099.65a	http://dx.doi.org/10.1136/bmj.315.7099.65a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XJ947	11644951	Green Published			2022-12-28	WOS:A1997XJ94700079
J	Rogers, A				Rogers, A			European bioethics treaty finally approved	LANCET			English	News Item																			0	1	1	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 5	1996	348	9032					953	953		10.1016/S0140-6736(05)65356-1	http://dx.doi.org/10.1016/S0140-6736(05)65356-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VL097	11654587				2022-12-28	WOS:A1996VL09700033
J	ROGERS, A				ROGERS, A			BIOETHICS CONVENTION	LANCET			English	Editorial Material																			0	0	0	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 11	1993	342	8885					1481	1482		10.1016/0140-6736(93)92952-P	http://dx.doi.org/10.1016/0140-6736(93)92952-P			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ML217	11643249				2022-12-28	WOS:A1993ML21700027
J	BRAHAMS, D				BRAHAMS, D			RESEARCH BAN ON FRAUDULENT DOCTOR	LANCET			English	Editorial Material																		LORD G, 1956, WLR, V1, P1312	1	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 2	1993	341	8836					45	45		10.1016/0140-6736(93)92508-Q	http://dx.doi.org/10.1016/0140-6736(93)92508-Q			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KF027	11643225				2022-12-28	WOS:A1993KF02700021
J	TONKS, A				TONKS, A			INTUBATION PRACTICE ON CADAVERS SHOULD STOP	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	15	14	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	AUG 8	1992	305	6849					332	332						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JJ032	11643027				2022-12-28	WOS:A1992JJ03200014
J	LEWIS, J				LEWIS, J			A COMMONS SUBCOMMITTEE ON MEDICAL-ETHICS	LANCET			English	Editorial Material																			0	2	2	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	APR 30	1988	1	8592					1005	1005						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	N1366	11644348				2022-12-28	WOS:A1988N136600056
J	Kandel, ER				Kandel, ER			Neuroscience - The molecular biology of memory storage: A dialogue between genes and synapses	SCIENCE			English	Review							LONG-TERM FACILITATION; GILL-WITHDRAWAL REFLEX; APLYSIA SENSORY NEURONS; CYCLIC ADENOSINE-MONOPHOSPHATE; CAMP-RESPONSIVE ELEMENT; BEHAVIORAL SENSITIZATION; STRUCTURAL-CHANGES; PROTEIN-SYNTHESIS; HETEROSYNAPTIC FACILITATION; SYNAPTIC FACILITATION	One of the most remarkable aspects of an animal's behavior is the ability to modify that behavior by learning, an ability that reaches its highest form in human beings. For me, learning and memory have proven to be endlessly fascinating mental processes because they address one of the fundamental features of human activity: our ability to acquire new ideas from experience and to retain these ideas over time in memory. Moreover, unlike other mental processes such as thought, language, and consciousness, learning seemed from the outset to be readily accessible to cellular and molecular analysis. I, therefore, have been curious to know: What changes in the brain when we learn? And, once something is learned, how is that information retained in the brain? I have tried to address these questions through a reductionist approach that would allow me to investigate elementary forms of learning and memory at a cellular molecular level-as specific molecular activities within identified nerve cells.	Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Ctr Neurobiol & Behav, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; New York State Psychiatry Institute	Kandel, ER (corresponding author), Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Ctr Neurobiol & Behav, Howard Hughes Med Inst, 1051 Riverside Dr, New York, NY 10032 USA.	erk5@columbia.edu						Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; AGNIHOTRI N, 2001, SOC NEUR ABSTR, V27; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; BAILEY CH, 1989, J NEUROSCI, V9, P1774; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P2373, DOI 10.1073/pnas.85.7.2373; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bartsch D, 2000, CELL, V103, P595, DOI 10.1016/S0092-8674(00)00163-X; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BRUNELLI M, 1976, SCIENCE, V194, P1178, DOI 10.1126/science.186870; BYRNE J, 1974, J NEUROPHYSIOL, V37, P1041, DOI 10.1152/jn.1974.37.5.1041; BYRNE JH, 1978, J NEUROPHYSIOL, V41, P402, DOI 10.1152/jn.1978.41.2.402; Byrne JH, 1996, J NEUROSCI, V16, P425; BYRNE JH, 1978, J NEUROPHYSIOL, V41, P418, DOI 10.1152/jn.1978.41.2.418; Cajal S.R.y., 1894, P R SOC LOND, V55, P444; CAREW TJ, 1972, SCIENCE, V175, P451, DOI 10.1126/science.175.4020.451; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CASTELLUCCI V, 1970, SCIENCE, V167, P1745, DOI 10.1126/science.167.3926.1745; CASTELLUCCI VF, 1982, J NEUROSCI, V2, P1673; CASTELLUCCI VF, 1980, P NATL ACAD SCI-BIOL, V77, P7492, DOI 10.1073/pnas.77.12.7492; CASTELLUCCI VF, 1978, SCIENCE, V202, P1306, DOI 10.1126/science.214854; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; CEDAR H, 1972, J GEN PHYSIOL, V60, P558, DOI 10.1085/jgp.60.5.558; CEDAR H, 1972, J GEN PHYSIOL, V60, P570, DOI 10.1085/jgp.60.5.570; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Ebbinghaus H., 1885, MEMORY CONTRIBUTION; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; FATT P, 1951, J PHYSIOL-LONDON, V115, P320, DOI 10.1113/jphysiol.1951.sp004675; FLEXNER LB, 1966, P NATL ACAD SCI USA, V55, P369, DOI 10.1073/pnas.55.2.369; FRAZIER WT, 1967, J NEUROPHYSIOL, V30, P1288, DOI 10.1152/jn.1967.30.6.1288; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; GLANZMAN DL, 1989, J NEUROSCI, V9, P4200; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; GREENGARD P, 1976, NATURE, V260, P101, DOI 10.1038/260101a0; HAWKINS RD, 1981, J NEUROPHYSIOL, V45, P304, DOI 10.1152/jn.1981.45.2.304; HAWKINS RD, 1981, J NEUROPHYSIOL, V45, P315, DOI 10.1152/jn.1981.45.2.315; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; Kandel E. R., 1979, BEHAV BIOL APLYSIA C; KANDEL ER, 1975, COLD SPRING HARB SYM, V40, P465; KANDEL ER, 1968, PHYSIOL REV, V48, P65, DOI 10.1152/physrev.1968.48.1.65; KANDEL ER, 1961, ANN NY ACAD SCI, V94, P570, DOI 10.1111/j.1749-6632.1961.tb35560.x; Kandel ER., 1976, CELLULAR BASIS BEHAV; KANTROS C, 2001, SOC NEUR ABSTR, V27; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; KLEIN M, 1980, P NATL ACAD SCI-BIOL, V77, P6912, DOI 10.1073/pnas.77.11.6912; KUPFERMANN I, 1970, SCIENCE, V167, P1743, DOI 10.1126/science.167.3926.1743; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; MACKEY SL, 1989, J NEUROSCI, V9, P4227; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Muller D, 1997, REV NEUROSCIENCE, V8, P77; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; PINSKER H, 1970, SCIENCE, V167, P1740, DOI 10.1126/science.167.3926.1740; PINSKER HM, 1973, SCIENCE, V182, P1039, DOI 10.1126/science.182.4116.1039; Rotenberg A, 2000, J NEUROSCI, V20, P8096; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; SCHWARTZ JH, 1971, J NEUROPHYSIOL, V34, P939, DOI 10.1152/jn.1971.34.6.939; SHUSTER MJ, 1985, NATURE, V313, P392, DOI 10.1038/313392a0; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Steward O, 1997, NEURON, V18, P9, DOI 10.1016/S0896-6273(01)80041-6; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1	79	2391	2477	11	643	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2001	294	5544					1030	1038		10.1126/science.1067020	http://dx.doi.org/10.1126/science.1067020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691980				2022-12-28	WOS:000172013800036
J	Lowenstein, TK; Timofeeff, MN; Brennan, ST; Hardie, LA; Demicco, RV				Lowenstein, TK; Timofeeff, MN; Brennan, ST; Hardie, LA; Demicco, RV			Oscillations in Phanerozoic seawater chemistry: Evidence from fluid inclusions	SCIENCE			English	Article							MARINE	Systematic changes in the chemistry of evaporated seawater contained in primary fluid inclusions in marine halites indicate that seawater chemistry has fluctuated during the Phanerozoic. The fluctuations are in phase with oscillations in seafloor spreading rates, volcanism, global sea level, and the primary mineralogies of marine limestones and evaporites. The data suggest that seawater had high Mg2+/Ca2+ ratios (>2.5) and relatively high Na+ concentrations during the Late Precambrian [544 to 543 million years ago (Ma)], Permian (258 to 251 Ma), and Tertiary through the present (40 to 0 Ma), when aragonite and MgSO4 salts were the dominant marine precipitates. Conversely, seawater had low Mg2+/Ca2+ ratios (<2.3) and relatively low Na+ concentrations during the Cambrian (540 to 520 Ma), Silurian (440 to 418 Ma), and Cretaceous (124 to 94 Ma), when calcite was the dominant nonskeletal carbonate and K-, Mg-, and Ca-bearing chloride salts, were the only potash evaporites.	SUNY Binghamton, Dept Geol Sci & Environm Studies, Binghamton, NY 13902 USA; Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Johns Hopkins University	Lowenstein, TK (corresponding author), SUNY Binghamton, Dept Geol Sci & Environm Studies, Binghamton, NY 13902 USA.	lowenst@binghamton.edu	Brennan, Sean/M-2157-2017	Brennan, Sean/0000-0002-7102-9359				AYORA C, 1994, GEOCHIM COSMOCHIM AC, V58, P3379, DOI 10.1016/0016-7037(94)90093-0; Fischer A.G., 1982, CLIMATE EARTH HIST, P97, DOI DOI 10.17226/11798; Hardie LA, 1996, GEOLOGY, V24, P279, DOI 10.1130/0091-7613(1996)024<0279:SVISCA>2.3.CO;2; HARVIE CE, 1984, GEOCHIM COSMOCHIM AC, V48, P723, DOI 10.1016/0016-7037(84)90098-X; Holland HD, 2000, INT GEOL REV, V42, P481, DOI 10.1080/00206810009465093; HORITA J, 1991, GEOCHIM COSMOCHIM AC, V55, P417, DOI 10.1016/0016-7037(91)90001-L; LOWENSTEIN TK, 1985, SEDIMENTOLOGY, V32, P627, DOI 10.1111/j.1365-3091.1985.tb00478.x; Morse JW, 1997, GEOLOGY, V25, P85, DOI 10.1130/0091-7613(1997)025<0085:IOTAMC>2.3.CO;2; Peryt T.M., 1996, ZENTRALBL GEOL PALAO, V11, P337; RUBEY WW, 1951, GEOL SOC AM BULL, V62, P1111, DOI 10.1130/0016-7606(1951)62[1111:GHOSW]2.0.CO;2; SANDBERG PA, 1983, NATURE, V305, P19, DOI 10.1038/305019a0; Stanley SM, 1999, GSA TODAY, V9, P1, DOI 10.1130/GSAT-1999-10-01-science; Timofeeff MN, 2000, CHEM GEOL, V164, P171, DOI 10.1016/S0009-2541(99)00153-9; Timofeeff MN, 2001, GEOCHIM COSMOCHIM AC, V65, P2293, DOI 10.1016/S0016-7037(01)00591-9; Zimmermann H, 2000, AM J SCI, V300, P723, DOI 10.2475/ajs.300.10.723	15	393	439	2	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2001	294	5544					1086	1088		10.1126/science.1064280	http://dx.doi.org/10.1126/science.1064280			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691988				2022-12-28	WOS:000172013800045
J	Niswender, KD; Morton, GJ; Stearns, WH; Rhodes, CJ; Myers, MG; Schwartz, MW				Niswender, KD; Morton, GJ; Stearns, WH; Rhodes, CJ; Myers, MG; Schwartz, MW			Intracellular signalling - Key enzyme in leptin-induced anorexia	NATURE			English	Article							ACTIVATION; 3-KINASE; OBESE; MICE		Univ Washington, Sch Med, Div Metab Endocrinol & Nutr, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; Pacific NW Res Inst, Seattle, WA 98122 USA	University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Niswender, KD (corresponding author), Univ Washington, Sch Med, Div Metab Endocrinol & Nutr, Seattle, WA 98104 USA.	mschwart@u.washington.edu	Schwartz, Michael W/H-9950-2012					Cone RD, 1996, RECENT PROG HORM RES, V51, P287; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Harvey J, 2000, J BIOL CHEM, V275, P4660, DOI 10.1074/jbc.275.7.4660; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; McMinn JE, 2000, AM J PHYSIOL-REG I, V279, pR695, DOI 10.1152/ajpregu.2000.279.2.R695; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Zhao AZ, 2000, J BIOL CHEM, V275, P11348, DOI 10.1074/jbc.275.15.11348	12	474	489	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2001	413	6858					794	795		10.1038/35101657	http://dx.doi.org/10.1038/35101657			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677594				2022-12-28	WOS:000171750200033
J	Jain, KK				Jain, KK			Biochips for gene spotting	SCIENCE			English	Article											Jain, KK (corresponding author), Blaesiring 7, CH-4057 Basel, Switzerland.	jain@pharmabiotech.ch						Braxton S, 1998, CURR OPIN BIOTECH, V9, P643, DOI 10.1016/S0958-1669(98)80144-4; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; JAIN KK, 2000, BIOCHIPS MICROARRAYS, P5; JAIN KK, 2001, PROTEOMICS TECHNOLOG, P35; JAIN KK, 2001, PERSONALISED MED; Kato-Maeda M, 2001, GENOME RES, V11, P547, DOI 10.1101/gr.166401; Lennon GG, 2000, DRUG DISCOV TODAY, V5, P59, DOI 10.1016/S1359-6446(99)01448-8; Nocito A, 2001, J PATHOL, V194, P349, DOI 10.1002/1096-9896(200107)194:3<349::AID-PATH887>3.0.CO;2-D; Schulze A, 2001, NAT CELL BIOL, V3, pE190, DOI 10.1038/35087138; Yun CW, 2000, J BIOL CHEM, V275, P10709, DOI 10.1074/jbc.275.14.10709	10	53	62	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					621	+		10.1126/science.294.5542.621	http://dx.doi.org/10.1126/science.294.5542.621			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641502				2022-12-28	WOS:000171695600052
J	Makarova, TL; Sundqvist, B; Hohne, R; Esquinazi, P; Kopelevich, Y; Scharff, P; Davydov, VA; Kashevarova, LS; Rakhmanina, AV				Makarova, TL; Sundqvist, B; Hohne, R; Esquinazi, P; Kopelevich, Y; Scharff, P; Davydov, VA; Kashevarova, LS; Rakhmanina, AV			RETRACTED: Magnetic carbon (Retracted Article. See vol 440, pg 707, 2006)	NATURE			English	Article; Retracted Publication							SUSCEPTIBILITY; PHASE; SUPERCONDUCTIVITY; FERROMAGNETISM; NMR	The discovery of nanostructured forms of molecular carbon has led to renewed interest in the varied properties of this element. Both graphite and C-60 can be electron-doped by alkali metals(1) to become superconducting; transition temperatures of up to 52 K have been attained by field-induced hole-doping of C-60 (ref. 2). Recent experiments(3,4) and theoretical studies(5,6) have suggested that electronic instabilities in pure graphite may give rise to superconducting and ferromagnetic properties, even at room temperature. Here we report the serendipitous discovery of strong magnetic signals in rhombohedral C-60. Our intention was to search for superconductivity in polymerized C-60; however, it appears that our high-pressure, high-temperature polymerization process results in a magnetically ordered state. The material exhibits features typical of ferromagnets: saturation magnetization, large hysteresis and attachment to a magnet at room temperature. The temperature dependences of the saturation and remanent magnetization indicate a Curie temperature near 500 K.	AF Ioffe Phys Tech Inst, St Petersburg 194021, Russia; Umea Univ, Dept Expt Phys, S-90187 Umea, Sweden; Tech Univ Ilmenau, Dept Chem, Inst Phys, D-98693 Ilmenau, Germany; Univ Leipzig, Dept Superconduct & Magnetism, D-04103 Leipzig, Germany; Univ Estadual Campinas, Inst Fis, BR-13083970 Campinas, SP, Brazil; Russian Acad Sci, Inst High Pressure Phys, Troitsk 142092, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Ioffe Physical Technical Institute; Umea University; Technische Universitat Ilmenau; Leipzig University; Universidade Estadual de Campinas; Russian Academy of Sciences; Vereshchagin Institute of High Pressure Physics, Russian Academy of Sciences	Makarova, TL (corresponding author), AF Ioffe Phys Tech Inst, St Petersburg 194021, Russia.	tatiana.makarova@physics.umu.se	KOPELEVITCH, IAKOV/AAW-4539-2020; Esquinazi, Pablo/ABF-7975-2021; Davydov, Valery/P-5673-2015; Davydov, Valery A./AAH-3195-2021	Esquinazi, Pablo/0000-0003-0649-1472; Davydov, Valery/0000-0002-8702-0340; Davydov, Valery A./0000-0002-8702-0340				ALLEMAND PM, 1991, SCIENCE, V253, P301, DOI 10.1126/science.253.5017.301; Davydov VA, 2000, PHYS REV B, V61, P11936, DOI 10.1103/PhysRevB.61.11936; DU G, 1993, J APPL PHYS, V73, P6566, DOI 10.1063/1.352565; Gonzalez J, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.134421; HADDON RC, 1991, NATURE, V350, P46, DOI 10.1038/350046a0; Harigaya K, 2001, J PHYS-CONDENS MAT, V13, P1295, DOI 10.1088/0953-8984/13/6/309; HEBARD AF, 1991, NATURE, V350, P600, DOI 10.1038/350600a0; IWASA Y, 1994, SCIENCE, V264, P1570, DOI 10.1126/science.264.5165.1570; KAHASHI M, 1991, PHYS REV LETT, V67, P746; Kempa H, 2000, SOLID STATE COMMUN, V115, P539, DOI 10.1016/S0038-1098(00)00233-7; Kopelevich Y, 2000, J LOW TEMP PHYS, V119, P691, DOI 10.1023/A:1004637814008; Lobach AS, 1998, FULLERENE SCI TECHN, V6, P375, DOI 10.1080/10641229809350209; LUO WL, 1994, PHYS REV LETT, V73, P186, DOI 10.1103/PhysRevLett.73.186; Makarova TL, 2001, SYNTHETIC MET, V121, P1099, DOI 10.1016/S0379-6779(00)00804-3; Makarova TL, 1999, ELEC SOC S, V99, P628; Makarova TL, 2001, CARBON, V39, P2203, DOI 10.1016/S0008-6223(01)00036-7; Makarova TL, 2000, MOL MATER, V13, P151; Miller JS, 2000, MRS BULL, V25, P21, DOI 10.1557/mrs2000.221; Mrzel A, 1998, CHEM PHYS LETT, V298, P329, DOI 10.1016/S0009-2614(98)01184-1; Narymbetov B, 2000, NATURE, V407, P883, DOI 10.1038/35038032; NUNEZREGUEIRO M, 1995, PHYS REV LETT, V74, P278, DOI 10.1103/PhysRevLett.74.278; OVCHINNIKOV AA, 1991, J MOL STRUC-THEOCHEM, V83, P133, DOI 10.1016/0166-1280(91)85138-W; Panich AM, 2001, J PHYS CHEM SOLIDS, V62, P959, DOI 10.1016/S0022-3697(00)00264-X; PEKKER S, 1994, SOLID STATE COMMUN, V90, P349, DOI 10.1016/0038-1098(94)90796-X; Saito T, 2000, PHYS REV B, V61, P16091, DOI 10.1103/PhysRevB.61.16091; Schon JH, 2000, NATURE, V408, P549, DOI 10.1038/35046008; Shul'Ga YM, 1998, MOL CRYST LIQ CRYS C, V10, P201; Sundqvist B, 1999, ADV PHYS, V48, P1, DOI 10.1080/000187399243464; WANG XK, 1994, J MATER RES, V9, P1578, DOI 10.1557/JMR.1994.1578; XU CH, 1995, PHYS REV LETT, V74, P274, DOI 10.1103/PhysRevLett.74.274	30	514	530	8	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					716	718		10.1038/35099527	http://dx.doi.org/10.1038/35099527			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607027				2022-12-28	WOS:000171608000039
J	Stevens, DR; Seifert, R; Bufe, B; Muller, F; Kremmer, E; Gauss, R; Meyerhof, W; Kaupp, UB; Lindemann, B				Stevens, DR; Seifert, R; Bufe, B; Muller, F; Kremmer, E; Gauss, R; Meyerhof, W; Kaupp, UB; Lindemann, B			Hyperpolarization-activated channels HCN1 and HCN4 mediate responses to sour stimuli	NATURE			English	Article							TASTE CELLS; PACEMAKER CHANNELS; INTRACELLULAR PH; CHORDA TYMPANI; CATION CURRENT; TRANSDUCTION; RAT; HAMSTER; NEURONS; FAMILY	Sour taste is initiated by protons acting at receptor proteins or channels. In vertebrates, transduction of this taste quality involves several parallel pathways(1-5). Here we examine the effects of sour stimuli on taste cells in slices of vallate papilla from rat. From a subset of cells, we identified a hyperpolarization-activated current that was enhanced by sour stimulation at the taste pore. This current resembled Ih found in neurons and cardio-myocytes(6,7), a current carried by members of the family of hyperpolarization-activated and cyclic-nucleotide-gated (HCN) channels(8-13). We show by in situ hybridization and immunohistochemistry that HCN1 and HCN4 are expressed in a subset of taste cells. By contrast, gustducin, the G-protein involved in bitter and sweet taste(14), is not expressed in these cells. Lowering extracellular pH causes a dose-dependent flattening of the activation curve of HCN channels and a shift in the voltage of half-maximal activation to more positive voltages. Our results indicate that HCN channels are gated by extracellular protons and may act as receptors for sour taste.	Univ Saarland, Dept Physiol, D-66421 Homburg, Germany; Forschungszentrum Julich, Inst Biol Informat Proc, D-52425 Julich, Germany; Deutsch Inst Ernahrungsforsch, Dept Mol Genet, D-14558 Potsdam, Germany; GSF, Inst Mol Immunol, D-81377 Munich, Germany	Saarland University; Helmholtz Association; Research Center Julich; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Lindemann, B (corresponding author), Univ Saarland, Dept Physiol, D-66421 Homburg, Germany.	phblin@uniklinik-saarland.de	Mueller, Frank/I-7196-2013; Bufe, Bernd/N-6685-2018	Mueller, Frank/0000-0001-7264-1227; Stevens, David/0000-0003-4651-1706; Bufe, Bernd/0000-0003-1610-0658				Boughter JD, 1997, J NEUROSCI, V17, P2852; DESIMONE JA, 1995, AM J PHYSIOL-CELL PH, V268, pC1295, DOI 10.1152/ajpcell.1995.268.5.C1295; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; GILBERTSON TA, 1992, J GEN PHYSIOL, V100, P803, DOI 10.1085/jgp.100.5.803; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; KINNAMON SC, 1988, P NATL ACAD SCI USA, V85, P7023, DOI 10.1073/pnas.85.18.7023; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Miyamoto T, 1998, J NEUROPHYSIOL, V80, P1852, DOI 10.1152/jn.1998.80.4.1852; Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8; Muller F, 2001, J PHYSIOL-LONDON, V532, P399, DOI 10.1111/j.1469-7793.2001.0399f.x; Munsch T, 1999, J PHYSIOL-LONDON, V519, P493, DOI 10.1111/j.1469-7793.1999.0493m.x; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Pittman DW, 1998, BRAIN RES, V790, P224, DOI 10.1016/S0006-8993(98)00059-6; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Stewart RE, 1998, AM J PHYSIOL-CELL PH, V275, pC227, DOI 10.1152/ajpcell.1998.275.1.C227; STRIEM B J, 1991, Cellular Physiology and Biochemistry, V1, P46, DOI 10.1159/000154592; Trotier D, 1996, J PHYSIOL-LONDON, V490, P611, DOI 10.1113/jphysiol.1996.sp021171; Ugawa S, 1998, NATURE, V395, P555, DOI 10.1038/26882; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Zong XG, 2001, J BIOL CHEM, V276, P6313, DOI 10.1074/jbc.M010326200	23	165	177	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2001	413	6856					631	635		10.1038/35098087	http://dx.doi.org/10.1038/35098087			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675786				2022-12-28	WOS:000171485700049
J	Benatar, SR				Benatar, SR			Personal views - Editorial ethics	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Cape Town, Sch Med, ZA-7925 Cape Town, South Africa	University of Cape Town	Benatar, SR (corresponding author), Univ Cape Town, Sch Med, ZA-7925 Cape Town, South Africa.								0	2	2	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 10	1998	316	7125					155	156						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YR408	11645021				2022-12-28	WOS:000071492300077
J	Emery, J				Emery, J			Silent suffering	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	DEC 16	1995	311	7020					1647	1647		10.1136/bmj.311.7020.1647	http://dx.doi.org/10.1136/bmj.311.7020.1647			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TL422	11644742	Green Published			2022-12-28	WOS:A1995TL42200080
J	ROBIN, ED; MCCAULEY, RF				ROBIN, ED; MCCAULEY, RF			CULTURAL LAG AND THE HIPPOCRATIC OATH	LANCET			English	Editorial Material									TSURAI INDIAN HLTH SERV CLIN,TRINIDAD,CO 95570									AKIN J, 1993, ADM RADIOL, V12, P75; BREWIN T, 1994, LANCET, V344, P1487; DAVIS DB, 1986, SLAVERY, P414; GARRISON FH, 1914, INTRO HIST MED, P55; OSLER W, 1947, AEQUANIMITAS OTHER A, P45; ROBIN ED, 1994, BRIT MED J, V309, P96; ROBIN ED, 1993, PROGNOSIS RISK ASSES, P3; ROBIN ED, 1985, CALIFORNIA PHYSI APR, P20; WITHINGTON ET, 1894, MED HIST	9	19	19	1	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	JUN 3	1995	345	8962					1422	1424		10.1016/S0140-6736(95)92604-6	http://dx.doi.org/10.1016/S0140-6736(95)92604-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RB441	11653149				2022-12-28	WOS:A1995RB44100016
J	ROGERS, A				ROGERS, A			BIOETHICS CONVENTION ENDORSED - AT A PRICE	LANCET			English	Editorial Material																			0	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	FEB 11	1995	345	8946					377	377		10.1016/S0140-6736(95)90354-2	http://dx.doi.org/10.1016/S0140-6736(95)90354-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QF722	11644661	Bronze			2022-12-28	WOS:A1995QF72200021
J	DIXON, B				DIXON, B			SELLING RESEARCH, AND IT PAYS	BRITISH MEDICAL JOURNAL			English	Editorial Material																		LIND S, 1986, NEW ENGLAND J M 0130, P312; SHULMAN S, 1988, TECHNOLOGY REV  0708, P7; SPIRO H, 1988, PERSPECTIVES BIO SUM, P589	3	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	NOV 26	1988	297	6660					1416	1416		10.1136/bmj.297.6660.1416	http://dx.doi.org/10.1136/bmj.297.6660.1416			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	R0904	11644357	Bronze, Green Published			2022-12-28	WOS:A1988R090400065
J	Page, MJ; Stevens, JA; Mittaz, JPD; Carrera, FJ				Page, MJ; Stevens, JA; Mittaz, JPD; Carrera, FJ			Submillimeter evidence for the coeval growth of massive black holes and galaxy bulges	SCIENCE			English	Article							ULTRALUMINOUS IRAS GALAXIES; X-RAY; ENERGY-DISTRIBUTIONS; SKY SURVEY; SUB-MM; EVOLUTION; CHANDRA; SCUBA	The correlation, found in nearby galaxies, between black hole mass and stellar bulge mass implies that the formation of these two components must be related. Here we report submillimeter photometry of eight x-ray-absorbed active galactic nuclei that have luminosities and redshifts characteristic of the sources that produce the bulk of the accretion luminosity in the universe. The four sources with the highest redshifts are detected at 850 micrometers, with flux densities between 5.9 and 10.1 millijanskies, and hence are ultraluminous infrared galaxies. If the emission is from dust heated by starbursts, then the majority of stars in spheroids were formed at the same time as their central black holes built up most of their mass by accretion. This would account for the observed demography of massive black holes in the local universe. The skewed rate of submillimeter detection with redshift is consistent with a high redshift epoch of star formation in radio-quiet active galactic nuclei, similar to that seen in radio galaxies.	UCL, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; Univ Cantabria, CSIC, Inst Fis Cantabria, E-39005 Santander, Spain	University of London; University College London; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Fisica de Cantabria (IFCA)	Page, MJ (corresponding author), UCL, Mullard Space Sci Lab, Holmbury St Mary, Dorking RH5 6NT, Surrey, England.	mjp@msst.uct.ac.uk	Carrera, Francisco J/H-1471-2015; Carrera, Francisco J./R-1618-2019	Carrera, Francisco J/0000-0003-2135-9023; Stevens, Jason/0000-0002-4010-8310				Archibald EN, 2001, MON NOT R ASTRON SOC, V323, P417, DOI 10.1046/j.1365-8711.2001.04188.x; Barger AJ, 2001, ASTRON J, V121, P662, DOI 10.1086/318742; Blain AW, 1999, ASTROPHYS J, V512, pL87, DOI 10.1086/311879; Ciliegi P, 1995, MON NOT R ASTRON SOC, V277, P1463, DOI 10.1093/mnras/277.4.1463; Condon JJ, 1998, ASTRON J, V115, P1693, DOI 10.1086/300337; Downes D, 1998, ASTROPHYS J, V507, P615, DOI 10.1086/306339; DRAINE BT, 1984, ASTROPHYS J, V285, P89, DOI 10.1086/162480; Dunlop JS, 2001, NEW ASTRON REV, V45, P609, DOI 10.1016/S1387-6473(01)00143-9; ELVIS M, 1994, ASTROPHYS J SUPPL S, V95, P1, DOI 10.1086/192093; Fabian AC, 2000, MON NOT R ASTRON SOC, V315, pL8, DOI 10.1046/j.1365-8711.2000.03621.x; Fabian AC, 1999, MON NOT R ASTRON SOC, V303, pL34, DOI 10.1046/j.1365-8711.1999.02404.x; GEHRELS N, 1986, ASTROPHYS J, V303, P336, DOI 10.1086/164079; Genzel R, 1998, ASTROPHYS J, V498, P579, DOI 10.1086/305576; Gilli R, 1999, ASTRON ASTROPHYS, V347, P424; HASINGER G, ISO SURVEYS DUSTY UN; Hawkins MRS, 2000, ASTRON ASTROPHYS SUP, V143, P465, DOI 10.1051/aas:2000190; HILDEBRAND RH, 1983, Q J ROY ASTRON SOC, V24, P267; Holland WS, 1999, MON NOT R ASTRON SOC, V303, P659, DOI 10.1046/j.1365-8711.1999.02111.x; Hornschemeier AE, 2001, ASTROPHYS J, V554, P742, DOI 10.1086/321420; Ivison RJ, 2000, MON NOT R ASTRON SOC, V315, P209, DOI 10.1046/j.1365-8711.2000.03376.x; KORMENDY J, IN PRESS 20 TEX S RE; Miyaji T, 2001, ASTRON ASTROPHYS, V369, P49, DOI 10.1051/0004-6361:20010102; Nolan LA, 2001, MON NOT R ASTRON SOC, V323, P308, DOI 10.1046/j.1365-8711.2001.04174.x; Page MJ, 2001, MON NOT R ASTRON SOC, V325, P575, DOI 10.1046/j.1365-8711.2001.04436.x; Page MJ, 1997, MON NOT R ASTRON SOC, V291, P324, DOI 10.1093/mnras/291.2.324; Rengelink RB, 1997, ASTRON ASTROPHYS SUP, V124, P259, DOI 10.1051/aas:1997358; Rigopoulou D, 1996, MON NOT R ASTRON SOC, V278, P1049, DOI 10.1093/mnras/278.4.1049; Rowan-Robinson M, 2000, MON NOT R ASTRON SOC, V316, P885, DOI 10.1046/j.1365-8711.2000.03588.x; Schonberg M, 1942, ASTROPHYS J, V96, P161, DOI 10.1086/144444; Severgnini P, 2000, ASTRON ASTROPHYS, V360, P457; Smail I, 1997, ASTROPHYS J, V490, pL5, DOI 10.1086/311017	31	84	84	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2516	2518		10.1126/science.1065880	http://dx.doi.org/10.1126/science.1065880			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11691953	Green Submitted			2022-12-28	WOS:000172927700048
J	Sahota, P; Rudolf, MCJ; Dixey, R; Hill, AJ; Barth, JH; Cade, J				Sahota, P; Rudolf, MCJ; Dixey, R; Hill, AJ; Barth, JH; Cade, J			Randomised controlled trial of primary school based intervention to reduce risk factors for obesity	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH; EDUCATION	Objective To assess if a school based intervention was effective in reducing risk factors for obesity. Design Group randomised controlled trial. Setting 10 primary schools in Leeds. Participants 634 children aged 7-11 years. Intervention Teacher training, modification of school meals, and the development of school action plans targeting the curriculum, physical education, tuck shops, and playground activities. Main outcome measures Body mass index, diet, physical activity, and psychological state. Results Vegetable consumption by 24 hour recall was higher in children in the intervention group than the control group (weighted mean difference 0.3 portions/day, 95% confidence interval 0.2 to 0.4), representing a difference equivalent to 50% of baseline consumption. Fruit consumption was lower in obese children in the intervention group (- 1.0, - 1.8 to - 0.2) than those in the control group, The three day diary showed higher consumption of high sugar foods (0.8, 0.1 to 1.6)) among overweight children in the intervention group than the control group. Sedentary behaviour was higher in overweight children in the intervention group (0.3, 0.0 to 0.7). Global self worth was higher in obese children in the intervention group (0.3,0.3 to 0.6), There was no difference in body mass index, other psychological measures, or dieting behaviour between the groups. Focus groups indicated higher levels of self reported behaviour change, understanding, and knowledge among children who had received the intervention. Conclusion Although it was successful in producing changes at school level, the programme had little effect on children's behaviour other than a modest increase in consumption of vegetables.	Leeds Community & Mental Hlth Trust, Leeds LS2 9DE, W Yorkshire, England; Leeds Metropolitan Univ, Sch Hlth Sci, Leeds LS1 2HE, W Yorkshire, England; Univ Leeds, Sch Med, Leeds LS2 9LT, W Yorkshire, England; Gen Infirm, Leeds LS1 3EX, W Yorkshire, England; Nuffield Inst Hlth, Leeds LS2 9PL, W Yorkshire, England	Leeds Beckett University; University of Leeds; Leeds General Infirmary; University of Leeds	Rudolf, MCJ (corresponding author), Leeds Community & Mental Hlth Trust, Belmont House, Leeds LS2 9DE, W Yorkshire, England.	Mary.Rudolf@leedsth.nhs.uk	Cade, Janet E/G-4250-2016; Barth, Julian H/F-6028-2010	Cade, Janet E/0000-0003-3421-0121; Hill, Andrew/0000-0003-3192-0427				ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; [Anonymous], 1995, Am J Public Health, V85, P183; CARLETON RA, 1995, AM J PUBLIC HEALTH, V85, P777, DOI 10.2105/AJPH.85.6.777; COLE TJ, 1993, CASTLEMEAD GROWTH PR; Contento IR, 1995, J NUTR EDUC, V27, P298, DOI DOI 10.1016/S0022-3182(12)80090-2; DIETZ WH, 1992, OBESITY, P606; FARQUHAR JW, 1990, JAMA-J AM MED ASSOC, V264, P359, DOI 10.1001/jama.264.3.359; Fruhbeck G, 2000, BRIT MED J, V320, P328, DOI 10.1136/bmj.320.7231.328; GARROW J, 1991, BRIT MED J, V303, P704, DOI 10.1136/bmj.303.6804.704; Green J, 1999, J PUBLIC HEALTH MED, V21, P133, DOI 10.1093/pubmed/21.2.133; Harter S., 1985, MANUAL SELF PERCEPTI; Hill AJ, 1998, INT J EAT DISORDER, V24, P405, DOI 10.1002/(SICI)1098-108X(199812)24:4&lt;405::AID-EAT7&gt;3.0.CO;2-D; HILL AJ, 1994, INT J OBESITY, V18, P383; LUEPKER RV, 1994, AM J PUBLIC HEALTH, V84, P1383, DOI 10.2105/AJPH.84.9.1383; Luepker RV, 1996, JAMA-J AM MED ASSOC, V275, P768, DOI 10.1001/jama.275.10.768; LYNN WR, 1995, AM J PUBLIC HEALTH, V85, P193; NHS Centre for Reviews and Dissemination, 1997, EFFECTIVE HLTH CARE, V3; Parcel GS, 1988, CHILDHOOD OBESITY BI, P143; RENISCOW K, 1993, ANN NY ACAD SCI, V699, P154; Rudolf MCJ, 2001, BRIT MED J, V322, P1094, DOI 10.1136/bmj.322.7294.1094; Sahota P, 2001, BRIT MED J, V323, P1027, DOI 10.1136/bmj.323.7320.1027; SansonFisher R, 1996, HEALTH PROMOT INT, V11, P227, DOI 10.1093/heapro/11.3.227; *STATACORP, 1999, STAT STAT SOFTW REL; Story M, 1999, INT J OBESITY, V23, pS43, DOI 10.1038/sj.ijo.0800859; Thompson SG, 1997, STAT MED, V16, P2063, DOI 10.1002/(SICI)1097-0258(19970930)16:18<2063::AID-SIM642>3.0.CO;2-8; Young I, 1989, HLTH SCH	26	225	232	4	59	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2001	323	7320					1029	1032		10.1136/bmj.323.7320.1029	http://dx.doi.org/10.1136/bmj.323.7320.1029			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	490MP	11691759	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000172055900015
J	Reya, T; Morrison, SJ; Clarke, MF; Weissman, IL				Reya, T; Morrison, SJ; Clarke, MF; Weissman, IL			Stem cells, cancer, and cancer stem cells	NATURE			English	Review							WNT GENE FAMILY; BONE-MARROW; TRANSGENIC MICE; BETA-CATENIN; IN-VIVO; EXPRESSION; TUMOR; LEUKEMIA; BCL-2; DIFFERENTIATION	Stem cell biology has come of age. Unequivocal proof that stem cells exist in the haematopoietic system has given way to the prospective isolation of several tissue-specific stem and progenitor cells, the initial delineation of their properties and expressed genetic programmes, and the beginnings of their utility in regenerative medicine. Perhaps the most important and useful property of stem cells is that of self-renewal. Through this property, striking parallels can be found between stem cells and cancer cells: tumours may often originate from the transformation of normal stem cells, similar signalling pathways may regulate self-renewal in stem cells and cancer cells, and cancer cells may include 'cancer stem cells'-rare cells with indefinite potential for self-renewal that drive tumorigenesis.	Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University	Reya, T (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	irv@stanford.edu	Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329				AKASHI K, 2001, DEV BIOL HEMATOPOIES, P15; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; Austin TW, 1997, BLOOD, V89, P3624, DOI 10.1182/blood.V89.10.3624.3624_3624_3635; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; BERGSAGEL DE, 1968, CANCER RES, V28, P2187; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bouwens L, 1996, J HISTOCHEM CYTOCHEM, V44, P947, DOI 10.1177/44.9.8773559; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; BRUCE WR, 1963, NATURE, V199, P79, DOI 10.1038/199079a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Domen J, 2000, J EXP MED, V192, P1707, DOI 10.1084/jem.192.12.1707; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; Feuerhake F, 2000, CELL TISSUE RES, V299, P47, DOI 10.1007/s004410050005; FIALKOW PJ, 1976, BIOCHIM BIOPHYS ACTA, V458, P283, DOI 10.1016/0304-419X(76)90003-2; FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Gailani M R, 1999, Adv Dermatol, V14, P261; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; George AA, 2001, BLOOD, V97, P3925, DOI 10.1182/blood.V97.12.3925; Golub TR, 2001, NEW ENGL J MED, V344, P601, DOI 10.1056/NEJM200102223440809; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; HARRISON DE, 1991, BLOOD, V78, P1237; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; HEPPNER GH, 1984, CANCER RES, V44, P2259; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Kogan SC, 2001, J EXP MED, V193, P531, DOI 10.1084/jem.193.4.531; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kummermehr Johann, 1997, P363, DOI 10.1016/B978-012563455-7/50013-1; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; LAGASSE E, 1994, J EXP MED, V179, P1047, DOI 10.1084/jem.179.3.1047; Leethanakul C, 2000, ONCOGENE, V19, P3220, DOI 10.1038/sj.onc.1203703; Lippman ME, 2000, NEW ENGL J MED, V342, P1119, DOI 10.1056/NEJM200004133421508; Mauro MJ, 2001, CURR OPIN ONCOL, V13, P3, DOI 10.1097/00001622-200101000-00002; MCGRATH MS, 1979, CELL, V17, P65, DOI 10.1016/0092-8674(79)90295-2; MCGRATH MS, 1980, NATURE, V285, P259, DOI 10.1038/285259a0; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Miller CL, 1997, P NATL ACAD SCI USA, V94, P13648, DOI 10.1073/pnas.94.25.13648; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; NOWELL PC, 1960, SCIENCE, V132, P1497; NOWELL PC, 1986, CANCER RES, V46, P2203; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; ONEILL HC, 1987, CELL, V49, P143, DOI 10.1016/0092-8674(87)90764-1; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PARK CH, 1971, JNCI-J NATL CANCER I, V46, P411; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Peters R, 1998, BLOOD, V92, P2041, DOI 10.1182/blood.V92.6.2041.418k34_2041_2052; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Polakis P, 2000, GENE DEV, V14, P1837; QUINN ER, IN PRESS BLOOD; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; SALSBURY AJ, 1975, CANCER TREAT REV, V2, P55, DOI 10.1016/S0305-7372(75)80015-6; SAWYERS CL, 1991, CELL, V64, P337, DOI 10.1016/0092-8674(91)90643-D; SELL S, 1994, LAB INVEST, V70, P6; Sgroi DC, 1999, CANCER RES, V59, P5656; SOUTHAM CM, 1961, CANCER, V14, P971, DOI 10.1002/1097-0142(196109/10)14:5<971::AID-CNCR2820140510>3.0.CO;2-O; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Stockler M, 2000, CANCER TREAT REV, V26, P151, DOI 10.1053/ctrv.1999.0161; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Terskikh AV, 2001, P NATL ACAD SCI USA, V98, P7934, DOI 10.1073/pnas.131200898; Traver D, 1998, IMMUNITY, V9, P47, DOI 10.1016/S1074-7613(00)80587-7; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Van den Berg DJ, 1998, BLOOD, V92, P3189, DOI 10.1182/blood.V92.9.3189.421k45_3189_3202; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; WEISSMAN IL, 1977, NEOPLASTIC TRANSFORM, P135; WILLIAMS SD, 1987, NEW ENGL J MED, V316, P1435, DOI 10.1056/NEJM198706043162302; WODINSKY ISIDORE, 1967, CANCER CHEMOTHER REP, V51, P415; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zhu AJ, 1999, DEVELOPMENT, V126, P2285	83	7127	7883	59	2460	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					105	111		10.1038/35102167	http://dx.doi.org/10.1038/35102167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689955	Green Published			2022-12-28	WOS:000171898900054
J	Brock, J; Sauaia, T; Ahnen, D; Marine, W; Schluter, W; Stevens, BR; Scinto, JD; Karp, H; Bratzler, D				Brock, J; Sauaia, T; Ahnen, D; Marine, W; Schluter, W; Stevens, BR; Scinto, JD; Karp, H; Bratzler, D			Process of care and outcomes for elderly patients hospitalized with peptic ulcer disease - Results from a quality improvement project	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SERIOUS GASTROINTESTINAL COMPLICATIONS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HELICOBACTER-PYLORI; DUODENAL-ULCER; DOUBLE-BLIND; ERADICATION; RANITIDINE; RECURRENCE; ARTHRITIS; RISK	Context Since publication in 1994 of guidelines for management of peptic ulcer disease (PUD), trends in physician practice and outcomes related to guideline application have not been evaluated. Objectives To describe changes in process of care that occurred in a quality improvement program for patients hospitalized with PUD and to evaluate associations between in-hospital treatment of PUD and 1-year rehospitalization for PUD and mortality in a subset of these patients. Design, Setting, and Patients Cohort study of 4292 sequential Medicare beneficiaries hospitalized at acute care hospitals with a principal diagnosis of PUD in 5 states (Colorado, Georgia, Connecticut, Oklahoma, and Virginia) in 1995 (baseline) and 1997 (remeasurement); outcomes were evaluated for 752 patients in Colorado. Main Outcome Measures Changes in rates of screening for Helicobacter pylori infection, treatment for H pylori infection, screening for nonsteroidal anti-inflammatory drug (NSAID) use, counseling about NSAID use; outcomes included rehospitalization for PUD and all-cause mortality within 1 year of discharge in Colorado. Results Screening for H pylori infection increased significantly (12%-19% increase; P<.001) in each of the 5 states. Treatment of H pylori infection increased in each state and was significantly increased for the entire group of hospitalizations examined (8% increase overalls P=.001). Despite increased screening, detection of H pylori infection was less frequent than expected in every state, (13%-24%) and did not increase in any state. Screening for and counseling about NSAIDs did not significantly increase overall or in any state. In the Colorado cohort, the proportion of patients rehospitalized was unchanged in 1995 (8.9%) and 1997 (6.8%), and 124 patients (16%) in the combined 1995 and 1997 cohorts died within 1 year, Treatment for H pylori was not associated with a reduction in rehospitalization within 1 year (adjusted odds ratio [OR], 1.24; 95% confidence interval [CI], 0.65-2.36) or with a reduction in mortality (adjusted OR, 1.08; 95% Cl, 0.68-1.71). Counseling about NSAID use was associated with a decrease in risk of 1-year rehospitalization for PUD (adjusted OR, 0.47; 95% CI, 0.22-0.99) and risk of all-cause mortality (adjusted OR, 0.44; 95% CI, 0.26-0.75). Conclusions This quality improvement program for elderly patients with PUD resulted in increased screening for H pylori and increased treatment of H pylori Infection but no change in counseling about NSAID use. However, with the low prevalence of H pylori detected, treatment of H pylori infection was not associated with a reduction in repeat hospitalization for PUD or subsequent mortality, whereas counseling about the risks of using NSAIDs was associated with a reduction in the risk of both outcomes.	Colorado Fdn Med Care, Aurora, CO 80014 USA; Univ Colorado, Sch Med, Dept Prevent Med, Denver, CO USA; Denver Vet Adm Hosp, Dept Gastroenterol, Denver, CO USA; Qualidigm, Middletown, CT USA; Univ Connecticut, Ctr Hlth, Sch Med, Farmington, CT USA; Georgia Med Care Fdn, Atlanta, GA USA; Oklahoma Fdn Med Qual, Oklahoma City, OK USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Connecticut	Brock, J (corresponding author), Colorado Fdn Med Care, 2851 S Parker Rd,Suite 1000, Aurora, CO 80014 USA.	jbrockp@yahoo.com			PHS HHS [5D33HP10030-03] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bero LA, 1998, BMJ-BRIT MED J, V317, P465; Berwick DM, 1998, ANN INTERN MED, V128, P651, DOI 10.7326/0003-4819-128-8-199804150-00009; BROWN DM, 1994, PUBLICATION NIH, P55; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; COGHLAN JG, 1987, LANCET, V2, P1109; DAVIES J, 1986, BRIT J RHEUMATOL, V25, P54; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DICKER RC, 1998, QUALITY CARE SURVEIL; GABRIEL SE, 1991, ANN INTERN MED, V115, P787, DOI 10.7326/0003-4819-115-10-787; GRAHAM DY, 1991, GASTROENTEROLOGY, V100, P1653, DOI 10.1016/0016-5085(91)90665-8; GRAHAM DY, 1992, ANN INTERN MED, V116, P705, DOI 10.7326/0003-4819-116-9-705; GRAHAM DY, 1993, SCAND J GASTROENTERO, V28, P939, DOI 10.3109/00365529309098288; GREENE JM, 1992, ARCH INTERN MED, V152, P1995, DOI 10.1001/archinte.152.10.1995; Haddix A, 1996, PREVENTION EFFECTIVE; HENTSCHEL E, 1993, NEW ENGL J MED, V328, P308, DOI 10.1056/NEJM199302043280503; HOSKING SW, 1992, GASTROENTEROLOGY, V102, P85; HOSMER DW, 1989, APPL LOGISTIC REGRES, P86; JASPERSEN D, 1995, GASTROINTEST ENDOSC, V41, P5, DOI 10.1016/S0016-5107(95)70267-9; JENCKS SF, 1992, JAMA-J AM MED ASSOC, V268, P900, DOI 10.1001/jama.268.7.900; JENSEN D M, 1992, Gastroenterology, V102, pA90; LABENZ J, 1994, DIGESTION, V55, P19, DOI 10.1159/000201117; LAINE L, 1998, SLEISENGER FORDTRANS, P205; LANAS AI, 1995, GASTROENTEROLOGY, V109, P1124, DOI 10.1016/0016-5085(95)90570-7; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LOEB DS, 1992, GASTROENTEROLOGY, V102, P1899, DOI 10.1016/0016-5085(92)90311-L; Malfertheiner P, 1997, GUT, V41, P8; MARSHALL BJ, 1988, LANCET, V2, P1437; Ofman JJ, 2000, AM J GASTROENTEROL, V95, P106; PAULUS HE, 1998, ARTHRITIS RHEUM, V31, P1450; *PEER REV ORG QUAL, 2001, PILL QUAL; RAUWS EAJ, 1990, LANCET, V335, P1233, DOI 10.1016/0140-6736(90)91301-P; ROKKAS T, 1995, GASTROINTEST ENDOSC, V41, P1, DOI 10.1016/S0016-5107(95)70266-0; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; Smith WR, 2000, CHEST, V118, p8S, DOI 10.1378/chest.118.2_suppl.8S; Soll AH, 1996, JAMA-J AM MED ASSOC, V275, P622; Sonnenberg A, 1996, AM J PUBLIC HEALTH, V86, P200, DOI 10.2105/AJPH.86.2.200; SONNENBERG A, 1994, PUBLICATION NIH, P359; *US DEP HHS, 1988, INT CLASS DIS 9 REV; WILSON MC, 1995, JAMA-J AM MED ASSOC, V274, P1630, DOI 10.1001/jama.274.20.1630; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65; Yeomans ND, 1998, NEW ENGL J MED, V338, P719, DOI 10.1056/NEJM199803123381104; 2000, MEDICARE PROVIDER AN	42	24	24	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2001	286	16					1985	+		10.1001/jama.286.16.1985	http://dx.doi.org/10.1001/jama.286.16.1985			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485JD	11667935				2022-12-28	WOS:000171750500022
J	Logan, RPH; Walker, MM				Logan, RPH; Walker, MM			ABC of the upper gastrointestinal tract - Epidemiology and diagnosis of Helicobacter pylori infection	BRITISH MEDICAL JOURNAL			English	Review									Univ Nottingham Hosp, Div Gastroenterol, Nottingham NG7 2UH, England; Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Histopathol, London SW7 2AZ, England	University of Nottingham; Imperial College London	Logan, RPH (corresponding author), Univ Nottingham Hosp, Div Gastroenterol, Nottingham NG7 2UH, England.		Walker, Marjorie Mary/F-6504-2013					Graham DY, 1997, GASTROENTEROLOGY, V113, P1983, DOI 10.1016/S0016-5085(97)70019-2; MISIEWICZ JJ, 1995, CLIN MANUAL HELICOBA	2	119	135	1	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 20	2001	323	7318					920	922		10.1136/bmj.323.7318.920	http://dx.doi.org/10.1136/bmj.323.7318.920			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486BH	11668141	Green Published			2022-12-28	WOS:000171798200027
J	Norman, RJ				Norman, RJ			Reproductive consequences of COX-2 inhibition	LANCET			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INFERTILITY		Univ Adelaide, Queen Elizabeth Hosp, Dept Obstet & Gynaecol, Reprod Med Unit, Woodville, SA 5011, Australia	University of Adelaide	Norman, RJ (corresponding author), Univ Adelaide, Queen Elizabeth Hosp, Dept Obstet & Gynaecol, Reprod Med Unit, Woodville, SA 5011, Australia.		Norman, Robert J/A-1155-2007	Norman, Robert J/0000-0002-3118-3896				Akil M, 1996, BRIT J RHEUMATOL, V35, P76; BRANNSTROM M, 1993, HUM REPROD, V8, P1762; DeWitt DL, 1999, MOL PHARMACOL, V55, P625; Duffy DM, 2001, MOL HUM REPROD, V7, P731, DOI 10.1093/molehr/7.8.731; ESPEY LL, 1994, BIOL REPROD, V50, P233, DOI 10.1095/biolreprod50.2.233; JANSSENCASPERS HAB, 1986, FERTIL STERIL, V46, P823; Joyce IM, 2001, ENDOCRINOLOGY, V142, P3187, DOI 10.1210/en.142.7.3187; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Matsumoto H, 2001, BIOL REPROD, V64, P1557, DOI 10.1095/biolreprod64.5.1557; Mendonca LLF, 2000, RHEUMATOLOGY, V39, P880, DOI 10.1093/rheumatology/39.8.880; Pall M, 2001, HUM REPROD, V16, P1323, DOI 10.1093/humrep/16.7.1323; Reese J, 2000, P NATL ACAD SCI USA, V97, P9759, DOI 10.1073/pnas.97.17.9759; Smith G, 1996, BRIT J RHEUMATOL, V35, P458; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97	15	20	23	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 20	2001	358	9290					1287	1288		10.1016/S0140-6736(01)06455-8	http://dx.doi.org/10.1016/S0140-6736(01)06455-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684206				2022-12-28	WOS:000171702500005
J	Staessen, JA; Wang, YG; Thijs, L				Staessen, JA; Wang, YG; Thijs, L			Cardiovascular protection and blood pressure reduction: a meta-analysis	LANCET			English	Article							ISOLATED SYSTOLIC HYPERTENSION; CONVERTING-ENZYME-INHIBITION; RANDOMIZED-TRIAL; MILD HYPERTENSION; ELDERLY-PATIENTS; ANTIHYPERTENSIVE TREATMENT; ACTIVE TREATMENT; OLDER PATIENTS; SWEDISH TRIAL; BETA-BLOCKERS	Background Whether antihypertensive drugs offer cardiovascular protection beyond blood pressure lowering has not been established. We aimed to investigate whether pharmacological properties of anti hypertensive drugs or reduction of systolic pressure accounted for cardiovascular outcome in hypertensive or high-risk patients. Methods In a meta-analysis we extracted summary statistics from published reports, and calculated pooled odds ratios for experimental versus reference treatment. We correlated across-trials odd ratios for differences in systolic pressure between groups. Findings We analysed nine randomised trials comparing treatments in 62 605 hypertensive patients. Compared with old drugs (diuretics and beta -blockers), calcium-channel blockers and angiotensin converting-enzyme inhibitors offered similar overall cardiovascular protection, but calcium-channel blockers provided more reduction in the risk of stroke (13.5%, 95% Cl 1.3-24.2, p=0.03) and less reduction in the risk of myocardial infarction (19.2%, 3.5-37.3, p=0.01). Heterogeneity was significant between trials because of high risk of cardiovascular events on doxazosin in one trial, and high risk of stroke on captopril in another; but systolic pressure differed between groups in these two trials by 2-3 mm Hg. Similar systolic differences occurred in a trial of diltiazem versus old drugs, and in three trials of converting-enzyme inhibitor against placebo in high-risk patients. Meta-regression across 27 trials (136 124 patients) showed that odds ratios could be explained by achieved differences in systolic pressure. Interpretation Our findings emphasise that blood pressure control is important. All antihypertensive drugs have similar long-term efficacy and safety. Calcium-channel blockers might be especially effective in stroke prevention. We did not find that converting-enzyme inhibitors or a-blockers affect cardiovascular prognosis beyond their antihypertensive effects.	Katholieke Univ Leuven, Studiecoordinatiecentrum, Lab Hypertensie, Dept Mol Cardiovasc Onderzoek, B-3000 Louvain, Belgium	KU Leuven	Staessen, JA (corresponding author), Katholieke Univ Leuven, Studiecoordinatiecentrum, Lab Hypertensie, Dept Mol Cardiovasc Onderzoek, Campus Gasthuisberg,Herestr 49, B-3000 Louvain, Belgium.	jan.staessen@med.kuleuven.ac.be	Staessen, Jan A/A-1065-2011	Staessen, Jan A/0000-0002-3026-1637; Thijs, Lutgarde/0000-0002-8108-2356				AMERY A, 1985, LANCET, V1, P1349; AMERY A, 1985, ARCH INT PHARMACOD T, V275, P300; [Anonymous], 1985, J Hypertens, V3, P379; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1973, BMJ-BRIT MED J, V3, P434; [Anonymous], 1974, JAMA-J AM MED ASSOC, V229, P409; [Anonymous], 1980, LANCET, V1, P1261; Borhani NO, 1996, JAMA-J AM MED ASSOC, V276, P785, DOI 10.1001/jama.276.10.785; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; CARTER AB, 1970, LANCET, V1, P485; Cashin-Hemphill L, 1999, AM J CARDIOL, V83, P43, DOI 10.1016/S0002-9149(98)00780-2; CASIGLIA E, 1994, JPN HEART J, V35, P589; COLLINS R, 1994, BRIT MED BULL, V50, P272, DOI 10.1093/oxfordjournals.bmb.a072892; COOK NR, 1995, ARCH INTERN MED, V155, P701, DOI 10.1001/archinte.155.7.701; COOPE J, 1986, BRIT MED J, V293, P1145, DOI 10.1136/bmj.293.6555.1145; Curb JD, 1996, JAMA-J AM MED ASSOC, V276, P1886, DOI 10.1001/jama.276.23.1886; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; Davies MJ, 1998, CIRCULATION, V97, P2382, DOI 10.1161/01.CIR.97.24.2382; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; Effects of treatment on morbidity in hypertension, 1970, JAMA-J AM MED ASSOC, V213, P1143, DOI DOI 10.1001/JAMA.213.7.1143; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; Gerstein HC, 2000, LANCET, V355, P253; Gong LS, 1996, J HYPERTENS, V14, P1237, DOI 10.1097/00004872-199610000-00013; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Hansson L, 2000, LANCET, V356, P359, DOI 10.1016/S0140-6736(00)02526-5; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hansson Lennart, 1997, Blood Pressure, V6, P365, DOI 10.3109/08037059709062096; HELGELAND A, 1980, AM J MED, V69, P725, DOI 10.1016/0002-9343(80)90438-6; *HYP DET FOLL UP P, 1979, JAMA-J AM MED ASSOC, V242, P2562; KURAMOTO K, 1981, JPN HEART J, V22, P75; Kuramoto K, 1999, HYPERTENSION, V34, P1129; Liu LS, 1998, J HYPERTENS, V16, P1823, DOI 10.1097/00004872-199816120-00016; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; MacMahon S, 2000, J AM COLL CARDIOL, V36, P438, DOI 10.1016/S0735-1097(00)00736-1; MEADE TW, 1992, BMJ-BRIT MED J, V304, P405; Neal B, 2000, LANCET, V356, P1955; NEATON JD, 1993, JAMA-J AM MED ASSOC, V270, P713, DOI 10.1001/jama.270.6.713; Pahor M, 2000, LANCET, V356, P1949, DOI 10.1016/S0140-6736(00)03306-7; Pitt B, 2000, CIRCULATION, V102, P1503, DOI 10.1161/01.CIR.102.13.1503; Rosei EA, 1997, J HYPERTENS, V15, P1337, DOI 10.1097/00004872-199715110-00019; SMITH WM, 1977, CIRC RES, V40, P98; SPRACKLING ME, 1981, BRIT MED J, V283, P1151, DOI 10.1136/bmj.283.6300.1151; STAESSEN J, 1990, J HYPERTENS, V8, P393, DOI 10.1097/00004872-199005000-00001; Staessen JA, 1999, HYPERTENSION, V33, P1476, DOI 10.1161/01.HYP.33.6.1476; Staessen JA, 2000, LANCET, V355, P865, DOI 10.1016/S0140-6736(99)07330-4; Staessen JA, 2000, EUR HEART J, V21, P2, DOI 10.1053/euhj.1999.1833; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Staessen JA, 2001, LANCET, V358, P1026, DOI 10.1016/S0140-6736(01)06226-2; STAESSEN JA, 1999, KIDNEY, P341; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Swales JD, 2000, J HUM HYPERTENS, V14, P477, DOI 10.1038/sj.jhh.1001062; Tatti P, 1998, DIABETES CARE, V21, P597, DOI 10.2337/diacare.21.4.597; Teo KK, 2000, CIRCULATION, V102, P1748; THIJS L, 1994, J HYPERTENS, V12, pS25; Tuomilehto J, 1999, NEW ENGL J MED, V340, P677, DOI 10.1056/NEJM199903043400902; *UK PROSP DIAB STU, 2000, BMJ-BRIT MED J, V317, P713; *VET ADM NAT HEART, 1977, CIRC RES S1, V40, P180; Veterans Administration Cooperative Study Group on Antihypertensive Agents, 1967, JAMA-J AM MED ASSOC, V202, P116, DOI DOI 10.1001/JAMA.1967.03130150084015; Wang JG, 2000, ARCH INTERN MED, V160, P211, DOI 10.1001/archinte.160.2.211; WIKSTRAND J, 1986, JAMA-J AM MED ASSOC, V255, P1304, DOI 10.1001/jama.255.10.1304; WILHELMSEN L, 1987, J HYPERTENS, V5, P561, DOI 10.1097/00004872-198710000-00009; WOLFF FW, 1966, J CHRON DIS, V19, P227, DOI 10.1016/0021-9681(66)90128-7; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zanchetti A, 1998, J HYPERTENS, V16, P1667, DOI 10.1097/00004872-199816110-00014	69	703	735	0	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2001	358	9290					1305	1315		10.1016/S0140-6736(01)06411-X	http://dx.doi.org/10.1016/S0140-6736(01)06411-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684211	Green Accepted			2022-12-28	WOS:000171702500010
J	Baldwin, MP; Dunkerton, TJ				Baldwin, MP; Dunkerton, TJ			Stratospheric harbingers of anomalous weather regimes	SCIENCE			English	Article							ARCTIC OSCILLATION; ATMOSPHERE	Observations show that large variations in the strength of the stratospheric circulation, appearing first above similar to 50 kilometers, descend to the lowermost stratosphere and are followed by anomalous tropospheric weather regimes. During the 60 days after the onset of these events, average surface pressure maps resemble closely the Arctic Oscillation pattern. These stratospheric events also precede shifts in the probability distributions of extreme values of the Arctic and North Atlantic Oscillations, the location of storm tracks, and the local likelihood of mid-latitude storms. Our observations suggest that these stratospheric harbingers may be used as a predictor of tropospheric weather regimes.	NW Res Associates, Bellevue, WA 98007 USA	NorthWest Research Associates	Baldwin, MP (corresponding author), NW Res Associates, 14508 NE 20th St, Bellevue, WA 98007 USA.	mark@nwra.com	Baldwin, Mark/J-6720-2012					Baldwin MP, 2001, REV GEOPHYS, V39, P179, DOI 10.1029/1999RG000073; Baldwin MP, 1999, J GEOPHYS RES-ATMOS, V104, P30937, DOI 10.1029/1999JD900445; DUNKERTON T, 1981, J ATMOS SCI, V38, P819, DOI 10.1175/1520-0469(1981)038<0819:SEALDF>2.0.CO;2; Dunkerton TJ, 2000, J ATMOS SCI, V57, P3838, DOI 10.1175/1520-0469(2000)057<3838:MDOTSM>2.0.CO;2; Gillett NP, 2001, J GEOPHYS RES-ATMOS, V106, P7891, DOI 10.1029/2000JD900720; Hartley DE, 1998, NATURE, V391, P471, DOI 10.1038/35112; HAYNES PH, 1989, Q J ROY METEOR SOC, V115, P1181, DOI 10.1002/qj.49711549002; HOLTON JR, 1980, J ATMOS SCI, V37, P2200, DOI 10.1175/1520-0469(1980)037<2200:TIOTEQ>2.0.CO;2; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; JULIAN PR, 1965, J ATMOS SCI, V22, P597, DOI 10.1175/1520-0469(1965)022<0597:ASOAED>2.0.CO;2; ORTLAND D, UNPUB; QUIROZ RS, 1977, GEOPHYS RES LETT, V4, P151, DOI 10.1029/GL004i004p00151; ROBINSON WA, 1988, J ATMOS SCI, V45, P2319, DOI 10.1175/1520-0469(1988)045<2319:AOLDBP>2.0.CO;2; Shindell DT, 2001, J GEOPHYS RES-ATMOS, V106, P7193, DOI 10.1029/2000JD900547; SHINE KP, 1987, Q J ROY METEOR SOC, V113, P603, DOI 10.1256/smsqj.47609; THOMPSON DH, UNPUB; Thompson DWJ, 2001, SCIENCE, V293, P85, DOI 10.1126/science.1058958; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; Wallace JM, 2000, Q J ROY METEOR SOC, V126, P791, DOI 10.1256/smsqj.56401; 1998, NASAS ATLAS EXTRATRO	21	1253	1313	8	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					581	584		10.1126/science.1063315	http://dx.doi.org/10.1126/science.1063315			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641495				2022-12-28	WOS:000171695600043
J	Alexopoulou, L; Holt, AC; Medzhitov, R; Flavell, RA				Alexopoulou, L; Holt, AC; Medzhitov, R; Flavell, RA			Recognition of double-stranded RNA and activation of NF-kappa B by Toll-like receptor 3	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; SIGNALING PATHWAYS; ADAPTER PROTEIN; CPG-DNA; MICE; PKR; FAMILY; CELLS; TLR4; ENDOTOXIN	Toll-like receptors (TLRs) are a family of innate immune-recognition receptors that recognize molecular patterns associated with microbial pathogens, and induce antimicrobial immune responses(1,2). Double-stranded RNA (dsRNA) is a molecular pattern associated with viral infection, because it is produced by most viruses at some point during their replication(3). Here we show that mammalian TLR3 recognizes dsRNA, and that activation of the receptor induces the activation of NF-kappaB and the production of type I interferons (IFNs). TLR3-deficient (TLR3(-/-)) mice showed reduced responses to polyinosine-polycytidylic acid (poly(I:C)), resistance to the lethal effect of poly(I:C) when sensitized with D-galactosamine (D-GalN), and reduced production of inflammatory cytokines. MyD88 is an adaptor protein that is shared by all the known TLRs(1). When activated by poly(I:C), TLR3 induces cytokine production through a signalling pathway dependent on MyD88. Moreover, poly(I:C) can induce activation of NF-kappaB and mitogen-activated protein (MAP) kinases independently of MyD88, and cause dendritic cells to mature.	Immunobiol Sect, New Haven, CT 06520 USA; Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Immunobiol Sect, New Haven, CT 06520 USA.		Alexopoulou, Lena/A-5041-2017	Alexopoulou, Lena/0000-0003-4619-697X				Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; Akira S, 2001, ADV IMMUNOL, V78, P1, DOI 10.1016/S0065-2776(01)78001-7; Akira S, 2000, BIOCHEM SOC T, V28, P551, DOI 10.1042/bst0280551; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoshino K, 1999, J IMMUNOL, V162, P3749; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; KIMURA M, 1994, AM J PHYSIOL-REG I, V267, pR1596, DOI 10.1152/ajpregu.1994.267.6.R1596; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Kumar M, 1998, MICROBIOL MOL BIOL R, V62, P1415, DOI 10.1128/MMBR.62.4.1415-1434.1998; Maggi LB, 2000, EMBO J, V19, P3630, DOI 10.1093/emboj/19.14.3630; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Takeuchi O, 1999, GENE, V231, P59, DOI 10.1016/S0378-1119(99)00098-0; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zhou AM, 1999, VIROLOGY, V258, P435, DOI 10.1006/viro.1999.9738	29	4619	4965	10	451	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					732	738		10.1038/35099560	http://dx.doi.org/10.1038/35099560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607032				2022-12-28	WOS:000171608000044
J	Kleijn, D; Berendse, F; Smit, R; Gilissen, N				Kleijn, D; Berendse, F; Smit, R; Gilissen, N			Agri-environment schemes do not effectively protect biodiversity in Dutch agricultural landscapes	NATURE			English	Article							CONSERVATION; GRASSLAND; DIVERSITY; ABUNDANCE; FARMLAND; EUROPE; POLICY; AREAS	Roughly 20% of the European Union's farmland is under some form of agri-environment scheme to counteract the negative impacts of modern agriculture on the environment 1. The associated costs represent about 4% (1.7 billion euros) of the European Union's total expenditure on the Common Agricultural Policy and are expected to rise to 10% in the near future(2). Although agri-environment schemes have been implemented in various countries for well over a decade, to date no reliable, sufficiently replicated studies have been performed to test whether such measures have the presumed positive effects on biodiversity(1,3,4). Here we present the results of a study evaluating the contribution of agri-environment schemes to the protection of biodiversity in intensively used Dutch agricultural landscapes. We surveyed plants, birds, hover flies and bees on 78 paired fields that either had agri-environment schemes in the form of management agreements or were managed conventionally. Management agreements were not effective in protecting the species richness of the investigated species groups: no positive effects on plant and bird species diversity were found. The four most common wader species were observed even less frequently on fields with management agreements. By contrast, hover flies and bees showed modest increases in species richness on fields with management agreements. Our results indicate that there is a pressing need for a scientifically sound evaluation of agri-environment schemes.	Univ Wageningen & Res Ctr, Nat Conservat & Plant Ecol Grp, NL-6708 PD Wageningen, Netherlands	Wageningen University & Research	Kleijn, D (corresponding author), Univ Wageningen & Res Ctr, Nat Conservat & Plant Ecol Grp, Bornsesteeg 69, NL-6708 PD Wageningen, Netherlands.	David.Kleijn@staf.ton.wau.nl	Kleijn, David/HCH-3477-2022	Kleijn, David/0000-0003-2500-7164				Bakker JP, 1999, TRENDS ECOL EVOL, V14, P63, DOI 10.1016/S0169-5347(98)01544-4; BANASZAK J, 1983, Polish Ecological Studies, V9, P421; BEINTEMA AJ, 1987, J APPL ECOL, V24, P743, DOI 10.2307/2403978; Beintema Albert J., 1997, P269; Berendse F., 1993, LANDSCAPE ECOLOGY ST, P104, DOI [10. 1007/978-94-011-2318-1, DOI 10.1007/978-94-011-2318-1]; Bignal EM, 1998, J APPL ECOL, V35, P949, DOI 10.1111/j.1365-2664.1998.tb00013.x; Branquart E, 2000, ECOGRAPHY, V23, P732, DOI 10.1034/j.1600-0587.2000.230610.x; Chamberlain DE, 1999, J APPL ECOL, V36, P856, DOI 10.1046/j.1365-2664.1999.00453.x; *COMM STAT DEP, 1993, GENST 5 REL 3 REF MA; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; European Commission, 1997, AG 2000, VI; Evans Andy, 1997, P331; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; Henderson IG, 2000, ECOGRAPHY, V23, P50, DOI 10.1034/j.1600-0587.2000.230106.x; Kokko H, 2001, EVOL ECOL RES, V3, P537; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; Milsom TP, 1998, BIOL CONSERV, V84, P119, DOI 10.1016/S0006-3207(97)00111-0; Ovenden GN, 1998, J APPL ECOL, V35, P955, DOI 10.1111/j.1365-2664.1998.tb00014.x; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Schekkerman Hans, 2000, Limosa, V73, P121; STANDEN V, 1984, J APPL ECOL, V21, P293, DOI 10.2307/2403055; VANDIJK AJ, 1996, SURVEYING BREEDING B	23	468	494	3	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					723	725		10.1038/35099540	http://dx.doi.org/10.1038/35099540			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607029				2022-12-28	WOS:000171608000041
J	Naish, TR; Woolfe, KJ; Barrett, PJ; Wilson, GS; Atkins, C; Bohaty, SM; Bucker, CJ; Claps, M; Davey, FJ; Dunbar, GB; Dunn, AG; Fielding, CR; Florindo, F; Hannah, MJ; Harwood, DM; Henrys, SA; Krissek, LA; Lavelle, M; van der Meer, J; McIntosh, WC; Niessen, F; Passchier, S; Powell, RD; Roberts, AP; Sagnotti, L; Scherer, RP; Strong, CP; Talarico, F; Verosub, KL; Villa, G; Watkins, DK; Webb, PN; Wonik, T				Naish, TR; Woolfe, KJ; Barrett, PJ; Wilson, GS; Atkins, C; Bohaty, SM; Bucker, CJ; Claps, M; Davey, FJ; Dunbar, GB; Dunn, AG; Fielding, CR; Florindo, F; Hannah, MJ; Harwood, DM; Henrys, SA; Krissek, LA; Lavelle, M; van der Meer, J; McIntosh, WC; Niessen, F; Passchier, S; Powell, RD; Roberts, AP; Sagnotti, L; Scherer, RP; Strong, CP; Talarico, F; Verosub, KL; Villa, G; Watkins, DK; Webb, PN; Wonik, T			Orbitally induced oscillations in the East Antarctic ice sheet at the Oligocene/Miocene boundary	NATURE			English	Article							ASTRONOMICAL CALIBRATION; GLACIATION; ISOTOPES; CLIMATE; MARGIN; BASIN	Between 34 and 15 million years (Myr) ago, when planetary temperatures were 3-4 degreesC warmer than at present and atmospheric CO2 concentrations were twice as high as today(1), the Antarctic ice sheets may have been unstable(2-7). Oxygen isotope records from deep-sea sediment cores suggest that during this time fluctuations in global temperatures and high-latitude continental ice volumes were influenced by orbital cycles(8-10). But it has hitherto not been possible to calibrate the inferred changes in ice volume with direct evidence for oscillations of the Antarctic ice sheets(11). Here we present sediment data from shallow marine cores in the western Ross Sea that exhibit well dated cyclic variations, and which link the extent of the East Antarctic ice sheet directly to orbital cycles during the Oligocene/Miocene transition (24.1-23.7 Myr ago). Three rapidly deposited glaci-marine sequences are constrained to a period of less than 450 kyr by our age model, suggesting that orbital influences at the frequencies of obliquity (40 kyr) and eccentricity (125 kyr) controlled the oscillations of the ice margin at that time. An erosional hiatus covering 250 kyr provides direct evidence for a major episode of global cooling and ice-sheet expansion about 23.7 Myr ago, which had previously been inferred from oxygen isotope data (Mil event(5)).	Inst Geol & Nucl Sci, Lower Hutt, New Zealand; James Cook Univ N Queensland, Sch Earth Sci, Townsville, Qld 4811, Australia; Victoria Univ Wellington, Antarctic Res Ctr, Wellington, New Zealand; Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; Univ Nebraska, Dept Geosci, Lincoln, NE 68588 USA; Inst Geowissensch Gemeinschaftsaufgaben, D-30655 Hannover, Germany; Univ Ancona, Ist Sci Mare, I-60131 Ancona, Italy; Natl Inst Water & Atmospher Res, Wellington, New Zealand; Univ Queensland, Dept Earth Sci, Brisbane, Qld 4072, Australia; Ist Nazl Geofis & Vulcanol, I-00143 Rome, Italy; Univ Southampton, Sch Ocean & Earth Sci, Southampton Oceanog Ctr, Southampton SO14 3XH, Hants, England; Ohio State Univ, Dept Geol Sci, Columbus, OH 43210 USA; British Antarctic Survey, Cambridge CB3 OET, England; Univ Amsterdam, Fys Geog & Bodemkundig Lab, NL-1018 VZ Amsterdam, Netherlands; New Mexico Inst Min & Technol, Socorro, NM 87801 USA; No Illinois Univ, Dept Geol & Environm Geosci, De Kalb, IL 60115 USA; Univ Siena, Dipartimento Sci Terra, I-53100 Siena, Italy; Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; Univ Parma, Dipartimento Sci Terra, I-43100 Parma, Italy; Ohio State Univ, Byrd Polar Res Ctr, Columbus, OH 43210 USA; Alfred Wegener Inst, D-27516 Bremerhaven, Germany	GNS Science - New Zealand; James Cook University; Victoria University Wellington; University of Oxford; University of Nebraska System; University of Nebraska Lincoln; Marche Polytechnic University; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Queensland; Istituto Nazionale Geofisica e Vulcanologia (INGV); NERC National Oceanography Centre; University of Southampton; University System of Ohio; Ohio State University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Amsterdam; New Mexico Institute of Mining Technology; Northern Illinois University; University of Siena; University of California System; University of California Davis; University of Parma; University System of Ohio; Ohio State University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Naish, TR (corresponding author), Inst Geol & Nucl Sci, POB 30368, Lower Hutt, New Zealand.	t.naish@gns.cri.nz	Passchier, Sandra/B-1993-2008; Florindo, Fabio/F-4119-2010; Watkins, David/AAJ-2571-2021; Florindo, Fabio/AAU-2548-2021; Passchier, Sandra/AAQ-2243-2021; Wilson, Gary/B-3803-2010; Hannah, Michael/H-1083-2015; Roberts, Andrew P/E-6422-2010; Sagnotti, Leonardo/AFM-3916-2022; Henrys, Stuart/ABD-7378-2020; Florindo, Fabio/M-1459-2019; talarico, franco/G-9472-2012	Passchier, Sandra/0000-0001-7204-7025; Florindo, Fabio/0000-0002-6058-9748; Passchier, Sandra/0000-0001-7204-7025; Hannah, Michael/0000-0002-2275-0086; Roberts, Andrew P/0000-0003-0566-8117; Sagnotti, Leonardo/0000-0003-3944-201X; Henrys, Stuart/0000-0002-7164-5274; Florindo, Fabio/0000-0002-6058-9748; Atkins, C/0000-0002-6513-6924; Wilson, Gary/0000-0003-0025-3641; talarico, franco/0000-0002-7254-4301; Niessen, Frank/0000-0001-6453-0594; Naish, Tim/0000-0002-1185-9932				BARRETT PJ, 1987, GEOLOGY, V15, P634, DOI 10.1130/0091-7613(1987)15<634:MROGAS>2.0.CO;2; BARRETT PJ, 1989, DSIR B, V245, P1; BUCKER C, 2000, TERRA ANTARTICA, V0007; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; CAPE ROBERTS SCIENCE TEAM, 2000, TERRA ANTARTICA, V7, P1; Fielding C.R., 1999, TERRA ANTARTICA, V6; Fielding C.R., 2000, STUDIES CAPE ROBERTS, V7, P323; Freeman KH, 1992, GLOBAL BIOGEOCHEM CY, V6, P185, DOI 10.1029/92GB00190; HAMBREY MJ, 1991, P OCEAN DRILLING PRO, V0119; HARWOOD DM, 1992, P OCEAN DRILLING PRO, V0120; HAYS DE, 1975, INIT REP DSDP, V28, P919; HENRYS SA, 2000, TERRA ANTARTICA, V7, P221; HOUGHTON J, 2001, 1 IPCC WORK GROUP, P1; HSU KJ, 1983, INIT REP DSDP, V73, P625; IMBRIE J, 1993, PALEOCEANOGRAPHY, V8, P699, DOI 10.1029/93PA02751; LASKAR J, 1993, ASTRON ASTROPHYS, V270, P522; LAVELLE M, 2000, TERRA ANTARTICA, V0007; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; McIntosh W. C., 2000, TERRA ANTARTICA, V7, P621; MILLER KG, 1991, J GEOPHYS RES-SOLID, V96, P6829, DOI 10.1029/90JB02015; Naish T, 1997, GEOL SOC AM BULL, V109, P978, DOI 10.1130/0016-7606(1997)109<0978:SSOSOK>2.3.CO;2; Passchier S., 2000, TERRA ANTARCT, V7, P401; Paul HA, 2000, PALEOCEANOGRAPHY, V15, P471, DOI 10.1029/1999PA000443; Powell R., 1981, ANN GLACIOL, V2, P129, DOI DOI 10.3189/172756481794352306; SCHERER RP, 2000, TERRA ANTARTICA, V0007; Shackleton NJ, 1999, PHILOS T R SOC A, V357, P1907, DOI 10.1098/rsta.1999.0407; Shackleton NJ, 2000, GEOLOGY, V28, P447, DOI 10.1130/0091-7613(2000)028<0447:ACAFTO>2.3.CO;2; TALARICO F, 2000, TERRA ANTARTICA, V0007; VANDERMEER JJM, 2000, TERRA ANTARTICA, V7, P339; WATKINS DK, 2000, TERRA ANTARTICA, V7, P443; WILSON GS, 2000, TERRA ANTARTICA, V7, P647; WILSON GS, 2000, TERRA ANTARTICA, V7, P631; Wise Sherwood W., 1991, CONTROVERSIES MODERN; ZACHOS JC, 1992, GEOLOGY, V20, P569, DOI 10.1130/0091-7613(1992)020<0569:EOISEO>2.3.CO;2; Zachos JC, 1996, PALEOCEANOGRAPHY, V11, P251, DOI 10.1029/96PA00571; Zachos JC, 1997, NATURE, V388, P567, DOI 10.1038/41528	36	188	191	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					719	723		10.1038/35099534	http://dx.doi.org/10.1038/35099534			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607028	Green Published			2022-12-28	WOS:000171608000040
J	Kiss, A; Meryn, S				Kiss, A; Meryn, S			Effect of sex and gender on psychosocial aspects of prostate and breast cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; RADICAL RETROPUBIC PROSTATECTOMY; SILDENAFIL CITRATE VIAGRA; PSYCHIATRIC MORBIDITY; GROUP INTERVENTIONS; SOCIAL SUPPORT; MEN; ONCOLOGISTS; DISTRESS; RECOGNITION		Univ Clin Basel, Dept Internal Med, Psychosomat Div, CH-4031 Basel, Switzerland; Univ Vienna, Fac Med, Ctr Adv Med Educ & Hlth Commun, A-1097 Vienna, Austria	University of Basel; University of Vienna	Kiss, A (corresponding author), Univ Clin Basel, Dept Internal Med, Psychosomat Div, Petersgraben 4, CH-4031 Basel, Switzerland.	akiss@uhbs.ch						BAIDER L, 1996, CANC FAMILY; Berman J R, 1999, Curr Opin Urol, V9, P563, DOI 10.1097/00042307-199911000-00012; Boehmer UE, 2001, PSYCHO-ONCOL, V10, P147, DOI 10.1002/pon.504; Brandeis JM, 2000, J UROLOGY, V163, P851, DOI 10.1016/S0022-5347(05)67818-4; Bruera E, 2001, J CLIN ONCOL, V19, P2883, DOI 10.1200/JCO.2001.19.11.2883; Carlson LE, 2001, CANCER NURS, V24, P231, DOI 10.1097/00002820-200106000-00010; Clark JA, 2001, J CLIN ONCOL, V19, P72, DOI 10.1200/JCO.2001.19.1.72; Classen C, 2001, ARCH GEN PSYCHIAT, V58, P494, DOI 10.1001/archpsyc.58.5.494; Cliff AM, 2000, BJU INT, V86, P834, DOI 10.1046/j.1464-410x.2000.00914.x; Coreil J, 1999, CANCER PRACT, V7, P122, DOI 10.1046/j.1523-5394.1999.07307.x; DePalma A, 2000, Semin Urol Oncol, V18, P178; Dorval M, 1999, J NATL CANCER I, V91, P54, DOI 10.1093/jnci/91.1.54; Edelman S, 2000, J PSYCHOSOC ONCOL, V18, P67, DOI 10.1300/J077v18n03_05; Fallowfield L, 2001, BRIT J CANCER, V84, P1011, DOI 10.1054/bjoc.2001.1724; Feldman-Stewart Deb, 2000, Health Expect, V3, P46, DOI 10.1046/j.1369-6513.2000.00082.x; GOOD GE, 2001, HDB PSYCHOL WOMEN GE; Gray RE, 2000, PSYCHO-ONCOLOGY, V9, P273, DOI 10.1002/1099-1611(200007/08)9:4<273::AID-PON463>3.0.CO;2-F; Grunfeld EA, 2001, BRIT J CANCER, V84, P1172, DOI 10.1054/bjoc.2001.1733; Helgeson VS, 1999, ARCH GEN PSYCHIAT, V56, P340, DOI 10.1001/archpsyc.56.4.340; Herr HW, 2000, J UROLOGY, V163, P1743, DOI 10.1016/S0022-5347(05)67533-7; Klemm P, 1999, COMPUT NURS, V17, P65; KORNBLITH AB, 1994, CANCER-AM CANCER SOC, V73, P2791, DOI 10.1002/1097-0142(19940601)73:11<2791::AID-CNCR2820731123>3.0.CO;2-9; Krizek C, 1999, CANCER PRACT, V7, P86, DOI 10.1046/j.1523-5394.1999.07206.x; Litwin MS, 2001, J UROLOGY, V165, P871, DOI 10.1016/S0022-5347(05)66547-0; MAGUIRE P, 1980, BMJ-BRIT MED J, V281, P1454, DOI 10.1136/bmj.281.6253.1454; Maguire P, 2000, EUR J CANCER, V36, P556; MAGUIRE P, 1990, EUR J CANCER, V32, P78; Mandelblatt JS, 2001, MED CARE, V39, P228, DOI 10.1097/00005650-200103000-00004; Nehra A, 1999, UROLOGY, V54, P587; Nordin K, 2001, EUR J CANCER, V37, P376, DOI 10.1016/S0959-8049(00)00398-1; Passik SD, 1998, J CLIN ONCOL, V16, P1594, DOI 10.1200/JCO.1998.16.4.1594; Roth AJ, 1998, CANCER, V82, P1904, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1904::AID-CNCR13>3.0.CO;2-X; Rowland JH, 2000, J NATL CANCER I, V92, P1422, DOI 10.1093/jnci/92.17.1422; Siegel T, 2001, J UROLOGY, V165, P430, DOI 10.1097/00005392-200102000-00019; Sollner W, 2001, BRIT J CANCER, V84, P179, DOI 10.1054/bjoc.2000.1545; Stanford JL, 2000, JAMA-J AM MED ASSOC, V283, P354, DOI 10.1001/jama.283.3.354; Steiner MS, 2000, J UROLOGY, V163, P870, DOI 10.1016/S0022-5347(05)67822-6; Visser A, 2001, PSYCHO-ONCOL, V10, pS32; Volkers N, 1999, J NATL CANCER I, V91, P1712, DOI 10.1093/jnci/91.20.1712; Walsh PC, 2000, J UROLOGY, V163, P1802, DOI 10.1016/S0022-5347(05)67547-7; Whelan T, 1999, J CLIN ONCOL, V17, P1727, DOI 10.1200/JCO.1999.17.6.1727; Witzemann TM, 2001, EXPLORING BIOL CONTR; Wong F, 2000, J PSYCHOSOM RES, V49, P13, DOI 10.1016/S0022-3999(99)00109-9; Zippe CD, 1999, UROLOGY, V54, P583	44	80	82	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2001	323	7320					1055	1058		10.1136/bmj.323.7320.1055	http://dx.doi.org/10.1136/bmj.323.7320.1055			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MP	11691767	Green Published			2022-12-28	WOS:000172055900024
J	Acremann, Y; Buess, M; Back, CH; Dumm, M; Bayreuther, G; Pescia, D				Acremann, Y; Buess, M; Back, CH; Dumm, M; Bayreuther, G; Pescia, D			Ultrafast generation of magnetic fields in a Schottky diode	NATURE			English	Article							MULTILAYER; EXCITATION; INJECTION; REVERSAL; DYNAMICS; FILMS	For the development of future magnetic data storage technologies, the ultrafast generation of local magnetic fields is essential. Subnanosecond excitation of the magnetic state has so far been achieved by launching current pulses into micro-coils and micro-striplines(1-6) and by using high-energy electron beams(7). Local injection of a spin-polarized current through an all-metal junction has been proposed as an efficient method of switching magnetic elements(8,9), and experiments seem to confirm this(10-13). Spin injection has also been observed in hybrid ferromagnetic-semiconductor structures(14,15). Here we introduce a different scheme for the ultrafast generation of local magnetic fields in such a hybrid structure. The basis of our approach is to optically pump a Schottky diode with a focused, similar to 150-fs laser pulse. The laser pulse generates a current across the semiconductor-metal junction, which in turn gives rise to an in-plane magnetic field. This scheme combines the localization of current injection techniques(11-13,16) with the speed of current generation at a Schottky barrier. Specific advantages include the ability to rapidly create local fields along any in-plane direction anywhere on the sample, the ability to scan the field over many magnetic elements and the ability to tune the magnitude of the field with the diode bias voltage.	ETH Zurich, Festkorperphys Lab, CH-8093 Zurich, Switzerland; Univ Regensburg, Inst Expt & Angew Phys, D-93040 Regensburg, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Regensburg	Pescia, D (corresponding author), ETH Zurich, Festkorperphys Lab, CH-8093 Zurich, Switzerland.		Back, Christian/AAD-7824-2021; Back, Christian/A-8969-2012	Back, Christian/0000-0003-3840-0993; Back, Christian/0000-0003-3840-0993				Acremann Y, 2000, SCIENCE, V290, P492, DOI 10.1126/science.290.5491.492; Back CH, 1999, SCIENCE, V285, P864, DOI 10.1126/science.285.5429.864; Bauer M, 2000, APPL PHYS LETT, V76, P2758, DOI 10.1063/1.126466; Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Choi BC, 2001, PHYS REV LETT, V86, P728, DOI 10.1103/PhysRevLett.86.728; Christianen PCM, 1996, J APPL PHYS, V80, P6831, DOI 10.1063/1.363749; Crawford TM, 1999, APPL PHYS LETT, V74, P3386, DOI 10.1063/1.123353; Dumm M, 2000, J APPL PHYS, V87, P5457, DOI 10.1063/1.373371; Fiederling R, 1999, NATURE, V402, P787, DOI 10.1038/45502; Hicken RJ, 1999, J APPL PHYS, V85, P4580, DOI 10.1063/1.370414; Hiebert WK, 1997, PHYS REV LETT, V79, P1134, DOI 10.1103/PhysRevLett.79.1134; KITTEL C, 1948, PHYS REV, V73, P155, DOI 10.1103/PhysRev.73.155; Koopmans B, 2000, PHYS REV LETT, V85, P844, DOI 10.1103/PhysRevLett.85.844; Myers EB, 1999, SCIENCE, V285, P867, DOI 10.1126/science.285.5429.867; Ohno Y, 1999, NATURE, V402, P790, DOI 10.1038/45509; PRINZ GA, 1982, J APPL PHYS, V53, P2087, DOI 10.1063/1.330707; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Tsoi M, 1998, PHYS REV LETT, V80, P4281, DOI 10.1103/PhysRevLett.80.4281; Weber W, 2001, SCIENCE, V291, P1015, DOI 10.1126/science.1057430; Wegrowe JE, 1999, EUROPHYS LETT, V45, P626, DOI 10.1209/epl/i1999-00213-1; YU G, 1999, PHYS REV LETT, V82, P3705; Zhu JG, 2000, J APPL PHYS, V87, P6668, DOI 10.1063/1.372805	22	38	38	1	32	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 01	2001	414	6859					51	54		10.1038/35102026	http://dx.doi.org/10.1038/35102026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689938				2022-12-28	WOS:000171898900037
J	Adam, D				Adam, D			UK changes policy on life insurance	NATURE			English	News Item																			0	1	1	1	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 01	2001	414	6859					6	6		10.1038/35102234	http://dx.doi.org/10.1038/35102234			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689906	Bronze			2022-12-28	WOS:000171898900009
J	Kondo, T; Wakayama, T; Naiki, T; Matsumoto, K; Sugimoto, K				Kondo, T; Wakayama, T; Naiki, T; Matsumoto, K; Sugimoto, K			Recruitment of Mec1 and Dcd1 checkpoint proteins to double-strand breaks through distinct mechanisms	SCIENCE			English	Article							DNA-DAMAGE CHECKPOINT; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; BUDDING YEAST; SLIDING CLAMP; COMPLEX; RAD24; RECOMBINATION; ADAPTATION; ARREST	In response to DNA damage, eukaryotic cells activate checkpoint pathways that arrest cell cycle progression and induce the expression of genes required for DNA repair. In budding yeast, the homothallic switching (HO) endonuclease creates a site-specific double-strand break at the mating type (MAT) Locus. Continuous HO expression results in the phosphorylation of Rad53, which is dependent on products of the ataxia telangiectasia mutated-related MEC1 gene and other checkpoint genes, including DDC1, RAD9, and RAD24. Chromatin immunoprecipitation experiments revealed that the Ddc1 protein associates with a region near the MAT locus after HO expression. Ddc1 association required Rad24 but not Mec1 or Rad9. Mec1 also associated with a region near the cleavage site after HO expression, but this association is independent of Ddc1, Rad9, and Rad24. Thus, Mec1 and Ddc1 are recruited independently to sites of DNA damage, suggesting the existence of two separate mechanisms involved in recognition of DNA damage.	Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4640814, Japan; Japan Sci & Technol Corp, CREST, Nagoya, Aichi 4640814, Japan	Nagoya University; Japan Science & Technology Agency (JST)	Kondo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4640814, Japan.	j46036a@nucc.cc.nagoya-u.ac.jp						Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; Burtelow MA, 2000, J BIOL CHEM, V275, P26343, DOI 10.1074/jbc.M001244200; CONNOLLY B, 1988, MOL CELL BIOL, V8, P2342, DOI 10.1128/MCB.8.6.2342; Demeter J, 2000, MOL CELL, V6, P487, DOI 10.1016/S1097-2765(00)00047-2; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Green CM, 2000, CURR BIOL, V10, P39, DOI 10.1016/S0960-9822(99)00263-8; Haber JE, 2000, MUTAT RES-FUND MOL M, V451, P53, DOI 10.1016/S0027-5107(00)00040-3; HERSKOWITZ I, 1991, METHOD ENZYMOL, V194, P132; Kondo T, 1999, MOL CELL BIOL, V19, P1136; KONDO T, UNPUB; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lewis LK, 1998, MOL CELL BIOL, V18, P1891, DOI 10.1128/MCB.18.4.1891; Longhese MP, 1998, EMBO J, V17, P5525, DOI 10.1093/emboj/17.19.5525; Naiki T, 2000, MOL CELL BIOL, V20, P5888, DOI 10.1128/MCB.20.16.5888-5896.2000; Paciotti V, 1998, EMBO J, V17, P4199, DOI 10.1093/emboj/17.14.4199; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Shimomura T, 1998, MOL CELL BIOL, V18, P5485, DOI 10.1128/MCB.18.9.5485; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Thelen MP, 1999, CELL, V96, P769, DOI 10.1016/S0092-8674(00)80587-5; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	26	219	223	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					867	870		10.1126/science.1063827	http://dx.doi.org/10.1126/science.1063827			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679674				2022-12-28	WOS:000171851800051
J	Zhang, SC; Hu, JP				Zhang, SC; Hu, JP			A four-dimensional generalization of the quantum Hall effect	SCIENCE			English	Article							EDGE STATES; EXCITATIONS; FLUID	We construct a generalization of the quantum Ha effect, where particles move in four dimensional space under a SU(2) gauge field. This system has a macroscopic number of degenerate single particle states. At appropriate integer or fractional filling fractions the system forms an incompressible quantum liquid. Gapped elementary excitation in the bulk interior and gapless elementary excitations at the boundary are investigated.	Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Tsing Hua Univ, Ctr Adv Studies, Beijing 100084, Peoples R China	Stanford University; Tsinghua University	Zhang, SC (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.		Hu, Jiangping/A-9154-2010; Zhang, Shou-Cheng/B-2794-2010; Hu, Jiangping/R-1382-2018; hu, jiangping/C-3320-2014	Hu, Jiangping/0000-0003-4480-1734; Hu, Jiangping/0000-0002-4837-7742; 				ANDERSON PW, 1997, BASIC NOTATIONS COND; BELAVIN AA, 1975, PHYS LETT B, V59, P85, DOI 10.1016/0370-2693(75)90163-X; Bethe H, 1931, Z PHYS, V71, P205, DOI 10.1007/BF01341708; BJORKEN JD, 1963, ANN PHYS-NEW YORK, V24, P174, DOI 10.1016/0003-4916(63)90069-1; CHAPLINE G, GRQC0012094; Demler E, 1999, ANN PHYS-NEW YORK, V271, P83, DOI 10.1006/aphy.1998.5866; Feynman R.P., 1995, FEYNMAN LECT GRAVITA; Fierz M, 1939, PROC R SOC LON SER-A, V173, P0211, DOI 10.1098/rspa.1939.0140; HALDANE FDM, 1983, PHYS REV LETT, V51, P605, DOI 10.1103/PhysRevLett.51.605; HALPERIN BI, 1982, PHYS REV B, V25, P2185, DOI 10.1103/PhysRevB.25.2185; JACKIW R, 1976, PHYS REV D, V14, P517, DOI 10.1103/PhysRevD.14.517; NIELSEN HB, 1984, NUCL PHYS B, V242, P542; Prange R. E., 1990, QUANTUM HALL EFFECT; STONE M, 1990, PHYS REV B, V42, P8399, DOI 10.1103/PhysRevB.42.8399; SUSSKIND L, HEPTH0101029; Talman J.D., 1968, SPECIAL FUNCTIONS GR; VOLOVIK GE, GRQC0101111; WEINBERG S, 1965, PHYS REV           B, V138, P988, DOI [10.1103/PhysRev.138.B988, DOI 10.1103/PHYSREV.138.B988]; WEN XG, 1990, PHYS REV LETT, V64, P2206, DOI 10.1103/PhysRevLett.64.2206; WITTEN E, 1988, COMMUN MATH PHYS, V117, P353, DOI 10.1007/BF01223371; YANG CN, 1978, J MATH PHYS, V19, P2622, DOI 10.1063/1.523618; YANG CN, 1978, J MATH PHYS, V19, P320, DOI 10.1063/1.523506; ZHANG SC, 1992, INT J MOD PHYS B, V6, P25, DOI 10.1142/S0217979292000037	24	348	356	0	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2001	294	5543					823	828		10.1126/science.294.5543.823	http://dx.doi.org/10.1126/science.294.5543.823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679662	Green Submitted			2022-12-28	WOS:000171851800038
J	McClelland, M; Sanderson, KE; Spieth, J; Clifton, SW; Latreille, P; Courtney, L; Porwollik, S; Ali, J; Dante, M; Du, FY; Hou, SF; Layman, D; Leonard, S; Nguyen, C; Scott, K; Holmes, A; Grewal, N; Mulvaney, E; Ryan, E; Sun, H; Florea, L; Miller, W; Stoneking, T; Nhan, M; Waterston, R; Wilson, RK				McClelland, M; Sanderson, KE; Spieth, J; Clifton, SW; Latreille, P; Courtney, L; Porwollik, S; Ali, J; Dante, M; Du, FY; Hou, SF; Layman, D; Leonard, S; Nguyen, C; Scott, K; Holmes, A; Grewal, N; Mulvaney, E; Ryan, E; Sun, H; Florea, L; Miller, W; Stoneking, T; Nhan, M; Waterston, R; Wilson, RK			Complete genome sequence of Salmonella enterica serovar typhimurium LT2	NATURE			English	Article							ESCHERICHIA-COLI; FOODBORNE ILLNESS; GENE-TRANSFER; IDENTIFICATION; EPIDEMIOLOGY; MALTOSE; SYSTEM	Salmonella enterica subspecies I, serovar Typhimurium (S. typhimurium), is a leading cause of human gastroenteritis, and is used as a mouse model of human typhoid fever(1). The incidence of non-typhoid salmonellosis is increasing worldwide(2-4), causing millions of infections and many deaths in the human population each year. Here we sequenced the 4,857-kilobase (kb) chromosome and 94-kb virulence plasmid of S. typhimurium strain LT2. The distribution of close homologues of S. typhimurium LT2 genes in eight related enterobacteria was determined using previously completed genomes of three related bacteria, sample sequencing of both S. enterica serovar Paratyphi A (S. paratyphi A) and Klebsiella pneumoniae, and hybridization of three unsequenced genomes to a microarray of S. typhimurium LT2 genes. Lateral transfer of genes is frequent, with 11% of the S. typhimurium LT2 genes missing from S. enterica serovar Typhi (S. typhi), and 29% missing from Escherichia coli K12. The 352 gene homologues of S. typhimurium LT2 confined to subspecies I of S. enterica- containing most mammalian and bird pathogens(5)- are useful for studies of epidemiology, host specificity and pathogenesis. Most of these homologues were previously unknown, and 50 may be exported to the periplasm or outer membrane, rendering them accessible as therapeutic or vaccine targets.	Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA	University of Calgary; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	McClelland, M (corresponding author), Sidney Kimmel Canc Ctr, 10835 Altman Row, San Diego, CA 92121 USA.		McClelland, Michael/A-8583-2011; Wilson, Richard K./AAF-4139-2019	Wilson, Richard K./0000-0002-1992-1358; McClelland, Michael/0000-0003-1788-9347				Ahmer BMM, 1999, J BACTERIOL, V181, P1364, DOI 10.1128/JB.181.4.1364-1368.1999; Bermudes D, 2000, ADV EXP MED BIOL, V465, P57; Blanc-Potard AB, 1999, J BACTERIOL, V181, P998, DOI 10.1128/JB.181.3.998-1004.1999; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bumann D, 2000, FEMS IMMUNOL MED MIC, V27, P357, DOI 10.1111/j.1574-695X.2000.tb01450.x; CHALKER RB, 1988, REV INFECT DIS, V10, P111; COOKE EM, 1990, LANCET, V336, P790, DOI 10.1016/0140-6736(90)93251-J; Decker K, 1999, MOL MICROBIOL, V32, P777, DOI 10.1046/j.1365-2958.1999.01395.x; Figueroa-Bossi N, 2001, MOL MICROBIOL, V39, P260, DOI 10.1046/j.1365-2958.2001.02234.x; Florea L, 2000, NUCLEIC ACIDS RES, V28, P3486, DOI 10.1093/nar/28.18.3486; GUPTA SD, 1995, J BACTERIOL, V177, P4207, DOI 10.1128/jb.177.15.4207-4215.1995; Lan RT, 1996, MOL BIOL EVOL, V13, P47, DOI 10.1093/oxfordjournals.molbev.a025569; LIU SL, 1993, J BACTERIOL, V175, P4104, DOI 10.1128/JB.175.13.4104-4120.1993; Liu SL, 1996, P NATL ACAD SCI USA, V93, P10303, DOI 10.1073/pnas.93.19.10303; Matsui H, 2001, J BACTERIOL, V183, P4652, DOI 10.1128/JB.183.15.4652-4658.2001; McClelland M, 2000, NUCLEIC ACIDS RES, V28, P4974, DOI 10.1093/nar/28.24.4974; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NEIDHARDT FC, 1996, CELLULAR MOL BIOL; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Popoff MY, 2000, RES MICROBIOL, V151, P893, DOI 10.1016/S0923-2508(00)01157-8; Porwollik S, 2001, MUTAT RES-FUND MOL M, V483, P1, DOI 10.1016/S0027-5107(01)00239-1; REIDL J, 1991, J BACTERIOL, V173, P4862, DOI 10.1128/jb.173.15.4862-4876.1991; SELANDER RK, 1996, CELLULAR MOL BIOL, P2691; Stanley TL, 2000, J BACTERIOL, V182, P4406, DOI 10.1128/JB.182.16.4406-4413.2000; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; TODD E, 1990, LANCET, V336, P788, DOI 10.1016/0140-6736(90)93250-S; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001	30	1450	3345	5	171	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					852	856		10.1038/35101614	http://dx.doi.org/10.1038/35101614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677609	Bronze			2022-12-28	WOS:000171750200048
J	Parkhill, J; Dougan, G; James, KD; Thomson, NR; Pickard, D; Wain, J; Churcher, C; Mungall, KL; Bentley, SD; Holden, MTG; Sebaihia, M; Baker, S; Basham, D; Brooks, K; Chillingworth, T; Connerton, P; Cronin, A; Davis, P; Davies, RM; Dowd, L; White, N; Farrar, J; Feltwell, T; Hamlin, N; Haque, A; Hien, TT; Holroyd, S; Jagels, K; Krogh, A; Larsen, TS; Leather, S; Moule, S; O'Gaora, P; Parry, C; Quail, M; Rutherford, K; Simmonds, M; Skelton, J; Stevens, K; Whitehead, S; Barrell, BG				Parkhill, J; Dougan, G; James, KD; Thomson, NR; Pickard, D; Wain, J; Churcher, C; Mungall, KL; Bentley, SD; Holden, MTG; Sebaihia, M; Baker, S; Basham, D; Brooks, K; Chillingworth, T; Connerton, P; Cronin, A; Davis, P; Davies, RM; Dowd, L; White, N; Farrar, J; Feltwell, T; Hamlin, N; Haque, A; Hien, TT; Holroyd, S; Jagels, K; Krogh, A; Larsen, TS; Leather, S; Moule, S; O'Gaora, P; Parry, C; Quail, M; Rutherford, K; Simmonds, M; Skelton, J; Stevens, K; Whitehead, S; Barrell, BG			Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18	NATURE			English	Article							COMPLETE DNA-SEQUENCE; YERSINIA-PESTIS; EPITHELIAL-CELLS; TYPHIMURIUM; IDENTIFICATION; PROTEIN; VIRULENCE; BACTERIA; PLASMID; STRAIN	Salmonella enterica serovar Typhi (S. typhi) is the aetiological agent of typhoid fever, a serious invasive bacterial disease of humans with an annual global burden of approximately 16 million cases, leading to 600,000 fatalities(1). Many S. enterica serovars actively invade the mucosal surface of the intestine but are normally contained in healthy individuals by the local immune defence mechanisms. However, S. typhi has evolved the ability to spread to the deeper tissues of humans, including liver, spleen and bone marrow. Here we have sequenced the 4,809,037-base pair (bp) genome of a S. typhi (CT18) that is resistant to multiple drugs, revealing the presence of hundreds of insertions and deletions compared with the Escherichia coli genome, ranging in size from single genes to large islands. Notably, the genome sequence identifies over two hundred pseudogenes, several corresponding to genes that are known to contribute to virulence in Salmonella typhimurium. This genetic degradation may contribute to the human-restricted host range for S. typhi. CT18 harbours a 218,150-bp multiple-drug-resistance incH1 plasmid (pHCM1), and a 106,516-bp cryptic plasmid (pHCM2), which shows recent common ancestry with a virulence plasmid of Yersinia pestis.	Sanger Ctr, Cambridge CB10 1SA, England; Univ London Imperial Coll Sci Technol & Med, Dept Sci Biol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; Univ Oxford, Ctr Trop Med, Oxford OX3 9DU, England; Univ Oxford, Wellcome Trust Clin Res Unit, Ctr Trop Dis, Ho Chi Minh City, Vietnam; Tech Univ Denmark, Biocentrum DTU, CTr Biol Sequence Anal, DK-2800 Lyngby, Denmark	Wellcome Trust Sanger Institute; Imperial College London; University of Oxford; University of Oxford; Technical University of Denmark	Parkhill, J (corresponding author), Sanger Ctr, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	parkhill@sanger.ac.uk; g.dougan@ic.ac.uk	Rutherford, Kim/Y-7995-2018; Haque, Ashraful/H-8697-2014; Sebaihia, Mohammed/AAF-6589-2019; Holden, Matthew TG/K-6449-2014; Wain, John/B-3446-2013; Connerton, Phillippa/K-2479-2019; White, Nick/AAC-6527-2019; O'Gaora, Peadar/F-9400-2011; White, Nicholas J/I-4629-2012; Farrar, Jeremy J./HGA-7610-2022; Parkhill, Julian/G-4703-2011; Quail, michael/ABE-6131-2020; Krogh, Anders/M-1541-2014; Thomson, Nicholas/P-5988-2014	Rutherford, Kim/0000-0001-6277-726X; Haque, Ashraful/0000-0003-2260-0026; Sebaihia, Mohammed/0000-0002-3324-3346; Holden, Matthew TG/0000-0002-4958-2166; Wain, John/0000-0002-1257-1148; White, Nick/0000-0002-1897-1978; O'Gaora, Peadar/0000-0002-6417-7054; Parkhill, Julian/0000-0002-7069-5958; Davis, Paul/0000-0001-5545-0824; Farrar, Jeremy/0000-0002-2700-623X; Krogh, Anders/0000-0002-5147-6282; Thomson, Nicholas/0000-0002-4432-8505; Davies, Robert/0000-0002-9983-1378; Connerton, Phillippa/0000-0002-7686-5700; Baker, Stephen/0000-0003-1308-5755				Bakshi CS, 2000, J BACTERIOL, V182, P2341, DOI 10.1128/JB.182.8.2341-2344.2000; Blanc-Potard AB, 1999, J BACTERIOL, V181, P998, DOI 10.1128/JB.181.3.998-1004.1999; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Doolittle RF, 1996, SCIENCE, V271, P470, DOI 10.1126/science.271.5248.470; HASHIMOTO Y, 1993, J BACTERIOL, V175, P4456, DOI 10.1128/JB.175.14.4456-4465.1993; Hensel M, 1999, MOL MICROBIOL, V32, P275, DOI 10.1046/j.1365-2958.1999.01345.x; Hu P, 1998, J BACTERIOL, V180, P5192, DOI 10.1128/JB.180.19.5192-5202.1998; IVANOV V, 1995, ELEMENTA, V2, P1; Jing DH, 1999, J BIOL CHEM, V274, P27287, DOI 10.1074/jbc.274.38.27287; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Kingsley RA, 2000, MOL MICROBIOL, V36, P1006, DOI 10.1046/j.1365-2958.2000.01907.x; Marcus SL, 2000, MICROBES INFECT, V2, P145, DOI 10.1016/S1286-4579(00)00273-2; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Mirold S, 1999, P NATL ACAD SCI USA, V96, P9845, DOI 10.1073/pnas.96.17.9845; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Parry C, 1998, LANCET, V351, P1289, DOI 10.1016/S0140-6736(05)79356-9; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Prentice MB, 2001, J BACTERIOL, V183, P2586, DOI 10.1128/JB.183.8.2586-2594.2001; REEVES MW, 1989, J CLIN MICROBIOL, V27, P313, DOI 10.1128/JCM.27.2.313-320.1989; ROSENBERG SM, 1994, SCIENCE, V265, P405, DOI 10.1126/science.8023163; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sanderson KE, 1998, ELECTROPHORESIS, V19, P569, DOI 10.1002/elps.1150190417; Sherburne CK, 2000, NUCLEIC ACIDS RES, V28, P2177, DOI 10.1093/nar/28.10.2177; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; Tsolis RM, 1999, INFECT IMMUN, V67, P6385; Wain J, 1998, J CLIN MICROBIOL, V36, P1683, DOI 10.1128/JCM.36.6.1683-1687.1998; Wong KK, 1998, INFECT IMMUN, V66, P3365, DOI 10.1128/IAI.66.7.3365-3371.1998; Zhang XL, 2000, INFECT IMMUN, V68, P3067, DOI 10.1128/IAI.68.6.3067-3073.2000	30	932	2322	6	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2001	413	6858					848	852		10.1038/35101607	http://dx.doi.org/10.1038/35101607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677608	Bronze			2022-12-28	WOS:000171750200047
J	Brocklebank, D; Wright, J; Cates, C				Brocklebank, D; Wright, J; Cates, C		Natl Hlth Technology Assessment In	Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MULTIDOSE POWDER INHALER; HYDROFLUOROALKANE-134A BECLOMETHASONE DIPROPIONATE; DRY-POWDER; CONVENTIONAL AEROSOL; MU-G; INHALATION; EQUIVALENCE; SPACER	Objective To determine the clinical effectiveness of pressurised metered dose inhalers (with or without spacer) compared with other hand held inhaler devices for the delivery of corticosteroids in stable asthma. Design Systematic review of randomised controlled trials. Data sources Cochrane Airways Group trials database (Medline, Embase, Cochrane controlled clinical trials register, and hand searching of 18 relevant journals), pharmaceutical companies, and bibliographies of included trials. Trials All trials in children or adults with stable asthma that compared a pressurised metered dose inhaler with any other hand held inhaler device delivering the same inhaled corticosteroid. Results 24 randomised controlled trials were included. Significant differences were found for forced expiratory volume in one second, morning peak expiratory flow rate, and use of drugs for additional relief with dry powder inhalers. However, either these were within clinically equivalent limits or the differences were not apparent once baseline characteristics had been taken into account. No significant differences were found between pressurised metered dose inhalers and any other hand held inhaler device for the following outcomes: lung function, symptoms, bronchial hyper-reactivity, systemic bioavailability, and use of additional relief bronchodilators. Conclusions No evidence was found that alternative inhaler devices (dry powder inhalers, breath actuated pressurised metered dose inhalers, or hydrofluoroalkane pressurised metered dose inhalers) are more effective than the pressurised metered dose inhalers for delivery of inhaled corticosteroids. Pressurised metered dose inhalers remain the most cost effective first line delivery devices.	Bradford Royal Infirm, Bradford Hosp NHS Trust, Bradford BD9 6RJ, W Yorkshire, England; Manor View Practice, Bushey Hlth Ctr, Bushey WD2 2NN, Herts, England	Bradford Royal Infirmary	Wright, J (corresponding author), Bradford Royal Infirm, Bradford Hosp NHS Trust, Bradford BD9 6RJ, W Yorkshire, England.	john.wright@bradfordhospitals.nhs.uk	Wright, John/H-1624-2012	Wright, John/0000-0001-9572-7293; Cates, Christopher/0000-0002-7056-9433				ADLER LM, 1997, THORAX S6, V52, pA57; AGERTOFT L, 1993, ARCH DIS CHILD, V69, P130, DOI 10.1136/adc.69.1.130; *BRIT THOR SOC NAT, 1997, THORAX S1, V52, pS11; CARMICHAEL J, 1978, BRIT MED J, V2, P657, DOI 10.1136/bmj.2.6138.657; CHATTERJEE SS, 1980, BRIT J DIS CHEST, V74, P175, DOI 10.1016/0007-0971(80)90030-3; Clarke M, 2000, REV MANAGER REVMAN C; Dahl R, 1997, BRIT J CLIN PRACT, V51, P11; Davies RJ, 1998, RESP MED, V92, P23, DOI 10.1016/S0954-6111(98)90214-1; Demedts M, 1999, INT J CLIN PRACT, V53, P331; DREPAUL BA, 1989, CLIN TRIALS J, V26, P335; EDMUNDS AT, 1979, ARCH DIS CHILD, V54, P233, DOI 10.1136/adc.54.3.233; ENGEL T, 1989, ALLERGY, V44, P220, DOI 10.1111/j.1398-9995.1989.tb02266.x; Gross G, 1999, CHEST, V115, P343, DOI 10.1378/chest.115.2.343; Guyatt GH, 1998, BRIT MED J, V316, P690, DOI 10.1136/bmj.316.7132.690; JENKINS M, 1995, J AEROSOL MED, V8, pS41; Koskela T, 2000, RESPIRATION, V67, P194, DOI 10.1159/000029486; LAL S, 1980, CLIN ALLERGY, V10, P259, DOI 10.1111/j.1365-2222.1980.tb02105.x; LUNDBACK B, 1993, RESP MED, V87, P609, DOI 10.1016/S0954-6111(05)80264-1; LUNDBACK B, 1994, EUR J CLIN RES, V5, P11; Nieminen MM, 1998, RESPIRATION, V65, P275, DOI 10.1159/000029276; NIEMINEN MM, 1995, ACTA THERAP, V21, P179; Poukkula A, 1998, CLIN DRUG INVEST, V16, P101, DOI 10.2165/00044011-199816020-00002; Toogood JH, 1997, J ALLERGY CLIN IMMUN, V99, P186, DOI 10.1016/S0091-6749(97)70094-0; VIDGREN P, 1994, ACTA THERAP, V20, P117; WOODMAN K, 1993, CURR MED RES OPIN, V13, P61, DOI 10.1185/03007999309111534; 2000, DRUG THER B, V38, P5	26	50	53	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2001	323	7318					896	900		10.1136/bmj.323.7318.896	http://dx.doi.org/10.1136/bmj.323.7318.896			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486BH	11668133	Bronze, Green Published			2022-12-28	WOS:000171798200017
J	Jurgensen, JS; Nibbe, L; Hoffmann, KT; Niehaus, L				Jurgensen, JS; Nibbe, L; Hoffmann, KT; Niehaus, L			Postpartum blindness	LANCET			English	Editorial Material							ECLAMPSIA; PREECLAMPSIA		Humboldt Univ, Dept Nephrol & Med Intens Care, Berlin, Germany; Humboldt Univ, Virchow Klinikum, Dept Radiol, Berlin, Germany; Humboldt Univ, Virchow Klinikum, Dept Neurol, Berlin, Germany; Humboldt Univ, Charite, Berlin, Germany	Humboldt University of Berlin; Humboldt University of Berlin; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Jurgensen, JS (corresponding author), Humboldt Univ, Dept Nephrol & Med Intens Care, Campus Virchow Klinikum, Berlin, Germany.			Hoffmann, Karl-Titus/0000-0001-7693-887X				CUNNINGHAM FG, 1995, AM J OBSTET GYNECOL, V172, P1291, DOI 10.1016/0002-9378(95)91495-1; Mattar F, 2000, AM J OBSTET GYNECOL, V182, P307, DOI 10.1016/S0002-9378(00)70216-X; Schaefer PW, 1997, STROKE, V28, P1082, DOI 10.1161/01.STR.28.5.1082; Schwartz RB, 2000, RADIOLOGY, V217, P371, DOI 10.1148/radiology.217.2.r00nv44371; Tompkins MJ, 1999, AM J OBSTET GYNECOL, V181, P304, DOI 10.1016/S0002-9378(99)70552-1	5	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 20	2001	358	9290					1338	1338		10.1016/S0140-6736(01)06416-9	http://dx.doi.org/10.1016/S0140-6736(01)06416-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684216				2022-12-28	WOS:000171702500015
J	Henson, SM; Costantino, RF; Cushing, JM; Desharnais, RA; Dennis, B; King, AA				Henson, SM; Costantino, RF; Cushing, JM; Desharnais, RA; Dennis, B; King, AA			Lattice effects observed in chaotic dynamics of experimental populations	SCIENCE			English	Article							INSECT POPULATION; CYCLES; MODELS; TRANSITIONS; COMPLEXITY; HABITATS	Animals and many plants are counted in discrete units. The collection of possible values (state space) of population numbers is thus a nonnegative integer lattice. Despite this fact, many mathematical population models assume a continuum of system states. The complex dynamics, such as chaos, often displayed by such continuous-state models have stimulated much ecological research; yet discrete-state models with bounded population size can display only cyclic behavior. Motivated by data from a population experiment, we compared the predictions of discrete-state and continuous-state population models. Neither the discrete- nor continuous-state models completely account for the data. Rather, the observed dynamics are explained by a stochastic blending of the chaotic dynamics predicted by the continuous-state model and the cyclic dynamics predicted by the discrete-state models. We suggest that such lattice effects could be an important component of natural population fluctuations.	Andrews Univ, Dept Math, Berrien Springs, MI 49104 USA; Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; Univ Arizona, Dept Math, Interdisciplinary Program Appl Math, Tucson, AZ 85721 USA; Calif State Univ Los Angeles, Dept Biol & Microbiol, Los Angeles, CA 90032 USA; Univ Idaho, Dept Fish & Wildlife Resources, Moscow, ID 83844 USA; Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	Andrews University; University of Rhode Island; University of Arizona; California State University System; California State University Los Angeles; Idaho; University of Idaho; University of California System; University of California Davis	Henson, SM (corresponding author), Andrews Univ, Dept Math, Berrien Springs, MI 49104 USA.	henson@andrews.edu	King, Aaron A/B-8092-2012	King, Aaron A/0000-0001-6159-3207; Cushing, Jim/0000-0003-1844-661X; Desharnais, Robert/0000-0003-2874-6835				BEDDINGTON JR, 1975, NATURE, V255, P58, DOI 10.1038/255058a0; Briggs CJ, 2000, J ANIM ECOL, V69, P352, DOI 10.1046/j.1365-2656.2000.00398.x; Chapman RN, 1928, ECOLOGY, V9, P111, DOI 10.2307/1929348; Costantino R. F., 1991, POPULATION DYNAMICS; COSTANTINO RF, 1995, NATURE, V375, P227, DOI 10.1038/375227a0; Costantino RF, 1997, SCIENCE, V275, P389, DOI 10.1126/science.275.5298.389; Costantino RF, 1998, B MATH BIOL, V60, P247, DOI 10.1006/bulm.1997.0017; CROMBIE AC, 1946, PROC R SOC SER B-BIO, V133, P76, DOI 10.1098/rspb.1946.0004; Cushing JM, 2001, CHAOS SOLITON FRACT, V12, P219, DOI 10.1016/S0960-0779(00)00109-0; Cushing JM, 1996, ECOL MODEL, V92, P111, DOI 10.1016/0304-3800(95)00170-0; Cushing JM, 1998, J ANIM ECOL, V67, P298, DOI 10.1046/j.1365-2656.1998.00194.x; Dennis B, 2001, ECOL MONOGR, V71, P277, DOI 10.1890/0012-9615(2001)071[0277:ECACDI]2.0.CO;2; Dennis B, 1997, J ANIM ECOL, V66, P704, DOI 10.2307/5923; DENNIS B, 1995, ECOL MONOGR, V65, P261, DOI 10.2307/2937060; Desharnais RA, 1997, SCIENCE, V276, P1881; Desharnais RA, 2001, ECOL LETT, V4, P229, DOI 10.1046/j.1461-0248.2001.00223.x; Hassell MP, 2000, J ANIM ECOL, V69, P543, DOI 10.1046/j.1365-2656.2000.00445.x; HASTINGS A, 1993, ANN REV ECOL SYST, V24; Henson SM, 1998, P ROY SOC B-BIOL SCI, V265, P2229, DOI 10.1098/rspb.1998.0564; Henson SM, 1999, B MATH BIOL, V61, P1121, DOI 10.1006/bulm.1999.0136; JACKSON EA, 1989, PERSPECTIVES NONLINE, V1, P216; May R.M., 1974, STABILITY COMPLEXITY; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; MAY RM, 1976, AM NAT, V110, P573, DOI 10.1086/283092; MORAN PAP, 1950, BIOMETRICS, V6, P250, DOI 10.2307/3001822; Nicholson A. J., 1935, P ZOOL SOC LOND, V105, P551, DOI DOI 10.1111/J.1096-3642.1935.TB01680.X; Nicholson AJ, 1933, J ANIM ECOL, V2, P132, DOI 10.2307/954; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Wilson HB, 1997, P ROY SOC B-BIOL SCI, V264, P1189, DOI 10.1098/rspb.1997.0164	29	67	70	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					602	605		10.1126/science.1063358	http://dx.doi.org/10.1126/science.1063358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641500	Green Submitted			2022-12-28	WOS:000171695600049
J	Lenski, RE				Lenski, RE			Genetics and evolution - Come fly, and leave the baggage behind	SCIENCE			English	Editorial Material							DELETERIOUS MUTATIONS; SEX; RECOMBINATION		Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA	Michigan State University	Lenski, RE (corresponding author), Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA.	lenski@msu.edu		Lenski, Richard/0000-0002-1064-8375				de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Lenski RE, 1999, J EVOLUTION BIOL, V12, P1034; MALMBERG RL, 1977, GENETICS, V86, P607; MAYNARD SMITH J., 1978, EVOLUTION SEX; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Otto SP, 1998, TRENDS ECOL EVOL, V13, P145, DOI 10.1016/S0169-5347(97)01260-3; PECK JR, 1994, GENETICS, V137, P597; Rice WR, 2001, SCIENCE, V294, P555, DOI 10.1126/science.1061380; Weismann A., 1887, NATURE, V36, P607; West SA, 1999, J EVOLUTION BIOL, V12, P1003	11	9	10	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					533	534		10.1126/science.1066241	http://dx.doi.org/10.1126/science.1066241			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641486				2022-12-28	WOS:000171695600031
J	Pattison, S				Pattison, S			Dealing with uncertainty	BRITISH MEDICAL JOURNAL			English	Editorial Material									Cardiff Univ, Dept Reigious & Theol Studies, Cardiff CF10 3EU, S Glam, Wales	Cardiff University	Pattison, S (corresponding author), Cardiff Univ, Dept Reigious & Theol Studies, Cardiff CF10 3EU, S Glam, Wales.							OAKLEY J, 1992, MORALITY EMOTIONS; Smith M., 1991, COMPANION ETHICS	2	4	4	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 13	2001	323	7317					840	840						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483RW	11683153				2022-12-28	WOS:000171650500028
J	Griffith, N				Griffith, N			Spawn of Satan? Widespread egg donation has led to a generation of superkids.	NATURE			English	Editorial Material																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	1999	402	6762					585	585		10.1038/45089	http://dx.doi.org/10.1038/45089			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264PC	11645188	Bronze			2022-12-28	WOS:000084189800031
J	Flanagin, A				Flanagin, A			Who wrote the declaration of Helsinki?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article																		1964, JAMA-J AM MED ASSOC, V189, P33	1	3	3	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	1997	277	11					926	926		10.1001/jama.277.11.926	http://dx.doi.org/10.1001/jama.277.11.926			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WM774	11644908				2022-12-28	WOS:A1997WM77400040
J	Modugno, G; Ferrari, G; Roati, G; Brecha, RJ; Simoni, A; Inguscio, M				Modugno, G; Ferrari, G; Roati, G; Brecha, RJ; Simoni, A; Inguscio, M			Bose-Einstein condensation of potassium atoms by sympathetic cooling	SCIENCE			English	Article							SCATTERING; RESONANCE; MOLECULES; ISOTOPES; GAS	We report on the Bose-Einstein condensation of potassium atoms, whereby quantum degeneracy is achieved by sympathetic cooling with evaporativety cooled rubidium. Because of the rapid thermalization of the two different atoms, the efficiency of the cooling process is high. The ability to achieve condensation by sympathetic cooling with a different species may provide a route to the production of degenerate systems with a larger choice of components.	Univ Florence, LENS, I-50125 Florence, Italy; Ist Nazl Fis Mat, I-50125 Florence, Italy; Univ Trent, Dipartimento Fis, I-38100 Trento, Italy; Univ Florence, Dipartimento Fis, I-50121 Florence, Italy	University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Trento; University of Florence	Modugno, G (corresponding author), Univ Florence, LENS, Largo Enrico Fermi 2, I-50125 Florence, Italy.		Ferrari, Gabriele/E-3755-2010; Ferrari, Gabriele/AAK-3657-2020; simoni, andrea/C-1410-2011; Modugno, Giovanni/AAT-9718-2021; Modugno, Giovanni/C-3179-2009; roati, giacomo/C-5459-2009	Ferrari, Gabriele/0000-0003-1827-5048; Ferrari, Gabriele/0000-0003-1827-5048; Modugno, Giovanni/0000-0002-4394-8593; Modugno, Giovanni/0000-0002-4394-8593; Inguscio, Massimo/0000-0001-8152-8103				ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Barrett MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.010404; Bethlem HL, 2000, NATURE, V406, P491, DOI 10.1038/35020030; Bloch I, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.021402; BRADLEY CC, 1995, PHYS REV LETT, V75, P1687, DOI 10.1103/PhysRevLett.75.1687; Cataliotti FS, 1998, PHYS REV A, V57, P1136, DOI 10.1103/PhysRevA.57.1136; Cornish SL, 2000, PHYS REV LETT, V85, P1795, DOI 10.1103/PhysRevLett.85.1795; Dalfovo F, 1999, REV MOD PHYS, V71, P463, DOI 10.1103/RevModPhys.71.463; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; Delannoy G, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.051602; DeMarco B, 1999, SCIENCE, V285, P1703, DOI 10.1126/science.285.5434.1703; Esslinger T, 1998, PHYS REV A, V58, pR2664, DOI 10.1103/PhysRevA.58.R2664; Ferrari G, 1999, OPT LETT, V24, P151, DOI 10.1364/OL.24.000151; Fioretti A, 1998, PHYS REV LETT, V80, P4402, DOI 10.1103/PhysRevLett.80.4402; Fried DG, 1998, PHYS REV LETT, V81, P3811, DOI 10.1103/PhysRevLett.81.3811; HINDS EA, 1993, TIME A RICH MEMORIAL; Inguscio M, 1999, P INT SCH PHYS ENR F; Kokkelmans SJJMF, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.031601; MONROE CR, 1993, PHYS REV LETT, V70, P414, DOI 10.1103/PhysRevLett.70.414; Myatt CJ, 1997, PHYS REV LETT, V78, P586, DOI 10.1103/PhysRevLett.78.586; Oates CW, 2000, OPT LETT, V25, P1603, DOI 10.1364/OL.25.001603; Prevedelli M, 1999, PHYS REV A, V59, P886, DOI 10.1103/PhysRevA.59.886; Robert A, 2001, SCIENCE, V292, P461, DOI 10.1126/science.1060622; Schreck F, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.080403; Schreck F, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.011402; Truscott AG, 2001, SCIENCE, V291, P2570, DOI 10.1126/science.1059318; Wang H, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.052704; WINELAND DJ, 1978, PHYS REV LETT, V40, P1639, DOI 10.1103/PhysRevLett.40.1639	28	324	334	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2001	294	5545					1320	1322		10.1126/science.1066687	http://dx.doi.org/10.1126/science.1066687			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11641466				2022-12-28	WOS:000172130200042
J	Barnes, PM; Price, L; Maddocks, A; Lyons, RA; Nash, P; McCabe, M				Barnes, PM; Price, L; Maddocks, A; Lyons, RA; Nash, P; McCabe, M			Unnecessary school absence after minor injury: case-control study	BRITISH MEDICAL JOURNAL			English	Article									Swansea NHS Trust, Cent Clin, Dept Community Child Hlth, Swansea SA1 1LT, W Glam, Wales; Iechyd Morgannwg Hlth Author, Dept Publ Hlth, Swansea SA1 1LT, W Glam, Wales; Neath Gen Hosp, Local Accid Ctr, Neath SA11 2LQ, Wales; Morriston Hosp, Swansea NHS Trust, Dept Accid & Emergency, Swansea SA6 6NL, W Glam, Wales	Morriston Hospital	Maddocks, A (corresponding author), Swansea NHS Trust, Cent Clin, Dept Community Child Hlth, Swansea SA1 1LT, W Glam, Wales.		Lyons, Ronan/G-7741-2012	Lyons, Ronan/0000-0001-5225-000X				KLERMAN LV, 1988, PEDIATR CLIN N AM, V35, P1253; Lyons R A, 1995, Inj Prev, V1, P173, DOI 10.1136/ip.1.3.173; TOWNSEND P, 1998, HLTH DEPRIVATION INE	3	21	21	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 3	2001	323	7320					1034	1035		10.1136/bmj.323.7320.1034	http://dx.doi.org/10.1136/bmj.323.7320.1034			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MP	11691761	Bronze, Green Published			2022-12-28	WOS:000172055900017
J	Carlsson, A				Carlsson, A			Neuroscience - A paradigm shift in brain research	SCIENCE			English	Review							CATECHOL AMINES; NMDA ANTAGONIST; RESERPINE; SCHIZOPHRENIA; PERSPECTIVES; HYPOTHESIS; PRECLAMOL; TYROSINE; RELEASE; M100907	As late as the 1950s, it was assumed that communication between nerve cells in the brain occurred predominantly, if not entirely, by electrical impulses. A decade later, the theory of chemical transmission, which until then had been thought to occur only In the peripheral nervous system, had gained strong entrance for the central nervous system. This paradigm shift opened up an enormous new perspective in brain research, not least by facilitating the study of brain function by means of chemical tools, which in different ways could modify the chemical signaling between nerve cells. Moreover, such toots sometimes turned out to be useful as therapeutic agents. Thus for the first time, a variety of disorders in the central nervous system could be treated effectively.	Univ Gothenburg, Dept Pharmacol, Gothenburg, Sweden	University of Gothenburg	Carlsson, A (corresponding author), Univ Gothenburg, Dept Pharmacol, Gothenburg, Sweden.	arvid.carlsson@pharm.gu.se	soler, martha maricel m gomez/L-6025-2014	soler, martha maricel m gomez/0000-0002-4412-8108				BERNTSSON PB, 1972, Patent No. 781105; BERTLER A, 1961, ACTA PHYSIOL SCAND, V51, P75, DOI 10.1111/j.1748-1716.1961.tb02115.x; BERTLER A, 1956, NATURWISSENSCHAFTEN, V43, P521, DOI 10.1007/BF00596980; Bunney Blynn Garland, 1995, P1205; Carlsson A, 1997, LIFE SCI, V61, P75, DOI 10.1016/S0024-3205(97)00228-2; CARLSSON A, 1988, NEUROPSYCHOPHARMACOL, V1, P179, DOI 10.1016/0893-133X(88)90012-7; CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140; Carlsson A, 1999, BRIT J PSYCHIAT, V174, P2, DOI 10.1192/S0007125000293574; CARLSSON A, 1959, PHARMACOL REV, V11, P490; Carlsson A, 1968, J Pharm Pharmacol, V20, P150; CARLSSON A, 1958, SCIENCE, V127, P471, DOI 10.1126/science.127.3296.471; CARLSSON A, 1987, ANNU REV NEUROSCI, V10, P19; CARLSSON A, 1957, NATURE, V180, P1200, DOI 10.1038/1801200a0; Carlsson A., 1995, P379; CARLSSON A, 1957, J PHARMACOL EXP THER, V120, P334; CARLSSON A, 1960, Psychiatr Neurol (Basel), V140, P220; CARLSSON A, 1969, J PHARM PHARMACOL, V21, P460, DOI 10.1111/j.2042-7158.1969.tb08287.x; CARLSSON A, 1972, N-S ARCH PHARMACOL, V275, P153, DOI 10.1007/BF00508904; CARLSSON A, 1969, EUR J PHARMACOL, V5, P357, DOI 10.1016/0014-2999(69)90113-7; Carlsson A., 1960, CIBA F S ADRENERGIC, P432; Carlsson A., 1966, MECHANISMS RELEASE B, P331; Carlsson A., 1998, HIST NEUROSCIENCE AU, V2, P28; CARLSSON A, 1956, KUNGL FYSIOGR SALLSK, V26, P1; Carlsson A, 1957, PSYCHOTROPIC DRUGS, P363; CARLSSON A, 1975, CHEM TOOLS CATECHOLA, V106, P219; Carlsson A, 1962, ACTA PHYSIOL SCAND S, V56, P1; CARLSSON A, 1975, CHEMICAL TOOLS CATEC, V2, P219; CARLSSON A, 1963, ACTA PHYSIOL SCAND S, V59, P215; CARLSSON M, 1990, TRENDS NEUROSCI, V13, P272, DOI 10.1016/0166-2236(90)90108-M; CARLSSON M, 1989, J NEURAL TRANSM, V75, P221, DOI 10.1007/BF01258633; Carlsson ML, 1999, J NEURAL TRANSM, V106, P123, DOI 10.1007/s007020050144; CLARK D, 1985, J NEURAL TRANSM, V62, P171, DOI 10.1007/BF01252236; CLARK D, 1984, EUR J PHARMACOL, V106, P185, DOI 10.1016/0014-2999(84)90694-0; Dahlstrom A, 1986, DISCOVERIES PHARM, V3, P97; KEHR W, 1972, J PHARM PHARMACOL, V24, P744, DOI 10.1111/j.2042-7158.1972.tb09104.x; Kern RS, 2001, SCHIZOPHR RES, V49, P234; Lahti AC, 1998, BIOL PSYCHIAT, V43, P2, DOI 10.1016/S0006-3223(97)00030-9; Martin P, 1998, J NEURAL TRANSM, V105, P365, DOI 10.1007/s007020050064; Potkin SG, 2001, SCHIZOPHR RES, V49, P242; SEIDEN LS, 1964, PSYCHOPHARMACOLOGIA, V5, P178, DOI 10.1007/BF00413240; SONESSON C, 1993, J MED CHEM, V36, P3188, DOI 10.1021/jm00073a021; SVENSSON A, 1995, J NEURAL TRANSM-GEN, V101, P127, DOI 10.1007/BF01271551; SVENSSON K, 1986, J NEURAL TRANSM, V65, P1, DOI 10.1007/BF01249608; TAMMINGA CA, 1992, J NEURAL TRANSM-GEN, V88, P165, DOI 10.1007/BF01244730; Tedroff J, 1998, SYNAPSE, V28, P280	45	138	140	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2001	294	5544					1021	1024		10.1126/science.1066969	http://dx.doi.org/10.1126/science.1066969			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691978				2022-12-28	WOS:000172013800034
J	Keeling, MJ; Woolhouse, MEJ; Shaw, DJ; Matthews, L; Chase-Topping, M; Haydon, DT; Cornell, SJ; Kappey, J; Wilesmith, J; Grenfell, BT				Keeling, MJ; Woolhouse, MEJ; Shaw, DJ; Matthews, L; Chase-Topping, M; Haydon, DT; Cornell, SJ; Kappey, J; Wilesmith, J; Grenfell, BT			Dynamics of the 2001 UK foot and mouth epidemic: Stochastic dispersal in a heterogeneous landscape	SCIENCE			English	Article							DISEASE EPIDEMIC; GREAT-BRITAIN; SPREAD; VACCINATION; STRATEGIES; MODELS; RATES; SHEEP; RISK; FMD	Foot-and-mouth is one of the world's most economically important livestock diseases. We developed an individual farm-based stochastic model of the current UK epidemic. The fine grain of the epidemiological data reveals the infection dynamics at an unusually high spatiotemporal resolution. We show that the spatial distribution, size, and species composition of farms all influence the observed pattern and regional variability of outbreaks. The other key dynamical component is long-tailed stochastic dispersal of infection, combining frequent local movements with occasional long jumps. We assess the history and possible duration of the epidemic, the performance of control strategies, and general implications for disease dynamics in space and time.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Edinburgh, Ctr Trop Vet Med, Roslin EH25 9RG, Midlothian, Scotland; Univ Guelph, Dept Zool, Guelph, ON N1G 2W1, Canada; Vet Labs Agcy, Addlestone KT15 3NB, Surrey, England	University of Cambridge; University of Edinburgh; University of Guelph; Veterinary Laboratories Agency	Keeling, MJ (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	matt@zoo.cam.ac.uk	Matthews, Louise/E-2913-2013; Keeling, Matt J/J-9280-2012; Cornell, Stephen J/D-3955-2009	Matthews, Louise/0000-0003-4420-8367; Keeling, Matt J/0000-0003-4639-4765; Shaw, Darren/0000-0003-2016-1541; Haydon, Daniel/0000-0002-1240-1886				ANDERSON R M, 1991; Bartlett M.S., 1956, P 3 BERK S MATH STAT, P81, DOI DOI 10.2307/2342553; Bates TW, 2001, AM J VET RES, V62, P1121, DOI 10.2460/ajvr.2001.62.1121; Bolker BM, 1999, AM NAT, V153, P575, DOI 10.1086/303199; Brownlie J, 2001, VET REC, V148, P358; Cannon RM, 1999, ENVIRON INT, V25, P713, DOI 10.1016/S0160-4120(99)00049-5; Cox SJ, 1999, VACCINE, V17, P1858, DOI 10.1016/S0264-410X(98)00486-1; Donaldson AI, 2001, VET REC, V148, P602, DOI 10.1136/vr.148.19.602; DURRETT R, 1994, PHILOS T ROY SOC B, V343, P329, DOI 10.1098/rstb.1994.0028; Enserink M, 2001, SCIENCE, V292, P410, DOI 10.1126/science.292.5516.410; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Giles J, 2001, NATURE, V410, P727, DOI 10.1038/35071239; Haydon DT, 1997, IMA J MATH APPL MED, V14, P1; Howard SC, 2000, RES VET SCI, V69, P189, DOI 10.1053/rvsc.2000.0415; HUGHJONES ME, 1972, RES VET SCI, V13, P411, DOI 10.1016/S0034-5288(18)33984-5; HUGHJONES ME, 1970, J HYG-CAMB, V68, P253, DOI 10.1017/S0022172400028722; Hutber AM, 2000, TROP ANIM HEALTH PRO, V32, P285, DOI 10.1023/A:1005212922884; Kao RR, 2001, VET REC, V148, P746, DOI 10.1136/vr.148.24.746; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Kitching R. P., 1994, State Veterinary Journal, V4, P7; Mason PW, 2001, AUST VET J, V79, P342, DOI 10.1111/j.1751-0813.2001.tb12009.x; MAY RM, 1988, PHILOS T ROY SOC B, V321, P565, DOI 10.1098/rstb.1988.0108; MOLLISON D, 1977, J ROY STAT SOC B MET, V39, P283; Morris RS, 2001, VET REC, V149, P137, DOI 10.1136/vr.149.5.137; Nielen M, 1996, PREV VET MED, V28, P143, DOI 10.1016/0167-5877(96)01042-2; Renshaw E., 1991, MODELLING BIOL POPUL, DOI 10.1017/CBO9780511624094; Salt J. S., 1997, VET VACCINOLOGY, P641; Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149; Woolhouse MEJ, 1996, EPIDEMIOL INFECT, V116, P363, DOI 10.1017/S0950268800052699	30	649	661	6	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					813	817		10.1126/science.1065973	http://dx.doi.org/10.1126/science.1065973			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679661				2022-12-28	WOS:000171851800036
J	Barbier, M; Attoub, S; Calvez, R; Laffargue, M; Jarry, A; Mareel, M; Altruda, F; Gespach, C; Wu, D; Lu, B; Hirsch, E; Wymann, MP				Barbier, M; Attoub, S; Calvez, R; Laffargue, M; Jarry, A; Mareel, M; Altruda, F; Gespach, C; Wu, D; Lu, B; Hirsch, E; Wymann, MP			Tumour biology - Weakening link to colorectal cancer?	NATURE			English	Article							PI3K-GAMMA; ROLES		Univ Fribourg, Inst Biochem, CH-1700 Fribourg, Switzerland; Hop St Antoine, INSERM, U482, F-75571 Paris 12, France; Hop Hotel Dieu, INSERM, U539, F-44035 Nantes, France; State Univ Ghent, Expt Cancerol Lab, B-9000 Ghent, Belgium; Univ Turin, Dipartimento Genet Biol & Biochim, I-10126 Turin, Italy; Univ Connecticut, Dept Genet & Dev Biol, Farmington, CT 06030 USA; Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA	University of Fribourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Ghent University; University of Turin; University of Connecticut; Harvard University; Boston Children's Hospital; Harvard Medical School	Barbier, M (corresponding author), Univ Fribourg, Inst Biochem, CH-1700 Fribourg, Switzerland.		Laffargue, Muriel/AAE-7849-2021; jarry, anne/O-5964-2015; Attoub, Samir/N-6852-2018; Wymann, Matthias P/C-3227-2008; Hirsch, Emilio/F-4848-2013	Wymann, Matthias P/0000-0003-3349-4281; Hirsch, Emilio/0000-0002-9073-6024; JARRY, Anne/0000-0002-3489-7800; Calvez, Ronan/0000-0001-5762-1244; Laffargue, Muriel/0000-0003-1833-639X				Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Branka JE, 1997, GASTROENTEROLOGY, V112, P1887, DOI 10.1053/gast.1997.v112.pm9178681; Hirsch E, 2000, GENE, V256, P69, DOI 10.1016/S0378-1119(00)00328-0; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Sasaki T, 2000, NATURE, V406, P897, DOI 10.1038/35022585; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Wymann MP, 2000, IMMUNOL TODAY, V21, P260, DOI 10.1016/S0167-5699(00)01649-2	11	43	45	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					796	796		10.1038/35101660	http://dx.doi.org/10.1038/35101660			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677595	Green Submitted, Bronze			2022-12-28	WOS:000171750200034
J	Delbanco, T; Hartman, EE				Delbanco, T; Hartman, EE			A 35-year-old woman experiencing difficulty with breastfeeding, 18 months later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article																		Lawrence RA, 2001, JAMA-J AM MED ASSOC, V285, P73, DOI 10.1001/jama.285.1.73	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2001	286	16					2022	+		10.1001/jama.286.16.2022	http://dx.doi.org/10.1001/jama.286.16.2022			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485JD	11667940				2022-12-28	WOS:000171750500027
J	McCloy, R; Stone, R				McCloy, R; Stone, R			Science, medicine, and the future - Virtual reality in surgery	BRITISH MEDICAL JOURNAL			English	Review							MIST VR; SIMULATOR		Manchester Royal Infirm, Wolfson Ctr Minimally Invas Therapy, Manchester M13 9WL, Lancs, England; Univ Manchester, Clin Res Div 1, Surg Univ, Manchester, Lancs, England; Univ Manchester, Clin Res Div 2, Surg Univ, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	McCloy, R (corresponding author), Manchester Royal Infirm, Wolfson Ctr Minimally Invas Therapy, Oxford Rd, Manchester M13 9WL, Lancs, England.	r.mccloy@man.ac.uk						Appleyard M, 2001, NEW ENGL J MED, V344, P232, DOI 10.1056/NEJM200101183440316; Boff K.R., 1988, ENG DATA COMPENDIUM, V1; Bradbury J, 2000, LANCET, V356, P2074, DOI 10.1016/S0140-6736(05)74292-6; BROOKS FP, 1988, CHI88 C P HUMAN FACT, P1; Chaudhry A, 1999, ANN ROY COLL SURG, V81, P281; Darzi A, 1999, BRIT MED J, V318, P887, DOI 10.1136/bmj.318.7188.887; EMMUS (European MultiMedia Usability Services), 1999, INTR ISO 13407; *EUR COMM, 2001, 5 FRAM PROGR; *INT SURG, 2001, DA VINC SURG SYST; John NW, 2001, ST HEAL T, V81, P212; Kidd MR, 1999, MED J AUSTRALIA, V171, P510, DOI 10.5694/j.1326-5377.1999.tb123778.x; Mao CD, 1999, NATURE, V397, P144, DOI 10.1038/16437; *MICR, 2001, WORLDS SMALL SUBM; *NHS INF AUTH, 2001, WAYS WORK INF; RAY NM, 1990, HUM FACTORS, V32, P477, DOI 10.1177/001872089003200409; SATAVA RM, 1995, ST HEAL T, V18, P334; Stone RJ, 1996, J MED VIRTUAL REALIT, V1, P42; STONE RJ, 1999, SURG COMPETENCE CHAL, P109; *SURG SCI, 2001, SURG SCI CUTT EDG SU; Taffinder N, 1998, ST HEAL T, V50, P124; Taffinder NJ, 1998, LANCET, V352, P1191, DOI 10.1016/S0140-6736(98)00034-8; WESTWOOD JD, 2000, MED MEETS VIRTUAL RE; Wilson MS, 1997, ANN ROY COLL SURG, V79, P403	23	158	163	1	31	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 20	2001	323	7318					912	915		10.1136/bmj.323.7318.912	http://dx.doi.org/10.1136/bmj.323.7318.912			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486BH	11668138	Green Published			2022-12-28	WOS:000171798200024
J	Steffan, JS; Bodai, L; Pallos, J; Poelman, M; McCampbell, A; Apostol, BL; Kazantsev, A; Schmidt, E; Zhu, YZ; Greenwald, M; Kurokawa, R; Housman, DE; Jackson, GR; Marsh, JL; Thompson, LM				Steffan, JS; Bodai, L; Pallos, J; Poelman, M; McCampbell, A; Apostol, BL; Kazantsev, A; Schmidt, E; Zhu, YZ; Greenwald, M; Kurokawa, R; Housman, DE; Jackson, GR; Marsh, JL; Thompson, LM			Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila	NATURE			English	Article							CREB-BINDING PROTEIN; HUNTINGTONS-DISEASE; EXPANDED POLYGLUTAMINE; MAMMALIAN-CELLS; TRANSGENIC MICE; LOCALIZATION; AGGREGATION; EXPRESSION; APOPTOSIS; GROWTH	Proteins with expanded polyglutamine repeats cause Huntington's disease and other neurodegenerative diseases. Transcriptional dysregulation and loss of function of transcriptional coactivator proteins have been implicated in the pathogenesis of these diseases(1). Huntington's disease is caused by expansion of a repeated sequence of the amino acid glutamine in the abnormal protein huntingtin (Htt). Here we show that the polyglutamine-containing domain of Htt, Htt exon 1 protein (Httex1p), directly binds the acetyltransferase domains of two distinct proteins: CREB-binding protein (CBP) and p300/CBP-associated factor (P/CAF). In cell-free assays, Httex1p also inhibits the acetyltransferase activity of at least three enzymes: p300, P/CAF and CBP. Expression of Httex1p in cultured cells reduces the level of the acetylated histones H3 and H4, and this reduction can be reversed by administering inhibitors of histone deacetylase (HDAC). In vivo, HDAC inhibitors arrest ongoing progressive neuronal degeneration induced by polyglutamine repeat expansion, and they reduce lethality in two Drosophila models of polyglutamine disease. These findings raise the possibility that therapy with HDAC inhibitors may slow or prevent the progressive neurodegeneration seen in Huntington's disease and other polyglutamine-repeat diseases, even after the onset of symptoms.	Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; NINCDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; University of California System; University of California Los Angeles	Thompson, LM (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Gillespie 2121, Irvine, CA 92697 USA.		Bodai, Laszlo/A-9764-2012; Pallos, Judit/AAE-6833-2020	Bodai, Laszlo/0000-0001-8411-626X; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002974, ZIANS002974] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AILSIALI S, 1998, NUCLEIC ACIDS RES, V26, P3869; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Franceschini N., 1972, INFORMATION PROCESSI, P75; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Goodman RH, 2000, GENE DEV, V14, P1553; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Neufeld TP, 1998, GENETICS, V148, P277; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Paulson HL, 1999, AM J HUM GENET, V64, P339, DOI 10.1086/302269; REUTER G, 1982, MOL GEN GENET, V188, P480, DOI 10.1007/BF00330052; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Suhr ST, 1998, P NATL ACAD SCI USA, V95, P7999, DOI 10.1073/pnas.95.14.7999; Wanker EE, 2000, BIOL CHEM, V381, P937, DOI 10.1515/BC.2000.114; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	27	944	1002	2	57	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					739	743		10.1038/35099568	http://dx.doi.org/10.1038/35099568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607033	Green Published			2022-12-28	WOS:000171608000045
J	Fagarasan, S; Kinoshita, K; Muramatsu, M; Ikuta, K; Honjo, T				Fagarasan, S; Kinoshita, K; Muramatsu, M; Ikuta, K; Honjo, T			In situ class switching and differentiation to IgA-producing cells in the gut lamina propria	NATURE			English	Article							CYTIDINE DEAMINASE AID; B-CELLS; SURFACE-RECEPTORS; MARGINAL ZONE; PLASMA-CELLS; CD40 LIGAND; FC RECEPTOR; MICE; ACTIVATION; EXPRESSION	One of the front lines of the immune defence is the gut mucosa, where immunoglobulin-alpha (IgA) is continuously produced to react with commensal bacteria and dietary antigens. It is generally accepted that, after antigenic stimulation in the Peyer's patches, IgA(+) lymphoblasts (B220(+)IgA(+)) migrate through the lymph and blood circulation, and eventually home to the lamina propria of the intestine(1,2). Mice that lack activation-induced cytidine deaminase (AID) are defective in class switch recombination (CSR) and somatic hypermutation(3). CSR changes the immunoglobulin heavy chain constant region (CH) gene being expressed from C mu to other CH genes, resulting in a switch of the immunoglobulin isotype from IgM to IgG, IgE or IgA. AID(-/-) mice also secrete large amounts of immunoglobulin-m (IgM) into faeces, and accumulate B220(-)IgM(+) plasma cells as well as B220(+)IgM(+) cells in the gut. Here we show that lamina propria B220(+)IgA(+) cells have just completed CSR, as they still express both AID and transcripts from circular DNA that has been 'looped-out' during CSR. Lamina propria IgM(+) B cells seem to be pre-committed to switching to IgA(+) in vitro as well as in vivo. Culturing lamina propria IgM(+) B cells together with lamina propria stromal cells enhances preferential switching and differentiation of B cells to IgA(+) plasma cells. We conclude that IgA(+) cells in the gut lamina propria are generated in situ from B220(+)IgM(+) lymphocytes.	Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Honjo, Tasuku/N-4470-2016; Muramatsu, Masamichi/C-4339-2015; Fagarasan, Sidonia/A-5258-2016	Muramatsu, Masamichi/0000-0002-0153-3533; Fagarasan, Sidonia/0000-0003-2086-6402; Ikuta, Koichi/0000-0003-1319-1021				COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188; Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477; Fagarasan S, 2000, IMMUNOL REV, V176, P205; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D; Kamata T, 2000, J IMMUNOL, V165, P1387, DOI 10.4049/jimmunol.165.3.1387; KINOSHITA K, IN PRESS P NATL ACAD; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; LEBMAN DA, 1987, J EXP MED, V166, P1405, DOI 10.1084/jem.166.5.1405; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Martin F, 1999, CURR TOP MICROBIOL, V246, P45; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; RAMSAY AJ, 1994, SCIENCE, V264, P561, DOI 10.1126/science.8160012; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Shparago N, 1996, INT IMMUNOL, V8, P781, DOI 10.1093/intimm/8.5.781; SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; TSENG J, 1981, J IMMUNOL, V127, P2039; WALDSCHMIDT TJ, 1988, J IMMUNOL, V140, P2148; WALDSCHMIDT TJ, 1991, INT IMMUNOL, V3, P305, DOI 10.1093/intimm/3.4.305; Watanabe N, 2000, J EXP MED, V192, P1577, DOI 10.1084/jem.192.11.1577; WHITLOCK CA, 1987, CELL, V48, P1009, DOI 10.1016/0092-8674(87)90709-4; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Ye SK, 1999, IMMUNITY, V11, P213, DOI 10.1016/S1074-7613(00)80096-5	31	325	338	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2001	413	6856					639	643		10.1038/35098100	http://dx.doi.org/10.1038/35098100			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675788				2022-12-28	WOS:000171485700051
J	Beecham, L; Dorozynski, A; Sheldon, T; Turone, F; Mach, A; Bosch, X; Charatan, FB; Mahkorn, DT; Siegel-Itzkovich, J				Beecham, L; Dorozynski, A; Sheldon, T; Turone, F; Mach, A; Bosch, X; Charatan, FB; Mahkorn, DT; Siegel-Itzkovich, J			Viagra falls: the debate over rationing continues	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	6	6	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 26	1998	317	7162					836	838						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125DN	11645103				2022-12-28	WOS:000076222300013
J	JACKSON, J				JACKSON, J			AN ETHICAL DEBATE - SHOULD OLDER WOMEN BE OFFERED IN-VITRO FERTILIZATION - CAN OLDER WOMEN COPE WITH MOTHERHOOD	BRITISH MEDICAL JOURNAL			English	Article											JACKSON, J (corresponding author), UNIV LEEDS,DEPT PHILOSOPHY,LEEDS,W YORKSHIRE,ENGLAND.								0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 3	1995	310	6992					1456	1457		10.1136/bmj.310.6992.1456	http://dx.doi.org/10.1136/bmj.310.6992.1456			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RC105	11644709	Green Published			2022-12-28	WOS:A1995RC10500030
J	LEECH, M				LEECH, M			PRISON MEDICINE - A PATIENTS PERSPECTIVE	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	3	3	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 5	1993	306	6891					1550	1550		10.1136/bmj.306.6891.1550	http://dx.doi.org/10.1136/bmj.306.6891.1550			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LF940	11643139	Bronze, Green Published			2022-12-28	WOS:A1993LF94000090
J	McKee, M; Shkolnikov, V				McKee, M; Shkolnikov, V			Understanding the toll of premature death among men in eastern Europe	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; LIFE EXPECTANCY; ADULT MORTALITY; ALCOHOL; RUSSIA; HEALTH; RATES; POPULATION; SMOKING; TRENDS		Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1E 7HT, England; Max Planck Inst Demog Res, D-18057 Rostock, Germany	University of London; London School of Hygiene & Tropical Medicine; Max Planck Society	McKee, M (corresponding author), Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, Keppel St, London WC1E 7HT, England.		Shkolnikov, Vladimir/D-2986-2017; McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	Shkolnikov, Vladimir/0000-0003-2259-5423; McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683				Bobak M, 1997, J EPIDEMIOL COMMUN H, V51, P272, DOI 10.1136/jech.51.3.272; Bobak M, 1998, SOC SCI MED, V47, P269, DOI 10.1016/S0277-9536(98)00095-1; Bobak M, 1996, BRIT MED J, V312, P421; Bobak M, 1999, ADDICTION, V94, P857, DOI 10.1046/j.1360-0443.1999.9468579.x; Bobak M, 1998, EUR J CLIN NUTR, V52, P632, DOI 10.1038/sj.ejcn.1600616; Britton A, 2000, J EPIDEMIOL COMMUN H, V54, P328, DOI 10.1136/jech.54.5.328; Chambers JC, 2001, J ROY SOC MED, V94, P10, DOI 10.1177/014107680109400103; Chenet L, 1997, J EPIDEMIOL COMMUN H, V51, P510, DOI 10.1136/jech.51.5.510; Chenet L, 1998, EUR J POPUL, V14, P19, DOI 10.1023/A:1006012620847; Chenet L, 1998, J EPIDEMIOL COMMUN H, V52, P772, DOI 10.1136/jech.52.12.772; European Centre on Health of Societies in Transition (ECOHOST), 1998, CHILDH INJ PRIOR AR; Evans C, 2000, BRIT MED J, V320, P218, DOI 10.1136/bmj.320.7229.218; FORSTER DP, 1990, LANCET, V335, P458, DOI 10.1016/0140-6736(90)90678-X; Hajdu P., 1995, EUR J PUBLIC HEALTH, V5, P259, DOI [DOI 10.1093/EURPUB/5.4.259, 10.1093/eurpub/5.4.259]; JEDRYCHOWSKI W, 1985, SCAND J SOC MED, V13, P49, DOI 10.1177/140349488501300201; Kitange HM, 1996, BRIT MED J, V312, P216, DOI 10.1136/bmj.312.7025.216; Kristenson M, 1997, BRIT MED J, V314, P629, DOI 10.1136/bmj.314.7081.629; Laks T, 1999, J INTERN MED, V246, P53, DOI 10.1046/j.1365-2796.1999.00505.x; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; LEVIATAN U, 1985, SOC SCI MED, V21, P545, DOI 10.1016/0277-9536(85)90039-5; McKee M, 1998, TOB CONTROL, V7, P22, DOI 10.1136/tc.7.1.22; McKee M, 2000, HEALTH POLICY PLANN, V15, P263, DOI 10.1093/heapol/15.3.263; McKee M, 1998, J ROY SOC MED, V91, P402, DOI 10.1177/014107689809100802; MCKEE M, 2001, POVERTY INEQUALITY H, P17; MCKEE M, IN PRESS HLTH CARE C; Ngongo KN, 1999, HEALTH POLICY, V48, P1, DOI 10.1016/S0168-8510(99)00029-9; Perova Natalia V., 1995, Annals of Epidemiology, V5, P179, DOI 10.1016/1047-2797(94)00104-2; PETO R, 1994, MORTALITY SMOKING; Pomerleau J, 2001, EUR J CLIN NUTR, V55, P200, DOI 10.1038/sj.ejcn.1601146; Rose R., 1995, E EUROPEAN CONSTITUT, V4, P34; SCHMIDT W, 1981, CANCER-AM CANCER SOC, V47, P1031, DOI 10.1002/1097-0142(19810301)47:5<1031::AID-CNCR2820470534>3.0.CO;2-C; SHAKHOV YA, 1993, ARTERIOSCLER THROMB, V13, P1770, DOI 10.1161/01.ATV.13.12.1770; Shkolnikov V, 2001, LANCET, V357, P917, DOI 10.1016/S0140-6736(00)04212-4; Shkolnikov V, 1999, EUR J EPIDEMIOL, V15, P203, DOI 10.1023/A:1007546800982; Shkolnikov VM, 1998, SOC SCI MED, V47, P357, DOI 10.1016/S0277-9536(98)00096-3; Shkolnikov VM, 2000, POLICIES CONTROL TRA; Sibai AM, 2001, J EPIDEMIOL COMMUN H, V55, P271, DOI 10.1136/jech.55.4.271; Stern V., 1999, SENTENCED DIE PROBLE; THUBRON C, 1999, SIBERIA, P29; VANGIJN J, 1993, HLTH ISSUES RELATED, P43; VIKHERT AM, 1986, J AM COLL CARDIOL, V8, pA3, DOI 10.1016/S0735-1097(86)80023-7; Walberg P, 1998, BRIT MED J, V317, P312, DOI 10.1136/bmj.317.7154.312; WALDRON I, 1993, SOC SCI MED, V36, P451, DOI 10.1016/0277-9536(93)90407-U; Walt, 2001, POVERTY INEQUALITY H, P58; WATSON P, 1995, SOC SCI MED, V41, P923, DOI 10.1016/0277-9536(94)00405-I; WATSON P, 1996, E W LIFE EXPECTANCY; *WHO, 2001, HLTH ALL DATABASE; Zatonski WA, 1998, BMJ-BRIT MED J, V316, P1047	48	113	116	1	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 3	2001	323	7320					1051	1055		10.1136/bmj.323.7320.1051	http://dx.doi.org/10.1136/bmj.323.7320.1051			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	490MP	11691766	Green Accepted, Green Published			2022-12-28	WOS:000172055900023
J	Stickgold, R; Hobson, JA; Fosse, R; Fosse, M				Stickgold, R; Hobson, JA; Fosse, R; Fosse, M			Sleep, learning, and dreams: Off-line memory reprocessing	SCIENCE			English	Review							EYE-MOVEMENT SLEEP; LONG-TERM POTENTIATION; LATE NOCTURNAL SLEEP; REM-SLEEP; PARADOXICAL SLEEP; FUNCTIONAL NEUROANATOMY; ADAPTIVE FUNCTION; MENTAL ACTIVITY; POSITIVE PHASE; BRAIN	Converging evidence and new research methodologies from across the neurosciences permit the neuroscientific study of the role of steep in off-line memory reprocessing, as well as the nature and function of dreaming. Evidence supports a rote for sleep in the consolidation of an array of learning and memory tasks. In addition, new methodologies allow the experimental manipulation of dream content at steep onset, permitting an objective and scientific study of this dream formation and a renewed search for the possible functions of dreaming and the biological processes subserving it.	Harvard Univ, Sch Med, Neurophysiol Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; Univ Oslo, Inst Psychol, N-0317 Oslo, Norway	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Oslo	Stickgold, R (corresponding author), Harvard Univ, Sch Med, Neurophysiol Lab, Boston, MA 02115 USA.	rstickgold@hms.harvard.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011744] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 11,744] Funding Source: Medline; NIMH NIH HHS [MH 48,832] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; Baylor GW, 2001, SLEEP, V24, P165; Beversdorf DQ, 1999, NEUROREPORT, V10, P2763, DOI 10.1097/00001756-199909090-00012; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Brandt JA, 2001, BRAIN RES, V898, P105, DOI 10.1016/S0006-8993(01)02149-7; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; CALVO JM, 1984, SLEEP, V7, P202, DOI 10.1093/sleep/7.3.202; CALVO JM, 1999, HDB BEHAV STATE CONT, P391; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cartwright R, 1998, PSYCHIAT RES, V81, P1, DOI 10.1016/S0165-1781(98)00089-4; CARTWRIGHT RD, 1975, PSYCHOPHYSIOLOGY, V12, P561, DOI 10.1111/j.1469-8986.1975.tb00047.x; CARTWRIGHT RD, 1983, ARCH GEN PSYCHIAT, V40, P197; CASTALDO V, 1974, PERCEPT MOTOR SKILL, V39, P1023, DOI 10.2466/pms.1974.39.3.1023; CHROBAK JJ, 1994, J NEUROSCI, V14, P6160; Churchill L, 2001, SLEEP, V24, P261, DOI 10.1093/sleep/24.3.261; CRICK F, 1983, NATURE, V304, P111, DOI 10.1038/304111a0; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Datta S, 2000, J NEUROSCI, V20, P8607, DOI 10.1523/JNEUROSCI.20-22-08607.2000; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; DEKONINCK J, 1989, INT J PSYCHOPHYSIOL, V8, P43, DOI 10.1016/0167-8760(89)90018-4; DINGES DF, 1990, CLEEP COGNITION, P159; EMBERGER KM, 2001, THESIS HARVARD U CAM; Engel AK, 1999, CONSCIOUS COGN, V8, P128, DOI 10.1006/ccog.1999.0389; Falkenstein M, 1995, EEG CL N SU, P287; Fosse MJ, 2001, SLEEP, V24, pA179; FOSSE MJ, 2001, THESIS HARVARD U CAM; Fosse R, 2001, PSYCHOL SCI, V12, P30, DOI 10.1111/1467-9280.00306; FOSSE R, IN PRESS SLEEP; FOULKES D, 1966, J ABNORM PSYCHOL, V71, P280, DOI 10.1037/h0023581; FOULKES DAVID, 1965, J ABNORM PSYCHOL, V70, P231, DOI 10.1037/h0022217; FOULKES WD, 1962, J ABNORM PSYCHOL, V65, P14, DOI 10.1037/h0040431; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Freud S., 1900, INTERPRETATION DREAM; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Gehring WJ, 1995, EEG CL N SU, P261; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; GIUDITTA A, 1995, BEHAV BRAIN RES, V69, P157, DOI 10.1016/0166-4328(95)00012-I; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; Graves L, 2001, TRENDS NEUROSCI, V24, P237, DOI 10.1016/S0166-2236(00)01744-6; GREENBERG R, 1972, BRIT J MED PSYCHOL, V45, P27, DOI 10.1111/j.2044-8341.1972.tb01416.x; GREENBERG R, 1972, PSYCHOSOM MED, V34, P257, DOI 10.1097/00006842-197205000-00007; GRIESER C, 1972, J ABNORM PSYCHOL, V80, P280, DOI 10.1037/h0033641; GUTWEIN BM, 1980, PHARMACOL BIOCHEM BE, V12, P377, DOI 10.1016/0091-3057(80)90040-4; Hartley David, 1791, OBSERVATIONS MAN HIS; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; HENNEVIN E, 1995, BEHAV BRAIN RES, V69, P125, DOI 10.1016/0166-4328(95)00013-J; HINTON GE, 1995, SCIENCE, V268, P1158, DOI 10.1126/science.7761831; Hirase H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-10-j0003.2001; Hobson JA, 1998, CURR OPIN NEUROBIOL, V8, P239, DOI 10.1016/S0959-4388(98)80146-3; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; HOBSON JA, 1994, CONSCIOUS COGN, V3, P1, DOI 10.1006/ccog.1994.1001; HOBSON JA, 1977, AM J PSYCHIAT, V134, P1335; Hobson JA, 2000, BEHAV BRAIN SCI, V23, P793, DOI 10.1017/S0140525X00003976; Hobson JA, 1998, NEUROREPORT, V9, pR1, DOI 10.1097/00001756-199802160-00033; HOBSON JA, 1990, SLEEP AND COGNITION, P25, DOI 10.1037/10499-002; HOBSON JA, 1995, CURR BIOL, V5, P35, DOI 10.1016/S0960-9822(95)00011-X; Holscher C, 1997, J NEUROSCI, V17, P6470; HORNE JA, 1984, BIOL PSYCHOL, V18, P165, DOI 10.1016/0301-0511(84)90001-2; Horne JA, 2000, NEUROSCI BIOBEHAV R, V24, P777, DOI 10.1016/S0149-7634(00)00037-3; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Jouvet Michel, 1999, PARADOX SLEEP STORY; KAMETANI H, 1990, LIFE SCI, V47, P421, DOI 10.1016/0024-3205(90)90300-G; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; KUPFER DJ, 1972, LANCET, V2, P684; LAUER C, 1987, PSYCHOPHYSIOLOGY, V24, P263, DOI 10.1111/j.1469-8986.1987.tb00293.x; Lewin I, 1973, SLEEP PHYSL BIOCH PS, P399, DOI DOI 10.1159/000428097; LLINAS R, 1993, P NATL ACAD SCI USA, V90, P2078, DOI 10.1073/pnas.90.5.2078; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; LUBIN A, 1976, PSYCHOPHYSIOLOGY, V13, P334, DOI 10.1111/j.1469-8986.1976.tb03086.x; Mamelak A N, 1989, J Cogn Neurosci, V1, P201, DOI 10.1162/jocn.1989.1.3.201; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Maquet P, 1996, NATURE, V383, P163, DOI 10.1038/383163a0; Maquet P, 1997, J NEUROSCI, V17, P2807; MCGRATH MJ, 1978, PSYCHOL BULL, V85, P24, DOI 10.1037/0033-2909.85.1.24; Morrison AR, 1999, RAPID EYE MOVEMENT SLEEP, P51; Nofzinger E. A., 1996, Society for Neuroscience Abstracts, V22, P27; Nofzinger EA, 1997, BRAIN RES, V770, P192, DOI 10.1016/S0006-8993(97)00807-X; Oksenberg A, 1996, DEV BRAIN RES, V97, P51, DOI 10.1016/S0165-3806(96)00131-9; Otto T, 1991, Hippocampus, V1, P181, DOI 10.1002/hipo.450010206; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; Plihal W, 1999, PSYCHONEUROENDOCRINO, V24, P313, DOI 10.1016/S0306-4530(98)00080-8; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; RECHTSCHAFFEN A, 1963, Can Psychiatr Assoc J, V8, P409; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Revonsuo A, 2000, BEHAV BRAIN SCI, V23, P877, DOI 10.1017/S0140525X00004015; REYNOLDS CF, 1993, BIOL PSYCHIAT, V34, P791, DOI 10.1016/0006-3223(93)90068-O; Ribeiro S, 1999, LEARN MEMORY, V6, P500, DOI 10.1101/lm.6.5.500; ROSS RJ, 1989, AM J PSYCHIAT, V146, P697; Rowley JT, 1998, CONSCIOUS COGN, V7, P67, DOI 10.1006/ccog.1998.0333; Schacter D. L., 1994, MEMORY SYSTEMS 1994; Shaffery JP, 1999, DEV BRAIN RES, V114, P109, DOI 10.1016/S0165-3806(99)00027-9; Siegel JM, 2001, SCIENCE, V294, P1058, DOI 10.1126/science.1063049; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; Smith C, 1996, BEHAV BRAIN RES, V78, P49, DOI 10.1016/0166-4328(95)00218-9; SMITH C, 1993, PSYCHOBIOLOGY, V21, P109; SMITH C, 1982, PHYSIOL BEHAV, V29, P469, DOI 10.1016/0031-9384(82)90268-2; SMITH C, 1985, NEUROSCI BIOBEHAV R, V9, P157, DOI 10.1016/0149-7634(85)90042-9; Smith C., 1987, SLEEP RES, V16, P211; SMITH C, 1987, SLEEP RES, V16, P536; Smith Carlyle, 1996, Physiology and Behavior, V59, P93, DOI 10.1016/0031-9384(95)02054-3; Smith CT, 1998, NEUROBIOL LEARN MEM, V69, P211, DOI 10.1006/nlme.1997.3809; Smith CT, 1993, FUNCTIONS DREAMING, P341; Solms M, 2000, BEHAV BRAIN SCI, V23, P843, DOI 10.1017/S0140525X00003988; Solms M., 1997, NEUROPSYCHOLOGY DREA; Stensvag K, 1999, J FISH DIS, V22, P337, DOI 10.1046/j.1365-2761.1999.00174.x; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2000, SCIENCE, V290, P350, DOI 10.1126/science.290.5490.350; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Stickgold R, 1999, J COGNITIVE NEUROSCI, V11, P182, DOI 10.1162/089892999563319; Stickgold R, 1998, TRENDS COGN SCI, V2, P484, DOI 10.1016/S1364-6613(98)01258-3; STICKGOLD R, IN PRESS SOC NEUR AB; Strauch Inge, 1996, SEARCH DREAMS RESULT; Tononi G, 2001, ARCH ITAL BIOL, V139, P221; Vertes RP, 2000, BEHAV BRAIN SCI, V23, P867, DOI 10.1017/S0140525X00004003; Vyazovskiy V, 2000, J SLEEP RES, V9, P367, DOI 10.1046/j.1365-2869.2000.00230.x; Wagner U, 2001, LEARN MEMORY, V8, P112, DOI 10.1101/lm.36801; Walker M. K., UNPUB; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WINOCUR G, 1990, BEHAV BRAIN RES, V38, P145, DOI 10.1016/0166-4328(90)90012-4	128	519	535	2	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2001	294	5544					1052	1057		10.1126/science.1063530	http://dx.doi.org/10.1126/science.1063530			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	489VU	11691983				2022-12-28	WOS:000172013800039
J	Bynum, WF				Bynum, WF			Nature's helping hand	NATURE			English	Editorial Material									UCL, Wellcome Trust Ctr Hist Med, London NW1 1AD, England	University of London; University College London	Bynum, WF (corresponding author), UCL, Wellcome Trust Ctr Hist Med, 24 Eversholt St, London NW1 1AD, England.							NESSE RM, 1995, EVOLUTION HEALING; Neuburger Max, 1932, DOCTRINE HEALING POW; Warner J.H., 1986, THERAPEUTIC PERSPECT	3	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					21	21		10.1038/35102123	http://dx.doi.org/10.1038/35102123			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689921	Bronze			2022-12-28	WOS:000171898900022
J	Zhou, YF; Morais-Cabral, JH; Kaufman, A; MacKinnon, R				Zhou, YF; Morais-Cabral, JH; Kaufman, A; MacKinnon, R			Chemistry of ion coordination and hydration revealed by a K+ channel-Fab complex at 2.0 angstrom resolution	NATURE			English	Article							POTASSIUM CHANNEL; CONDUCTION; PORE	Ion transport proteins must remove an ion's hydration shell to coordinate the ion selectively on the basis of its size and charge. To discover how the K+ channel solves this fundamental aspect of ion conduction, we solved the structure of the KcsA K+ channel in complex with a monoclonal Fab antibody fragment at 2.0 Angstrom resolution. Here we show how the K+ channel displaces water molecules around an ion at its extracellular entryway, and how it holds a K+ ion in a square antiprism of water molecules in a cavity near its intracellular entryway. Carbonyl oxygen atoms within the selectivity filter form a very similar square antiprism around each K+ binding site, as if to mimic the waters of hydration. The selectivity filter changes its ion coordination structure in low K+ solutions. This structural change is crucial to the operation of the selectivity filter in the cellular context, where the K+ ion concentration near the selectivity filter varies in response to channel gating.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockvax.rockefeller.edu	Morais-Cabral, Joao H/J-4914-2013	Morais-Cabral, Joao H/0000-0002-4461-9716				ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRADEN BC, 1994, J MOL BIOL, V243, P767, DOI 10.1016/0022-2836(94)90046-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clare Speakman J., 1972, STRUCTURE BONDING, P141; DEMO SD, 1992, BIOPHYS J, V61, P639, DOI 10.1016/S0006-3495(92)81869-6; DOBLER M, 1969, HELV CHIM ACTA, V52, P2573, DOI 10.1002/hlca.19690520840; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DUNITZ JD, 1977, BIOL ASPECTS INORGAN, P113; Harlow E., 1989, ANTIBODIES LAB MANUA; Hille B., 1992, IONIC CHANNELS EXCIT; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; Jencks W. P., 1987, CATALYSIS CHEM ENZYM; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080; MILLER C, 1987, J GEN PHYSIOL, V90, P427, DOI 10.1085/jgp.90.3.427; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NEUPERTLAVES K, 1975, HELV CHIM ACTA, V58, P432, DOI 10.1002/hlca.19750580212; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; OSTERMEIER C, 1995, NAT STRUCT BIOL, V2, P842, DOI 10.1038/nsb1095-842; OTTING G, 1991, SCIENCE, V254, P974, DOI 10.1126/science.1948083; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; Zheng J, 1998, J GEN PHYSIOL, V112, P457, DOI 10.1085/jgp.112.4.457	30	1624	1660	10	243	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					43	48		10.1038/35102009	http://dx.doi.org/10.1038/35102009			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689936				2022-12-28	WOS:000171898900035
J	Clayton, D; McKeigue, PM				Clayton, D; McKeigue, PM			Epidemiological methods for studying genes and environmental factors in complex diseases	LANCET			English	Review							METHYLENETETRAHYDROFOLATE REDUCTASE; RISK; POPULATIONS; DIET	Exploration of the human genome presents new challenges and opportunities for epidemiological research. Although the case-control design is quicker and cheaper for study of associations between genotype and risk of disease than the cohort design, cohort studies have been recommended because they can be used to study gene-environment interactions. Although the scientific relevance of statistical Interaction Is pertinent, the main disadvantage of the case-control design-susceptibility to bias when estimating effects of exposures that are measured retrospectively-does not necessarily apply when studying statistical interaction between genotype and environmental exposure. Because correctly designed genetic association studies are equivalent to randomised comparisons between genotypes, conclusions about cause can be drawn from genetic associations even when the risk ratio is modest. For adequate statistical power to detect such modest risk ratios, the case-control design is more feasible than the cohort design.	Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 2QQ, England; London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; London School of Hygiene & Tropical Medicine	Clayton, D (corresponding author), Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Hills Rd, Cambridge CB2 2QQ, England.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060343] Funding Source: NIH RePORTER; NIMH NIH HHS [MH60343] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bailey LB, 1999, J NUTR, V129, P919, DOI 10.1093/jn/129.5.919; Cordell HJ, 2001, GENETICS, V158, P357; COX DR, 1984, INT STAT REV, V52, P1, DOI 10.2307/1403235; GIOVANNUCCI E, 1993, AM J EPIDEMIOL, V137, P502, DOI 10.1093/oxfordjournals.aje.a116703; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; Khoury MJ, 1996, AM J EPIDEMIOL, V144, P207; KHOURY MJ, 1995, AM J HUM GENET, V56, P835; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; MEADE TW, 1986, LANCET, V2, P533, DOI 10.1016/S0140-6736(86)90111-X; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; RobertsThomson IC, 1996, LANCET, V347, P1372, DOI 10.1016/S0140-6736(96)91012-0; Rose G., 1992, STRATEGY PREVENTIVE; Shields DC, 1999, AM J HUM GENET, V64, P1045, DOI 10.1086/302310; Shpilberg O, 1997, J CLIN EPIDEMIOL, V50, P633, DOI 10.1016/S0895-4356(97)00052-8; TAUBE H, 1995, SCIENCE, V269, P163; THOMPSON WD, 1991, J CLIN EPIDEMIOL, V44, P221, DOI 10.1016/0895-4356(91)90033-6; VANDENBROUCKE JP, 1994, LANCET, V344, P1453, DOI 10.1016/S0140-6736(94)90286-0; Youngman LD, 2000, CIRCULATION, V102, P31	18	360	364	0	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 20	2001	358	9290					1356	1360		10.1016/S0140-6736(01)06418-2	http://dx.doi.org/10.1016/S0140-6736(01)06418-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684236				2022-12-28	WOS:000171702500033
J	Padkin, A; Rowan, K; Black, N				Padkin, A; Rowan, K; Black, N			Using high quality clinical databases to complement the results of randomised controlled trials: the case of recombinant human activated protein C	BRITISH MEDICAL JOURNAL			English	Article							CARE		Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Serv Res Unit, London WC1E 7HT, England; Intens Care Natl Audit & Res Ctr, London WC1H 9HR, England	University of London; London School of Hygiene & Tropical Medicine; Intensive Care National Audit & Research Centre	Padkin, A (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Serv Res Unit, London WC1E 7HT, England.							APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Black N, 2001, BRIT MED J, V323, P275, DOI 10.1136/bmj.323.7307.275; Black N, 1996, BRIT MED J, V312, P1215; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; *BRIT MED ASS, 1992, 33 BMA RPS; Britton A, 1999, J Health Serv Res Policy, V4, P112; Goldfrad C, 2000, LANCET, V355, P1138, DOI 10.1016/S0140-6736(00)02062-6; MATHER CMP, 1995, ANAESTHESIA, V50, P189, DOI 10.1111/j.1365-2044.1995.tb04552.x; MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; ROWAN K, 2001, PROGRAMME INTENSIVE, P51; ROWAN K, 2000, HLTH CARE UK     SPR, P42; Turner S, 1998, BRIT MED J, V316, P343, DOI 10.1136/bmj.316.7128.343	15	43	43	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 20	2001	323	7318					923	926		10.1136/bmj.323.7318.923	http://dx.doi.org/10.1136/bmj.323.7318.923			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486BH	11668142	Green Accepted, Green Published			2022-12-28	WOS:000171798200028
J	Strasser, K; Hurt, E				Strasser, K; Hurt, E			Splicing factor Sub2p is required for nuclear mRNA export through its interaction with Yra1p	NATURE			English	Article							YEAST HOMOLOG; MEX67P; IDENTIFICATION; BINDING; PROTEIN	The yeast nuclear protein Yra1p is an essential export factor for mRNA. Yra1p interacts directly with the mRNA transport factor Mex67p/Mtr2p, which is associated with the nuclear pore(1,2). Here, we report a genetic interaction between YRA1 and SUB2, the gene for a DEAD box helicase involved in splicing(3-5). Mutation of SUB2 as well as its overexpression leads to a defect in mRNA export. Moreover, Yra1p and Sub2p bind directly to each other both in vivo and in vitro. Significantly, Sub2p and Mex67p/Mtr2p bind to the same domains of Yra1p, and the proteins compete for binding to Yra1p. Together, these data indicate that the spliceosomal component Sub2p is also important in mRNA export and may function to recruit Yra1p to the mRNA. Sub2p may then be displaced from Yra1p by the binding of Mex67p/Mtr2p, which participates in the export of mRNA through the nuclear pores.	BZH, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Hurt, E (corresponding author), BZH, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	eg5@ix.urz.uni-heidelberg.de	Ed Hurt, Dr./AAE-8874-2019	Ed Hurt, Dr./0000-0002-4535-8255; Strasser, Katja/0000-0003-3533-5516				Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Hurt E, 2000, J BIOL CHEM, V275, P8361, DOI 10.1074/jbc.275.12.8361; Jensen TH, 2001, MOL CELL, V7, P887, DOI 10.1016/S1097-2765(01)00232-5; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; Libri D, 2001, GENE DEV, V15, P36, DOI 10.1101/gad.852101; Portenoy RK, 1997, J PALLIATIVE CARE, V13, P56; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Virbasius CMA, 1999, MOL CELL, V4, P219, DOI 10.1016/S1097-2765(00)80369-X; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Zhang M, 2001, GENE DEV, V15, P30, DOI 10.1101/gad.851701; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	17	242	246	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2001	413	6856					648	652		10.1038/35098113	http://dx.doi.org/10.1038/35098113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675790				2022-12-28	WOS:000171485700053
J	Gurdon, JB; Bourillot, PY				Gurdon, JB; Bourillot, PY			Morphogen gradient interpretation	NATURE			English	Review							TGF-BETA SUPERFAMILY; WING IMAGINAL DISC; LONG-RANGE ACTION; DROSOPHILA EMBRYO; ACTIVIN RECEPTOR; DPP; POSITION; PATTERN; CELLS; THRESHOLDS	A morphogen gradient is an important concept in developmental biology, because it describes a mechanism by which the emission of a signal from one part of an embryo can determine the location, differentiation and fate of many surrounding cells. The value of this idea has been clear for over half a century, but only recently have experimental systems and methods of analysis progressed to the point where we begin to understand how a cell can sense and respond to tiny changes in minute concentrations of extracellular signalling factors.	Wellcome CRC Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge	Gurdon, JB (corresponding author), Wellcome CRC Inst, Tennis Court Rd, Cambridge CB2 1QR, England.		Bourillot, Pierre-Yves/M-6956-2014	Bourillot, Pierre-Yves/0000-0003-1657-8555; GURDON, JOHN/0000-0002-5621-3799				Affolter M, 2001, EMBO J, V20, P3298, DOI 10.1093/emboj/20.13.3298; Ashe HL, 2000, DEVELOPMENT, V127, P3305; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Chen CM, 1999, DEVELOPMENT, V126, P5441; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chen Y, 2001, NATURE, V411, P607, DOI 10.1038/35079121; COOKE J, 1995, BIOESSAYS, V17, P93, DOI 10.1002/bies.950170202; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Dorfman R, 2001, DEVELOPMENT, V128, P965; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Dyson S, 1998, CELL, V93, P557, DOI 10.1016/S0092-8674(00)81185-X; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Faure S, 2000, DEVELOPMENT, V127, P2917; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; Graff JM, 1996, CELL, V85, P479, DOI 10.1016/S0092-8674(00)81249-0; GREEN JBA, 1992, CELL, V71, P731, DOI 10.1016/0092-8674(92)90550-V; Gritsman K, 2000, DEVELOPMENT, V127, P921; GURDON JB, 1995, NATURE, V376, P520, DOI 10.1038/376520a0; Gurdon JB, 1998, CELL, V95, P159, DOI 10.1016/S0092-8674(00)81747-X; Gurdon JB, 1999, DEVELOPMENT, V126, P5309; GURDON JB, 1994, NATURE, V371, P487, DOI 10.1038/371487a0; HEMMATIBRIVANLOU A, 1992, NATURE, V359, P609, DOI 10.1038/359609a0; HOGAN BLM, 1992, NATURE, V359, P237, DOI 10.1038/359237a0; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Klein T, 1999, DEVELOPMENT, V126, P913; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lecuit T, 1998, DEVELOPMENT, V125, P4901; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; McDowell N, 1997, CURR BIOL, V7, P671, DOI 10.1016/S0960-9822(06)00294-6; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Neul JL, 1998, CELL, V95, P483, DOI 10.1016/S0092-8674(00)81616-5; Neumann C, 1997, BIOESSAYS, V19, P721, DOI 10.1002/bies.950190813; Nguyen M, 1998, CELL, V95, P495, DOI 10.1016/S0092-8674(00)81617-7; Pages F, 2000, TRENDS GENET, V16, P40, DOI 10.1016/S0168-9525(99)01880-6; Papin C, 2000, DEV BIOL, V217, P166, DOI 10.1006/dbio.1999.9531; Podos SD, 1999, TRENDS GENET, V15, P396, DOI 10.1016/S0168-9525(99)01854-5; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Rulifson EJ, 2000, MOL CELL, V6, P117, DOI 10.1016/S1097-2765(00)00013-7; Shimizu K, 1999, P NATL ACAD SCI USA, V96, P6791, DOI 10.1073/pnas.96.12.6791; SLACK JMW, 1994, CURR BIOL, V4, P116, DOI 10.1016/S0960-9822(94)00027-8; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; WHARTON KA, 1993, DEVELOPMENT, V117, P807; WOLPERT L, 1998, PRINCIPLES DEV, P399; WOLPERT L, 1989, DEVELOPMENT S, P3; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	50	525	545	0	64	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					797	803		10.1038/35101500	http://dx.doi.org/10.1038/35101500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677596				2022-12-28	WOS:000171750200035
J	Cincotta, RP; Crane, BB				Cincotta, RP; Crane, BB			Public health - The Mexico City policy and US family planning assistance	SCIENCE			English	Editorial Material									Populat Act Int, Res Dept, Washington, DC 20036 USA; Ipas, Chapel Hill, NC 27516 USA		Cincotta, RP (corresponding author), Populat Act Int, Res Dept, 1300 19th St NW, Washington, DC 20036 USA.	cincotta@popact.org						BLANE J, 1990, 5 POP TECHN ASS PROJ; BUSH GW, 2001, MEMORANDUM ADM US AG; Camp S, 1987, NYU J INT LAW POLITI, V20, P35; CAMP S, COMMUNICATION; *COMM PRES DEB, 2000, 1 2000 GOR BUSH PRES; *DIV REPR HLTH, 1998, WHORHTMSM9716 DIV RE; HALE RW, 2001, COMMUNICATION   0504; NOWELS L, 2001, IB96026 C RES SERV; PAXMAN JM, UNPUB; *POP CRIS COMM, 1988, IMP MEX CIT POL FAM; Rahman A, 1998, INT FAM PLAN PERSPEC, V24, P56, DOI 10.2307/2991926; SIONCKE J, 2001, MATERNAL MORTALITY U; *UN POP FUND, 1999, GLOB POP ASS REP 199; *US SEN US HOUS RE, 2000, LEG FOR REL 1999, P36; *USAID, 2001, CONTR INF B USAID; *WHIT HOUS OFF PRE, 2001, MEX CIT POL	16	15	15	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					525	526		10.1126/science.1063403	http://dx.doi.org/10.1126/science.1063403			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641484				2022-12-28	WOS:000171695600026
J	Rice, WR; Chippindale, AK				Rice, WR; Chippindale, AK			Sexual recombination and the power of natural selection	SCIENCE			English	Article							DELETERIOUS MUTATIONS; DIRECTIONAL SELECTION; GENETIC-VARIABILITY; ADVANTAGE; EVOLUTION; FITNESS; ACCUMULATION; EPISTASIS; LINKAGE; LIMITS	Theory predicts that recombination will increase the effectiveness of natural selection. A Drosophila melanogaster model system was developed that increased experimental power with the use of high experimental replication, explicit tracking of individual genes, and high but natural levels of background selection. Each of 34 independent experiments traced the fate of a newly arisen mutation located within genome-wide, synthetic chromosomes that were propagated with or without recombination. An intrinsic advantage to recombination was demonstrated by the finding that the realized strength of selection on new mutations was markedly increased when recombination was present.	Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Rice, WR (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	rice@lifesci.ucsb.edu						BARTON NH, 1995, GENETICS, V140, P821; Birdsell J, 1996, P NATL ACAD SCI USA, V93, P908, DOI 10.1073/pnas.93.2.908; CARSON HL, 1958, COLD SPRING HARB SYM, V23, P291, DOI 10.1101/SQB.1958.023.01.030; CHAO L, 1990, NATURE, V348, P454, DOI 10.1038/348454a0; CHARLESWORTH B, 1994, GENET RES, V63, P213, DOI 10.1017/S0016672300032365; CHARLESWORTH D, 1993, J HERED, V84, P321, DOI 10.1093/oxfordjournals.jhered.a111351; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; deVisser JAGM, 1996, P ROY SOC B-BIOL SCI, V263, P193, DOI 10.1098/rspb.1996.0031; Endler J.A., 1986, Monographs in Population Biology, pviii; FELSENSTEIN J, 1974, GENETICS, V78, P737; Fisher R. A., 1930, GENETICAL THEORY NAT, P135; FLEXON PB, 1982, NATURE, V298, P672, DOI 10.1038/298672a0; Fowler K, 1997, P ROY SOC B-BIOL SCI, V264, P191, DOI 10.1098/rspb.1997.0027; GEER BW, 1962, AM NAT, V96, P175, DOI 10.1086/282220; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; KIMURA M, 1968, GENET RES, V11, P247, DOI 10.1017/S0016672300011459; KIMURA M, 1966, GENETICS, V54, P1337; KONDRASHOV AS, 1984, GENET RES, V44, P199, DOI 10.1017/S0016672300026392; KOROL AB, 1994, HEREDITY, V72, P64, DOI 10.1038/hdy.1994.7; LI WH, 1978, GENETICS, V90, P349; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; MALMBERG RL, 1977, GENETICS, V86, P607; MANNING JT, 1984, ACTA BIOTHEOR, V33, P219, DOI 10.1007/BF00048429; MARKOW TA, 1975, GENETICS, V79, P527; MAYNARD SMITH J., 1978, EVOLUTION SEX; MCPHEE CP, 1970, GENET RES, V16, P1, DOI 10.1017/S0016672300002238; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; PECK JR, 1994, GENETICS, V137, P597; Rice WR, 1998, GENETICA, V102-3, P71, DOI 10.1023/A:1017055429755; RICE WR, 1994, SCIENCE, V263, P230, DOI 10.1126/science.8284674; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; Rice WR, 1999, J EVOLUTION BIOL, V12, P1047; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; THOMPSON V, 1977, GENETICS, V85, P125; THOMPSON V, 1976, Evolutionary Theory, V1, P131; Van Valen L., 1973, EVOL THEORY REV, V1, P1, DOI DOI 10.1038/344864A0; WOLF HG, 1987, GENETICA, V72, P151, DOI 10.1007/BF00123174; Wright S, 1931, GENETICS, V16, P0097; Zeyl C, 1997, NATURE, V388, P465, DOI 10.1038/41312	40	119	126	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					555	559		10.1126/science.1061380	http://dx.doi.org/10.1126/science.1061380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641490				2022-12-28	WOS:000171695600036
J	Schalkwijk, J; Zweers, MC; Steijlen, PM; Dean, WB; Taylor, G; van Vlijmen, IM; van Haren, B; Miller, WL; Bristow, J				Schalkwijk, J; Zweers, MC; Steijlen, PM; Dean, WB; Taylor, G; van Vlijmen, IM; van Haren, B; Miller, WL; Bristow, J			A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYNDROME TYPE-I; COL5A1 GENE; COLLAGEN FIBRILS; GRAVIS FORM; EXPRESSION; PROPEPTIDE; MUTATIONS; NOSOLOGY; KNOCKOUT; DISTINCT	Background: The Ehlers-Danlos syndrome is a heritable connective-tissue disorder caused by defects in fibrillar-collagen metabolism. Mutations in the type V collagen genes account for up to 50 percent of cases of classic Ehlers-Danlos syndrome, but many other cases are unexplained. We investigated whether the deficiency of the tenascins, extracellular-matrix proteins that are highly expressed in connective tissues, was associated with the Ehlers-Danlos syndrome. Methods: We screened serum samples from 151 patients with the classic, hypermobility, or vascular types of the Ehlers-Danlos syndrome; 75 patients with psoriasis; 93 patients with rheumatoid arthritis; and 21 healthy persons for the presence of tenascin-X and tenascin-C by enzyme-linked immunosorbent assay. We examined the expression of tenascins and type V collagen in skin by immunohistochemical methods and sequenced the tenascin-X gene. Results: Tenascin-X was present in serum from all normal subjects, all patients with psoriasis, all patients with rheumatoid arthritis, and 146 of 151 patients with the Ehlers-Danlos syndrome. Tenascin-X was absent from the serum of the five remaining patients with Ehlers-Danlos syndrome, who were unrelated. Tenascin-X deficiency was confirmed in these patients by analysis of skin fibroblasts and by immunostaining of skin. The expression of tenascin-C and type V collagen was normal in these patients. All five of these patients had hypermobile joints, hyperelastic skin, and easy bruising, without atrophic scarring. Tenascin-X mutations were identified in all tenascin-X-deficient patients; one patient had a homozygous tenascin-X gene deletion, one was heterozygous for the deletion, and three others had homozygous truncating point mutations, confirming a causative role for tenascin-X and a recessive pattern of inheritance. Conclusions: Tenascin-X deficiency causes a clinically distinct, recessive form of the Ehlers-Danlos syndrome. This finding indicates that factors other than the collagens or collagen-processing enzymes can cause the syndrome and suggests a central role for tenascin-X in maintaining the integrity of collagenous matrix. (N Engl J Med 2001;345:1167-75.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Calif San Francisco, Dept Pediat, Laurel Hts Campus,3333 Calif St,Box 1245, San Francisco, CA 94118 USA; Univ Med Ctr Nijmegen, Dept Dermatol, NL-6500 HB Nijmegen, Netherlands	University of California System; University of California San Francisco; Radboud University Nijmegen	Schalkwijk, J (corresponding author), Univ Calif San Francisco, Dept Pediat, Laurel Hts Campus,3333 Calif St,Box 1245, San Francisco, CA 94118 USA.	j.schalkwijk@derma.azn.nl	Steijlen, Peter/X-2729-2019; Zweers, Manon/E-5090-2016; van Vlijmen-Willems, Ivonne MJJ/P-5336-2015; Schalkwijk, Joost/R-7509-2019; Miller, Walter L/J-3696-2012; Schalkwijk, Joost/N-1774-2013	van Vlijmen-Willems, Ivonne MJJ/0000-0002-3522-2573; Schalkwijk, Joost/0000-0002-1308-1319; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042154, R01DK037922] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL02695] Funding Source: Medline; NIDDK NIH HHS [DK37922, DK42154] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; BRISTOW J, 1993, J CELL BIOL, V122, P265, DOI 10.1083/jcb.122.1.265; Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104; BURCH GH, 1995, DEV DYNAM, V203, P491, DOI 10.1002/aja.1002030411; Burrows NP, 1998, AM J HUM GENET, V63, P390, DOI 10.1086/301948; BYERS PH, 1994, J INVEST DERMATOL, V103, pS47, DOI 10.1038/jid.1994.9; DePaepe A, 1997, AM J HUM GENET, V60, P547; Elefteriou F, 1997, J BIOL CHEM, V272, P22866, DOI 10.1074/jbc.272.36.22866; Erickson HP, 1993, CURR OPIN CELL BIOL, V5, P869, DOI 10.1016/0955-0674(93)90037-Q; ERICKSON HP, 1993, J CELL BIOL, V120, P1079, DOI 10.1083/jcb.120.5.1079; Erickson HP, 1997, NAT GENET, V17, P5, DOI 10.1038/ng0997-5; GEFFROTIN C, 1995, EUR J BIOCHEM, V231, P83, DOI 10.1111/j.1432-1033.1995.0083f.x; GITELMAN SE, 1992, MOL CELL BIOL, V12, P2124, DOI 10.1128/MCB.12.5.2124; Giunta C, 2000, AM J MED GENET, V90, P72, DOI 10.1002/(SICI)1096-8628(20000103)90:1<72::AID-AJMG13>3.0.CO;2-C; HYLAND J, 1992, NAT GENET, V2, P228, DOI 10.1038/ng1192-228; Latijnhouwers MAHE, 1998, ACTA DERM-VENEREOL, V78, P331; Lethias C, 1996, MATRIX BIOL, V15, P11, DOI 10.1016/S0945-053X(96)90122-5; Mackie EJ, 1999, J CELL SCI, V112, P3847; Mackie EJ, 1996, J ANAT, V188, P157; Mao JR, 2001, J CLIN INVEST, V107, P1063, DOI 10.1172/JCI12881; MATSUMOTO K, 1994, J CELL BIOL, V125, P483, DOI 10.1083/jcb.125.2.483; MOREL Y, 1989, P NATL ACAD SCI USA, V86, P6582, DOI 10.1073/pnas.86.17.6582; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; SCHALKWIJK J, 1991, AM J PATHOL, V139, P1143; Schwarze U, 2000, AM J HUM GENET, V66, P1757, DOI 10.1086/302933; SMITH LT, 1992, AM J HUM GENET, V51, P235; Smith LT, 1997, J INVEST DERMATOL, V108, P241, DOI 10.1111/1523-1747.ep12286441; TEE MK, 1995, GENOMICS, V28, P171, DOI 10.1006/geno.1995.1128; Toriello HV, 1996, NAT GENET, V13, P361, DOI 10.1038/ng0796-361; VERSTRAETEN AA, 1992, BRIT J DERMATOL, V127, P571, DOI 10.1111/j.1365-2133.1992.tb14867.x; VOGEL A, 1979, LAB INVEST, V40, P201; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; Wenstrup RJ, 2000, AM J HUM GENET, V66, P1766, DOI 10.1086/302930	34	274	276	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2001	345	16					1167	1175		10.1056/NEJMoa002939	http://dx.doi.org/10.1056/NEJMoa002939			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482YX	11642233	Green Published			2022-12-28	WOS:000171605800004
J	Sorensen, TL; Blom, M; Monnet, DL; Frimodt-Moller, N; Poulsen, RL; Espersen, F				Sorensen, TL; Blom, M; Monnet, DL; Frimodt-Moller, N; Poulsen, RL; Espersen, F			Transient intestinal carriage after ingestion of antibiotic-resistant Enterococcus faecium from chicken and pork.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOSPITALIZED-PATIENTS; DIGESTIVE TRACTS; GNOTOBIOTIC MICE; VANCOMYCIN; POULTRY; SUSCEPTIBILITY; NETHERLANDS; COMMUNITY; FAECALIS	Background: Antibiotic-resistant enterococci are often present in retail meats, but it is unclear whether the ingestion of these contaminants leads to sustained intestinal carriage. Methods: We conducted a randomized, double-blind study in 18 healthy volunteers. Six ingested a mixture of 10(sup 7) colony-forming units (CFU) of two glycopeptide-resistant strains of Enterococcus faecium obtained from chicken purchased at a grocery store, six ingested 10(sup 7) CFU of a streptogramin-resistant strain of E. faecium obtained from a pig at slaughter, and six ingested 10(sup 7) CFU of a glycopeptide-susceptible and streptogramin-susceptible strain of E. faecium from chicken purchased at a grocery store. Suspensions of enterococci were prepared in 250 ml of whole milk and were well within the amounts deemed acceptable by Danish food regulations. Stool samples were collected before exposure, daily for 1 week after ingestion, and at 14 and 35 days. Resistant enterococci in stools were identified by selective culture techniques; further molecular characterization of the organisms was also conducted. Results: At the outset, none of the subjects were colonized with glycopeptide-resistant or streptogramin-resistant E. faecium. After ingestion of the study strains, these same strains were isolated from the stools of all subjects, in various concentrations. The test strain was isolated in stool from 8 of 12 subjects on day 6, and from 1 of 12 on day 14. All stool samples were negative at 35 days. Conclusions: The ingestion of resistant E. faecium of animal origin leads to detectable concentrations of the resistant strain in stools for up to 14 days after ingestion. The organisms survive gastric passage and multiply. (N Engl J Med 2001;345:1161-6.) Copyright (C) 2001 Massachusetts Medical Society.	Statens Serum Inst, Dept Microbiol Res & Dev, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Frimodt-Moller, N (corresponding author), Statens Serum Inst, Dept Microbiol Res & Dev, 5 Artillerivej, DK-2300 Copenhagen S, Denmark.	nfm@ssi.dk	Frimodt-Moller, Niels/G-1187-2018	Frimodt-Moller, Niels/0000-0003-1966-8302				Berchieri Angelo, 1999, Clin Microbiol Infect, V5, P97, DOI 10.1111/j.1469-0691.1999.tb00110.x; Coque TM, 1996, ANTIMICROB AGENTS CH, V40, P2605, DOI 10.1128/AAC.40.11.2605; *DAN VET LAB, 1998, DANMAP 97 CONS ANT A; DOUCETPOPULAIRE F, 1991, ANTIMICROB AGENTS CH, V35, P185, DOI 10.1128/AAC.35.1.185; DOUCETPOPULAIRE F, 1992, ANTIMICROB AGENTS CH, V36, P502, DOI 10.1128/AAC.36.2.502; Endtz HP, 1997, J CLIN MICROBIOL, V35, P3026, DOI 10.1128/JCM.35.12.3026-3031.1997; Gambarotto K, 2000, J CLIN MICROBIOL, V38, P620, DOI 10.1128/JCM.38.2.620-624.2000; Goossens Herman, 1999, Clin Microbiol Infect, V5, P64, DOI 10.1111/j.1469-0691.1999.tb00104.x; GORDON CLA, 1991, CAN J MICROBIOL, V37, P609, DOI 10.1139/m91-103; HARTMAN PA, 1960, APPL MICROBIOL, V8, P114, DOI 10.1128/AEM.8.2.114-116.1960; Jacobsen B. L., 1999, Microbial Ecology in Health and Disease, V11, P241, DOI 10.1080/08910609908540834; Jensen LB, 1998, ANTIMICROB AGENTS CH, V42, P2463, DOI 10.1128/AAC.42.9.2463; Pavia M, 2000, J FOOD PROTECT, V63, P912, DOI 10.4315/0362-028X-63.7.912; Poulsen RL, 1999, APMIS, V107, P404, DOI 10.1111/j.1699-0463.1999.tb01573.x; RAJ H, 1961, APPL MICROBIOL, V9, P295, DOI 10.1128/AEM.9.4.295-303.1961; Robredo B, 2000, INT J FOOD MICROBIOL, V54, P197, DOI 10.1016/S0168-1605(99)00195-6; Shoemaker NB, 2001, APPL ENVIRON MICROB, V67, P561, DOI 10.1128/AEM.67.2.561-568.2001; Torell E, 1999, J CLIN MICROBIOL, V37, P3509, DOI 10.1128/JCM.37.11.3509-3513.1999; TURTURA GC, 1994, MICROBIOL RES, V149, P203, DOI 10.1016/S0944-5013(11)80120-5; van den Braak N, 1998, J CLIN MICROBIOL, V36, P1927, DOI 10.1128/JCM.36.7.1927-1932.1998; VanderAuwera P, 1996, J INFECT DIS, V173, P1129, DOI 10.1093/infdis/173.5.1129	21	130	136	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2001	345	16					1161	1166		10.1056/NEJMoa010692	http://dx.doi.org/10.1056/NEJMoa010692			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482YX	11642232				2022-12-28	WOS:000171605800003
J	Goldstein, DJ; Roon, KI; Offen, WW; Ramadan, NM; Phebus, LA; Johnson, KW; Schaus, JM; Ferrari, MD				Goldstein, DJ; Roon, KI; Offen, WW; Ramadan, NM; Phebus, LA; Johnson, KW; Schaus, JM; Ferrari, MD			Selective seratonin 1F (5-HT1F) receptor agonist LY334370 for acute migraine: a randomised controlled trial	LANCET			English	Article							NEUROGENIC DURAL INFLAMMATION; INHIBITION; LY344864; SUBTYPE; BINDING; CLONING	Background Triptans (5-HT1B/1D receptor agonists) are effective drugs for acute migraine, but the side-effect of coronary vasoconstriction restricts their use in patients who are at risk of coronary artery disease. We have studied the efficacy of LY334370, a selective serotonin 1F (5-HT1F) receptor agonist with preclinical efficacy and no vasoconstriction, for migraine relief. Methods We gave LY334370 (20, 60, or 200 mg) or placebo to 99 outpatients with moderate or severe migraine headaches in a double blind, parallel group study. We measured efficacy by sustained response, response at 2 h, pain free at 2 h, and sustained pain free. Findings The proportions of patients with defined endpoints for placebo and LY334370 20, 60, and 200 mg, respectively, were: sustained response, two of 26 (8%), three of 22 (1.4%), 11 of 30 (37%), and 11 of 21 (52%) (dose response p<0.001); response, five of 26 (19%), four of 22 (18%), 15 of 30 (50%), and 15 of 21 (71%) (p<0.001); pain free, one of 26 (4%), none of 22, eight of 30 (27%), and eight of 21 (38%) (p=0.001): sustained pain free, one of 26 (4%), none of 22, seven of 30 (23%), and seven of 21 (33%) (P=0.002); recurrence rates, one of five (20%), none of four, four of 15 (27%), and three of 15 (20%). More patients given LY334370 than placebo reported asthenia, somnolence, and dizziness. Interpretation Our findings show that LY334370 is effective in treatment of acute migraine through selective trigeminovascular neuronal inhibition.	Eli Lilly & Co, Lilly Res Labs, Lilly Corp Ctr, Div Neurosci, Indianapolis, IN 46285 USA; Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res, Indianapolis, IN 46285 USA	Eli Lilly; Indiana University System; Indiana University-Purdue University Indianapolis; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Eli Lilly	Goldstein, DJ (corresponding author), Eli Lilly & Co, Lilly Res Labs, Lilly Corp Ctr, Div Neurosci, Indianapolis, IN 46285 USA.	DJGoldstein@Lilly.com	Ferrari, Michel D./ABE-3758-2021	Ferrari, Michel D./0000-0001-9691-9449				Adham N, 1997, NEUROPHARMACOLOGY, V36, P569, DOI 10.1016/S0028-3908(97)00020-8; ADHAM N, 1993, P NATL ACAD SCI USA, V90, P408, DOI 10.1073/pnas.90.2.408; [Anonymous], 1991, Cephalalgia, V11, P1; Bouchelet I, 2000, BRIT J PHARMACOL, V129, P501, DOI 10.1038/sj.bjp.0703081; Cohen ML, 2000, BRIT J PHARMACOL, V131, P562, DOI 10.1038/sj.bjp.0703587; Cohen ML, 1999, J PHARMACOL EXP THER, V290, P935; Cumberbatch MJ, 1999, BRIT J PHARMACOL, V126, P1478, DOI 10.1038/sj.bjp.0702444; Davies GM, 2000, CEPHALALGIA, V20, P554, DOI 10.1046/j.1468-2982.2000.00082.x; Ferrand JL, 1999, CONT SHELF RES, V19, P23, DOI 10.1016/S0278-4343(98)00070-3; Ferrari MD, 1998, LANCET, V351, P1043, DOI 10.1016/S0140-6736(97)11370-8; Goadsby PJ, 1998, ANN NEUROL, V43, P711, DOI 10.1002/ana.410430605; Goldstein DJ, 1997, CEPHALALGIA, V17, P785, DOI 10.1046/j.1468-2982.1997.1707785.x; Goldstein DJ, 1999, CEPHALALGIA, V19, P248, DOI 10.1046/j.1468-2982.1999.019004248.x; Johnson KW, 1997, NEUROREPORT, V8, P2237, DOI 10.1097/00001756-199707070-00029; Phebus LA, 1997, LIFE SCI, V61, P2117, DOI 10.1016/S0024-3205(97)00885-0; Shepheard S, 1999, CEPHALALGIA, V19, P851, DOI 10.1046/j.1468-2982.1999.1910851.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Wainscott DB, 1998, EUR J PHARMACOL, V352, P117, DOI 10.1016/S0014-2999(98)00336-7	18	120	131	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2001	358	9289					1230	1234		10.1016/S0140-6736(01)06347-4	http://dx.doi.org/10.1016/S0140-6736(01)06347-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675061				2022-12-28	WOS:000171527000013
J	Murray, S				Murray, S			Care in the community: A conflict of interests?	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 7	1996	313	7057					632	632						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VG108	11644810				2022-12-28	WOS:A1996VG10800076
J	Beech, BAL				Beech, BAL			How could I breast feed with a man in the room?	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Dillner L, 1996, BRIT MED J, V312, P200	1	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 27	1996	312	7025					256	256						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TT486	11644767				2022-12-28	WOS:A1996TT48600085
J	MORRISON, R				MORRISON, R			PATIENTS SENSE OF COMPLETION	BRITISH MEDICAL JOURNAL			English	Editorial Material											MORRISON, R (corresponding author), EASTBOURNE HOSP NHS TRUST,EASTBOURNE,E SUSSEX,ENGLAND.								0	9	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 25	1994	308	6945					1722	1722		10.1136/bmj.308.6945.1722	http://dx.doi.org/10.1136/bmj.308.6945.1722			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NU483	11644549	Green Published			2022-12-28	WOS:A1994NU48300095
J	Harris, A; Misiewicz, JJ				Harris, A; Misiewicz, JJ			ABC of the upper gastrointestinal tract - Management of Helicobacter pylori infection	BRITISH MEDICAL JOURNAL			English	Review									Kent & Sussex Hosp, Tunbridge Wells, England; Cent Middlesex Hosp, Dept Gastroenterol & Nutr, London NW10 7NS, England	Imperial College London	Harris, A (corresponding author), Kent & Sussex Hosp, Tunbridge Wells, England.								0	20	23	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 3	2001	323	7320					1047	1050		10.1136/bmj.323.7320.1047	http://dx.doi.org/10.1136/bmj.323.7320.1047			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MP	11691765	Green Published			2022-12-28	WOS:000172055900022
J	Philip, RK; Gul, R; Dunworth, M; Keane, N				Philip, RK; Gul, R; Dunworth, M; Keane, N			Ireland lacks consensus on neonatal vitamin K prophylaxis	BRITISH MEDICAL JOURNAL			English	Letter							CHILDHOOD-CANCER		Reg Matern Hosp, Neonatal Intens Care Unit, Limerick, Ireland		Philip, RK (corresponding author), Reg Matern Hosp, Neonatal Intens Care Unit, Limerick, Ireland.							Ansell P, 2001, BRIT MED J, V322, P1148, DOI 10.1136/bmj.322.7295.1148; GOLDING J, 1992, BRIT MED J, V305, P341, DOI 10.1136/bmj.305.6849.341; JonvilleBera AP, 1997, EUR J CLIN PHARMACOL, V52, P333, DOI 10.1007/s002280050297; Parker L, 1998, BRIT MED J, V316, P189, DOI 10.1136/bmj.316.7126.189	4	4	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 3	2001	323	7320					1068	1068		10.1136/bmj.323.7320.1068	http://dx.doi.org/10.1136/bmj.323.7320.1068			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MP	11691771	Green Published			2022-12-28	WOS:000172055900040
J	Lovell-Badge, R				Lovell-Badge, R			The future for stem cell research	NATURE			English	Article							PRIMORDIAL GERM-CELLS; CULTURE; PROLIFERATION; PRECURSORS; DERIVATION; LINES	Stem cells have offered much hope by promising to greatly extend the numbers and range of patients who could benefit from transplants, and to provide cell replacement therapy to treat debilitating diseases such as diabetes, Parkinson's and Huntington's disease. The issue of stem cell research is politically charged, prompting biologists to begin engaging in ethical debates, and generating in the general public an unusually high level of interest in this aspect of biology. But excitement notwithstanding, there is a long way to go in basic research before new therapies will be established, and now the pressure is on for scientists and clinicians to deliver.	Natl Inst Med Res, MRC, Div Dev Genet, London NW7 1AA, England	MRC National Institute for Medical Research	Lovell-Badge, R (corresponding author), Natl Inst Med Res, MRC, Div Dev Genet, Ridgeway,Mill Hill, London NW7 1AA, England.	rlovell@nimr.mrc.ac.uk		Lovell-Badge, Robin/0000-0001-9364-4179				Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Eguchi G, 1993, CURR OPIN CELL BIOL, V5, P1023, DOI 10.1016/0955-0674(93)90087-7; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Langa F, 2000, J CELL SCI, V113, P3463; Le Lievre C S, 1975, J Embryol Exp Morphol, V34, P125; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; MARSHAK DR, 2001, STEM CELL BIOL; MARTIN GR, 1974, CELL, V2, P163, DOI 10.1016/0092-8674(74)90090-7; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2001, DEVELOPMENT, V128, P2333; Ohta H, 2000, DEVELOPMENT, V127, P2125; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Rivolta MN, 1998, P ROY SOC B-BIOL SCI, V265, P1595, DOI 10.1098/rspb.1998.0477; ROBERSON DF, 1992, HEARING RES, V57, P166, DOI 10.1016/0378-5955(92)90149-H; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Streit A, 1999, TRENDS GENET, V15, P20, DOI 10.1016/S0168-9525(98)01620-5; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	27	89	119	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					88	91		10.1038/35102150	http://dx.doi.org/10.1038/35102150			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689952				2022-12-28	WOS:000171898900051
J	Stebbins, CE; Galan, JE				Stebbins, CE; Galan, JE			Maintenance of an unfolded polypeptide by a cognate chaperone in bacterial type III secretion	NATURE			English	Article							PROTEIN; MODULATION; PROGRAM; SYSTEM; MODEL; SPTP	Many bacterial pathogens use a type III protein secretion system to deliver virulence effector proteins directly into the host cell cytosol, where they modulate cellular processes(1,2). A requirement for the effective translocation of several such effector proteins is the binding of specific cytosolic chaperones, which typically interact with discrete domains in the virulence factors(3,4,5). We report here the crystal structure at 1.9 Angstrom resolution of the chaperone-binding domain of the Salmonella effector protein SptP with its cognate chaperone SicP. The structure reveals that this domain is maintained in an extended, unfolded conformation that is wound around three successive chaperone molecules. Short segments from two different SptP molecules are juxtaposed by the chaperones, where they dimerize across a hydrophobic interface. These results imply that the chaperones associated with the type III secretion system maintain their substrates in a secretion-competent state that is capable of engaging the secretion machinery to travel through the type III apparatus in an unfolded or partially folded manner.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.	jorge.galan@yale.edu	Stebbins, Erec/N-2565-2018	Stebbins, Erec/0000-0001-6229-5308				Bennett JCQ, 2000, TRENDS MICROBIOL, V8, P202, DOI 10.1016/S0966-842X(00)01751-0; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Evdokimov AG, 2001, ACTA CRYSTALLOGR D, V57, P793, DOI 10.1107/S0907444901004875; Fu YX, 1998, J BACTERIOL, V180, P3393, DOI 10.1128/JB.180.13.3393-3399.1998; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaniga K, 1996, MOL MICROBIOL, V21, P633, DOI 10.1111/j.1365-2958.1996.tb02571.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; SMITH CL, IN PRESS MOL MICROBI; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Stebbins CE, 2000, MOL CELL, V6, P1449, DOI 10.1016/S1097-2765(00)00141-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493; Wattiau P, 1996, MOL MICROBIOL, V20, P255, DOI 10.1111/j.1365-2958.1996.tb02614.x	24	247	254	2	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					77	81		10.1038/35102073	http://dx.doi.org/10.1038/35102073			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689946				2022-12-28	WOS:000171898900045
J	Herndon, DN; Hart, DW; Wolf, SE; Chinkes, DL; Wolfe, RR				Herndon, DN; Hart, DW; Wolf, SE; Chinkes, DL; Wolfe, RR			Reversal of catabolism by beta-blockade after severe burns.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	30th Annual Meeting of the Western-Trauma-Association	FEB 27-MAR 04, 2000	SQUAW VALLEY, CALIFORNIA	Western Trauma Assoc			ENERGY-METABOLISM; MUSCLE CATABOLISM; PROTEIN-SYNTHESIS; WHOLE-BODY; CATECHOLAMINES; CLENBUTEROL; KINETICS; CHILDREN; INFUSION; MODEL	Background: The catecholamine-mediated hypermetabolic response to severe burns causes increased energy expenditure and muscle-protein catabolism. We hypothesized that blockade of beta -adrenergic stimulation with propranolol would decrease resting energy expenditure and muscle catabolism in patients with severe burns. Methods: Twenty-five children with acute and severe burns (more than 40 percent of total body-surface area) were studied in a randomized trial. Thirteen received oral propranolol for at least two weeks, and 12 served as untreated controls. The dose of propranolol was adjusted to decrease the resting heart rate by 20 percent from each patient's base-line value. Resting energy expenditure and skeletal-muscle protein kinetics were measured before and after two weeks of beta-blockade (or no therapy, in controls). Body composition was measured serially throughout hospitalization. Results: Patients in the control group and the propranolol group were similar with respect to age, weight, percentage of total body-surface area burned, percentage of body-surface area with third-degree burns, and length of time from injury to metabolic study. Beta-blockade decreased the heart rates and resting energy expenditure in the propranolol group, both as compared with the base-line values (P<0.001 and P=0.01, respectively) and as compared with the values in the control group (P=0.03 and P=0.001, respectively). The net muscle-protein balance increased by 82 percent over base-line values in the propranolol group (P=0.002), whereas it decreased by 27 percent in the control group (P not significant). The fat-free mass, as measured by whole-body potassium scanning, did not change substantially in the propranolol group, whereas it decreased by a mean (+/-SE) of 9+/-2 percent in the control group (P=0.003). Conclusions: In children with burns, treatment with propranolol during hospitalization attenuates hypermetabolism and reverses muscle-protein catabolism.	Univ Texas, Med Branch, Shriners Hosp Children, Dept Surg, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston	Herndon, DN (corresponding author), Univ Texas, Med Branch, Shriners Hosp Children, Dept Surg, 815 Market St, Galveston, TX 77550 USA.			Wolf, Steven/0000-0003-2972-3440	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008256, P50GM060338, R01GM056687] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1 RR 00073] Funding Source: Medline; NIGMS NIH HHS [2T32GM0825611, GM56687-02, 1P50GM60338-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASCH MJ, 1973, ANN SURG, V178, P218, DOI 10.1097/00000658-197308000-00020; BARON PW, 1997, K BURN CARE REHABIL, V18, P223; BESSEY PQ, 1989, WORLD J SURG, V13, P465, DOI 10.1007/BF01660758; BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE514; BIOLO G, 1992, JPEN-PARENTER ENTER, V16, P305, DOI 10.1177/0148607192016004305; BREITENSTEIN E, 1990, BURNS, V16, P259, DOI 10.1016/0305-4179(90)90136-K; Chang DW, 1998, SHOCK, V10, P155, DOI 10.1097/00024382-199809000-00001; EISEMANN JH, 1988, J ANIM SCI, V66, P342; ELLIS KJ, 1992, J RADIOAN NUCL CH AR, V161, P61, DOI 10.1007/BF02034880; FORBES GB, 1956, J CLIN INVEST, V35, P596, DOI 10.1172/JCI103313; GOODALL M, 1957, ANN SURG, V145, P479, DOI 10.1097/00000658-195704000-00004; GORE DC, 1991, ARCH SURG-CHICAGO, V126, P38; GORE DC, 1991, ANN SURG, V213, P568, DOI 10.1097/00000658-199106000-00006; HARRISON TS, 1967, ANN SURG, V165, P169, DOI 10.1097/00000658-196702000-00002; Hart DW, 2001, ANN SURG, V233, P556, DOI 10.1097/00000658-200104000-00012; Hart DW, 2000, ANN SURG, V232, P455, DOI 10.1097/00000658-200010000-00001; Hart DW, 2000, SURGERY, V128, P312, DOI 10.1067/msy.2000.108059; Herndon DN, 1999, ANN SURG, V229, P713, DOI 10.1097/00000658-199905000-00014; HERNDON DN, 1994, ARCH SURG-CHICAGO, V129, P1301; HERNDON DN, 1988, ANN SURG, V208, P484, DOI 10.1097/00000658-198810000-00010; HONEYCUTT D, 1992, Journal of Burn Care and Rehabilitation, V13, P181, DOI 10.1097/00004630-199203000-00001; KIEN CL, 1978, ANN SURG, V187, P383, DOI 10.1097/00000658-197804000-00007; MACRAE JC, 1988, BRIT J NUTR, V59, P457, DOI 10.1079/BJN19880055; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; MINIFEE PK, 1989, J PEDIATR SURG, V24, P806, DOI 10.1016/S0022-3468(89)80541-X; Monk DN, 1996, ANN SURG, V223, P395, DOI 10.1097/00000658-199604000-00008; NEWSOME TW, 1973, ANN SURG, V178, P215, DOI 10.1097/00000658-197308000-00019; REISS W, 1956, J CLIN INVEST, V35, P62; SAKURAI Y, 1995, ANN SURG, V222, P283, DOI 10.1097/00000658-199509000-00007; Sakurai Y, 1995, ANN SURG, V222, P294; Tipton KD, 2001, AM J PHYSIOL-ENDOC M, V281, pE197, DOI 10.1152/ajpendo.2001.281.2.E197; Wang ZM, 1996, J APPL PHYSIOL, V80, P824, DOI 10.1152/jappl.1996.80.3.824; Wells JCK, 1999, AM J CLIN NUTR, V69, P904; WILMORE DW, 1978, SURG CLIN N AM, V58, P1173; WILMORE DW, 1974, ANN SURG, V180, P653, DOI 10.1097/00000658-197410000-00031	35	387	398	0	11	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2001	345	17					1223	1229		10.1056/NEJMoa010342	http://dx.doi.org/10.1056/NEJMoa010342			7	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485RU	11680441	Bronze			2022-12-28	WOS:000171773100001
J	Petrogiannis-Haliotis, T; Sakoulas, G; Kirby, J; Koralnik, IJ; Dvorak, AM; Monahan-Earley, R; De Girolami, PC; De Girolami, U; Upton, M; Major, EO; Pfister, LA; Joseph, JT				Petrogiannis-Haliotis, T; Sakoulas, G; Kirby, J; Koralnik, IJ; Dvorak, AM; Monahan-Earley, R; De Girolami, PC; De Girolami, U; Upton, M; Major, EO; Pfister, LA; Joseph, JT			Brief report: BK-related polyomavirus vasculopathy in a renal-transplant recipient.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONCODING CONTROL REGION; JC-VIRUS; INTERSTITIAL NEPHRITIS; BRAIN-TISSUE; INFECTION; INDIVIDUALS; PATIENT; DISEASE; AIDS; IDENTIFICATION		Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Internal Med, Div Infect Dis, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Dept Pathol, Div Neuropathol, Boston, MA 02115 USA; NINCDS, Lab Mol Med & Neurosci, Bethesda, MD 20892 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Joseph, JT (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, KS418,330 Brookline Ave, Boston, MA 02115 USA.		Kirby, James/K-4438-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001919] Funding Source: NIH RePORTER; NIAID NIH HHS [AI/HL 44066] Funding Source: Medline; NINDS NIH HHS [NS01919] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agostini HT, 1997, J INFECT DIS, V176, P1, DOI 10.1086/514010; ARTHUR RR, 1989, J CLIN MICROBIOL, V27, P1174, DOI 10.1128/JCM.27.6.1174-1179.1989; Bratt G, 1999, AIDS, V13, P1071, DOI 10.1097/00002030-199906180-00010; Chatterjee M, 2000, J MED VIROL, V60, P353, DOI 10.1002/(SICI)1096-9071(200003)60:3&lt;353::AID-JMV16&gt;3.0.CO;2-R; Cubukcu-Dimopulo O, 2000, AM J SURG PATHOL, V24, P145, DOI 10.1097/00000478-200001000-00019; DORRIES K, 1994, VIROLOGY, V198, P59, DOI 10.1006/viro.1994.1008; Dorries K, 1998, DEV BIOLOGICALS, V94, P71; DVORAK AM, 1987, J ELECTRON MICR TECH, V6, P255, DOI 10.1002/jemt.1060060302; Hamilton RS, 2000, J CLIN MICROBIOL, V38, P105; Hedquist BG, 1999, OPHTHALMOLOGY, V106, P129, DOI 10.1016/S0161-6420(99)90014-3; ITOYAMA Y, 1982, ANN NEUROL, V11, P396, DOI 10.1002/ana.410110414; JOHNSEN JI, 1995, J GEN VIROL, V76, P1571, DOI 10.1099/0022-1317-76-7-1571; Koralnik IJ, 1999, J NEUROVIROL, V5, P430, DOI 10.3109/13550289909029484; Mathur VS, 1997, AM J KIDNEY DIS, V29, P754; MOENS U, 1995, VIRUS GENES, V10, P261, DOI 10.1007/BF01701816; Parton RG, 1999, IMMUNOL REV, V168, P23, DOI 10.1111/j.1600-065X.1999.tb01280.x; Pho MT, 2000, J VIROL, V74, P2288, DOI 10.1128/JVI.74.5.2288-2292.2000; ROSEN S, 1983, NEW ENGL J MED, V308, P1192, DOI 10.1056/NEJM198305193082004; RZIHA HJ, 1978, MED MICROBIOL IMMUN, V165, P73, DOI 10.1007/BF02122742; Sandler ES, 1997, BONE MARROW TRANSPL, V20, P163, DOI 10.1038/sj.bmt.1700849; Shah K. V., 1996, FIELDS VIROLOGY, V2, P2027; Shah KV, 2000, NEPHROL DIAL TRANSPL, V15, P754, DOI 10.1093/ndt/15.6.754; Smith RD, 1998, J CLIN MICROBIOL, V36, P1660, DOI 10.1128/JCM.36.6.1660-1665.1998; VALLBRACHT A, 1993, AM J PATHOL, V143, P29; WALKER DL, 1985, HDB CLIN NEUROLOGY, V47, P503	25	103	108	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2001	345	17					1250	1255		10.1056/NEJMoa010319	http://dx.doi.org/10.1056/NEJMoa010319			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485RU	11680445				2022-12-28	WOS:000171773100005
J	Winklbauer, R; Medina, A; Swain, RK; Steinbeisser, H				Winklbauer, R; Medina, A; Swain, RK; Steinbeisser, H			Frizzled-7 signalling controls tissue separation during Xenopus gastrulation	NATURE			English	Article							CONVERGENT EXTENSION MOVEMENTS; GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; SIGNALING PATHWAYS; WNT; MORPHOGENESIS; MESODERM; EMBRYOS; TARGET	Cell signalling through Frizzled receptors has evolved to considerable complexity within the metazoans. The Frizzled-dependent signalling cascade comprises several branches, whose differential activation depends on specific Wnt ligands, Frizzled receptor isoforms and the cellular context. In Xenopus laevis embryos, the canonical beta -catenin pathway contributes to the establishment of the dorsal-ventral axis(1). A different branch, referred to as the planar cell polarity pathway, is essential for cell polarization during elongation of the axial mesoderm by convergent extension(2). Here we demonstrate that a third branch of the cascade is independent of Dishevelled function and involves signalling through trimeric G proteins and protein kinase C (PKC). During gastrulation, Frizzled-7 (Fz7)-dependent PKC signalling controls cell-sorting behaviour in the mesoderm. Loss of zygotic Fz7 function results in the inability of involuted anterior mesoderm to separate from the ectoderm, which leads to severe gastrulation defects. This result provides a developmentally relevant in vivo function for the Fz/PKC pathway in vertebrates.	Max Planck Inst Dev Biol, Dept Cell Biol, D-72076 Tubingen, Germany	Max Planck Society	Steinbeisser, H (corresponding author), Max Planck Inst Dev Biol, Dept Cell Biol, Spemann Str 35, D-72076 Tubingen, Germany.			Swain, Rajeeb/0000-0003-4815-8221				Deardorff' MA, 1998, DEVELOPMENT, V125, P2687; Djiane A, 2000, DEVELOPMENT, V127, P3091; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Medina A, 2000, DEV DYNAM, V218, P671, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1017>3.0.CO;2-9; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Munchberg SR, 1999, MECH DEVELOP, V80, P53, DOI 10.1016/S0925-4773(98)00193-2; OTTE AP, 1992, CELL, V68, P1021, DOI 10.1016/0092-8674(92)90074-M; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Shi DL, 1998, MECH DEVELOP, V70, P35, DOI 10.1016/S0925-4773(97)00166-4; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Sumanas S, 2000, DEVELOPMENT, V127, P1981; Tada M, 2000, DEVELOPMENT, V127, P2227; Wacker S, 2000, DEV BIOL, V224, P428, DOI 10.1006/dbio.2000.9794; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Winklbauer R, 1999, DEVELOPMENT, V126, P3703; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	21	215	223	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					856	860		10.1038/35101621	http://dx.doi.org/10.1038/35101621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677610				2022-12-28	WOS:000171750200049
J	Jasper, JD; Goel, R; Einarson, A; Gallo, M; Koren, G				Jasper, JD; Goel, R; Einarson, A; Gallo, M; Koren, G			Effects of framing on teratogenic risk perception in pregnant women	LANCET			English	Article								We examined the effects of information presentation (framing) on women's perception of fetal risk, and their Intention to use a safe drug during pregnancy. Half the women received negatively-framed information (1-3% chance of having a malformed child), the other half received positively-framed information (97-99% chance of having a normal child). Women In the negative group had a significantly higher perception of teratogenic risk (14.9%) than those in the positive group (8.3%), p=0.0484, and were less likely to want to take the drug. These findings suggest that health professionals and policy makers need to carefully consider how information is best presented.	Univ Toronto, Fac Pharm, Toronto, ON, Canada; Hosp Sick Children, Div Clin Pharmacol & Toxicol, Motherisk Program, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Jasper, JD (corresponding author), Univ Toledo, Dept Psychol, 2801 W Bancroft St, Toledo, OH 43606 USA.		Goel, Ritika/HGC-0111-2022; Koren, Gideon/AAG-7726-2019	Koren, Gideon/0000-0002-9234-0875				Einarson A, 2001, J PSYCHIATR NEUROSCI, V26, P44; KOREN G, 1989, AM J OBSTET GYNECOL, V160, P1190, DOI 10.1016/0002-9378(89)90186-5; LEVIN IP, 1988, J CONSUM RES, V15, P374, DOI 10.1086/209174; Levin IP, 1998, ORGAN BEHAV HUM DEC, V76, P149, DOI 10.1006/obhd.1998.2804; MCNEIL BJ, 1982, NEW ENGL J MED, V306, P1259, DOI 10.1056/NEJM198205273062103	5	49	53	0	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1237	1238		10.1016/S0140-6736(01)06353-X	http://dx.doi.org/10.1016/S0140-6736(01)06353-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481NX	11675064				2022-12-28	WOS:000171527000016
J	Silver, LM				Silver, LM			The second creation - The age of biological control by the scientists who cloned dolly	SCIENCE			English	Book Review									Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	Princeton University; Princeton University	Silver, LM (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.							Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Kolata Gina, 1998, CLONE ROAD DOLLY PAT; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; WILMUT I, 2000, 2 CREATION AGE BIOL	4	0	1	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1404	1405		10.1126/science.287.5457.1404	http://dx.doi.org/10.1126/science.287.5457.1404			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	11645195				2022-12-28	WOS:000085531600022
J	Thornton, S				Thornton, S			Personal view - The child B case - Reflections of a chief executive	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 21	1997	314	7097					1838	1839		10.1136/bmj.314.7097.1838a	http://dx.doi.org/10.1136/bmj.314.7097.1838a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XG166	11644948	Green Published			2022-12-28	WOS:A1997XG16600064
J	Rogers, A				Rogers, A			Europe presses on with bioethics convention	LANCET			English	News Item																			0	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUL 6	1996	348	9019					53	53		10.1016/S0140-6736(05)64373-5	http://dx.doi.org/10.1016/S0140-6736(05)64373-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UV923	11660207				2022-12-28	WOS:A1996UV92300033
J	BRAHAMS, D				BRAHAMS, D			CHLORAMBUCIL INFERTILITY AND SPERM BANKING	LANCET			English	Editorial Material																			0	4	4	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 15	1992	339	8790					420	420		10.1016/0140-6736(92)90098-N	http://dx.doi.org/10.1016/0140-6736(92)90098-N			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HD659	11659388				2022-12-28	WOS:A1992HD65900016
J	[Anonymous]				[Anonymous]			PATIENTS RIGHT TO KNOW IN JAPAN	LANCET			English	Editorial Material																		BRAHAMS D, 1989, LANCET, V2, P173; JOSEPH J, 1990, TIMES           1102; KIMURA R, 1988, BIOETHICAL SOCIOLEGA	3	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	1990	336	8726					1309	1310						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ943	11642858				2022-12-28	WOS:A1990EJ94300021
J	DIXON, B				DIXON, B			CHARTING THE GENOME	BRITISH MEDICAL JOURNAL			English	Editorial Material																		WILLIAMSON B, 1989, BRIT MED J, V299, P22	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	AUG 26	1989	299	6698					574	574		10.1136/bmj.299.6698.574	http://dx.doi.org/10.1136/bmj.299.6698.574			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM802	11644418	Bronze, Green Published			2022-12-28	WOS:A1989AM80200053
J	JASTRZEBSKI, GB				JASTRZEBSKI, GB			A SHARED OATH ON ENTERING MEDICINE - TRUST AND ALLIANCE	ANNALS OF INTERNAL MEDICINE			English	Note																		CLOUSER KD, 1985, ANN INTERN MED, V103, P941, DOI 10.7326/0003-4819-103-6-941	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	1989	110	2					173	173		10.7326/0003-4819-110-2-173_2	http://dx.doi.org/10.7326/0003-4819-110-2-173_2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	R8915	11644363				2022-12-28	WOS:A1989R891500026
J	RICHMAN, N				RICHMAN, N			CHILDREN AND APARTHEID	BRITISH MEDICAL JOURNAL			English	Editorial Material											RICHMAN, N (corresponding author), INST CHILD HLTH,CHILD PSYCHOL,LONDON WC1N 1EH,ENGLAND.							BRITTAIN V, 1988, CHILDREN RESISTANCE; TUTU D, 1987, UNICEF REPORT CHILDR, P59; 1988, LANCET, V1, P623; 1987, S AFRICAN MED J S, V71	4	4	4	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	AUG 13	1988	297	6646					495	495		10.1136/bmj.297.6646.495	http://dx.doi.org/10.1136/bmj.297.6646.495			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P6653	11644345	Bronze, Green Published			2022-12-28	WOS:A1988P665300080
J	KORYAGIN, A				KORYAGIN, A			WORLD PSYCHIATRY - READMITTING THE SOVIET-UNION	LANCET			English	Article																			0	2	2	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUL 30	1988	2	8605					268	269						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	P4528	11644351				2022-12-28	WOS:A1988P452800014
J	Bianco, P; Robey, PG				Bianco, P; Robey, PG			Stem cells in tissue engineering	NATURE			English	Article							MARROW STROMAL CELLS; GENE-THERAPY; IN-VITRO; BONE; TRANSPLANTATION; REGENERATION; EXPRESSION; REPAIR; VIVO; PROSPECTS	The concept of producing 'spare parts' of the body for replacement of damaged or lost organs lies at the core of the varied biotechnological practices referred to generally as tissue engineering. Use of postnatal stem cells has the potential to significantly alter the perspective of tissue engineering. Successful long-term restoration of continuously self-renewing tissues such as skin, for example, depends on the use of extensively self-renewing stem cells. The identification and isolation of stem cells from a number of tissues provides appropriate targets for prospective gene therapies.	Univ Roma La Sapienza, Dipartimento Med Sperimentale & Patol, I-00161 Rome, Italy; Natl Inst Dent & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD USA	Sapienza University Rome; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Bianco, P (corresponding author), Univ Roma La Sapienza, Dipartimento Med Sperimentale & Patol, I-00161 Rome, Italy.		Robey, Pamela Gehron/H-1429-2011	Robey, Pamela Gehron/0000-0002-5316-5576	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000649] Funding Source: NIH RePORTER; Telethon [E.1029] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Telethon(Fondazione Telethon)		Asahara T, 2000, GENE THER, V7, P451, DOI 10.1038/sj.gt.3301142; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Bjorklund A, 2000, NOVART FDN SYMP, V231, P7; Bonadio J, 2000, ADV DRUG DELIVER REV, V44, P185, DOI 10.1016/S0169-409X(00)00094-6; Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007; Dellambra E, 2000, HUM GENE THER, V11, P2283, DOI 10.1089/104303400750035825; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Hou Z, 1999, P NATL ACAD SCI USA, V96, P7294, DOI 10.1073/pnas.96.13.7294; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jen KY, 2000, STEM CELLS, V18, P307, DOI 10.1634/stemcells.18-5-307; Johnstone B, 1999, CLIN ORTHOP RELAT R, pS156, DOI 10.1097/00003086-199910001-00017; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kon E, 2000, J BIOMED MATER RES, V49, P328; Krebsbach PH, 1998, TRANSPLANTATION, V66, P1272, DOI 10.1097/00007890-199811270-00002; Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lagasse E, 2001, IMMUNITY, V14, P425, DOI 10.1016/S1074-7613(01)00123-6; Langstaff S, 1999, BIOMATERIALS, V20, P1727, DOI 10.1016/S0142-9612(99)00086-1; Lanzov VA, 1999, MOL GENET METAB, V68, P276, DOI 10.1006/mgme.1999.2910; Li JL, 2000, GENETICS, V156, P809; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Mankani MH, 2001, ARCH SURG-CHICAGO, V136, P263, DOI 10.1001/archsurg.136.3.263; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516; Ramiya VK, 2000, NAT MED, V6, P278; Ruszczak Z, 2000, DERMATOL SURG, V26, P219, DOI 10.1046/j.1524-4725.2000.09215.x; Stock UA, 2001, ANNU REV MED, V52, P443, DOI 10.1146/annurev.med.52.1.443; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212	42	735	799	4	148	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 01	2001	414	6859					118	121		10.1038/35102181	http://dx.doi.org/10.1038/35102181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689957				2022-12-28	WOS:000171898900056
J	McLaren, A				McLaren, A			Ethical and social considerations of stem cell research	NATURE			English	Editorial Material									Univ Cambridge, Wellcome CRC Inst, Cambridge CB2 1QR, England	University of Cambridge	McLaren, A (corresponding author), Univ Cambridge, Wellcome CRC Inst, Tennis Court Rd, Cambridge CB2 1QR, England.							Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lanzendorf SE, 2001, FERTIL STERIL, V76, P132, DOI 10.1016/S0015-0282(01)01825-8; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Robertson JA, 2001, NAT REV GENET, V2, P74, DOI 10.1038/35047594	6	126	135	0	43	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 01	2001	414	6859					129	131		10.1038/35102194	http://dx.doi.org/10.1038/35102194			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689959				2022-12-28	WOS:000171898900058
J	Cates, C				Cates, C			Extracts from "Clinical evidence" - Chronic asthma	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REGULAR INHALED SALBUTAMOL; LONG-TERM TREATMENT; TO-MODERATE ASTHMA; QUALITY-OF-LIFE; TRIAMCINOLONE ACETONIDE; BETA-AGONISTS; SALMETEROL; BUDESONIDE; ZAFIRLUKAST; BECLOMETHASONE		Manor View Practice, Bushey WD2 2NN, Herts, England		Cates, C (corresponding author), Manor View Practice, Bushey WD2 2NN, Herts, England.	chriscates@email.msn.com		Cates, Christopher/0000-0002-7056-9433				AHRENS RC, 1990, J ASTHMA, V27, P11, DOI 10.3109/02770909009073289; Barnes PJ, 1998, AM J RESP CRIT CARE, V157, pS1, DOI 10.1164/ajrccm.157.3.157315; Bernstein DI, 1998, J ALLERGY CLIN IMMUN, V101, P433, DOI 10.1016/S0091-6749(98)70349-5; Bleecker ER, 2000, J ALLERGY CLIN IMMUN, V105, P1123, DOI 10.1067/mai.2000.106043; Bronsky E, 1998, ANN ALLERG ASTHMA IM, V80, P295, DOI 10.1016/S1081-1206(10)62972-9; Busse WW, 1998, J ALLERGY CLIN IMMUN, V101, P457, DOI 10.1016/S0091-6749(98)70353-7; CASTLE W, 1993, BRIT MED J, V306, P1034, DOI 10.1136/bmj.306.6884.1034; CATES C, 2001, CLIN EVIDENCE, P1011; CHANYEUNG M, 1995, NEW ENGL J MED, V333, P107, DOI 10.1056/NEJM199507133330207; CHEUNG D, 1992, NEW ENGL J MED, V327, P1198, DOI 10.1056/NEJM199210223271703; COCKCROFT DW, 1993, LANCET, V342, P833, DOI 10.1016/0140-6736(93)92695-P; CRANE J, 1989, LANCET, V1, P917; Cumming RG, 1997, NEW ENGL J MED, V337, P8, DOI 10.1056/NEJM199707033370102; Dennis SM, 2000, LANCET, V355, P1675, DOI 10.1016/S0140-6736(00)02238-8; Drazen JM, 1996, NEW ENGL J MED, V335, P841, DOI 10.1056/NEJM199609193351202; DUCHARME FM, 2000, COCHRANE DATABASE SY; DUFF AL, 1992, PEDIATR CLIN N AM, V39, P1277; Eckerskorn U, 1987, Dev Ophthalmol, V15, P82; Fish JE, 1997, CLIN THER, V19, P675, DOI 10.1016/S0149-2918(97)80092-6; FitzGerald JM, 1999, J ALLERGY CLIN IMMUN, V103, P427, DOI 10.1016/S0091-6749(99)70467-7; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; HATOUM HT, 1994, ANN PHARMACOTHER, V28, P1285; Kaur B, 1998, BRIT MED J, V316, P118; Kemp J, 1999, ANN ALLERG ASTHMA IM, V82, P463, DOI 10.1016/S1081-1206(10)62722-6; Kemp JP, 1998, J ALLERGY CLIN IMMUN, V101, P188, DOI 10.1016/S0091-6749(98)70383-5; KERREBIJN KF, 1987, J ALLERGY CLIN IMMUN, V79, P653, DOI 10.1016/S0091-6749(87)80163-X; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; McFadden ER, 1999, J ALLERGY CLIN IMMUN, V104, P46, DOI 10.1016/S0091-6749(99)70112-0; *NAT HEART BLOOD L, 1997, NIH PUBL, P20; Nathan RA, 1998, J ALLERGY CLIN IMMUN, V102, P935, DOI 10.1016/S0091-6749(98)70331-8; Nathan RA, 1999, ANN ALLERG ASTHMA IM, V82, P521, DOI 10.1016/S1081-1206(10)63159-6; Nelson JA, 1998, NEW ENGL J MED, V339, P141, DOI 10.1056/NEJM199807163390301; O'Byrne P, 1996, CAN RESPIR J, V3, P169; OCONNOR BJ, 1992, NEW ENGL J MED, V327, P1204, DOI 10.1056/NEJM199210223271704; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Pearson MG, 1997, THORAX, V52, pS1; Ramsdell JW, 1998, ANN ALLERG ASTHMA IM, V80, P385, DOI 10.1016/S1081-1206(10)62988-2; Roy A, 1996, EUR RESPIR J, V9, P226, DOI 10.1183/09031936.96.09020226; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; Shrewsbury S, 2000, BMJ-BRIT MED J, V320, P1368, DOI 10.1136/bmj.320.7246.1368; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; Suissa S, 1997, ANN INTERN MED, V126, P177, DOI 10.7326/0003-4819-126-3-199702010-00001; TOOGOOD JH, 1980, J ALLERGY CLIN IMMUN, V65, P145, DOI 10.1016/0091-6749(80)90200-6; TOOGOOD JH, 1993, J ALLERGY CLIN IMMUN, V91, P571, DOI 10.1016/0091-6749(93)90263-F; WEUSTEN BLAM, 1993, SEMIN ARTHRITIS RHEU, V23, P183, DOI 10.1016/S0049-0172(05)80039-3; Woolcock AJ, 1997, CIBA F SYMP, V206, P122	46	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2001	323	7319					976	979		10.1136/bmj.323.7319.976	http://dx.doi.org/10.1136/bmj.323.7319.976			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488CU	11679388	Green Published			2022-12-28	WOS:000171918500019
J	Glaser, P; Frangeul, L; Buchrieser, C; Rusniok, C; Amend, A; Baquero, F; Berche, P; Bloecker, H; Brandt, P; Chakraborty, T; Charbit, A; Chetouani, F; Couve, E; de Daruvar, A; Dehoux, P; Domann, E; Dominguez-Bernal, G; Duchaud, E; Durant, L; Dussurget, O; Entian, KD; Fsihi, H; Garcia-Del Portillo, F; Garrido, P; Gautier, L; Goebel, W; Gomez-Lopez, N; Hain, T; Hauf, J; Jackson, D; Jones, LM; Kaerst, U; Kreft, J; Kuhn, M; Kunst, F; Kurapkat, G; Madueno, E; Maitournam, A; Vicente, JM; Ng, E; Nedjari, H; Nordsiek, G; Novella, S; de Pablos, B; Perez-Diaz, JC; Purcell, R; Remmel, B; Rose, M; Schlueter, T; Simoes, N; Tierrez, A; Vazquez-Boland, JA; Voss, H; Wehland, J; Cossart, P				Glaser, P; Frangeul, L; Buchrieser, C; Rusniok, C; Amend, A; Baquero, F; Berche, P; Bloecker, H; Brandt, P; Chakraborty, T; Charbit, A; Chetouani, F; Couve, E; de Daruvar, A; Dehoux, P; Domann, E; Dominguez-Bernal, G; Duchaud, E; Durant, L; Dussurget, O; Entian, KD; Fsihi, H; Garcia-Del Portillo, F; Garrido, P; Gautier, L; Goebel, W; Gomez-Lopez, N; Hain, T; Hauf, J; Jackson, D; Jones, LM; Kaerst, U; Kreft, J; Kuhn, M; Kunst, F; Kurapkat, G; Madueno, E; Maitournam, A; Vicente, JM; Ng, E; Nedjari, H; Nordsiek, G; Novella, S; de Pablos, B; Perez-Diaz, JC; Purcell, R; Remmel, B; Rose, M; Schlueter, T; Simoes, N; Tierrez, A; Vazquez-Boland, JA; Voss, H; Wehland, J; Cossart, P			Comparative genomics of Listeria species	SCIENCE			English	Article							VIRULENCE GENE; MONOCYTOGENES; SEQUENCE; SURFACE; PROTEIN; STRAIN; INIB	Listeria monocytogenes is a food-borne pathogen with a high mortality rate that has also emerged as a paradigm for intraceitular parasitism. We present and compare the genome sequences of L. monocytogenes (2,944,528 base pairs) and a nonpathogenic species, L. innocua (3,011,209 base pairs). We found a large number of predicted genes encoding surface and secreted proteins, transporters, and transcriptional regulators, consistent with the ability of both species to adapt to diverse environments. The presence of 270 L. monocytogenes and 149 L. innocua strain-specific genes (clustered in 100 and 63 islets, respectively) suggests that virulence in Listeria results from multiple gene acquisition and deletion events.	Inst Pasteur, Unite Interact Bacteries Cellules, F-75724 Paris, France; Inst Pasteur, Serv Informat Sci, F-75724 Paris, France; Inst Med Microbiol, D-35392 Giessen, Germany; Hosp Ramon & Cajal, Microbiol Serv, E-28034 Madrid, Spain; Fac Med Necker Enfants Malad, INSERM, U411, F-75730 Paris, France; Gesell Biotechnol Forsch mbH, Dept Cell Biol & Immunol, D-38124 Braunschweig, Germany; LION Biosci AG, D-69120 Heidelberg, Germany; Univ Complutense, Fac Vet, Dept Patol Anim 1, Grp Patogenesis Mol Bacteriana, E-28040 Madrid, Spain; Sci Res & Dev GmbH, D-61440 Oberursel, Germany; Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; Univ Wurzburg, Lehrstuhl Mikrobiol, Biozentrum, TB1, D-97074 Wurzburg, Germany	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Hospital Universitario Ramon y Cajal; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Gesellschaft fur Biotechnologische Forschung mbH; Complutense University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of Wurzburg	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, 25-28 Rue Dr Roux, F-75724 Paris, France.	pcossart@pasteur.fr	Gautier, Laurent/F-9849-2012; FSIHI, Hafida/H-9852-2014; Entian, Karl-Dieter/D-3080-2011; Frangeul, Lionel/G-3617-2015; Kuhn, Michael/M-5207-2013; Novella, Susana/A-7406-2017; García-del Portillo, Francisco/D-2576-2009; Glaser, Philippe/O-2641-2015	Novella, Susana/0000-0001-8303-7252; Glaser, Philippe/0000-0003-4156-2782; Schlueter, Thomas/0000-0001-5829-9381; Dominguez-Bernal, Gustavo/0000-0002-7693-653X; Buchrieser, Carmen/0000-0003-3477-9190; charbit, alain/0000-0001-5243-4861; Jones, Louis/0000-0002-3080-9770; Purcell, Rachel/0000-0002-2684-4530; Garcia-del Portillo, Francisco/0000-0002-4120-0530; Vazquez-Boland, Jose A/0000-0003-4521-5972; Lionel, Frangeul/0000-0002-0992-8775				Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Braun L, 1997, MOL MICROBIOL, V25, P285, DOI 10.1046/j.1365-2958.1997.4621825.x; Brehm K, 1999, J BACTERIOL, V181, P5024, DOI 10.1128/JB.181.16.5024-5032.1999; Chakraborty T, 2000, INT J MED MICROBIOL, V290, P167; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cossart P, 1998, EMBO J, V17, P3797, DOI 10.1093/emboj/17.14.3797; DOMANN E, 1992, EMBO J, V11, P1981, DOI 10.1002/j.1460-2075.1992.tb05252.x; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; GOEBEL W, 2000, GRAM POSITIVE PATHOG, V1, P439; Jonquieres R, 1999, MOL MICROBIOL, V34, P902, DOI 10.1046/j.1365-2958.1999.01652.x; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; KREFT J, 2001, INT J MED MICROBIOL, V2, P291; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; MACKANESS GB, 1964, J EXP MED, V120, P105, DOI 10.1084/jem.120.1.105; Nair S, 2000, MOL MICROBIOL, V35, P800, DOI 10.1046/j.1365-2958.2000.01752.x; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; PREMARATNE RJ, APPL ENV MICROBIOL, V57, P3046; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001	25	1126	2096	5	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					849	852						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679669				2022-12-28	WOS:000171851800046
J	Schon, JH; Kloc, C; Siegrist, T; Steigerwald, M; Svensson, C; Batlogg, B				Schon, JH; Kloc, C; Siegrist, T; Steigerwald, M; Svensson, C; Batlogg, B			RETRACTED: Superconductivity in single crystals of the fullerene C-70 (Retracted article. See vol 422 pg 92 2003)	NATURE			English	Article; Retracted Publication							X-RAY-DIFFRACTION; TRANSPORT-PROPERTIES; C-36; C60	The observation of superconductivity in doped C-60 has attracted much attention(1-3), as these materials represent an entirely new class of superconductors. A maximum transition temperature (Tc) of 40 K has been reported(4) for electron-doped C-60 crystals, while a Tc of 52 K has been seen 5 in hole-doped crystals; only the copper oxide superconductors have higher transition temperatures. The results for C-60 raise the intriguing questions of whether conventional electron-phonon coupling alone(1) can produce such high transition temperatures, and whether even higher transition temperatures might be observed in other fullerenes(6-8). There have, however, been no conrrmed reports of superconductivity in other fullerenes, though it has recently been observed in carbon nanotubes(9). Here we report the observation of superconductivity in single crystals of electric-field-doped C-70. The maximum transition temperature of about 7 K is achieved when the sample is doped to approximately four electrons per C-70 molecule, which corresponds to a half-filled conduction band. We anticipate superconductivity in smaller fullerenes at temperatures even higher than in C-60 if the right charge density can be induced.	Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; Univ Konstanz, Dept Phys, D-78457 Constance, Germany; Agere Syst, Murray Hill, NJ 07974 USA; Lund Univ, S-22100 Lund, Sweden; Swiss Fed Inst Technol, Solid State Phys Lab, CH-8093 Zurich, Switzerland	Alcatel-Lucent; Lucent Technologies; AT&T; University of Konstanz; Broadcom; LSI Corporation; Lund University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Batlogg, B (corresponding author), Bell Labs, Lucent Technol, 600 Mt Ave, Murray Hill, NJ 07974 USA.	batlogg@solid.phys.ethz.ch	Kloc, Christian/A-2255-2011; Siegrist, Theo/R-3855-2019	Siegrist, Theo/0000-0001-5368-1442				Blanc E, 1996, EUROPHYS LETT, V33, P205, DOI 10.1209/epl/i1996-00322-3; BLANC E, 1994, EUROPHYS LETT, V27, P359, DOI 10.1209/0295-5075/27/5/005; BURGI HB, 1992, ANGEW CHEM INT EDIT, V31, P640, DOI 10.1002/anie.199206401; Chen XH, 2000, J AM CHEM SOC, V122, P5729, DOI 10.1021/ja993881m; Cohen ML, 1999, AIP CONF PROC, V483, P359, DOI 10.1063/1.59602; Devos A, 1998, PHYS REV B, V58, P8236, DOI 10.1103/PhysRevB.58.8236; GOLDEN MS, 1995, J PHYS-CONDENS MAT, V7, P8219, DOI 10.1088/0953-8984/7/43/004; Gunnarsson O, 1997, REV MOD PHYS, V69, P575, DOI 10.1103/RevModPhys.69.575; HADDON RC, 1991, NATURE, V350, P320, DOI 10.1038/350320a0; HEBARD AF, 1991, NATURE, V350, P600, DOI 10.1038/350600a0; HOSOYA M, 1994, PHYS REV B, V49, P4981, DOI 10.1103/PhysRevB.49.4981; KOBAYASHI M, 1993, PHYS REV B, V48, P16877, DOI 10.1103/PhysRevB.48.16877; Ohno K, 1996, CHEM PHYS LETT, V255, P367, DOI 10.1016/0009-2614(96)00389-2; PALSTRA TTM, 1995, SOLID STATE COMMUN, V93, P327, DOI 10.1016/0038-1098(94)00786-1; Piskoti C, 1998, NATURE, V393, P771, DOI 10.1038/31668; Ramirez A. P., 1994, Superconductivity Review, V1, P1; SAITO S, 1991, PHYS REV B, V44, P11532, DOI 10.1103/PhysRevB.44.11532; SCHLUTER M, 1992, PHYS REV LETT, V68, P526, DOI 10.1103/PhysRevLett.68.526; Schon JH, 2000, NATURE, V408, P549, DOI 10.1038/35046008; Schon JH, 2000, NATURE, V406, P702, DOI 10.1038/35021011; Schon JH, 2000, SCIENCE, V288, P656, DOI 10.1126/science.288.5466.656; Schon JH, 2001, NATURE, V410, P189, DOI 10.1038/35065565; TAKAHASHI T, 1992, PHYSICA C, V190, P205, DOI 10.1016/0921-4534(92)90596-5; Tang ZK, 2001, SCIENCE, V292, P2462, DOI 10.1126/science.1060470; WANG ZH, 1993, PHYS REV B, V48, P10657, DOI 10.1103/PhysRevB.48.10657; WANG ZH, 1994, PHYS REV B, V49, P15890, DOI 10.1103/PhysRevB.49.15890	26	32	34	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2001	413	6858					831	833		10.1038/35101577	http://dx.doi.org/10.1038/35101577			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677603				2022-12-28	WOS:000171750200042
J	Viscoli, CM; Brass, LM; Kernan, WN; Sarrel, PM; Suissa, S; Horwitz, RI				Viscoli, CM; Brass, LM; Kernan, WN; Sarrel, PM; Suissa, S; Horwitz, RI			A clinical trial of estrogen-replacement therapy after ischemic stroke.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; POSTMENOPAUSAL ESTROGEN; MYOCARDIAL-INFARCTION; FOLLOW-UP; RISK; PROGESTIN; USERS; PREVENTION; HORMONES; COHORT	Background: Observational studies have suggested that estrogen-replacement therapy may reduce a woman's risk of stroke and death. Methods: We conducted a randomized, double-blind, placebo-controlled trial of estrogen therapy (1 mg of estradiol-17 beta per day) in 664 postmenopausal women (mean age, 71 years) who had recently had an ischemic stroke or transient ischemic attack. Women were recruited from 21 hospitals in the United States and were followed for the occurrence of stroke or death. Results: During a mean follow-up period of 2.8 years, there were 99 strokes or deaths among the women in the estradiol group, and 93 among those in the placebo group (relative risk in the estradiol group, 1.1; 95 percent confidence interval, 0.8 to 1.4). Estrogen therapy did not reduce the risk of death alone (relative risk, 1.2; 95 percent confidence interval, 0.8 to 1.8) or the risk of nonfatal stroke (relative risk, 1.0; 95 percent confidence interval, 0.7 to 1.4). The women who were randomly assigned to receive estrogen therapy had a higher risk of fatal stroke (relative risk, 2.9; 95 percent confidence interval, 0.9 to 9.0), and their nonfatal strokes were associated with slightly worse neurologic and functional deficits. Conclusions: Estradiol does not reduce mortality or the recurrence of stroke in postmenopausal women with cerebrovascular disease. This therapy should not be prescribed for the secondary prevention of cerebrovascular disease.	Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT 06510 USA; Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; McGill Univ, Dept Med, Montreal, PQ, Canada	Yale University; Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; McGill University; McGill University	Viscoli, CM (corresponding author), Yale Univ, Sch Med, Dept Med, 333 Cedar St,Rm 1072 LMP,POB 208056, New Haven, CT 06520 USA.				PHS HHS [1-RO1-N531251] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 1995, JAMA-J AM MED ASSOC, V274, P1676; BARRETTCONNOR E, 1991, ANN INTERN MED, V115, P455, DOI 10.7326/0003-4819-115-6-455; Berman RS, 1996, J WOMENS HLTH, V5, P213, DOI [10.1089/jwh.1996.5.213, DOI 10.1089/JWH.1996.5.213]; BOYSEN G, 1988, STROKE, V19, P1345, DOI 10.1161/01.STR.19.11.1345; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; CASAGRANDE JT, 1978, BIOMETRICS, V34, P483, DOI 10.2307/2530613; COX DR, 1972, J R STAT SOC B, V34, P187; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; Daly E, 1996, LANCET, V348, P977, DOI 10.1016/S0140-6736(96)07113-9; FALKEBORN M, 1993, ARCH INTERN MED, V153, P1201, DOI 10.1001/archinte.153.10.1201; FINUCANE FF, 1993, ARCH INTERN MED, V153, P73, DOI 10.1001/archinte.153.1.73; GEBARA OCE, 1995, CIRCULATION, V91, P1952, DOI 10.1161/01.CIR.91.7.1952; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; HUNT K, 1990, BRIT J OBSTET GYNAEC, V97, P1080, DOI 10.1111/j.1471-0528.1990.tb02494.x; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karanjia PN, 1997, NEUROLOGY, V48, P346, DOI 10.1212/WNL.48.2.346; Kernan W N, 1998, J Stroke Cerebrovasc Dis, V7, P85, DOI 10.1016/S1052-3057(98)80026-8; KERNAN WN, 1991, ANN INTERN MED, V114, P552, DOI 10.7326/0003-4819-114-7-552; KNATTERUD G, 1988, JAMA-J AM MED ASSOC, V260, P2849; Koh KK, 1997, NEW ENGL J MED, V336, P683, DOI 10.1056/NEJM199703063361002; LIEBERMAN EH, 1994, ANN INTERN MED, V121, P936, DOI 10.7326/0003-4819-121-12-199412150-00005; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; MOHONEY FI, 1965, MD STATE MED J, P61; Murphy DD, 1998, J NEUROSCI, V18, P2550; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; PADWICK ML, 1986, NEW ENGL J MED, V315, P930, DOI 10.1056/NEJM198610093151504; PAGANINIHILL A, 1988, BMJ-BRIT MED J, V297, P519, DOI 10.1136/bmj.297.6647.519; Pedersen AT, 1997, LANCET, V350, P1277, DOI 10.1016/S0140-6736(97)06005-4; PETITTI DB, 1979, JAMA-J AM MED ASSOC, V242, P1150, DOI 10.1001/jama.242.11.1150; Petitti DB, 1998, STROKE, V29, P23, DOI 10.1161/01.STR.29.1.23; PFEFFER RI, 1978, J CHRON DIS, V31, P389, DOI 10.1016/0021-9681(78)90003-6; PFEFFER RI, 1976, AM J EPIDEMIOL, V103, P445, DOI 10.1093/oxfordjournals.aje.a112246; RAVNIKAR VA, 1987, AM J OBSTET GYNECOL, V156, P1332, DOI 10.1016/0002-9378(87)90173-6; ROSENBERG SH, 1980, WESTERN J MED, V133, P292; SARREL PM, 1990, MATURITAS, V12, P287, DOI 10.1016/0378-5122(90)90008-T; Simon JA, 2001, CIRCULATION, V103, P638, DOI 10.1161/01.cir.103.5.638; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; THOMPSON SG, 1989, J EPIDEMIOL COMMUN H, V43, P173, DOI 10.1136/jech.43.2.173; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; van Baal WM, 1999, THROMB HAEMOSTASIS, V81, P925, DOI 10.1055/s-0037-1614600; WHISNANT JP, 1990, STROKE, V21, P707, DOI 10.1161/01.STR.21.5.707; WILSON PWF, 1985, NEW ENGL J MED, V313, P1038, DOI 10.1056/NEJM198510243131702	45	651	667	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2001	345	17					1243	1249		10.1056/NEJMoa010534	http://dx.doi.org/10.1056/NEJMoa010534			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485RU	11680444				2022-12-28	WOS:000171773100004
J	Porse, BT; Pedersen, TA; Xu, XF; Lindberg, B; Wewer, UM; Friis-Hansen, L; Nerlov, C				Porse, BT; Pedersen, TA; Xu, XF; Lindberg, B; Wewer, UM; Friis-Hansen, L; Nerlov, C			E2F repression by C/EBP alpha is required for adipogenesis and granulopoiesis in vivo	CELL			English	Article							BINDING-PROTEIN-ALPHA; CELL-PROLIFERATION; S-PHASE; RETINOBLASTOMA PROTEIN; LINEAGE COMMITMENT; ADIPOSE CONVERSION; PROGENITOR CELLS; GENE-EXPRESSION; NEWBORN MICE; DIFFERENTIATION	The C/EBP alpha transcription factor is required for differentiation of adipocytes and neutrophil granulocytes, and controls cellular proliferation in vivo. To address the molecular mechanisms of C/EBP alpha action, we have identified C/EBP alpha mutants defective in repression of E2F-dependent transcription and found them to be impaired in their ability to suppress cellular proliferation, and to induce adipocyte differentiation in vitro. Using targeted mutagenesis of the mouse germline, we show that E2F repression-deficient C/EBP alpha alleles failed to support adipocyte and granulocyte differentiation in vivo. These results indicate that E2F repression by C/EBP alpha is critical for its ability to induce terminal differentiation, and thus provide genetic evidence that direct cell cycle control by a mammalian lineageinstructive transcription factor couples cellular growth arrest and differentiation.	Univ Copenhagen Hosp, Lab Gene Therapy Res, DK-2100 Copenhagen O, Denmark; Univ Copenhagen Hosp, Inst Pathol, DK-2100 Copenhagen, Denmark; Univ Copenhagen Hosp, Dept Clin Biochem, DK-2100 Copenhagen O, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Nerlov, C (corresponding author), Univ Copenhagen Hosp, Lab Gene Therapy Res, DK-2100 Copenhagen O, Denmark.		Porse, Bo/B-1332-2012	Porse, Bo/0000-0001-6043-0844; Friis-Hansen, Lennart/0000-0002-7222-0163				Bergh G, 1999, BLOOD, V94, P1971; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Crosson SM, 2000, J BIOL CHEM, V275, P5804, DOI 10.1074/jbc.275.8.5804; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dicker AJ, 2000, ONCOGENE, V19, P2887, DOI 10.1038/sj.onc.1203610; Flodby P, 1996, J BIOL CHEM, V271, P24753, DOI 10.1074/jbc.271.40.24753; HANAUER A, 1984, EMBO J, V3, P2627, DOI 10.1002/j.1460-2075.1984.tb02185.x; HENDRICKSTAYLOR LR, 1995, NUCLEIC ACIDS RES, V23, P4726, DOI 10.1093/nar/23.22.4726; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Johansen LM, 2001, MOL CELL BIOL, V21, P3789, DOI 10.1128/MCB.21.11.3789-3806.2001; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533; McNagny KM, 1998, EMBO J, V17, P3669, DOI 10.1093/emboj/17.13.3669; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Mori A, 1999, ONCOGENE, V18, P6209, DOI 10.1038/sj.onc.1203044; Muller C, 1999, P NATL ACAD SCI USA, V96, P7276, DOI 10.1073/pnas.96.13.7276; NERLOV C, 1994, GENE DEV, V8, P350, DOI 10.1101/gad.8.3.350; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Park JS, 2000, MOL BIOL CELL, V11, P2915, DOI 10.1091/mbc.11.9.2915; Querfurth E, 2000, GENE DEV, V14, P2515, DOI 10.1101/gad.177200; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Slomiany BA, 2000, MOL CELL BIOL, V20, P5986, DOI 10.1128/MCB.20.16.5986-5997.2000; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P3621, DOI 10.1093/nar/27.17.3621; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; Timchenko NA, 1999, MOL CELL BIOL, V19, P2936; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Vigo E, 1999, MOL CELL BIOL, V19, P6379; WANG J, 1995, CELL GROWTH DIFFER, V6, P1299; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	40	277	283	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					247	258		10.1016/S0092-8674(01)00516-5	http://dx.doi.org/10.1016/S0092-8674(01)00516-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672531	Bronze			2022-12-28	WOS:000171694800013
J	Wang, Q; Zhang, PZ; Freymueller, JT; Bilham, R; Larson, KM; Lai, X; You, XZ; Niu, ZJ; Wu, JC; Li, YX; Liu, JN; Yang, ZQ; Chen, QZ				Wang, Q; Zhang, PZ; Freymueller, JT; Bilham, R; Larson, KM; Lai, X; You, XZ; Niu, ZJ; Wu, JC; Li, YX; Liu, JN; Yang, ZQ; Chen, QZ			Present-day crustal deformation in China constrained by global positioning system measurements	SCIENCE			English	Article							ACTIVE DEFORMATION; GPS; VELOCITY; SLIP; ASIA; MOTION; RATES; FIELD	Global Positioning System (GPS) measurements in China indicate that crustal shortening accommodates most of India's penetration into Eurasia. Deformation within the Tibetan Plateau and its margins, the Himalaya, the Altyn Tagh, and the Qilian Shan, absorbs more than 90% of the relative motion between the Indian and Eurasian plates. Internal shortening of the Tibetan plateau itself accounts for more than one-third of the total convergence. However, the Tibetan plateau south of the Kunlun and Ganzi-Mani faults is moving eastward relative to both India and Eurasia. This movement is accommodated through rotation of material around the eastern Syntaxis. The North China and South China blocks, east of the Tibetan Plateau, move coherently east-southeastward at rates of 2 to 8 millimeters per year and 6 to 11 millimeters per year, respectively, with respect to the stable Eurasia.	China Seismol Bur, Ctr Crustal Movement Studies, Beijing 100029, Peoples R China; China Seismol Bur, Inst Seismol, Wuhan 430071, Peoples R China; China Seismol Bur, Inst Geol, Beijing 100029, Peoples R China; Univ Alaska, Inst Geophys, Fairbanks, AK 99775 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; Univ Colorado, CIRES, Boulder, CO 80309 USA; Univ Colorado, Dept Aerosp Engn Sci, Boulder, CO 80309 USA; China Seismol Bur, Crustal Deformat Monitoring Ctr 1, Tianjin 300180, Peoples R China; Wuhan Univ, Sch Geodesy & Geomat, Wuhan 430071, Peoples R China; Changan Univ, Dept Surveying Engn, Xian 710064, Peoples R China	China Earthquake Administration; China Earthquake Administration; China Earthquake Administration; University of Alaska System; University of Alaska Fairbanks; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; China Earthquake Administration; Wuhan University; Chang'an University	Zhang, PZ (corresponding author), China Seismol Bur, Ctr Crustal Movement Studies, Beijing 100029, Peoples R China.	peizhen@public3.bta.net.cn	Larson, Kristine M/J-7623-2018	Larson, Kristine M/0000-0003-4666-8885; Freymueller, Jeffrey/0000-0003-0614-0306; Bilham, Roger/0000-0002-5547-4102				Abdrakhmatov KY, 1996, NATURE, V384, P450, DOI 10.1038/384450a0; Amijo R, 1986, J GEOPHYS RES, V91, P13803; ARMIJO R, 1989, J GEOPHYS RES-SOLID, V94, P2787, DOI 10.1029/JB094iB03p02787; AVOUAC JP, 1993, GEOPHYS RES LETT, V20, P895, DOI 10.1029/93GL00128; Bendick R, 2000, NATURE, V404, P69, DOI 10.1038/35003555; Bilham R, 1997, NATURE, V386, P61, DOI 10.1038/386061a0; Calais E, 1998, GEOPHYS RES LETT, V25, P4003, DOI 10.1029/1998GL900067; Chen Z, 2000, J GEOPHYS RES-SOL EA, V105, P16215, DOI 10.1029/2000JB900092; DEMETS C, 1990, GEOPHYS J INT, V101, P425, DOI 10.1111/j.1365-246X.1990.tb06579.x; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; England P, 1997, GEOPHYS J INT, V130, P551, DOI 10.1111/j.1365-246X.1997.tb01853.x; GORDON RG, 1999, EOS T AGU S, V80, pF273; HEFLIN M, 1992, GEOPHYS RES LETT, V19, P131, DOI 10.1029/91GL02933; Holt WE, 2000, J GEOPHYS RES-SOL EA, V105, P19185, DOI 10.1029/2000JB900045; HOUSEMAN G, 1986, J GEOPHYS RES-SOLID, V91, P3651, DOI 10.1029/JB091iB03p03651; King RW, 1997, GEOLOGY, V25, P179, DOI 10.1130/0091-7613(1997)025<0179:GMOCMI>2.3.CO;2; Larson KM, 1999, J GEOPHYS RES-SOL EA, V104, P1077, DOI 10.1029/1998JB900043; Larson KM, 1997, J GEOPHYS RES-SOL EA, V102, P9961, DOI 10.1029/97JB00514; LICHTEN SM, 1987, J GEOPHYS RES-SOLID, V92, P12751, DOI 10.1029/JB092iB12p12751; Molnar P, 1996, J GEOPHYS RES-SOL EA, V101, P545, DOI 10.1029/95JB02503; MOLNAR P, 1975, SCIENCE, V189, P419, DOI 10.1126/science.189.4201.419; MOLNAR P, 1984, J GEOPHYS RES, V89, P6203, DOI 10.1029/JB089iB07p06203; Paul J, 2001, GEOPHYS RES LETT, V28, P647, DOI 10.1029/2000GL011832; PELTZER G, 1988, J GEOPHYS RES-SOLID, V93, P15085, DOI 10.1029/JB093iB12p15085; Shen ZK, 2000, J GEOPHYS RES-SOL EA, V105, P5721, DOI 10.1029/1999JB900391; Sillard P, 1998, GEOPHYS RES LETT, V25, P3223, DOI 10.1029/98GL52489; Van der Woerd J, 1998, GEOLOGY, V26, P695, DOI 10.1130/0091-7613(1998)026<0695:HLSRDB>2.3.CO;2; Wang Q, 2001, SCI CHINA SER D, V31, P529; Zhang P.Z., 1996, EARTHQUAKE RES CHINA, V12, P127, DOI DOI 10.1007/BF02974893; ZHU WY, 1997, SCI CHINA SER D, V27, P385; Zumberge JF, 1997, J GEOPHYS RES-SOL EA, V102, P5005, DOI 10.1029/96JB03860	31	898	1207	6	243	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					574	577		10.1126/science.1063647	http://dx.doi.org/10.1126/science.1063647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641493				2022-12-28	WOS:000171695600041
J	Taylor, CM				Taylor, CM			Complement factor H and the haemolytic uraemic syndrome	LANCET			English	Editorial Material							MUTATIONS; PROTECTS; CELLS		Birmingham Childrens Hosp, Dept Nephrol, Birmingham B4 6NH, W Midlands, England	University of Birmingham	Taylor, CM (corresponding author), Birmingham Childrens Hosp, Dept Nephrol, Birmingham B4 6NH, W Midlands, England.	cm.taylor@bhamchildrens.wmids.nhs.uk						Aslam M, 2001, J MOL BIOL, V309, P1117, DOI 10.1006/jmbi.2001.4720; Ault BH, 2000, PEDIATR NEPHROL, V14, P1045, DOI 10.1007/s004670050069; Buddles MRH, 2000, AM J HUM GENET, V66, P1721, DOI 10.1086/302877; Caprioli J, 2001, J AM SOC NEPHROL, V12, P297, DOI 10.1681/ASN.V122297; Fitzpatrick MM, 1992, HEMOLYTIC UREMIC SYN, P163; Gershov D, 2000, J EXP MED, V192, P1353, DOI 10.1084/jem.192.9.1353; Hindmarsh EJ, 1998, J IMMUNOL, V160, P6128; Jokiranta TS, 2000, J BIOL CHEM, V275, P27657; Landau D, 2001, J PEDIATR-US, V138, P412, DOI 10.1067/mpd.2001.112649; Nangaku M, 1998, J AM SOC NEPHROL, V9, P590; Noris M, 1999, J AM SOC NEPHROL, V10, P281; Pangburn MK, 2000, J IMMUNOL, V164, P4742, DOI 10.4049/jimmunol.164.9.4742; Perez-Caballero D, 2001, AM J HUM GENET, V68, P478, DOI 10.1086/318201; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; Taylor CM, 2001, SEMIN THROMB HEMOST, V27, P185, DOI 10.1055/s-2001-15247; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1111/j.1523-1755.1998.00824.x; Ying LH, 1999, AM J HUM GENET, V65, P1538, DOI 10.1086/302673; Zipfel PF, 2001, SEMIN THROMB HEMOST, V27, P191, DOI 10.1055/s-2001-15248	18	48	49	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2001	358	9289					1200	1202		10.1016/S0140-6736(01)06339-5	http://dx.doi.org/10.1016/S0140-6736(01)06339-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675053				2022-12-28	WOS:000171527000005
J	Suzuki, D				Suzuki, D			A personal journey through genetics and civil rights	SCIENCE			English	Editorial Material									Univ British Columbia, Sustainable Dev Res Inst, Vancouver, BC V6K 4S2, Canada	University of British Columbia	Suzuki, D (corresponding author), Univ British Columbia, Sustainable Dev Res Inst, Vancouver, BC V6K 4S2, Canada.								0	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 18	1998	281	5384					1796	1797		10.1126/science.281.5384.1796	http://dx.doi.org/10.1126/science.281.5384.1796			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121HK	11645101				2022-12-28	WOS:000076007100019
J	Buck, G				Buck, G			An open letter to Dr Seed	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 1	1998	279	13					977	977						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD283	11655212				2022-12-28	WOS:000072669700001
J	HOWARD, R				HOWARD, R			MEMORABLE PATIENTS - INSIGHT AND HONESTY	BRITISH MEDICAL JOURNAL			English	Editorial Material														Howard, Robert/0000-0002-3071-2338					0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAR 20	1993	306	6880					764	764		10.1136/bmj.306.6880.764	http://dx.doi.org/10.1136/bmj.306.6880.764			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU173	11643118	Green Published, Bronze			2022-12-28	WOS:A1993KU17300027
J	Koffman, J				Koffman, J			There must be a better way	BRITISH MEDICAL JOURNAL			English	Editorial Material														Koffman, Jonathan/0000-0001-8513-5681					0	2	2	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 27	1998	316	7149					1989	1990		10.1136/bmj.316.7149.1989a	http://dx.doi.org/10.1136/bmj.316.7149.1989a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZY568	11682719				2022-12-28	WOS:000074636700086
J	Boettcher, B				Boettcher, B			Fatal episodes in medical history	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	DEC 5	1998	317	7172					1603	1603						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146VC	9836691				2022-12-28	WOS:000077451700090
J	AOUN, H				AOUN, H			FROM THE EYE OF THE STORM, WITH THE EYES OF A PHYSICIAN	ANNALS OF INTERNAL MEDICINE			English	Note						ACQUIRED IMMUNODEFICIENCY SYNDROME; PHYSICIAN-PATIENT RELATIONS; EDUCATION, MEDICAL; SOCIAL SUPPORT; ETHICS, MEDICAL		A physician acquires a terrible disease and, as a patient, is confronted with aspects of medical care that contribute to the suffering rather than the healing. As a result of these experiences, his views on what constitutes a good physician become simpler. A good physician cares for his patients and works toward preserving their dignity and independence. The issue is raised of whether current medical education can be effective in producing that caring physician, for it is particularly in caring for patients with catastrophic or incurable illnesses that the role of the physician is more, not less, important.										AOUN H, 1989, NEW ENGL J MED, V321, P693, DOI 10.1056/NEJM198909073211020; AOUN H, 1991, NEW ENGL J MED, V324, P265, DOI 10.1056/NEJM199101243240412; Harrison TR, 1950, PRINCIPLES INTERNAL; NATELSON BH, 1990, TOMORROWS DOCTORS PA; Peabody FW, 1927, J AMER MED ASSOC, V88, P0877, DOI 10.1001/jama.1927.02680380001001; RABIN D, 1982, NEW ENGL J MED, V307, P506, DOI 10.1056/NEJM198208193070827; RABIN R, 1985, 6 PARTS LOVE ONE FAM; TOSTESON DC, 1990, NEW ENGL J MED, V322, P234, DOI 10.1056/NEJM199001253220405	8	23	23	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	1992	116	4					335	338		10.7326/0003-4819-116-4-335	http://dx.doi.org/10.7326/0003-4819-116-4-335			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HD546	11651175				2022-12-28	WOS:A1992HD54600012
J	Venn-Treloar, J				Venn-Treloar, J			Nuchal translucency - screening without consent	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	16	16	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 28	1998	316	7136					1027	1027						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZF034	11645042				2022-12-28	WOS:000072856100081
